0001193125-23-272454.txt : 20231107 0001193125-23-272454.hdr.sgml : 20231107 20231107162032 ACCESSION NUMBER: 0001193125-23-272454 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 87 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231107 DATE AS OF CHANGE: 20231107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SLR Investment Corp. CENTRAL INDEX KEY: 0001418076 IRS NUMBER: 261381340 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 814-00754 FILM NUMBER: 231384244 BUSINESS ADDRESS: STREET 1: 500 PARK AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 993-1670 MAIL ADDRESS: STREET 1: 500 PARK AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Solar Capital Ltd. DATE OF NAME CHANGE: 20071109 10-Q 1 d458881d10q.htm 10-Q 10-Q
falseQ30001418076--12-31NYhttp://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestmentshttp://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestmentsAmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows:Investment is on non-accrual status.Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2023 in these controlled investments are as follows:Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2023, on a fair value basis, non-qualifying assets in the portfolio represented 25.1% of the total assets of the Company.OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.Indicates an investment that is wholly held by the Company through NEFPASS LLC.Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of September 30, 2023.The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows:Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 24.2% of the total assets of the Company.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.Spread is 1.00% Cash / 6.00% PIK.Interest is paid in kind (“PIK”).iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.Denotes a subsidiary of SLR Equipment Finance.In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK.Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022.The Company became an Affiliated Person to Bayside Opco, LLC and Bayside Parent, LLC on May 31, 2023 and to Amerimark Intermediate Holdings, LLC and SLR- AMI Topco Blocker, LLC on June 16, 2023.Non-income producing security.SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.See note 10 to the consolidated financial statements.Denotes a Level 1 investment.Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.See note 11 to the consolidated financial statements.Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.See note 13 to the consolidated financial statements.See note 9 to the consolidated financial statements.See note 12 to the consolidated financial statements.See note 17 to the consolidated financial statements.Spread is 5.75% Cash / 0.50% PIK.BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK.Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.The Company also holds this security on its Consolidated Statements of Assets and Liabilities.Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2023, asset coverage was 182.3%.The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.Aggregate net unrealized appreciation for U.S. federal income tax purposes is $31,537; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $152,992 and $121,455, respectively, based on a tax cost of $2,139,519. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK.Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839.Service fees are included within the Company’s Consolidated Statements of Operations as other income.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of September 30, 2023.Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively. 0001418076 2023-01-01 2023-09-30 0001418076 2023-07-01 2023-09-30 0001418076 2022-07-01 2022-09-30 0001418076 2022-01-01 2022-09-30 0001418076 2023-09-30 0001418076 2022-12-31 0001418076 2023-11-03 0001418076 2023-05-09 0001418076 2023-05-09 2023-05-09 0001418076 2022-01-01 2022-12-31 0001418076 2022-09-30 0001418076 2021-12-31 0001418076 2019-12-18 2019-12-18 0001418076 2022-04-01 2022-04-01 0001418076 2015-12-31 0001418076 2014-12-31 0001418076 2013-12-31 0001418076 2020-12-31 0001418076 2019-12-31 0001418076 2018-12-31 0001418076 2017-12-31 0001418076 2016-12-31 0001418076 2023-06-30 0001418076 2022-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member slrc:InvestmentInSeniorSecuredLoansMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember slrc:InvestmentInSeniorSecuredLoansMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member slrc:EquipmentFinancingMember 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember slrc:EquipmentFinancingMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:EquipmentFinancingMember 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember slrc:PreferredEquityMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:PreferredEquityMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember us-gaap:EquitySecuritiesMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationTechniqueRecoveryApproachMember slrc:MeasurementInputRecoverableAmountMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2023-09-30 0001418076 srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember 2023-09-30 0001418076 srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember 2023-09-30 0001418076 srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember 2023-09-30 0001418076 srt:MinimumMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:EquipmentFinancingMember 2023-09-30 0001418076 srt:MaximumMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:EquipmentFinancingMember 2023-09-30 0001418076 srt:WeightedAverageMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:EquipmentFinancingMember 2023-09-30 0001418076 srt:MinimumMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:PreferredEquityMember 2023-09-30 0001418076 srt:MaximumMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:PreferredEquityMember 2023-09-30 0001418076 srt:WeightedAverageMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:PreferredEquityMember 2023-09-30 0001418076 srt:MinimumMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:EquitySecuritiesMember 2023-09-30 0001418076 srt:MaximumMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:EquitySecuritiesMember 2023-09-30 0001418076 srt:WeightedAverageMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:EquitySecuritiesMember 2023-09-30 0001418076 srt:MinimumMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:EquitySecuritiesMember 2023-09-30 0001418076 srt:MaximumMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:EquitySecuritiesMember 2023-09-30 0001418076 srt:WeightedAverageMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:EquitySecuritiesMember 2023-09-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2023-09-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-09-30 0001418076 slrc:CreditFacilityOneMember 2023-09-30 0001418076 slrc:NmcSeniorCreditFacilityMember 2023-09-30 0001418076 slrc:SeniorSecuredCommitmentsMember slrc:SlrBusinessCreditMember 2023-09-30 0001418076 slrc:SlrBusinessCreditMember 2023-09-30 0001418076 slrc:KbhtMember 2023-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-09-30 0001418076 slrc:CreditFacilityMember 2023-09-30 0001418076 slrc:SlrHealthcareAblMember srt:MinimumMember 2023-09-30 0001418076 slrc:SlrHealthcareAblMember srt:MaximumMember 2023-09-30 0001418076 slrc:SeniorSecuredCommitmentsMember 2023-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-09-30 0001418076 slrc:KaseyaIncMember 2023-09-30 0001418076 slrc:BridgeBioPharmaIncMember 2023-09-30 0001418076 slrc:VapothermInc.Member 2023-09-30 0001418076 slrc:IcimsInc.Member 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CreditFacilityMember slrc:CitiBankNaMember 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2023-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-09-30 0001418076 slrc:AllStatesAgPartsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:OrthopedicCarePartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:NeuroneticsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:AlkemeIntermediateHoldingsLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UVPManagementLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:TheTownsendCompanyLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:AccessionRiskManagementGroupIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:WestNrParentIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:TilleyDistributionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:GsmAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:CompositeTechnologyAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:HighStreetBuyerIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2023-09-30 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:TaucManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:GlookoInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2023-09-30 0001418076 slrc:ApeelTechnologyIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:HumanInterestIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:CVAUSAManagementLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:BdgMediaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OnsMsoLlcMember 2023-09-30 0001418076 slrc:IcimsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:CerapedicsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2023-09-30 0001418076 slrc:ArdelyxIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnitedDigestiveMsoParentLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2023-09-30 0001418076 slrc:KaseyaIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UrologyManagementHoldingsIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2023-09-30 0001418076 slrc:VertosMedicalInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2023-09-30 0001418076 slrc:BasicFunInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2023-09-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:EnverusHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:PediatricHomeRespiratoryServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2023-09-30 0001418076 slrc:BaymarkHealthServicesIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2023-09-30 0001418076 slrc:PlasticsManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2023-09-30 0001418076 slrc:MontefioreNyackHospitalMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:BaysideOpcoLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:CreditFacilityMember 2023-09-30 0001418076 slrc:CreditFacilityOneMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2023-09-30 0001418076 slrc:TermLoansMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-09-30 0001418076 slrc:WestNrParentIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:WaterUtilitiesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:PlasticsManagementLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:RqmCorpMember slrc:LifeSciencesToolsAndServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:DiversifiedConsumerServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:HealthCareEquipmentAndSuppliesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:TheTownsendCompanyLLCMember slrc:CommercialServicesAndSuppliesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:TilleyDistributionIncMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:PackagedFoodsAndMeatsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:UrologyManagementHoldingsIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:KidDistroHoldingsLlcMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:OnsMsoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:PhynetDermatologyLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:PinnacleTreatmentCentersIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:CcSagHoldingsCorpMember slrc:DiversifiedConsumerServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:FertilityItcInvestmentHoldcoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:IcimsIncMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:KaseyaIncMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:AccessionRiskManagementGroupIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:AegisToxicologySciencesCorporationMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:AlkemeIntermediaryHoldingsLlcMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:AllStatesAgPartsLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember srt:ManagementMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:ASCHoldcoLLCMember 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Foundation Consumer Brands, LLC | Personal Products |S+625 |1.00 % |11.77 %|2/12/2021 |2/12/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Fertility (ITC) Investment Holdco, LLC |Health Care Providers & Services |S+650 |1.00 % |11.63 % |1/4/2023 |1/3/2029 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Erie Construction Mid-west, LLC |Building Products |S+475 |1.00 % |10.34 % |4/1/2022 |7/30/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |GSM Acquisition Corp. |Leisure Equipment & Products |S+500 |1.00 % |10.65 % |4/1/2022 |11/16/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |High Street Buyer, Inc. |Insurance |S+600 |0.75 % |11.54 % |4/1/2022 |4/16/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Higginbotham Insurance Agency, Inc.(16) |Insurance |S+550 |1.00 % |10.92 % |4/1/2022 |11/15/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Human Interest Inc. |Internet Software & Services |S+785 |1.00 % |13.18 % |6/30/2022 |7/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |iCIMS, Inc. |Software |S+725 |0.75 % |12.14 % |8/18/2022 |8/18/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kingsbridge Holdings, LLC |Multi-Sector Holdings |S+700 |1.00 % |1.00 % |12/21/2018 |12/21/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kid Distro Holdings, LLC (Distro Kid) |Software |S+550 |1.00 % |11.04 % |9/24/2021 |10/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kaseya, Inc. |Software |S+625 |0.75 % |11.58 % |6/22/2022 |6/22/2022 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |KORE Wireless Group, Inc. |Logix Holding Company, LLC |S+550 | |10.99 % |12/21/2018 |12/21/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Luxury Asset Capital, LLC |Thrifts & Mortgage Finance |S+675 |1.00 % |12.19 % |7/15/2022 |7/15/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Logix Holding Company, LLC |Communications Equipment |L+575 |1.00 % |11.48 % |9/14/2018 |12/22/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Maurices, Incorporated |Specialty Retail |S+675 |1.00 % |9.94 % |8/27/2021 |6/1/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Maxor Acquisition, Inc. |Health Care Providers & Services |S+675 |1.00 % |12.48 % |3/1/2023 |3/1/2029 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Oldco AI, LLC (f/k/a Amerimark) |Internet & Catalog Retail |S+800 |1.00 % | |7/28/2021 |10/15/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Oldco AI, LLC(f/k/a Amerimark) |Internet & Catalog Retail |P+475 |1.00 % |13.25 % |6/16/2023 |10/31/2023 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |NSPC Intermediate Corp. (National Spine) |Health Care Providers & Services |S+850 |1.00 % |13.20 % |4/1/2022 |2/13/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |ONS MSO, LLC |Health Care Providers & Services |S+625 |1.00 % |11.62 % |2/10/2023 |7/8/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Pediatric Home Respiratory Services, LLC |Health Care Providers & Services |S+625 |1.00 % |11.67 % |8/19/2022 |12/4/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Orthopedic Care Partners Management, LLC |Health Care Providers & Services |S+650 |1.00 % |11.96 % |8/17/2022 |5/16/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Opco, LLC |Healthcare Providers & Services |S+700 |1.00 % |12.54 % |5/31/2023 |5/31/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Opco, LLC |Healthcare Providers & Services |S+725 |1.00 % |12.79 %|5/31/2023 |5/31/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |CC SAG Holdings Corp. (Spectrum Automotive) |Diversified Consumer Services |S+575 |0.75 % |11.18 % |6/29/2021 |6/29/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |BDG Media, Inc | Media |P+525 |5.50 % |13.75 % |7/18/2022 |7/31/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Parent, LLC |Healthcare Providers & Services |S+1000 |1.00 % |15.54 % |5/31/2023 |5/31/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Composite Technology Acquisition Corp. |Building Products |S+450 |1.00 % |10.04 % |4/1/2022 |2/1/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Enhanced Permanent Capital, LLC |Capital Markets |S+700 |S+700 |12.26 % |12/29/2020 |12/29/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |CVAUSA Management, LLC |Health Care Providers & Services |S+650 |1.00 % |11.59 % |5/22/2023 |5/22/2029 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) |Trading Companies & Distributors |S+475 |1.00 % |10.24 % |4/1/2022 |12/31/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Enverus Holdings, Inc. (fka Drilling Info Holdings) |IT Services |S+450 | |9.92 % |4/1/2022 |7/30/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Apex Services Partners, LLC |Diversified Consumer Services |S+525 |1.00 % |10.67 % |8/31/2022 |7/31/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |All States Ag Parts, LLC|Trading Companies & Distributors |S+600 |1.00 % |11.60 % |4/1/2022 |9/1/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Alkeme Intermediary Holdings, LLC |Insurance |S+650 |1.00 % |11.92 % |9/20/2023 |10/28/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Atria Wealth Solutions, Inc. |Diversified Financial Services |S+650 |1.00 % |12.15 % |9/14/2018 |2/29/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |BayMark Health Services, Inc. |Health Care Providers & Services |S+500 |1.00 % |10.65 % |4/1/2022 |6/11/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Basic Fun, Inc.|Specialty Retail |S+650 |1.00 % |12.17 % |10/30/2020 |7/2/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Aegis Toxicology Sciences Corporation |Health Care Providers & Services |S+550 |1.00 % |11.13 % |5/7/2018 |5/9/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.) |Insurance |S+550 |0.75% |11.02% |4/1/2022 |11/1/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Peter C. Foy & Associates Insurance Services, LLC |Insurance |S+600 |0.75 % |11.43 % |4/1/2022 |11/1/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |PhyNet Dermatology LLC |Health Care Providers & Services |S+625 |1.00 % |11.45 % |9/5/2018 |8/16/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |RQM+ Corp. |Life Sciences Tools & Services |S+575 |1.00 % |11.40 % |8/20/2021 |8/12/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Plastics Management, LLC |Health Care Providers & Services|S+500 |1.00 % |10.44 %|4/1/2022 |8/18/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Pinnacle Treatment Centers, Inc. |Health Care Providers & Services |S+675 |1.00 % |12.10 % |1/22/2020 |1/2/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |RxSense Holdings LLC |Diversified Consumer Services |S+500 |1.00 % |10.47 % |4/1/2022 |3/13/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SHO Holding I Corporation (Shoes for Crews) |Footwear |S+523 |1.00 % |10.86 % |4/1/2022 |4/27/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SCP Eye Care, LLC |Health Care Providers & Services |S+575 |1.00 % |11.17 % |10/6/2022 |10/6/2022 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Southern Orthodontic Partners Management, LLC |Health Care Providers & Services |S+625 |1.00 % |11.89 % |6/3/2022 |1/27/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Stryten Resources LLC |Stryten Resources LLC |S+800 |1.00 % |13.43 % |8/11/2021 |10/12/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |The Townsend Company, LLC |Commercial Services & Supplies |S+625 |1.00 % |11.57 % |8/17/2023 |8/15/2029 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |TAUC Management, LLC |Health Care Providers & Services |L+525 |1.00 % |10.59 % |4/1/2022 |2/12/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SunMed Group Holdings, LLC |Health Care Equipment & Supplies |S+550 |0.75 % |10.99 % |6/16/2021|6/16/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Tilley Distribution, Inc. |Trading Companies & Distributors |S+600 |1.00 % |11.54 % |4/1/2022 |12/31/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |United Digestive MSO Parent, LLC |Health Care Providers & Services |S+675 | 1.00 % |12.29 % |3/30/2023 |3/30/2029 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Ultimate Baked Goods Midco LLC (Rise Baking) |Packaged Foods & Meats |S+625 |1.00 % |11.67 % |8/12/2021 |8/13/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Urology Management Holdings, Inc. |Health Care Providers & Services |S+625 |1.00 % |11.79 % |2/7/2023 |6/15/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |UVP Management, LLC |Health Care Providers & Services |S+625 |1.00 % |11.79 % |9/18/2023 |9/15/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |World Insurance Associates, LLC | Insurance |S+575 |1.00 % |11.14 % |4/1/2022 |4/1/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |West-NR Parent, Inc. |Insurance |S+625 |1.00 % |11.72 % |8/1/2023 |12/27/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Vessco Midco Holdings, LLC |Water Utilities |S+450 |1.00 % |9.92 % |4/1/2022 |11/2/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Arcutis Biotherapeutics Inc |Pharamceuticals |S+745 |0.10 % |12.88 % |12/22/2021 |1/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans |ACRES Commercial Mortgage, LLC |Diversified Financial Services |S+705 |1.00 % |12.49 % |12/24/2021 |8/21/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Bank Debt/Senior Secured Loans |RD Holdco Inc |Diversified Consumer Services |S+975 |1.00% |12/23/2013 |10/12/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans |FGI Worldwide LLC |Diversified Financial Services |S+650 |1.00 % |11.82 % |4/17/2023 |4/17/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Alimera Sciences Inc|Pharmaceuticals|S+515|4.60%|10.48 %|12/31/2019|5/1/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Apeel Technology Inc |Biotechnology |S+625 |1.00 % |8.75 % |6/29/2022 |6/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans Vapotherm Inc |Health Care Equipment and Supplies |S+930 |1.00 % |14.73 % |2/18/2022 |2/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Vertos Medical Inc |Health Care Equipment and Supplies |S+515 |4.75 % |10.48 % |6/14/2023 |7/1/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Meditrina Inc |Health Care Equipment & Supplies |S+550 |3.45 % |10.83 % |12/20/2022 |12/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Neuronetics Inc |Health Care Equipment & Supplies |S+565 |3.95 % |10.98 % |3/2/2020 |3/29/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |OmniGuide Holdings Inc |Health Care Equipment and Supplies |S+580 |5.31 % |11.23 % |7/30/2018 |11/1/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans Outset Medical Inc |Health Care Equipment and Supplies |S+515 |2.75 % |10.48 % |11/3/2022 |11/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Ardelyx Inc |Pharmaceuticals |S+795 |1.00 % |13.30 % |2/23/2022 |3/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |BridgeBio Pharma Inc |Biotechnology |9.00 % |11/17/2021 |11/17/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Cerapedics Inc |Biotechnology |S+620 |2.75 % |11.53 % |12/27/2022 |1/1/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Glooko Inc |Health Care Technology |S+790 |0.10 % |13.33 % |9/30/2021 |10/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | First National Capital LLC | Diversified Financial Services | 9.00% | 11/5/2021 | 8/1/2026 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 2023-09-30 0001418076 Equipment Financing 26.9% | Georgia Jet Inc | Airlines | 8.00% | 12/4/2017 | 1/4/2024 2023-09-30 0001418076 Equipment Financing 26.9% | GMT Corporation | Machinery | 10.71% | 10/23/2018 | 1/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | Hawkeye Contracting Company LLC | Construction & Engineering | 10.50% | 10/8/2021 | 11/1/2025 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Environmental Protection & Improvement Company LLC | Road & Rail | 8.25% | 9/30/2020 | 10/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% | Equipment Operating Leases LLC | Multi-Sector Holdings | 8.37% | 4/27/2018 | 4/27/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Extreme Steel Crane & Rigging LLC | Commercial Services & Supplies | 9.52% | 3/3/2023 | 3/3/2027 2023-09-30 0001418076 Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Dongwon Autopart Technology Inc | Auto Components | 7.96% | 2/2/2021 | 1/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | Double S Industrial Contractors Inc | Commercial Services & Supplies | 8.60% | 7/28/2023 | 8/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Zamborelli Enterprises Pacific Souther Foundation | Diversified Consumer Services | 8.91% | 12/7/2022 | 1/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% | Womble Company Inc | Energy Equipment & Services | 9.11% | 12/27/2019 | 1/1/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% | Up Trucking Services LLC | Road & Rail | 11.21% | 3/23/2018 | 8/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Waste Pro of Florida Inc & Waste Pro USA Inc | Commercial Services & Supplies | 9.17% | 4/18/2023 | 4/18/2028 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Star Coaches Inc | Road & Rail | 8.42% | 3/9/2018 | 4/1/2025 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | The Smedley Company & Smedley Services Inc | Commercial Services & Supplies | 4.07% | 7/31/2017 | 1/15/2028 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 2023-09-30 0001418076 Equipment Financing 26.9% | RH Land Construction LLC & Harbor Dredging LA Inc | Construction & Engineering | 8.08% | 5/10/2023 | 5/10/2026 2023-09-30 0001418076 Equipment Financing 26.9% | Royal Express Inc | Road & Rail | 9.53% | 1/17/2019 | 2/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Rotten Rock Hardscaping & Tree Service | Diversified Consumer Services | 8.21% | 12/6/2022 | 12/6/2027 2023-09-30 0001418076 Equipment Financing 26.9% | Rutt Services LLC | Commercial Services & Supplies | 8.95% | 8/11/2023 | 8/11/2030 2023-09-30 0001418076 Equipment Financing 26.9% | Signet Marine Corporation | Transportation Infrastructure | 8.50% | 10/31/2022 | 11/1/2029 2023-09-30 0001418076 Equipment Financing 26.9% | SLR Equipment Finance | Multi-Sector Holdings | 8.50% | 1/24/2022 | 1/27/2024 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Miranda Logistics Enterprise Inc | Construction & Engineering | 7.69% | 4/14/2023 | 4/14/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Mountain Air Helicopters Inc | Commercial Services & Supplies | 10.00% | 7/31/2017 | 2/28/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Nimble Crane LLC | Commercial Services & Supplies | 9.18% | 7/13/2023 | 7/13/2028 2023-09-30 0001418076 Equipment Financing 26.9% | No Limit Construction Services LLC | Commercial Services & Supplies | 7.73% | 5/5/2023 | 6/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Ozzies Inc | Commercial Services & Supplies | 10.72% | 12/23/2022 | 1/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% | PCX Aerostructures LLC | Aerospace & Defense | 9.32% | 11/23/2022 | 12/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Rane Light Metal Castings Inc | Machinery | 10.00% | 6/1/2020 | 6/1/2024 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | International Automotive Components Group North America Inc | Auto Components | 7.95% | 6/23/2021 | 6/23/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Kool Pak LLC | Road & Rail | 8.58% | 2/5/2018 | 3/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Loc Performance Products LLC | Machinery | 10.50% | 12/29/2022 | 6/1/2027 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2023-09-30 0001418076 Equipment Financing 26.9% |A&A Crane and Rigging, LLC |Commercial Services & Supplies |7.78% |3/27/2023 |3/27/2028 2023-09-30 0001418076 Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 | srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 | srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% |AmeraMex International Inc|Commercial Services and Supplies |10.00% |3/29/2019 |4/15/2025 2023-09-30 0001418076 Equipment Financing 26.9% |Bazzini LLC|Food and Staples Retailing |10.46% |12/23/2022 |1/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 srt:MaximumMember 2023-09-30 0001418076 Equipment Financing 26.9% |Bowman Energy Solutions LLC |Commercial Services and Supplies |7.42% |7/1/2022 |8/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% |C Port or Stone LLC |Oil Gas and Consumable Fuels |8.54% |10/7/2022 |11/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2023-09-30 0001418076 Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 2023-09-30 0001418076 Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 srt:MinimumMember 2023-09-30 0001418076 Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 srt:MaximumMember 2023-09-30 0001418076 Cash Equivalents 33.7% | U.S. Treasury Bill | Government | 9/29/2023 | 11/21/2023 2023-09-30 0001418076 Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 | 2023-09-30 0001418076 Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2023-09-30 0001418076 Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2023-09-30 0001418076 Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 2023-09-30 0001418076 Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 2023-09-30 0001418076 Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 2023-09-30 0001418076 Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 2023-09-30 0001418076 Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 2023-09-30 0001418076 Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 2023-09-30 0001418076 Equipment Financing | SLR Equipment Finance Equity Interests | Multi-Sector Holdings | 7/31/2017 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Assertio Holdings Inc | Pharmaceuticals | 7/31/2023 2023-09-30 0001418076 Common Equity Equity Interests Warrants | aTyr Pharma Inc Warrants | Pharmaceuticals | 11/18/2016 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Bayside Parent LLC | Health Care Providers & Services | 5/31/2023 2023-09-30 0001418076 Common Equity Equity Interests Warrants | CardioFocus Inc Warrants | Health Care Equipment & Supplies | 3/31/2017 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Centrexion Therapeutics Inc Warrants | Pharmaceuticals | 6/28/2019 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2023-09-30 0001418076 Common Equity Equity Interests Warrants | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Meditrina, Inc. Warrants | Health Care Equipment & Supplies | 12/20/2022 2023-09-30 0001418076 Common Equity Equity Interests Warrants | NSPC Holdings, LLC (National Spine) | Health Care Providers & Services | 2/13/2023 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Class B | Diversified Consumer Services | 12/23/2013 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Warrants | Diversified Consumer Services | 12/23/2013 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Senseonics Holdings, Inc | Health Care Equipment & Supplies | 7/25/2019 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR-AMI Topco Blocker, LLC | Internet & Catalog Retail | 6/16/2023 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Business Credit | Diversified Financial Services | 4/1/2022 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Senior Lending Program LLC | Asset Management | 12/1/2022 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Vapotherm, Inc. Warrants | Health Care Equipment & Supplies | 2/18/2022 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) | Health Care Equipment & Supplies | 5/10/2018 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Vertos Medical, Inc. Warrants| Health Care Equipment & Supplies | 6/14/2023 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Total First Lien Life Science Senior Secured Loans 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans 2023-09-30 0001418076 Cash Equivalents 33.7% | Investments & Cash Equivalents 254.1% 2023-09-30 0001418076 Common Equity Equity Interests Warrants 2023-09-30 0001418076 Equipment Financing 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans 2023-09-30 0001418076 Cash Equivalents 33.7% | Liabilities in Excess of Other Assets (154.1%) 2023-09-30 0001418076 Cash Equivalents 33.7% | Net Assets 100.0% 2023-09-30 0001418076 slrc:DiversifiedFinancialServicesIncludesSLRCreditSolutionsSLRBusinessCreditAndSLRHealthcareABLMember 2023-09-30 0001418076 slrc:MultiSectorHoldingsMember 2023-09-30 0001418076 slrc:HealthCareProvidersAndServicesMember 2023-09-30 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2023-09-30 0001418076 slrc:InsuranceMember 2023-09-30 0001418076 slrc:PharmaceuticalsMember 2023-09-30 0001418076 slrc:SoftwareMember 2023-09-30 0001418076 slrc:DiversifiedConsumerServicesMember 2023-09-30 0001418076 slrc:BiotechnologyMember 2023-09-30 0001418076 slrc:CapitalMarketsMember 2023-09-30 0001418076 slrc:CommercialServicesAndSuppliesMember 2023-09-30 0001418076 slrc:ThriftsMortgageFinanceMember 2023-09-30 0001418076 us-gaap:AssetManagement1Member 2023-09-30 0001418076 slrc:RoadAndRailMember 2023-09-30 0001418076 slrc:PersonalProductsMember 2023-09-30 0001418076 slrc:LifeSciencesToolsAndServicesMember 2023-09-30 0001418076 slrc:WirelessTelecommunicationServicesMember 2023-09-30 0001418076 slrc:InternetSoftwareServicesMember 2023-09-30 0001418076 slrc:BuildingProductsMember 2023-09-30 0001418076 slrc:TransportationInfrastructureMember 2023-09-30 0001418076 slrc:InternetAndCatalogRetailMember 2023-09-30 0001418076 slrc:PackagedFoodsAndMeatsMember 2023-09-30 0001418076 slrc:CommunicationsEquipmentMember 2023-09-30 0001418076 slrc:HealthCareTechnologyMember 2023-09-30 0001418076 slrc:ItServicesMember 2023-09-30 0001418076 slrc:LeisureEquipmentProductsMember 2023-09-30 0001418076 slrc:TradingCompaniesDistributorsMember 2023-09-30 0001418076 slrc:AutoPartsAndEquipmentMember 2023-09-30 0001418076 slrc:SpecialtyRetailMember 2023-09-30 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2023-09-30 0001418076 slrc:AerospaceAndDefenseMember 2023-09-30 0001418076 slrc:OilGasAndConsumableFuelsMember 2023-09-30 0001418076 slrc:AutoComponentsMember 2023-09-30 0001418076 slrc:FootwearMember 2023-09-30 0001418076 slrc:MediaMember 2023-09-30 0001418076 slrc:AirlinesMember 2023-09-30 0001418076 slrc:MachineryMember 2023-09-30 0001418076 slrc:MetalsAndMiningMember 2023-09-30 0001418076 slrc:WaterUtilitiesMember 2023-09-30 0001418076 slrc:FoodStaplesRetailingMember 2023-09-30 0001418076 slrc:ConstructionAndEngineeringMember 2023-09-30 0001418076 slrc:ConsumerFinanceMember 2023-09-30 0001418076 slrc:EnergyEquipmentAndServicesMember 2023-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 srt:MinimumMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 srt:MaximumMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 srt:MinimumMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 srt:MaximumMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember srt:WeightedAverageMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MinimumMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 srt:MaximumMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 srt:MinimumMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 srt:MaximumMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 srt:MinimumMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:PreferredEquityMember 2022-12-31 0001418076 srt:MaximumMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:PreferredEquityMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember slrc:PreferredEquityMember 2022-12-31 0001418076 srt:MinimumMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 srt:MaximumMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 srt:MinimumMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 srt:MaximumMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 slrc:BlackScholesPricingModelMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:KbhtMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-12-31 0001418076 slrc:AmerimarkMember 2022-12-31 0001418076 slrc:BridgeBioPharmaIncMember 2022-12-31 0001418076 slrc:OmniGuideHoldingsIncMember 2022-12-31 0001418076 slrc:VapothermInc.Member 2022-12-31 0001418076 slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:AllStatesAgPartsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:OrthopedicCarePartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:NeuroneticsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:AlkemeIntermediateHoldingsLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UVPManagementLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:TheTownsendCompanyLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:AccessionRiskManagementGroupIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:WestNrParentIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:TilleyDistributionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:GsmAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:CompositeTechnologyAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2022-12-31 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:TaucManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2022-12-31 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2022-12-31 0001418076 slrc:ApeelTechnologyIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:HumanInterestIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:CVAUSAManagementLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:BdgMediaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OnsMsoLlcMember 2022-12-31 0001418076 slrc:IcimsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:CerapedicsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2022-12-31 0001418076 slrc:ArdelyxIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnitedDigestiveMsoParentLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2022-12-31 0001418076 slrc:KaseyaIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UrologyManagementHoldingsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:VertosMedicalInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2022-12-31 0001418076 slrc:ErieConstructionMidwestLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2022-12-31 0001418076 slrc:RxsenseHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:EnverusHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:PlasticsManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-12-31 0001418076 slrc:MontefioreNyackHospitalMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2022-12-31 0001418076 slrc:PediatricHomeRespiratoryServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:BaysideOpcoLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:CreditFacilityMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TermLoansMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Aegis Toxicology Sciences Corporation |Health Care Providers & Services |L+550 |1.00% |10.09% |5/7/2018 |5/9/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |American Teleconferencing Services Ltd |Communications Equipment |L+650 |1.00% |5/5/2016 |9/9/2021 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |All States Ag Parts LLC |Trading Companies & Distributors |S+575 |10.19% |4/1/2022 |9/1/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |American Teleconferencing Services Ltd |Communications Equipment |L+650 |1.00% |9/17/2021 |1/31/2023 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |AmeriMark Intermediate Holdings LLC |Internet & Catalog Retail |L+800 |1.00% |14.77% |7/28/2021 |10/15/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Apex Services Partners LLC |Diversified Consumer Services |S+525 |1.00% |9.80% |8/31/2022 |7/31/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Atria Wealth Solutions Inc. |Diversified Financial Services |S+600 |1.00% |10.84% |9/14/2018 |2/29/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Basic Fun Inc. |Specialty Retail |L+550 |1.00% |10.27% |10/30/2020 |10/30/2023 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |BayMark Health Services Inc. |Health Care Providers & Services |L+500 |1.00% |9.73% |4/1/2022 |6/11/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |BDG Media Inc. |Media |L+900 |0.25% |13.17% |7/18/2022 |4/27/2023 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |CC SAG Holdings Corp. (Spectrum Automotive) |Diversified Consumer Services |L+575 |0.75% |10.48% |6/29/2021 |6/29/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Composite Technology Acquisition Corp. |Building Products |L+475 |1.00% |9.73% |4/1/2022 |2/1/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Copper River Seafoods Inc. |Food Products |P+275 |10.25% |8/31/2022 |4/23/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |DeepIntent Inc. |Media |P+175 |9.25% |10/12/2022 |3/25/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Enhanced Permanent Capital LLC |Capital Markets |L+700 |1.00% |10.13% |12/29/2020 |12/29/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) |Trading Companies & Distributors |S+475 |1.00% |9.43% |4/1/2022 |12/31/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Enverus Holdings Inc. (fka Drilling Info Holdings) |IT Services |L+450 |8.88% |4/1/2022 |7/30/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Erie Construction Mid-west LLC |Building Products |S+475 |1.00% |9.79% |4/1/2022 |7/30/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Foundation Consumer Brands LLC |Personal Products |L+550 |1.00% |10.15% |2/12/2021 |2/12/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |GSM Acquisition Corp. |Leisure Equipment & Products |S+500 |1.00% |9.03% |4/1/2022 |11/16/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Higginbotham Insurance Agency Inc. |Insurance |L+525 |0.75% |9.63% |4/1/2022 |11/25/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |High Street Buyer Inc. |Insurance |L+600|0.75% |10.73% |4/1/2022 |4/16/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Human Interest Inc. |Internet Software & Services |S+785 |1.00% |11.97% |6/30/2022 |7/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |iCIMS Inc. |Software |S+725 |0.75% |11.52% |8/18/2022 |8/18/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Ivy Fertility Services LLC |Health Care Providers & Services |L+625 |1.00% |10.39% |12/22/2021 |2/25/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kaseya Inc. |Software |S+575 |0.75% |10.33% |6/22/2022 |6/23/2029 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kid Distro Holdings LLC (Distro Kid) |Software |L+575 |1.00% |10.48% |9/24/2021 |10/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kingsbridge Holdings LLC |Multi-Sector Holdings |L+700 |1.00% |10.75% |12/21/2018 |12/21/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |KORE Wireless Group Inc. |Wireless Telecommunication Services |S+550 |10.08% |12/21/2018 |12/21/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Logix Holding Company LLC |Communications Equipment |L+575 |1.00% |10.13% |9/14/2018 |12/22/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Luxury Asset Capital LLC |Thrifts & Mortgage Finance |S+675 |1.00% |10.99% |7/15/2022 |7/15/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Maurices Incorporated |Specialty Retail |S+675 |1.00% |8.74% |8/27/2021 |6/1/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Montefiore Nyack Hospital |Health Care Providers & Services |L+495 |9.72% |8/9/2022 |11/15/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |NAC Holdings Corporation (Jaguar) |Insurance |S+525 |1.00% |9.45% |7/30/2021 |9/28/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |National Spine and Pain Centers LLC |Health Care Providers & Services |L+500 |1.00% |7.31% |4/1/2022 |6/2/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |One Touch Direct LLC |Commercial Services & Supplies |P+75 |8.25% |4/3/2020 |3/30/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Orthopedic Care Partners Management LLC |Health Care Providers & Services |S+650 |1.00% |10.91% |8/17/2022 |5/16/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Pediatric Home Respiratory Services LLC |Health Care Providers & Services |S+625 |1.00% |10.67% |8/19/2022 |12/4/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Peter C. Foy & Associates Insurance Services LLC |Insurance |S+600 |0.75% |10.44% |4/1/2022 |11/1/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |PhyNet Dermatology LLC |Health Care Providers & Services |S+625 |1.00% |9.81% |9/5/2018 |8/16/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Pinnacle Treatment Centers Inc.|Health Care Providers & Services |S+650 |1.00% |10.57% |1/22/2020 |1/2/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Plastics Management LLC |Health Care Providers & Services |S+500 |1.00% |9.89% |4/1/2022 |8/18/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |PPT Management Holdings LLC |Health Care Providers & Services |L+850 |1.00% |12.83% |9/14/2018 |1/30/2023 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RQM+ Corp. |Life Sciences Tools & Services |S+575 |1.00% |10.97% |8/20/2021 |8/12/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RSC Acquisition Inc. |Insurance |S+550 |0.75% |9.26% |4/1/2022 |11/1/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RxSense Holdings LLC |Diversified Consumer Services |L+500 |1.00% |9.41% |4/1/2022 |3/13/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SCP Eye Care LLC |Health Care Providers & Services |S+575 |1.00% |9.46% |10/6/2022 |10/5/2029 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SHO Holding I Corporation (Shoes for Crews) |Footwear |L+523 |1.00% |9.66% |4/1/2022 |4/27/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Southern Orthodontic Partners Management LLC |Health Care Providers & Services |S+600 |1.00% |10.77%|1/27/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SPAR Marketing Force Inc. |Media |P+95 |8.45% |7/18/2022 |10/10/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Stryten Resources LLC |Auto Parts & Equipment |S+800 |1.00% |12.44% |8/11/2021 |10/12/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SunMed Group Holdings LLC |Health Care Equipment & Supplies |L+575 |0.75% |10.48% |6/16/2021 |6/16/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |TAUC Management LLC |Health Care Providers & Services |L+525 |1.00% |9.98% |4/1/2022 |2/12/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Tilley Distribution Inc. |Trading Companies & Distributors |S+550 |1.00% |10.14% |4/1/2022 |12/31/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Ultimate Baked Goods Midco LLC (Rise Baking) |Packaged Foods & Meats |L+650 |1.00% |10.88% |8/12/2021 |8/13/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Vessco Midco Holdings LLC |Water Utilities |L+450 |1.00% |7.87% |4/1/2022 |11/2/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |World Insurance Associates LLC |Insurance |S+575 |1.00 |9.31 |4/1/2022 |4/1/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |Second Lien Asset-Based Senior Secured Loans |ACRES Commercial Mortgage LLC |Diversified Financial Services |S+705 |1.00% |11.38% |12/24/2021 |8/21/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |Second Lien Bank Debt/Senior Secured Loans |RD Holdco Inc. |Diversified Consumer Services |S+975 |1.00% |12/23/2013 |10/12/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Alimera Sciences Inc. |Pharmaceuticals |L+765 |1.78% |11.82% |12/31/2019 |7/1/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Apeel Technology Inc |Biotechnology |S+625 |1.00% |8.75% |6/29/2022 |6/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Arcutis Biotherapeutics Inc. |Pharamceuticals |L+745 |0.10% |11.62% |12/22/2021 |1/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Ardelyx Inc. |Pharamceuticals |L+795 |0.10% |12.12% |2/23/2022 |3/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |BridgeBio Pharma Inc. |Biotechnology |9.00% |11/17/2021 |11/17/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Centrexion Therapeutics Inc. |Pharmaceuticals |L+725 |2.45% |11.42% |6/28/2019 |1/1/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Cerapedics Inc. |Biotechnology |S+620 |2.75% |10.52% |12/27/2022 |1/1/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Glooko Inc. |Health Care Technology |L+790 |0.10% |12.07% |9/30/2021 |10/1/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Meditrina Inc. |Health Care Equipment & Supplies |S+550 |3.45% |9.82% |12/20/2022 |12/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Neuronetics Inc. |Health Care Equipment & Supplies |L+765 |1.66% |11.82% |3/2/2020 |2/28/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |OmniGuide Holdings Inc. |Health Care Equipment & Supplies |L+1405 |0.10% |18.22% |7/30/2018 |7/1/2023 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Outset Medical Inc. |Health Care Equipment & Supplies |S+515 |2.75% |9.33% |11/3/2022 |11/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Spectrum Pharmaceuticals Inc. |Biotechnology |S+570 |2.30% |9.88% |9/21/2022 |9/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Vapotherm Inc. |Health Care Equipment & Supplies |S+830 |1.00% |12.58% |2/18/2022 |2/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Champion Air LLC |Airlines |10.00% |3/19/2018 |1/1/2023 2022-12-31 0001418076 Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Dongwon Autopart Technology Inc. |Auto Components |7.96% |2/2/2021 | 1/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Drillers Choice Inc. |Commercial Services & Supplies |8.00% |10/31/2022 | 11/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |EasyPak LLC |Containers & Packaging |9.01% |1/6/2021 | 1/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Environmental Protection & Improvement Company LLC |Road & Rail |8.25% |9/30/2020 | 10/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Equipment Operating Leases LLC |Multi-Sector Holdings |8.37% |4/27/2018 | 4/27/2025 2022-12-31 0001418076 Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |First National Capital LLC |Diversified Financial Services | 9.00% |11/5/2021 | 8/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Georgia Jet Inc. |Airlines | 8.00% |12/4/2017 | 1/4/2024 2022-12-31 0001418076 Equipment Financing 26.6% |GMT Corporation |Machinery | 10.71% |10/23/2018 | 1/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Hawkeye Contracting Company LLC |Construction & Engineering | 10.50% |10/8/2021 | 11/1/2025 2022-12-31 0001418076 Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |International Automotive Components Group North America Inc.|Auto Components | 7.95% |6/23/2021 | 6/23/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Kool Pak LLC |Road & Rail | 8.58% |2/5/2018 | 3/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Loc Performance Products LLC |Machinery | 10.50% |12/29/2022 | 6/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Mountain Air Helicopters Inc. |Commercial Services & Supplies | 10.00% |7/31/2017 | 2/28/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Ozzies Inc. |Commercial Services & Supplies | 10.72% |12/23/2022 | 1/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |PCX Aerostructures LLC |Aerospace & Defense | 9.32% |11/23/2022 | 12/1/2028 2022-12-31 0001418076 Equipment Financing 26.6% |Rane Light Metal Castings Inc. |Machinery | 10.00% |6/1/2020 | 6/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Royal Coach Lines Inc. |Road & Rail | 9.56% |11/21/2019 | 8/1/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Royal Express Inc. |Road & Rail | 9.53% |1/17/2019 | 2/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Rotten Rock Hardscaping & Tree Service |Diversified Consumer Services | 8.21% |12/6/2022 | 12/6/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Signet Marine Corporation |Transportation Infrastructure | 8.50% |10/31/2022 |7/1/2029 2022-12-31 0001418076 Equipment Financing 26.6% |SLR Equipment Finance |Multi-Sector Holdings | 8.50% |1/24/2022 |1/24/2023 2022-12-31 0001418076 Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Star Coaches Inc. |Road & Rail | 8.42% |3/9/2018 |4/1/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |The Smedley Company & Smedley Services Inc. |Commercial Services & Supplies | 4.07% |7/31/2017 |1/15/2028 2022-12-31 0001418076 Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |U.S. Crane & Rigging LLC |Commercial Services & Supplies | 10.92% |12/23/2022 |3/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Up Trucking Services LLC |Road & Rail | 11.21% |3/23/2018 |8/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Womble Company Inc. |DEnergy Equipment & Services |9.11% |12/27/2019 |1/1/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Zamborelli Enterprises Pacific Souther Foundation |Diversified Consumer Services |8.91% |12/7/2022 |1/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |AmeraMex International Inc. |Commercial Services & Supplies |10.00% |3/29/2019 |9/15/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Bazzini LLC |Food & Staples Retailing |10.46% |12/23/2022 |1/1/2028 2022-12-31 0001418076 Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Bowman Energy Solutions LLC |Commercial Services & Supplies |7.42% |7/1/2022 |8/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |C-Port/Stone LLC |Oil, Gas & Consumable Fuels |8.54% |10/7/2022 |11/1/2027 2022-12-31 0001418076 Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023 2022-12-31 0001418076 Cash Equivalents 41.8% | U.S. Treasury Bill | Government | 12/30/2022 | 2/23/2023 2022-12-31 0001418076 Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029 2022-12-31 0001418076 Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2022-12-31 0001418076 Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028 2022-12-31 0001418076 Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023 2022-12-31 0001418076 Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |SLR Equipment Finance Equity Interests |Multi-Sector Holdings |7/31/2017 2022-12-31 0001418076 Common Equity Equity Interests Warrants | aTyr Pharma Inc Warrants | Pharmaceuticals | 11/18/2016 2022-12-31 0001418076 Common Equity Equity Interests Warrants | CardioFocus Inc Warrants | Health Care Equipment & Supplies | 3/31/2017 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Centrexion Therapeutics Inc Warrants | Pharmaceuticals | 6/28/2019 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2022-12-31 0001418076 Common Equity Equity Interests Warrants | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Meditrina, Inc. Warrants | Health Care Equipment & Supplies | 12/20/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Class B | Diversified Consumer Services | 12/23/2013 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Warrants | Diversified Consumer Services | 12/23/2013 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Senseonics Holdings, Inc | Health Care Equipment & Supplies | 7/25/2019 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Business Credit | Diversified Financial Services | 4/1/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Senior Lending Program LLC | Asset Management | 12/1/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Spectrum Pharmaceuticals, Inc. Warrants | Biotechnology | 9/21/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Vapotherm, Inc. Warrants | Health Care Equipment & Supplies | 2/18/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) | Health Care Equipment & Supplies | 5/10/2018 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Total First Lien Life Science Senior Secured Loans 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans 2022-12-31 0001418076 Equipment Financing 2022-12-31 0001418076 Common Equity Equity Interests Warrants 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Investments 208.7% 2022-12-31 0001418076 Cash Equivalents 41.8% | Investments & Cash Equivalents 250.5% 2022-12-31 0001418076 Cash Equivalents 41.8% | Liabilities in Excess of Other Assets (150.5%) 2022-12-31 0001418076 Cash Equivalents 41.8% | Net Assets 100.0% 2022-12-31 0001418076 slrc:DiversifiedFinancialServicesIncludesSLRCreditSolutionsSLRBusinessCreditAndSLRHealthcareABLMember 2022-12-31 0001418076 slrc:MultiSectorHoldingsMember 2022-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2022-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2022-12-31 0001418076 slrc:PharmaceuticalsMember 2022-12-31 0001418076 slrc:SoftwareMember 2022-12-31 0001418076 slrc:InsuranceMember 2022-12-31 0001418076 slrc:BiotechnologyMember 2022-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2022-12-31 0001418076 slrc:MediaMember 2022-12-31 0001418076 slrc:RoadAndRailMember 2022-12-31 0001418076 slrc:PersonalProductsMember 2022-12-31 0001418076 slrc:CapitalMarketsMember 2022-12-31 0001418076 slrc:ThriftsMortgageFinanceMember 2022-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2022-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2022-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2022-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2022-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2022-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2022-12-31 0001418076 slrc:InternetSoftwareServicesMember 2022-12-31 0001418076 slrc:BuildingProductsMember 2022-12-31 0001418076 slrc:TradingCompaniesDistributorsMember 2022-12-31 0001418076 slrc:HealthCareTechnologyMember 2022-12-31 0001418076 slrc:TransportationInfrastructureMember 2022-12-31 0001418076 slrc:CommunicationsEquipmentMember 2022-12-31 0001418076 slrc:ItServicesMember 2022-12-31 0001418076 slrc:LeisureEquipmentProductsMember 2022-12-31 0001418076 slrc:SpecialtyRetailMember 2022-12-31 0001418076 us-gaap:AssetManagement1Member 2022-12-31 0001418076 slrc:FoodProductsMember 2022-12-31 0001418076 slrc:AutoComponentsMember 2022-12-31 0001418076 slrc:AirlinesMember 2022-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2022-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2022-12-31 0001418076 slrc:AerospaceAndDefenseMember 2022-12-31 0001418076 slrc:MachineryMember 2022-12-31 0001418076 slrc:FootwearMember 2022-12-31 0001418076 slrc:MetalsAndMiningMember 2022-12-31 0001418076 slrc:FoodStaplesRetailingMember 2022-12-31 0001418076 slrc:WaterUtilitiesMember 2022-12-31 0001418076 slrc:ConsumerFinanceMember 2022-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2022-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2022-12-31 0001418076 slrc:ContainersAndPackagingMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-07-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-07-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-07-01 2023-09-30 0001418076 slrc:AdvisoryAgreementMember 2023-07-01 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-07-01 2023-09-30 0001418076 slrc:EquipmentFinancingMember 2023-07-01 2023-09-30 0001418076 slrc:PreferredEquityMember 2023-07-01 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember 2023-07-01 2023-09-30 0001418076 slrc:SlrBusinessCreditMember 2023-07-01 2023-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2023-07-01 2023-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-07-01 2023-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-07-01 2023-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-07-01 2023-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-07-01 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-07-01 2023-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-07-01 2022-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-07-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-07-01 2022-09-30 0001418076 slrc:AdvisoryAgreementMember 2022-07-01 2022-09-30 0001418076 slrc:SlrBusinessCreditMember 2022-07-01 2022-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-07-01 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-07-01 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-07-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-07-01 2022-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-07-01 2022-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:AdvisoryAgreementMember 2022-01-01 2022-09-30 0001418076 slrc:SlrBusinessCreditMember 2022-01-01 2022-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-01-01 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-01-01 2022-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 srt:MinimumMember 2023-01-01 2023-09-30 0001418076 srt:MaximumMember 2023-01-01 2023-09-30 0001418076 slrc:AdvisoryAgreementMember srt:MaximumMember 2023-01-01 2023-09-30 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2023-01-01 2023-09-30 0001418076 slrc:AdvisoryAgreementMember 2023-01-01 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-01-01 2023-09-30 0001418076 slrc:EquipmentFinancingMember 2023-01-01 2023-09-30 0001418076 slrc:PreferredEquityMember 2023-01-01 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember 2023-01-01 2023-09-30 0001418076 slrc:SpreadOneMember 2023-01-01 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationTechniqueRecoveryApproachMember slrc:MeasurementInputRecoverableAmountMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001418076 slrc:SlrBusinessCreditMember 2023-01-01 2023-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2023-01-01 2023-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CreditFacilityMember 2023-01-01 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CitiBankNaMember slrc:SunsSpvLlcMember 2023-01-01 2023-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-01-01 2023-09-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-01-01 2023-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-01-01 2023-09-30 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2023-01-01 2023-09-30 0001418076 slrc:BaysideOpcoLLCOneMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:BaysideOpcoLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:AmeriMarkIntermediateHoldingsOneLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CitiBankNaMember slrc:SunsSpvLlcMember srt:MinimumMember 2023-01-01 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MaximumMember slrc:LondonInterbankOfferedRateMember slrc:CitiBankNaMember 2023-01-01 2023-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-01-01 2023-09-30 0001418076 us-gaap:RevolvingCreditFacilityMember slrc:SlrBusinessCreditFacilityMember 2023-01-01 2023-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-01-01 2023-09-30 0001418076 slrc:AccessionRiskManagementGroupIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:AegisToxicologySciencesCorporationMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:AlkemeIntermediaryHoldingsLlcMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:AllStatesAgPartsLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CcSagHoldingsCorpMember slrc:DiversifiedConsumerServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:FertilityItcInvestmentHoldcoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:IcimsIncMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:KaseyaIncMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:KidDistroHoldingsLlcMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember slrc:OnsMsoLlcMember 2023-01-01 2023-09-30 0001418076 slrc:PhynetDermatologyLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:PinnacleTreatmentCentersIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:PlasticsManagementLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:RqmCorpMember slrc:LifeSciencesToolsAndServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:DiversifiedConsumerServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:HealthCareEquipmentAndSuppliesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:TheTownsendCompanyLLCMember slrc:CommercialServicesAndSuppliesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:TilleyDistributionIncMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:PackagedFoodsAndMeatsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:UrologyManagementHoldingsIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:WaterUtilitiesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:WestNrParentIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Womble Company Inc | Energy Equipment & Services | 9.11% | 12/27/2019 | 1/1/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Zamborelli Enterprises Pacific Souther Foundation | Diversified Consumer Services | 8.91% | 12/7/2022 | 1/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing | SLR Equipment Finance Equity Interests | Multi-Sector Holdings | 7/31/2017 2023-01-01 2023-09-30 0001418076 Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Assertio Holdings Inc | Pharmaceuticals | 7/31/2023 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | aTyr Pharma Inc Warrants | Pharmaceuticals | 11/18/2016 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Bayside Parent LLC | Health Care Providers & Services | 5/31/2023 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | CardioFocus Inc Warrants | Health Care Equipment & Supplies | 3/31/2017 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Centrexion Therapeutics Inc Warrants | Pharmaceuticals | 6/28/2019 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Meditrina, Inc. Warrants | Health Care Equipment & Supplies | 12/20/2022 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | NSPC Holdings, LLC (National Spine) | Health Care Providers & Services | 2/13/2023 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Class B | Diversified Consumer Services | 12/23/2013 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Warrants | Diversified Consumer Services | 12/23/2013 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Senseonics Holdings, Inc | Health Care Equipment & Supplies | 7/25/2019 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR-AMI Topco Blocker, LLC | Internet & Catalog Retail | 6/16/2023 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Business Credit | Diversified Financial Services | 4/1/2022 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Senior Lending Program LLC | Asset Management | 12/1/2022 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Vapotherm, Inc. Warrants | Health Care Equipment & Supplies | 2/18/2022 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) | Health Care Equipment & Supplies | 5/10/2018 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Vertos Medical, Inc. Warrants| Health Care Equipment & Supplies | 6/14/2023 2023-01-01 2023-09-30 0001418076 Cash Equivalents 33.7% | U.S. Treasury Bill | Government | 9/29/2023 | 11/21/2023 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.) |Insurance |S+550 |0.75% |11.02% |4/1/2022 |11/1/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Aegis Toxicology Sciences Corporation |Health Care Providers & Services |S+550 |1.00 % |11.13 % |5/7/2018 |5/9/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Alkeme Intermediary Holdings, LLC |Insurance |S+650 |1.00 % |11.92 % |9/20/2023 |10/28/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |All States Ag Parts, LLC|Trading Companies & Distributors |S+600 |1.00 % |11.60 % |4/1/2022 |9/1/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Apex Services Partners, LLC |Diversified Consumer Services |S+525 |1.00 % |10.67 % |8/31/2022 |7/31/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Atria Wealth Solutions, Inc. |Diversified Financial Services |S+650 |1.00 % |12.15 % |9/14/2018 |2/29/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Basic Fun, Inc.|Specialty Retail |S+650 |1.00 % |12.17 % |10/30/2020 |7/2/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |BayMark Health Services, Inc. |Health Care Providers & Services |S+500 |1.00 % |10.65 % |4/1/2022 |6/11/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Opco, LLC |Healthcare Providers & Services |S+700 |1.00 % |12.54 % |5/31/2023 |5/31/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Opco, LLC |Healthcare Providers & Services |S+725 |1.00 % |12.79 %|5/31/2023 |5/31/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Parent, LLC |Healthcare Providers & Services |S+1000 |1.00 % |15.54 % |5/31/2023 |5/31/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |BDG Media, Inc | Media |P+525 |5.50 % |13.75 % |7/18/2022 |7/31/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |CC SAG Holdings Corp. (Spectrum Automotive) |Diversified Consumer Services |S+575 |0.75 % |11.18 % |6/29/2021 |6/29/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Composite Technology Acquisition Corp. |Building Products |S+450 |1.00 % |10.04 % |4/1/2022 |2/1/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |CVAUSA Management, LLC |Health Care Providers & Services |S+650 |1.00 % |11.59 % |5/22/2023 |5/22/2029 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Enhanced Permanent Capital, LLC |Capital Markets |S+700 |S+700 |12.26 % |12/29/2020 |12/29/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) |Trading Companies & Distributors |S+475 |1.00 % |10.24 % |4/1/2022 |12/31/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Enverus Holdings, Inc. (fka Drilling Info Holdings) |IT Services |S+450 | |9.92 % |4/1/2022 |7/30/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Erie Construction Mid-west, LLC |Building Products |S+475 |1.00 % |10.34 % |4/1/2022 |7/30/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Fertility (ITC) Investment Holdco, LLC |Health Care Providers & Services |S+650 |1.00 % |11.63 % |1/4/2023 |1/3/2029 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Foundation Consumer Brands, LLC | Personal Products |S+625 |1.00 % |11.77 %|2/12/2021 |2/12/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |GSM Acquisition Corp. |Leisure Equipment & Products |S+500 |1.00 % |10.65 % |4/1/2022 |11/16/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Higginbotham Insurance Agency, Inc.(16) |Insurance |S+550 |1.00 % |10.92 % |4/1/2022 |11/15/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |High Street Buyer, Inc. |Insurance |S+600 |0.75 % |11.54 % |4/1/2022 |4/16/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Human Interest Inc. |Internet Software & Services |S+785 |1.00 % |13.18 % |6/30/2022 |7/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |iCIMS, Inc. |Software |S+725 |0.75 % |12.14 % |8/18/2022 |8/18/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kaseya, Inc. |Software |S+625 |0.75 % |11.58 % |6/22/2022 |6/22/2022 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kid Distro Holdings, LLC (Distro Kid) |Software |S+550 |1.00 % |11.04 % |9/24/2021 |10/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kingsbridge Holdings, LLC |Multi-Sector Holdings |S+700 |1.00 % |1.00 % |12/21/2018 |12/21/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |KORE Wireless Group, Inc. |Logix Holding Company, LLC |S+550 | |10.99 % |12/21/2018 |12/21/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Logix Holding Company, LLC |Communications Equipment |L+575 |1.00 % |11.48 % |9/14/2018 |12/22/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Luxury Asset Capital, LLC |Thrifts & Mortgage Finance |S+675 |1.00 % |12.19 % |7/15/2022 |7/15/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Maurices, Incorporated |Specialty Retail |S+675 |1.00 % |9.94 % |8/27/2021 |6/1/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Maxor Acquisition, Inc. |Health Care Providers & Services |S+675 |1.00 % |12.48 % |3/1/2023 |3/1/2029 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |NSPC Intermediate Corp. (National Spine) |Health Care Providers & Services |S+850 |1.00 % |13.20 % |4/1/2022 |2/13/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Oldco AI, LLC(f/k/a Amerimark) |Internet & Catalog Retail |P+475 |1.00 % |13.25 % |6/16/2023 |10/31/2023 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Oldco AI, LLC (f/k/a Amerimark) |Internet & Catalog Retail |S+800 |1.00 % | |7/28/2021 |10/15/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |ONS MSO, LLC |Health Care Providers & Services |S+625 |1.00 % |11.62 % |2/10/2023 |7/8/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Orthopedic Care Partners Management, LLC |Health Care Providers & Services |S+650 |1.00 % |11.96 % |8/17/2022 |5/16/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Pediatric Home Respiratory Services, LLC |Health Care Providers & Services |S+625 |1.00 % |11.67 % |8/19/2022 |12/4/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Peter C. Foy & Associates Insurance Services, LLC |Insurance |S+600 |0.75 % |11.43 % |4/1/2022 |11/1/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |PhyNet Dermatology LLC |Health Care Providers & Services |S+625 |1.00 % |11.45 % |9/5/2018 |8/16/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Pinnacle Treatment Centers, Inc. |Health Care Providers & Services |S+675 |1.00 % |12.10 % |1/22/2020 |1/2/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Plastics Management, LLC |Health Care Providers & Services|S+500 |1.00 % |10.44 %|4/1/2022 |8/18/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |RQM+ Corp. |Life Sciences Tools & Services |S+575 |1.00 % |11.40 % |8/20/2021 |8/12/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |RxSense Holdings LLC |Diversified Consumer Services |S+500 |1.00 % |10.47 % |4/1/2022 |3/13/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SCP Eye Care, LLC |Health Care Providers & Services |S+575 |1.00 % |11.17 % |10/6/2022 |10/6/2022 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SHO Holding I Corporation (Shoes for Crews) |Footwear |S+523 |1.00 % |10.86 % |4/1/2022 |4/27/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Southern Orthodontic Partners Management, LLC |Health Care Providers & Services |S+625 |1.00 % |11.89 % |6/3/2022 |1/27/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Stryten Resources LLC |Stryten Resources LLC |S+800 |1.00 % |13.43 % |8/11/2021 |10/12/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SunMed Group Holdings, LLC |Health Care Equipment & Supplies |S+550 |0.75 % |10.99 % |6/16/2021|6/16/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |TAUC Management, LLC |Health Care Providers & Services |L+525 |1.00 % |10.59 % |4/1/2022 |2/12/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |The Townsend Company, LLC |Commercial Services & Supplies |S+625 |1.00 % |11.57 % |8/17/2023 |8/15/2029 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Tilley Distribution, Inc. |Trading Companies & Distributors |S+600 |1.00 % |11.54 % |4/1/2022 |12/31/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Ultimate Baked Goods Midco LLC (Rise Baking) |Packaged Foods & Meats |S+625 |1.00 % |11.67 % |8/12/2021 |8/13/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |United Digestive MSO Parent, LLC |Health Care Providers & Services |S+675 | 1.00 % |12.29 % |3/30/2023 |3/30/2029 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Urology Management Holdings, Inc. |Health Care Providers & Services |S+625 |1.00 % |11.79 % |2/7/2023 |6/15/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |UVP Management, LLC |Health Care Providers & Services |S+625 |1.00 % |11.79 % |9/18/2023 |9/15/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Vessco Midco Holdings, LLC |Water Utilities |S+450 |1.00 % |9.92 % |4/1/2022 |11/2/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |West-NR Parent, Inc. |Insurance |S+625 |1.00 % |11.72 % |8/1/2023 |12/27/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |World Insurance Associates, LLC | Insurance |S+575 |1.00 % |11.14 % |4/1/2022 |4/1/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans |ACRES Commercial Mortgage, LLC |Diversified Financial Services |S+705 |1.00 % |12.49 % |12/24/2021 |8/21/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans |FGI Worldwide LLC |Diversified Financial Services |S+650 |1.00 % |11.82 % |4/17/2023 |4/17/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Bank Debt/Senior Secured Loans |RD Holdco Inc |Diversified Consumer Services |S+975 |1.00% |12/23/2013 |10/12/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Alimera Sciences Inc|Pharmaceuticals|S+515|4.60%|10.48 %|12/31/2019|5/1/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Apeel Technology Inc |Biotechnology |S+625 |1.00 % |8.75 % |6/29/2022 |6/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Arcutis Biotherapeutics Inc |Pharamceuticals |S+745 |0.10 % |12.88 % |12/22/2021 |1/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Ardelyx Inc |Pharmaceuticals |S+795 |1.00 % |13.30 % |2/23/2022 |3/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |BridgeBio Pharma Inc |Biotechnology |9.00 % |11/17/2021 |11/17/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Cerapedics Inc |Biotechnology |S+620 |2.75 % |11.53 % |12/27/2022 |1/1/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Glooko Inc |Health Care Technology |S+790 |0.10 % |13.33 % |9/30/2021 |10/1/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Meditrina Inc |Health Care Equipment & Supplies |S+550 |3.45 % |10.83 % |12/20/2022 |12/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Neuronetics Inc |Health Care Equipment & Supplies |S+565 |3.95 % |10.98 % |3/2/2020 |3/29/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |OmniGuide Holdings Inc |Health Care Equipment and Supplies |S+580 |5.31 % |11.23 % |7/30/2018 |11/1/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans Outset Medical Inc |Health Care Equipment and Supplies |S+515 |2.75 % |10.48 % |11/3/2022 |11/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans Vapotherm Inc |Health Care Equipment and Supplies |S+930 |1.00 % |14.73 % |2/18/2022 |2/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Vertos Medical Inc |Health Care Equipment and Supplies |S+515 |4.75 % |10.48 % |6/14/2023 |7/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |A&A Crane and Rigging, LLC |Commercial Services & Supplies |7.78% |3/27/2023 |3/27/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 | 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |AmeraMex International Inc|Commercial Services and Supplies |10.00% |3/29/2019 |4/15/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Bazzini LLC|Food and Staples Retailing |10.46% |12/23/2022 |1/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Bowman Energy Solutions LLC |Commercial Services and Supplies |7.42% |7/1/2022 |8/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |C Port or Stone LLC |Oil Gas and Consumable Fuels |8.54% |10/7/2022 |11/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Dongwon Autopart Technology Inc | Auto Components | 7.96% | 2/2/2021 | 1/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Double S Industrial Contractors Inc | Commercial Services & Supplies | 8.60% | 7/28/2023 | 8/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Environmental Protection & Improvement Company LLC | Road & Rail | 8.25% | 9/30/2020 | 10/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Equipment Operating Leases LLC | Multi-Sector Holdings | 8.37% | 4/27/2018 | 4/27/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Extreme Steel Crane & Rigging LLC | Commercial Services & Supplies | 9.52% | 3/3/2023 | 3/3/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | First National Capital LLC | Diversified Financial Services | 9.00% | 11/5/2021 | 8/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Georgia Jet Inc | Airlines | 8.00% | 12/4/2017 | 1/4/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | GMT Corporation | Machinery | 10.71% | 10/23/2018 | 1/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Hawkeye Contracting Company LLC | Construction & Engineering | 10.50% | 10/8/2021 | 11/1/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | International Automotive Components Group North America Inc | Auto Components | 7.95% | 6/23/2021 | 6/23/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Kool Pak LLC | Road & Rail | 8.58% | 2/5/2018 | 3/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Loc Performance Products LLC | Machinery | 10.50% | 12/29/2022 | 6/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Miranda Logistics Enterprise Inc | Construction & Engineering | 7.69% | 4/14/2023 | 4/14/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Mountain Air Helicopters Inc | Commercial Services & Supplies | 10.00% | 7/31/2017 | 2/28/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Nimble Crane LLC | Commercial Services & Supplies | 9.18% | 7/13/2023 | 7/13/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | No Limit Construction Services LLC | Commercial Services & Supplies | 7.73% | 5/5/2023 | 6/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Ozzies Inc | Commercial Services & Supplies | 10.72% | 12/23/2022 | 1/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | PCX Aerostructures LLC | Aerospace & Defense | 9.32% | 11/23/2022 | 12/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Rane Light Metal Castings Inc | Machinery | 10.00% | 6/1/2020 | 6/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | RH Land Construction LLC & Harbor Dredging LA Inc | Construction & Engineering | 8.08% | 5/10/2023 | 5/10/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Royal Express Inc | Road & Rail | 9.53% | 1/17/2019 | 2/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Rotten Rock Hardscaping & Tree Service | Diversified Consumer Services | 8.21% | 12/6/2022 | 12/6/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Rutt Services LLC | Commercial Services & Supplies | 8.95% | 8/11/2023 | 8/11/2030 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Signet Marine Corporation | Transportation Infrastructure | 8.50% | 10/31/2022 | 11/1/2029 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | SLR Equipment Finance | Multi-Sector Holdings | 8.50% | 1/24/2022 | 1/27/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Star Coaches Inc | Road & Rail | 8.42% | 3/9/2018 | 4/1/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | The Smedley Company & Smedley Services Inc | Commercial Services & Supplies | 4.07% | 7/31/2017 | 1/15/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Up Trucking Services LLC | Road & Rail | 11.21% | 3/23/2018 | 8/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Waste Pro of Florida Inc & Waste Pro USA Inc | Commercial Services & Supplies | 9.17% | 4/18/2023 | 4/18/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2023-01-01 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:SpreadOneMember 2022-01-01 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 Cash Equivalents 41.8% | U.S. Treasury Bill | Government | 12/30/2022 | 2/23/2023 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | aTyr Pharma Inc Warrants | Pharmaceuticals | 11/18/2016 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | CardioFocus Inc Warrants | Health Care Equipment & Supplies | 3/31/2017 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Centrexion Therapeutics Inc Warrants | Pharmaceuticals | 6/28/2019 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Meditrina, Inc. Warrants | Health Care Equipment & Supplies | 12/20/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Class B | Diversified Consumer Services | 12/23/2013 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Warrants | Diversified Consumer Services | 12/23/2013 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Senseonics Holdings, Inc | Health Care Equipment & Supplies | 7/25/2019 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Business Credit | Diversified Financial Services | 4/1/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Senior Lending Program LLC | Asset Management | 12/1/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Spectrum Pharmaceuticals, Inc. Warrants | Biotechnology | 9/21/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Vapotherm, Inc. Warrants | Health Care Equipment & Supplies | 2/18/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) | Health Care Equipment & Supplies | 5/10/2018 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Foundation Consumer Brands LLC |Personal Products |L+550 |1.00% |10.15% |2/12/2021 |2/12/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |GSM Acquisition Corp. |Leisure Equipment & Products |S+500 |1.00% |9.03% |4/1/2022 |11/16/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Higginbotham Insurance Agency Inc. |Insurance |L+525 |0.75% |9.63% |4/1/2022 |11/25/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |High Street Buyer Inc. |Insurance |L+600|0.75% |10.73% |4/1/2022 |4/16/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Human Interest Inc. |Internet Software & Services |S+785 |1.00% |11.97% |6/30/2022 |7/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |iCIMS Inc. |Software |S+725 |0.75% |11.52% |8/18/2022 |8/18/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Ivy Fertility Services LLC |Health Care Providers & Services |L+625 |1.00% |10.39% |12/22/2021 |2/25/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kaseya Inc. |Software |S+575 |0.75% |10.33% |6/22/2022 |6/23/2029 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kid Distro Holdings LLC (Distro Kid) |Software |L+575 |1.00% |10.48% |9/24/2021 |10/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kingsbridge Holdings LLC |Multi-Sector Holdings |L+700 |1.00% |10.75% |12/21/2018 |12/21/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |KORE Wireless Group Inc. |Wireless Telecommunication Services |S+550 |10.08% |12/21/2018 |12/21/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Logix Holding Company LLC |Communications Equipment |L+575 |1.00% |10.13% |9/14/2018 |12/22/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Luxury Asset Capital LLC |Thrifts & Mortgage Finance |S+675 |1.00% |10.99% |7/15/2022 |7/15/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Maurices Incorporated |Specialty Retail |S+675 |1.00% |8.74% |8/27/2021 |6/1/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Montefiore Nyack Hospital |Health Care Providers & Services |L+495 |9.72% |8/9/2022 |11/15/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |NAC Holdings Corporation (Jaguar) |Insurance |S+525 |1.00% |9.45% |7/30/2021 |9/28/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |National Spine and Pain Centers LLC |Health Care Providers & Services |L+500 |1.00% |7.31% |4/1/2022 |6/2/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |One Touch Direct LLC |Commercial Services & Supplies |P+75 |8.25% |4/3/2020 |3/30/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Orthopedic Care Partners Management LLC |Health Care Providers & Services |S+650 |1.00% |10.91% |8/17/2022 |5/16/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Pediatric Home Respiratory Services LLC |Health Care Providers & Services |S+625 |1.00% |10.67% |8/19/2022 |12/4/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Peter C. Foy & Associates Insurance Services LLC |Insurance |S+600 |0.75% |10.44% |4/1/2022 |11/1/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |PhyNet Dermatology LLC |Health Care Providers & Services |S+625 |1.00% |9.81% |9/5/2018 |8/16/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Pinnacle Treatment Centers Inc.|Health Care Providers & Services |S+650 |1.00% |10.57% |1/22/2020 |1/2/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Plastics Management LLC |Health Care Providers & Services |S+500 |1.00% |9.89% |4/1/2022 |8/18/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |PPT Management Holdings LLC |Health Care Providers & Services |L+850 |1.00% |12.83% |9/14/2018 |1/30/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RQM+ Corp. |Life Sciences Tools & Services |S+575 |1.00% |10.97% |8/20/2021 |8/12/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RSC Acquisition Inc. |Insurance |S+550 |0.75% |9.26% |4/1/2022 |11/1/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RxSense Holdings LLC |Diversified Consumer Services |L+500 |1.00% |9.41% |4/1/2022 |3/13/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SCP Eye Care LLC |Health Care Providers & Services |S+575 |1.00% |9.46% |10/6/2022 |10/5/2029 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SHO Holding I Corporation (Shoes for Crews) |Footwear |L+523 |1.00% |9.66% |4/1/2022 |4/27/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Southern Orthodontic Partners Management LLC |Health Care Providers & Services |S+600 |1.00% |10.77%|1/27/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SPAR Marketing Force Inc. |Media |P+95 |8.45% |7/18/2022 |10/10/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Stryten Resources LLC |Auto Parts & Equipment |S+800 |1.00% |12.44% |8/11/2021 |10/12/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SunMed Group Holdings LLC |Health Care Equipment & Supplies |L+575 |0.75% |10.48% |6/16/2021 |6/16/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |TAUC Management LLC |Health Care Providers & Services |L+525 |1.00% |9.98% |4/1/2022 |2/12/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Tilley Distribution Inc. |Trading Companies & Distributors |S+550 |1.00% |10.14% |4/1/2022 |12/31/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Ultimate Baked Goods Midco LLC (Rise Baking) |Packaged Foods & Meats |L+650 |1.00% |10.88% |8/12/2021 |8/13/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Vessco Midco Holdings LLC |Water Utilities |L+450 |1.00% |7.87% |4/1/2022 |11/2/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |World Insurance Associates LLC |Insurance |S+575 |1.00 |9.31 |4/1/2022 |4/1/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |Second Lien Asset-Based Senior Secured Loans |ACRES Commercial Mortgage LLC |Diversified Financial Services |S+705 |1.00% |11.38% |12/24/2021 |8/21/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |Second Lien Bank Debt/Senior Secured Loans |RD Holdco Inc. |Diversified Consumer Services |S+975 |1.00% |12/23/2013 |10/12/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Alimera Sciences Inc. |Pharmaceuticals |L+765 |1.78% |11.82% |12/31/2019 |7/1/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Apeel Technology Inc |Biotechnology |S+625 |1.00% |8.75% |6/29/2022 |6/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Arcutis Biotherapeutics Inc. |Pharamceuticals |L+745 |0.10% |11.62% |12/22/2021 |1/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Ardelyx Inc. |Pharamceuticals |L+795 |0.10% |12.12% |2/23/2022 |3/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |BridgeBio Pharma Inc. |Biotechnology |9.00% |11/17/2021 |11/17/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Centrexion Therapeutics Inc. |Pharmaceuticals |L+725 |2.45% |11.42% |6/28/2019 |1/1/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Cerapedics Inc. |Biotechnology |S+620 |2.75% |10.52% |12/27/2022 |1/1/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Glooko Inc. |Health Care Technology |L+790 |0.10% |12.07% |9/30/2021 |10/1/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Meditrina Inc. |Health Care Equipment & Supplies |S+550 |3.45% |9.82% |12/20/2022 |12/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Neuronetics Inc. |Health Care Equipment & Supplies |L+765 |1.66% |11.82% |3/2/2020 |2/28/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |OmniGuide Holdings Inc. |Health Care Equipment & Supplies |L+1405 |0.10% |18.22% |7/30/2018 |7/1/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Outset Medical Inc. |Health Care Equipment & Supplies |S+515 |2.75% |9.33% |11/3/2022 |11/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Spectrum Pharmaceuticals Inc. |Biotechnology |S+570 |2.30% |9.88% |9/21/2022 |9/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Vapotherm Inc. |Health Care Equipment & Supplies |S+830 |1.00% |12.58% |2/18/2022 |2/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |AmeraMex International Inc. |Commercial Services & Supplies |10.00% |3/29/2019 |9/15/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Bazzini LLC |Food & Staples Retailing |10.46% |12/23/2022 |1/1/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Bowman Energy Solutions LLC |Commercial Services & Supplies |7.42% |7/1/2022 |8/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |C-Port/Stone LLC |Oil, Gas & Consumable Fuels |8.54% |10/7/2022 |11/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Champion Air LLC |Airlines |10.00% |3/19/2018 |1/1/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Dongwon Autopart Technology Inc. |Auto Components |7.96% |2/2/2021 | 1/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Drillers Choice Inc. |Commercial Services & Supplies |8.00% |10/31/2022 | 11/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |EasyPak LLC |Containers & Packaging |9.01% |1/6/2021 | 1/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Environmental Protection & Improvement Company LLC |Road & Rail |8.25% |9/30/2020 | 10/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Equipment Operating Leases LLC |Multi-Sector Holdings |8.37% |4/27/2018 | 4/27/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |First National Capital LLC |Diversified Financial Services | 9.00% |11/5/2021 | 8/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Georgia Jet Inc. |Airlines | 8.00% |12/4/2017 | 1/4/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |GMT Corporation |Machinery | 10.71% |10/23/2018 | 1/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Hawkeye Contracting Company LLC |Construction & Engineering | 10.50% |10/8/2021 | 11/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |International Automotive Components Group North America Inc.|Auto Components | 7.95% |6/23/2021 | 6/23/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Kool Pak LLC |Road & Rail | 8.58% |2/5/2018 | 3/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Loc Performance Products LLC |Machinery | 10.50% |12/29/2022 | 6/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Mountain Air Helicopters Inc. |Commercial Services & Supplies | 10.00% |7/31/2017 | 2/28/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Ozzies Inc. |Commercial Services & Supplies | 10.72% |12/23/2022 | 1/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |PCX Aerostructures LLC |Aerospace & Defense | 9.32% |11/23/2022 | 12/1/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Rane Light Metal Castings Inc. |Machinery | 10.00% |6/1/2020 | 6/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Royal Coach Lines Inc. |Road & Rail | 9.56% |11/21/2019 | 8/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Royal Express Inc. |Road & Rail | 9.53% |1/17/2019 | 2/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Rotten Rock Hardscaping & Tree Service |Diversified Consumer Services | 8.21% |12/6/2022 | 12/6/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Signet Marine Corporation |Transportation Infrastructure | 8.50% |10/31/2022 |7/1/2029 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |SLR Equipment Finance |Multi-Sector Holdings | 8.50% |1/24/2022 |1/24/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Star Coaches Inc. |Road & Rail | 8.42% |3/9/2018 |4/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |The Smedley Company & Smedley Services Inc. |Commercial Services & Supplies | 4.07% |7/31/2017 |1/15/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |U.S. Crane & Rigging LLC |Commercial Services & Supplies | 10.92% |12/23/2022 |3/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Up Trucking Services LLC |Road & Rail | 11.21% |3/23/2018 |8/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Womble Company Inc. |DEnergy Equipment & Services |9.11% |12/27/2019 |1/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Zamborelli Enterprises Pacific Souther Foundation |Diversified Consumer Services |8.91% |12/7/2022 |1/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |SLR Equipment Finance Equity Interests |Multi-Sector Holdings |7/31/2017 2022-01-01 2022-12-31 0001418076 Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Aegis Toxicology Sciences Corporation |Health Care Providers & Services |L+550 |1.00% |10.09% |5/7/2018 |5/9/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |All States Ag Parts LLC |Trading Companies & Distributors |S+575 |10.19% |4/1/2022 |9/1/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |American Teleconferencing Services Ltd |Communications Equipment |L+650 |1.00% |5/5/2016 |9/9/2021 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |American Teleconferencing Services Ltd |Communications Equipment |L+650 |1.00% |9/17/2021 |1/31/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |AmeriMark Intermediate Holdings LLC |Internet & Catalog Retail |L+800 |1.00% |14.77% |7/28/2021 |10/15/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Apex Services Partners LLC |Diversified Consumer Services |S+525 |1.00% |9.80% |8/31/2022 |7/31/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Atria Wealth Solutions Inc. |Diversified Financial Services |S+600 |1.00% |10.84% |9/14/2018 |2/29/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Basic Fun Inc. |Specialty Retail |L+550 |1.00% |10.27% |10/30/2020 |10/30/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |BayMark Health Services Inc. |Health Care Providers & Services |L+500 |1.00% |9.73% |4/1/2022 |6/11/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |BDG Media Inc. |Media |L+900 |0.25% |13.17% |7/18/2022 |4/27/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |CC SAG Holdings Corp. (Spectrum Automotive) |Diversified Consumer Services |L+575 |0.75% |10.48% |6/29/2021 |6/29/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Composite Technology Acquisition Corp. |Building Products |L+475 |1.00% |9.73% |4/1/2022 |2/1/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Copper River Seafoods Inc. |Food Products |P+275 |10.25% |8/31/2022 |4/23/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |DeepIntent Inc. |Media |P+175 |9.25% |10/12/2022 |3/25/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Enhanced Permanent Capital LLC |Capital Markets |L+700 |1.00% |10.13% |12/29/2020 |12/29/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) |Trading Companies & Distributors |S+475 |1.00% |9.43% |4/1/2022 |12/31/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Enverus Holdings Inc. (fka Drilling Info Holdings) |IT Services |L+450 |8.88% |4/1/2022 |7/30/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Erie Construction Mid-west LLC |Building Products |S+475 |1.00% |9.79% |4/1/2022 |7/30/2027 2022-01-01 2022-12-31 0001418076 us-gaap:IPOMember 2010-02-10 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 0001418076 us-gaap:OverAllotmentOptionMember 2010-02-10 0001418076 us-gaap:CommonStockMember slrc:SunsCompanyMergerMember 2022-04-01 2022-04-01 0001418076 slrc:CreditFacilityOneMember 2022-04-01 0001418076 us-gaap:CommonStockMember slrc:SunsCompanyMergerMember 2022-04-01 0001418076 slrc:CreditFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TermLoansMember 2021-12-31 0001418076 slrc:NefpassFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 2021-12-31 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 0001418076 Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2022-12-12 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 slrc:CitiBankNaMember slrc:SunsSpvLlcMember slrc:TermLoanAndCreditFacilityMember srt:MaximumMember 2011-08-26 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SecuredOvernightFinancingRateMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MaximumMember slrc:CitiBankNaMember slrc:SecuredOvernightFinancingRateMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 0001418076 slrc:AmendmentAgreementToIncreaseCreditFacilityMember us-gaap:LineOfCreditMember slrc:CitiBankNaMember slrc:SunsSpvLlcMember 2021-12-28 0001418076 slrc:CreditFacilityCommitmentExpiredMember us-gaap:LineOfCreditMember slrc:CitiBankNaMember slrc:SunsSpvLlcMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MaximumMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalFinancialMember 2012-11-30 2012-11-30 0001418076 slrc:CrystalFinancialMember 2012-11-30 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 2012-12-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 0001418076 us-gaap:RevolvingCreditFacilityMember 2012-12-28 0001418076 slrc:SlrBusinessCreditFacilityMember 2016-07-28 2016-07-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalCapitalFinancialHoldingsLlcMember 2016-07-28 0001418076 slrc:SlrEquipmentFinanceMember 2017-07-31 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember srt:MaximumMember 2020-11-03 0001418076 srt:MinimumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:SlrHealthcareAblMember 2013-09-30 0001418076 slrc:NorthMillCapitalLlcMember 2017-10-20 0001418076 slrc:EspSscCorporationMember 2017-10-20 0001418076 slrc:NorthMillCapitalLlcMember 2018-05-01 0001418076 slrc:EspSscCorporationMember 2018-05-01 0001418076 slrc:SummitFinancialResourcesMember 2019-06-28 0001418076 slrc:NmHoldcoMember 2019-06-28 0001418076 slrc:NmcsCreditFacilityMember 2019-06-28 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 2021-06-03 0001418076 slrc:SunsMember 2021-06-03 0001418076 slrc:NmcsCreditFacilityMember 2021-06-03 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 0001418076 us-gaap:InvestorMember slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-10-12 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-06 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-09-14 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-18 2019-12-18 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 2019-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-08-24 0001418076 slrc:SlrEquipmentFinanceMember 2023-08-24 2023-08-24 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-11-07 0001418076 slrc:CreditFacilityMember 2013-12-31 0001418076 slrc:SeniorSecuredNotesMember 2013-12-31 0001418076 slrc:TermLoansMember 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-12-31 0001418076 slrc:CreditFacilityMember 2014-12-31 0001418076 slrc:SeniorSecuredNotesMember 2014-12-31 0001418076 slrc:TermLoansMember 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-12-31 0001418076 slrc:CreditFacilityMember 2015-12-31 0001418076 slrc:TermLoansMember 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-12-31 0001418076 slrc:SeniorSecuredNotesMember 2015-12-31 0001418076 slrc:CreditFacilityMember 2016-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2016-12-31 0001418076 slrc:TermLoansMember 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-12-31 0001418076 slrc:SeniorSecuredNotesMember 2016-12-31 0001418076 slrc:CreditFacilityMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-12-31 0001418076 slrc:TermLoansMember 2017-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2017-12-31 0001418076 slrc:SeniorSecuredNotesMember 2017-12-31 0001418076 slrc:CreditFacilityMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2018-12-31 0001418076 slrc:NefpassFacilityMember 2018-12-31 0001418076 slrc:SslpFacilityMember 2018-12-31 0001418076 slrc:TermLoansMember 2018-12-31 0001418076 slrc:CreditFacilityMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2019-12-31 0001418076 slrc:SslpFacilityMember 2019-12-31 0001418076 slrc:TermLoansMember 2019-12-31 0001418076 slrc:NefpassFacilityMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-31 0001418076 slrc:CreditFacilityMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2020-12-31 0001418076 slrc:TermLoansMember 2020-12-31 0001418076 slrc:NefpassFacilityMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember 2023-06-30 0001418076 slrc:PreferredEquityMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-09-30 0001418076 slrc:EquipmentFinancingMember 2023-09-30 0001418076 slrc:PreferredEquityMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:BaysideParentLlcEquityMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlramiTopcoBlockerLlcMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:AmeriMarkIntermediateHoldingsOneLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:BaysideOpcoLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:BaysideOpcoLLCOneMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:BaysideParentLlcLoanMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2023-09-30 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:BaysideOpcoLLCOneMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:BaysideOpcoLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:AmeriMarkIntermediateHoldingsOneLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-12-31 iso4217:USD xbrli:shares utr:Day xbrli:pure utr:Year iso4217:USD xbrli:shares slrc:issuers slrc:loans slrc:fund slrc:Customers
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
 
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarter Ended September 30, 2023
 
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number:
814-00754
 
 
SLR INVESTMENT CORP.
(Exact name of registrant as specified in its charter)
 
 
 
Maryland
 
26-1381340
(State of Incorporation)
 
(I.R.S. Employer
Identification No.)
   
500 Park Avenue
New York, N.Y.
 
10022
(Address of principal executive offices)
 
(Zip Code)
(212993-1670
(Registrant’s telephone number, including area code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
 
Trading
Symbol(s)
 
Name of Each Exchange
on Which Registered
Common Stock, par value $0.01 per share
 
SLRC
 
The NASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90
days.    
Yes
  ☒    No  ☐ 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such
files).    
Yes
  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
       
Non-accelerated filer      Smaller Reporting company  
       
Emerging growth company           
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange
Act).    Yes  ☐    No  
The number of shares of the registrant’s Common Stock, $0.01 par value, outstanding as of November 3, 2023 was 54,554,634.
 
 
 

SLR INVESTMENT CORP.
FORM
10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2023
TABLE
OF
CONTENTS
 
    
PAGE
 
  
Item 1.
        3  
        4  
        5  
        6  
        7  
   Consolidated Schedule of Investments as of December 31, 2022      12  
   Notes to Consolidated Financial Statements (unaudited)      17  
   Report of Independent Registered Public Accounting Firm      38  
Item 2.
   Management’s Discussion and Analysis of Financial Condition and Results of Operations      39  
Item 3.
   Quantitative and Qualitative Disclosures About Market Risk      58  
Item 4.
   Controls and Procedures      58  
  
Item 1.
   Legal Proceedings      59  
Item 1A.
   Risk Factors      59  
Item 2.
   Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities      61  
Item 3.
   Defaults Upon Senior Securities      61  
Item 4.
   Mine Safety Disclosures      61  
Item 5.
   Other Information      61  
Item 6.
   Exhibits      61  
   Signatures      63  
 

PART I. FINANCIAL INFORMATION
In this Quarterly Report, “Company”, “we”, “us”, and “our” refer to SLR Investment Corp. unless the context states otherwise.
 
Item 1.
Financial Statements
SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(in thousands, except share amounts)
 
    
September 30,
2023 (unaudited)
   
December 31,
2022
 
Assets
                
Investments at fair value:
                
Companies less than 5% owned (cost: $1,305,572 and $1,312,701, respectively)
   $ 1,320,729     $ 1,289,082  
Companies 5% to 25% owned (cost: $59,983 and $0, respectively)
     43,405        
Companies more than 25% owned (cost: $839,062 and $821,886, respectively)
     806,922       797,594  
Cash
     10,266       10,743  
Cash equivalents (cost: $332,557 and $417,590, respectively)
     332,557       417,590  
Dividends receivable
     10,993       11,192  
Interest receivable
     11,828       9,706  
Receivable for investments sold
     1,598       1,124  
Prepaid expenses and other assets
     788       664  
    
 
 
   
 
 
 
Total assets
   $ 2,539,086     $ 2,537,695  
    
 
 
   
 
 
 
Liabilities
                
Debt ($1,197,750 and $1,093,200 face amounts, respectively, reported net of unamortized debt issuance costs of $5,996 and $7,202, respectively. See notes 6 and 7)
   $ 1,191,754     $ 1,085,998  
Payable for investments and cash equivalents purchased
     332,557       417,611  
Distributions payable
           7,481  
Management fee payable (see note 3)
     8,051       7,964  
Performance-based incentive fee payable (see note 3)
     5,621       5,422  
Interest payable (see note 7)
     7,416       7,943  
Administrative services payable (see note 3)
     3,678       1,488  
Other liabilities and accrued expenses
     4,624       4,057  
    
 
 
   
 
 
 
Total liabilities
   $ 1,553,701     $ 1,537,964  
    
 
 
   
 
 
 
Commitments and contingencies (see note 14)
            
Net Assets
                
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,554,634 and 54,555,380 shares issued and outstanding, respectively
   $ 546     $ 546  
Paid-in
capital in excess of par
     1,162,559       1,162,569  
Accumulated distributable net loss
     (177,720     (163,384
    
 
 
   
 
 
 
Total net assets
   $ 985,385     $ 999,731  
    
 
 
   
 
 
 
Net Asset Value Per Share
   $ 18.06     $ 18.33  
    
 
 
   
 
 
 
See notes to consolidated financial statements.
 
3

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
(in thousands, except share amounts)
 
    
Three months ended
   
Nine months ended
 
    
September 30, 2023
   
September 30, 2022
   
September 30, 2023
   
September 30, 2022
 
INVESTMENT INCOME:
        
Interest:
        
Companies less than 5% owned
   $ 43,696     $ 32,933     $ 122,301     $ 82,450  
Companies 5% to 25% owned
     816             1,081        
Companies more than 25% owned
     2,879       2,431       8,404       6,914  
Dividends:
        
Companies more than 25% owned
     11,429       11,969       33,782       32,767  
Other income:
        
Companies less than 5% owned
     735       234       3,814       1,222  
Companies more than 25% owned
     86             143        
  
 
 
   
 
 
   
 
 
   
 
 
 
Total investment income
     59,641       47,567       169,525       123,353  
  
 
 
   
 
 
   
 
 
   
 
 
 
EXPENSES:
        
Management fees (see note 3)
   $ 8,051     $ 7,890     $ 23,635     $ 22,019  
Performance-based incentive fees (see note 3)
     5,796       4,965       16,943       9,699  
Interest and other credit facility expenses (see note 7)
     19,874       12,784       53,002       31,464  
Administrative services expense (see note 3)
     1,575       1,132       4,563       3,684  
Other general and administrative expenses
     1,161       935       3,610       4,212  
  
 
 
   
 
 
   
 
 
   
 
 
 
Total expenses
     36,457       27,706       101,753       71,078  
  
 
 
   
 
 
   
 
 
   
 
 
 
Performance-based incentive fees waived (see note 3)
     (175     (194     (410     (1,552
  
 
 
   
 
 
   
 
 
   
 
 
 
Net expenses
     36,282       27,512       101,343       69,526  
  
 
 
   
 
 
   
 
 
   
 
 
 
Net investment income
   $ 23,359     $ 20,055     $ 68,182     $ 53,827  
  
 
 
   
 
 
   
 
 
   
 
 
 
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:
        
Net realized loss on investments and cash equivalents (companies less than 5% owned)
   $ (30,951   $ (37,326   $ (29,766   $ (37,401
  
 
 
   
 
 
   
 
 
   
 
 
 
Net change in unrealized gain (loss) on investments and cash equivalents:
        
Companies less than 5% owned
     33,439       28,783       24,349       3,521  
Companies 5% to 25% owned
     1,065             (2,151      
Companies more than 25% owned
     35       2,016       (7,848     (20,602
  
 
 
   
 
 
   
 
 
   
 
 
 
Net change in unrealized gain (loss) on investments and cash equivalents
     34,539       30,799       14,350       (17,081
  
 
 
   
 
 
   
 
 
   
 
 
 
Net realized and unrealized gain (loss) on investments and cash equivalents
     3,588       (6,527     (15,416     (54,482
  
 
 
   
 
 
   
 
 
   
 
 
 
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS
   $ 26,947     $ 13,528     $ 52,766     $ (655
  
 
 
   
 
 
   
 
 
   
 
 
 
EARNINGS (LOSS) PER SHARE (see note 5)
   $ 0.49     $ 0.25     $ 0.97     $ (0.01
  
 
 
   
 
 
   
 
 
   
 
 
 
See notes to consolidated financial statements.
 
4
SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (unaudited)
(in thousands, except share amounts)
 
    
Three months ended
   
Nine months ended
 
    
September 30, 2023
   
September 30, 2022
   
September 30, 2023
   
September 30, 2022
 
Increase (decrease) in net assets resulting from operations:
        
Net investment income
   $ 23,359     $ 20,055     $ 68,182     $ 53,827  
Net realized loss
     (30,951     (37,326     (29,766     (37,401
Net change in unrealized gain (loss)
     34,539       30,799       14,350       (17,081
  
 
 
   
 
 
   
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     26,947       13,528       52,766       (655
  
 
 
   
 
 
   
 
 
   
 
 
 
Distributions to stockholders:
        
From net investment income
     (22,367     (20,055     (67,102     (53,827
From return of capital
           (2,401           (8,413
  
 
 
   
 
 
   
 
 
   
 
 
 
Net distributions to stockholders
     (22,367     (22,456     (67,102     (62,240
  
 
 
   
 
 
   
 
 
   
 
 
 
Capital transactions
(see note 12)
:
        
Issuance of common stock
                       226,839  
Repurchases of common stock
                 (10      
  
 
 
   
 
 
   
 
 
   
 
 
 
Net capital transactions
                 (10     226,839  
  
 
 
   
 
 
   
 
 
   
 
 
 
Total increase (decrease) in net assets
     4,580       (8,928     (14,346     163,944  
Net assets at beginning of period
     980,805       1,015,153       999,731       842,281  
  
 
 
   
 
 
   
 
 
   
 
 
 
Net assets at end of period
   $ 985,385     $ 1,006,225     $ 985,385     $ 1,006,225  
  
 
 
   
 
 
   
 
 
   
 
 
 
Capital stock activity
(see note 12)
:
        
Issuance of common stock
                       12,511,825  
Repurchases of common stock
                 (746      
  
 
 
   
 
 
   
 
 
   
 
 
 
Net capital stock activity
                 (746     12,511,825  
  
 
 
   
 
 
   
 
 
   
 
 
 
See notes to consolidated financial statements.
 
5

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
(in thousands)
 
    
Nine months ended
 
    
September 30, 2023
   
September 30, 2022
 
Cash Flows from Operating Activities:
    
Net increase (decrease) in net assets resulting from
operations
   $ 52,766     $ (655
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:
    
Net realized loss on investments and cash equivalents
     29,766       37,401  
Net change in unrealized (gain) loss on investments
     (14,350     17,081  
Deferred financing costs/market discount
     1,561       1,631  
(Increase) decrease in operating assets:
    
Purchase of investments
     (556,348     (406,302
Proceeds from disposition of investments
     474,599       259,784  
Net accretion of discount on investments
     (9,315     (7,760
Capitalization of
payment-in-kind
income
     (8,936     (1,753
Collections of
payment-in-kind
income
     204       1,112  
Receivable for investments sold
     (474     102  
Interest receivable
     (2,122     (2,935
Dividends receivable
     199       (2,514
Prepaid expenses and other assets
     (124     (319
Cash acquired in the Mergers
           2,313  
Increase (decrease) in operating liabilities:
    
Payable for investments and cash equivalents purchased
     (85,054     (51,089
Management fee payable
     87       455  
Performance-based incentive fee payable
     199       2,907  
Administrative services expense payable
     2,190       (1,396
Interest payable
     (527     2,591  
Other liabilities and accrued expenses
     567       600  
  
 
 
   
 
 
 
Net Cash Used in Operating Activities
     (115,112     (148,746
  
 
 
   
 
 
 
Cash Flows from Financing Activities:
    
Cash distributions paid
     (74,583     (72,081
Proceeds from unsecured borrowings
           134,914  
Repayment of unsecured borrowings
     (75,000     (150,000
Proceeds from secured borrowings
     667,695       743,892  
Repayment of secured borrowings
     (488,500     (554,000
Repurchase of common stock
     (10      
  
 
 
   
 
 
 
Net Cash Provided by Financing Activities
     29,602       102,725  
  
 
 
   
 
 
 
NET DECREASE IN CASH AND CASH EQUIVALENTS
     (85,510     (46,021
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
     428,333       322,935  
  
 
 
   
 
 
 
CASH AND CASH EQUIVALENTS AT END OF PERIOD
   $ 342,823     $ 276,914  
  
 
 
   
 
 
 
Supplemental disclosure of cash flow information:
    
Cash paid for interest
   $ 53,529     $ 28,873  
Issuance of shares in connection with the Mergers (1)
           226,839  
  
 
 
   
 
 
 
 
(1)
On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839.
See notes to consolidated financial statements.
 
6

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited)
September 30, 2023
(in thousands, except share/unit amounts)
 
Description
  
Industry
    
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Senior Secured Loans
132.0%
                       
First Lien Bank Debt/Senior Secured Loans
                       
Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.) (16)
     Insurance        S+550       0.75     11.02     4/1/2022        11/1/2026      $ 20,221      $ 20,071      $ 20,221  
Aegis Toxicology Sciences Corporation(16)
     Health Care Providers & Services        S+550       1.00     11.13     5/7/2018        5/9/2025        13,420        13,218        13,420  
Alkeme Intermediary Holdings, LLC
     Insurance        S+650       1.00     11.92     9/20/2023        10/28/2026        8,524        8,270        8,268  
All States Ag Parts, LLC(16)
     Trading Companies & Distributors        S+600       1.00     11.60     4/1/2022        9/1/2026        2,177        2,148        2,177  
Apex Services Partners, LLC(16)
     Diversified Consumer Services        S+525       1.00     10.67     8/31/2022        7/31/2025        13,916        13,641        13,916  
Atria Wealth Solutions, Inc.(16)
     Diversified Financial Services        S+650       1.00     12.15     9/14/2018        2/29/2024        16,288        16,170        16,288  
Basic Fun, Inc.(16)
     Specialty Retail        S+650       1.00     12.17     10/30/2020        7/2/2024        2,150        2,149        2,150  
BayMark Health Services, Inc.(16)
     Health Care Providers & Services        S+500       1.00     10.65     4/1/2022        6/11/2027        8,286        8,021        8,286  
Bayside Opco, LLC(27)
     Healthcare Providers & Services        S+700
(15)
 
    1.00     12.54     5/31/2023        5/31/2026        402        402        402  
Bayside Opco, LLC(27)
     Healthcare Providers & Services        S+725
(11)
 
    1.00     12.79     5/31/2023        5/31/2026        18,807        18,807        18,807  
Bayside Parent, LLC(27)
     Healthcare Providers & Services        S+1000
(11)
 
    1.00     15.54     5/31/2023        5/31/2026        4,959        4,959        4,959  
BDG Media, Inc.
     Media        P+525       5.50     13.75     7/18/2022        7/31/2025        5,354        5,354        5,354  
CC SAG Holdings Corp. (Spectrum Automotive)(16)
     Diversified Consumer Services        S+575       0.75     11.18     6/29/2021        6/29/2028        36,588        36,020        36,588  
Composite Technology Acquisition Corp.(16)
     Building Products        S+450       1.00     10.04     4/1/2022        2/1/2025        11,028        10,765        11,028  
CVAUSA Management, LLC
     Health Care Providers & Services        S+650       1.00     11.59     5/22/2023        5/22/2029        18,855        18,308        18,289  
Enhanced Permanent Capital, LLC(3)
     Capital Markets        S+700       1.00     12.26     12/29/2020        12/29/2025        42,521        41,790        42,521  
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin)(16)
     Trading Companies & Distributors        S+475       1.00     10.24     4/1/2022        12/31/2025        4,630        4,507        4,630  
Enverus Holdings, Inc. (fka Drilling Info Holdings)(16)
     IT Services        S+450             9.92     4/1/2022        7/30/2025        11,277        10,950        11,277  
Erie Construction
Mid-west,
LLC(16)
     Building Products        S+475       1.00     10.34     4/1/2022        7/30/2027        8,572        8,296        8,572  
Fertility (ITC) Investment Holdco, LLC
     Health Care Providers & Services        S+650       1.00     11.63     1/4/2023        1/3/2029        22,653        22,034        22,653  
Foundation Consumer Brands, LLC(16)
     Personal Products        S+625       1.00     11.77     2/12/2021        2/12/2027        27,560        26,963        27,560  
GSM Acquisition Corp.(16)
     Leisure Equipment & Products        S+500       1.00     10.65     4/1/2022        11/16/2026        10,939        10,578        10,939  
Higginbotham Insurance Agency, Inc.(16)
     Insurance        S+550       1.00     10.92     4/1/2022        11/15/2028        28,856        28,856        28,856  
High Street Buyer, Inc.(16)
     Insurance        S+600       0.75     11.54     4/1/2022        4/16/2028        3,191        3,034        3,191  
Human Interest Inc.
     Internet Software & Services        S+785       1.00     13.18     6/30/2022        7/1/2027        20,104        19,903        20,104  
iCIMS, Inc.
     Software        S+725       0.75     12.14 %
(26)
 
    8/18/2022        8/18/2028        30,762        30,327        30,762  
Kaseya, Inc.(16)
     Software        S+625       0.75     11.58 %
(29)
 
    6/22/2022        6/23/2029        24,365        24,050        24,365  
Kid Distro Holdings, LLC (Distro Kid)(16)
     Software        S+550       1.00     11.04     9/24/2021        10/1/2027        20,259        19,969        20,259  
Kingsbridge Holdings, LLC(2)
     Multi-Sector Holdings        S+700       1.00     12.40     12/21/2018        12/21/2024        80,000        79,872        80,000  
KORE Wireless Group, Inc.(16)
     Wireless Telecommunication Services        S+550             10.99     12/21/2018        12/21/2024        23,404        23,108        23,404  
Logix Holding Company, LLC(16)
     Communications Equipment        L+575       1.00     11.48     9/14/2018        12/22/2024        14,009        13,516        13,729  
Luxury Asset Capital, LLC(16)
     Thrifts & Mortgage Finance        S+675       1.00     12.19     7/15/2022        7/15/2027        30,500        30,005        30,500  
Maurices, Incorporated(16)
     Specialty Retail        S+675       1.00     9.94     8/27/2021        6/1/2024        7,395        7,346        7,395  
Maxor Acquisition, Inc.
     Health Care Providers & Services        S+675       1.00     12.48     3/1/2023        3/1/2029        23,783        23,118        23,783  
NSPC Intermediate Corp. (National Spine)
     Health Care Providers & Services        S+850       1.00     13.20     4/1/2022        2/13/2026        2,216        2,136        2,216  
Oldco AI, LLC(f/k/a Amerimark)(14)(27)
     Internet & Catalog Retail        P+475       1.00     13.25     6/16/2023        10/31/2023        321        321        321  
Oldco AI, LLC (f/k/a Amerimark)(14)(27)**
     Internet & Catalog Retail        S+800       1.00           7/28/2021        10/15/2026        4,855        4,204         
ONS MSO, LLC
     Health Care Providers & Services        S+625       1.00     11.62     2/10/2023        7/8/2025        17,192        16,798        17,192  
Orthopedic Care Partners Management, LLC
     Health Care Providers & Services        S+650       1.00     11.96     8/17/2022        5/16/2024        5,502        5,473        5,420  
Pediatric Home Respiratory Services, LLC
     Health Care Providers & Services        S+625       1.00     11.67     8/19/2022        12/4/2024        3,118        3,082        3,118  
Peter C. Foy & Associates Insurance Services, LLC
     Insurance        S+600       0.75     11.43     4/1/2022        11/1/2028        16,920        16,668        16,581  
PhyNet Dermatology LLC
     Health Care Providers & Services        S+625       1.00     11.45     9/5/2018        8/16/2024        8,374        8,361        8,374  
Pinnacle Treatment Centers, Inc.(16)
     Health Care Providers & Services        S+675       1.00     12.10     1/22/2020        1/2/2026        25,243        24,903        25,243  
Plastics Management, LLC(16)
     Health Care Providers & Services        S+500       1.00     10.44     4/1/2022        8/18/2027        17,184        16,493        17,184  
RQM+ Corp.(16)
     Life Sciences Tools & Services        S+575       1.00     11.40     8/20/2021        8/12/2026        23,696        23,361        23,696  
RxSense Holdings LLC(16)
     Diversified Consumer Services        S+500       1.00     10.47     4/1/2022        3/13/2026        8,677        8,369        8,677  
SCP Eye Care, LLC
     Health Care Providers & Services        S+575       1.00     11.17     10/6/2022        10/5/2029        9,562        9,281        9,562  
SHO Holding I Corporation (Shoes for Crews)(16)
     Footwear        S+523       1.00     10.86     4/1/2022        4/27/2024        5,659        5,505        5,376  
Southern Orthodontic Partners Management, LLC(16)
     Health Care Providers & Services        S+625       1.00     11.89     6/3/2022        1/27/2026        11,505        11,319        11,274  
Stryten Resources LLC
     Auto Parts & Equipment        S+800       1.00     13.43     8/11/2021        10/12/2026        10,725        10,581        10,586  
SunMed Group Holdings, LLC(16)
     Health Care Equipment & Supplies        S+550       0.75     10.99     6/16/2021        6/16/2028        15,020        14,700        15,020  
TAUC Management, LLC(16)
     Health Care Providers & Services        L+525       1.00     10.59     4/1/2022        2/12/2027        6,893        6,630        6,411  
The Townsend Company, LLC
     Commercial Services & Supplies        S+625       1.00     11.57     8/17/2023        8/15/2029        10,073        9,825        9,821  
Tilley Distribution, Inc.(16)
     Trading Companies & Distributors        S+600       1.00     11.54     4/1/2022        12/31/2026        3,848        3,692        3,848  
Ultimate Baked Goods Midco LLC (Rise Baking)(16)
     Packaged Foods & Meats        S+625       1.00     11.67     8/12/2021        8/13/2027        14,858        14,397        14,858  
United Digestive MSO Parent, LLC
     Health Care Providers & Services        S+675       1.00     12.29     3/30/2023        3/30/2029        13,257        12,882        13,257  
Urology Management Holdings, Inc.
     Health Care Providers & Services        S+625       1.00     11.79     2/7/2023        6/15/2026        7,138        6,959        7,066  
UVP Management, LLC
     Health Care Providers & Services        S+625       1.00     11.79     9/18/2023        9/15/2025        15,444        15,063        15,058  
Vessco Midco Holdings, LLC(16)
     Water Utilities        S+450       1.00     9.92     4/1/2022        11/2/2026        2,466        2,408        2,466  
West-NR
Parent, Inc.
     Insurance        S+625       1.00     11.72     8/1/2023        12/27/2027        13,201        12,945        12,937  
World Insurance Associates, LLC(16)
     Insurance        S+575       1.00     11.14     4/1/2022        4/1/2026        48,250        48,141        48,250  
                    
 
 
    
 
 
 
Total First Lien Bank Debt/Senior Secured Loans
                     $ 921,022      $ 928,465  
                    
 
 
    
 
 
 
Second Lien Asset-Based Senior Secured Loans
                       
ACRES Commercial Mortgage, LLC
     Diversified Financial Services        S+705       1.00     12.49     12/24/2021        8/21/2028        29,925      $ 29,455      $ 29,925  
FGI Worldwide LLC
     Diversified Financial Services        S+650       1.00     11.82     4/17/2023        4/17/2028        8,206        8,015        8,206  
                    
 
 
    
 
 
 
                     $ 37,470      $ 38,131  
                    
 
 
    
 
 
 
Second Lien Bank Debt/Senior Secured Loans
                       
RD Holdco, Inc.** (2)
     Diversified Consumer Services        S+975
(11)
 
    1.00           12/23/2013        10/12/2026        15,065      $ 12,297      $ 7,532  
                    
 
 
    
 
 
 
 
See notes to consolidated financial statements.
 
 
7
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
September 30, 2023
(in thousands, except share/unit amounts)
 
Description
  
Industry
  
Spread
Above
Index
(7)
    
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Senior Secured Loans (continued) —
                        
First Lien Life Science Senior Secured Loans
                        
Alimera Sciences, Inc.(16)
   Pharmaceuticals      S+515        4.60     10.48     12/31/2019        5/1/2028      $  34,738      $ 34,857      $ 37,186  
Apeel Technology, Inc
   Biotechnology      S+625        1.00     8.75     6/29/2022        6/1/2027        3,643        3,641        4,062  
Arcutis Biotherapeutics, Inc.(3)
   Pharamceuticals      S+745        0.10     12.88     12/22/2021        1/1/2027        66,849        67,893        68,019  
Ardelyx, Inc.(3)
   Pharmaceuticals      S+795        1.00     13.30     2/23/2022        3/1/2027        9,475        9,526        10,503  
BridgeBio Pharma, Inc.(3)
   Biotechnology                   9.00 %
(22)
 
    11/17/2021        11/17/2026        40,753        40,487        40,854  
Cerapedics, Inc.
   Biotechnology      S+620        2.75     11.53     12/27/2022        1/1/2028        26,939        27,000        27,007  
Glooko, Inc.(16)
   Health Care Technology      S+790        0.10     13.33     9/30/2021        10/1/2026        11,912        11,984        12,150  
Meditrina, Inc.
   Health Care Equipment & Supplies      S+550        3.45     10.83     12/20/2022        12/1/2027        3,367        3,365        3,384  
Neuronetics, Inc.(16)
   Health Care Equipment & Supplies      S+565        3.95     10.98     3/2/2020        3/29/2028        19,299        19,256        19,396  
OmniGuide Holdings, Inc. (13)
   Health Care Equipment & Supplies      S+580        5.31     11.23     7/30/2018        11/1/2025        24,500        24,590        24,561  
Outset Medical, Inc.(3)(16)
   Health Care Equipment & Supplies      S+515        2.75     10.48     11/3/2022        11/1/2027        35,084        35,162        35,171  
Vapotherm, Inc.
   Health Care Equipment & Supplies      S+930        1.00     14.73 %
(24)
 
    2/18/2022        2/1/2027        36,826        37,086        37,378  
Vertos Medical, Inc.
   Health Care Equipment & Supplies      S+515        4.75     10.48     6/14/2023        7/1/2028        6,651        6,587        6,567  
                     
 
 
    
 
 
 
Total First Lien Life Science Senior
Secured Loans
 
   $ 321,434      $ 326,238  
  
 
 
    
 
 
 
Total Senior Secured Loans
 
  
$
 1,292,223
 
  
$
 1,300,366
 
                     
 
 
    
 
 
 
 
Description
  
Industry
  
Interest Rate
(1)
 
Acquisition
Date
  
Maturity

Date
  
Par Amount
    
Cost
    
Fair
Value
 
Equipment Financing — 26.9%
                   
A&A Crane and Rigging, LLC (10)
   Commercial Services & Supplies    7.78%   3/27/2023    3/27/2028    $ 72      $ 72      $ 72  
Aero Operating LLC (10)
   Commercial Services & Supplies   
8.47-9.64%
  2/12/2021   
3/1/2025-12/1/2026
     1,493        1,492        1,491  
AFG Dallas III, LLC (10)
   Diversified Consumer Services   
10.00-11.29%
  8/11/2022   
8/11/2026-3/1/2027
     1,182        1,182        1,182  
Air Methods Corporation (10)
   Airlines   
7.08-7.13%
  11/3/2021   
11/3/2026-11/23/2026
     3,231        3,275        3,231  
AmeraMex International, Inc. (10)
   Commercial Services & Supplies    10.00%   3/29/2019    4/15/2025      563        563        569  
Bazzini, LLC (10)
   Food & Staples Retailing    10.46%   12/23/2022    1/1/2028      2,084        2,146        2,084  
Boart Longyear Company (10)
   Metals & Mining   
8.31-10.44%
  5/28/2020   
7/1/2024-10/7/2026
     2,870        2,870        2,870  
Bowman Energy Solutions, LLC (10)
   Commercial Services & Supplies    7.42%   7/1/2022    8/1/2026      124        124        124  
C-Port/Stone
LLC (10)
   Oil, Gas & Consumable Fuels    8.54%   10/7/2022    11/1/2027      6,366        6,206        6,175  
Capital City Jet Center, Inc. (10)
   Airlines    10.00%   4/4/2018   
10/4/2023-6/22/2026
     1,536        1,536        1,528  
Carolina’s Contracting, LLC (10)
   Diversified Consumer Services   
8.40
-
8.72
%
  3/7/2023   
3/7/2028-5/18/2028
     3,688        3,723        3,688  
CKD Holdings, Inc. (10)
   Road & Rail   
8.10
-
8.60
%
  9/22/2022   
6/22/2026-9/22/2027
     3,076        3,076        3,076  
Clubcorp Holdings, Inc. (10)
   Hotels, Restaurants & Leisure   
9.36-13.01%
  5/27/2021   
4/1/2025-5/1/2028
     6,880        6,880        6,880  
Complete Equipment Rentals, LLC (10)
   Commercial Services & Supplies   
6.75-7.15%
  3/23/2023   
4/1/2028-6/1/2028
     1,926        1,895        1,893  
Dongwon Autopart Technology Inc. (10)
   Auto Components    7.96%   2/2/2021    1/1/2026      1,411        1,424        1,411  
Double S Industrial Contractors, Inc. (10)
   Commercial Services & Supplies    8.60%   7/28/2023    8/1/2027      119        119        119  
Drillers Choice, Inc. (10)
   Commercial Services & Supplies   
8.00-10.08%
  10/31/2022   
11/1/2027-6/1/2029
     1,962        1,965        1,962  
Energy Drilling Services, LLC (10)
   Diversified Consumer Services   
6.58-9.16%
  8/26/2022   
11/9/2025-9/1/2027
     1,139        1,139        1,139  
Environmental Protection & Improvement Company, LLC (10)
   Road & Rail    8.25%   9/30/2020    10/1/2027      4,746        4,769        4,746  
Equipment Operating Leases, LLC (2)(12)
   Multi-Sector Holdings    8.37%   4/27/2018    4/27/2025      3,498        3,498        3,411  
Extreme Steel Crane & Rigging, LLC (10)
   Commercial Services & Supplies    9.52%   3/3/2023    3/3/2027      902        910        902  
First American Commercial Bancorp,
Inc. (10)
   Diversified Financial Services   
7.50-9.02%
  10/28/2021   
10/1/2026-3/1/2027
     2,449        2,451        2,449  
First National Capital, LLC (10)
   Diversified Financial Services    9.00%   11/5/2021    8/1/2026      5,739        5,739        5,739  
Freightsol LLC (10)
   Road & Rail   
12.51-12.89%
  4/9/2019    11/1/2023      289        289        289  
Georgia Jet, Inc. (10)
   Airlines    8.00%   12/4/2017    1/4/2024      128        128        128  
GMT Corporation (10)
   Machinery    10.71%   10/23/2018    1/1/2026      4,070        4,073        4,070  
Hawkeye Contracting Company, LLC (10)
   Construction & Engineering    10.50%   10/8/2021    11/1/2025      769        769        769  
HTI Logistics Corporation (10)
   Commercial Services & Supplies   
9.69-9.94%
  11/15/2018   
5/1/2024-9/1/2025
     189        189        184  
International Automotive Components Group, North America, Inc. (10)
   Auto Components    7.95%   6/23/2021    6/23/2025      4,375        4,394        4,288  
Kool Pak, LLC (10)
   Road & Rail    8.58%   2/5/2018    3/1/2024      71        71        71  
Loc Performance Products, LLC (10)
   Machinery    10.50%   12/29/2022    6/1/2027      673        673        673  
Loyer Capital LLC (2)(12)
   Multi-Sector Holdings   
8.73-11.52%
  5/16/2019   
5/16/2024-9/25/2024
     7,500        7,500        7,361  
Lux Credit Consultants, LLC (10)
   Road & Rail   
8.28-12.09%
  6/17/2021   
12/1/2024-12/1/2026
     12,142        12,142        12,142  
Lux Vending, LLC (10)
   Consumer Finance   
12.46-13.26%
  8/20/2021   
7/20/2024-10/1/2024
     895        903        895  
Miranda Logistics Enterprise, Inc. (10)
   Construction & Engineering    7.69%   4/14/2023    4/14/2028      824        824        824  
Mountain Air Helicopters, Inc. (10)
   Commercial Services & Supplies    10.00%   7/31/2017    2/28/2025      279        278        279  
Nimble Crane LLC (10)
   Commercial Services & Supplies    9.18%   7/13/2023    7/13/2028      975        975        975  
No Limit Construction Services, LLC (10)
   Commercial Services & Supplies    7.73%   5/5/2023    6/1/2028      124        124        124  
Ozzies, Inc. (10)
   Commercial Services & Supplies    10.72%   12/23/2022    1/1/2027      1,731        1,783        1,731  
PCX Aerostructures LLC (10)
   Aerospace & Defense    9.32%   11/23/2022    12/1/2028      2,401        2,401        2,401  
Rane Light Metal Castings Inc. (10)
   Machinery    10.00%   6/1/2020    6/1/2024      83        83        83  
Rango, Inc. (10)
   Commercial Services & Supplies   
9.33-9.77%
  9/24/2019   
10/1/2023-11/1/2024
     731        742        717  
Rayzor’s Edge LLC (10)
   Diversified Consumer Services   
7.69-8.27%
  5/19/2023   
5/18/2030-6/30/2030
     732        732        732  
RH Land Construction, LLC & Harbor Dredging LA, Inc. (10)
   Construction & Engineering    8.08%   5/10/2023    5/10/2026      124        124        124  
Royal Express Inc. (10)
   Road & Rail    9.53%   1/17/2019    2/1/2024      220        221        220  
Rotten Rock Hardscaping & Tree Service (10)
   Diversified Consumer Services    8.21%   12/6/2022    12/6/2027      214        214        214  
Rutt Services, LLC (10)
   Commercial Services & Supplies    8.95%   8/11/2023    8/11/2030      1,201        1,201        1,201  
Signet Marine Corporation (10)
   Transportation Infrastructure    8.50%   10/31/2022    11/1/2029      12,712        12,753        12,712  
SLR Equipment Finance(2)
   Multi-Sector Holdings    8.50%   1/24/2022    1/27/2024      2,500        2,500        2,500  
Smiley Lifting Solutions, LLC(10)
   Commercial Services & Supplies   
7.82-8.61%
  6/30/2022   
9/15/2026-6/27/2030
     6,123        6,123        6,123  
ST Coaches, LLC (10)
   Road & Rail   
8.50-8.58%
  7/31/2017   
10/1/2023-1/25/2025
     1,111        1,111        1,075  
Star Coaches Inc. (10)
   Road & Rail    8.42%   3/9/2018    4/1/2025      2,472        2,472        2,218  
Superior Transportation, Inc. (10)
   Road & Rail   
10.22-10.63%
  7/31/2017    1/1/2026      2,589        2,589        2,589  
The Smedley Company & Smedley Services, Inc. (10)
   Commercial Services & Supplies    4.07%   7/31/2017    1/15/2028      1,476        1,476        1,476  
Trinity Equipment, Inc. (10)
   Commercial Services & Supplies   
8.78-8.93%
  5/4/2023   
5/4/2028-5/19/2028
     1,407        1,407        1,407  
Trinity Equipment Rentals, Inc. (10)
   Commercial Services & Supplies   
7.94-8.75%
  10/8/2021   
11/1/2024-12/1/2026
     416        416        416  
U.S. Crane & Rigging, LLC (10)
   Commercial Services & Supplies   
8.73%-10.92%
  12/23/2022   
3/1/2027-9/1/2028
     2,717        2,717        2,717  
Up Trucking Services, LLC (10)
   Road & Rail    11.21%   3/23/2018    8/1/2024      256        258        256  
Waste Pro of Florida, Inc. & Waste Pro USA, Inc. (10)
   Commercial Services & Supplies    9.17%   4/18/2023    4/18/2028      9,330        9,485        9,330  
Wind River Environmental, LLC (10)
   Diversified Consumer Services   
8.43-10.00%
  7/31/2019   
8/1/2024-10/5/2025
     387        387        387  
Womble Company, Inc. (10)
   Energy Equipment & Services    9.11%   12/27/2019    1/1/2025      256        256        246  
Worldwide Flight Services, Inc. (10)
   Transportation Infrastructure   
8.32-9.93%
  9/23/2022   
9/23/2027-8/16/2028
     3,192        3,240        3,192  
Zamborelli Enterprises Pacific Souther Foundation (10)
   Diversified Consumer Services    8.91%   12/7/2022    1/1/2027      606        611        606  
See notes to consolidated financial statements.
 
8
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
September 30, 2023
(in thousands, except share/unit amounts)
 
Description
  
Industry
    
Acquisition
Date
    
Shares/Units
    
Cost
    
Fair
Value
 
Equipment Financing (continued) —
              
SLR Equipment Finance Equity Interests (2)(9)(17)*
    
Multi-Sector Holdings
       7/31/2017        200        145,000        120,820  
           
 
 
    
 
 
 
Total Equipment Financing
           
$
290,688
 
  
$
265,306
 
           
 
 
    
 
 
 
 
Description
  
Industry
    
Interest Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Preferred Equity – 0.4%
                   
SOINT, LLC (2)(3)(4)
     Aerospace &
Defense
 
 
     5.00 %
(11)
 
    6/8/2012        6/30/2025             $ 5,114      $ 3,801  
                
 
 
    
 
 
 
 
Description
  
Industry
  
Acquisition
Date
    
Shares/
Units
    
Cost
    
Fair
Value
 
Common Equity/Equity Interests/Warrants— 61.1%
              
Assertio Holdings, Inc. (8)*
   Pharmaceuticals      7/31/2023        12,510      $ 51      $ 32  
aTyr Pharma, Inc. Warrants *
   Pharmaceuticals      11/18/2016        6,347        106         
Bayside Parent, LLC (27)*
   Health Care Providers & Services      5/31/2023        6,526        11,411        3,816  
CardioFocus, Inc. Warrants *
   Health Care Equipment & Supplies      3/31/2017        90        51         
Centrexion Therapeutics, Inc. Warrants *
   Pharmaceuticals      6/28/2019        289,102        136        50  
Conventus Orthopaedics, Inc. Warrants *
   Health Care Equipment & Supplies      6/15/2016        157,500        65         
Delphinus Medical Technologies, Inc. Warrants *
   Health Care Equipment & Supplies      8/18/2017        444,388        74        87  
Essence Group Holdings Corporation (Lumeris) Warrants *
   Health Care Technology      3/22/2017        260,000        129        342  
KBH Topco LLC (Kingsbridge) (2)(5)(18)
   Multi-Sector Holdings      11/3/2020        73,500,000        136,596        146,000  
Meditrina, Inc. Warrants *
   Health Care Equipment & Supplies      12/20/2022        29,366        23        20  
NSPC Holdings, LLC (National Spine) *
   Health Care Providers & Services      2/13/2023        207,043        657        273  
RD Holdco, Inc. (Rug Doctor) (2)*
   Diversified Consumer Services      12/23/2013        231,177        15,683         
RD Holdco, Inc. (Rug Doctor) Class B (2)*
   Diversified Consumer Services      12/23/2013        522        5,216         
RD Holdco, Inc. (Rug Doctor) Warrants (2)*
   Diversified Consumer Services      12/23/2013        30,370        381         
Senseonics Holdings, Inc. (3)(8)*
   Health Care Equipment & Supplies      7/25/2019        469,353        235        283  
SLR-AMI
Topco Blocker, LLC (27)(28)*
   Internet & Catalog Retail      6/16/2023               19,880        15,100  
SLR Business Credit (2)(3)(19)
   Diversified Financial Services      4/1/2022        100        81,583        90,370  
SLR Credit Solutions (2)(3)(20)
   Diversified Financial Services      12/28/2012        280,303        280,737        281,000  
SLR Healthcare ABL (2)(3)(21)
   Diversified Financial Services      4/1/2022        32,839        34,335        34,850  
SLR Senior Lending Program LLC (2)(3)(25)
   Asset Management      12/1/2022               28,750        29,277  
Vapotherm, Inc. Warrants*
   Health Care Equipment & Supplies      2/18/2022        48,969        290        28  
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics)
   Health Care Equipment & Supplies      5/10/2018        2,230        152         
Vertos Medical, Inc. Warrants*
   Health Care Equipment & Supplies      6/14/2023        161,761        51        55  
           
 
 
    
 
 
 
Total Common Equity/Equity Interests/Warrants
           
$
616,592
 
  
$
601,583
 
           
 
 
    
 
 
 
Total Investments (6) — 220.4%
           
$
 2,204,617
 
  
$
 2,171,056
 
           
 
 
    
 
 
 
 
Description
  
Industry
    
Acquisition
Date
    
Maturity

Date
    
Par Amount
               
Cash Equivalents — 33.7%
                 
U.S. Treasury Bill
     Government        9/29/2023        11/21/2023      $ 335,000      $ 332,557      $ 332,557  
              
 
 
    
 
 
 
Total Investments & Cash Equivalents —254.1%
 
  
$
2,537,174
 
  
$
2,503,613
 
Liabilities in Excess of Other Assets — (154.1%)
 
        (1,518,228
                 
 
 
 
Net Assets — 100.0%
 
     
$
985,385
 
                 
 
 
 
 
(1)
Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of September 30, 2023.
(2)
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2023 in these controlled investments are as follows:
 
Name of Issuer
  
Fair Value at
December 31,
2022
    
Gross
Additions
    
Gross
Reductions
   
Realized
Gain
(Loss)
    
Change in
Unrealized
Gain
(Loss)
   
Fair Value at
September 30,
2023
    
Interest/
Dividend/Misc
Income
 
Equipment Operating Leases, LLC
   $ 3,741      $      $ (338   $      $ 8     $ 3,411      $ 231  
Kingsbridge Holdings, LLC
     80,000                            (70     80,000        7,434  
KBH Topco, LLC (Kingsbridge)
     148,444                            (2,444     146,000        10,500  
Loyer Capital LLC
     7,361                                  7,361        565  
RD Holdco, Inc. (Rug Doctor, common equity)
                                              
RD Holdco, Inc. (Rug Doctor, class B)
                                              
RD Holdco, Inc. (Rug Doctor, warrants)
                                              
RD Holdco, Inc. (debt)
     6,521        507                     504       7,532         
SLR Business Credit
     89,370                            1,000       90,370        5,250  
SLR Credit Solutions
     288,760                            (7,760     281,000        15,000  
SLR Equipment Finance (equity)
     120,820                                  120,820         
SLR Equipment Finance (debt)
     5,000        2,500        (5,000                  2,500        174  
SLR Healthcare ABL
     34,350                            500       34,850        2,595  
SLR Senior Lending Program LLC
     9,426        19,250                     601       29,277        393  
SOINT, LLC
     3,801        187                     (187     3,801        187  
  
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
   $ 797,594      $ 22,444      $ (5,338   $      $ (7,848   $ 806,922      $ 42,329  
  
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
See notes to consolidated financial statements.
 
9
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
September 30, 2023
(in thousands)
 
(3)
Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making
follow-on
investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2023, on a fair value basis,
non-qualifying
assets in the portfolio represented 25.1% of the total assets of the Company.
(4)
The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.
(5)
Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
(6)
Aggregate net unrealized appreciation for U.S. federal income tax purposes is $31,537; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $152,992 and $121,455, respectively, based on a tax cost of $2,139,519. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
(7)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
(8)
Denotes a Level 1 investment.
(9)
SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
(10)
Indicates an investment that is wholly held by the Company through NEFPASS LLC.
(11)
Interest is paid in kind (“PIK”).
(12)
Denotes a subsidiary of SLR Equipment Finance.
(13)
OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are
co-borrowers.
(14)
AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each
co-Borrowers.
(15)
Spread is 1.00% Cash / 6.00% PIK.
(16)
Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
(17)
See note 10 to the consolidated financial statements.
(18)
See note 11 to the consolidated financial statements.
(19)
See note 13 to the consolidated financial statements.
(20)
See note 9 to the consolidated financial statements.
(21)
See note 12 to the consolidated financial statements.
(22)
BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.
(23)
The Company became an Affiliated Person to Bayside Opco, LLC and Bayside Parent, LLC on May 31, 2023 and to Amerimark Intermediate Holdings, LLC and SLR- AMI Topco Blocker, LLC on June 16, 2023.
(24)
Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK.
(25)
See note 17 to the consolidated financial statements.
(26)
iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.
(27)
Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows:
 
Name of Issuer
  
Fair Value at
Date of
Affiliation(23)
    
Gross
Additions
    
Gross
Reductions
   
Realized
Gain (Loss)
    
Change in
Unrealized
Gain
(Loss)
   
Fair Value at
September 30,
2023
    
Interest Income
 
Oldco AI, LLC (f/k/a AmeriMark)
   $      $ 1,262      $ (941   $      $     $ 321      $ 15  
Oldco AI, LLC (f/k/a AmeriMark)
     9,371               (12,866            3,495               
Bayside Opco, LLC
     846        21        (465                  402        32  
Bayside Opco, LLC
     18,224        583                           18,807        784  
Bayside Parent, LLC (loan)
     4,773        186                           4,959        250  
Bayside Parent, LLC (equity)
     4,681                            (865     3,816         
SLR-AMI
Topco Blocker, LLC
     7,014        12,867                     (4,781     15,100         
  
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
   $ 44,909      $ 14,919      $ (14,272   $      $ (2,151   $ 43,405      $ 1,081  
  
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
 
(28)
Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.
(29)
Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.
*
Non-income
producing security.
**
Investment is on
non-accrual
status.
See notes to consolidated financial statements.
 
10

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
September 30, 2023
(in thousands)
 
 
Industry Classification
  
Percentage of Total
Investments (at fair value) as
of September 30, 2023
 
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL)
     21.6
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)
     16.6
Health Care Providers & Services
     11.8
Health Care Equipment & Supplies
     6.5
Insurance
     6.4
Pharmaceuticals
     5.3
Software
     3.5
Diversified Consumer Services
     3.4
Biotechnology
     3.3
Capital Markets
     2.0
Commercial Services & Supplies
     2.0
Thrifts & Mortgage Finance
     1.4
Asset Management
     1.4
Road & Rail
     1.3
Personal Products
     1.3
Life Sciences Tools & Services
     1.1
Wireless Telecommunication Services
     1.1
Internet Software & Services
     0.9
Building Products
     0.9
Transportation Infrastructure
     0.7
Internet & Catalog Retail
     0.7
Packaged Foods & Meats
     0.7
Communications Equipment
     0.6
Health Care Technology
     0.6
IT Services
     0.5
Leisure Equipment & Products
     0.5
Trading Companies & Distributors
     0.5
Auto Parts & Equipment
     0.5
Specialty Retail
     0.4
Hotels, Restaurants & Leisure
     0.3
Aerospace & Defense
     0.3
Oil, Gas & Consumable Fuels
     0.3
Auto Components
     0.3
Footwear
     0.3
Media
     0.2
Airlines
     0.2
Machinery
     0.2
Metals & Mining
     0.1
Water Utilities
     0.1
Food & Staples Retailing
     0.1
Construction & Engineering
     0.1
Consumer Finance
     0.0
Energy Equipment & Services
     0.0
  
 
 
 
Total Investments
     100.0
  
 
 
 
See notes
to
consolidated financial statements.
 
11

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
   
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair
Value
 
Senior Secured Loans —124.6%
                 
First Lien Bank Debt/Senior Secured Loans
                 
Aegis Toxicology Sciences Corporation(16)
    Health Care Providers & Services       L+550       1.00     10.09     5/7/2018       5/9/2025     $ 17,103     $ 16,793     $ 17,103  
All States Ag Parts, LLC(16)
    Trading Companies & Distributors       S+575       1.00     10.19     4/1/2022       9/1/2026       4,197       4,081       4,197  
American Teleconferencing Services, Ltd**
    Communications Equipment       L+650       1.00           5/5/2016       9/9/2021       36,135       25,926        
American Teleconferencing Services, Ltd**
    Communications Equipment       L+650       1.00           9/17/2021       1/31/2023       6,405       6,254       224  
AmeriMark Intermediate Holdings, LLC(14)
    Internet & Catalog Retail       L+800       1.00     14.77     7/28/2021       10/15/2026       24,087       23,711       22,882  
Apex Services Partners, LLC(16)
    Diversified Consumer Services       S+525       1.00     9.80     8/31/2022       7/31/2025       14,021       13,644       14,021  
Atria Wealth Solutions, Inc.(16)
    Diversified Financial Services       S+600       1.00     10.84     9/14/2018       2/29/2024       8,149       8,107       8,149  
Basic Fun, Inc.(16)
    Specialty Retail       L+550       1.00     10.27     10/30/2020       10/30/2023       2,162       2,152       2,162  
BayMark Health Services, Inc.(16)
    Health Care Providers & Services       L+500       1.00     9.73     4/1/2022       6/11/2027       9,432       9,078       9,432  
BDG Media, Inc.
    Media       L+900       0.25     13.17     7/18/2022       4/27/2023       14,454       14,454       14,454  
CC SAG Holdings Corp. (Spectrum
Automotive)(16)
    Diversified Consumer Services       L+575       0.75     10.48     6/29/2021       6/29/2028       20,427       20,057       20,427  
Composite Technology Acquisition Corp.(16)
    Building Products       L+475       1.00     9.73     4/1/2022       2/1/2025       10,386       9,983       10,386  
Copper River Seafoods, Inc.
    Food Products       P+275             10.25     8/31/2022       4/23/2025       8,405       8,405       8,405  
DeepIntent, Inc.
    Media       P+175             9.25     10/12/2022       3/25/2025       16,951       16,951       16,951  
Enhanced Permanent Capital, LLC(3)
    Capital Markets       L+700       1.00     10.13     12/29/2020       12/29/2025       35,205       34,496       35,205  
ENS Holdings III Corp. & ES Opco USA
LLC (Bluefin)(16)
    Trading Companies & Distributors       S+475       1.00     9.43     4/1/2022       12/31/2025       4,978       4,804       4,978  
Enverus Holdings, Inc. (fka Drilling Info Holdings)(16)
    IT Services       L+450             8.88     4/1/2022       7/30/2025       11,598       11,129       11,598  
Erie Construction
Mid-west,
LLC(16)
    Building Products       S+475       1.00     9.79     4/1/2022       7/30/2027       8,915       8,580       8,915  
Foundation Consumer Brands, LLC(16)
    Personal Products       L+550       1.00     10.15     2/12/2021       2/12/2027       35,273       34,421       35,273  
GSM Acquisition Corp.(16)
    Leisure Equipment & Products       S+500       1.00     9.03     4/1/2022       11/16/2026       11,022       10,562       10,912  
Higginbotham Insurance Agency, Inc.(16)
    Insurance       L+525       0.75     9.63     4/1/2022       11/25/2026       6,223       5,994       6,223  
High Street Buyer, Inc.(16)
    Insurance       L+600       0.75     10.73     4/1/2022       4/16/2028       5,188       4,900       5,188  
Human Interest Inc.
    Internet Software & Services       S+785       1.00     11.97     6/30/2022       7/1/2027       20,104       19,783       20,104  
iCIMS, Inc.
    Software       S+725       0.75     11.52 %
(26)
 
    8/18/2022       8/18/2028       32,084       31,548       31,522  
Ivy Fertility Services, LLC
    Health Care Providers & Services       L+625       1.00     10.39     12/22/2021       2/25/2026       30,092       29,415       30,393  
Kaseya, Inc.(16)
    Software       S+575       0.75     10.33     6/22/2022       6/23/2029       32,426       31,966       32,426  
Kid Distro Holdings, LLC (Distro Kid)(16)
    Software       L+575       1.00     10.48     9/24/2021       10/1/2027       26,452       26,015       26,452  
Kingsbridge Holdings, LLC(2)
    Multi-Sector Holdings       L+700       1.00     10.75     12/21/2018       12/21/2024       80,000       79,800       80,000  
KORE Wireless Group, Inc.(16)
    Wireless Telecommunication Services       S+550             10.08     12/21/2018       12/21/2024       23,588       23,123       23,588  
Logix Holding Company, LLC(16)
    Communications Equipment       L+575       1.00     10.13     9/14/2018       12/22/2024       14,009       13,246       13,449  
Luxury Asset Capital, LLC(16)
    Thrifts & Mortgage Finance       S+675       1.00     10.99     7/15/2022       7/15/2027       27,500       26,991       27,500  
Maurices, Incorporated(16)
    Specialty Retail       S+675       1.00     8.74     8/27/2021       6/1/2024       7,808       7,678       7,808  
Montefiore Nyack Hospital
    Health Care Providers & Services       L+495             9.72     8/9/2022       11/15/2024       3,966       3,966       3,966  
NAC Holdings Corporation (Jaguar)(16)
    Insurance       S+525       1.00     9.45     7/30/2021       9/28/2024       28,603       28,214       28,603  
National Spine and Pain Centers, LLC
    Health Care Providers & Services       L+500       1.00     7.31     4/1/2022       6/2/2024       2,681       2,564       2,547  
One Touch Direct, LLC
    Commercial Services & Supplies       P+75             8.25     4/3/2020       3/30/2024       4,431       4,431       4,431  
Orthopedic Care Partners Management, LLC
    Health Care Providers & Services       S+650       1.00     10.91     8/17/2022       5/16/2024       3,111       3,092       3,111  
Pediatric Home Respiratory Services, LLC
    Health Care Providers & Services       S+625       1.00     10.67     8/19/2022       12/4/2024       1,327       1,309       1,313  
Peter C. Foy & Associates Insurance Services,
LLC
    Insurance       S+600       0.75     10.44     4/1/2022       11/1/2028       10,854       10,699       10,854  
PhyNet Dermatology LLC
    Health Care Providers & Services       S+625
(15)
 
    1.00     9.81     9/5/2018       8/16/2024       14,458       14,420       14,458  
Pinnacle Treatment Centers, Inc.(16)
    Health Care Providers & Services       S+650       1.00     10.57     1/22/2020       1/2/2026       27,997       27,528       27,367  
Plastics Management, LLC(16)
    Health Care Providers & Services       S+500       1.00     9.89     4/1/2022       8/18/2027       9,491       9,161       9,491  
PPT Management Holdings, LLC(16)
    Health Care Providers & Services       L+850
(11)
 
    1.00     12.83     9/14/2018       1/30/2023       32,163       31,987       25,827  
RQM+ Corp.(16)
    Life Sciences Tools & Services       S+575       1.00     10.97     8/20/2021       8/12/2026       26,823       26,455       26,823  
RSC Acquisition, Inc.(16)
    Insurance       S+550       0.75     9.26     4/1/2022       11/1/2026       6,985       6,813       6,985  
RxSense Holdings LLC(16)
    Diversified Consumer Services       L+500       1.00     9.41     4/1/2022       3/13/2026       11,775       11,357       11,775  
SCP Eye Care, LLC
    Health Care Providers & Services       S+575       1.00     9.46     10/6/2022       10/5/2029       8,314       8,050       8,044  
SHO Holding I Corporation (Shoes for
Crews)(16)
    Footwear       L+523       1.00     9.66     4/1/2022       4/27/2024       5,704       5,361       5,419  
Southern Orthodontic Partners Management, LLC(16)
    Health Care Providers & Services       S+600       1.00     10.77     6/3/2022       1/27/2026       1,399       1,387       1,399  
SPAR Marketing Force, Inc.
    Media       P+95             8.45     7/18/2022       10/10/2024       9,162       9,162       9,162  
Stryten Resources LLC
    Auto Parts & Equipment       S+800       1.00     12.44     8/11/2021       10/12/2026       25,922       25,506       25,922  
SunMed Group Holdings, LLC(16)
    Health Care Equipment & Supplies       L+575       0.75     10.48     6/16/2021       6/16/2028       24,953       24,446       24,953  
TAUC Management, LLC(16)
    Health Care Providers & Services       L+525       1.00     9.98     4/1/2022       2/12/2027       6,899       6,585       6,864  
Tilley Distribution, Inc.(16)
    Trading Companies & Distributors       S+550       1.00     10.14     4/1/2022       12/31/2026       9,996       9,527       9,996  
Ultimate Baked Goods Midco LLC (Rise
Baking)(16)
    Packaged Foods & Meats       L+650       1.00     10.88     8/12/2021       8/13/2027       24,789       24,038       24,789  
Vessco Midco Holdings, LLC(16)
    Water Utilities       L+450       1.00     7.87     4/1/2022       11/2/2026       1,728       1,668       1,728  
World Insurance Associates, LLC(16)
    Insurance       S+575       1.00     9.31     4/1/2022       4/1/2026       31,624       30,785       30,359  
               
 
 
   
 
 
 
Total First Lien Bank Debt/Senior
Secured Loans
 
  $ 912,558     $ 886,513  
 
 
 
   
 
 
 
Second Lien Asset-Based Senior Secured
Loans
                 
ACRES Commercial Mortgage, LLC
    Diversified Financial Services       S+705       1.00     11.38     12/24/2021       8/21/2028       29,925     $ 29,398     $ 29,925  
               
 
 
   
 
 
 
Second Lien Bank Debt/Senior Secured Loans
                 
RD Holdco, Inc.** (2)
    Diversified Consumer Services       S+975
(11)
 
    1.00  
 
 
    12/23/2013       10/12/2026       13,043     $ 11,791     $ 6,521  
               
 
 
   
 
 
 
   
See notes to consolidated financial statements.
 
12

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
 
Description
  
Industry
  
Spread
Above
Index
(7)
    
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Senior Secured Loans (continued) —
                        
First Lien Life Science Senior Secured Loans
                        
Alimera Sciences, Inc.(16)
   Pharmaceuticals      L+765        1.78     11.82     12/31/2019        7/1/2024      $ 23,159      $ 23,894      $ 24,433  
Apeel Technology, Inc
   Biotechnology      S+625        1.00     8.75     6/29/2022        6/1/2027        3,643        3,620        3,643  
Arcutis Biotherapeutics, Inc.(3)
   Pharamceuticals      L+745        0.10     11.62     12/22/2021        1/1/2027        66,849        67,077        67,685  
Ardelyx, Inc.(3)
   Pharmaceuticals      L+795        0.10     12.12     2/23/2022        3/1/2027        9,475        9,437        9,499  
BridgeBio Pharma, Inc.(3)
   Biotechnology   
 
 
  
 
 
    9.00 %
(22)
 
    11/17/2021        11/17/2026        39,839        39,340        39,839  
Centrexion Therapeutics, Inc.
   Pharmaceuticals      L+725        2.45     11.42     6/28/2019        1/1/2024        11,844        12,372        12,555  
Cerapedics, Inc.
   Biotechnology      S+620        2.75     10.52     12/27/2022        1/1/2028        26,939        26,874        26,872  
Glooko, Inc.(16)
   Health Care Technology      L+790        0.10     12.07     9/30/2021        10/1/2026        15,883        15,867        15,922  
Meditrina, Inc.
   Health Care Equipment & Supplies      S+550        3.45     9.82     12/20/2022        12/1/2027        3,367        3,338        3,359  
Neuronetics, Inc.(16)
   Health Care Equipment & Supplies      L+765        1.66     11.82     3/2/2020        2/28/2025        18,012        18,450        19,003  
OmniGuide Holdings, Inc. (13)
   Health Care Equipment & Supplies      L+1405        0.10     18.22 %
(23)
 
    7/30/2018        7/1/2023        19,201        19,380        19,777  
Outset Medical, Inc.(3)
   Health Care Equipment & Supplies      S+515        2.75     9.33     11/3/2022        11/1/2027        35,084        34,880        34,820  
Spectrum Pharmaceuticals, Inc.(16)
   Biotechnology      S+570        2.30     9.88     9/21/2022        9/1/2027        10,525        10,406        10,420  
Vapotherm, Inc.
   Health Care Equipment & Supplies      S+830        1.00     12.58 %
(24)
 
    2/18/2022        2/1/2027        34,455        34,270        34,628  
                     
 
 
    
 
 
 
Total First Lien Life Science Senior Secured Loans
 
   $ 319,205      $ 322,455  
  
 
 
    
 
 
 
Total Senior Secured Loans
 
  
$
1,272,952
 
  
$
1,245,414
 
  
 
 
    
 
 
 
 
Description
  
Industry
  
Interest Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Equipment Financing — 26.6%
                   
Aero Operating LLC (10)
   Commercial Services & Supplies     
8.47-9.64%
      2/12/2021       
3/1/2025-12/1/2026
     $ 2,264      $ 2,262      $ 2,262  
AFG Dallas III, LLC (10)
   Diversified Consumer Services      10.00%       8/11/2022       
8/11/2026-8/29/2026
       1,036        1,036        1,036  
Air Methods Corporation (10)
   Airlines     
7.08-7.13%
      11/3/2021       
11/3/2026-11/23/2026
       3,600        3,660        3,600  
AmeraMex International, Inc. (10)
   Commercial Services & Supplies      10.00%       3/29/2019        9/15/2024        1,059        1,059        1,069  
Bazzini, LLC (10)
   Food & Staples Retailing      10.46%       12/23/2022        1/1/2028        2,365        2,440        2,365  
Boart Longyear Company (10)
   Metals & Mining     
8.31-10.44%
      5/28/2020       
7/1/2024-10/7/2026
       4,568        4,568        4,568  
Bowman Energy Solutions, LLC (10)
   Commercial Services & Supplies      7.42%       7/1/2022        8/1/2026        153        153        153  
C-Port/Stone
LLC (10)
   Oil, Gas & Consumable Fuels      8.54%       10/7/2022        11/1/2027        6,708        6,514        6,507  
Capital City Jet Center, Inc. (10)
   Airlines      10.00%       4/4/2018       
10/4/2023-6/22/2026
       2,241        2,241        2,214  
Champion Air, LLC (10)
   Airlines      10.00%       3/19/2018        1/1/2023        1,055        1,055        1,055  
CKD Holdings, Inc. (10)
   Road & Rail     
8.10-8.60%
      9/22/2022       
3/22/2026-9/22/2027
       3,690        3,690        3,690  
Clubcorp Holdings, Inc. (10)
   Hotels, Restaurants & Leisure     
9.36-13.01%
      5/27/2021       
4/1/2025-1/1/2028
       6,539        6,539        6,539  
Dongwon Autopart Technology Inc. (10)
   Auto Components      7.96%       2/2/2021        1/1/2026        1,828        1,849        1,828  
Drillers Choice, Inc. (10)
   Commercial Services & Supplies      8.00%       10/31/2022        11/1/2027        1,589        1,589        1,589  
EasyPak, LLC (10)
   Containers & Packaging      9.01%       1/6/2021        1/1/2024        276        276        276  
Energy Drilling Services, LLC (10)
   Diversified Consumer Services     
6.58-9.16%
      8/26/2022       
12/9/2025-9/1/2027
       1,321        1,321        1,295  
Environmental Protection & Improvement Company, LLC (10)
   Road & Rail      8.25%       9/30/2020        10/1/2027        5,270        5,300        5,270  
Equipment Operating Leases, LLC (2)(12)
   Multi-Sector Holdings      8.37%       4/27/2018        4/27/2025        3,837        3,837        3,741  
First American Commercial Bancorp, Inc. (10)
   Diversified Financial Services     
7.50-9.02%
      10/28/2021       
10/1/2026-3/1/2027
       2,938        2,941        2,938  
First National Capital, LLC (10)
   Diversified Financial Services      9.00%       11/5/2021        8/1/2026        7,116        7,116        7,116  
Freightsol LLC (10)
   Road & Rail     
12.51-12.89%
      4/9/2019        11/1/2023        779        784        779  
Garda CL Technical Services, Inc. (10)
   Commercial Services & Supplies     
8.30-8.77%
      3/22/2018       
6/5/2023-10/5/2023
       469        469        468  
Georgia Jet, Inc. (10)
   Airlines      8.00%       12/4/2017        1/4/2024        425        425        425  
GMT Corporation (10)
   Machinery      10.71%       10/23/2018        1/1/2026        4,801        4,806        4,801  
Hawkeye Contracting Company, LLC (10)
   Construction & Engineering      10.50%       10/8/2021        11/1/2025        997        997        997  
HTI Logistics Corporation (10)
   Commercial Services & Supplies     
9.69-9.94%
      11/15/2018       
5/1/2024-9/1/2025
       290        290        283  
International Automotive Components Group, North America, Inc. (10)
   Auto Components      7.95%       6/23/2021        6/23/2025        6,072        6,109        5,951  
Kool Pak, LLC (10)
   Road & Rail      8.58%       2/5/2018        3/1/2024        194        194        194  
Loc Performance Products, LLC (10)
   Machinery      10.50%       12/29/2022        6/1/2027        767        767        767  
Loyer Capital LLC (2)(12)
   Multi-Sector Holdings     
8.73-11.52%
      5/16/2019       
5/16/2024-9/25/2024
       7,500        7,500        7,361  
Lux Credit Consultants, LLC (10)
   Road & Rail     
8.28-12.09%
      6/17/2021       
12/1/2024-12/1/2026
       16,411        16,411        16,411  
Lux Vending, LLC (10)
   Consumer Finance     
12.46-13.26%
      8/20/2021       
8/20/2024-10/1/2024
       1,638        1,663        1,638  
Mountain Air Helicopters, Inc. (10)
   Commercial Services & Supplies      10.00%       7/31/2017        2/28/2025        369        368        369  
Ozzies, Inc. (10)
   Commercial Services & Supplies      10.72%       12/23/2022        1/1/2027        2,005        2,072        2,005  
PCX Aerostructures LLC (10)
   Aerospace & Defense      9.32%       11/23/2022        12/1/2028        2,658        2,658        2,658  
Rane Light Metal Castings Inc. (10)
   Machinery      10.00%       6/1/2020        6/1/2024        159        159        159  
Rango, Inc. (10)
   Commercial Services & Supplies     
9.33-9.79%
      9/24/2019       
4/1/2023-11/1/2024
       1,940        1,960        1,904  
Royal Coach Lines, Inc.(10)
   Road & Rail      9.56%       11/21/2019        8/1/2025        849        849        775  
Royal Express Inc. (10)
   Road & Rail      9.53%       1/17/2019        2/1/2024        428        431        428  
Rotten Rock Hardscaping & Tree Service (10)
   Diversified Consumer Services      8.21%       12/6/2022        12/6/2027        245        245        245  
Signet Marine Corporation (10)
   Transportation Infrastructure      8.50%       10/31/2022        7/1/2029        14,102        14,152        14,102  
SLR Equipment Finance(2)
   Multi-Sector Holdings      8.50%       1/24/2022        1/24/2023        5,000        5,000        5,000  
Smiley Lifting Solutions, LLC(10)
   Commercial Services & Supplies     
7.82-8.28%
      6/30/2022       
9/15/2026-12/29/2029
       4,139        4,139        4,139  
ST Coaches, LLC (10)
   Road & Rail     
8.47-8.58%
      7/31/2017       
7/1/2023-1/25/2025
       1,521        1,521        1,459  
Star Coaches Inc. (10)
   Road & Rail      8.42%       3/9/2018        4/1/2025        2,887        2,887        2,591  
Superior Transportation, Inc. (10)
   Road & Rail     
10.22-10.63%
      7/31/2017        1/1/2026        3,369        3,369        3,369  
The Smedley Company & Smedley Services, Inc. (10)
   Commercial Services & Supplies      4.07%       7/31/2017        1/15/2028        1,706        1,706        1,706  
Trinity Equipment Rentals, Inc. (10)
   Commercial Services & Supplies     
7.94-8.75%
      10/8/2021       
11/1/2024-12/1/2026
       577        577        577  
U.S. Crane & Rigging, LLC (10)
   Commercial Services & Supplies      10.92%       12/23/2022        3/1/2027        2,005        2,005        2,005  
Up Trucking Services, LLC (10)
   Road & Rail      11.21%       3/23/2018        8/1/2024        469        473        469  
Wind River Environmental, LLC (10)
   Diversified Consumer Services     
8.43-10.00%
      7/31/2019       
8/1/2024-10/5/2025
       604        605        604  
Womble Company, Inc. (10)
   Energy Equipment & Services      9.11%       12/27/2019        1/1/2025        386        386        371  
Worldwide Flight Services, Inc. (10)
   Transportation Infrastructure     
8.32-9.36%
      9/23/2022       
9/23/2027-10/28/2027
       304        308        304  
Zamborelli Enterprises Pacific Souther Foundation (10)
   Diversified Consumer Services      8.91%       12/7/2022        1/1/2027        707        714        707  
      
Shares/Units
               
SLR Equipment Finance Equity Interests (2)(9)(17)*
   Multi-Sector Holdings        7/31/2017           200        145,000        120,820  
                
 
 
    
 
 
 
Total Equipment Financing
                
$
291,445
 
  
$
265,952
 
                
 
 
    
 
 
 
See notes to consolidated financial statements.
 
13
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
 
Description
  
Industry
  
Interest Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Preferred Equity – 0.4%
                
SOINT, LLC (2)(3)(4)
   Aerospace & Defense      5.00 %
(11)
 
    6/8/2012        6/30/2023        49,273      $ 4,927      $ 3,801  
                
 
 
    
 
 
 
 
Description
  
Industry
  
Acquisition
Date
    
Shares/Units
    
Cost
    
Fair
Value
 
Common Equity/Equity Interests/Warrants—57.1%
              
aTyr Pharma, Inc. Warrants *
   Pharmaceuticals      11/18/2016        6,347      $ 106      $  
CardioFocus, Inc. Warrants *
   Health Care Equipment & Supplies      3/31/2017        90        51         
Centrexion Therapeutics, Inc. Warrants *
   Pharmaceuticals      6/28/2019        289,102        136        82  
Conventus Orthopaedics, Inc. Warrants *
   Health Care Equipment & Supplies      6/15/2016        157,500        65         
Delphinus Medical Technologies, Inc. Warrants *
   Health Care Equipment & Supplies      8/18/2017        444,388        74        103  
Essence Group Holdings Corporation (Lumeris) Warrants *
   Health Care Technology      3/22/2017        260,000        129        366  
KBH Topco LLC (Kingsbridge) (2)(5)(18)
   Multi-Sector Holdings      11/3/2020        73,500,000        136,596        148,444  
Meditrina, Inc. Warrants *
   Health Care Equipment & Supplies      12/20/2022        29,366        23        23  
RD Holdco, Inc. (Rug Doctor) (2)*
   Diversified Consumer Services      12/23/2013        231,177        15,683         
RD Holdco, Inc. (Rug Doctor) Class B (2)*
   Diversified Consumer Services      12/23/2013        522        5,216         
RD Holdco, Inc. (Rug Doctor) Warrants (2)*
   Diversified Consumer Services      12/23/2013        30,370        381         
Senseonics Holdings, Inc. (3)(8)*
   Health Care Equipment & Supplies      7/25/2019        469,353        235        483  
SLR Business Credit (2)(3)(19)
   Diversified Financial Services      4/1/2022        100        81,583        89,370  
SLR Credit Solutions (2)(3)(20)
   Diversified Financial Services      12/28/2012        280,303        280,737        288,760  
SLR Healthcare ABL (2)(3)(21)
   Diversified Financial Services      4/1/2022        32,839        34,335        34,350  
SLR Senior Lending Program LLC (2)(3)(25)
   Asset Management      12/1/2022               9,500        9,426  
Spectrum Pharmaceuticals, Inc. Warrants *
   Biotechnology      9/21/2022        159,470        51        15  
Vapotherm, Inc. Warrants*
   Health Care Equipment & Supplies      2/18/2022        36,996        210        87  
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics)
   Health Care Equipment & Supplies      5/10/2018        33,430        152         
           
 
 
    
 
 
 
Total Common Equity/Equity Interests/Warrants
 
  
$
565,263
 
  
$
571,509
 
           
 
 
    
 
 
 
Total Investments (6) — 208.7%
 
  
$
2,134,587
 
  
$
2,086,676
 
           
 
 
    
 
 
 
 
Description
  
Industry
    
Acquisition
Date
    
Maturity

Date
    
Par Amount
               
Cash Equivalents — 41.8%
                 
U.S. Treasury Bill
     Government        12/30/2022        2/23/2023      $ 420,000      $ 417,590      $ 417,590  
              
 
 
    
 
 
 
Total Investments & Cash Equivalents —250.5%
              
$
2,552,177
    
$
2,504,266
 
Liabilities in Excess of Other Assets — (150.5%)
                    (1,504,535
                 
 
 
 
Net Assets — 100.0%
                 
$
999,731
 
                 
 
 
 
 
(1)
Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022.
(2)
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows:
 
Name of Issuer
  
Fair Value at
December 31,
2021
    
Gross
Additions
    
Gross
Reductions
   
Realized
Gain
(Loss)
    
Change in
Unrealized
Gain
(Loss)
   
Fair Value at
December 31,
2022
    
Interest/
Dividend
Income
 
Equipment Operating Leases, LLC
   $ 18,939      $      $ (15,833   $      $ 635     $ 3,741      $ 749  
Kingsbridge Holdings, LLC
     80,000                            (87     80,000        7,402  
KBH Topco, LLC (Kingsbridge)
     145,996                            2,448       148,444        15,225  
Loyer Capital LLC
     10,725               (3,500            136       7,361        1,003  
RD Holdco, Inc. (Rug Doctor, common equity)
                                              
RD Holdco, Inc. (Rug Doctor, class B)
     5,216                            (5,216             
RD Holdco, Inc. (Rug Doctor, warrants)
                                              
RD Holdco, Inc. (debt)
     11,829        685                     (5,280     6,521        (18
SLR Business Credit
            81,583                     7,787       89,370        5,150  
SLR Credit Solutions
     298,766                            (10,006     288,760        20,500  
SLR Equipment Finance (equity)
     129,102                            (8,282     120,820         
SLR Equipment Finance (debt)
            5,000                           5,000        379  
SLR Healthcare ABL
            34,335                     15       34,350        2,595  
SLR Senior Lending Program LLC
            9,500                     (74     9,426         
SOAGG LLC
     1,121               (447            (674            647  
SOINT, LLC
     4,509        266        (942            (32     3,801        266  
  
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
   $ 706,203      $ 131,369      $ (20,722   $      $ (18,630   $ 797,594      $ 53,898  
  
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
See notes to consolidated financial statements.
 
14

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands)
 
 
(3)
Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making
follow-on
investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis,
non-qualifying
assets in the portfolio represented 24.2% of the total assets of the Company.
(4)
The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.
(5)
Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
(6)
Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
(7)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
(8)
Denotes a Level 1 investment.
(9)
SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
(10)
Indicates an investment that is wholly held by the Company through NEFPASS LLC.
(11)
Interest is paid in kind (“PIK”).
(12)
Denotes a subsidiary of SLR Equipment Finance.
(13)
OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are
co-borrowers.
(14)
AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each
co-Borrowers.
Amerimark may elect to defer up to 8.00% of the coupon as PIK.
(15)
Spread is 5.75% Cash / 0.50% PIK.
(16)
Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
(17)
See note 10 to the consolidated financial statements.
(18)
See note 11 to the consolidated financial statements.
(19)
See note 13 to the consolidated financial statements.
(20)
See note 9 to the consolidated financial statements.
(21)
See note 12 to the consolidated financial statements.
(22)
BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.
(23)
OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK.
(24)
Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.
(25)
See note 17 to the consolidated financial statements.
(26)
iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.
*
Non-income
producing security.
**
Investment is on
non-accrual
status.
See notes to consolidated financial statements.
 
15
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands)
 
Industry Classification
  
Percentage of Total
Investments (at fair value) as
of December 31, 2022
 
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL)
     22.1
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)
     17.5
Health Care Providers & Services
     7.7
Health Care Equipment & Supplies
     6.6
Pharmaceuticals
     5.5
Software
     4.3
Insurance
     4.2
Biotechnology
     3.9
Diversified Consumer Services
     2.7
Media
     1.9
Road & Rail
     1.7
Personal Products
     1.7
Capital Markets
     1.7
Thrifts & Mortgage Finance
     1.3
Life Sciences Tools & Services
     1.3
Auto Parts & Equipment
     1.2
Packaged Foods & Meats
     1.2
Wireless Telecommunication Services
     1.1
Commercial Services & Supplies
     1.1
Internet & Catalog Retail
     1.1
Internet Software & Services
     1.0
Building Products
     0.9
Trading Companies & Distributors
     0.9
Health Care Technology
     0.8
Transportation Infrastructure
     0.7
Communications Equipment
     0.7
IT Services
     0.6
Leisure Equipment & Products
     0.5
Specialty Retail
     0.5
Asset Management
     0.5
Food Products
     0.4
Auto Components
     0.4
Airlines
     0.3
Hotels, Restaurants & Leisure
     0.3
Oil, Gas & Consumable Fuels
     0.3
Aerospace & Defense
     0.3
Machinery
     0.3
Footwear
     0.3
Metals & Mining
     0.2
Food & Staples Retailing
     0.1
Water Utilities
     0.1
Consumer Finance
     0.1
Construction & Engineering
     0.0
Energy Equipment & Services
     0.0
Containers & Packaging
     0.0
  
 
 
 
Total Investments
     100.0
  
 
 
 
See notes to consolidated financial statements.
 
16

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
September 30, 2023
(in thousands, except share amounts)
 
Note 1. Organization
SLR Investment Corp. (the “Company”, “SLRC”, “we”, “us” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.
The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.
On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”) pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders.
Note 2. Significant Accounting Policies
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.
Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form
10-Q
and Regulation
S-X,
as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2023.
 
17

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included.
The significant accounting policies consistently followed by the Company are:
 
  (a)
Investment transactions are accounted for on the trade date;
 
  (b)
Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under GAAP, the Board has approved a multi-step valuation process each quarter, as described below:
 
  (1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
  (2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
  (3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
  (4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
  (5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
 
18

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the nine months ended September 30, 2023, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
 
  (c)
Gains or losses on investments are calculated by using the specific identification method.
 
  (d)
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other
non-recurring
fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned.
 
  (e)
The Company intends to comply with the applicable provisions of the Code pertaining to RICs to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.
 
  (f)
Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.
 
  (g)
Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.
 
  (h)
In accordance with Regulation
S-X
and ASC Topic 810—
Consolidation
, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.
 
19

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
  (i)
The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.
 
  (j)
In accordance with ASC
835-30,
the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.
 
  (k)
The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are
marked-to-market
by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.
 
  (l)
The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC
946-20-25.
 
  (m)
Investments that are expected to pay regularly scheduled interest in cash are generally placed on
non-accrual
status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.
 
  (n)
The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.
 
20

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
Note 3. Agreements
The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the
day-to-day
operations of, and provides investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee).
Pre-incentive
fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s
pre-incentive
fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s
pre-incentive
fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s
pre-incentive
fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately
pro-rated
for any period of less than three months.
The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross
investment-by-investment
basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three and nine months ended September 30, 2023 and 2022.
For the three and nine months ended September 30, 2023, the Company recognized $8,051 and $23,635, respectively, in base management fees and $5,796 and $16,943, respectively, in performance-based incentive fees. For the three and nine months ended September 30, 2023, $175 and $410, respectively, of such performance-based incentive fees were waived. For the three and nine months ended September 30, 2022, the Company recognized $7,890 and $22,019, respectively, in base management fees and $4,965 and $9,699, respectively, in gross performance-based incentive fees. For the three and nine months ended September 30, 2022, $194 and $1,552 of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment
Adviser.     
The Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.
For the three and nine months ended September 30, 2023, the Company recognized expenses under the Administration Agreement of $1,575 and $4,563 respectively. For the three and nine months ended September 30, 2022, the Company recognized expenses under the Administration Agreement of $1,132 and $3,684 respectively. No managerial assistance fees were accrued or collected for the three and nine months ended September 30, 2023 and 2022.
 
21

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
Note 4. Net Asset Value Per Share
At September 30, 2023, the Company’s total net assets and net asset value per share were $985,385 and $18.06, respectively. This compares to total net assets and net asset value per share at December 31, 2022 of $999,731 and $18.33, respectively.
Note 5. Earnings Per Share
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the three and nine months ended September 30, 2023 and 2022:
 
    
Three months ended September 30,
    
Nine months ended September 30,
 
    
2023
    
2022
    
2023
    
2022
 
Earnings (loss) per share (basic & diluted)
                                   
Numerator—net increase (decrease) in net assets resulting from operations:
   $ 26,947      $ 13,528      $ 52,766      $ (655
Denominator – weighted average shares:
     54,554,634        54,772,651        54,554,639        50,647,874  
Earnings (loss) per share:
   $ 0.49      $ 0.25      $ 0.97      ($ 0.01
Note 6. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level
 1.
 Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
Level
 2.
 Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:
 
  a)
Quoted prices for similar assets or liabilities in active markets;
 
  b)
Quoted prices for identical or similar assets or liabilities in
non-active
markets;
 
  c)
Pricing models whose inputs are observable for substantially the full term of the asset or liability; and
 
  d)
Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.
Level
 3.
Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.
When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).
Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.
 
22

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
The following tables present the balances of assets measured at fair value on a recurring basis, as of September 30, 2023 and December 31, 2022:
Fair Value Measurements
As of September 30, 2023
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
                                            
Senior Secured Loans
   $      $      $ 1,300,366      $      $ 1,300,366  
Equipment Financing
                   265,306               265,306  
Preferred Equity
                   3,801               3,801  
Common Equity/Equity Interests/Warrants
     315               571,991        29,277        601,583  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 315      $      $ 2,141,464      $ 29,277      $ 2,171,056  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value Measurements
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
                                            
Senior Secured Loans
   $      $      $ 1,245,414      $      $ 1,245,414  
Equipment Financing
                   265,952               265,952  
Preferred Equity
                   3,801               3,801  
Common Equity/Equity Interests/Warrants
     483               561,600        9,426        571,509  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 483      $      $ 2,076,767      $ 9,426      $ 2,086,676  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
In accordance with ASC
820-10,
certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
 
23

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
The following tables provide a summary of the changes in fair value of Level 3 assets for the three and nine months ended September 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at September 30, 2023:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
    
Equipment

Financing
    
Preferred Equity
    
Common Equity/
Equity
Interests/
Warrants
    
Total
 
Fair value, June
 30, 2023
   $ 1,318,512      $ 271,333      $ 3,801      $ 566,427      $ 2,160,073  
Total gains or losses included in earnings:
                                            
Net realized loss
     (29,555                           (29,555
Net change in unrealized gain (loss)
     41,505        190        (64      (7,280      34,351  
Purchase of investment securities
*
     168,421        4,190        64        12,895        185,570  
Proceeds from dispositions of investment securities
     (198,517      (10,407             (51      (208,975
Transfers in/out of Level 3
                                  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair value, September
 30, 2023
   $ 1,300,366      $ 265,306      $ 3,801      $ 571,991      $ 2,141,464  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                            
Net change in unrealized gain (loss)
   $ 9,782      $ 190      $ (64)      $ (7,251    $ 2,657  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
Senior Secured
Loans
    
Equipment

Financing
    
Preferred Equity
    
Common Equity/
Equity
Interests/
Warrants
    
Total
 
Fair value, December
 31, 2022
   $ 1,245,414      $ 265,952      $ 3,801      $ 561,600      $ 2,076,767  
Total gains or losses included in earnings:
                                            
Net realized loss
     (28,398                           (28,398
Net change in unrealized gain (loss)
     35,682        111        (187      (21,639      13,967  
Purchase of investment securities
*
     488,757        34,274        187        32,081        555,299  
Proceeds from dispositions of investment securities
     (441,089      (35,031             (51      (476,171
Transfers in/out of Level 3
                                  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair value, September
 30, 2023
   $ 1,300,366      $ 265,306      $ 3,801      $ 571,991      $ 2,141,464  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                            
Net change in unrealized gain (loss)
   $ 29,925      $ 111      $ (187    $ (21,639    $ 8,210  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
Includes PIK capitalization and accretion of discount
While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at September 30, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $521,500, $206,250, $120,313, $80,750, $68,438, $43,375 and $119,138, respectively.
 
24

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
    
Equipment

Financing
    
Preferred Equity
    
Common Equity/
Equity
Interests/
Warrants
    
Total
 
Fair value, December
 31, 2021
   $ 939,690      $ 273,795      $ 5,630      $ 450,381      $ 1,669,496  
Total gains or losses included in earnings:
                                            
Net realized gain (loss)
     (36,244                    6        (36,238
Net change in unrealized loss
     (8,065      (6,924      (706      (5,048      (20,743
Purchase of investment securities(1)
     796,389        84,168        266        116,272        997,095  
Proceeds from dispositions of investment securities
     (446,356      (85,087      (1,389      (11      (532,843
Transfers in/out of Level 3
                                  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair value, December
 31, 2022
   $ 1,245,414      $ 265,952      $ 3,801      $ 561,600      $ 2,076,767  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                            
Net change in unrealized loss
   $ (8,920    $ (6,924    $ (706    $ (5,048    $ (21,598
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Mergers.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
      
Net change in unrealized (gain) loss
      
Borrowings
      
Repayments
     (150,000
Transfers in/out of Level 3
      
    
 
 
 
Ending fair value
   $  
    
 
 
 
The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively.
 
25

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
Quantitative Information about Level 3 Fair Value Measurements
The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.
Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of September 30, 2023 is summarized in the table below:
 
    
Asset or
Liability
    
Fair Value at
September 30, 2023
    
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
     Asset      $
$
1,292,834
7,532
 
 
   Income Approach
Recovery Analysis
  Market Yield
Recoverable Amount
  
10.1% -20.5% (12.8%)
N/A
Equipment Financing
     Asset      $
$
144,486
120,820
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
8.5% -9.5% (9.5%)
1.1x-1.4x (1.2x)
Preferred Equity
     Asset      $ 3,801      Income Approach   Market Yield   
5.0% -5.0% (5.0%)
Common Equity/Equity Interests/Warrants
     Asset      $
$
165,771
406,220
 
 
   Market Multiple
(2)
Market Approach
  Comparable Multiple
Return on Equity
  
6.3x -11.5x (8.8x)
5.5% -30.7% (10.7%)
 
(1)
Includes $120,820 of investments valued using an implied multiple.
(2)
Includes $855 of investments valued using a Black-Scholes model and $164,916 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below:
 
    
Asset or
Liability
    
Fair Value at
December 31, 2022
    
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
     Asset      $
$
1,212,842
32,572
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
9.4% -18.2% (12.0%)
0.1x-21.4x (12.4x)
Equipment Financing
     Asset      $
$
145,132
120,820
 
 
   I
ncome Approach
Market Multiple
(2)
  Market Yield
Comparable Multiple
  
8.5% -9.7% (9.7%)
1.1x-1.4x (1.2x)
Preferred Equity
     Asset      $ 3,801      I
ncome Approach
  Market Yield   
5.0% -5.0% (5.0%)
Common Equity/Equity Interests/Warrants
     Asset      $
$
149,120
412,480
 
 
   Market Multiple
(3)
Market Approach
  Comparable Multiple
Return on Equity
   7.8x –9.8x (8.8x)
6.6% -35.2% (9.2%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using an implied multiple.
(3)
Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple.
Significan
t increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving
bid-ask
spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments.
 
26

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
Note 7. Debt
Our debt obligations consisted of the following as of September 30, 2023 and December 31, 2022:
 
    
September 30, 2023
   
December 31, 2022
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 521,500      $ 517,582
(1)
 
  $ 393,000      $ 388,254
(1)
 
SPV Credit Facility
     206,250        205,263
(2)
 
    155,200        154,302
(2)
 
2023 Unsecured Notes
                  75,000        74,979
(3)
 
2024 Unsecured Notes
     125,000        124,637
(4)
 
    125,000        124,421
(4)
 
2025 Unsecured Notes
     85,000        84,738
(5)
 
    85,000        84,613
(5)
 
2026 Unsecured Notes
     75,000        74,586
(6)
 
    75,000        74,498
(6)
 
2027 Unsecured Notes
     50,000        49,963
(7)
 
    50,000        49,953
(7)
 
2027 Series F Unsecured Notes
     135,000        134,985
(8)
 
    135,000        134,978
(8)
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 1,197,750      $ 1,191,754     $ 1,093,200      $ 1,085,998  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $3,918 and $4,746 as of September 30, 2023 and December 31, 2022, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $987 and $898 as of September 30, 2023 and December 31, 2022, respectively.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $363 and $579 as of September 30, 2023 and December 31, 2022, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized market discount of $262 and $387 as of September 30, 2023 and December 31, 2022, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $414 and $502 as of September 30, 2023 and December 31, 2022, respectively.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $37 and $47 as of September 30, 2023 and December 31, 2022, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $15 and $22 as of September 30, 2023 and December 31, 2022, respectively.
Unsecured Notes
On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
 
27

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full on the maturity date, January 20, 2023
.     
Revolving and Term Loan Facilities
On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, subsequent to an August 29, 2023 amendment, the commitment under the SPV Credit Facility is $275,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is SOFR plus
2.00%-2.50%
with no SOFR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2023, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $206,250.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment, a
$25,000 
November 2022 upsizing and 
a $40,000
August 2023 commitment expiration, the Credit Facility is composed of $585,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At September 30, 2023, outstanding USD equivalent borrowings under the Credit Facility totaled $521,500, composed of $421,500 of revolving credit and $100,000 of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.
The average annualized interest cost for all borrowings for the nine months ended September 30, 2023 and the year ended December 31, 2022 was 5.79% and 4.09%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the nine months ended September 30, 2023 and the year ended December 31, 2022 were $1,273,200 and $1,164,200, respectively.
 
28

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
Note 8. Financial Highlights
The following is a schedule of financial highlights for the nine months ended September 30, 2023 and 2022:
 
    
Nine months ended
September 30, 2023
   
Nine months ended
September 30, 2022
 
Per Share Data: (a)
                
Net asset value, beginning of year
   $ 18.33     $ 19.93  
    
 
 
   
 
 
 
Net investment income
     1.25       1.06  
Net realized and unrealized loss
     (0.29     (1.08 )* 
    
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     0.96       (0.02
Issuance of common stock in connection with the Mergers
     —        (0.31
Distributions to stockholders:
                
From distributable earnings
     (1.23     (1.06
From return of capital
           (0.17
    
 
 
   
 
 
 
Net asset value, end of period
   $ 18.06     $ 18.37  
    
 
 
   
 
 
 
Per share market value, end of period
   $ 15.39     $ 12.32  
Total Return (b)(c)
     20.07     (27.75 %) 
Net assets, end of period
   $ 985,385     $ 1,006,225  
Shares outstanding, end of period
     54,554,634       54,772,651  
Ratios to average net assets (c):
                
Net investment income
     6.90     5.51
    
 
 
   
 
 
 
Operating expenses
     4.89 %**      3.90 %** 
Interest and other credit facility expenses
     5.37     3.22
    
 
 
   
 
 
 
Total expenses
     10.26 %**      7.12 %** 
    
 
 
   
 
 
 
Average debt outstanding
   $ 1,161,095     $ 951,995  
Portfolio turnover ratio
     22.1     13.8
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period.
(b)
Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2022 and December 31, 2021 was $13.91 and $18.43, respectively. Total return does not include a sales load.
(c)
Not annualized for periods less than one year.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the nine months ended September 30, 2023, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.93% and 10.30%, respectively, without the performance-based incentive fee waiver. For the nine months ended September 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.06% and 7.28%, respectively, without the performance-based incentive fee waiver.
Note 9. SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of September 30, 2023, total commitments to the revolving credit facility are $300,000.
As of September 30, 2023 SLR Credit had 32 funded commitments to 28 different issuers with total funded loans of approximately $469,495 on total assets of $506,081. As of December 31, 2022 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439,484 on total assets of $460,683. As of September 30, 2023 and December 31, 2022, the largest loan outstanding totaled $40,725 and $33,420, respectively. For the same periods, the average exposure per issuer was $16,768 and $17,579, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $284,472 and $224,325 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Credit had net income of $4,315 and $3,897, respectively, on gross income of $13,897 and $8,596, respectively. For the nine months ended September 30, 2023 and 2022, SLR Credit had net income of $1,411 and $8,557, respectively, on gross income of $42,350 and $22,171, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
 
29

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
Note 10. SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000
non-recourse
facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023. In June 2023, the facility was amended to extend the maturity date to January 31, 2024, with updated commitments totaling $152,147, effective August 1, 2023.
As of September 30, 2023, SLR Equipment had 141 funded equipment-backed leases and loans to 56 different customers with a total net investment in leases and loans of approximately $199,831 on total assets of $251,031. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190,830 on total assets of $241,813. As of September 30, 2023 and December 31, 2022, the largest position outstanding totaled $18,319 and $19,259, respectively. For the same periods, the average exposure per customer was $3,568 and $3,234, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $130,557 and $114,977 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and September 30, 2022, SLR Equipment had net income (loss) of ($1,176) and $1,034, respectively, on gross income of $4,783 and $6,486, respectively. For the nine months ended September 30, 2023 and September 30, 2022, SLR Equipment had net loss of $2,193 and $125, respectively, on gross income of $15,174 and $15,704, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
Note 11. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of September 30, 2023 and December 31, 2022, KBHT had total assets of $783,089 and $777,151, respectively. For the same periods, debt recourse to KBHT totaled $239,505 and $222,094, respectively, and
non-recourse
debt totaled $353,415 and $353,128, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2023 and 2022, KBHT had net income of $2,129 and $3,327, respectively, on gross income of $85,544 and $71,332, respectively. For the nine months ended September 30, 2023 and 2022, KBHT had net income of $7,151 and $10,393, respectively, on gross income of $229,051 and $215,074, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
Note 12. SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of September 30, 2023, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022. Effective with an amendment dated August 24, 2023, SLR Healthcare has a $150,000
non-recourse
credit facility, which is expandable to $200,000 under its accordion facility. The maturity date of this facility is March 31, 2026.
 
30

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2023, the portfolio totaled approximately $237,000 of commitments with a total net investment in loans of $106,484 on total assets of $113,832. As of December 31, 2022, the portfolio totaled approximately $242,106 of commitments with a total net investment in loans of $92,383 on total assets of $108,705. At September 30, 2023, the portfolio consisted of 38 issuers with an average balance of approximately $2,802 versus 41 issuers with an average balance of approximately $2,253 at December 31, 2022. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $81,000 and $77,000 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Healthcare had net income of $1,532 and $822, respectively, on gross income of $4,833 and $3,020, respectively. For the nine months ended September 30, 2023 and 2022, SLR Healthcare had net income of $3,925 and $2,543, respectively, on gross income of $13,109 and $7,898, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
Note 13. SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2023, the portfolio totaled approximately $612,399 of commitments, of which $257,818 were funded, on total assets of $302,912. As of December 31, 2022, the portfolio totaled approximately $603,432 of commitments, of which $286,006 were funded, on total assets of $332,247. At September 30, 2023, the portfolio consisted of 98 issuers with an average balance of approximately $2,631 versus 108 issuers with an average balance of approximately $2,648 at December 31, 2022. NMC has a senior credit facility with a bank lending group for $285,307 which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had approximately $199,449 and $214,425 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Business Credit had net income of $1,779 and $1,977 respectively, on gross income of $9,709 and $7,607, respectively. For the nine months ended September 30, 2023 and 2022, SLR Business Credit had net income of $5,211 and $5,703 respectively, on gross income of $27,868 and $20,378, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
 
31

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
Note 14. Commitments and Contingencies
Off-Balance
Sheet Arrangements
The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of September 30, 2023 and December 31, 2022 is $367,295 and $364,163, respectively, comprised of the following:
 
    
September 30,
2023
    
December 31,
2022
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Outset Medical, Inc.
     35,084        35,084  
Apeel Technology, Inc.
     32,786        32,786  
Southern Orthodontic Partners Management, LLC
     21,931        1,918  
SLR Senior Lending Program LLC*
     21,250        40,500  
Orthopedic Care Partners Management, LLC
     20,770        1,620  
Human Interest, Inc.
     20,104        20,104  
CVAUSA Management, LLC
     18,239         
BDG Media, Inc.
     12,646        3,546  
Neuronetics, Inc.
     11,579         
ONS MSO, LLC
     10,961         
iCIMS, Inc.
     10,506        11,435  
Cerapedics, Inc.
     9,217        6,735  
Alkeme Intermediate Holdings, LLC
     8,531         
Arcutis Biotherapeutics, Inc.
     8,356        8,356  
Ardelyx, Inc.
     7,752        7,752  
West-NR
Parent, Inc.
     6,830         
United Digestive MSO Parent, LLC
     5,259         
Peter C. Foy & Associates Insurance Services, LLC
     5,062        1,094  
Luxury Asset Capital, LLC
     4,500        7,500  
UVP Management, LLC
     4,386         
Kaseya, Inc.
     3,769        3,936  
Urology Management Holdings, Inc.
     3,596         
The Townsend Company, LLC
     3,556         
SLR Equipment Finance
     3,500        1,000  
Vertos Medical, Inc.
     3,325         
Foundation Consumer Brands, LLC
     3,009        3,009  
Kid Distro Holdings, LLC
     2,650        2,650  
Maurices, Incorporated
     2,589        4,314  
Erie Construction
Mid-west,
LLC
     2,403        1,248  
Ultimate Baked Goods Midco LLC
     2,371        1,636  
Basic Fun, Inc.
     2,150        2,675  
Bayside Opco, LLC
     1,721         
SunMed Group Holdings, LLC
     1,621        843  
SCP Eye Care, LLC
     1,459        2,771  
SLR Healthcare ABL*
     1,400        1,400  
RxSense Holdings LLC
     1,250        1,250  
Enverus Holdings, Inc.
     1,239        1,004  
Tilley Distribution, Inc.
     1,158        525  
GSM Acquisition Corp.
     862        784  
Composite Technology Acquisition Corp
     796        1,537  
High Street Buyer, Inc.
     631        327  
CC SAG Holdings Corp. (Spectrum Automotive)
     548        20,670  
ENS Holdings III Corp, LLC
     461        144  
Pinnacle Treatment Centers, Inc.
     386        1,745  
Vessco Midco Holdings, LLC
     327        3,892  
TAUC Management, LLC
     294        294  
All States Ag Parts, LLC
     212        135  
Glooko, Inc.
            17,868  
World Insurance Associates, LLC
            17,117  
Spectrum Pharmaceuticals, Inc.
            8,771  
Atria Wealth Solutions, Inc.
            8,215  
Accession Risk Management Group, Inc.
            7,498  
Copper River Seafoods, Inc.
            3,595  
Meditrina, Inc.
            3,367  
One Touch Direct, LLC
            3,069  
DeepIntent, Inc.
            3,049  
Plastics Management, LLC
            2,424  
Pediatric Home Respiratory Services, LLC
            1,805  
Ivy Fertility Services, LLC
            1,571  
NAC Holdings Corporation
            1,479  
SPAR Marketing Force, Inc.
            1,338  
Montefiore Nyack Hospital
            1,034  
American Teleconferencing Services, Ltd
            1,090  
BayMark Health Services, Inc.
            391  
    
 
 
    
 
 
 
Total Commitments
   $ 367,295      $ 364,163  
    
 
 
    
 
 
 
 
*
The Company controls the funding of these commitments and may cancel them at its discretion.
 
32
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the respective portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of September 30, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
Note 15. Capital Share Transactions
As of September 30, 2023 and September 30, 2022, 200,000,000 shares of $0.01 par value capital stock were authorized.
Transactions in capital stock were as follows:
 
    
Shares
    
Amount
 
    
Three months ended
September 30, 2023
    
Three months ended
September 30, 2022
    
Three months ended
September 30, 2023
    
Three months ended
September 30, 2022
 
Shares issued in connection with the Mergers
                 $      $  
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
                 $      $  
    
 
 
    
 
 
    
 
 
    
 
 
 
     
    
Shares
    
Amount
 
    
Nine months ended
September 30, 2023
    
Nine months ended
September 30, 2022
    
Nine months ended
September 30, 2023
    
Nine months ended
September 30, 2022
 
Shares issued in connection with the Mergers
            12,511,825      $      $ 226,839  
Shares repurchased
     (746           $ (10    $  
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     (746      12,511,825      $ (10    $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
Note 16. Stock Repurchase Program
On May 9, 2023, our Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 10, 2024 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. For the nine months ended September 30, 2023, the Company repurchased 746 shares at an average price of approximately $14.02 per share, inclusive of commissions. The total dollar amount of shares repurchased for the nine months ended September 30, 2023 was $10. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2022 was $3,038.
 
33

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
Note 17. SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2023, there were $79,200 of borrowings outstanding on the SSLP Facility.
As of September 30, 2023, the Company and the Investor had contributed combined equity capital in the amount of $57,500. As of September 30, 2023, the Company and the Investors’ remaining commitments to SSLP totaled $21,250 and $21,250, respectively. The Company, along with the Investor, controls the funding of SSLP and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor.
As of September 30, 2023 and December 31, 2022, SSLP had total assets of $137,447 and $19,105, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 27 and 7 different borrowers, respectively. For the three months ended September 30, 2023, SSLP invested $57,456 in 16 portfolio companies. Investments prepaid totaled $1,658 for the three months ended September 30, 2023. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in 7 portfolio companies. Investments prepaid totaled $68 for the period December 1, 2022 (commencement of operations) through December 31, 2022.
 
34

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
SSLP Portfolio as of September 30, 2023
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Accession Risk Management Group, Inc.
(4)
   Insurance      S+550        0.75     11.02     11/1/26      $ 9,078      $ 9,078      $ 9,078  
Aegis Toxicology Sciences Corporation
(4)
   Health Care Providers & Services      S+550        1.00     11.13     5/9/25        2,960        2,960        2,960  
Alkeme Intermediary Holdings, LLC
(4)
   Insurance      S+650        1.00     11.92     10/28/26        3,021        2,931        2,930  
All States Ag Parts, LLC
(4)
   Trading Companies & Distributors      S+600        1.00     11.60     9/1/26        2,138        2,138        2,138  
Atria Wealth Solutions, Inc.
(4)
   Diversified Financial Services      S+650        1.00     12.15     2/29/24        2,475        2,475        2,475  
BayMark Health Services, Inc.
(4)
   Health Care Providers & Services      S+500        1.00     10.65     6/11/27        4,043        4,043        4,043  
CC SAG Holdings Corp.
(4)
   Diversified Consumer Services      S+575        0.75     11.18     6/29/28        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
   Trading Companies & Distributors      S+475        1.00     10.24     12/31/25        1,089        1,089        1,089  
Fertility (ITC) Investment Holdco, LLC
(4)
   Health Care Providers & Services      S+650        1.00     11.63     1/3/29        5,970        5,799        5,970  
Foundation Consumer Brands, LLC
(4)
   Personal Products      S+625        1.00     11.77     2/12/27        8,911        8,911        8,911  
High Street Buyer, Inc.
(4)
   Insurance      S+600        0.75     11.54     4/16/28        4,433        4,433        4,433  
iCIMS, Inc.
(4)
   Software      S+725        0.75     12.14     8/18/28        3,059        3,028        3,059  
Kaseya, Inc.
(4)
   Software      S+625        0.75     11.58     6/23/29        9,000        9,000        9,000  
Kid Distro Holdings, LLC
(4)
   Software      S+550        1.00     11.04     10/1/27        8,962        8,962        8,962  
ONS MSO, LLC
(4)
   Health Care Providers & Services      S+625        1.00     11.62     7/8/25        5,936        5,779        5,936  
PhyNet Dermatology LLC
(4)
   Health Care Providers & Services      S+625        1.00     11.45     8/16/24        5,964        5,964        5,964  
Pinnacle Treatment Centers, Inc.
(4)
   Health Care Providers & Services      S+675        1.00     12.10     1/2/26        4,725        4,725        4,725  
Plastics Management, LLC
(4)
   Health Care Providers & Services      S+500        1.00     10.44     8/18/27        5,651        5,476        5,651  
RQM+ Corp.
(4)
   Life Sciences Tools & Services      S+575        1.00     11.40     8/12/26        5,970        5,970        5,970  
RxSense Holdings LLC
(4)
   Diversified Consumer Services      S+500        1.00     10.47     3/13/26        2,977        2,977        2,977  
SunMed Group Holdings, LLC
(4)
   Health Care Equipment & Supplies      S+550        0.75     10.99     6/16/28        8,971        8,971        8,971  
The Townsend Company, LLC
(4)
   Commercial Services & Supplies      S+625        1.00     11.57     8/15/29        3,570        3,482        3,481  
Tilley Distribution, Inc.
(4)
   Trading Companies & Distributors      S+600        1.00     11.54     12/31/26        5,963        5,963        5,963  
Ultimate Baked Goods Midco LLC
(4)
   Packaged Foods & Meats      S+625        1.00     11.67     8/13/27        8,977        8,977        8,977  
Urology Management Holdings, Inc.
(4)
   Health Care Providers & Services      S+625        1.00     11.79     6/15/26        2,465        2,403        2,440  
Vessco Midco Holdings, LLC
(4)
   Water Utilities      S+450        1.00     9.92     11/2/26        1,845        1,845        1,845  
West-NR
Parent, Inc.
(4)
   Insurance      S+625        1.00     11.72     12/27/27        2,674        2,622        2,621  
                                                    
 
 
    
 
 
 
                                                     $ 132,993      $ 133,561  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of September 30, 2023.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
 
35

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
SSLP Portfolio as of December 31, 2022
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
   Diversified Financial Services      S+600        1.00     10.84     2/29/24      $ 2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
   Health Care Providers & Services      L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
   Trading Companies & Distributors      L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
   Personal Products      L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
   Insurance      L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
   Health Care Providers & Services      L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
   Software      L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                                                    
 
 
    
 
 
 
                                                     $ 18,032      $ 18,062  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Below is certain summarized financial information for SSLP as of September 30, 2023 and December 31, 2022 and for the three and nine months ended September 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
    
September 30,
2023
    
December 31,
2022
 
Selected Balance Sheet Information for SSLP:
                 
Investments at fair value (cost $132,993 and $18,032, respectively)
   $ 133,561      $ 18,062  
Cash and other assets
     3,886        1,043  
    
 
 
    
 
 
 
Total assets
   $ 137,447      $ 19,105  
    
 
 
    
 
 
 
Debt outstanding
   $ 77,826      $  
Distributions payable
     500         
Interest payable and other credit facility related expenses
     358        165  
Accrued expenses and other payables
     209        89  
    
 
 
    
 
 
 
Total liabilities
   $ 78,893      $ 254  
    
 
 
    
 
 
 
Members’ equity
   $ 58,554      $ 18,851  
    
 
 
    
 
 
 
Total liabilities and members’ equity
   $ 137,447      $ 19,105  
    
 
 
    
 
 
 
 
36
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2023
(in thousands, except share amounts)
 
    
For the three
months ended
September 30,
2023
    
For the nine
months ended
September 30,
2023
    
For the period
December 1, 2022
(commencement
of operations) to
December 31,
2022
 
Selected Income Statement Information for SSLP:
        
Interest income
   $ 2,757      $ 5,371      $ 152  
  
 
 
    
 
 
    
 
 
 
Service fees*
     66        123      $ 4  
Interest and other credit facility expenses
     1,773        4,025        166  
Organizational costs
                   73  
Other general and administrative expenses
     32        89        88  
  
 
 
    
 
 
    
 
 
 
Total expenses
     1,871        4,237        331  
  
 
 
    
 
 
    
 
 
 
Net investment income (loss)
   $ 886      $ 1,134      $ (179
  
 
 
    
 
 
    
 
 
 
Realized gain on investments
            30         
Net change in unrealized gain on investments
     177        538        30  
  
 
 
    
 
 
    
 
 
 
Net realized and unrealized gain on investments
   $ 177      $ 568        30  
  
 
 
    
 
 
    
 
 
 
Net income (loss)
   $ 1,063      $ 1,702      $ (149
  
 
 
    
 
 
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
Note 18. Subsequent Events
The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.
On November 7, 2023, the Board declared a quarterly distribution of $0.41 per share payable on December 28, 2023 to holders of record as of December 14, 2023.
 
37

Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
SLR Investment Corp.:
Results of Review of Interim Financial Information
We have reviewed the consolidated statement of assets and liabilities of SLR Investment Corp. (and subsidiaries) (the Company), including the consolidated schedule of investments, as of September 30, 2023, the related consolidated statements of operations and changes in net assets, for the three-month and nine-month periods ended September 30, 2023 and 2022, the related consolidated statements of cash flows for the nine-month periods ended September 30, 2023 and 2022, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statement of assets and liabilities, including the consolidated schedule of investments, of the Company as of December 31, 2022, and the related consolidated statements of operations, changes in net assets, and cash flows for the year then ended (not presented herein); and in our report dated February 28, 2023, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated statement of assets and liabilities, including the consolidated schedule of investments, as of December 31, 2022, is fairly stated, in all material respects, in relation to the consolidated statement of assets and liabilities, including the consolidated schedule of investments, from which it has been derived.
Basis for Review Results
This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
 
/s/ KPMG LLP
New York, New York
November 7, 2023
 
 
38

Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
The information contained in this section should be read in conjunction with our consolidated financial statements and notes thereto appearing elsewhere in this report.
Some of the statements in this report constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained herein involve risks and uncertainties, including statements as to:
 
 
 
our future operating results, including our ability to achieve objectives;
 
 
 
our business prospects and the prospects of our portfolio companies;
 
 
 
the impact of investments that we expect to make;
 
 
 
our contractual arrangements and relationships with third parties;
 
 
 
the dependence of our future success on the general economy and its impact on the industries in which we invest;
 
 
 
the impact of any protracted decline in the liquidity of credit markets on our business;
 
 
 
the ability of our portfolio companies to achieve their objectives;
 
 
 
the valuation of our investments in portfolio companies, particularly those having no liquid trading market;
 
 
 
market conditions and our ability to access alternative debt markets and additional debt and equity capital;
 
 
 
our expected financings and investments;
 
 
 
the adequacy of our cash resources and working capital;
 
 
 
the timing of cash flows, if any, from the operations of our portfolio companies;
 
 
 
the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments;
 
 
 
the ability of the Investment Adviser to attract and retain highly talented professionals;
 
 
 
the ability of the Investment Adviser to adequately allocate investment opportunities among the Company and its other advisory clients;
 
 
 
any conflicts of interest posed by the structure of the management fee and incentive fee to be paid to the Investment Adviser;
 
 
 
changes in political, economic or industry conditions, relations between the United States, Russia, Ukraine and other nations, the interest rate environment or conditions affecting the financial and capital markets;
 
 
 
the escalating conflict in the Middle East;
 
 
 
changes in the general economy, slowing economy, rising inflation, risk of recession and risks in respect of a failure to increase the U.S. debt ceiling; and
 
 
 
our ability to anticipate and identify evolving market expectations with respect to environmental, social and governance matters, including the environmental impacts of our portfolio companies’ supply chains and operations.
These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:
 
 
 
an economic downturn could impair our portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of our investments in such portfolio companies;
 
 
 
a contraction of available credit and/or an inability to access the equity markets could impair our lending and investment activities;
 
 
 
interest rate volatility could adversely affect our results, particularly because we use leverage as part of our investment strategy;
 
 
 
currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to the extent that we receive payments denominated in foreign currency rather than U.S. dollars;
 
 
 
the risks, uncertainties and other factors we identify in Item 1A. —   Risk Factors contained in our Annual Report on Form
10-K
for the year ended December 31, 2022, elsewhere in this Quarterly Report on Form
10-Q
and in our other filings with the SEC.
We generally use words such as “anticipates,” “believes,” “expects,” “intends” and similar expressions to identify forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements for any reason, including any factors set forth in “Risk Factors” and elsewhere in this report.
We have based the forward-looking statements included in this report on information available to us on the date of this report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including any annual reports on Form
10-K,
quarterly reports on Form
10-Q
and current reports on Form
8-K.
 
39

Overview
SLR Investment Corp. (the “Company”, “SLRC”, “we” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S federal income tax purposes, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, we priced our initial public offering, selling 5.68 million shares of our common stock. Concurrent with our initial public offering, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, and Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, collectively purchased an additional 0.6 million shares of our common stock through a private placement transaction exempt from registration under the Securities Act of 1933, as amended.
We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. Our investment objective is to generate both current income and capital appreciation through debt and equity investments. We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. Our business is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our investments generally range between $5 million and $100 million each, although we expect that this investment size will vary proportionately with the size of our capital base and/or with strategic initiatives. Our investment activities are managed by SLR Capital Partners, LLC (the “Investment Adviser”) and supervised by the board of directors (the “Board)”, a majority of whom are
non-interested,
as such term is defined in the 1940 Act. SLR Capital Management, LLC (the “Administrator”) provides the administrative services necessary for us to operate.
In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to enhance our overall returns. These investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States.
Recent Developments
On November 7, 2023, the Board declared a quarterly distribution of $0.41 per share payable on December 28, 2023 to holders of record as of December 14, 2023.
Investments
Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity for such companies, the general economic environment and the competitive environment for the types of investments we make. As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” The definition of “eligible portfolio company” includes certain public companies that do not have any securities listed on a national securities exchange and companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.
Revenue
We generate revenue primarily in the form of interest and dividend income from the securities we hold and capital gains, if any, on investment securities that we may sell. Our debt investments generally have a stated term of three to seven years and typically bear interest at a floating rate usually determined on the basis of a benchmark London interbank offered rate (“LIBOR”), the Secured Overnight Financing Rate (“SOFR”), commercial paper rate, or the prime rate. Interest on our debt investments is generally payable monthly or quarterly but may be
bi-monthly
or semi-annually. In addition, our investments may provide
payment-in-kind
(“PIK”) income. Such amounts of accrued PIK income are added to the cost of the investment on the respective capitalization dates and generally become due at maturity of the investment or upon the investment being called by the issuer. We may also generate revenue in the form of commitment, origination, structuring fees, fees for providing managerial assistance and, if applicable, consulting fees, etc.
 
40

Expenses
All investment professionals of the investment adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by the Investment Adviser. We bear all other costs and expenses of our operations and transactions, including (without limitation):
 
   
the cost of our organization and public offerings;
 
   
the cost of calculating our net asset value, including the cost of any third-party valuation services;
 
   
the cost of effecting sales and repurchases of our shares and other securities;
 
   
interest payable on debt, if any, to finance our investments;
 
   
fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees;
 
   
transfer agent and custodial fees;
 
   
fees and expenses associated with marketing efforts;
 
   
federal and state registration fees, any stock exchange listing fees;
 
   
federal, state and local taxes;
 
   
independent directors’ fees and expenses;
 
   
brokerage commissions;
 
   
fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums;
 
   
direct costs and expenses of administration, including printing, mailing, long distance telephone and staff;
 
   
fees and expenses associated with independent audits and outside legal costs;
 
   
costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and
 
   
all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs.
We expect our general and administrative operating expenses related to our ongoing operations to increase moderately in dollar terms. During periods of asset growth, we generally expect our general and administrative operating expenses to decline as a percentage of our total assets and increase during periods of asset declines. Incentive fees, interest expense and costs relating to future offerings of securities, among others, may also increase or reduce overall operating expenses based on portfolio performance, interest rate benchmarks, and offerings of our securities relative to comparative periods, among other factors.
Portfolio and Investment Activity
During the three months ended September 30, 2023, we invested approximately $187.4 million across 35 portfolio companies. This compares to investing approximately $245.4 million in 44 portfolio companies for the three months ended September 30, 2022. Investments sold, prepaid or repaid during the three months ended September 30, 2023 totaled approximately $205.6 million versus approximately $81.1 million for the three months ended September 30, 2022.
 
41

At September 30, 2023, our portfolio consisted of 154 portfolio companies and was invested 37.1% in cash flow senior secured loans, 25.2% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 22.6% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 15.1% in life science senior secured loans, in each case, measured at fair value, versus 135 portfolio companies invested 30.2% in cash flow senior secured loans, 31.9% in asset-based senior secured loans / SLR Credit, 21.6% in equipment senior secured financings / SLR Equipment / KBH, and 16.3% in life science senior secured loans, in each case, measured at fair value, at September 30, 2022.
At September 30, 2023, 78.4% or $1.68 billion of our income producing investment portfolio
*
is floating rate and 21.6% or $462.1 million is fixed rate, measured at fair value. At September 30, 2022, 79.7% or $1.71 billion of our income producing investment portfolio
*
is floating rate and 20.3% or $434.9 million is fixed rate, measured at fair value. As of September 30, 2023 and 2022, we had two and two issuers, respectively, on
non-accrual
status.
 
*
 
We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio.
SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275 million in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400 million at November 30, 2012 and a $275 million committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5.7 million. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of September 30, 2023, total commitments to the revolving credit facility are $300 million.
As of September 30, 2023, SLR Credit had 32 funded commitments to 28 different issuers with total funded loans of approximately $469.5 million on total assets of $506.1 million. As of December 31, 2022, SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439.5 million on total assets of $460.7 million. As of September 30, 2023 and December 31, 2022, the largest loan outstanding totaled $40.7 million and $33.4 million, respectively. For the same periods, the average exposure per issuer was $16.8 million and $17.6 million, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $284.5 million and $224.3 million of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Credit had net income of $4.3 million and $3.9 million, respectively, on gross income of $13.9 million and $8.6 million, respectively. For the nine months ended September 30, 2023 and 2022, SLR Credit had net income of $1.4 million and $8.6 million, respectively, on gross income of $42.4 million and $22.2 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Credit will be able to maintain consistent dividend payments to us.
SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209.9 million in cash to effect the transaction, of which $145.0 million was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64.9 million was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150.0 million
non-recourse
facility with an accordion feature to expand up to $250.0 million. In September 2019, SLR Equipment amended the facility, increasing commitments to $214.0 million with an accordion feature to expand up to $314.0, million and extended the maturity date of the facility to July 31, 2023. In June 2023, the facility was amended to extend the maturity date to January 31, 2024, with updated commitments totaling $152.1 million, effective August 1, 2023.
As of September 30, 2023, SLR Equipment had 141 funded equipment-backed leases and loans to 56 different customers with a total net investment in leases and loans of approximately $199.8 million on total assets of $251.0 million. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190.8 million on total assets of $241.8 million. As of September 30, 2023 and December 31, 2022, the largest position outstanding totaled $18.3 million and $19.3 million, respectively. For the same periods, the average exposure per customer was $3.6 million and $3.2 million, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $130.6 million and $115.0 million of borrowings outstanding at September 30, 2023 and December 31, 2022,
 
42

respectively. For the three months ended September 30, 2023 and 2022, SLR Equipment had net income (loss) of ($1.2) million and $1.0 million, respectively, on gross income of $4.8 million and $6.5 million, respectively. For the nine months ended September 30, 2023 and 2022, SLR Equipment had net loss of $2.2 million and $0.1 million, respectively, on gross income of $15.2 million and $15.7 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Equipment’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Equipment will be able to maintain consistent dividend payments to us.
Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216.6 million to effect the transaction, of which $136.6 million was invested to acquire 87.5% of KBHT’s equity and $80.0 million in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of September 30, 2023 and December 31, 2022, KBHT had total assets of $783.1 million and $777.2 million, respectively. For the same periods, debt recourse to KBHT totaled $239.5 million and $222.1 million, respectively, and
non-recourse
debt totaled $353.4 million and $353.1 million, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2023 and 2022, KBHT had net income of $2.1 million and $3.3 million, respectively, on gross income of $85.5 million and $71.3 million, respectively. For the nine months ended September 30, 2023 and 2022, KBHT had net income of $7.2 million and $10.4 million, respectively, on gross income of $229.1 million and $215.1 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32.8 million. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of September 30, 2023, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022. Effective with an amendment dated August 24, 2023, SLR Healthcare has a $150 million
non-recourse
credit facility, which is expandable to $200 million under its accordion facility. The maturity date of this facility is March 31, 2026.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2023, the portfolio totaled approximately $237.0 million of commitments with a total net investment in loans of $106.5 million on total assets of $113.8 million. As of December 31, 2022, the portfolio totaled approximately $242.1 million of commitments with a total net investment in loans of $92.4 million on total assets of $108.7 million. At September 30, 2023, the portfolio consisted of 38 issuers with an average balance of approximately $2.8 million versus 41 issuers with an average balance of approximately $2.3 million at December 31, 2022. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $81.0 million and $77.0 million of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Healthcare had net income of $1.5 million and $0.8 million, respectively, on gross income of $4.8 million and $3.0 million, respectively. For the nine months ended September 30, 2023 and 2022, SLR Healthcare had net income of $3.9 million and $2.5 million, respectively, on gross income of $13.1 million and $7.9 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Healthcare’s funded commitments, the timing of originations, and the repayment of financings, the Company cannot guarantee that SLR Healthcare will be able to maintain consistent dividend payments to us.
SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based small-to-medium-sized businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51.0 million to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation.     
 
43

Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15.5 million transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66.7 million was financed with equity from SUNS of $19.0 million and borrowings on NMC’s credit facility of $47.7 million.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2023, the portfolio totaled approximately $612.4 million of commitments, of which $257.8 million were funded, on total assets of $302.9 million. As of December 31, 2022, the portfolio totaled approximately $603.4 million of commitments, of which $286.0 million were funded, on total assets of $332.2 million. At September 30, 2023, the portfolio consisted of 98 issuers with an average balance of approximately $2.6 million versus 108 issuers with an average balance of approximately $2.6 million at December 31, 2022. NMC has a senior credit facility with a bank lending group for $285.3 million, which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had approximately $199.4 million and $214.4 million of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Business Credit had net income of $1.8 million and $2.0 million, respectively, on gross income of $9.7 million and $7.6 million, respectively. For the nine months ended September 30, 2023 and 2022, SLR Business Credit had net income of $5.2 million and $5.7 million, respectively, on gross income of $27.9 million and $20.4 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
Stock Repurchase Program
On May 9, 2023, our Board authorized an extension of a program for the purpose of repurchasing up to $50 million of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 10, 2024 or until $50 million of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. For the nine months ended September 30, 2023, the Company repurchased 746 shares at an average price of approximately $14.02 per share, inclusive of commissions. The total dollar amount of shares repurchased for the nine months ended September 30, 2023 was $0.01 million. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2022 was $3.0 million.
SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50 million, resulting in a total equity commitment of $100 million. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100 million senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2023, there were $79.2 million of borrowings outstanding on the SSLP Facility.
 
44

As of September 30, 2023 the Company and the Investor had contributed combined equity capital in the amount of $57.5 million. As of September 30, 2023, the Company and the Investor’s remaining commitments to SSLP totaled $21.25 million and $21.25 million, respectively. The Company, along with the Investor, controls the funding of SSLP, and SSLP may not call the unfunded commitments of the Company or the Investor without approval of both the Company and the Investor.
As of September 30, 2023 and December 31, 2022, SSLP had total assets of $137.4 million and $19.1 million, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 27 and 7 different borrowers, respectively. For the three months ended September 30, 2023, SSLP invested $57.5 million in 16 portfolio companies. Investments prepaid totaled $1.7 million for the three months ended September 30, 2023. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18.1 million in 7 portfolio companies. Investments prepaid totaled $0.1 million for the period December 1, 2022 (commencement of operations) through December 31, 2022.
SSLP Portfolio as of September 30, 2023 (dollar amounts in thousands)
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Accession Risk Management Group, Inc.
(4)
   Insurance      S+550        0.75     11.02     11/1/26      $ 9,078      $ 9,078      $ 9,078  
Aegis Toxicology Sciences Corporation
(4)
   Health Care Providers & Services      S+550        1.00     11.13     5/9/25        2,960        2,960        2,960  
Alkeme Intermediary Holdings, LLC
(4)
   Insurance      S+650        1.00     11.92     10/28/26        3,021        2,931        2,930  
All States Ag Parts, LLC
(4)
   Trading Companies & Distributors      S+600        1.00     11.60     9/1/26        2,138        2,138        2,138  
Atria Wealth Solutions, Inc.
(4)
   Diversified Financial Services      S+650        1.00     12.15     2/29/24        2,475        2,475        2,475  
BayMark Health Services, Inc.
(4)
   Health Care Providers & Services      S+500        1.00     10.65     6/11/27        4,043        4,043        4,043  
CC SAG Holdings Corp.
(4)
   Diversified Consumer Services      S+575        0.75     11.18     6/29/28        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
   Trading Companies & Distributors      S+475        1.00     10.24     12/31/25        1,089        1,089        1,089  
Fertility (ITC) Investment Holdco, LLC
(4)
   Health Care Providers & Services      S+650        1.00     11.63     1/3/29        5,970        5,799        5,970  
Foundation Consumer Brands, LLC
(4)
   Personal Products      S+625        1.00     11.77     2/12/27        8,911        8,911        8,911  
High Street Buyer, Inc.
(4)
   Insurance      S+600        0.75     11.54     4/16/28        4,433        4,433        4,433  
iCIMS, Inc.
(4)
   Software      S+725        0.75     12.14     8/18/28        3,059        3,028        3,059  
Kaseya, Inc.
(4)
   Software      S+625        0.75     11.58     6/23/29        9,000        9,000        9,000  
Kid Distro Holdings, LLC
(4)
   Software      S+550        1.00     11.04     10/1/27        8,962        8,962        8,962  
ONS MSO, LLC
(4)
   Health Care Providers & Services      S+625        1.00     11.62     7/8/25        5,936        5,779        5,936  
PhyNet Dermatology LLC
(4)
   Health Care Providers & Services      S+625        1.00     11.45     8/16/24        5,964        5,964        5,964  
Pinnacle Treatment Centers, Inc.
(4)
   Health Care Providers & Services      S+675        1.00     12.10     1/2/26        4,725        4,725        4,725  
Plastics Management, LLC
(4)
   Health Care Providers & Services      S+500        1.00     10.44     8/18/27        5,651        5,476        5,651  
RQM+ Corp.
(4)
   Life Sciences Tools & Services      S+575        1.00     11.40     8/12/26        5,970        5,970        5,970  
RxSense Holdings LLC
(4)
   Diversified Consumer Services      S+500        1.00     10.47     3/13/26        2,977        2,977        2,977  
SunMed Group Holdings, LLC
(4)
   Health Care Equipment &
Supplies
     S+550        0.75     10.99     6/16/28        8,971        8,971        8,971  
The Townsend Company, LLC
(4)
   Commercial Services & Supplies      S+625        1.00     11.57     8/15/29        3,570        3,482        3,481  
Tilley Distribution, Inc.
(4)
   Trading Companies & Distributors      S+600        1.00     11.54     12/31/26        5,963        5,963        5,963  
Ultimate Baked Goods Midco LLC
(4)
   Packaged Foods & Meats      S+625        1.00     11.67     8/13/27        8,977        8,977        8,977  
Urology Management Holdings, Inc.
(4)
   Health Care Providers & Services      S+625        1.00     11.79     6/15/26        2,465        2,403        2,440  
Vessco Midco Holdings, LLC
(4)
   Water Utilities      S+450        1.00     9.92     11/2/26        1,845        1,845        1,845  
West-NR
Parent, Inc.
(4)
   Insurance      S+625        1.00     11.72     12/27/27        2,674        2,622        2,621  
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of September 30, 2023.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
 
45

SSLP Portfolio as of December 31, 2022 (dollar amounts in thousands)
 
Description
  
Industry
    
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
     Diversified Financial Services        S+600        1.00     10.84     2/29/24      $  2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
     Health Care Providers & Services        L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
    
Trading Companies &
Distributors
 
 
     L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
     Personal Products        L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
     Insurance        L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
     Health Care Providers & Services        L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
     Software        L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                  
 
 
    
 
 
 
                   $  18,032      $  18,062  
                  
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Below is certain summarized financial information for SSLP as of September 30, 2023 and December 31, 2022 and for the three and nine months ended September 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
    
September 30,
2023
    
December 31,
2022
 
Selected Balance Sheet Information for SSLP (in thousands):
     
Investments at fair value (cost $132,993 and $18,032, respectively)
   $ 133,561      $ 18,062  
Cash and other assets
     3,886        1,043  
  
 
 
    
 
 
 
Total assets
   $ 137,447      $ 19,105  
  
 
 
    
 
 
 
Debt outstanding
   $ 77,826      $ —   
Distributions payable
     500        —   
Interest payable and other credit facility related expenses
     358        165  
Accrued expenses and other payables
     209        89  
  
 
 
    
 
 
 
Total liabilities
   $ 78,893      $ 254  
  
 
 
    
 
 
 
Members’ equity
   $ 58,554      $ 18,851  
  
 
 
    
 
 
 
Total liabilities and members’ equity
   $ 137,447      $ 19,105  
  
 
 
    
 
 
 
 
46

    
For the three
months ended
September 30, 2023
    
For the nine
months ended
September 30, 2023
    
For the period
December 1, 2022
(commencement of
operations) to
December 31, 2022
 
Selected Income Statement Information for SSLP (in thousands):
        
Interest income
   $ 2,757      $ 5,371      $ 152  
  
 
 
    
 
 
    
 
 
 
Service fees*
     66        123      $ 4  
Interest and other credit facility expenses
     1,773        4,025        166  
Organizational costs
     —         —         73  
Other general and administrative expenses
     32        89        88  
  
 
 
    
 
 
    
 
 
 
Total expenses
     1,871        4,237        331  
  
 
 
    
 
 
    
 
 
 
Net investment income (loss)
   $ 886      $ 1,134      $ (179
  
 
 
    
 
 
    
 
 
 
Realized gain on investments
     —         30        —   
Net change in unrealized gain on investments
     177        538        30  
  
 
 
    
 
 
    
 
 
 
Net realized and unrealized gain on investments
   $ 177      $ 568        30  
  
 
 
    
 
 
    
 
 
 
Net income (loss)
   $ 1,063      $ 1,702      $ (149
  
 
 
    
 
 
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
Critical Accounting Policies
The preparation of consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and revenues and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following items as critical accounting policies. Within the context of these critical accounting policies and disclosed subsequent events herein, we are not currently aware of any other reasonably likely events or circumstances that would result in materially different amounts being reported.
Valuation of Portfolio Investments
In December 2020, the SEC adopted new Rule
2a-5
under the 1940 Act addressing fair valuation of fund investments. The new rule sets forth requirements for good faith determinations of fair value, as well as for the performance of fair value determinations, including related oversight and reporting obligations. The new rule also defines “readily available market quotations” for purposes of the definition of “value” under the 1940 Act, and the SEC noted that this definition will apply in all contexts under the 1940 Act. The Company complies with Rule
2a-5’s
valuation requirements.
We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with GAAP, and the 1940 Act. The Board will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
It is anticipated that in respect of many of the Company’s assets, readily available market quotations will not be obtainable and that such assets will be valued at fair value. A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation.
Our valuation procedures are set forth in more detail in Note 2(b) to the Company’s Consolidated Financial Statements. Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our consolidated financial statements.
 
47

Revenue Recognition
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Investments that are expected to pay regularly scheduled interest and/or dividends in cash are generally placed on
non-accrual
status when principal or interest/dividend cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest/dividend cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest or dividends are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining interest or dividend obligations. Interest or dividend cash payments received on investments may be recognized as income or applied to principal depending upon management’s judgment. Some of our investments may have contractual PIK income. PIK income computed at the contractual rate, as applicable, is accrued and reflected as a receivable up to the capitalization date. PIK investments offer issuers the option at each payment date of making payments in cash or in additional securities. When additional securities are received, they typically have the same terms, including maturity dates and interest rates as the original securities issued. On these payment dates, the Company capitalizes the accrued interest or dividends receivable (reflecting such amounts as the basis in the additional securities received). PIK generally becomes due at the maturity of the investment or upon the investment being called by the issuer. At the point the Company believes PIK is not expected to be realized, the PIK investment will be placed on
non-accrual
status. When a PIK investment is placed on
non-accrual
status, the accrued, uncapitalized interest or dividends is reversed from the related receivable through interest or dividend income, respectively. The Company does not reverse previously capitalized PIK income. Upon capitalization, PIK is subject to the fair value estimates associated with their related investments. PIK investments on
non-accrual
status are restored to accrual status if the Company again believes that PIK is expected to be realized. Loan origination fees, original issue discount, and market discounts are capitalized and amortized into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record prepayment premiums on loans and other investments as interest income when we receive such amounts. Capital structuring fees are recorded as other income when earned.
The typically higher yields and interest rates on PIK securities, to the extent we invested, reflects the payment deferral and increased credit risk associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the
loan-to-value
ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on
non-cash
accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the three and nine months ended September 30, 2023, capitalized PIK income totaled $2.7 million and $8.9 million, respectively. For the three and nine months ended September 30, 2022, capitalized PIK income totaled $0.7 million and $1.7 million, respectively.
Net Realized Gain or Loss and Net Change in Unrealized Gain or Loss
We generally measure realized gain or loss by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized origination or commitment fees and prepayment penalties. The net change in unrealized gain or loss reflects the change in portfolio investment values during the reporting period, including the reversal of previously recorded unrealized gain or loss, when gains or losses are realized. Gains or losses on investments are calculated by using the specific identification method.
Income Taxes
SLRC, a U.S. corporation, has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. In order to qualify for U.S. federal income taxation as a RIC, the Company is required, among other things, to timely distribute to its stockholders at least 90% of investment company taxable income, as defined by the Code, for each year. Depending on the level of taxable income earned in a given tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year distributions, the Company accrues an estimated excise tax, if any, on estimated excess taxable income.
Recent Accounting Pronouncements
None.
RESULTS OF OPERATIONS
Results comparisons are for the three and nine months ended September 30, 2023 and September 30, 2022:
 
48

Investment Income
For the three and nine months ended September 30, 2023, gross investment income totaled $59.6 million and $169.5 million, respectively. For the three and nine months ended September 30, 2022, gross investment income totaled $47.6 million and $123.4 million, respectively. The increase in gross investment income for the year over year three month periods was primarily due to net growth of the income producing portfolio as well as an increase in index rates.    
Expenses
Net expenses totaled $36.3 million and $101.3 million, respectively, for the three and nine months ended September 30, 2023, of which $13.8 million and $40.6 million, respectively, were base management fees and performance-based incentive fees and $19.9 million and $53.0 million, respectively, were interest and other credit facility expenses. Over the same periods, $0.2 million and $0.4 million of performance-based incentive fees were waived. Administrative services and other general and administrative expenses totaled $2.7 million and $8.2 million, respectively, for the three and nine months ended September 30, 2023. Net expenses totaled $27.5 million and $69.5 million, respectively, for the three and nine months ended September 30, 2022, of which $12.9 million and $31.7 million, respectively, were base management fees and gross performance-based incentive fees and $12.8 million and $31.5 million, respectively, were interest and other credit facility expenses. Over the same periods, $0.2 million and $1.6 million, respectively, of performance-based incentive fees were waived. Administrative services and other general and administrative expenses totaled $2.1 million and $7.9 million, respectively, for the three and nine months ended September 30, 2022. Expenses generally consist of management and performance-based incentive fees, interest and other credit facility expenses, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses, and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The increase in expenses for the three and nine months ended September 30, 2023 versus the three and nine months ended September 30, 2022 was primarily due to higher management fees, incentive fees and interest expense on a larger portfolio. Additionally, there was an increase in index rates on borrowings.
Net Investment Income
The Company’s net investment income totaled $23.4 million and $68.2 million, or $0.43 and $1.25, per average share, respectively, for the three and nine months ended September 30, 2023. The Company’s net investment income totaled $20.1 million and $53.8 million, or $0.37 and $1.06, per average share, respectively, for the three and nine months ended September 30, 2022.
Net Realized Loss
The Company had investment sales and prepayments totaling approximately $206 million and $473 million, respectively, for the three and nine months ended September 30, 2023. Net realized losses over the same periods were $31.0 million and $29.8 million, respectively. The Company had investment sales and prepayments totaling approximately $81 million and $261 million, respectively, for the three and nine months ended September 30, 2022. Net realized losses over the same periods were $37.3 million and $37.4 million, respectively. Net realized losses for the three and nine months ended September 30, 2023 were primarily related to our investment in American Teleconferencing Services, Ltd. Net realized losses for the three and nine months ended September 30, 2022 were primarily related to our investment in PhyMed Management, LLC.
Net Change in Unrealized Gain (Loss)
For the three and nine months ended September 30, 2023, net change in unrealized gain on the Company’s assets totaled $34.5 million and $14.4 million, respectively. Net unrealized gain for the three months ended September 30, 2023 is primarily due to the reversal of previously recognized unrealized depreciation on our investment in American Teleconferencing Services, Ltd. as well as appreciation in the value of our investments in Alimera Sciences, Inc. and SLR Credit Solutions, among others, partially offset by depreciation in the value of our investments in KBH Topco, LLC, among others. Net unrealized gain for the nine months ended September 30, 2023 is primarily due to the reversal of previously recognized unrealized depreciation on our investment in American Teleconferencing Services, Ltd. as well as appreciation in the value of our investments in Alimera Sciences, Inc., among others, partially offset by depreciation in the value of our investments in Oldco AI, LLC (f/k/a AmeriMark), SLR Credit Solutions and KBT Topco, LLC, among others. For the three and nine months ended September 30, 2022, net change in unrealized gain (loss) on the Company’s assets and liabilities totaled $30.8 million and ($17.1) million, respectively. Net unrealized gain for the three months ended September 30, 2022 is primarily due to the reversal of previously recognized unrealized depreciation on our investment in PhyMed Management LLC, as well as appreciation in the value of our investments in SLR Business Credit, Alimera Sciences, Inc. and Kingsbridge Holdings, LLC, among others, partially offset by depreciation in the value of our investments in SLR Equipment Finance, PPT Management Holdings, LLC, KBH Topco, LLC, SLR Healthcare ABL and SLR Credit Solutions, among others. Net unrealized loss for the nine months ended September 30, 2022 is primarily due to depreciation in the value of our investments in RD Holdco, Inc., American Teleconferencing Services, Ltd., SLR Credit Solutions and SLR Equipment Finance, among others, partially offset by the reversal of previously recognized unrealized depreciation on our investment in PhyMed Management LLC as well as appreciation on the value of our investments in SLR Business Credit and Alimera Sciences, Inc. in addition to unrealized appreciation on assets acquired in the Mergers due to the accounting treatment of the purchase discount.
 
49

Net Increase (Decrease) in Net Assets From Operations
For the three and nine months ended September 30, 2023, the Company had a net increase in net assets resulting from operations of $26.9 million and $52.8 million, respectively. For the same periods, earnings per average share were $0.49 and $0.97, respectively. For the three and nine months ended September 30, 2022, the Company had a net increase (decrease) in net assets resulting from operations of $13.5 million and ($0.7) million, respectively. For the same periods, earnings (losses) per average share were $0.25 and ($0.01), respectively.
LIQUIDITY AND CAPITAL RESOURCES
The Company’s liquidity and capital resources are generated and generally available through its Credit Facility and SPV Credit Facility (as defined below), the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic
follow-on
equity and/or debt offerings. As of September 30, 2023, we had a total of $200.8 million of unused borrowing capacity under the Credit Facility and SPV Credit Facility, subject to borrowing base limits.
We may from time to time issue equity and/or debt securities in either public or private offerings. The issuance of such securities will depend on future market conditions, funding needs and other factors and there can be no assurance that any such issuance will occur or be successful. The primary uses of existing funds and any funds raised in the future is expected to be for investments in portfolio companies, repayment of indebtedness, cash distributions to our stockholders, or for other general corporate purposes.
Debt
On April 1, 2022, we entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to our assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, subsequent to an August 29, 2023 amendment, the commitment under the SPV Credit Facility is $275 million; however, the commitment can also be expanded up to $600 million. The stated interest rate on the SPV Credit Facility is SOFR plus
2.00%-2.50%
with no SOFR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2023, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $206.3 million.
On April 1, 2022, we entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to our assumption of $85 million in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, we expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135 million of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment, a $25 million November 2022 upsizing and a $40 million August 2023 commitment expiration, the Credit Facility is composed of $585 million of revolving credit and $100 million of term loans.    Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.    The
Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, require the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At September 30, 2023, outstanding USD equivalent borrowings under the Credit Facility totaled $521.5 million, composed of $421.5 million of revolving credit and $100.0 million of term loans.
 
50

On September 14, 2021, the Company closed a private offering of $50 million of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125 million of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75 million of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 22, 2017, we issued $75 million in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73.8 million. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full at maturity on January 20, 2023.    
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. At September 30, 2023, the Company was in compliance with all financial and operational covenants required by the Debt Instruments.
Cash Equivalents
We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time to time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on the Credit Facility, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose is excluded from total assets for purposes of computing the asset base upon which the management fee is determined. We held a face amount of $335 million in cash equivalents as of September 30, 2023.
Contractual Obligations
A summary of our significant contractual payment obligations is as follows as of September 30, 2023:
Payments Due by Period (in millions)
 
    
Total
    
Less than
1 Year
    
1-3 Years
    
3-5 Years
    
More Than
5 Years
 
Revolving credit facilities (1)
   $ 627.8      $ —       $  206.3      $  421.5      $ —   
Unsecured senior notes
     470.0        —         210.0        260.0        —   
Term loans
     100.0        —         —         100.0        —   
 
(1)
As of September 30, 2023, we had a total of $232.3 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.
Under the provisions of the 1940 Act, we are permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss.
We have also entered into two contracts under which we have future commitments: the Advisory Agreement, pursuant to which the Investment Adviser has agreed to serve as our investment adviser, and the Administration Agreement, pursuant to which the Administrator has agreed to furnish us with the facilities and administrative services necessary to conduct our
day-to-day
operations and provide on our behalf managerial assistance to those portfolio companies to which we are required to provide such assistance. Payments under the Advisory Agreement are equal to (1) a percentage of the value of our average gross assets and (2) a
two-part
incentive fee. Payments under the Administration Agreement are equal to an amount based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including rent, technology systems, insurance and our allocable portion of the costs of our chief financial officer and chief compliance officer and their respective staffs. Either party may terminate each of the Advisory Agreement and administration agreement without penalty upon 60 days written notice to the other. See note 3 to our Consolidated Financial Statements.
 
51

On July 31, 2017, the Company, NEFPASS LLC and NEFCORP LLC entered into a servicing agreement.    NEFCORP LLC was engaged to provide NEFPASS LLC with administrative services related to the loans and capital leases held by NEFPASS LLC. NEFPASS LLC may terminate this agreement upon 30 days written notice to NEFCORP LLC.
On October 7, 2022, the Company committed $50 million to SSLP and entered into a servicing agreement. SSLP engaged and retained the Company to provide certain administrative services relating to the facilities, supplies and necessary ongoing overhead support services for the operation of SSLP’s ongoing business affairs in exchange for a fee.
Senior Securities
Information about our senior securities is shown in the following table (in thousands) as of the quarter ended September 30, 2023 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Credit Facility
                                   
Fiscal 2023 (through September 30, 2023)
   $ 421,500      $ 642               N/A  
Fiscal 2022
     293,000        513               N/A  
Fiscal 2021
     222,500        552               N/A  
Fiscal 2020
     126,000        421               N/A  
Fiscal 2019
     42,900        182               N/A  
Fiscal 2018
     96,400        593               N/A  
Fiscal 2017
     245,600        1,225               N/A  
Fiscal 2016
     115,200        990               N/A  
Fiscal 2015
     207,900        1,459               N/A  
Fiscal 2014
                          N/A  
Fiscal 2013
                          N/A  
SPV Credit Facility
                                   
Fiscal 2023 (through September 30, 2023)
     206,250        314               N/A  
Fiscal 2022
     155,200        272               N/A  
2022 Unsecured Notes
                                   
Fiscal 2022
                          N/A  
Fiscal 2021
     150,000        372               N/A  
Fiscal 2020
     150,000        501               N/A  
Fiscal 2019
     150,000        638               N/A  
Fiscal 2018
     150,000        923               N/A  
Fiscal 2017
     150,000        748               N/A  
Fiscal 2016
     50,000        430               N/A  
2022 Tranche C Notes
                                   
Fiscal 2022
                          N/A  
Fiscal 2021
     21,000        52               N/A  
Fiscal 2020
     21,000        70               N/A  
Fiscal 2019
     21,000        89               N/A  
Fiscal 2018
     21,000        129               N/A  
Fiscal 2017
     21,000        105               N/A  
2023 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
                          N/A  
Fiscal 2022
     75,000        131               N/A  
Fiscal 2021
     75,000        186               N/A  
Fiscal 2020
     75,000        250               N/A  
Fiscal 2019
     75,000        319               N/A  
Fiscal 2018
     75,000        461               N/A  
Fiscal 2017
     75,000        374               N/A  
 
52

Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
2024 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     125,000        190               N/A  
Fiscal 2022
     125,000        219               N/A  
Fiscal 2021
     125,000        309               N/A  
Fiscal 2020
     125,000        417               N/A  
Fiscal 2019
     125,000        531               N/A  
2025 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     85,000        129               N/A  
Fiscal 2022
     85,000        149               N/A  
2026 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     75,000        114               N/A  
Fiscal 2022
     75,000        131               N/A  
Fiscal 2021
     75,000        186               N/A  
Fiscal 2020
     75,000        250               N/A  
Fiscal 2019
     75,000        319               N/A  
2027 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     50,000        76               N/A  
Fiscal 2022
     50,000        88               N/A  
Fiscal 2021
     50,000        124               N/A  
2027 Series F Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     135,000        206               N/A  
Fiscal 2022
     135,000        237               N/A  
2042 Unsecured Notes
                                   
Fiscal 2017
                          N/A  
Fiscal 2016
     100,000        859             $ 1,002  
Fiscal 2015
     100,000        702               982  
Fiscal 2014
     100,000        2,294               943  
Fiscal 2013
     100,000        2,411               934  
Senior Secured Notes
                                   
Fiscal 2017
                          N/A  
Fiscal 2016
     75,000        645               N/A  
Fiscal 2015
     75,000        527               N/A  
Fiscal 2014
     75,000        1,721               N/A  
Fiscal 2013
     75,000        1,808               N/A  
Term Loans
                                   
Fiscal 2023 (through September 30, 2023)
     100,000        152               N/A  
Fiscal 2022
     100,000        175               N/A  
Fiscal 2021
     100,000        248               N/A  
Fiscal 2020
     75,000        250               N/A  
Fiscal 2019
     75,000        319               N/A  
Fiscal 2018
     50,000        308               N/A  
Fiscal 2017
     50,000        250               N/A  
Fiscal 2016
     50,000        430               N/A  
Fiscal 2015
     50,000        351               N/A  
Fiscal 2014
     50,000        1,147               N/A  
Fiscal 2013
     50,000        1,206               N/A  
NEFPASS Facility
                                   
Fiscal 2021
                          N/A  
Fiscal 2020
     30,000        100               N/A  
Fiscal 2019
     30,000        128               N/A  
Fiscal 2018
     30,000        185               N/A  
 
53
SSLP Facility
                                   
Fiscal 2019
                          N/A  
Fiscal 2018
     53,785        331               N/A  
Total Senior Securities
                                   
Fiscal 2023 (through September 30, 2023)
   $ 1,197,750      $ 1,823               N/A  
Fiscal 2022
     1,093,200        1,915               N/A  
Fiscal 2021
     818,500        2,029               N/A  
Fiscal 2020
     677,000        2,259               N/A  
Fiscal 2019
     593,900        2,525               N/A  
Fiscal 2018
     476,185        2,930               N/A  
Fiscal 2017
     541,600        2,702               N/A  
Fiscal 2016
     390,200        3,354               N/A  
Fiscal 2015
     432,900        3,039               N/A  
Fiscal 2014
     225,000        5,162               N/A  
Fiscal 2013
     225,000        5,425               N/A  
 
(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2023, asset coverage was 182.3%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
Off-Balance
Sheet Arrangements
From time to time and in the normal course of business, the Company may make unfunded capital commitments to current or prospective portfolio companies. Typically, the Company may agree to provide delayed-draw term loans or, to a lesser extent, revolving loan or equity commitments. These unfunded capital commitments always take into account the Company’s liquidity and cash available for investment, portfolio and issuer diversification, and other considerations. Accordingly, the Company had the following unfunded capital commitments at September 30, 2023 and December 31, 2022, respectively:
 
54

    
September 30,
2023
    
December 31, 2022
 
(in millions)
                 
SLR Credit Solutions*
   $ 44.3      $ 44.3  
Outset Medical, Inc.
     35.1        35.1  
Apeel Technology, Inc.
     32.8        32.8  
Southern Orthodontic Partners Management, LLC
     21.9        1.9  
SLR Senior Lending Program LLC*
     21.3        40.5  
Orthopedic Care Partners Management, LLC
     20.8        1.6  
Human Interest, Inc.
     20.1        20.1  
CVAUSA Management, LLC
     18.2        —   
BDG Media, Inc.
     12.6        3.5  
Neuronetics, Inc.
     11.6        —   
ONS MSO, LLC
     11.0        —   
iCIMS, Inc.
     10.5        11.4  
Cerapedics, Inc.
     9.2        6.7  
Alkeme Intermediate Holdings, LLC
     8.5        —   
Arcutis Biotherapeutics, Inc.
     8.4        8.4  
Ardelyx, Inc.
     7.8        7.8  
West-NR
Parent, Inc.
     6.8        —   
United Digestive MSO Parent, LLC
     5.2        —   
Peter C. Foy & Associates Insurance Services, LLC
     5.1        1.1  
Luxury Asset Capital, LLC
     4.5        7.5  
UVP Management, LLC
     4.4        —   
Kaseya, Inc.
     3.8        3.9  
Urology Management Holdings, Inc.
     3.6        —   
The Townsend Company, LLC
     3.5        —   
SLR Equipment Finance
     3.5        1.0  
Vertos Medical, Inc.
     3.3        —   
Foundation Consumer Brands, LLC
     3.0        3.0  
Kid Distro Holdings, LLC
     2.7        2.7  
Maurices, Incorporated
     2.6        4.3  
Erie Construction
Mid-west,
LLC
     2.4        1.3  
Ultimate Baked Goods Midco LLC
     2.4        1.6  
Basic Fun, Inc.
     2.1        2.7  
Bayside Opco, LLC
     1.7        —   
SunMed Group Holdings, LLC
     1.6        0.8  
SCP Eye Care, LLC
     1.5        2.8  
SLR Healthcare ABL*
     1.4        1.4  
RxSense Holdings LLC
     1.3        1.3  
Enverus Holdings, Inc.
     1.2        1.0  
Tilley Distribution, Inc.
     1.1        0.5  
GSM Acquisition Corp.
     0.9        0.8  
Composite Technology Acquisition Corp.
     0.8        1.5  
High Street Buyer, Inc.
     0.6        0.3  
CC SAG Holdings Corp. (Spectrum Automotive)
     0.5        20.7  
ENS Holdings III Corp, LLC
     0.5        0.1  
Pinnacle Treatment Centers, Inc.
     0.4        1.7  
Vessco Midco Holdings, LLC
     0.3        3.9  
TAUC Management, LLC
     0.3        0.3  
All States Ag Parts, LLC
     0.2        0.1  
Glooko, Inc.
     —         17.9  
World Insurance Associates, LLC
     —         17.1  
Spectrum Pharmaceuticals, Inc.
     —         8.8  
Atria Wealth Solutions, Inc.
     —         8.2  
Accession Risk Management Group, Inc.
     —         7.5  
Copper River Seafoods, Inc.
     —         3.6  
Meditrina, Inc.
     —         3.4  
One Touch Direct, LLC
     —         3.1  
DeepIntent, Inc.
     —         3.1  
Plastics Management, LLC
     —         2.4  
Pediatric Home Respiratory Services, LLC
     —         1.8  
Ivy Fertility Services, LLC
     —         1.6  
NAC Holdings Corporation
     —         1.5  
SPAR Marketing Force, Inc.
     —         1.3  
Montefiore Nyack Hospital
     —         1.0  
American Teleconferencing Services, Ltd.
     —         1.1  
BayMark Health Services, Inc.
     —         0.4  
    
 
 
    
 
 
 
Total Commitments
   $  367.3      $  364.2  
    
 
 
    
 
 
 
 
*
The Company controls the funding of these commitments and may cancel them at its discretion.
The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the respective portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of September 30, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
In the normal course of business, we invest or trade in various financial instruments and may enter into various investment activities with
off-balance
sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of
off-balance
sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities.
 
55

Distributions
The following table reflects the cash distributions per share on our common stock for the two most recent fiscal years and the current fiscal year to date:
 
Date Declared
  
Record Date
    
Payment Date
    
Amount
 
Fiscal 2023
                          
November 7, 2023
     December 14, 2023        December 28, 2023      $ 0.41  
September 5, 2023
     September 20, 2023        September 28, 2023        0.136667  
August 8, 2023
     August 18, 2023        August 30, 2023        0.136667  
July 5, 2023
     July 20, 2023        August 1, 2023        0.136667  
June 1, 2023
     June 20, 2023        June 29, 2023        0.136667  
May 10, 2023
     May 24, 2023        June 1, 2023        0.136667  
April 4, 2023
     April 20, 2023        May 2, 2023        0.136667  
February 28, 2023
     March 23, 2023        April 4, 2023        0.136667  
February 2, 2023
     February 16, 2023        March 1, 2023        0.136667  
January 10, 2023.
     January 26, 2023        February 2, 2023        0.136667  
                      
 
 
 
Total 2023
                     $ 1.64  
                      
 
 
 
Fiscal 2022
                          
December 6, 2022
     December 22, 2022        January 5, 2023      $ 0.136667  
November 2, 2022
     November 17, 2022        December 1, 2022        0.136667  
October 5, 2022
     October 20, 2022        November 2, 2022        0.136667  
September 2, 2022
     September 20, 2022        October 4, 2022        0.136667  
August 2, 2022
     August 18, 2022        September 1, 2022        0.136667  
July 6, 2022
     July 21, 2022        August 2, 2022        0.136667  
June 3, 2022
     June 23, 2022        July 5, 2022        0.136667  
May 3, 2022
     May 19, 2022        June 2, 2022        0.136667  
April 4, 2022
     April 21, 2022        May 3, 2022        0.136667  
March 1, 2022
     March 18, 2022        April 1, 2022        0.41  
                      
 
 
 
Total 2022
                     $ 1.64  
                      
 
 
 
Fiscal 2021
                          
November 3, 2021
     December 16, 2021        January 5, 2022      $ 0.41  
August 3, 2021
     September 23, 2021        October 5, 2021        0.41  
May 5, 2021
     June 23, 2021        July 2, 2021        0.41  
February 24, 2021.
     March 18, 2021        April 2, 2021        0.41  
                      
 
 
 
Total 2021
                     $ 1.64  
                      
 
 
 
Tax characteristics of all distributions will be reported to stockholders on Form 1099 after the end of the calendar year. Future monthly distributions, if any, will be determined by the Board. We expect that our distributions to stockholders will generally be from accumulated net investment income, from net realized capital gains or
non-taxable
return of capital, if any, as applicable.
We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC tax treatment, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (
i.e.
, net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.
We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders’ cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash distributions.
We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, the Credit Facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a RIC. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual
payment-in-kind
income, which represents contractual income added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a RIC.
 
56

With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to stockholders.
Related Parties
We have entered into a number of business relationships with affiliated or related parties, including the following:
 
 
 
We have entered into the Advisory Agreement with the Investment Adviser. Mr. Gross, our Chairman,
Co-Chief
Executive Officer and President and Mr. Spohler, our
Co-Chief
Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, the Investment Adviser. In addition, Mr. Kajee, our Chief Financial Officer and Treasurer serves as the Chief Financial Officer for the Investment Adviser.
 
 
 
The Administrator provides us with the office facilities and administrative services necessary to conduct
day-to-day
operations pursuant to our Administration Agreement. We reimburse the Administrator for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and the compensation of our chief compliance officer, our chief financial officer and their respective staffs.
 
 
 
We have entered into a license agreement with the Investment Adviser, pursuant to which the Investment Adviser has granted us a
non-exclusive,
royalty-free license to use the licensed marks “SOLAR” and “SLR”.
The Investment Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, the Investment Adviser presently serves as investment adviser to SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured loans, including
non-traditional
asset-based loans and first lien loans, SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and SLR Private Credit BDC II LLC, an unlisted BDC focused on first lien senior secured floating rate loans. In addition, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, and Shiraz Kajee, our Chief Financial Officer and Treasurer, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC. The Investment Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or its affiliates may determine that we should invest
side-by-side
with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Investment Adviser’s allocation procedures. On June 13, 2017, the Investment Adviser received an exemptive order that permits the Company to participate in
negotiated co-investment transactions
with certain affiliates, in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to various conditions (the “Order”). If the Company is unable to rely on the Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although the Investment Adviser’s investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of the Investment Adviser.
Related party transactions may occur among us, SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL and SLR Equipment.    These transactions may occur in the normal course of business. No administrative or other fees are paid to the Investment Adviser by SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL or SLR Equipment.
In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.
 
57

Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are subject to financial market risks, including changes in interest rates. Uncertainty with respect to rising interest rates, inflationary pressures, risks in respect of a failure to increase the U.S. debt ceiling or a downgrade in the U.S. credit rating, the wars between Ukraine and Russia and health epidemics and pandemics introduced significant volatility in the financial markets, and the effects of this volatility have materially impacted and could continue to materially impact our market risks. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In a low interest rate environment, including a reduction of LIBOR and SOFR to zero, the difference between the total interest income earned on interest earning assets and the total interest expense incurred on interest bearing liabilities may be compressed, reducing our net interest income and potentially adversely affecting our operating results. Conversely, in a rising interest rate environment, such as the current economic environment, such difference could potentially increase thereby increasing our net investment income. During the nine months ended September 30, 2023, certain investments in our comprehensive investment portfolio had floating interest rates. These floating rate investments were primarily based on floating LIBOR or SOFR and typically have durations of one to three months after which they reset to current market interest rates. Additionally, some of these investments have floors. The Company also has revolving credit facilities that are generally based on floating SOFR. Assuming no changes to our balance sheet as of September 30, 2023 and no new defaults by portfolio companies, a hypothetical one percent decrease in LIBOR and SOFR on our comprehensive floating rate assets and liabilities would decrease our net investment income by seven cents per average share over the next twelve months. Assuming no changes to our balance sheet as of September 30, 2023 and no new defaults by portfolio companies, a hypothetical one percent increase in LIBOR and SOFR on our comprehensive floating rate assets and liabilities would increase our net investment income by approximately eight cents per average share over the next twelve months. However, we may hedge against interest rate fluctuations from time to time by using standard hedging instruments such as futures, options, swaps and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in any benefits of certain changes in interest rates with respect to our portfolio of investments. At September 30, 2023, we had no interest rate hedging instruments outstanding on our balance sheet.
 
Increase (Decrease) in LIBOR and SOFR
  
 
(1.00
%) 
 
 
1.00
Increase (Decrease) in Net Investment Income Per Share Per Year
  
$
(0.07
 
$
0.08
 
We may also have exposure to foreign currencies through various investments. These investments are converted into U.S. dollars at the balance sheet date, exposing us to movements in foreign exchange rates. In order to reduce our exposure to fluctuations in foreign exchange rates, we may borrow from time to time in such currencies under our multi-currency revolving credit facility or enter into forward currency or similar contracts.
Item 4. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
As of September 30, 2023 (the end of the period covered by this report), we, including our
Co-Chief
Executive Officers and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule
13a-15(e)
of the Securities Act of 1934, as amended (the “Exchange Act”). Based on that evaluation, our management, including the
Co-Chief
Executive Officers and Chief Financial Officer, concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.
(b) Changes in Internal Controls Over Financial Reporting
Management has not identified any change in the Company’s internal control over financial reporting that occurred during the third quarter of 2023 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
58

PART II. OTHER INFORMATION
Item 1. Legal Proceedings
We and our consolidated subsidiaries are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us or our consolidated subsidiaries. From time to time, we and our consolidated subsidiaries may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.
Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on
Form 10-K, which
could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factors set forth below, there have been no material changes during the period ended September 30, 2023 to the risk factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on Form
10-K.
Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or
non-performance
by financial institutions or transactional counterparties could have a material adverse effect on us, the Investment Adviser and our portfolio companies.
Cash not held in custody accounts and held by us, our Investment Adviser and by our portfolio companies in
non-interest-bearing
and interest-bearing operating accounts could, at times, exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. If such banking institutions were to fail, we, our Investment Adviser, or our portfolio companies could lose all or a portion of those amounts held in excess of such insurance limits. In addition, actual events involving limited liquidity, defaults,
non-performance
or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems, which could adversely affect our, our Investment Adviser’s and our portfolio companies’ business, financial condition, results of operations, or prospects.
Although we and our Investment Adviser assess our and our portfolio companies’ banking and financing relationships as we believe necessary or appropriate, our and our portfolio companies’ access to funding sources and other credit arrangements in amounts adequate to finance or capitalize current and projected future business operations could be significantly impaired by factors that affect the financial institutions with which we, our Investment Adviser or our portfolio companies have arrangements directly or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we, our Investment Adviser or our portfolio companies have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally.
In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us, our Investment Adviser, or our portfolio companies to acquire financing on acceptable terms or at all.
Our stock repurchase program could affect the price of our common stock and increase volatility and may be suspended or terminated at any time, which may result in a decrease in the trading price of our common stock.
On May 9, 2023, the Board most recently extended our share repurchase program (the “Program”), under which we can repurchase up to $50 million of our outstanding common stock. Under the Program, purchases can be made at management’s discretion from time to time in open-market transactions, in accordance with all applicable securities laws and regulations, at prices below the Company’s NAV as reported in its most recently published consolidated financial statements. We have in the past, and could in the future, enter into a plan to repurchase shares of our common stock pursuant to the Program in a manner intended to comply with the requirements of Rule
10b5-1
under the Exchange Act.
 
59

The Program is discretionary and whether purchases will be made under the Program and how much will be purchased at any time is uncertain and dependent on prevailing market prices and trading volumes, all of which we cannot predict. These activities could have the effect of maintaining the market price of our common stock or retarding a decline in the market price of the common stock, and, as a result, the price of our common stock could be higher than the price that otherwise might exist in the open market. Repurchases pursuant to the Program could affect the price of our common stock and increase its volatility. The existence of the Program could also cause the price of our common stock to be higher than it would be in the absence of such a program and could potentially reduce the market liquidity for our common stock. There can be no assurance that any stock repurchases will enhance stockholder value because the market price of our common stock could decline below the levels at which we repurchased such shares. Any failure to repurchase shares after we have announced our intention to do so could negatively impact our reputation and investor confidence in us and could negatively impact our stock price. Although the Program is intended to enhance long-term stockholder value, short-term stock price fluctuations could reduce the Program’s effectiveness.
The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.
The London Interbank Offered Rate (“LIBOR”) is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies.
The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom’s Financial Conduct Authority (“FCA”), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBORs, including USD LIBOR, except in very limited circumstances.
In the United States, SOFR is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions.
As of the filing date of this Quarterly Report on Form
10-Q,
many of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on SOFR (“CME Term SOFR”) or CME Term SOFR plus a fixed spread adjustment. CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed,
one-month
and three-month CME Group traded SOFR futures contracts and, in some cases,
over-the-counter
SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Since CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used. Further, the composition and characteristics of SOFR and CME Term SOFR are not the same as those of LIBOR. Even with the application of a fixed spread adjustment, LIBOR and CME Term SOFR will not have the same composition and characteristics, and there can be no assurance that the replacement rate, as so adjusted, will be a direct substitute for LIBOR.
There can be no guarantee that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse to the interests of investors in loans referencing SOFR. If the manner in which SOFR or CME Term SOFR is calculated is changed, that change may result in a reduction of the amount of interest payable on such loans and the trading prices of the SOFR Loans. In addition, there can be no guarantee that loans referencing SOFR or CME Term SOFR will continue to reference those rates until maturity or that, in the future, our loans will reference benchmark rates other than CME Term SOFR. Should any of these events occur, our loans, and the yield generated thereby, could be affected. Specifically, the anticipated yield on our loans may not be fully realized and our loans may be subject to increased pricing volatility and market risk.
 
60

Item 2.
Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
We did not engage in unregistered sales of securities during the quarter ended September 30, 2023.
 
Item 3.
Defaults Upon Senior Securities
None.
 
Item 4.
Mine Safety Disclosures
Not applicable.
 
Item 5.
Other Information
Rule
10b5-1
Trading Plans
During the fiscal quarter ended September 30, 2023, none of our directors or officers (as defined in Rule
16a-1(f)
under the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule
10b5-1(c)
under the Exchange Act or any
“non-Rule
10b5-1
trading arrangement” as defined in Item 408(c) of Regulation
S-K.
 
Item 6.
Exhibits
The following exhibits are filed as part of this report or hereby incorporated by reference
to
exhibits previously filed with the SEC:
 
Exhibit
Number
  
Description
    2.1
  
    3.1
  
    3.2
  
    4.1
  
    4.2
  
  23.1
  
  31.1
  
  31.2
  
  31.3
  
  32.1
  
  32.2
  
  32.3
  
101.INS
  
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.*
101.SCH
  
Inline XBRL Taxonomy Extension Schema Document*
101.CAL
  
Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF
  
Inline XBRL Taxonomy Extension Definition Linkbase Document*
 
61

Exhibit
Number
  
Description
   
101.LAB    Inline XBRL Taxonomy Extension Label Linkbase Document*
   
101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document*
   
104    Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
(1)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Pre-Effective
Amendment No. 7 (File
No. 333-148734)
filed on January 7, 2010.
(2)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
(File No
333-148734)
filed on February 9, 2010.
(3)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Post-Effective Amendment No. 6 (File
No. 333-172968)
filed on November 16, 2012.
(4)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on December 1, 2021.
*
Filed herewith.
 
62

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on November 7, 2023.
 
SLR INVESTMENT CORP.
   
By:   /s/ M
ICHAEL
S. G
ROSS
   
Michael S. Gross
Co-Chief Executive Officer
(Principal Executive Officer)
   
By:   /s/ B
RUCE
J. S
POHLER
   
Bruce J. Spohler
Co-Chief Executive Officer
(Principal Executive Officer)
   
By:   /s/ S
HIRAZ
Y. K
AJEE
   
Shiraz Y. Kajee
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
63
EX-23.1 2 d458881dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

November 7, 2023

SLR Investment Corp.

New York, New York

Re: Registration Statement No. 333-255662

With respect to the subject registration statement, we acknowledge our awareness of the use therein of our report dated November 7, 2023 related to our review of interim financial information.

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

 

/s/ KPMG LLP

New York, New York
EX-31.1 3 d458881dex311.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael S. Gross, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 7th day of November, 2023

  /s/ MICHAEL S. GROSS
  Michael S. Gross
EX-31.2 4 d458881dex312.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Bruce J. Spohler, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 7th day of November, 2023

 

/s/ BRUCE J. SPOHLER  
Bruce J. Spohler  
EX-31.3 5 d458881dex313.htm EX-31.3 EX-31.3

EXHIBIT 31.3

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Shiraz Y. Kajee, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 7th day of November, 2023

 

/s/ SHIRAZ Y. KAJEE  
Shiraz Y. Kajee  
EX-32.1 6 d458881dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, MICHAEL S. GROSS, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

  /s/ MICHAEL S. GROSS
Name:   Michael S. Gross
Date:   November 7, 2023
EX-32.2 7 d458881dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, BRUCE J. SPOHLER, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

  /s/ BRUCE J. SPOHLER
Name:   Bruce J. Spohler
Date:   November 7, 2023
EX-32.3 8 d458881dex323.htm EX-32.3 EX-32.3

EXHIBIT 32.3

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, SHIRAZ Y. KAJEE, the Chief Financial Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

  /s/ SHIRAZ Y. KAJEE
Name:   Shiraz Y. Kajee
Date:   November 7, 2023
EX-101.SCH 9 slrc-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Consolidated Statements of Assets And Liabilities link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Consolidated Statements of Changes In Net Assets link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Consolidated Schedule of Investments link:presentationLink link:definitionLink link:calculationLink 1009 - Statement - Consolidated Schedule of Investments Alternate link:presentationLink link:definitionLink link:calculationLink 1010 - Statement - Consolidated Schedule of Investments (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 999001 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 999002 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 999003 - Disclosure - Agreements link:presentationLink link:definitionLink link:calculationLink 999004 - Disclosure - Net Asset Value Per Share link:presentationLink link:definitionLink link:calculationLink 999005 - Disclosure - Earnings Per Share link:presentationLink link:definitionLink link:calculationLink 999006 - Disclosure - Fair Value link:presentationLink link:definitionLink link:calculationLink 999007 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 999008 - Disclosure - Financial Highlights link:presentationLink link:definitionLink link:calculationLink 999009 - Disclosure - SLR Credit Solutions link:presentationLink link:definitionLink link:calculationLink 999010 - Disclosure - SLR Equipment Finance link:presentationLink link:definitionLink link:calculationLink 999011 - Disclosure - Kingsbridge Holdings, LLC link:presentationLink link:definitionLink link:calculationLink 999012 - Disclosure - SLR Healthcare ABL link:presentationLink link:definitionLink link:calculationLink 999013 - Disclosure - SLR Business Credit link:presentationLink link:definitionLink link:calculationLink 999014 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 999015 - Disclosure - Capital Share Transactions link:presentationLink link:definitionLink link:calculationLink 999016 - Disclosure - Stock Repurchase Program link:presentationLink link:definitionLink link:calculationLink 999017 - Disclosure - SLR Senior Lending Program LLC link:presentationLink link:definitionLink link:calculationLink 999018 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 999019 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 999020 - Disclosure - Fair Value (Tables) link:presentationLink link:definitionLink link:calculationLink 999021 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 999022 - Disclosure - Financial Highlights (Tables) link:presentationLink link:definitionLink link:calculationLink 999023 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 999024 - Disclosure - Capital Share Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 999025 - Disclosure - SLR Senior Lending Program LLC (Tables) link:presentationLink link:definitionLink link:calculationLink 999026 - Disclosure - Organization - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999027 - Disclosure - Significant Accounting Policies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999028 - Disclosure - Agreements - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999029 - Disclosure - Net Asset Value Per Share - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999030 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details) link:presentationLink link:definitionLink link:calculationLink 999031 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:definitionLink link:calculationLink 999032 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 999033 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) link:presentationLink link:definitionLink link:calculationLink 999034 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999035 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) link:presentationLink link:definitionLink link:calculationLink 999036 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999037 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 999038 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999039 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999040 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details) link:presentationLink link:definitionLink link:calculationLink 999041 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 999042 - Disclosure - SLR Credit Solutions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999043 - Disclosure - SLR Equipment Finance - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999044 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999045 - Disclosure - SLR Healthcare ABL - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999046 - Disclosure - SLR Business Credit - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999047 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999048 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) link:presentationLink link:definitionLink link:calculationLink 999049 - Disclosure - Capital Share Transactions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999050 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details) link:presentationLink link:definitionLink link:calculationLink 999051 - Disclosure - Stock Repurchase Program - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999052 - Disclosure - SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) link:presentationLink link:definitionLink link:calculationLink 999053 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) link:presentationLink link:definitionLink link:calculationLink 999054 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999055 - Disclosure - SLR Senior Lending Program LLC - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999056 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 10 slrc-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 slrc-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 slrc-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 13 slrc-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page - shares
9 Months Ended
Sep. 30, 2023
Nov. 03, 2023
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Registrant Name SLR INVESTMENT CORP.  
Securities Act File Number 814-00754  
Entity Tax Identification Number 26-1381340  
Trading Symbol SLRC  
Entity Central Index Key 0001418076  
Current Fiscal Year End Date --12-31  
Document Quarterly Report true  
Document Transition Report false  
Entity Current Reporting Status Yes  
Entity Filer Category Large Accelerated Filer  
Entity Interactive Data Current Yes  
City Area Code 212  
Local Phone Number 993-1670  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Address, Address Line One 500 Park Avenue  
Entity Shell Company false  
Title of 12(b) Security Common Stock, par value $0.01 per share  
Security Exchange Name NASDAQ  
Entity Address, State or Province NY  
Entity Address, City or Town New York  
Entity Address, Postal Zip Code 10022  
Entity Incorporation, State or Country Code MD  
Entity Common Stock, Shares Outstanding   54,554,634
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Assets And Liabilities - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Investments at fair value:    
Investments at fair value: [1] $ 2,171,056  
Cash 10,266 $ 10,743
Cash equivalents (cost: $332,557 and $417,590, respectively) 332,557 417,590
Dividends receivable 10,993 11,192
Interest receivable 11,828 9,706
Receivable for investments sold 1,598 1,124
Prepaid expenses and other assets 788 664
Total assets 2,539,086 2,537,695
Liabilities    
Debt ($1,197,750 and $1,093,200 face amounts, respectively, reported net of unamortized debt issuance costs of $5,996 and $7,202, respectively. See notes 6 and 7) 1,191,754 1,085,998
Payable for investments and cash equivalents purchased 332,557 417,611
Distributions payable 0 7,481
Management fee payable (see note 3) 8,051 7,964
Performance-based incentive fee payable (see note 3) 5,621 5,422
Interest payable (see note 7) 7,416 7,943
Administrative services payable (see note 3) 3,678 1,488
Other liabilities and accrued expenses 4,624 4,057
Total liabilities 1,553,701 1,537,964
Commitments and contingencies (see note 14)
Net Assets    
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,554,634 and 54,555,380 shares issued and outstanding, respectively 546 546
Paid-in capital in excess of par 1,162,559 1,162,569
Accumulated distributable net loss (177,720) (163,384)
Total net assets $ 985,385 $ 999,731
Net Asset Value Per Share $ 18.06 $ 18.33
Companies less than 5% owned [Member]    
Investments at fair value:    
Investments at fair value: $ 1,320,729 $ 1,289,082
Companies more than 25% owned [Member]    
Investments at fair value:    
Investments at fair value: 806,922 797,594
Companies 5% to 25% owned [Member]    
Investments at fair value:    
Investments at fair value: $ 43,405 $ 0
[1] Aggregate net unrealized appreciation for U.S. federal income tax purposes is $31,537; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $152,992 and $121,455, respectively, based on a tax cost of $2,139,519. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Assets And Liabilities (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Investment owned, at cost [1] $ 2,204,617  
Cash equivalents at cost 332,557 $ 417,590
Debt instrument, face amount 1,197,750 1,093,200
Debt issuance costs $ 5,996 $ 7,202
Common stock, par or stated value per share $ 0.01 $ 0.01
Common Stock, shares authorized 200,000,000 200,000,000
Common stock, shares, issued 54,554,634 54,555,380
Common stock, shares, outstanding 54,554,634 54,555,380
Companies less than 5% owned [Member]    
Investment owned, at cost $ 1,305,572 $ 1,312,701
Companies 5% to 25% owned [Member]    
Investment owned, at cost 59,983 0
Companies more than 25% owned [Member]    
Investment owned, at cost $ 839,062 $ 821,886
[1] Aggregate net unrealized appreciation for U.S. federal income tax purposes is $31,537; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $152,992 and $121,455, respectively, based on a tax cost of $2,139,519. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
INVESTMENT INCOME:        
Total investment income $ 59,641 $ 47,567 $ 169,525 $ 123,353
EXPENSES:        
Management fees (see note 3) 8,051 7,890 23,635 22,019
Performance-based incentive fees (see note 3) 5,796 4,965 16,943 9,699
Interest and other credit facility expenses (see note 7) 19,874 12,784 53,002 31,464
Administrative services expense (see note 3) 1,575 1,132 4,563 3,684
Other general and administrative expenses 1,161 935 3,610 4,212
Total expenses 36,457 27,706 101,753 71,078
Performance-based incentive fees waived (see note 3) (175) (194) (410) (1,552)
Net expenses 36,282 27,512 101,343 69,526
Net investment income 23,359 20,055 68,182 53,827
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:        
Net realized loss on investments and cash equivalents (companies less than 5% owned) (30,951) (37,326) (29,766) (37,401)
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents 34,539 30,799 14,350 (17,081)
Net realized and unrealized gain (loss) on investments and cash equivalents 3,588 (6,527) (15,416) (54,482)
Net increase (decrease) in net assets resulting from operations $ 26,947 $ 13,528 $ 52,766 $ (655)
Earnings (loss) Per Share, Basic $ 0.49 $ 0.25 $ 0.97 $ (0.01)
Earnings (loss) Per Share, Diluted $ 0.49 $ 0.25 $ 0.97 $ (0.01)
Companies less than 5% owned [Member]        
INVESTMENT INCOME:        
Interest $ 43,696 $ 32,933 $ 122,301 $ 82,450
Other income 735 234 3,814 1,222
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents 33,439 28,783 24,349 3,521
Companies 5% to 25% owned [Member]        
INVESTMENT INCOME:        
Interest 816 0 1,081 0
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents 1,065 0 (2,151) 0
Companies more than 25% owned [Member]        
INVESTMENT INCOME:        
Interest 2,879 2,431 8,404 6,914
Dividends 11,429 11,969 33,782 32,767
Other income 86 0 143 0
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents $ 35 $ 2,016 $ (7,848) $ (20,602)
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Changes In Net Assets - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Increase (decrease) in net assets resulting from operations:        
Net investment income $ 23,359 $ 20,055 $ 68,182 $ 53,827
Net realized loss (30,951) (37,326) (29,766) (37,401)
Net change in unrealized gain (loss) 34,539 30,799 14,350 (17,081)
Net increase (decrease) in net assets resulting from operations 26,947 13,528 52,766 (655)
Distributions to stockholders:        
From net investment income (22,367) (20,055) (67,102) (53,827)
From return of capital 0 (2,401) 0 (8,413)
Net distributions to stockholders (22,367) (22,456) (67,102) (62,240)
Capital transactions (see note 12):        
Issuance of common stock 0 0 0 226,839
Repurchases of common stock 0 0 (10) 0
Net capital transactions 0 0 (10) 226,839
Total increase (decrease) in net assets 4,580 (8,928) (14,346) 163,944
Net assets at beginning of period 980,805 1,015,153 999,731 842,281
Net assets at end of period $ 985,385 $ 1,006,225 $ 985,385 $ 1,006,225
Capital stock activity (see note 12):        
Issuance of common stock 0 0 0 12,511,825
Repurchases of common stock 0 0 (746) 0
Net capital stock activity 0 0 (746) 12,511,825
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities    
Net increase (decrease) in net assets resulting from operations $ 52,766 $ (655)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:    
Net realized loss on investments and cash equivalents 29,766 37,401
Net change in unrealized (gain) loss on investments (14,350) 17,081
Deferred financing costs/market discount 1,561 1,631
(Increase) decrease in operating assets:    
Purchase of investments (556,348) (406,302)
Proceeds from disposition of investments 474,599 259,784
Net accretion of discount on investments (9,315) (7,760)
Capitalization of payment-in-kind income (8,936) (1,753)
Collections of payment-in-kind income 204 1,112
Receivable for investments sold (474) 102
Interest receivable (2,122) (2,935)
Dividends receivable 199 (2,514)
Prepaid expenses and other assets (124) (319)
Cash acquired in the Mergers 0 2,313
Increase (decrease) in operating liabilities:    
Payable for investments and cash equivalents purchased (85,054) (51,089)
Management fee payable 87 455
Performance-based incentive fee payable 199 2,907
Administrative services expense payable 2,190 (1,396)
Interest payable (527) 2,591
Other liabilities and accrued expenses 567 600
Net Cash Used in Operating Activities (115,112) (148,746)
Cash Flows from Financing Activities:    
Cash distributions paid (74,583) (72,081)
Proceeds from unsecured borrowings 0 134,914
Repayment of unsecured borrowings (75,000) (150,000)
Proceeds from secured borrowings 667,695 743,892
Repayment of secured borrowings (488,500) (554,000)
Repurchase of common stock (10) 0
Net Cash Provided by Financing Activities 29,602 102,725
NET DECREASE IN CASH AND CASH EQUIVALENTS (85,510) (46,021)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 428,333 322,935
CASH AND CASH EQUIVALENTS AT END OF PERIOD 342,823 276,914
Supplemental disclosure of cash flow information:    
Cash paid for interest 53,529 28,873
Issuance of shares in connection with the Mergers [1] $ 0 $ 226,839
[1] On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839.
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows (Parenthetical)
$ in Thousands
Apr. 01, 2022
USD ($)
Statement of Cash Flows [Abstract]  
Noncash or part noncash acquisition, value of assets acquired $ 244,691
Stock issued $ 226,839
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Schedule of Investments - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Dec. 12, 2022
[9],[12]
Schedule of Investments [Line Items]      
Cost [1] $ 2,204,617    
Fair Value [1] $ 2,171,056    
Percentage of Total Investments (at fair value) 100.00% 100.00%  
Diversified Financial Services Includes SLR Credit Solutions SLR Business Credit And SLR Healthcare ABL [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 21.60% 22.10%  
Multi Sector Holdings [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 16.60% 17.50%  
Health Care Providers and Services [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 11.80% 7.70%  
Health Care Equipment and Supplies [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 6.50% 6.60%  
Insurance [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 6.40% 4.20%  
Pharmaceuticals [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 5.30% 5.50%  
Software [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 3.50% 4.30%  
Diversified Consumer Services [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 3.40% 2.70%  
Biotechnology [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 3.30% 3.90%  
Capital Markets [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 2.00% 1.70%  
Commercial Services and Supplies [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 2.00% 1.10%  
Thrifts Mortgage Finance [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 1.40% 1.30%  
Asset Management [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 1.40% 0.50%  
Road and Rail [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 1.30% 1.70%  
Personal Products [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 1.30% 1.70%  
Life Sciences Tools and Services [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 1.10% 1.30%  
Wireless Telecommunication Services [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 1.10% 1.10%  
Internet Software Services [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.90% 1.00%  
Building Products [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.90% 0.90%  
Transportation Infrastructure [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.70% 0.70%  
Internet and Catalog Retail [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.70% 1.10%  
Packaged Foods and Meats [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.70% 1.20%  
Communications Equipment [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.60% 0.70%  
Health Care Technology [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.60% 0.80%  
IT Services [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.50% 0.60%  
Leisure Equipment Products [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.50% 0.50%  
Trading Companies Distributors [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.50% 0.90%  
Auto Parts and Equipment [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.50% 1.20%  
Specialty Retail [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.40% 0.50%  
Hotels, Restaurants and Leisure [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.30% 0.30%  
Aerospace and Defense [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.30% 0.30%  
Oil, Gas and Consumable Fuels [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.30% 0.30%  
Auto Components [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.30% 0.40%  
Footwear [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.30% 0.30%  
Media [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.20% 1.90%  
Airlines [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.20% 0.30%  
Machinery [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.20% 0.30%  
Metals and Mining [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.10% 0.20%  
Water Utilities [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.10% 0.10%  
Food Staples Retailing [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.10% 0.10%  
Construction and Engineering [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.10% 0.00%  
Consumer Finance [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.00% 0.10%  
Energy Equipment and Services [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value) 0.00% 0.00%  
Food Products [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value)   0.40%  
Containers and Packaging [Member]      
Schedule of Investments [Line Items]      
Percentage of Total Investments (at fair value)   0.00%  
Investment, Identifier [Axis]: Cash Equivalents 33.7% | Investments & Cash Equivalents 254.1%      
Schedule of Investments [Line Items]      
Cost $ 2,537,174    
Fair Value 2,503,613    
Investment, Identifier [Axis]: Cash Equivalents 33.7% | Liabilities in Excess of Other Assets (154.1%)      
Schedule of Investments [Line Items]      
Fair Value (1,518,228)    
Investment, Identifier [Axis]: Cash Equivalents 33.7% | Net Assets 100.0%      
Schedule of Investments [Line Items]      
Fair Value $ 985,385    
Investment, Identifier [Axis]: Cash Equivalents 33.7% | U.S. Treasury Bill | Government | 9/29/2023 | 11/21/2023      
Schedule of Investments [Line Items]      
Industry Government    
Acquisition Date Sep. 29, 2023    
Maturity Date Nov. 21, 2023    
Par Amount $ 335,000    
Cost 332,557    
Fair Value 332,557    
Investment, Identifier [Axis]: Cash Equivalents 41.8% | Investments & Cash Equivalents 250.5%      
Schedule of Investments [Line Items]      
Cost   $ 2,552,177  
Fair Value   2,504,266  
Investment, Identifier [Axis]: Cash Equivalents 41.8% | Liabilities in Excess of Other Assets (150.5%)      
Schedule of Investments [Line Items]      
Fair Value   (1,504,535)  
Investment, Identifier [Axis]: Cash Equivalents 41.8% | Net Assets 100.0%      
Schedule of Investments [Line Items]      
Fair Value   $ 999,731  
Investment, Identifier [Axis]: Cash Equivalents 41.8% | U.S. Treasury Bill | Government | 12/30/2022 | 2/23/2023      
Schedule of Investments [Line Items]      
Industry   Government  
Acquisition Date   Dec. 30, 2022  
Maturity Date   Feb. 23, 2023  
Par Amount   $ 420,000  
Cost   417,590  
Fair Value   417,590  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants      
Schedule of Investments [Line Items]      
Cost 616,592 565,263  
Fair Value $ 601,583 $ 571,509  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Assertio Holdings Inc | Pharmaceuticals | 7/31/2023      
Schedule of Investments [Line Items]      
Industry [2],[3] Pharmaceuticals    
Acquisition Date [2],[3] Jul. 31, 2023    
Shares/Units [2],[3] 12,510    
Cost [2],[3] $ 51    
Fair Value [2],[3] $ 32    
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Bayside Parent LLC | Health Care Providers & Services | 5/31/2023      
Schedule of Investments [Line Items]      
Industry [3],[4] Health Care Providers & Services    
Acquisition Date [3],[4] May 31, 2023    
Shares/Units [3],[4] 6,526    
Cost [3],[4] $ 11,411    
Fair Value [3],[4] $ 3,816    
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | CardioFocus Inc Warrants | Health Care Equipment & Supplies | 3/31/2017      
Schedule of Investments [Line Items]      
Industry [3] Health Care Equipment & Supplies Health Care Equipment & Supplies  
Acquisition Date [3] Mar. 31, 2017 Mar. 31, 2017  
Shares/Units [3] 90 90  
Cost [3] $ 51 $ 51  
Fair Value [3] $ 0 $ 0  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Centrexion Therapeutics Inc Warrants | Pharmaceuticals | 6/28/2019      
Schedule of Investments [Line Items]      
Industry [3] Pharmaceuticals Pharmaceuticals  
Acquisition Date [3] Jun. 28, 2019 Jun. 28, 2019  
Shares/Units [3] 289,102 289,102  
Cost [3] $ 136 $ 136  
Fair Value [3] $ 50 $ 82  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016      
Schedule of Investments [Line Items]      
Industry [3] Health Care Equipment & Supplies Health Care Equipment & Supplies  
Acquisition Date [3] Jun. 15, 2016 Jun. 15, 2016  
Shares/Units [3] 157,500 157,500  
Cost [3] $ 65 $ 65  
Fair Value [3] $ 0 $ 0  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017      
Schedule of Investments [Line Items]      
Industry [3] Health Care Equipment & Supplies Health Care Equipment & Supplies  
Acquisition Date [3] Aug. 18, 2017 Aug. 18, 2017  
Shares/Units [3] 444,388 444,388  
Cost [3] $ 74 $ 74  
Fair Value [3] $ 87 $ 103  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017      
Schedule of Investments [Line Items]      
Industry [3] Health Care Technology Health Care Technology  
Acquisition Date [3] Mar. 22, 2017 Mar. 22, 2017  
Shares/Units [3] 260,000 260,000  
Cost [3] $ 129 $ 129  
Fair Value [3] $ 342 366  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Investments 208.7%      
Schedule of Investments [Line Items]      
Cost [5]   2,134,587  
Fair Value [5]   $ 2,086,676  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020      
Schedule of Investments [Line Items]      
Industry [7],[8] Multi-Sector Holdings [6] Multi-Sector Holdings [9]  
Acquisition Date [7],[8] Nov. 03, 2020 [6] Nov. 03, 2020 [9]  
Shares/Units [7],[8] 73,500,000 [6] 73,500,000 [9]  
Cost [7],[8] $ 136,596 [6] $ 136,596 [9]  
Fair Value [7],[8] $ 146,000 [6] $ 148,444 [9]  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Meditrina, Inc. Warrants | Health Care Equipment & Supplies | 12/20/2022      
Schedule of Investments [Line Items]      
Industry [3] Health Care Equipment & Supplies Health Care Equipment & Supplies  
Acquisition Date [3] Dec. 20, 2022 Dec. 20, 2022  
Shares/Units [3] 29,366 29,366  
Cost [3] $ 23 $ 23  
Fair Value [3] $ 20 $ 23  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | NSPC Holdings, LLC (National Spine) | Health Care Providers & Services | 2/13/2023      
Schedule of Investments [Line Items]      
Industry [3] Health Care Providers & Services    
Acquisition Date [3] Feb. 13, 2023    
Shares/Units [3] 207,043    
Cost [3] $ 657    
Fair Value [3] $ 273    
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Class B | Diversified Consumer Services | 12/23/2013      
Schedule of Investments [Line Items]      
Industry [3] Diversified Consumer Services [6] Diversified Consumer Services [9]  
Acquisition Date [3] Dec. 23, 2013 [6] Dec. 23, 2013 [9]  
Shares/Units [3] 522 [6] 522 [9]  
Cost [3] $ 5,216 [6] $ 5,216 [9]  
Fair Value [3] $ 0 [6] $ 0 [9]  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Warrants | Diversified Consumer Services | 12/23/2013      
Schedule of Investments [Line Items]      
Industry [3] Diversified Consumer Services [6] Diversified Consumer Services [9]  
Acquisition Date [3] Dec. 23, 2013 [6] Dec. 23, 2013 [9]  
Shares/Units [3] 30,370 [6] 30,370 [9]  
Cost [3] $ 381 [6] $ 381 [9]  
Fair Value [3] $ 0 [6] $ 0 [9]  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013      
Schedule of Investments [Line Items]      
Industry [3] Diversified Consumer Services [6] Diversified Consumer Services [9]  
Acquisition Date [3] Dec. 23, 2013 [6] Dec. 23, 2013 [9]  
Shares/Units [3] 231,177 [6] 231,177 [9]  
Cost [3] $ 15,683 [6] $ 15,683 [9]  
Fair Value [3] $ 0 [6] $ 0 [9]  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | SLR Business Credit | Diversified Financial Services | 4/1/2022      
Schedule of Investments [Line Items]      
Industry [11] Diversified Financial Services [6],[10] Diversified Financial Services [9],[12]  
Acquisition Date [11] Apr. 01, 2022 [6],[10] Apr. 01, 2022 [9],[12]  
Shares/Units [11] 100 [6],[10] 100 [9],[12]  
Cost [11] $ 81,583 [6],[10] $ 81,583 [9],[12]  
Fair Value [11] $ 90,370 [6],[10] $ 89,370 [9],[12]  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | SLR Credit Solutions | Diversified Financial Services | 12/28/2012      
Schedule of Investments [Line Items]      
Industry [13] Diversified Financial Services [6],[10] Diversified Financial Services [9],[12]  
Acquisition Date [13] Dec. 28, 2012 [6],[10] Dec. 28, 2012 [9],[12]  
Shares/Units [13] 280,303 [6],[10] 280,303 [9],[12]  
Cost [13] $ 280,737 [6],[10] $ 280,737 [9],[12]  
Fair Value [13] $ 281,000 [6],[10] $ 288,760 [9],[12]  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022      
Schedule of Investments [Line Items]      
Industry [14] Diversified Financial Services [6],[10] Diversified Financial Services [9],[12]  
Acquisition Date [14] Apr. 01, 2022 [6],[10] Apr. 01, 2022 [9],[12]  
Shares/Units [14] 32,839 [6],[10] 32,839 [9],[12]  
Cost [14] $ 34,335 [6],[10] $ 34,335 [9],[12]  
Fair Value [14] $ 34,850 [6],[10] $ 34,350 [9],[12]  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | SLR Senior Lending Program LLC | Asset Management | 12/1/2022      
Schedule of Investments [Line Items]      
Industry [15] Asset Management [6],[10] Asset Management [9],[12]  
Acquisition Date [15] Dec. 01, 2022 [6],[10] Dec. 01, 2022 [9],[12]  
Shares/Units [15] 0 [6],[10] 0 [9],[12]  
Cost [15] $ 28,750 [6],[10] $ 9,500 [9],[12]  
Fair Value [15] $ 29,277 [6],[10] $ 9,426 [9],[12]  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | SLR-AMI Topco Blocker, LLC | Internet & Catalog Retail | 6/16/2023      
Schedule of Investments [Line Items]      
Industry [3],[4],[16] Internet & Catalog Retail    
Acquisition Date [3],[4],[16] Jun. 16, 2023    
Shares/Units [3],[4],[16] 0    
Cost [3],[4],[16] $ 19,880    
Fair Value [3],[4],[16] $ 15,100    
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Senseonics Holdings, Inc | Health Care Equipment & Supplies | 7/25/2019      
Schedule of Investments [Line Items]      
Industry [2],[3] Health Care Equipment & Supplies [10] Health Care Equipment & Supplies [12]  
Acquisition Date [2],[3] Jul. 25, 2019 [10] Jul. 25, 2019 [12]  
Shares/Units [2],[3] 469,353 [10] 469,353 [12]  
Cost [2],[3] $ 235 [10] $ 235 [12]  
Fair Value [2],[3] $ 283 [10] $ 483 [12]  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Spectrum Pharmaceuticals, Inc. Warrants | Biotechnology | 9/21/2022      
Schedule of Investments [Line Items]      
Industry [3]   Biotechnology  
Acquisition Date [3]   Sep. 21, 2022  
Shares/Units [3]   159,470  
Cost [3]   $ 51  
Fair Value [3]   $ 15  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Vapotherm, Inc. Warrants | Health Care Equipment & Supplies | 2/18/2022      
Schedule of Investments [Line Items]      
Industry [3] Health Care Equipment & Supplies Health Care Equipment & Supplies  
Acquisition Date [3] Feb. 18, 2022 Feb. 18, 2022  
Shares/Units [3] 48,969 36,996  
Cost [3] $ 290 $ 210  
Fair Value [3] $ 28 $ 87  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) | Health Care Equipment & Supplies | 5/10/2018      
Schedule of Investments [Line Items]      
Industry [3] Health Care Equipment & Supplies Health Care Equipment & Supplies  
Acquisition Date [3] May 10, 2018 May 10, 2018  
Shares/Units [3] 2,230 33,430  
Cost [3] $ 152 $ 152  
Fair Value [3] $ 0 $ 0  
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | Vertos Medical, Inc. Warrants| Health Care Equipment & Supplies | 6/14/2023      
Schedule of Investments [Line Items]      
Industry [3] Health Care Equipment & Supplies    
Acquisition Date [3] Jun. 14, 2023    
Shares/Units [3] 161,761    
Cost [3] $ 51    
Fair Value [3] $ 55    
Investment, Identifier [Axis]: Common Equity Equity Interests Warrants | aTyr Pharma Inc Warrants | Pharmaceuticals | 11/18/2016      
Schedule of Investments [Line Items]      
Industry [3] Pharmaceuticals Pharmaceuticals  
Acquisition Date [3] Nov. 18, 2016 Nov. 18, 2016  
Shares/Units [3] 6,347 6,347  
Cost [3] $ 106 $ 106  
Fair Value [3] 0 0  
Investment, Identifier [Axis]: Equipment Financing      
Schedule of Investments [Line Items]      
Cost 290,688 291,445  
Fair Value $ 265,306 $ 265,952  
Investment, Identifier [Axis]: Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026      
Schedule of Investments [Line Items]      
Industry [17]   Diversified Consumer Services  
Interest Rate [17],[18]   10.00%  
Acquisition Date [17]   Aug. 11, 2022  
Par Amount [17]   $ 1,036  
Cost [17]   1,036  
Fair Value [17]   $ 1,036  
Investment, Identifier [Axis]: Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Maturity Date [17]   Aug. 11, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Maturity Date [17]   Aug. 29, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Acquisition Date [17]   Feb. 12, 2021  
Par Amount [17]   $ 2,264  
Cost [17]   2,262  
Fair Value [17]   $ 2,262  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.47%  
Maturity Date [17]   Mar. 01, 2025  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   9.64%  
Maturity Date [17]   Dec. 01, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026      
Schedule of Investments [Line Items]      
Industry [17]   Airlines  
Acquisition Date [17]   Nov. 03, 2021  
Par Amount [17]   $ 3,600  
Cost [17]   3,660  
Fair Value [17]   $ 3,600  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   7.08%  
Maturity Date [17]   Nov. 03, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   7.13%  
Maturity Date [17]   Nov. 23, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |AmeraMex International Inc. |Commercial Services & Supplies |10.00% |3/29/2019 |9/15/2024      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Interest Rate [17],[18]   10.00%  
Acquisition Date [17]   Mar. 29, 2019  
Maturity Date [17]   Sep. 15, 2024  
Par Amount [17]   $ 1,059  
Cost [17]   1,059  
Fair Value [17]   $ 1,069  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Bazzini LLC |Food & Staples Retailing |10.46% |12/23/2022 |1/1/2028      
Schedule of Investments [Line Items]      
Industry [17]   Food & Staples Retailing  
Interest Rate [17],[18]   10.46%  
Acquisition Date [17]   Dec. 23, 2022  
Maturity Date [17]   Jan. 01, 2028  
Par Amount [17]   $ 2,365  
Cost [17]   2,440  
Fair Value [17]   $ 2,365  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026      
Schedule of Investments [Line Items]      
Industry [17]   Metals & Mining  
Acquisition Date [17]   May 28, 2020  
Par Amount [17]   $ 4,568  
Cost [17]   4,568  
Fair Value [17]   $ 4,568  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.31%  
Maturity Date [17]   Jul. 01, 2024  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   10.44%  
Maturity Date [17]   Oct. 07, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Bowman Energy Solutions LLC |Commercial Services & Supplies |7.42% |7/1/2022 |8/1/2026      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Interest Rate [17],[18]   7.42%  
Acquisition Date [17]   Jul. 01, 2022  
Maturity Date [17]   Aug. 01, 2026  
Par Amount [17]   $ 153  
Cost [17]   153  
Fair Value [17]   $ 153  
Investment, Identifier [Axis]: Equipment Financing 26.6% |C-Port/Stone LLC |Oil, Gas & Consumable Fuels |8.54% |10/7/2022 |11/1/2027      
Schedule of Investments [Line Items]      
Industry [17]   Oil, Gas & Consumable Fuels  
Interest Rate [17],[18]   8.54%  
Acquisition Date [17]   Oct. 07, 2022  
Maturity Date [17]   Nov. 01, 2027  
Par Amount [17]   $ 6,708  
Cost [17]   6,514  
Fair Value [17]   $ 6,507  
Investment, Identifier [Axis]: Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Acquisition Date [17]   Sep. 22, 2022  
Par Amount [17]   $ 3,690  
Cost [17]   3,690  
Fair Value [17]   $ 3,690  
Investment, Identifier [Axis]: Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.10%  
Maturity Date [17]   Mar. 22, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.60%  
Maturity Date [17]   Sep. 22, 2027  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026      
Schedule of Investments [Line Items]      
Industry [17]   Airlines  
Interest Rate [17],[18]   10.00%  
Acquisition Date [17]   Apr. 04, 2018  
Par Amount [17]   $ 2,241  
Cost [17]   2,241  
Fair Value [17]   $ 2,214  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Maturity Date [17]   Oct. 04, 2023  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Maturity Date [17]   Jun. 22, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Champion Air LLC |Airlines |10.00% |3/19/2018 |1/1/2023      
Schedule of Investments [Line Items]      
Industry [17]   Airlines  
Interest Rate [17],[18]   10.00%  
Acquisition Date [17]   Mar. 19, 2018  
Maturity Date [17]   Jan. 01, 2023  
Par Amount [17]   $ 1,055  
Cost [17]   1,055  
Fair Value [17]   $ 1,055  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028      
Schedule of Investments [Line Items]      
Industry [17]   Hotels, Restaurants & Leisure  
Acquisition Date [17]   May 27, 2021  
Par Amount [17]   $ 6,539  
Cost [17]   6,539  
Fair Value [17]   $ 6,539  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   9.36%  
Maturity Date [17]   Apr. 01, 2025  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   13.01%  
Maturity Date [17]   Jan. 01, 2028  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Dongwon Autopart Technology Inc. |Auto Components |7.96% |2/2/2021 | 1/1/2026      
Schedule of Investments [Line Items]      
Industry [17]   Auto Components  
Interest Rate [17],[18]   7.96%  
Acquisition Date [17]   Feb. 02, 2021  
Maturity Date [17]   Jan. 01, 2026  
Par Amount [17]   $ 1,828  
Cost [17]   1,849  
Fair Value [17]   $ 1,828  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Drillers Choice Inc. |Commercial Services & Supplies |8.00% |10/31/2022 | 11/1/2027      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Interest Rate [17],[18]   8.00%  
Acquisition Date [17]   Oct. 31, 2022  
Maturity Date [17]   Nov. 01, 2027  
Par Amount [17]   $ 1,589  
Cost [17]   1,589  
Fair Value [17]   $ 1,589  
Investment, Identifier [Axis]: Equipment Financing 26.6% |EasyPak LLC |Containers & Packaging |9.01% |1/6/2021 | 1/1/2024      
Schedule of Investments [Line Items]      
Industry [17]   Containers & Packaging  
Interest Rate [17],[18]   9.01%  
Acquisition Date [17]   Jan. 06, 2021  
Maturity Date [17]   Jan. 01, 2024  
Par Amount [17]   $ 276  
Cost [17]   276  
Fair Value [17]   $ 276  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027      
Schedule of Investments [Line Items]      
Industry [17]   Diversified Consumer Services  
Acquisition Date [17]   Aug. 26, 2022  
Par Amount [17]   $ 1,321  
Cost [17]   1,321  
Fair Value [17]   $ 1,295  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   6.58%  
Maturity Date [17]   Dec. 09, 2025  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   9.16%  
Maturity Date [17]   Sep. 01, 2027  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Environmental Protection & Improvement Company LLC |Road & Rail |8.25% |9/30/2020 | 10/1/2027      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Interest Rate [17],[18]   8.25%  
Acquisition Date [17]   Sep. 30, 2020  
Maturity Date [17]   Oct. 01, 2027  
Par Amount [17]   $ 5,270  
Cost [17]   5,300  
Fair Value [17]   $ 5,270  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Equipment Operating Leases LLC |Multi-Sector Holdings |8.37% |4/27/2018 | 4/27/2025      
Schedule of Investments [Line Items]      
Industry [9],[19]   Multi-Sector Holdings  
Interest Rate [9],[18],[19]   8.37%  
Acquisition Date [9],[19]   Apr. 27, 2018  
Maturity Date [9],[19]   Apr. 27, 2025  
Par Amount [9],[19]   $ 3,837  
Cost [9],[19]   3,837  
Fair Value [9],[19]   $ 3,741  
Investment, Identifier [Axis]: Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027      
Schedule of Investments [Line Items]      
Industry [17]   Diversified Financial Services  
Acquisition Date [17]   Oct. 28, 2021  
Par Amount [17]   $ 2,938  
Cost [17]   2,941  
Fair Value [17]   $ 2,938  
Investment, Identifier [Axis]: Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   7.50%  
Maturity Date [17]   Oct. 01, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   9.02%  
Maturity Date [17]   Mar. 01, 2027  
Investment, Identifier [Axis]: Equipment Financing 26.6% |First National Capital LLC |Diversified Financial Services | 9.00% |11/5/2021 | 8/1/2026      
Schedule of Investments [Line Items]      
Industry [17]   Diversified Financial Services  
Interest Rate [17],[18]   9.00%  
Acquisition Date [17]   Nov. 05, 2021  
Maturity Date [17]   Aug. 01, 2026  
Par Amount [17]   $ 7,116  
Cost [17]   7,116  
Fair Value [17]   $ 7,116  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Acquisition Date [17]   Apr. 09, 2019  
Maturity Date [17]   Nov. 01, 2023  
Par Amount [17]   $ 779  
Cost [17]   784  
Fair Value [17]   $ 779  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   12.51%  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   12.89%  
Investment, Identifier [Axis]: Equipment Financing 26.6% |GMT Corporation |Machinery | 10.71% |10/23/2018 | 1/1/2026      
Schedule of Investments [Line Items]      
Industry [17]   Machinery  
Interest Rate [17],[18]   10.71%  
Acquisition Date [17]   Oct. 23, 2018  
Maturity Date [17]   Jan. 01, 2026  
Par Amount [17]   $ 4,801  
Cost [17]   4,806  
Fair Value [17]   $ 4,801  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Acquisition Date [17]   Mar. 22, 2018  
Par Amount [17]   $ 469  
Cost [17]   469  
Fair Value [17]   $ 468  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.30%  
Maturity Date [17]   Jun. 05, 2023  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.77%  
Maturity Date [17]   Oct. 05, 2023  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Georgia Jet Inc. |Airlines | 8.00% |12/4/2017 | 1/4/2024      
Schedule of Investments [Line Items]      
Industry [17]   Airlines  
Interest Rate [17],[18]   8.00%  
Acquisition Date [17]   Dec. 04, 2017  
Maturity Date [17]   Jan. 04, 2024  
Par Amount [17]   $ 425  
Cost [17]   425  
Fair Value [17]   $ 425  
Investment, Identifier [Axis]: Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Acquisition Date [17]   Nov. 15, 2018  
Par Amount [17]   $ 290  
Cost [17]   290  
Fair Value [17]   $ 283  
Investment, Identifier [Axis]: Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   9.69%  
Maturity Date [17]   May 01, 2024  
Investment, Identifier [Axis]: Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   9.94%  
Maturity Date [17]   Sep. 01, 2025  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Hawkeye Contracting Company LLC |Construction & Engineering | 10.50% |10/8/2021 | 11/1/2025      
Schedule of Investments [Line Items]      
Industry [17]   Construction & Engineering  
Interest Rate [17],[18]   10.50%  
Acquisition Date [17]   Oct. 08, 2021  
Maturity Date [17]   Nov. 01, 2025  
Par Amount [17]   $ 997  
Cost [17]   997  
Fair Value [17]   $ 997  
Investment, Identifier [Axis]: Equipment Financing 26.6% |International Automotive Components Group North America Inc.|Auto Components | 7.95% |6/23/2021 | 6/23/2025      
Schedule of Investments [Line Items]      
Industry [17]   Auto Components  
Interest Rate [17],[18]   7.95%  
Acquisition Date [17]   Jun. 23, 2021  
Maturity Date [17]   Jun. 23, 2025  
Par Amount [17]   $ 6,072  
Cost [17]   6,109  
Fair Value [17]   $ 5,951  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Kool Pak LLC |Road & Rail | 8.58% |2/5/2018 | 3/1/2024      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Interest Rate [17],[18]   8.58%  
Acquisition Date [17]   Feb. 05, 2018  
Maturity Date [17]   Mar. 01, 2024  
Par Amount [17]   $ 194  
Cost [17]   194  
Fair Value [17]   $ 194  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Loc Performance Products LLC |Machinery | 10.50% |12/29/2022 | 6/1/2027      
Schedule of Investments [Line Items]      
Industry [17]   Machinery  
Interest Rate [17],[18]   10.50%  
Acquisition Date [17]   Dec. 29, 2022  
Maturity Date [17]   Jun. 01, 2027  
Par Amount [17]   $ 767  
Cost [17]   767  
Fair Value [17]   $ 767  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024      
Schedule of Investments [Line Items]      
Industry [9],[19]   Multi-Sector Holdings  
Acquisition Date [9],[19]   May 16, 2019  
Par Amount [9],[19]   $ 7,500  
Cost [9],[19]   7,500  
Fair Value [9],[19]   $ 7,361  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [9],[18],[19]   8.73%  
Maturity Date [9],[19]   May 16, 2024  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [9],[18],[19]   11.52%  
Maturity Date [9],[19]   Sep. 25, 2024  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Acquisition Date [17]   Jun. 17, 2021  
Par Amount [17]   $ 16,411  
Cost [17]   16,411  
Fair Value [17]   $ 16,411  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.28%  
Maturity Date [17]   Dec. 01, 2024  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   12.09%  
Maturity Date [17]   Dec. 01, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024      
Schedule of Investments [Line Items]      
Industry [17]   Consumer Finance  
Acquisition Date [17]   Aug. 20, 2021  
Par Amount [17]   $ 1,638  
Cost [17]   1,663  
Fair Value [17]   $ 1,638  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   12.46%  
Maturity Date [17]   Aug. 20, 2024  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   13.26%  
Maturity Date [17]   Oct. 01, 2024  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Mountain Air Helicopters Inc. |Commercial Services & Supplies | 10.00% |7/31/2017 | 2/28/2025      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Interest Rate [17],[18]   10.00%  
Acquisition Date [17]   Jul. 31, 2017  
Maturity Date [17]   Feb. 28, 2025  
Par Amount [17]   $ 369  
Cost [17]   368  
Fair Value [17]   $ 369  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Ozzies Inc. |Commercial Services & Supplies | 10.72% |12/23/2022 | 1/1/2027      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Interest Rate [17],[18]   10.72%  
Acquisition Date [17]   Dec. 23, 2022  
Maturity Date [17]   Jan. 01, 2027  
Par Amount [17]   $ 2,005  
Cost [17]   2,072  
Fair Value [17]   $ 2,005  
Investment, Identifier [Axis]: Equipment Financing 26.6% |PCX Aerostructures LLC |Aerospace & Defense | 9.32% |11/23/2022 | 12/1/2028      
Schedule of Investments [Line Items]      
Industry [17]   Aerospace & Defense  
Interest Rate [17],[18]   9.32%  
Acquisition Date [17]   Nov. 23, 2022  
Maturity Date [17]   Dec. 01, 2028  
Par Amount [17]   $ 2,658  
Cost [17]   2,658  
Fair Value [17]   $ 2,658  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Rane Light Metal Castings Inc. |Machinery | 10.00% |6/1/2020 | 6/1/2024      
Schedule of Investments [Line Items]      
Industry [17]   Machinery  
Interest Rate [17],[18]   10.00%  
Acquisition Date [17]   Jun. 01, 2020  
Maturity Date [17]   Jun. 01, 2024  
Par Amount [17]   $ 159  
Cost [17]   159  
Fair Value [17]   $ 159  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Acquisition Date [17]   Sep. 24, 2019  
Par Amount [17]   $ 1,940  
Cost [17]   1,960  
Fair Value [17]   $ 1,904  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   9.33%  
Maturity Date [17]   Apr. 01, 2023  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   9.79%  
Maturity Date [17]   Nov. 01, 2024  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Rotten Rock Hardscaping & Tree Service |Diversified Consumer Services | 8.21% |12/6/2022 | 12/6/2027      
Schedule of Investments [Line Items]      
Industry [17]   Diversified Consumer Services  
Interest Rate [17],[18]   8.21%  
Acquisition Date [17]   Dec. 06, 2022  
Maturity Date [17]   Dec. 06, 2027  
Par Amount [17]   $ 245  
Cost [17]   245  
Fair Value [17]   $ 245  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Royal Coach Lines Inc. |Road & Rail | 9.56% |11/21/2019 | 8/1/2025      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Interest Rate [17],[18]   9.56%  
Acquisition Date [17]   Nov. 21, 2019  
Maturity Date [17]   Aug. 01, 2025  
Par Amount [17]   $ 849  
Cost [17]   849  
Fair Value [17]   $ 775  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Royal Express Inc. |Road & Rail | 9.53% |1/17/2019 | 2/1/2024      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Interest Rate [17],[18]   9.53%  
Acquisition Date [17]   Jan. 17, 2019  
Maturity Date [17]   Feb. 01, 2024  
Par Amount [17]   $ 428  
Cost [17]   431  
Fair Value [17]   $ 428  
Investment, Identifier [Axis]: Equipment Financing 26.6% |SLR Equipment Finance Equity Interests |Multi-Sector Holdings |7/31/2017      
Schedule of Investments [Line Items]      
Industry [3],[9],[20],[21]   Multi-Sector Holdings  
Acquisition Date [3],[9],[20],[21]   Jul. 31, 2017  
Shares/Units [3],[9],[20],[21]   200  
Cost [3],[9],[20],[21]   $ 145,000  
Fair Value [3],[9],[20],[21]   $ 120,820  
Investment, Identifier [Axis]: Equipment Financing 26.6% |SLR Equipment Finance |Multi-Sector Holdings | 8.50% |1/24/2022 |1/24/2023      
Schedule of Investments [Line Items]      
Industry [9]   Multi-Sector Holdings  
Interest Rate [9],[18]   8.50%  
Acquisition Date [9]   Jan. 24, 2022  
Maturity Date [9]   Jan. 24, 2023  
Par Amount [9]   $ 5,000  
Cost [9]   5,000  
Fair Value [9]   $ 5,000  
Investment, Identifier [Axis]: Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Acquisition Date [17]   Jul. 31, 2017  
Par Amount [17]   $ 1,521  
Cost [17]   1,521  
Fair Value [17]   $ 1,459  
Investment, Identifier [Axis]: Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.47%  
Maturity Date [17]   Jul. 01, 2023  
Investment, Identifier [Axis]: Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.58%  
Maturity Date [17]   Jan. 25, 2025  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Signet Marine Corporation |Transportation Infrastructure | 8.50% |10/31/2022 |7/1/2029      
Schedule of Investments [Line Items]      
Industry [17]   Transportation Infrastructure  
Interest Rate [17],[18]   8.50%  
Acquisition Date [17]   Oct. 31, 2022  
Maturity Date [17]   Jul. 01, 2029  
Par Amount [17]   $ 14,102  
Cost [17]   14,152  
Fair Value [17]   $ 14,102  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Acquisition Date [17]   Jun. 30, 2022  
Par Amount [17]   $ 4,139  
Cost [17]   4,139  
Fair Value [17]   $ 4,139  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   7.82%  
Maturity Date [17]   Sep. 15, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.28%  
Maturity Date [17]   Dec. 29, 2029  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Star Coaches Inc. |Road & Rail | 8.42% |3/9/2018 |4/1/2025      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Interest Rate [17],[18]   8.42%  
Acquisition Date [17]   Mar. 09, 2018  
Maturity Date [17]   Apr. 01, 2025  
Par Amount [17]   $ 2,887  
Cost [17]   2,887  
Fair Value [17]   $ 2,591  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Acquisition Date [17]   Jul. 31, 2017  
Maturity Date [17]   Jan. 01, 2026  
Par Amount [17]   $ 3,369  
Cost [17]   3,369  
Fair Value [17]   $ 3,369  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   10.22%  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   10.63%  
Investment, Identifier [Axis]: Equipment Financing 26.6% |The Smedley Company & Smedley Services Inc. |Commercial Services & Supplies | 4.07% |7/31/2017 |1/15/2028      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Interest Rate [17],[18]   4.07%  
Acquisition Date [17]   Jul. 31, 2017  
Maturity Date [17]   Jan. 15, 2028  
Par Amount [17]   $ 1,706  
Cost [17]   1,706  
Fair Value [17]   $ 1,706  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Acquisition Date [17]   Oct. 08, 2021  
Par Amount [17]   $ 577  
Cost [17]   577  
Fair Value [17]   $ 577  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   7.94%  
Maturity Date [17]   Nov. 01, 2024  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.75%  
Maturity Date [17]   Dec. 01, 2026  
Investment, Identifier [Axis]: Equipment Financing 26.6% |U.S. Crane & Rigging LLC |Commercial Services & Supplies | 10.92% |12/23/2022 |3/1/2027      
Schedule of Investments [Line Items]      
Industry [17]   Commercial Services & Supplies  
Interest Rate [17],[18]   10.92%  
Acquisition Date [17]   Dec. 23, 2022  
Maturity Date [17]   Mar. 01, 2027  
Par Amount [17]   $ 2,005  
Cost [17]   2,005  
Fair Value [17]   $ 2,005  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Up Trucking Services LLC |Road & Rail | 11.21% |3/23/2018 |8/1/2024      
Schedule of Investments [Line Items]      
Industry [17]   Road & Rail  
Interest Rate [17],[18]   11.21%  
Acquisition Date [17]   Mar. 23, 2018  
Maturity Date [17]   Aug. 01, 2024  
Par Amount [17]   $ 469  
Cost [17]   473  
Fair Value [17]   $ 469  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025      
Schedule of Investments [Line Items]      
Industry [17]   Diversified Consumer Services  
Acquisition Date [17]   Jul. 31, 2019  
Par Amount [17]   $ 604  
Cost [17]   605  
Fair Value [17]   $ 604  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.43%  
Maturity Date [17]   Aug. 01, 2024  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   10.00%  
Maturity Date [17]   Oct. 05, 2025  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Womble Company Inc. |DEnergy Equipment & Services |9.11% |12/27/2019 |1/1/2025      
Schedule of Investments [Line Items]      
Industry [17]   Energy Equipment & Services  
Interest Rate [17],[18]   9.11%  
Acquisition Date [17]   Dec. 27, 2019  
Maturity Date [17]   Jan. 01, 2025  
Par Amount [17]   $ 386  
Cost [17]   386  
Fair Value [17]   $ 371  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027      
Schedule of Investments [Line Items]      
Industry [17]   Transportation Infrastructure  
Acquisition Date [17]   Sep. 23, 2022  
Par Amount [17]   $ 304  
Cost [17]   308  
Fair Value [17]   $ 304  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   8.32%  
Maturity Date [17]   Sep. 23, 2027  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[18]   9.36%  
Maturity Date [17]   Oct. 28, 2027  
Investment, Identifier [Axis]: Equipment Financing 26.6% |Zamborelli Enterprises Pacific Souther Foundation |Diversified Consumer Services |8.91% |12/7/2022 |1/1/2027      
Schedule of Investments [Line Items]      
Industry [17]   Diversified Consumer Services  
Interest Rate [17],[18]   8.91%  
Acquisition Date [17]   Dec. 07, 2022  
Maturity Date [17]   Jan. 01, 2027  
Par Amount [17]   $ 707  
Cost [17]   714  
Fair Value [17]   $ 707  
Investment, Identifier [Axis]: Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027      
Schedule of Investments [Line Items]      
Industry [17] Road & Rail    
Acquisition Date [17] Sep. 22, 2022    
Par Amount [17] $ 3,076    
Cost [17] 3,076    
Fair Value [17] $ 3,076    
Investment, Identifier [Axis]: Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.10%    
Maturity Date [17] Jun. 22, 2026    
Investment, Identifier [Axis]: Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.60%    
Maturity Date [17] Sep. 22, 2027    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028      
Schedule of Investments [Line Items]      
Industry [17] Diversified Consumer Services    
Acquisition Date [17] Mar. 07, 2023    
Par Amount [17] $ 3,688    
Cost [17] 3,723    
Fair Value [17] $ 3,688    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.40%    
Maturity Date [17] Mar. 07, 2028    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.72%    
Maturity Date [17] May 18, 2028    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028      
Schedule of Investments [Line Items]      
Industry [17] Hotels, Restaurants & Leisure    
Acquisition Date [17] May 27, 2021    
Par Amount [17] $ 6,880    
Cost [17] 6,880    
Fair Value [17] $ 6,880    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 9.36%    
Maturity Date [17] Apr. 01, 2025    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 13.01%    
Maturity Date [17] May 01, 2028    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Acquisition Date [17] Mar. 23, 2023    
Par Amount [17] $ 1,926    
Cost [17] 1,895    
Fair Value [17] $ 1,893    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 6.75%    
Maturity Date [17] Apr. 01, 2028    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 7.15%    
Maturity Date [17] Jun. 01, 2028    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Dongwon Autopart Technology Inc | Auto Components | 7.96% | 2/2/2021 | 1/1/2026      
Schedule of Investments [Line Items]      
Industry [17] Auto Components    
Interest Rate [17],[22] 7.96%    
Acquisition Date [17] Feb. 02, 2021    
Maturity Date [17] Jan. 01, 2026    
Par Amount [17] $ 1,411    
Cost [17] 1,424    
Fair Value [17] $ 1,411    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Double S Industrial Contractors Inc | Commercial Services & Supplies | 8.60% | 7/28/2023 | 8/1/2027      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 8.60%    
Acquisition Date [17] Jul. 28, 2023    
Maturity Date [17] Aug. 01, 2027    
Par Amount [17] $ 119    
Cost [17] 119    
Fair Value [17] $ 119    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Acquisition Date [17] Oct. 31, 2022    
Par Amount [17] $ 1,962    
Cost [17] 1,965    
Fair Value [17] $ 1,962    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.00%    
Maturity Date [17] Nov. 01, 2027    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 10.08%    
Maturity Date [17] Jun. 01, 2029    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027      
Schedule of Investments [Line Items]      
Industry [17] Diversified Consumer Services    
Acquisition Date [17] Aug. 26, 2022    
Par Amount [17] $ 1,139    
Cost [17] 1,139    
Fair Value [17] $ 1,139    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 6.58%    
Maturity Date [17] Nov. 09, 2025    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 9.16%    
Maturity Date [17] Sep. 01, 2027    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Environmental Protection & Improvement Company LLC | Road & Rail | 8.25% | 9/30/2020 | 10/1/2027      
Schedule of Investments [Line Items]      
Industry [17] Road & Rail    
Interest Rate [17],[22] 8.25%    
Acquisition Date [17] Sep. 30, 2020    
Maturity Date [17] Oct. 01, 2027    
Par Amount [17] $ 4,746    
Cost [17] 4,769    
Fair Value [17] $ 4,746    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Equipment Operating Leases LLC | Multi-Sector Holdings | 8.37% | 4/27/2018 | 4/27/2025      
Schedule of Investments [Line Items]      
Industry [6],[19] Multi-Sector Holdings    
Interest Rate [6],[19],[22] 8.37%    
Acquisition Date [6],[19] Apr. 27, 2018    
Maturity Date [6],[19] Apr. 27, 2025    
Par Amount [6],[19] $ 3,498    
Cost [6],[19] 3,498    
Fair Value [6],[19] $ 3,411    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Extreme Steel Crane & Rigging LLC | Commercial Services & Supplies | 9.52% | 3/3/2023 | 3/3/2027      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 9.52%    
Acquisition Date [17] Mar. 03, 2023    
Maturity Date [17] Mar. 03, 2027    
Par Amount [17] $ 902    
Cost [17] 910    
Fair Value [17] $ 902    
Investment, Identifier [Axis]: Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027      
Schedule of Investments [Line Items]      
Industry [17] Diversified Financial Services    
Acquisition Date [17] Oct. 28, 2021    
Par Amount [17] $ 2,449    
Cost [17] 2,451    
Fair Value [17] $ 2,449    
Investment, Identifier [Axis]: Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 7.50%    
Maturity Date [17] Oct. 01, 2026    
Investment, Identifier [Axis]: Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 9.02%    
Maturity Date [17] Mar. 01, 2027    
Investment, Identifier [Axis]: Equipment Financing 26.9% | First National Capital LLC | Diversified Financial Services | 9.00% | 11/5/2021 | 8/1/2026      
Schedule of Investments [Line Items]      
Industry [17] Diversified Financial Services    
Interest Rate [17],[22] 9.00%    
Acquisition Date [17] Nov. 05, 2021    
Maturity Date [17] Aug. 01, 2026    
Par Amount [17] $ 5,739    
Cost [17] 5,739    
Fair Value [17] $ 5,739    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023      
Schedule of Investments [Line Items]      
Industry [17] Road & Rail    
Acquisition Date [17] Apr. 09, 2019    
Maturity Date [17] Nov. 01, 2023    
Par Amount [17] $ 289    
Cost [17] 289    
Fair Value [17] $ 289    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 12.51%    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 12.89%    
Investment, Identifier [Axis]: Equipment Financing 26.9% | GMT Corporation | Machinery | 10.71% | 10/23/2018 | 1/1/2026      
Schedule of Investments [Line Items]      
Industry [17] Machinery    
Interest Rate [17],[22] 10.71%    
Acquisition Date [17] Oct. 23, 2018    
Maturity Date [17] Jan. 01, 2026    
Par Amount [17] $ 4,070    
Cost [17] 4,073    
Fair Value [17] $ 4,070    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Georgia Jet Inc | Airlines | 8.00% | 12/4/2017 | 1/4/2024      
Schedule of Investments [Line Items]      
Industry [17] Airlines    
Interest Rate [17],[22] 8.00%    
Acquisition Date [17] Dec. 04, 2017    
Maturity Date [17] Jan. 04, 2024    
Par Amount [17] $ 128    
Cost [17] 128    
Fair Value [17] $ 128    
Investment, Identifier [Axis]: Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Acquisition Date [17] Nov. 15, 2018    
Par Amount [17] $ 189    
Cost [17] 189    
Fair Value [17] $ 184    
Investment, Identifier [Axis]: Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 9.69%    
Maturity Date [17] May 01, 2024    
Investment, Identifier [Axis]: Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 9.94%    
Maturity Date [17] Sep. 01, 2025    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Hawkeye Contracting Company LLC | Construction & Engineering | 10.50% | 10/8/2021 | 11/1/2025      
Schedule of Investments [Line Items]      
Industry [17] Construction & Engineering    
Interest Rate [17],[22] 10.50%    
Acquisition Date [17] Oct. 08, 2021    
Maturity Date [17] Nov. 01, 2025    
Par Amount [17] $ 769    
Cost [17] 769    
Fair Value [17] $ 769    
Investment, Identifier [Axis]: Equipment Financing 26.9% | International Automotive Components Group North America Inc | Auto Components | 7.95% | 6/23/2021 | 6/23/2025      
Schedule of Investments [Line Items]      
Industry [17] Auto Components    
Interest Rate [17],[22] 7.95%    
Acquisition Date [17] Jun. 23, 2021    
Maturity Date [17] Jun. 23, 2025    
Par Amount [17] $ 4,375    
Cost [17] 4,394    
Fair Value [17] $ 4,288    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Kool Pak LLC | Road & Rail | 8.58% | 2/5/2018 | 3/1/2024      
Schedule of Investments [Line Items]      
Industry [17] Road & Rail    
Interest Rate [17],[22] 8.58%    
Acquisition Date [17] Feb. 05, 2018    
Maturity Date [17] Mar. 01, 2024    
Par Amount [17] $ 71    
Cost [17] 71    
Fair Value [17] $ 71    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Loc Performance Products LLC | Machinery | 10.50% | 12/29/2022 | 6/1/2027      
Schedule of Investments [Line Items]      
Industry [17] Machinery    
Interest Rate [17],[22] 10.50%    
Acquisition Date [17] Dec. 29, 2022    
Maturity Date [17] Jun. 01, 2027    
Par Amount [17] $ 673    
Cost [17] 673    
Fair Value [17] $ 673    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024      
Schedule of Investments [Line Items]      
Industry [6],[19] Multi-Sector Holdings    
Acquisition Date [6],[19] May 16, 2019    
Par Amount [6],[19] $ 7,500    
Cost [6],[19] 7,500    
Fair Value [6],[19] $ 7,361    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [6],[19],[22] 8.73%    
Maturity Date [6],[19] May 16, 2024    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [6],[19],[22] 11.52%    
Maturity Date [6],[19] Sep. 25, 2024    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026      
Schedule of Investments [Line Items]      
Industry [17] Road & Rail    
Acquisition Date [17] Jun. 17, 2021    
Par Amount [17] $ 12,142    
Cost [17] 12,142    
Fair Value [17] $ 12,142    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.28%    
Maturity Date [17] Dec. 01, 2024    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 12.09%    
Maturity Date [17] Dec. 01, 2026    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024      
Schedule of Investments [Line Items]      
Industry [17] Consumer Finance    
Acquisition Date [17] Aug. 20, 2021    
Par Amount [17] $ 895    
Cost [17] 903    
Fair Value [17] $ 895    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 12.46%    
Maturity Date [17] Jul. 20, 2024    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 13.26%    
Maturity Date [17] Oct. 01, 2024    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Miranda Logistics Enterprise Inc | Construction & Engineering | 7.69% | 4/14/2023 | 4/14/2028      
Schedule of Investments [Line Items]      
Industry [17] Construction & Engineering    
Interest Rate [17],[22] 7.69%    
Acquisition Date [17] Apr. 14, 2023    
Maturity Date [17] Apr. 14, 2028    
Par Amount [17] $ 824    
Cost [17] 824    
Fair Value [17] $ 824    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Mountain Air Helicopters Inc | Commercial Services & Supplies | 10.00% | 7/31/2017 | 2/28/2025      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 10.00%    
Acquisition Date [17] Jul. 31, 2017    
Maturity Date [17] Feb. 28, 2025    
Par Amount [17] $ 279    
Cost [17] 278    
Fair Value [17] $ 279    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Nimble Crane LLC | Commercial Services & Supplies | 9.18% | 7/13/2023 | 7/13/2028      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 9.18%    
Acquisition Date [17] Jul. 13, 2023    
Maturity Date [17] Jul. 13, 2028    
Par Amount [17] $ 975    
Cost [17] 975    
Fair Value [17] $ 975    
Investment, Identifier [Axis]: Equipment Financing 26.9% | No Limit Construction Services LLC | Commercial Services & Supplies | 7.73% | 5/5/2023 | 6/1/2028      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 7.73%    
Acquisition Date [17] May 05, 2023    
Maturity Date [17] Jun. 01, 2028    
Par Amount [17] $ 124    
Cost [17] 124    
Fair Value [17] $ 124    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Ozzies Inc | Commercial Services & Supplies | 10.72% | 12/23/2022 | 1/1/2027      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 10.72%    
Acquisition Date [17] Dec. 23, 2022    
Maturity Date [17] Jan. 01, 2027    
Par Amount [17] $ 1,731    
Cost [17] 1,783    
Fair Value [17] $ 1,731    
Investment, Identifier [Axis]: Equipment Financing 26.9% | PCX Aerostructures LLC | Aerospace & Defense | 9.32% | 11/23/2022 | 12/1/2028      
Schedule of Investments [Line Items]      
Industry [17] Aerospace & Defense    
Interest Rate [17],[22] 9.32%    
Acquisition Date [17] Nov. 23, 2022    
Maturity Date [17] Dec. 01, 2028    
Par Amount [17] $ 2,401    
Cost [17] 2,401    
Fair Value [17] $ 2,401    
Investment, Identifier [Axis]: Equipment Financing 26.9% | RH Land Construction LLC & Harbor Dredging LA Inc | Construction & Engineering | 8.08% | 5/10/2023 | 5/10/2026      
Schedule of Investments [Line Items]      
Industry [17] Construction & Engineering    
Interest Rate [17],[22] 8.08%    
Acquisition Date [17] May 10, 2023    
Maturity Date [17] May 10, 2026    
Par Amount [17] $ 124    
Cost [17] 124    
Fair Value [17] $ 124    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Rane Light Metal Castings Inc | Machinery | 10.00% | 6/1/2020 | 6/1/2024      
Schedule of Investments [Line Items]      
Industry [17] Machinery    
Interest Rate [17],[22] 10.00%    
Acquisition Date [17] Jun. 01, 2020    
Maturity Date [17] Jun. 01, 2024    
Par Amount [17] $ 83    
Cost [17] 83    
Fair Value [17] $ 83    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Acquisition Date [17] Sep. 24, 2019    
Par Amount [17] $ 731    
Cost [17] 742    
Fair Value [17] $ 717    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 9.33%    
Maturity Date [17] Oct. 01, 2023    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 9.77%    
Maturity Date [17] Nov. 01, 2024    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030      
Schedule of Investments [Line Items]      
Industry [17] Diversified Consumer Services    
Acquisition Date [17] May 19, 2023    
Par Amount [17] $ 732    
Cost [17] 732    
Fair Value [17] $ 732    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 7.69%    
Maturity Date [17] May 18, 2030    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.27%    
Maturity Date [17] Jun. 30, 2030    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Rotten Rock Hardscaping & Tree Service | Diversified Consumer Services | 8.21% | 12/6/2022 | 12/6/2027      
Schedule of Investments [Line Items]      
Industry [17] Diversified Consumer Services    
Interest Rate [17],[22] 8.21%    
Acquisition Date [17] Dec. 06, 2022    
Maturity Date [17] Dec. 06, 2027    
Par Amount [17] $ 214    
Cost [17] 214    
Fair Value [17] $ 214    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Royal Express Inc | Road & Rail | 9.53% | 1/17/2019 | 2/1/2024      
Schedule of Investments [Line Items]      
Industry [17] Road & Rail    
Interest Rate [17],[22] 9.53%    
Acquisition Date [17] Jan. 17, 2019    
Maturity Date [17] Feb. 01, 2024    
Par Amount [17] $ 220    
Cost [17] 221    
Fair Value [17] $ 220    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Rutt Services LLC | Commercial Services & Supplies | 8.95% | 8/11/2023 | 8/11/2030      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 8.95%    
Acquisition Date [17] Aug. 11, 2023    
Maturity Date [17] Aug. 11, 2030    
Par Amount [17] $ 1,201    
Cost [17] 1,201    
Fair Value [17] $ 1,201    
Investment, Identifier [Axis]: Equipment Financing 26.9% | SLR Equipment Finance | Multi-Sector Holdings | 8.50% | 1/24/2022 | 1/27/2024      
Schedule of Investments [Line Items]      
Industry [6] Multi-Sector Holdings    
Interest Rate [6],[22] 8.50%    
Acquisition Date [6] Jan. 24, 2022    
Maturity Date [6] Jan. 27, 2024    
Par Amount [6] $ 2,500    
Cost [6] 2,500    
Fair Value [6] $ 2,500    
Investment, Identifier [Axis]: Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025      
Schedule of Investments [Line Items]      
Industry [17] Road & Rail    
Acquisition Date [17] Jul. 31, 2017    
Par Amount [17] $ 1,111    
Cost [17] 1,111    
Fair Value [17] $ 1,075    
Investment, Identifier [Axis]: Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.50%    
Maturity Date [17] Oct. 01, 2023    
Investment, Identifier [Axis]: Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.58%    
Maturity Date [17] Jan. 25, 2025    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Signet Marine Corporation | Transportation Infrastructure | 8.50% | 10/31/2022 | 11/1/2029      
Schedule of Investments [Line Items]      
Industry [17] Transportation Infrastructure    
Interest Rate [17],[22] 8.50%    
Acquisition Date [17] Oct. 31, 2022    
Maturity Date [17] Nov. 01, 2029    
Par Amount [17] $ 12,712    
Cost [17] 12,753    
Fair Value [17] $ 12,712    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Acquisition Date [17] Jun. 30, 2022    
Par Amount [17] $ 6,123    
Cost [17] 6,123    
Fair Value [17] $ 6,123    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 7.82%    
Maturity Date [17] Sep. 15, 2026    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.61%    
Maturity Date [17] Jun. 27, 2030    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Star Coaches Inc | Road & Rail | 8.42% | 3/9/2018 | 4/1/2025      
Schedule of Investments [Line Items]      
Industry [17] Road & Rail    
Interest Rate [17],[22] 8.42%    
Acquisition Date [17] Mar. 09, 2018    
Maturity Date [17] Apr. 01, 2025    
Par Amount [17] $ 2,472    
Cost [17] 2,472    
Fair Value [17] $ 2,218    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026      
Schedule of Investments [Line Items]      
Industry [17] Road & Rail    
Acquisition Date [17] Jul. 31, 2017    
Maturity Date [17] Jan. 01, 2026    
Par Amount [17] $ 2,589    
Cost [17] 2,589    
Fair Value [17] $ 2,589    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 10.22%    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 10.63%    
Investment, Identifier [Axis]: Equipment Financing 26.9% | The Smedley Company & Smedley Services Inc | Commercial Services & Supplies | 4.07% | 7/31/2017 | 1/15/2028      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 4.07%    
Acquisition Date [17] Jul. 31, 2017    
Maturity Date [17] Jan. 15, 2028    
Par Amount [17] $ 1,476    
Cost [17] 1,476    
Fair Value [17] $ 1,476    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Acquisition Date [17] May 04, 2023    
Par Amount [17] $ 1,407    
Cost [17] 1,407    
Fair Value [17] $ 1,407    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.78%    
Maturity Date [17] May 04, 2028    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.93%    
Maturity Date [17] May 19, 2028    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Acquisition Date [17] Oct. 08, 2021    
Par Amount [17] $ 416    
Cost [17] 416    
Fair Value [17] $ 416    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 7.94%    
Maturity Date [17] Nov. 01, 2024    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.75%    
Maturity Date [17] Dec. 01, 2026    
Investment, Identifier [Axis]: Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Acquisition Date [17] Dec. 23, 2022    
Par Amount [17] $ 2,717    
Cost [17] 2,717    
Fair Value [17] $ 2,717    
Investment, Identifier [Axis]: Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.73%    
Maturity Date [17] Mar. 01, 2027    
Investment, Identifier [Axis]: Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 10.92%    
Maturity Date [17] Sep. 01, 2028    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Up Trucking Services LLC | Road & Rail | 11.21% | 3/23/2018 | 8/1/2024      
Schedule of Investments [Line Items]      
Industry [17] Road & Rail    
Interest Rate [17],[22] 11.21%    
Acquisition Date [17] Mar. 23, 2018    
Maturity Date [17] Aug. 01, 2024    
Par Amount [17] $ 256    
Cost [17] 258    
Fair Value [17] $ 256    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Waste Pro of Florida Inc & Waste Pro USA Inc | Commercial Services & Supplies | 9.17% | 4/18/2023 | 4/18/2028      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 9.17%    
Acquisition Date [17] Apr. 18, 2023    
Maturity Date [17] Apr. 18, 2028    
Par Amount [17] $ 9,330    
Cost [17] 9,485    
Fair Value [17] $ 9,330    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025      
Schedule of Investments [Line Items]      
Industry [17] Diversified Consumer Services    
Acquisition Date [17] Jul. 31, 2019    
Par Amount [17] $ 387    
Cost [17] 387    
Fair Value [17] $ 387    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.43%    
Maturity Date [17] Aug. 01, 2024    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 10.00%    
Maturity Date [17] Oct. 05, 2025    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Womble Company Inc | Energy Equipment & Services | 9.11% | 12/27/2019 | 1/1/2025      
Schedule of Investments [Line Items]      
Industry [17] Energy Equipment & Services    
Interest Rate [17],[22] 9.11%    
Acquisition Date [17] Dec. 27, 2019    
Maturity Date [17] Jan. 01, 2025    
Par Amount [17] $ 256    
Cost [17] 256    
Fair Value [17] $ 246    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028      
Schedule of Investments [Line Items]      
Industry [17] Transportation Infrastructure    
Acquisition Date [17] Sep. 23, 2022    
Par Amount [17] $ 3,192    
Cost [17] 3,240    
Fair Value [17] $ 3,192    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.32%    
Maturity Date [17] Sep. 23, 2027    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 9.93%    
Maturity Date [17] Aug. 16, 2028    
Investment, Identifier [Axis]: Equipment Financing 26.9% | Zamborelli Enterprises Pacific Souther Foundation | Diversified Consumer Services | 8.91% | 12/7/2022 | 1/1/2027      
Schedule of Investments [Line Items]      
Industry [17] Diversified Consumer Services    
Interest Rate [17],[22] 8.91%    
Acquisition Date [17] Dec. 07, 2022    
Maturity Date [17] Jan. 01, 2027    
Par Amount [17] $ 606    
Cost [17] 611    
Fair Value [17] $ 606    
Investment, Identifier [Axis]: Equipment Financing 26.9% |A&A Crane and Rigging, LLC |Commercial Services & Supplies |7.78% |3/27/2023 |3/27/2028      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 7.78%    
Acquisition Date [17] Mar. 27, 2023    
Maturity Date [17] Mar. 27, 2028    
Par Amount [17] $ 72    
Cost [17] 72    
Fair Value [17] $ 72    
Investment, Identifier [Axis]: Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027      
Schedule of Investments [Line Items]      
Industry [17] Diversified Consumer Services    
Acquisition Date [17] Aug. 11, 2022    
Par Amount [17] $ 1,182    
Cost [17] 1,182    
Fair Value [17] $ 1,182    
Investment, Identifier [Axis]: Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 10.00%    
Maturity Date [17] Aug. 11, 2026    
Investment, Identifier [Axis]: Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 11.29%    
Maturity Date [17] Mar. 01, 2027    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 |      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Acquisition Date [17] Feb. 12, 2021    
Par Amount [17] $ 1,493    
Cost [17] 1,492    
Fair Value [17] $ 1,491    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 | | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.47%    
Maturity Date [17] Mar. 01, 2025    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 | | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 9.64%    
Maturity Date [17] Dec. 01, 2026    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026      
Schedule of Investments [Line Items]      
Industry [17] Airlines    
Acquisition Date [17] Nov. 03, 2021    
Par Amount [17] $ 3,231    
Cost [17] 3,275    
Fair Value [17] $ 3,231    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 7.08%    
Maturity Date [17] Nov. 03, 2026    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 7.13%    
Maturity Date [17] Nov. 23, 2026    
Investment, Identifier [Axis]: Equipment Financing 26.9% |AmeraMex International Inc|Commercial Services and Supplies |10.00% |3/29/2019 |4/15/2025      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 10.00%    
Acquisition Date [17] Mar. 29, 2019    
Maturity Date [17] Apr. 15, 2025    
Par Amount [17] $ 563    
Cost [17] 563    
Fair Value [17] $ 569    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Bazzini LLC|Food and Staples Retailing |10.46% |12/23/2022 |1/1/2028      
Schedule of Investments [Line Items]      
Industry [17] Food & Staples Retailing    
Interest Rate [17],[22] 10.46%    
Acquisition Date [17] Dec. 23, 2022    
Maturity Date [17] Jan. 01, 2028    
Par Amount [17] $ 2,084    
Cost [17] 2,146    
Fair Value [17] $ 2,084    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026      
Schedule of Investments [Line Items]      
Industry [17] Metals & Mining    
Acquisition Date [17] May 28, 2020    
Par Amount [17] $ 2,870    
Cost [17] 2,870    
Fair Value [17] $ 2,870    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 8.31%    
Maturity Date [17] Jul. 01, 2024    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Interest Rate [17],[22] 10.44%    
Maturity Date [17] Oct. 07, 2026    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Bowman Energy Solutions LLC |Commercial Services and Supplies |7.42% |7/1/2022 |8/1/2026      
Schedule of Investments [Line Items]      
Industry [17] Commercial Services & Supplies    
Interest Rate [17],[22] 7.42%    
Acquisition Date [17] Jul. 01, 2022    
Maturity Date [17] Aug. 01, 2026    
Par Amount [17] $ 124    
Cost [17] 124    
Fair Value [17] $ 124    
Investment, Identifier [Axis]: Equipment Financing 26.9% |C Port or Stone LLC |Oil Gas and Consumable Fuels |8.54% |10/7/2022 |11/1/2027      
Schedule of Investments [Line Items]      
Industry [17] Oil, Gas & Consumable Fuels    
Interest Rate [17],[22] 8.54%    
Acquisition Date [17] Oct. 07, 2022    
Maturity Date [17] Nov. 01, 2027    
Par Amount [17] $ 6,366    
Cost [17] 6,206    
Fair Value [17] $ 6,175    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026      
Schedule of Investments [Line Items]      
Industry [17] Airlines    
Interest Rate [17],[22] 10.00%    
Acquisition Date [17] Apr. 04, 2018    
Par Amount [17] $ 1,536    
Cost [17] 1,536    
Fair Value [17] $ 1,528    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 | Minimum [Member]      
Schedule of Investments [Line Items]      
Maturity Date [17] Oct. 04, 2023    
Investment, Identifier [Axis]: Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 | Maximum [Member]      
Schedule of Investments [Line Items]      
Maturity Date [17] Jun. 22, 2026    
Investment, Identifier [Axis]: Equipment Financing | SLR Equipment Finance Equity Interests | Multi-Sector Holdings | 7/31/2017      
Schedule of Investments [Line Items]      
Industry [3],[6],[20],[21] Multi-Sector Holdings    
Acquisition Date [3],[6],[20],[21] Jul. 31, 2017    
Shares/Units [3],[6],[20],[21] 200    
Cost [3],[6],[20],[21] $ 145,000    
Fair Value [3],[6],[20],[21] $ 120,820    
Investment, Identifier [Axis]: Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025      
Schedule of Investments [Line Items]      
Industry [23] Aerospace & Defense [6],[10] Aerospace & Defense [9],[12]  
Interest Rate [9],[12],[18],[23],[24]   5.00%  
Interest Rate [6],[10],[22],[23],[24] 5.00%    
Acquisition Date [23] Jun. 08, 2012 [6],[10] Jun. 08, 2012 [9],[12]  
Maturity Date [23] Jun. 30, 2025 [6],[10] Jun. 30, 2023 [9],[12]  
Par Amount [23] $ 0 [6],[10] $ 49,273 [9],[12]  
Cost [23] 5,114 [6],[10] 4,927 [9],[12]  
Fair Value [23] 3,801 [6],[10]   $ 3,801
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans      
Schedule of Investments [Line Items]      
Cost   912,558  
Fair Value   $ 886,513  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Aegis Toxicology Sciences Corporation |Health Care Providers & Services |L+550 |1.00% |10.09% |5/7/2018 |5/9/2025      
Schedule of Investments [Line Items]      
Industry [25]   Health Care Providers & Services  
Spread Above Index [25],[26]   550.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.09%  
Acquisition Date [25]   May 07, 2018  
Maturity Date [25]   May 09, 2025  
Par Amount [25]   $ 17,103  
Cost [25]   16,793  
Fair Value [25]   $ 17,103  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |All States Ag Parts LLC |Trading Companies & Distributors |S+575 |10.19% |4/1/2022 |9/1/2026      
Schedule of Investments [Line Items]      
Industry [25]   Trading Companies & Distributors  
Spread Above Index [25],[26]   575.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.19%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Sep. 01, 2026  
Par Amount [25]   $ 4,197  
Cost [25]   4,081  
Fair Value [25]   $ 4,197  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |AmeriMark Intermediate Holdings LLC |Internet & Catalog Retail |L+800 |1.00% |14.77% |7/28/2021 |10/15/2026      
Schedule of Investments [Line Items]      
Industry [27]   Internet & Catalog Retail  
Spread Above Index [26],[27]   800.00%  
Floor [27]   1.00%  
Interest Rate [18],[27]   14.77%  
Acquisition Date [27]   Jul. 28, 2021  
Maturity Date [27]   Oct. 15, 2026  
Par Amount [27]   $ 24,087  
Cost [27]   23,711  
Fair Value [27]   $ 22,882  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |American Teleconferencing Services Ltd |Communications Equipment |L+650 |1.00% |5/5/2016 |9/9/2021      
Schedule of Investments [Line Items]      
Industry [28]   Communications Equipment  
Spread Above Index [26],[28]   650.00%  
Floor [28]   1.00%  
Interest Rate [18],[28]   0.00%  
Acquisition Date [28]   May 05, 2016  
Maturity Date [28]   Sep. 09, 2021  
Par Amount [28]   $ 36,135  
Cost [28]   25,926  
Fair Value [28]   $ 0  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |American Teleconferencing Services Ltd |Communications Equipment |L+650 |1.00% |9/17/2021 |1/31/2023      
Schedule of Investments [Line Items]      
Industry [28]   Communications Equipment  
Spread Above Index [26],[28]   650.00%  
Floor [28]   1.00%  
Interest Rate [18],[28]   0.00%  
Acquisition Date [28]   Sep. 17, 2021  
Maturity Date [28]   Jan. 31, 2023  
Par Amount [28]   $ 6,405  
Cost [28]   6,254  
Fair Value [28]   $ 224  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Apex Services Partners LLC |Diversified Consumer Services |S+525 |1.00% |9.80% |8/31/2022 |7/31/2025      
Schedule of Investments [Line Items]      
Industry [25]   Diversified Consumer Services  
Spread Above Index [25],[26]   525.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.80%  
Acquisition Date [25]   Aug. 31, 2022  
Maturity Date [25]   Jul. 31, 2025  
Par Amount [25]   $ 14,021  
Cost [25]   13,644  
Fair Value [25]   $ 14,021  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Atria Wealth Solutions Inc. |Diversified Financial Services |S+600 |1.00% |10.84% |9/14/2018 |2/29/2024      
Schedule of Investments [Line Items]      
Industry [25]   Diversified Financial Services  
Spread Above Index [25],[26]   600.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.84%  
Acquisition Date [25]   Sep. 14, 2018  
Maturity Date [25]   Feb. 29, 2024  
Par Amount [25]   $ 8,149  
Cost [25]   8,107  
Fair Value [25]   $ 8,149  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |BDG Media Inc. |Media |L+900 |0.25% |13.17% |7/18/2022 |4/27/2023      
Schedule of Investments [Line Items]      
Industry   Media  
Spread Above Index [26]   900.00%  
Floor   0.25%  
Interest Rate [18]   13.17%  
Acquisition Date   Jul. 18, 2022  
Maturity Date   Apr. 27, 2023  
Par Amount   $ 14,454  
Cost   14,454  
Fair Value   $ 14,454  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Basic Fun Inc. |Specialty Retail |L+550 |1.00% |10.27% |10/30/2020 |10/30/2023      
Schedule of Investments [Line Items]      
Industry [25]   Specialty Retail  
Spread Above Index [25],[26]   550.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.27%  
Acquisition Date [25]   Oct. 30, 2020  
Maturity Date [25]   Oct. 30, 2023  
Par Amount [25]   $ 2,162  
Cost [25]   2,152  
Fair Value [25]   $ 2,162  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |BayMark Health Services Inc. |Health Care Providers & Services |L+500 |1.00% |9.73% |4/1/2022 |6/11/2027      
Schedule of Investments [Line Items]      
Industry [25]   Health Care Providers & Services  
Spread Above Index [25],[26]   500.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.73%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Jun. 11, 2027  
Par Amount [25]   $ 9,432  
Cost [25]   9,078  
Fair Value [25]   $ 9,432  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |CC SAG Holdings Corp. (Spectrum Automotive) |Diversified Consumer Services |L+575 |0.75% |10.48% |6/29/2021 |6/29/2028      
Schedule of Investments [Line Items]      
Industry [25]   Diversified Consumer Services  
Spread Above Index [25],[26]   575.00%  
Floor [25]   0.75%  
Interest Rate [18],[25]   10.48%  
Acquisition Date [25]   Jun. 29, 2021  
Maturity Date [25]   Jun. 29, 2028  
Par Amount [25]   $ 20,427  
Cost [25]   20,057  
Fair Value [25]   $ 20,427  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Composite Technology Acquisition Corp. |Building Products |L+475 |1.00% |9.73% |4/1/2022 |2/1/2025      
Schedule of Investments [Line Items]      
Industry [25]   Building Products  
Spread Above Index [25],[26]   475.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.73%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Feb. 01, 2025  
Par Amount [25]   $ 10,386  
Cost [25]   9,983  
Fair Value [25]   $ 10,386  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Copper River Seafoods Inc. |Food Products |P+275 |10.25% |8/31/2022 |4/23/2025      
Schedule of Investments [Line Items]      
Industry   Food Products  
Spread Above Index [26]   275.00%  
Floor   0.00%  
Interest Rate [18]   10.25%  
Acquisition Date   Aug. 31, 2022  
Maturity Date   Apr. 23, 2025  
Par Amount   $ 8,405  
Cost   8,405  
Fair Value   $ 8,405  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |DeepIntent Inc. |Media |P+175 |9.25% |10/12/2022 |3/25/2025      
Schedule of Investments [Line Items]      
Industry   Media  
Spread Above Index [26]   175.00%  
Floor   0.00%  
Interest Rate [18]   9.25%  
Acquisition Date   Oct. 12, 2022  
Maturity Date   Mar. 25, 2025  
Par Amount   $ 16,951  
Cost   16,951  
Fair Value   $ 16,951  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) |Trading Companies & Distributors |S+475 |1.00% |9.43% |4/1/2022 |12/31/2025      
Schedule of Investments [Line Items]      
Industry [25]   Trading Companies & Distributors  
Spread Above Index [25],[26]   475.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.43%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Dec. 31, 2025  
Par Amount [25]   $ 4,978  
Cost [25]   4,804  
Fair Value [25]   $ 4,978  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Enhanced Permanent Capital LLC |Capital Markets |L+700 |1.00% |10.13% |12/29/2020 |12/29/2025      
Schedule of Investments [Line Items]      
Industry   Capital Markets  
Spread Above Index [12],[26]   700.00%  
Floor [12]   1.00%  
Interest Rate [12],[18]   10.13%  
Acquisition Date [12]   Dec. 29, 2020  
Maturity Date [12]   Dec. 29, 2025  
Par Amount [12]   $ 35,205  
Cost [12]   34,496  
Fair Value [12]   $ 35,205  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Enverus Holdings Inc. (fka Drilling Info Holdings) |IT Services |L+450 |8.88% |4/1/2022 |7/30/2025      
Schedule of Investments [Line Items]      
Industry [25]   IT Services  
Spread Above Index [25],[26]   450.00%  
Floor [25]   0.00%  
Interest Rate [18],[25]   8.88%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Jul. 30, 2025  
Par Amount [25]   $ 11,598  
Cost [25]   11,129  
Fair Value [25]   $ 11,598  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Erie Construction Mid-west LLC |Building Products |S+475 |1.00% |9.79% |4/1/2022 |7/30/2027      
Schedule of Investments [Line Items]      
Industry [25]   Building Products  
Spread Above Index [25],[26]   475.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.79%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Jul. 30, 2027  
Par Amount [25]   $ 8,915  
Cost [25]   8,580  
Fair Value [25]   $ 8,915  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Foundation Consumer Brands LLC |Personal Products |L+550 |1.00% |10.15% |2/12/2021 |2/12/2027      
Schedule of Investments [Line Items]      
Industry [25]   Personal Products  
Spread Above Index [25],[26]   550.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.15%  
Acquisition Date [25]   Feb. 12, 2021  
Maturity Date [25]   Feb. 12, 2027  
Par Amount [25]   $ 35,273  
Cost [25]   34,421  
Fair Value [25]   $ 35,273  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |GSM Acquisition Corp. |Leisure Equipment & Products |S+500 |1.00% |9.03% |4/1/2022 |11/16/2026      
Schedule of Investments [Line Items]      
Industry [25]   Leisure Equipment & Products  
Spread Above Index [25],[26]   500.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.03%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Nov. 16, 2026  
Par Amount [25]   $ 11,022  
Cost [25]   10,562  
Fair Value [25]   $ 10,912  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Higginbotham Insurance Agency Inc. |Insurance |L+525 |0.75% |9.63% |4/1/2022 |11/25/2026      
Schedule of Investments [Line Items]      
Industry [25]   Insurance  
Spread Above Index [25],[26]   525.00%  
Floor [25]   0.75%  
Interest Rate [18],[25]   9.63%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Nov. 25, 2026  
Par Amount [25]   $ 6,223  
Cost [25]   5,994  
Fair Value [25]   $ 6,223  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |High Street Buyer Inc. |Insurance |L+600|0.75% |10.73% |4/1/2022 |4/16/2028      
Schedule of Investments [Line Items]      
Industry [25]   Insurance  
Spread Above Index [25],[26]   600.00%  
Floor [25]   0.75%  
Interest Rate [18],[25]   10.73%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Apr. 16, 2028  
Par Amount [25]   $ 5,188  
Cost [25]   4,900  
Fair Value [25]   $ 5,188  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Human Interest Inc. |Internet Software & Services |S+785 |1.00% |11.97% |6/30/2022 |7/1/2027      
Schedule of Investments [Line Items]      
Industry   Internet Software & Services  
Spread Above Index [26]   785.00%  
Floor   1.00%  
Interest Rate [18]   11.97%  
Acquisition Date   Jun. 30, 2022  
Maturity Date   Jul. 01, 2027  
Par Amount   $ 20,104  
Cost   19,783  
Fair Value   $ 20,104  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Ivy Fertility Services LLC |Health Care Providers & Services |L+625 |1.00% |10.39% |12/22/2021 |2/25/2026      
Schedule of Investments [Line Items]      
Industry   Health Care Providers & Services  
Spread Above Index [26]   625.00%  
Floor   1.00%  
Interest Rate [18]   10.39%  
Acquisition Date   Dec. 22, 2021  
Maturity Date   Feb. 25, 2026  
Par Amount   $ 30,092  
Cost   29,415  
Fair Value   $ 30,393  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |KORE Wireless Group Inc. |Wireless Telecommunication Services |S+550 |10.08% |12/21/2018 |12/21/2024      
Schedule of Investments [Line Items]      
Industry [25]   Wireless Telecommunication Services  
Spread Above Index [25],[26]   550.00%  
Floor [25]   0.00%  
Interest Rate [18],[25]   10.08%  
Acquisition Date [25]   Dec. 21, 2018  
Maturity Date [25]   Dec. 21, 2024  
Par Amount [25]   $ 23,588  
Cost [25]   23,123  
Fair Value [25]   $ 23,588  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kaseya Inc. |Software |S+575 |0.75% |10.33% |6/22/2022 |6/23/2029      
Schedule of Investments [Line Items]      
Industry [25]   Software  
Spread Above Index [25],[26]   575.00%  
Floor [25]   0.75%  
Interest Rate [18],[25]   10.33%  
Acquisition Date [25]   Jun. 22, 2022  
Maturity Date [25]   Jun. 23, 2029  
Par Amount [25]   $ 32,426  
Cost [25]   31,966  
Fair Value [25]   $ 32,426  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kid Distro Holdings LLC (Distro Kid) |Software |L+575 |1.00% |10.48% |9/24/2021 |10/1/2027      
Schedule of Investments [Line Items]      
Industry [25]   Software  
Spread Above Index [25],[26]   575.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.48%  
Acquisition Date [25]   Sep. 24, 2021  
Maturity Date [25]   Oct. 01, 2027  
Par Amount [25]   $ 26,452  
Cost [25]   26,015  
Fair Value [25]   $ 26,452  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kingsbridge Holdings LLC |Multi-Sector Holdings |L+700 |1.00% |10.75% |12/21/2018 |12/21/2024      
Schedule of Investments [Line Items]      
Industry   Multi-Sector Holdings  
Spread Above Index [9],[26]   700.00%  
Floor [9]   1.00%  
Interest Rate [9],[18]   10.75%  
Acquisition Date [9]   Dec. 21, 2018  
Maturity Date [9]   Dec. 21, 2024  
Par Amount [9]   $ 80,000  
Cost [9]   79,800  
Fair Value [9]   $ 80,000  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Logix Holding Company LLC |Communications Equipment |L+575 |1.00% |10.13% |9/14/2018 |12/22/2024      
Schedule of Investments [Line Items]      
Industry [25]   Communications Equipment  
Spread Above Index [25],[26]   575.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.13%  
Acquisition Date [25]   Sep. 14, 2018  
Maturity Date [25]   Dec. 22, 2024  
Par Amount [25]   $ 14,009  
Cost [25]   13,246  
Fair Value [25]   $ 13,449  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Luxury Asset Capital LLC |Thrifts & Mortgage Finance |S+675 |1.00% |10.99% |7/15/2022 |7/15/2027      
Schedule of Investments [Line Items]      
Industry [25]   Thrifts & Mortgage Finance  
Spread Above Index [25],[26]   675.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.99%  
Acquisition Date [25]   Jul. 15, 2022  
Maturity Date [25]   Jul. 15, 2027  
Par Amount [25]   $ 27,500  
Cost [25]   26,991  
Fair Value [25]   $ 27,500  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Maurices Incorporated |Specialty Retail |S+675 |1.00% |8.74% |8/27/2021 |6/1/2024      
Schedule of Investments [Line Items]      
Industry [25]   Specialty Retail  
Spread Above Index [25],[26]   675.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   8.74%  
Acquisition Date [25]   Aug. 27, 2021  
Maturity Date [25]   Jun. 01, 2024  
Par Amount [25]   $ 7,808  
Cost [25]   7,678  
Fair Value [25]   $ 7,808  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Montefiore Nyack Hospital |Health Care Providers & Services |L+495 |9.72% |8/9/2022 |11/15/2024      
Schedule of Investments [Line Items]      
Industry   Health Care Providers & Services  
Spread Above Index [26]   495.00%  
Floor   0.00%  
Interest Rate [18]   9.72%  
Acquisition Date   Aug. 09, 2022  
Maturity Date   Nov. 15, 2024  
Par Amount   $ 3,966  
Cost   3,966  
Fair Value   $ 3,966  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |NAC Holdings Corporation (Jaguar) |Insurance |S+525 |1.00% |9.45% |7/30/2021 |9/28/2024      
Schedule of Investments [Line Items]      
Industry [25]   Insurance  
Spread Above Index [25],[26]   525.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.45%  
Acquisition Date [25]   Jul. 30, 2021  
Maturity Date [25]   Sep. 28, 2024  
Par Amount [25]   $ 28,603  
Cost [25]   28,214  
Fair Value [25]   $ 28,603  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |National Spine and Pain Centers LLC |Health Care Providers & Services |L+500 |1.00% |7.31% |4/1/2022 |6/2/2024      
Schedule of Investments [Line Items]      
Industry   Health Care Providers & Services  
Spread Above Index [26]   500.00%  
Floor   1.00%  
Interest Rate [18]   7.31%  
Acquisition Date   Apr. 01, 2022  
Maturity Date   Jun. 02, 2024  
Par Amount   $ 2,681  
Cost   2,564  
Fair Value   $ 2,547  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |One Touch Direct LLC |Commercial Services & Supplies |P+75 |8.25% |4/3/2020 |3/30/2024      
Schedule of Investments [Line Items]      
Industry   Commercial Services & Supplies  
Spread Above Index [26]   75.00%  
Floor   0.00%  
Interest Rate [18]   8.25%  
Acquisition Date   Apr. 03, 2020  
Maturity Date   Mar. 30, 2024  
Par Amount   $ 4,431  
Cost   4,431  
Fair Value   $ 4,431  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Orthopedic Care Partners Management LLC |Health Care Providers & Services |S+650 |1.00% |10.91% |8/17/2022 |5/16/2024      
Schedule of Investments [Line Items]      
Industry   Health Care Providers & Services  
Spread Above Index [26]   650.00%  
Floor   1.00%  
Interest Rate [18]   10.91%  
Acquisition Date   Aug. 17, 2022  
Maturity Date   May 16, 2024  
Par Amount   $ 3,111  
Cost   3,092  
Fair Value   $ 3,111  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |PPT Management Holdings LLC |Health Care Providers & Services |L+850 |1.00% |12.83% |9/14/2018 |1/30/2023      
Schedule of Investments [Line Items]      
Industry [25]   Health Care Providers & Services  
Spread Above Index [24],[25],[26]   850.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   12.83%  
Acquisition Date [25]   Sep. 14, 2018  
Maturity Date [25]   Jan. 30, 2023  
Par Amount [25]   $ 32,163  
Cost [25]   31,987  
Fair Value [25]   $ 25,827  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Pediatric Home Respiratory Services LLC |Health Care Providers & Services |S+625 |1.00% |10.67% |8/19/2022 |12/4/2024      
Schedule of Investments [Line Items]      
Industry   Health Care Providers & Services  
Spread Above Index [26]   625.00%  
Floor   1.00%  
Interest Rate [18]   10.67%  
Acquisition Date   Aug. 19, 2022  
Maturity Date   Dec. 04, 2024  
Par Amount   $ 1,327  
Cost   1,309  
Fair Value   $ 1,313  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Peter C. Foy & Associates Insurance Services LLC |Insurance |S+600 |0.75% |10.44% |4/1/2022 |11/1/2028      
Schedule of Investments [Line Items]      
Industry   Insurance  
Spread Above Index [26]   600.00%  
Floor   0.75%  
Interest Rate [18]   10.44%  
Acquisition Date   Apr. 01, 2022  
Maturity Date   Nov. 01, 2028  
Par Amount   $ 10,854  
Cost   10,699  
Fair Value   $ 10,854  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |PhyNet Dermatology LLC |Health Care Providers & Services |S+625 |1.00% |9.81% |9/5/2018 |8/16/2024      
Schedule of Investments [Line Items]      
Industry   Health Care Providers & Services  
Spread Above Index [26],[29]   625.00%  
Floor   1.00%  
Interest Rate [18]   9.81%  
Acquisition Date   Sep. 05, 2018  
Maturity Date   Aug. 16, 2024  
Par Amount   $ 14,458  
Cost   14,420  
Fair Value   $ 14,458  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Pinnacle Treatment Centers Inc.|Health Care Providers & Services |S+650 |1.00% |10.57% |1/22/2020 |1/2/2026      
Schedule of Investments [Line Items]      
Industry [25]   Health Care Providers & Services  
Spread Above Index [25],[26]   650.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.57%  
Acquisition Date [25]   Jan. 22, 2020  
Maturity Date [25]   Jan. 02, 2026  
Par Amount [25]   $ 27,997  
Cost [25]   27,528  
Fair Value [25]   $ 27,367  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Plastics Management LLC |Health Care Providers & Services |S+500 |1.00% |9.89% |4/1/2022 |8/18/2027      
Schedule of Investments [Line Items]      
Industry [25]   Health Care Providers & Services  
Spread Above Index [25],[26]   500.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.89%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Aug. 18, 2027  
Par Amount [25]   $ 9,491  
Cost [25]   9,161  
Fair Value [25]   $ 9,491  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RQM+ Corp. |Life Sciences Tools & Services |S+575 |1.00% |10.97% |8/20/2021 |8/12/2026      
Schedule of Investments [Line Items]      
Industry [25]   Life Sciences Tools & Services  
Spread Above Index [25],[26]   575.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.97%  
Acquisition Date [25]   Aug. 20, 2021  
Maturity Date [25]   Aug. 12, 2026  
Par Amount [25]   $ 26,823  
Cost [25]   26,455  
Fair Value [25]   $ 26,823  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RSC Acquisition Inc. |Insurance |S+550 |0.75% |9.26% |4/1/2022 |11/1/2026      
Schedule of Investments [Line Items]      
Industry [25]   Insurance  
Spread Above Index [25],[26]   550.00%  
Floor [25]   0.75%  
Interest Rate [18],[25]   9.26%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Nov. 01, 2026  
Par Amount [25]   $ 6,985  
Cost [25]   6,813  
Fair Value [25]   $ 6,985  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RxSense Holdings LLC |Diversified Consumer Services |L+500 |1.00% |9.41% |4/1/2022 |3/13/2026      
Schedule of Investments [Line Items]      
Industry [25]   Diversified Consumer Services  
Spread Above Index [25],[26]   500.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.41%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Mar. 13, 2026  
Par Amount [25]   $ 11,775  
Cost [25]   11,357  
Fair Value [25]   $ 11,775  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SCP Eye Care LLC |Health Care Providers & Services |S+575 |1.00% |9.46% |10/6/2022 |10/5/2029      
Schedule of Investments [Line Items]      
Industry   Health Care Providers & Services  
Spread Above Index [26]   575.00%  
Floor   1.00%  
Interest Rate [18]   9.46%  
Acquisition Date   Oct. 06, 2022  
Maturity Date   Oct. 05, 2029  
Par Amount   $ 8,314  
Cost   8,050  
Fair Value   $ 8,044  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SHO Holding I Corporation (Shoes for Crews) |Footwear |L+523 |1.00% |9.66% |4/1/2022 |4/27/2024      
Schedule of Investments [Line Items]      
Industry [25]   Footwear  
Spread Above Index [25],[26]   523.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.66%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Apr. 27, 2024  
Par Amount [25]   $ 5,704  
Cost [25]   5,361  
Fair Value [25]   $ 5,419  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SPAR Marketing Force Inc. |Media |P+95 |8.45% |7/18/2022 |10/10/2024      
Schedule of Investments [Line Items]      
Industry   Media  
Spread Above Index [26]   95.00%  
Floor   0.00%  
Interest Rate [18]   8.45%  
Acquisition Date   Jul. 18, 2022  
Maturity Date   Oct. 10, 2024  
Par Amount   $ 9,162  
Cost   9,162  
Fair Value   $ 9,162  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Southern Orthodontic Partners Management LLC |Health Care Providers & Services |S+600 |1.00% |10.77%|1/27/2026      
Schedule of Investments [Line Items]      
Industry [25]   Health Care Providers & Services  
Spread Above Index [25],[26]   600.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.77%  
Acquisition Date [25]   Jun. 03, 2022  
Maturity Date [25]   Jan. 27, 2026  
Par Amount [25]   $ 1,399  
Cost [25]   1,387  
Fair Value [25]   $ 1,399  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Stryten Resources LLC |Auto Parts & Equipment |S+800 |1.00% |12.44% |8/11/2021 |10/12/2026      
Schedule of Investments [Line Items]      
Industry   Auto Parts & Equipment  
Spread Above Index [26]   800.00%  
Floor   1.00%  
Interest Rate [18]   12.44%  
Acquisition Date   Aug. 11, 2021  
Maturity Date   Oct. 12, 2026  
Par Amount   $ 25,922  
Cost   25,506  
Fair Value   $ 25,922  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SunMed Group Holdings LLC |Health Care Equipment & Supplies |L+575 |0.75% |10.48% |6/16/2021 |6/16/2028      
Schedule of Investments [Line Items]      
Industry [25]   Health Care Equipment & Supplies  
Spread Above Index [25],[26]   575.00%  
Floor [25]   0.75%  
Interest Rate [18],[25]   10.48%  
Acquisition Date [25]   Jun. 16, 2021  
Maturity Date [25]   Jun. 16, 2028  
Par Amount [25]   $ 24,953  
Cost [25]   24,446  
Fair Value [25]   $ 24,953  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |TAUC Management LLC |Health Care Providers & Services |L+525 |1.00% |9.98% |4/1/2022 |2/12/2027      
Schedule of Investments [Line Items]      
Industry [25]   Health Care Providers & Services  
Spread Above Index [25],[26]   525.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.98%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Feb. 12, 2027  
Par Amount [25]   $ 6,899  
Cost [25]   6,585  
Fair Value [25]   $ 6,864  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Tilley Distribution Inc. |Trading Companies & Distributors |S+550 |1.00% |10.14% |4/1/2022 |12/31/2026      
Schedule of Investments [Line Items]      
Industry [25]   Trading Companies & Distributors  
Spread Above Index [25],[26]   550.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.14%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Dec. 31, 2026  
Par Amount [25]   $ 9,996  
Cost [25]   9,527  
Fair Value [25]   $ 9,996  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Ultimate Baked Goods Midco LLC (Rise Baking) |Packaged Foods & Meats |L+650 |1.00% |10.88% |8/12/2021 |8/13/2027      
Schedule of Investments [Line Items]      
Industry [25]   Packaged Foods & Meats  
Spread Above Index [25],[26]   650.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   10.88%  
Acquisition Date [25]   Aug. 12, 2021  
Maturity Date [25]   Aug. 13, 2027  
Par Amount [25]   $ 24,789  
Cost [25]   24,038  
Fair Value [25]   $ 24,789  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Vessco Midco Holdings LLC |Water Utilities |L+450 |1.00% |7.87% |4/1/2022 |11/2/2026      
Schedule of Investments [Line Items]      
Industry [25]   Water Utilities  
Spread Above Index [25],[26]   450.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   7.87%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Nov. 02, 2026  
Par Amount [25]   $ 1,728  
Cost [25]   1,668  
Fair Value [25]   $ 1,728  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |World Insurance Associates LLC |Insurance |S+575 |1.00 |9.31 |4/1/2022 |4/1/2026      
Schedule of Investments [Line Items]      
Industry [25]   Insurance  
Spread Above Index [25],[26]   575.00%  
Floor [25]   1.00%  
Interest Rate [18],[25]   9.31%  
Acquisition Date [25]   Apr. 01, 2022  
Maturity Date [25]   Apr. 01, 2026  
Par Amount [25]   $ 31,624  
Cost [25]   30,785  
Fair Value [25]   $ 30,359  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |iCIMS Inc. |Software |S+725 |0.75% |11.52% |8/18/2022 |8/18/2028      
Schedule of Investments [Line Items]      
Industry   Software  
Spread Above Index [26]   725.00%  
Floor   0.75%  
Interest Rate [18],[30]   11.52%  
Acquisition Date   Aug. 18, 2022  
Maturity Date   Aug. 18, 2028  
Par Amount   $ 32,084  
Cost   31,548  
Fair Value   31,522  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans      
Schedule of Investments [Line Items]      
Cost   1,272,952  
Fair Value   $ 1,245,414  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Alimera Sciences Inc. |Pharmaceuticals |L+765 |1.78% |11.82% |12/31/2019 |7/1/2024      
Schedule of Investments [Line Items]      
Industry [25]   Pharmaceuticals  
Spread Above Index [25],[26]   765.00%  
Floor [25]   1.78%  
Interest Rate [18],[25]   11.82%  
Acquisition Date [25]   Dec. 31, 2019  
Maturity Date [25]   Jul. 01, 2024  
Par Amount [25]   $ 23,159  
Cost [25]   23,894  
Fair Value [25]   $ 24,433  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Apeel Technology Inc |Biotechnology |S+625 |1.00% |8.75% |6/29/2022 |6/1/2027      
Schedule of Investments [Line Items]      
Industry   Biotechnology  
Spread Above Index [26]   625.00%  
Floor   1.00%  
Interest Rate [18]   8.75%  
Acquisition Date   Jun. 29, 2022  
Maturity Date   Jun. 01, 2027  
Par Amount   $ 3,643  
Cost   3,620  
Fair Value   $ 3,643  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Arcutis Biotherapeutics Inc. |Pharamceuticals |L+745 |0.10% |11.62% |12/22/2021 |1/1/2027      
Schedule of Investments [Line Items]      
Industry [12]   Pharamceuticals  
Spread Above Index [12],[26]   745.00%  
Floor [12]   0.10%  
Interest Rate [12],[18]   11.62%  
Acquisition Date [12]   Dec. 22, 2021  
Maturity Date [12]   Jan. 01, 2027  
Par Amount [12]   $ 66,849  
Cost [12]   67,077  
Fair Value [12]   $ 67,685  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Ardelyx Inc. |Pharamceuticals |L+795 |0.10% |12.12% |2/23/2022 |3/1/2027      
Schedule of Investments [Line Items]      
Industry [12]   Pharmaceuticals  
Spread Above Index [12],[26]   795.00%  
Floor [12]   0.10%  
Interest Rate [12],[18]   12.12%  
Acquisition Date [12]   Feb. 23, 2022  
Maturity Date [12]   Mar. 01, 2027  
Par Amount [12]   $ 9,475  
Cost [12]   9,437  
Fair Value [12]   $ 9,499  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |BridgeBio Pharma Inc. |Biotechnology |9.00% |11/17/2021 |11/17/2026      
Schedule of Investments [Line Items]      
Industry [12]   Biotechnology  
Spread Above Index [12],[26]   0.00%  
Floor [12]   0.00%  
Interest Rate [12],[18],[31]   9.00%  
Acquisition Date [12]   Nov. 17, 2021  
Maturity Date [12]   Nov. 17, 2026  
Par Amount [12]   $ 39,839  
Cost [12]   39,340  
Fair Value [12]   $ 39,839  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Centrexion Therapeutics Inc. |Pharmaceuticals |L+725 |2.45% |11.42% |6/28/2019 |1/1/2024      
Schedule of Investments [Line Items]      
Industry   Pharmaceuticals  
Spread Above Index [26]   725.00%  
Floor   2.45%  
Interest Rate [18]   11.42%  
Acquisition Date   Jun. 28, 2019  
Maturity Date   Jan. 01, 2024  
Par Amount   $ 11,844  
Cost   12,372  
Fair Value   $ 12,555  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Cerapedics Inc. |Biotechnology |S+620 |2.75% |10.52% |12/27/2022 |1/1/2028      
Schedule of Investments [Line Items]      
Industry   Biotechnology  
Spread Above Index [26]   620.00%  
Floor   2.75%  
Interest Rate [18]   10.52%  
Acquisition Date   Dec. 27, 2022  
Maturity Date   Jan. 01, 2028  
Par Amount   $ 26,939  
Cost   26,874  
Fair Value   $ 26,872  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Glooko Inc. |Health Care Technology |L+790 |0.10% |12.07% |9/30/2021 |10/1/2026      
Schedule of Investments [Line Items]      
Industry [25]   Health Care Technology  
Spread Above Index [25],[26]   790.00%  
Floor [25]   0.10%  
Interest Rate [18],[25]   12.07%  
Acquisition Date [25]   Sep. 30, 2021  
Maturity Date [25]   Oct. 01, 2026  
Par Amount [25]   $ 15,883  
Cost [25]   15,867  
Fair Value [25]   $ 15,922  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Meditrina Inc. |Health Care Equipment & Supplies |S+550 |3.45% |9.82% |12/20/2022 |12/1/2027      
Schedule of Investments [Line Items]      
Industry   Health Care Equipment & Supplies  
Spread Above Index [26]   550.00%  
Floor   3.45%  
Interest Rate [18]   9.82%  
Acquisition Date   Dec. 20, 2022  
Maturity Date   Dec. 01, 2027  
Par Amount   $ 3,367  
Cost   3,338  
Fair Value   $ 3,359  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Neuronetics Inc. |Health Care Equipment & Supplies |L+765 |1.66% |11.82% |3/2/2020 |2/28/2025      
Schedule of Investments [Line Items]      
Industry [25]   Health Care Equipment & Supplies  
Spread Above Index [25],[26]   765.00%  
Floor [25]   1.66%  
Interest Rate [18],[25]   11.82%  
Acquisition Date [25]   Mar. 02, 2020  
Maturity Date [25]   Feb. 28, 2025  
Par Amount [25]   $ 18,012  
Cost [25]   18,450  
Fair Value [25]   $ 19,003  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |OmniGuide Holdings Inc. |Health Care Equipment & Supplies |L+1405 |0.10% |18.22% |7/30/2018 |7/1/2023      
Schedule of Investments [Line Items]      
Industry [32]   Health Care Equipment & Supplies  
Spread Above Index [26],[32]   1405.00%  
Floor [32]   0.10%  
Interest Rate [18],[32],[33]   18.22%  
Acquisition Date [32]   Jul. 30, 2018  
Maturity Date [32]   Jul. 01, 2023  
Par Amount [32]   $ 19,201  
Cost [32]   19,380  
Fair Value [32]   $ 19,777  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Outset Medical Inc. |Health Care Equipment & Supplies |S+515 |2.75% |9.33% |11/3/2022 |11/1/2027      
Schedule of Investments [Line Items]      
Industry [12]   Health Care Equipment & Supplies  
Spread Above Index [12],[26]   515.00%  
Floor [12]   2.75%  
Interest Rate [12],[18]   9.33%  
Acquisition Date [12]   Nov. 03, 2022  
Maturity Date [12]   Nov. 01, 2027  
Par Amount [12]   $ 35,084  
Cost [12]   34,880  
Fair Value [12]   $ 34,820  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Spectrum Pharmaceuticals Inc. |Biotechnology |S+570 |2.30% |9.88% |9/21/2022 |9/1/2027      
Schedule of Investments [Line Items]      
Industry [25]   Biotechnology  
Spread Above Index [25],[26]   570.00%  
Floor [25]   2.30%  
Interest Rate [18],[25]   9.88%  
Acquisition Date [25]   Sep. 21, 2022  
Maturity Date [25]   Sep. 01, 2027  
Par Amount [25]   $ 10,525  
Cost [25]   10,406  
Fair Value [25]   10,420  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Total First Lien Life Science Senior Secured Loans      
Schedule of Investments [Line Items]      
Cost   319,205  
Fair Value   $ 322,455  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Vapotherm Inc. |Health Care Equipment & Supplies |S+830 |1.00% |12.58% |2/18/2022 |2/1/2027      
Schedule of Investments [Line Items]      
Industry   Health Care Equipment & Supplies  
Spread Above Index [26]   830.00%  
Floor   1.00%  
Interest Rate [18],[34]   12.58%  
Acquisition Date   Feb. 18, 2022  
Maturity Date   Feb. 01, 2027  
Par Amount   $ 34,455  
Cost   34,270  
Fair Value   $ 34,628  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |Second Lien Asset-Based Senior Secured Loans |ACRES Commercial Mortgage LLC |Diversified Financial Services |S+705 |1.00% |11.38% |12/24/2021 |8/21/2028      
Schedule of Investments [Line Items]      
Industry   Diversified Financial Services  
Spread Above Index [26]   705.00%  
Floor   1.00%  
Interest Rate [18]   11.38%  
Acquisition Date   Dec. 24, 2021  
Maturity Date   Aug. 21, 2028  
Par Amount   $ 29,925  
Cost   29,398  
Fair Value   $ 29,925  
Investment, Identifier [Axis]: Senior Secured Loans 124.6% |Second Lien Bank Debt/Senior Secured Loans |RD Holdco Inc. |Diversified Consumer Services |S+975 |1.00% |12/23/2013 |10/12/2026      
Schedule of Investments [Line Items]      
Industry [9],[28]   Diversified Consumer Services  
Spread Above Index [9],[24],[26],[28]   975.00%  
Floor [9],[28]   1.00%  
Interest Rate [9],[18],[28]   0.00%  
Acquisition Date [9],[28]   Dec. 23, 2013  
Maturity Date [9],[28]   Oct. 12, 2026  
Par Amount [9],[28]   $ 13,043  
Cost [9],[28]   11,791  
Fair Value [9],[28]   $ 6,521  
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans      
Schedule of Investments [Line Items]      
Cost 921,022    
Fair Value $ 928,465    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.) |Insurance |S+550 |0.75% |11.02% |4/1/2022 |11/1/2026      
Schedule of Investments [Line Items]      
Industry [25] Insurance    
Spread Above Index [25],[26] 550.00%    
Floor [25] 0.75%    
Interest Rate [22],[25] 11.02%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Nov. 01, 2026    
Par Amount [25] $ 20,221    
Cost [25] 20,071    
Fair Value [25] $ 20,221    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Aegis Toxicology Sciences Corporation |Health Care Providers & Services |S+550 |1.00 % |11.13 % |5/7/2018 |5/9/2025      
Schedule of Investments [Line Items]      
Industry [25] Health Care Providers & Services    
Spread Above Index [25],[26] 550.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 11.13%    
Acquisition Date [25] May 07, 2018    
Maturity Date [25] May 09, 2025    
Par Amount [25] $ 13,420    
Cost [25] 13,218    
Fair Value [25] $ 13,420    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Alkeme Intermediary Holdings, LLC |Insurance |S+650 |1.00 % |11.92 % |9/20/2023 |10/28/2026      
Schedule of Investments [Line Items]      
Industry Insurance    
Spread Above Index [26] 650.00%    
Floor 1.00%    
Interest Rate [22] 11.92%    
Acquisition Date Sep. 20, 2023    
Maturity Date Oct. 28, 2026    
Par Amount $ 8,524    
Cost 8,270    
Fair Value $ 8,268    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |All States Ag Parts, LLC|Trading Companies & Distributors |S+600 |1.00 % |11.60 % |4/1/2022 |9/1/2026      
Schedule of Investments [Line Items]      
Industry [25] Trading Companies & Distributors    
Spread Above Index [25],[26] 600.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 11.60%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Sep. 01, 2026    
Par Amount [25] $ 2,177    
Cost [25] 2,148    
Fair Value [25] $ 2,177    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Apex Services Partners, LLC |Diversified Consumer Services |S+525 |1.00 % |10.67 % |8/31/2022 |7/31/2025      
Schedule of Investments [Line Items]      
Industry [25] Diversified Consumer Services    
Spread Above Index [25],[26] 525.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.67%    
Acquisition Date [25] Aug. 31, 2022    
Maturity Date [25] Jul. 31, 2025    
Par Amount [25] $ 13,916    
Cost [25] 13,641    
Fair Value [25] $ 13,916    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Atria Wealth Solutions, Inc. |Diversified Financial Services |S+650 |1.00 % |12.15 % |9/14/2018 |2/29/2024      
Schedule of Investments [Line Items]      
Industry [25] Diversified Financial Services    
Spread Above Index [25],[26] 650.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 12.15%    
Acquisition Date [25] Sep. 14, 2018    
Maturity Date [25] Feb. 29, 2024    
Par Amount [25] $ 16,288    
Cost [25] 16,170    
Fair Value [25] $ 16,288    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |BDG Media, Inc | Media |P+525 |5.50 % |13.75 % |7/18/2022 |7/31/2025      
Schedule of Investments [Line Items]      
Industry Media    
Spread Above Index [26] 525.00%    
Floor 5.50%    
Interest Rate [22] 13.75%    
Acquisition Date Jul. 18, 2022    
Maturity Date Jul. 31, 2025    
Par Amount $ 5,354    
Cost 5,354    
Fair Value $ 5,354    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Basic Fun, Inc.|Specialty Retail |S+650 |1.00 % |12.17 % |10/30/2020 |7/2/2024      
Schedule of Investments [Line Items]      
Industry [25] Specialty Retail    
Spread Above Index [25],[26] 650.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 12.17%    
Acquisition Date [25] Oct. 30, 2020    
Maturity Date [25] Jul. 02, 2024    
Par Amount [25] $ 2,150    
Cost [25] 2,149    
Fair Value [25] $ 2,150    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |BayMark Health Services, Inc. |Health Care Providers & Services |S+500 |1.00 % |10.65 % |4/1/2022 |6/11/2027      
Schedule of Investments [Line Items]      
Industry [25] Health Care Providers & Services    
Spread Above Index [25],[26] 500.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.65%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Jun. 11, 2027    
Par Amount [25] $ 8,286    
Cost [25] 8,021    
Fair Value [25] $ 8,286    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Opco, LLC |Healthcare Providers & Services |S+700 |1.00 % |12.54 % |5/31/2023 |5/31/2026      
Schedule of Investments [Line Items]      
Industry [4] Healthcare Providers & Services    
Spread Above Index [4],[26],[35] 700.00%    
Floor [4] 1.00%    
Interest Rate [4],[22] 12.54%    
Acquisition Date [4] May 31, 2023    
Maturity Date [4] May 31, 2026    
Par Amount [4] $ 402    
Cost [4] 402    
Fair Value [4] $ 402    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Opco, LLC |Healthcare Providers & Services |S+725 |1.00 % |12.79 %|5/31/2023 |5/31/2026      
Schedule of Investments [Line Items]      
Industry [4] Healthcare Providers & Services    
Spread Above Index [4],[24],[26] 725.00%    
Floor [4] 1.00%    
Interest Rate [4],[22] 12.79%    
Acquisition Date [4] May 31, 2023    
Maturity Date [4] May 31, 2026    
Par Amount [4] $ 18,807    
Cost [4] 18,807    
Fair Value [4] $ 18,807    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Parent, LLC |Healthcare Providers & Services |S+1000 |1.00 % |15.54 % |5/31/2023 |5/31/2026      
Schedule of Investments [Line Items]      
Industry [4] Healthcare Providers & Services    
Spread Above Index [4],[24],[26] 1000.00%    
Floor [4] 1.00%    
Interest Rate [4],[22] 15.54%    
Acquisition Date [4] May 31, 2023    
Maturity Date [4] May 31, 2026    
Par Amount [4] $ 4,959    
Cost [4] 4,959    
Fair Value [4] $ 4,959    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |CC SAG Holdings Corp. (Spectrum Automotive) |Diversified Consumer Services |S+575 |0.75 % |11.18 % |6/29/2021 |6/29/2028      
Schedule of Investments [Line Items]      
Industry [25] Diversified Consumer Services    
Spread Above Index [25],[26] 575.00%    
Floor [25] 0.75%    
Interest Rate [22],[25] 11.18%    
Acquisition Date [25] Jun. 29, 2021    
Maturity Date [25] Jun. 29, 2028    
Par Amount [25] $ 36,588    
Cost [25] 36,020    
Fair Value [25] $ 36,588    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |CVAUSA Management, LLC |Health Care Providers & Services |S+650 |1.00 % |11.59 % |5/22/2023 |5/22/2029      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 650.00%    
Floor 1.00%    
Interest Rate [22] 11.59%    
Acquisition Date May 22, 2023    
Maturity Date May 22, 2029    
Par Amount $ 18,855    
Cost 18,308    
Fair Value $ 18,289    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Composite Technology Acquisition Corp. |Building Products |S+450 |1.00 % |10.04 % |4/1/2022 |2/1/2025      
Schedule of Investments [Line Items]      
Industry [25] Building Products    
Spread Above Index [25],[26] 450.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.04%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Feb. 01, 2025    
Par Amount [25] $ 11,028    
Cost [25] 10,765    
Fair Value [25] $ 11,028    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) |Trading Companies & Distributors |S+475 |1.00 % |10.24 % |4/1/2022 |12/31/2025      
Schedule of Investments [Line Items]      
Industry [25] Trading Companies & Distributors    
Spread Above Index [25],[26] 475.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.24%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Dec. 31, 2025    
Par Amount [25] $ 4,630    
Cost [25] 4,507    
Fair Value [25] $ 4,630    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Enhanced Permanent Capital, LLC |Capital Markets |S+700 |S+700 |12.26 % |12/29/2020 |12/29/2025      
Schedule of Investments [Line Items]      
Industry [10] Capital Markets    
Spread Above Index [10],[26] 700.00%    
Floor [10] 1.00%    
Interest Rate [10],[22] 12.26%    
Acquisition Date [10] Dec. 29, 2020    
Maturity Date [10] Dec. 29, 2025    
Par Amount [10] $ 42,521    
Cost [10] 41,790    
Fair Value [10] $ 42,521    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Enverus Holdings, Inc. (fka Drilling Info Holdings) |IT Services |S+450 | |9.92 % |4/1/2022 |7/30/2025      
Schedule of Investments [Line Items]      
Industry [25] IT Services    
Spread Above Index [25],[26] 450.00%    
Floor [25] 0.00%    
Interest Rate [22],[25] 9.92%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Jul. 30, 2025    
Par Amount [25] $ 11,277    
Cost [25] 10,950    
Fair Value [25] $ 11,277    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Erie Construction Mid-west, LLC |Building Products |S+475 |1.00 % |10.34 % |4/1/2022 |7/30/2027      
Schedule of Investments [Line Items]      
Industry [25] Building Products    
Spread Above Index [25],[26] 475.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.34%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Jul. 30, 2027    
Par Amount [25] $ 8,572    
Cost [25] 8,296    
Fair Value [25] $ 8,572    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Fertility (ITC) Investment Holdco, LLC |Health Care Providers & Services |S+650 |1.00 % |11.63 % |1/4/2023 |1/3/2029      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 650.00%    
Floor 1.00%    
Interest Rate [22] 11.63%    
Acquisition Date Jan. 04, 2023    
Maturity Date Jan. 03, 2029    
Par Amount $ 22,653    
Cost 22,034    
Fair Value $ 22,653    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Foundation Consumer Brands, LLC | Personal Products |S+625 |1.00 % |11.77 %|2/12/2021 |2/12/2027      
Schedule of Investments [Line Items]      
Industry [25] Personal Products    
Spread Above Index [25],[26] 625.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 11.77%    
Acquisition Date [25] Feb. 12, 2021    
Maturity Date [25] Feb. 12, 2027    
Par Amount [25] $ 27,560    
Cost [25] 26,963    
Fair Value [25] $ 27,560    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |GSM Acquisition Corp. |Leisure Equipment & Products |S+500 |1.00 % |10.65 % |4/1/2022 |11/16/2026      
Schedule of Investments [Line Items]      
Industry [25] Leisure Equipment & Products    
Spread Above Index [25],[26] 500.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.65%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Nov. 16, 2026    
Par Amount [25] $ 10,939    
Cost [25] 10,578    
Fair Value [25] $ 10,939    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Higginbotham Insurance Agency, Inc.(16) |Insurance |S+550 |1.00 % |10.92 % |4/1/2022 |11/15/2028      
Schedule of Investments [Line Items]      
Industry [25] Insurance    
Spread Above Index [25],[26] 550.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.92%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Nov. 15, 2028    
Par Amount [25] $ 28,856    
Cost [25] 28,856    
Fair Value [25] $ 28,856    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |High Street Buyer, Inc. |Insurance |S+600 |0.75 % |11.54 % |4/1/2022 |4/16/2028      
Schedule of Investments [Line Items]      
Industry [25] Insurance    
Spread Above Index [25],[26] 600.00%    
Floor [25] 0.75%    
Interest Rate [22],[25] 11.54%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Apr. 16, 2028    
Par Amount [25] $ 3,191    
Cost [25] 3,034    
Fair Value [25] $ 3,191    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Human Interest Inc. |Internet Software & Services |S+785 |1.00 % |13.18 % |6/30/2022 |7/1/2027      
Schedule of Investments [Line Items]      
Industry Internet Software & Services    
Spread Above Index [26] 785.00%    
Floor 1.00%    
Interest Rate [22] 13.18%    
Acquisition Date Jun. 30, 2022    
Maturity Date Jul. 01, 2027    
Par Amount $ 20,104    
Cost 19,903    
Fair Value $ 20,104    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |KORE Wireless Group, Inc. |Logix Holding Company, LLC |S+550 | |10.99 % |12/21/2018 |12/21/2024      
Schedule of Investments [Line Items]      
Industry [25] Wireless Telecommunication Services    
Spread Above Index [25],[26] 550.00%    
Floor [25] 0.00%    
Interest Rate [22],[25] 10.99%    
Acquisition Date [25] Dec. 21, 2018    
Maturity Date [25] Dec. 21, 2024    
Par Amount [25] $ 23,404    
Cost [25] 23,108    
Fair Value [25] $ 23,404    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kaseya, Inc. |Software |S+625 |0.75 % |11.58 % |6/22/2022 |6/22/2022      
Schedule of Investments [Line Items]      
Industry [25] Software    
Spread Above Index [25],[26] 625.00%    
Floor [25] 0.75%    
Interest Rate [22],[25],[36] 11.58%    
Acquisition Date [25] Jun. 22, 2022    
Maturity Date [25] Jun. 23, 2029    
Par Amount [25] $ 24,365    
Cost [25] 24,050    
Fair Value [25] $ 24,365    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kid Distro Holdings, LLC (Distro Kid) |Software |S+550 |1.00 % |11.04 % |9/24/2021 |10/1/2027      
Schedule of Investments [Line Items]      
Industry [25] Software    
Spread Above Index [25],[26] 550.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 11.04%    
Acquisition Date [25] Sep. 24, 2021    
Maturity Date [25] Oct. 01, 2027    
Par Amount [25] $ 20,259    
Cost [25] 19,969    
Fair Value [25] $ 20,259    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kingsbridge Holdings, LLC |Multi-Sector Holdings |S+700 |1.00 % |1.00 % |12/21/2018 |12/21/2024      
Schedule of Investments [Line Items]      
Industry Multi-Sector Holdings    
Spread Above Index [26] 700.00%    
Floor 1.00%    
Interest Rate [22] 12.40%    
Acquisition Date Dec. 21, 2018    
Maturity Date Dec. 21, 2024    
Par Amount $ 80,000    
Cost 79,872    
Fair Value $ 80,000    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Logix Holding Company, LLC |Communications Equipment |L+575 |1.00 % |11.48 % |9/14/2018 |12/22/2024      
Schedule of Investments [Line Items]      
Industry [25] Communications Equipment    
Spread Above Index [25],[26] 575.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 11.48%    
Acquisition Date [25] Sep. 14, 2018    
Maturity Date [25] Dec. 22, 2024    
Par Amount [25] $ 14,009    
Cost [25] 13,516    
Fair Value [25] $ 13,729    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Luxury Asset Capital, LLC |Thrifts & Mortgage Finance |S+675 |1.00 % |12.19 % |7/15/2022 |7/15/2027      
Schedule of Investments [Line Items]      
Industry [25] Thrifts & Mortgage Finance    
Spread Above Index [25],[26] 675.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 12.19%    
Acquisition Date [25] Jul. 15, 2022    
Maturity Date [25] Jul. 15, 2027    
Par Amount [25] $ 30,500    
Cost [25] 30,005    
Fair Value [25] $ 30,500    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Maurices, Incorporated |Specialty Retail |S+675 |1.00 % |9.94 % |8/27/2021 |6/1/2024      
Schedule of Investments [Line Items]      
Industry [25] Specialty Retail    
Spread Above Index [25],[26] 675.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 9.94%    
Acquisition Date [25] Aug. 27, 2021    
Maturity Date [25] Jun. 01, 2024    
Par Amount [25] $ 7,395    
Cost [25] 7,346    
Fair Value [25] $ 7,395    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Maxor Acquisition, Inc. |Health Care Providers & Services |S+675 |1.00 % |12.48 % |3/1/2023 |3/1/2029      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 675.00%    
Floor 1.00%    
Interest Rate [22] 12.48%    
Acquisition Date Mar. 01, 2023    
Maturity Date Mar. 01, 2029    
Par Amount $ 23,783    
Cost 23,118    
Fair Value $ 23,783    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |NSPC Intermediate Corp. (National Spine) |Health Care Providers & Services |S+850 |1.00 % |13.20 % |4/1/2022 |2/13/2026      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 850.00%    
Floor 1.00%    
Interest Rate [22] 13.20%    
Acquisition Date Apr. 01, 2022    
Maturity Date Feb. 13, 2026    
Par Amount $ 2,216    
Cost 2,136    
Fair Value $ 2,216    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |ONS MSO, LLC |Health Care Providers & Services |S+625 |1.00 % |11.62 % |2/10/2023 |7/8/2025      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 625.00%    
Floor 1.00%    
Interest Rate [22] 11.62%    
Acquisition Date Feb. 10, 2023    
Maturity Date Jul. 08, 2025    
Par Amount $ 17,192    
Cost 16,798    
Fair Value $ 17,192    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Oldco AI, LLC (f/k/a Amerimark) |Internet & Catalog Retail |S+800 |1.00 % | |7/28/2021 |10/15/2026      
Schedule of Investments [Line Items]      
Industry [4],[28],[37] Internet & Catalog Retail    
Spread Above Index [4],[26],[28],[37] 800.00%    
Floor [4],[28],[37] 1.00%    
Interest Rate [4],[22],[28],[37] 0.00%    
Acquisition Date [4],[28],[37] Jul. 28, 2021    
Maturity Date [4],[28],[37] Oct. 15, 2026    
Par Amount [4],[28],[37] $ 4,855    
Cost [4],[28],[37] 4,204    
Fair Value [4],[28],[37] $ 0    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Oldco AI, LLC(f/k/a Amerimark) |Internet & Catalog Retail |P+475 |1.00 % |13.25 % |6/16/2023 |10/31/2023      
Schedule of Investments [Line Items]      
Industry [4],[37] Internet & Catalog Retail    
Spread Above Index [4],[26],[37] 475.00%    
Floor [4],[37] 1.00%    
Interest Rate [4],[22],[37] 13.25%    
Acquisition Date [4],[37] Jun. 16, 2023    
Maturity Date [4],[37] Oct. 31, 2023    
Par Amount [4],[37] $ 321    
Cost [4],[37] 321    
Fair Value [4],[37] $ 321    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Orthopedic Care Partners Management, LLC |Health Care Providers & Services |S+650 |1.00 % |11.96 % |8/17/2022 |5/16/2024      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 650.00%    
Floor 1.00%    
Interest Rate [22] 11.96%    
Acquisition Date Aug. 17, 2022    
Maturity Date May 16, 2024    
Par Amount $ 5,502    
Cost 5,473    
Fair Value $ 5,420    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Pediatric Home Respiratory Services, LLC |Health Care Providers & Services |S+625 |1.00 % |11.67 % |8/19/2022 |12/4/2024      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 625.00%    
Floor 1.00%    
Interest Rate [22] 11.67%    
Acquisition Date Aug. 19, 2022    
Maturity Date Dec. 04, 2024    
Par Amount $ 3,118    
Cost 3,082    
Fair Value $ 3,118    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Peter C. Foy & Associates Insurance Services, LLC |Insurance |S+600 |0.75 % |11.43 % |4/1/2022 |11/1/2028      
Schedule of Investments [Line Items]      
Industry Insurance    
Spread Above Index [26] 600.00%    
Floor 0.75%    
Interest Rate [22] 11.43%    
Acquisition Date Apr. 01, 2022    
Maturity Date Nov. 01, 2028    
Par Amount $ 16,920    
Cost 16,668    
Fair Value $ 16,581    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |PhyNet Dermatology LLC |Health Care Providers & Services |S+625 |1.00 % |11.45 % |9/5/2018 |8/16/2024      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 625.00%    
Floor 1.00%    
Interest Rate [22] 11.45%    
Acquisition Date Sep. 05, 2018    
Maturity Date Aug. 16, 2024    
Par Amount $ 8,374    
Cost 8,361    
Fair Value $ 8,374    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Pinnacle Treatment Centers, Inc. |Health Care Providers & Services |S+675 |1.00 % |12.10 % |1/22/2020 |1/2/2026      
Schedule of Investments [Line Items]      
Industry [25] Health Care Providers & Services    
Spread Above Index [25],[26] 675.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 12.10%    
Acquisition Date [25] Jan. 22, 2020    
Maturity Date [25] Jan. 02, 2026    
Par Amount [25] $ 25,243    
Cost [25] 24,903    
Fair Value [25] $ 25,243    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Plastics Management, LLC |Health Care Providers & Services|S+500 |1.00 % |10.44 %|4/1/2022 |8/18/2027      
Schedule of Investments [Line Items]      
Industry [25] Health Care Providers & Services    
Spread Above Index [25],[26] 500.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.44%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Aug. 18, 2027    
Par Amount [25] $ 17,184    
Cost [25] 16,493    
Fair Value [25] $ 17,184    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |RQM+ Corp. |Life Sciences Tools & Services |S+575 |1.00 % |11.40 % |8/20/2021 |8/12/2026      
Schedule of Investments [Line Items]      
Industry [25] Life Sciences Tools & Services    
Spread Above Index [25],[26] 575.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 11.40%    
Acquisition Date [25] Aug. 20, 2021    
Maturity Date [25] Aug. 12, 2026    
Par Amount [25] $ 23,696    
Cost [25] 23,361    
Fair Value [25] $ 23,696    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |RxSense Holdings LLC |Diversified Consumer Services |S+500 |1.00 % |10.47 % |4/1/2022 |3/13/2026      
Schedule of Investments [Line Items]      
Industry [25] Diversified Consumer Services    
Spread Above Index [25],[26] 500.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.47%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Mar. 13, 2026    
Par Amount [25] $ 8,677    
Cost [25] 8,369    
Fair Value [25] $ 8,677    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SCP Eye Care, LLC |Health Care Providers & Services |S+575 |1.00 % |11.17 % |10/6/2022 |10/6/2022      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 575.00%    
Floor 1.00%    
Interest Rate [22] 11.17%    
Acquisition Date Oct. 06, 2022    
Maturity Date Oct. 05, 2029    
Par Amount $ 9,562    
Cost 9,281    
Fair Value $ 9,562    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SHO Holding I Corporation (Shoes for Crews) |Footwear |S+523 |1.00 % |10.86 % |4/1/2022 |4/27/2024      
Schedule of Investments [Line Items]      
Industry [25] Footwear    
Spread Above Index [25],[26] 523.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.86%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Apr. 27, 2024    
Par Amount [25] $ 5,659    
Cost [25] 5,505    
Fair Value [25] $ 5,376    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Southern Orthodontic Partners Management, LLC |Health Care Providers & Services |S+625 |1.00 % |11.89 % |6/3/2022 |1/27/2026      
Schedule of Investments [Line Items]      
Industry [25] Health Care Providers & Services    
Spread Above Index [25],[26] 625.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 11.89%    
Acquisition Date [25] Jun. 03, 2022    
Maturity Date [25] Jan. 27, 2026    
Par Amount [25] $ 11,505    
Cost [25] 11,319    
Fair Value [25] $ 11,274    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Stryten Resources LLC |Stryten Resources LLC |S+800 |1.00 % |13.43 % |8/11/2021 |10/12/2026      
Schedule of Investments [Line Items]      
Industry Auto Parts & Equipment    
Spread Above Index [26] 800.00%    
Floor 1.00%    
Interest Rate [22] 13.43%    
Acquisition Date Aug. 11, 2021    
Maturity Date Oct. 12, 2026    
Par Amount $ 10,725    
Cost 10,581    
Fair Value $ 10,586    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SunMed Group Holdings, LLC |Health Care Equipment & Supplies |S+550 |0.75 % |10.99 % |6/16/2021|6/16/2028      
Schedule of Investments [Line Items]      
Industry [25] Health Care Equipment & Supplies    
Spread Above Index [25],[26] 550.00%    
Floor [25] 0.75%    
Interest Rate [22],[25] 10.99%    
Acquisition Date [25] Jun. 16, 2021    
Maturity Date [25] Jun. 16, 2028    
Par Amount [25] $ 15,020    
Cost [25] 14,700    
Fair Value [25] $ 15,020    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |TAUC Management, LLC |Health Care Providers & Services |L+525 |1.00 % |10.59 % |4/1/2022 |2/12/2027      
Schedule of Investments [Line Items]      
Industry [25] Health Care Providers & Services    
Spread Above Index [25],[26] 525.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 10.59%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Feb. 12, 2027    
Par Amount [25] $ 6,893    
Cost [25] 6,630    
Fair Value [25] $ 6,411    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |The Townsend Company, LLC |Commercial Services & Supplies |S+625 |1.00 % |11.57 % |8/17/2023 |8/15/2029      
Schedule of Investments [Line Items]      
Industry Commercial Services & Supplies    
Spread Above Index [26] 625.00%    
Floor 1.00%    
Interest Rate [22] 11.57%    
Acquisition Date Aug. 17, 2023    
Maturity Date Aug. 15, 2029    
Par Amount $ 10,073    
Cost 9,825    
Fair Value $ 9,821    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Tilley Distribution, Inc. |Trading Companies & Distributors |S+600 |1.00 % |11.54 % |4/1/2022 |12/31/2026      
Schedule of Investments [Line Items]      
Industry [25] Trading Companies & Distributors    
Spread Above Index [25],[26] 600.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 11.54%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Dec. 31, 2026    
Par Amount [25] $ 3,848    
Cost [25] 3,692    
Fair Value [25] $ 3,848    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |UVP Management, LLC |Health Care Providers & Services |S+625 |1.00 % |11.79 % |9/18/2023 |9/15/2025      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 625.00%    
Floor 1.00%    
Interest Rate [22] 11.79%    
Acquisition Date Sep. 18, 2023    
Maturity Date Sep. 15, 2025    
Par Amount $ 15,444    
Cost 15,063    
Fair Value $ 15,058    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Ultimate Baked Goods Midco LLC (Rise Baking) |Packaged Foods & Meats |S+625 |1.00 % |11.67 % |8/12/2021 |8/13/2027      
Schedule of Investments [Line Items]      
Industry [25] Packaged Foods & Meats    
Spread Above Index [25],[26] 625.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 11.67%    
Acquisition Date [25] Aug. 12, 2021    
Maturity Date [25] Aug. 13, 2027    
Par Amount [25] $ 14,858    
Cost [25] 14,397    
Fair Value [25] $ 14,858    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |United Digestive MSO Parent, LLC |Health Care Providers & Services |S+675 | 1.00 % |12.29 % |3/30/2023 |3/30/2029      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 675.00%    
Floor 1.00%    
Interest Rate [22] 12.29%    
Acquisition Date Mar. 30, 2023    
Maturity Date Mar. 30, 2029    
Par Amount $ 13,257    
Cost 12,882    
Fair Value $ 13,257    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Urology Management Holdings, Inc. |Health Care Providers & Services |S+625 |1.00 % |11.79 % |2/7/2023 |6/15/2026      
Schedule of Investments [Line Items]      
Industry Health Care Providers & Services    
Spread Above Index [26] 625.00%    
Floor 1.00%    
Interest Rate [22] 11.79%    
Acquisition Date Feb. 07, 2023    
Maturity Date Jun. 15, 2026    
Par Amount $ 7,138    
Cost 6,959    
Fair Value $ 7,066    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Vessco Midco Holdings, LLC |Water Utilities |S+450 |1.00 % |9.92 % |4/1/2022 |11/2/2026      
Schedule of Investments [Line Items]      
Industry [25] Water Utilities    
Spread Above Index [25],[26] 450.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 9.92%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Nov. 02, 2026    
Par Amount [25] $ 2,466    
Cost [25] 2,408    
Fair Value [25] $ 2,466    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |West-NR Parent, Inc. |Insurance |S+625 |1.00 % |11.72 % |8/1/2023 |12/27/2027      
Schedule of Investments [Line Items]      
Industry Insurance    
Spread Above Index [26] 625.00%    
Floor 1.00%    
Interest Rate [22] 11.72%    
Acquisition Date Aug. 01, 2023    
Maturity Date Dec. 27, 2027    
Par Amount $ 13,201    
Cost 12,945    
Fair Value $ 12,937    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |World Insurance Associates, LLC | Insurance |S+575 |1.00 % |11.14 % |4/1/2022 |4/1/2026      
Schedule of Investments [Line Items]      
Industry [25] Insurance    
Spread Above Index [25],[26] 575.00%    
Floor [25] 1.00%    
Interest Rate [22],[25] 11.14%    
Acquisition Date [25] Apr. 01, 2022    
Maturity Date [25] Apr. 01, 2026    
Par Amount [25] $ 48,250    
Cost [25] 48,141    
Fair Value [25] $ 48,250    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |iCIMS, Inc. |Software |S+725 |0.75 % |12.14 % |8/18/2022 |8/18/2028      
Schedule of Investments [Line Items]      
Industry Software    
Spread Above Index [26] 725.00%    
Floor 0.75%    
Interest Rate [22],[30] 12.14%    
Acquisition Date Aug. 18, 2022    
Maturity Date Aug. 18, 2028    
Par Amount $ 30,762    
Cost 30,327    
Fair Value 30,762    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans      
Schedule of Investments [Line Items]      
Cost 1,292,223    
Fair Value $ 1,300,366    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans Outset Medical Inc |Health Care Equipment and Supplies |S+515 |2.75 % |10.48 % |11/3/2022 |11/1/2027      
Schedule of Investments [Line Items]      
Industry [10],[25] Health Care Equipment & Supplies    
Spread Above Index [10],[25],[26] 515.00%    
Floor [10],[25] 2.75%    
Interest Rate [10],[22],[25] 10.48%    
Acquisition Date [10],[25] Nov. 03, 2022    
Maturity Date [10],[25] Nov. 01, 2027    
Par Amount [10],[25] $ 35,084    
Cost [10],[25] 35,162    
Fair Value [10],[25] $ 35,171    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans Vapotherm Inc |Health Care Equipment and Supplies |S+930 |1.00 % |14.73 % |2/18/2022 |2/1/2027      
Schedule of Investments [Line Items]      
Industry Health Care Equipment & Supplies    
Spread Above Index [26] 930.00%    
Floor 1.00%    
Interest Rate [22],[38] 14.73%    
Acquisition Date Feb. 18, 2022    
Maturity Date Feb. 01, 2027    
Par Amount $ 36,826    
Cost 37,086    
Fair Value $ 37,378    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Alimera Sciences Inc|Pharmaceuticals|S+515|4.60%|10.48 %|12/31/2019|5/1/2028      
Schedule of Investments [Line Items]      
Industry [25] Pharmaceuticals    
Spread Above Index [25],[26] 515.00%    
Floor [25] 4.60%    
Interest Rate [22],[25] 10.48%    
Acquisition Date [25] Dec. 31, 2019    
Maturity Date [25] May 01, 2028    
Par Amount [25] $ 34,738    
Cost [25] 34,857    
Fair Value [25] $ 37,186    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Apeel Technology Inc |Biotechnology |S+625 |1.00 % |8.75 % |6/29/2022 |6/1/2027      
Schedule of Investments [Line Items]      
Industry Biotechnology    
Spread Above Index [26] 625.00%    
Floor 1.00%    
Interest Rate [22] 8.75%    
Acquisition Date Jun. 29, 2022    
Maturity Date Jun. 01, 2027    
Par Amount $ 3,643    
Cost 3,641    
Fair Value $ 4,062    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Arcutis Biotherapeutics Inc |Pharamceuticals |S+745 |0.10 % |12.88 % |12/22/2021 |1/1/2027      
Schedule of Investments [Line Items]      
Industry [10] Pharamceuticals    
Spread Above Index [10],[26] 745.00%    
Floor [10] 0.10%    
Interest Rate [10],[22] 12.88%    
Acquisition Date [10] Dec. 22, 2021    
Maturity Date [10] Jan. 01, 2027    
Par Amount [10] $ 66,849    
Cost [10] 67,893    
Fair Value [10] $ 68,019    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Ardelyx Inc |Pharmaceuticals |S+795 |1.00 % |13.30 % |2/23/2022 |3/1/2027      
Schedule of Investments [Line Items]      
Industry [10] Pharmaceuticals    
Spread Above Index [10],[26] 795.00%    
Floor [10] 1.00%    
Interest Rate [10],[22] 13.30%    
Acquisition Date [10] Feb. 23, 2022    
Maturity Date [10] Mar. 01, 2027    
Par Amount [10] $ 9,475    
Cost [10] 9,526    
Fair Value [10] $ 10,503    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |BridgeBio Pharma Inc |Biotechnology |9.00 % |11/17/2021 |11/17/2026      
Schedule of Investments [Line Items]      
Industry [10] Biotechnology    
Spread Above Index [10],[26] 0.00%    
Floor [10] 0.00%    
Interest Rate [10],[22],[31] 9.00%    
Acquisition Date [10] Nov. 17, 2021    
Maturity Date [10] Nov. 17, 2026    
Par Amount [10] $ 40,753    
Cost [10] 40,487    
Fair Value [10] $ 40,854    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Cerapedics Inc |Biotechnology |S+620 |2.75 % |11.53 % |12/27/2022 |1/1/2028      
Schedule of Investments [Line Items]      
Industry Biotechnology    
Spread Above Index [26] 620.00%    
Floor 2.75%    
Interest Rate [22] 11.53%    
Acquisition Date Dec. 27, 2022    
Maturity Date Jan. 01, 2028    
Par Amount $ 26,939    
Cost 27,000    
Fair Value $ 27,007    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Glooko Inc |Health Care Technology |S+790 |0.10 % |13.33 % |9/30/2021 |10/1/2026      
Schedule of Investments [Line Items]      
Industry [25] Health Care Technology    
Spread Above Index [25],[26] 790.00%    
Floor [25] 0.10%    
Interest Rate [22],[25] 13.33%    
Acquisition Date [25] Sep. 30, 2021    
Maturity Date [25] Oct. 01, 2026    
Par Amount [25] $ 11,912    
Cost [25] 11,984    
Fair Value [25] $ 12,150    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Meditrina Inc |Health Care Equipment & Supplies |S+550 |3.45 % |10.83 % |12/20/2022 |12/1/2027      
Schedule of Investments [Line Items]      
Industry Health Care Equipment & Supplies    
Spread Above Index [26] 550.00%    
Floor 3.45%    
Interest Rate [22] 10.83%    
Acquisition Date Dec. 20, 2022    
Maturity Date Dec. 01, 2027    
Par Amount $ 3,367    
Cost 3,365    
Fair Value $ 3,384    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Neuronetics Inc |Health Care Equipment & Supplies |S+565 |3.95 % |10.98 % |3/2/2020 |3/29/2028      
Schedule of Investments [Line Items]      
Industry [25] Health Care Equipment & Supplies    
Spread Above Index [25],[26] 565.00%    
Floor [25] 3.95%    
Interest Rate [22],[25] 10.98%    
Acquisition Date [25] Mar. 02, 2020    
Maturity Date [25] Mar. 29, 2028    
Par Amount [25] $ 19,299    
Cost [25] 19,256    
Fair Value [25] $ 19,396    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |OmniGuide Holdings Inc |Health Care Equipment and Supplies |S+580 |5.31 % |11.23 % |7/30/2018 |11/1/2025      
Schedule of Investments [Line Items]      
Industry [32] Health Care Equipment & Supplies    
Spread Above Index [26] 580.00%    
Floor 5.31%    
Interest Rate [22] 11.23%    
Acquisition Date [32] Jul. 30, 2018    
Maturity Date Nov. 01, 2025    
Par Amount [32] $ 24,500    
Cost [32] 24,590    
Fair Value [32] 24,561    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Total First Lien Life Science Senior Secured Loans      
Schedule of Investments [Line Items]      
Cost 321,434    
Fair Value $ 326,238    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Vertos Medical Inc |Health Care Equipment and Supplies |S+515 |4.75 % |10.48 % |6/14/2023 |7/1/2028      
Schedule of Investments [Line Items]      
Industry Health Care Equipment & Supplies    
Spread Above Index [26] 515.00%    
Floor 4.75%    
Interest Rate [22] 10.48%    
Acquisition Date Jun. 14, 2023    
Maturity Date Jul. 01, 2028    
Par Amount $ 6,651    
Cost 6,587    
Fair Value 6,567    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans      
Schedule of Investments [Line Items]      
Cost 37,470    
Fair Value $ 38,131    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans |ACRES Commercial Mortgage, LLC |Diversified Financial Services |S+705 |1.00 % |12.49 % |12/24/2021 |8/21/2028      
Schedule of Investments [Line Items]      
Industry Diversified Financial Services    
Spread Above Index [26] 705.00%    
Floor 1.00%    
Interest Rate [22] 12.49%    
Acquisition Date Dec. 24, 2021    
Maturity Date Aug. 21, 2028    
Par Amount $ 29,925    
Cost 29,455    
Fair Value $ 29,925    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans |FGI Worldwide LLC |Diversified Financial Services |S+650 |1.00 % |11.82 % |4/17/2023 |4/17/2028      
Schedule of Investments [Line Items]      
Industry Diversified Financial Services    
Spread Above Index [26] 650.00%    
Floor 1.00%    
Interest Rate [22] 11.82%    
Acquisition Date Apr. 17, 2023    
Maturity Date Apr. 17, 2028    
Par Amount $ 8,206    
Cost 8,015    
Fair Value $ 8,206    
Investment, Identifier [Axis]: Senior Secured Loans 132.0% |Second Lien Bank Debt/Senior Secured Loans |RD Holdco Inc |Diversified Consumer Services |S+975 |1.00% |12/23/2013 |10/12/2026      
Schedule of Investments [Line Items]      
Industry [6],[28] Diversified Consumer Services    
Spread Above Index [6],[24],[26],[28] 975.00%    
Floor [6] 1.00%    
Interest Rate [6],[22],[28] 0.00%    
Acquisition Date [6],[28] Dec. 23, 2013    
Maturity Date [6],[28] Oct. 12, 2026    
Par Amount [6],[28] $ 15,065    
Cost [6],[28] 12,297    
Fair Value [6],[28] $ 7,532    
[1] Aggregate net unrealized appreciation for U.S. federal income tax purposes is $31,537; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $152,992 and $121,455, respectively, based on a tax cost of $2,139,519. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
[2] Denotes a Level 1 investment.
[3] Non-income producing security.
[4] Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows:
[5] Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
[6] Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2023 in these controlled investments are as follows:
[7] Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
[8] See note 11 to the consolidated financial statements.
[9] Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows:
[10] Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2023, on a fair value basis, non-qualifying assets in the portfolio represented 25.1% of the total assets of the Company.
[11] See note 13 to the consolidated financial statements.
[12] Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 24.2% of the total assets of the Company.
[13] See note 9 to the consolidated financial statements.
[14] See note 12 to the consolidated financial statements.
[15] See note 17 to the consolidated financial statements.
[16] Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.
[17] Indicates an investment that is wholly held by the Company through NEFPASS LLC.
[18] Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022.
[19] Denotes a subsidiary of SLR Equipment Finance.
[20] SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
[21] See note 10 to the consolidated financial statements.
[22] Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of September 30, 2023.
[23] The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.
[24] Interest is paid in kind (“PIK”).
[25] Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
[26] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
[27] AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK.
[28] Investment is on non-accrual status.
[29] Spread is 5.75% Cash / 0.50% PIK.
[30] iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.
[31] BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.
[32] OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.
[33] OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK.
[34] Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.
[35] Spread is 1.00% Cash / 6.00% PIK.
[36] Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.
[37] AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.
[38] Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK.
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Schedule of Investments (Parenthetical) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Percentage representing senior secured loans in investments owned 132.00% 124.60%
Percentage representing equipment financing in investments owned 26.90% 26.60%
Percentage representing preferred equity in investments owned 0.40% 0.40%
Percentage representing common equity or equity interests or warrants owned 61.10% 57.10%
Percentage representing total investments in investments owned 220.40% 208.70%
Percentage representing cash equivalents in investments owned 33.70% 41.80%
Percentage representing total investments and cash equivalents in investments owned 254.10% 250.50%
Percentage representing liabilities in excess of other assets in investments owned (154.10%) (150.50%)
Percentage representing net assets in investments owned 100.00% 100.00%
Percentage of outstanding voting securities of the investment 25.00% 25.00%
Percentage of non-qualifying assets in the portfolio of total assets 25.10% 24.20%
Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net $ 31,537 $ 17,187
Tax Basis of Investments, Gross, Unrealized Appreciation 152,992 161,053
Tax Basis of Investments, Gross, Unrealized Depreciation 121,455 143,866
Investment Owned tax costs 2,139,519 $ 2,069,489
Investment Company Change in Net Assets    
Ending balance [1] $ 2,171,056  
Spread One [Member]    
Percentage spread as cash 1.00% 5.75%
Percentage spread as paid in kind 6.00% 0.50%
SLR Senior Lending Program LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance [2],[3] $ 18,062  
Ending balance [2],[3] $ 133,561 $ 18,062
Amerimark [Member]    
Investment interest rate, Paid in kind   8.00%
Bridge Bio Pharma, Inc [Member]    
Investment interest rate, Paid in kind 3.00% 3.00%
Omni Guide Holdings, Inc [Member]    
Investment interest rate, Paid in kind   10.00%
Vapotherm, Inc. [Member]    
Investment interest rate, Paid in kind 9.00% 8.00%
iCIMS, Inc. [Member]    
Investment interest rate, Paid in kind 3.875% 3.875%
ASC Holdco LLC [Member]    
Investment Company Change in Net Assets    
Investment company percentage of holding 7.30%  
Kaseya, Inc. [Member]    
Investment interest rate, Paid in kind 2.50%  
Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance $ 797,594 $ 706,203
Gross Additions 22,444 131,369
Gross Reductions (5,338) (20,722)
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (7,848) (18,630)
Ending balance 806,922 797,594
Interest/Dividend Income 42,329 53,898
Companies more than 25% owned [Member] | Equipment Operating Leases LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance 3,741 18,939
Gross Additions 0 0
Gross Reductions (338) (15,833)
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 8 635
Ending balance 3,411 3,741
Interest/Dividend Income 231 749
Companies more than 25% owned [Member] | Kingsbridge Holdings, LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance 80,000 80,000
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (70) (87)
Ending balance 80,000 80,000
Interest/Dividend Income 7,434 7,402
Companies more than 25% owned [Member] | KBH Topco LLC (Kingsbridge) [Member]    
Investment Company Change in Net Assets    
Beginning balance 148,444 145,996
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (2,444) 2,448
Ending balance 146,000 148,444
Interest/Dividend Income 10,500 15,225
Companies more than 25% owned [Member] | Loyer Capital LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance 7,361 10,725
Gross Additions 0 0
Gross Reductions 0 (3,500)
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 136
Ending balance 7,361 7,361
Interest/Dividend Income 565 1,003
Companies more than 25% owned [Member] | RD Holdco Inc Common Equity [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 0
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 0
Ending balance 0 0
Interest/Dividend Income 0 0
Companies more than 25% owned [Member] | RD Holdco Inc Class B [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 5,216
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 (5,216)
Ending balance 0 0
Interest/Dividend Income 0 0
Companies more than 25% owned [Member] | RD Holdco Inc Warrants [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 0
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 0
Ending balance 0 0
Interest/Dividend Income 0 0
Companies more than 25% owned [Member] | RD Holdco Inc Debt [Member]    
Investment Company Change in Net Assets    
Beginning balance 6,521 11,829
Gross Additions 507 685
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 504 (5,280)
Ending balance 7,532 6,521
Interest/Dividend Income 0 (18)
Companies more than 25% owned [Member] | SLR Business Credit [Member]    
Investment Company Change in Net Assets    
Beginning balance 89,370 0
Gross Additions 0 81,583
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 1,000 7,787
Ending balance 90,370 89,370
Interest/Dividend Income 5,250 5,150
Companies more than 25% owned [Member] | SLR Credit Solutions [Member]    
Investment Company Change in Net Assets    
Beginning balance 288,760 298,766
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (7,760) (10,006)
Ending balance 281,000 288,760
Interest/Dividend Income 15,000 20,500
Companies more than 25% owned [Member] | SLR Equipment Finance Equity [Member]    
Investment Company Change in Net Assets    
Beginning balance 120,820 129,102
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 (8,282)
Ending balance 120,820 120,820
Interest/Dividend Income 0 0
Companies more than 25% owned [Member] | SLR Equipment Finance Debt [Member]    
Investment Company Change in Net Assets    
Beginning balance 5,000 0
Gross Additions 2,500 5,000
Gross Reductions (5,000) 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 0
Ending balance 2,500 5,000
Interest/Dividend Income 174 379
Companies more than 25% owned [Member] | SLR Healthcare ABL [Member]    
Investment Company Change in Net Assets    
Beginning balance 34,350 0
Gross Additions 0 34,335
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 500 15
Ending balance 34,850 34,350
Interest/Dividend Income 2,595 2,595
Companies more than 25% owned [Member] | SLR Senior Lending Program LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance 9,426 0
Gross Additions 19,250 9,500
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 601 (74)
Ending balance 29,277 9,426
Interest/Dividend Income 393 0
Companies more than 25% owned [Member] | SOAGG LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 1,121
Gross Additions   0
Gross Reductions   (447)
Net realized gain (loss)   0
Net change in unrealized gain (loss)   (674)
Ending balance   0
Interest/Dividend Income   647
Companies more than 25% owned [Member] | SOINT LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance 3,801 4,509
Gross Additions 187 266
Gross Reductions 0 (942)
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (187) (32)
Ending balance 3,801 3,801
Interest/Dividend Income 187 266
Companies more than 5% less than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance [4] 44,909  
Gross Additions 14,919  
Gross Reductions (14,272)  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) (2,151)  
Ending balance 43,405 44,909 [4]
Interest/Dividend Income 1,081  
Companies more than 5% less than 25% owned [Member] | AmeriMark Intermediate Holdings LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance [4] 0  
Gross Additions 1,262  
Gross Reductions (941)  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 0  
Ending balance 321 0 [4]
Interest/Dividend Income 15  
Companies more than 5% less than 25% owned [Member] | AmeriMark Intermediate Holdings LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance [4] 9,371  
Gross Additions 0  
Gross Reductions (12,866)  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 3,495  
Ending balance 0 9,371 [4]
Interest/Dividend Income 0  
Companies more than 5% less than 25% owned [Member] | Bayside Opco LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance [4] 846  
Gross Additions 21  
Gross Reductions (465)  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 0  
Ending balance 402 846 [4]
Interest/Dividend Income 32  
Companies more than 5% less than 25% owned [Member] | Bayside Opco LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance [4] 18,224  
Gross Additions 583  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 0  
Ending balance 18,807 18,224 [4]
Interest/Dividend Income 784  
Companies more than 5% less than 25% owned [Member] | Bayside Parent, LLC (loan) [Member]    
Investment Company Change in Net Assets    
Beginning balance [4] 4,773  
Gross Additions 186  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 0  
Ending balance 4,959 4,773 [4]
Interest/Dividend Income 250  
Companies more than 5% less than 25% owned [Member] | Bayside Parent, LLC (equity) [Member]    
Investment Company Change in Net Assets    
Beginning balance [4] 4,681  
Gross Additions 0  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) (865)  
Ending balance 3,816 4,681 [4]
Interest/Dividend Income 0  
Companies more than 5% less than 25% owned [Member] | SLRAMI Topco Blocker, LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance [4] 7,014  
Gross Additions 12,867  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) (4,781)  
Ending balance 15,100 $ 7,014 [4]
Interest/Dividend Income $ 0  
[1] Aggregate net unrealized appreciation for U.S. federal income tax purposes is $31,537; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $152,992 and $121,455, respectively, based on a tax cost of $2,139,519. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
[2] Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
[3] The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
[4] The Company became an Affiliated Person to Bayside Opco, LLC and Bayside Parent, LLC on May 31, 2023 and to Amerimark Intermediate Holdings, LLC and SLR- AMI Topco Blocker, LLC on June 16, 2023.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Insider Trading Arrangements
9 Months Ended
Sep. 30, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.23.3
N-2 - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cover [Abstract]                        
Entity Central Index Key 0001418076                      
Amendment Flag false                      
Securities Act File Number 814-00754                      
Document Type 10-Q                      
Entity Registrant Name SLR INVESTMENT CORP.                      
Entity Address, Address Line One 500 Park Avenue                      
Entity Address, City or Town New York                      
Entity Address, State or Province NY                      
Entity Address, Postal Zip Code 10022                      
City Area Code 212                      
Local Phone Number 993-1670                      
Entity Emerging Growth Company false                      
Financial Highlights [Abstract]                        
Senior Securities [Table Text Block]
Information about our senior securities is shown in the following table (in thousands) as of the quarter ended September 30, 2023 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Credit Facility
                                   
Fiscal 2023 (through September 30, 2023)
   $ 421,500      $ 642        —         N/A  
Fiscal 2022
     293,000        513        —         N/A  
Fiscal 2021
     222,500        552        —         N/A  
Fiscal 2020
     126,000        421        —         N/A  
Fiscal 2019
     42,900        182        —         N/A  
Fiscal 2018
     96,400        593        —         N/A  
Fiscal 2017
     245,600        1,225        —         N/A  
Fiscal 2016
     115,200        990        —         N/A  
Fiscal 2015
     207,900        1,459        —         N/A  
Fiscal 2014
     —         —         —         N/A  
Fiscal 2013
     —         —         —         N/A  
SPV Credit Facility
                                   
Fiscal 2023 (through September 30, 2023)
     206,250        314        —         N/A  
Fiscal 2022
     155,200        272        —         N/A  
2022 Unsecured Notes
                                   
Fiscal 2022
     —         —         —         N/A  
Fiscal 2021
     150,000        372        —         N/A  
Fiscal 2020
     150,000        501        —         N/A  
Fiscal 2019
     150,000        638        —         N/A  
Fiscal 2018
     150,000        923        —         N/A  
Fiscal 2017
     150,000        748        —         N/A  
Fiscal 2016
     50,000        430        —         N/A  
2022 Tranche C Notes
                                   
Fiscal 2022
     —         —         —         N/A  
Fiscal 2021
     21,000        52        —         N/A  
Fiscal 2020
     21,000        70        —         N/A  
Fiscal 2019
     21,000        89        —         N/A  
Fiscal 2018
     21,000        129        —         N/A  
Fiscal 2017
     21,000        105        —         N/A  
2023 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     —         —         —         N/A  
Fiscal 2022
     75,000        131        —         N/A  
Fiscal 2021
     75,000        186        —         N/A  
Fiscal 2020
     75,000        250        —         N/A  
Fiscal 2019
     75,000        319        —         N/A  
Fiscal 2018
     75,000        461        —         N/A  
Fiscal 2017
     75,000        374        —         N/A  
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
2024 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     125,000        190        —         N/A  
Fiscal 2022
     125,000        219        —         N/A  
Fiscal 2021
     125,000        309        —         N/A  
Fiscal 2020
     125,000        417        —         N/A  
Fiscal 2019
     125,000        531        —         N/A  
2025 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     85,000        129        —         N/A  
Fiscal 2022
     85,000        149        —         N/A  
2026 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     75,000        114        —         N/A  
Fiscal 2022
     75,000        131        —         N/A  
Fiscal 2021
     75,000        186        —         N/A  
Fiscal 2020
     75,000        250        —         N/A  
Fiscal 2019
     75,000        319        —         N/A  
2027 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     50,000        76        —         N/A  
Fiscal 2022
     50,000        88        —         N/A  
Fiscal 2021
     50,000        124        —         N/A  
2027 Series F Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     135,000        206        —         N/A  
Fiscal 2022
     135,000        237        —         N/A  
2042 Unsecured Notes
                                   
Fiscal 2017
     —         —         —         N/A  
Fiscal 2016
     100,000        859        —       $ 1,002  
Fiscal 2015
     100,000        702        —         982  
Fiscal 2014
     100,000        2,294        —         943  
Fiscal 2013
     100,000        2,411        —         934  
Senior Secured Notes
                                   
Fiscal 2017
     —         —         —         N/A  
Fiscal 2016
     75,000        645        —         N/A  
Fiscal 2015
     75,000        527        —         N/A  
Fiscal 2014
     75,000        1,721        —         N/A  
Fiscal 2013
     75,000        1,808        —         N/A  
Term Loans
                                   
Fiscal 2023 (through September 30, 2023)
     100,000        152        —         N/A  
Fiscal 2022
     100,000        175        —         N/A  
Fiscal 2021
     100,000        248        —         N/A  
Fiscal 2020
     75,000        250        —         N/A  
Fiscal 2019
     75,000        319        —         N/A  
Fiscal 2018
     50,000        308        —         N/A  
Fiscal 2017
     50,000        250        —         N/A  
Fiscal 2016
     50,000        430        —         N/A  
Fiscal 2015
     50,000        351        —         N/A  
Fiscal 2014
     50,000        1,147        —         N/A  
Fiscal 2013
     50,000        1,206        —         N/A  
NEFPASS Facility
                                   
Fiscal 2021
     —         —         —         N/A  
Fiscal 2020
     30,000        100        —         N/A  
Fiscal 2019
     30,000        128        —         N/A  
Fiscal 2018
     30,000        185        —         N/A  
SSLP Facility
                                   
Fiscal 2019
     —         —         —         N/A  
Fiscal 2018
     53,785        331        —         N/A  
Total Senior Securities
                                   
Fiscal 2023 (through September 30, 2023)
   $ 1,197,750      $ 1,823        —         N/A  
Fiscal 2022
     1,093,200        1,915        —         N/A  
Fiscal 2021
     818,500        2,029        —         N/A  
Fiscal 2020
     677,000        2,259        —         N/A  
Fiscal 2019
     593,900        2,525        —         N/A  
Fiscal 2018
     476,185        2,930        —         N/A  
Fiscal 2017
     541,600        2,702        —         N/A  
Fiscal 2016
     390,200        3,354        —         N/A  
Fiscal 2015
     432,900        3,039        —         N/A  
Fiscal 2014
     225,000        5,162        —         N/A  
Fiscal 2013
     225,000        5,425        —         N/A  
 
(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2023, asset coverage was 182.3%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
                     
Senior Securities Amount [1] $ 1,197,750 $ 390,200 $ 432,900 $ 225,000 $ 225,000 $ 1,093,200   $ 818,500 $ 677,000 $ 593,900 $ 476,185 $ 541,600
Senior Securities Coverage per Unit [2] $ 1,823 $ 3,354 $ 3,039 $ 5,162 $ 5,425 $ 1,915   $ 2,029 $ 2,259 $ 2,525 $ 2,930 $ 2,702
Preferred Stock Liquidating Preference [3] $ 0 $ 0 $ 0 $ 0 $ 0 0   0 $ 0 $ 0 $ 0 $ 0
Senior Securities, Note [Text Block]
Senior Securities
Information about our senior securities is shown in the following table (in thousands) as of the quarter ended September 30, 2023 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Credit Facility
                                   
Fiscal 2023 (through September 30, 2023)
   $ 421,500      $ 642        —         N/A  
Fiscal 2022
     293,000        513        —         N/A  
Fiscal 2021
     222,500        552        —         N/A  
Fiscal 2020
     126,000        421        —         N/A  
Fiscal 2019
     42,900        182        —         N/A  
Fiscal 2018
     96,400        593        —         N/A  
Fiscal 2017
     245,600        1,225        —         N/A  
Fiscal 2016
     115,200        990        —         N/A  
Fiscal 2015
     207,900        1,459        —         N/A  
Fiscal 2014
     —         —         —         N/A  
Fiscal 2013
     —         —         —         N/A  
SPV Credit Facility
                                   
Fiscal 2023 (through September 30, 2023)
     206,250        314        —         N/A  
Fiscal 2022
     155,200        272        —         N/A  
2022 Unsecured Notes
                                   
Fiscal 2022
     —         —         —         N/A  
Fiscal 2021
     150,000        372        —         N/A  
Fiscal 2020
     150,000        501        —         N/A  
Fiscal 2019
     150,000        638        —         N/A  
Fiscal 2018
     150,000        923        —         N/A  
Fiscal 2017
     150,000        748        —         N/A  
Fiscal 2016
     50,000        430        —         N/A  
2022 Tranche C Notes
                                   
Fiscal 2022
     —         —         —         N/A  
Fiscal 2021
     21,000        52        —         N/A  
Fiscal 2020
     21,000        70        —         N/A  
Fiscal 2019
     21,000        89        —         N/A  
Fiscal 2018
     21,000        129        —         N/A  
Fiscal 2017
     21,000        105        —         N/A  
2023 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     —         —         —         N/A  
Fiscal 2022
     75,000        131        —         N/A  
Fiscal 2021
     75,000        186        —         N/A  
Fiscal 2020
     75,000        250        —         N/A  
Fiscal 2019
     75,000        319        —         N/A  
Fiscal 2018
     75,000        461        —         N/A  
Fiscal 2017
     75,000        374        —         N/A  
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
2024 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     125,000        190        —         N/A  
Fiscal 2022
     125,000        219        —         N/A  
Fiscal 2021
     125,000        309        —         N/A  
Fiscal 2020
     125,000        417        —         N/A  
Fiscal 2019
     125,000        531        —         N/A  
2025 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     85,000        129        —         N/A  
Fiscal 2022
     85,000        149        —         N/A  
2026 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     75,000        114        —         N/A  
Fiscal 2022
     75,000        131        —         N/A  
Fiscal 2021
     75,000        186        —         N/A  
Fiscal 2020
     75,000        250        —         N/A  
Fiscal 2019
     75,000        319        —         N/A  
2027 Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     50,000        76        —         N/A  
Fiscal 2022
     50,000        88        —         N/A  
Fiscal 2021
     50,000        124        —         N/A  
2027 Series F Unsecured Notes
                                   
Fiscal 2023 (through September 30, 2023)
     135,000        206        —         N/A  
Fiscal 2022
     135,000        237        —         N/A  
2042 Unsecured Notes
                                   
Fiscal 2017
     —         —         —         N/A  
Fiscal 2016
     100,000        859        —       $ 1,002  
Fiscal 2015
     100,000        702        —         982  
Fiscal 2014
     100,000        2,294        —         943  
Fiscal 2013
     100,000        2,411        —         934  
Senior Secured Notes
                                   
Fiscal 2017
     —         —         —         N/A  
Fiscal 2016
     75,000        645        —         N/A  
Fiscal 2015
     75,000        527        —         N/A  
Fiscal 2014
     75,000        1,721        —         N/A  
Fiscal 2013
     75,000        1,808        —         N/A  
Term Loans
                                   
Fiscal 2023 (through September 30, 2023)
     100,000        152        —         N/A  
Fiscal 2022
     100,000        175        —         N/A  
Fiscal 2021
     100,000        248        —         N/A  
Fiscal 2020
     75,000        250        —         N/A  
Fiscal 2019
     75,000        319        —         N/A  
Fiscal 2018
     50,000        308        —         N/A  
Fiscal 2017
     50,000        250        —         N/A  
Fiscal 2016
     50,000        430        —         N/A  
Fiscal 2015
     50,000        351        —         N/A  
Fiscal 2014
     50,000        1,147        —         N/A  
Fiscal 2013
     50,000        1,206        —         N/A  
NEFPASS Facility
                                   
Fiscal 2021
     —         —         —         N/A  
Fiscal 2020
     30,000        100        —         N/A  
Fiscal 2019
     30,000        128        —         N/A  
Fiscal 2018
     30,000        185        —         N/A  
SSLP Facility
                                   
Fiscal 2019
     —         —         —         N/A  
Fiscal 2018
     53,785        331        —         N/A  
Total Senior Securities
                                   
Fiscal 2023 (through September 30, 2023)
   $ 1,197,750      $ 1,823        —         N/A  
Fiscal 2022
     1,093,200        1,915        —         N/A  
Fiscal 2021
     818,500        2,029        —         N/A  
Fiscal 2020
     677,000        2,259        —         N/A  
Fiscal 2019
     593,900        2,525        —         N/A  
Fiscal 2018
     476,185        2,930        —         N/A  
Fiscal 2017
     541,600        2,702        —         N/A  
Fiscal 2016
     390,200        3,354        —         N/A  
Fiscal 2015
     432,900        3,039        —         N/A  
Fiscal 2014
     225,000        5,162        —         N/A  
Fiscal 2013
     225,000        5,425        —         N/A  
 
(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2023, asset coverage was 182.3%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
                     
General Description of Registrant [Abstract]                        
Investment Objectives and Practices [Text Block]
Portfolio and Investment Activity
During the three months ended September 30, 2023, we invested approximately $187.4 million across 35 portfolio companies. This compares to investing approximately $245.4 million in 44 portfolio companies for the three months ended September 30, 2022. Investments sold, prepaid or repaid during the three months ended September 30, 2023 totaled approximately $205.6 million versus approximately $81.1 million for the three months ended September 30, 2022.
At September 30, 2023, our portfolio consisted of 154 portfolio companies and was invested 37.1% in cash flow senior secured loans, 25.2% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 22.6% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 15.1% in life science senior secured loans, in each case, measured at fair value, versus 135 portfolio companies invested 30.2% in cash flow senior secured loans, 31.9% in asset-based senior secured loans / SLR Credit, 21.6% in equipment senior secured financings / SLR Equipment / KBH, and 16.3% in life science senior secured loans, in each case, measured at fair value, at September 30, 2022.
At September 30, 2023, 78.4% or $1.68 billion of our income producing investment portfolio
*
is floating rate and 21.6% or $462.1 million is fixed rate, measured at fair value. At September 30, 2022, 79.7% or $1.71 billion of our income producing investment portfolio
*
is floating rate and 20.3% or $434.9 million is fixed rate, measured at fair value. As of September 30, 2023 and 2022, we had two and two issuers, respectively, on
non-accrual
status.
 
*
 
We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio.
                     
Risk Factors [Table Text Block]
Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on
Form 10-K, which
could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factors set forth below, there have been no material changes during the period ended September 30, 2023 to the risk factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on Form
10-K.
Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or
non-performance
by financial institutions or transactional counterparties could have a material adverse effect on us, the Investment Adviser and our portfolio companies.
Cash not held in custody accounts and held by us, our Investment Adviser and by our portfolio companies in
non-interest-bearing
and interest-bearing operating accounts could, at times, exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. If such banking institutions were to fail, we, our Investment Adviser, or our portfolio companies could lose all or a portion of those amounts held in excess of such insurance limits. In addition, actual events involving limited liquidity, defaults,
non-performance
or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems, which could adversely affect our, our Investment Adviser’s and our portfolio companies’ business, financial condition, results of operations, or prospects.
Although we and our Investment Adviser assess our and our portfolio companies’ banking and financing relationships as we believe necessary or appropriate, our and our portfolio companies’ access to funding sources and other credit arrangements in amounts adequate to finance or capitalize current and projected future business operations could be significantly impaired by factors that affect the financial institutions with which we, our Investment Adviser or our portfolio companies have arrangements directly or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we, our Investment Adviser or our portfolio companies have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally.
In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us, our Investment Adviser, or our portfolio companies to acquire financing on acceptable terms or at all.
Our stock repurchase program could affect the price of our common stock and increase volatility and may be suspended or terminated at any time, which may result in a decrease in the trading price of our common stock.
On May 9, 2023, the Board most recently extended our share repurchase program (the “Program”), under which we can repurchase up to $50 million of our outstanding common stock. Under the Program, purchases can be made at management’s discretion from time to time in open-market transactions, in accordance with all applicable securities laws and regulations, at prices below the Company’s NAV as reported in its most recently published consolidated financial statements. We have in the past, and could in the future, enter into a plan to repurchase shares of our common stock pursuant to the Program in a manner intended to comply with the requirements of Rule
10b5-1
under the Exchange Act.
The Program is discretionary and whether purchases will be made under the Program and how much will be purchased at any time is uncertain and dependent on prevailing market prices and trading volumes, all of which we cannot predict. These activities could have the effect of maintaining the market price of our common stock or retarding a decline in the market price of the common stock, and, as a result, the price of our common stock could be higher than the price that otherwise might exist in the open market. Repurchases pursuant to the Program could affect the price of our common stock and increase its volatility. The existence of the Program could also cause the price of our common stock to be higher than it would be in the absence of such a program and could potentially reduce the market liquidity for our common stock. There can be no assurance that any stock repurchases will enhance stockholder value because the market price of our common stock could decline below the levels at which we repurchased such shares. Any failure to repurchase shares after we have announced our intention to do so could negatively impact our reputation and investor confidence in us and could negatively impact our stock price. Although the Program is intended to enhance long-term stockholder value, short-term stock price fluctuations could reduce the Program’s effectiveness.
The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.
The London Interbank Offered Rate (“LIBOR”) is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies.
The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom’s Financial Conduct Authority (“FCA”), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBORs, including USD LIBOR, except in very limited circumstances.
In the United States, SOFR is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions.
As of the filing date of this Quarterly Report on Form
10-Q,
many of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on SOFR (“CME Term SOFR”) or CME Term SOFR plus a fixed spread adjustment. CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed,
one-month
and three-month CME Group traded SOFR futures contracts and, in some cases,
over-the-counter
SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Since CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used. Further, the composition and characteristics of SOFR and CME Term SOFR are not the same as those of LIBOR. Even with the application of a fixed spread adjustment, LIBOR and CME Term SOFR will not have the same composition and characteristics, and there can be no assurance that the replacement rate, as so adjusted, will be a direct substitute for LIBOR.
There can be no guarantee that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse to the interests of investors in loans referencing SOFR. If the manner in which SOFR or CME Term SOFR is calculated is changed, that change may result in a reduction of the amount of interest payable on such loans and the trading prices of the SOFR Loans. In addition, there can be no guarantee that loans referencing SOFR or CME Term SOFR will continue to reference those rates until maturity or that, in the future, our loans will reference benchmark rates other than CME Term SOFR. Should any of these events occur, our loans, and the yield generated thereby, could be affected. Specifically, the anticipated yield on our loans may not be fully realized and our loans may be subject to increased pricing volatility and market risk.
                     
NAV Per Share $ 18.06         $ 18.33 $ 18.37 $ 19.93        
Credit Facility [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 421,500 $ 115,200 $ 207,900 $ 0 $ 0 $ 293,000   $ 222,500 $ 126,000 $ 42,900 $ 96,400 $ 245,600
Senior Securities Coverage per Unit [2] $ 642 $ 990 $ 1,459 $ 0 $ 0 $ 513   $ 552 $ 421 $ 182 $ 593 $ 1,225
Preferred Stock Liquidating Preference [3] $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0 $ 0
SPV Credit Facility [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 206,250         $ 155,200            
Senior Securities Coverage per Unit [2] $ 314         $ 272            
Preferred Stock Liquidating Preference [3] $ 0         $ 0            
2022 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]   $ 50,000       $ 0   $ 150,000 $ 150,000 $ 150,000 $ 150,000 $ 150,000
Senior Securities Coverage per Unit [2]   $ 430       $ 0   $ 372 $ 501 $ 638 $ 923 $ 748
Preferred Stock Liquidating Preference [3]   $ 0       $ 0   $ 0 $ 0 $ 0 $ 0 $ 0
2022 Tranche C Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]           $ 0   $ 21,000 $ 21,000 $ 21,000 $ 21,000 $ 21,000
Senior Securities Coverage per Unit [2]           $ 0   $ 52 $ 70 $ 89 $ 129 $ 105
Preferred Stock Liquidating Preference [3]           $ 0   $ 0 $ 0 $ 0 $ 0 $ 0
2023 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 0         $ 75,000   $ 75,000 $ 75,000 $ 75,000 $ 75,000 $ 75,000
Senior Securities Coverage per Unit [2] $ 0         $ 131   $ 186 $ 250 $ 319 $ 461 $ 374
Preferred Stock Liquidating Preference [3] $ 0         $ 0   $ 0 $ 0 $ 0 $ 0 $ 0
2024 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 125,000         $ 125,000   $ 125,000 $ 125,000 $ 125,000    
Senior Securities Coverage per Unit [2] $ 190         $ 219   $ 309 $ 417 $ 531    
Preferred Stock Liquidating Preference [3] $ 0         $ 0   $ 0 $ 0 $ 0    
2025 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 85,000         $ 85,000            
Senior Securities Coverage per Unit [2] $ 129         $ 149            
Preferred Stock Liquidating Preference [3] $ 0         $ 0            
2026 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 75,000         $ 75,000   $ 75,000 $ 75,000 $ 75,000    
Senior Securities Coverage per Unit [2] $ 114         $ 131   $ 186 $ 250 $ 319    
Preferred Stock Liquidating Preference [3] $ 0         $ 0   $ 0 $ 0 $ 0    
2027 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 50,000         $ 50,000   $ 50,000        
Senior Securities Coverage per Unit [2] $ 76         $ 88   $ 124        
Preferred Stock Liquidating Preference [3] $ 0         $ 0   $ 0        
2027 Series F Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 135,000         $ 135,000            
Senior Securities Coverage per Unit [2] $ 206         $ 237            
Preferred Stock Liquidating Preference [3] $ 0         $ 0            
2042 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]   $ 100,000 $ 100,000 $ 100,000 $ 100,000             $ 0
Senior Securities Coverage per Unit [2]   $ 859 $ 702 $ 2,294 $ 2,411             $ 0
Preferred Stock Liquidating Preference [3]   0 0 0 0             $ 0
Senior Securities Average Market Value per Unit [4]   $ 1,002 $ 982 $ 943 $ 934              
Senior Secured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]   $ 75,000 $ 75,000 $ 75,000 $ 75,000             $ 0
Senior Securities Coverage per Unit [2]   $ 645 $ 527 $ 1,721 $ 1,808             $ 0
Preferred Stock Liquidating Preference [3]   $ 0 $ 0 $ 0 $ 0             $ 0
Term Loans [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 100,000 $ 50,000 $ 50,000 $ 50,000 $ 50,000 $ 100,000   $ 100,000 $ 75,000 $ 75,000 $ 50,000 $ 50,000
Senior Securities Coverage per Unit [2] $ 152 $ 430 $ 351 $ 1,147 $ 1,206 $ 175   $ 248 $ 250 $ 319 $ 308 $ 250
Preferred Stock Liquidating Preference [3] $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0 $ 0
NEFPASS Facility [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]               $ 0 $ 30,000 $ 30,000 $ 30,000  
Senior Securities Coverage per Unit [2]               $ 0 $ 100 $ 128 $ 185  
Preferred Stock Liquidating Preference [3]               $ 0 $ 0 $ 0 $ 0  
SSLP Facility [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]                   $ 0 $ 53,785  
Senior Securities Coverage per Unit [2]                   $ 0 $ 331  
Preferred Stock Liquidating Preference [3]                   $ 0 $ 0  
[1] Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
[2] The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2023, asset coverage was 182.3%.
[3] The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
[4] Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Organization
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization
Note 1. Organization
SLR Investment Corp. (the “Company”, “SLRC”, “we”, “us” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.
The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.
On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”) pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies
Note 2. Significant Accounting Policies
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.
Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form
10-Q
and Regulation
S-X,
as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2023.
 
In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included.
The significant accounting policies consistently followed by the Company are:
 
  (a)
Investment transactions are accounted for on the trade date;
 
  (b)
Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under GAAP, the Board has approved a multi-step valuation process each quarter, as described below:
 
  (1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
  (2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
  (3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
  (4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
  (5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
 
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the nine months ended September 30, 2023, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
 
  (c)
Gains or losses on investments are calculated by using the specific identification method.
 
  (d)
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other
non-recurring
fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned.
 
  (e)
The Company intends to comply with the applicable provisions of the Code pertaining to RICs to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.
 
  (f)
Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.
 
  (g)
Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.
 
  (h)
In accordance with Regulation
S-X
and ASC Topic 810—
Consolidation
, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.
 
  (i)
The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.
 
  (j)
In accordance with ASC
835-30,
the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.
 
  (k)
The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are
marked-to-market
by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.
 
  (l)
The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC
946-20-25.
 
  (m)
Investments that are expected to pay regularly scheduled interest in cash are generally placed on
non-accrual
status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.
 
  (n)
The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Agreements
9 Months Ended
Sep. 30, 2023
Agreements [Abstract]  
Agreements
Note 3. Agreements
The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the
day-to-day
operations of, and provides investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee).
Pre-incentive
fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s
pre-incentive
fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s
pre-incentive
fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s
pre-incentive
fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately
pro-rated
for any period of less than three months.
The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross
investment-by-investment
basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three and nine months ended September 30, 2023 and 2022.
For the three and nine months ended September 30, 2023, the Company recognized $8,051 and $23,635, respectively, in base management fees and $5,796 and $16,943, respectively, in performance-based incentive fees. For the three and nine months ended September 30, 2023, $175 and $410, respectively, of such performance-based incentive fees were waived. For the three and nine months ended September 30, 2022, the Company recognized $7,890 and $22,019, respectively, in base management fees and $4,965 and $9,699, respectively, in gross performance-based incentive fees. For the three and nine months ended September 30, 2022, $194 and $1,552 of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment
Adviser.     
The Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.
For the three and nine months ended September 30, 2023, the Company recognized expenses under the Administration Agreement of $1,575 and $4,563 respectively. For the three and nine months ended September 30, 2022, the Company recognized expenses under the Administration Agreement of $1,132 and $3,684 respectively. No managerial assistance fees were accrued or collected for the three and nine months ended September 30, 2023 and 2022.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Net Asset Value Per Share
9 Months Ended
Sep. 30, 2023
Net Asset Value Per Share [Abstract]  
Net Asset Value Per Share
Note 4. Net Asset Value Per Share
At September 30, 2023, the Company’s total net assets and net asset value per share were $985,385 and $18.06, respectively. This compares to total net assets and net asset value per share at December 31, 2022 of $999,731 and $18.33, respectively.
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Earnings Per Share
Note 5. Earnings Per Share
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the three and nine months ended September 30, 2023 and 2022:
 
    
Three months ended September 30,
    
Nine months ended September 30,
 
    
2023
    
2022
    
2023
    
2022
 
Earnings (loss) per share (basic & diluted)
                                   
Numerator—net increase (decrease) in net assets resulting from operations:
   $ 26,947      $ 13,528      $ 52,766      $ (655
Denominator – weighted average shares:
     54,554,634        54,772,651        54,554,639        50,647,874  
Earnings (loss) per share:
   $ 0.49      $ 0.25      $ 0.97      ($ 0.01
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value
Note 6. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level
 1.
 Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
Level
 2.
 Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:
 
  a)
Quoted prices for similar assets or liabilities in active markets;
 
  b)
Quoted prices for identical or similar assets or liabilities in
non-active
markets;
 
  c)
Pricing models whose inputs are observable for substantially the full term of the asset or liability; and
 
  d)
Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.
Level
 3.
Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.
When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).
Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.
 
The following tables present the balances of assets measured at fair value on a recurring basis, as of September 30, 2023 and December 31, 2022:
Fair Value Measurements
As of September 30, 2023
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
                                            
Senior Secured Loans
   $ —       $ —       $ 1,300,366      $ —       $ 1,300,366  
Equipment Financing
     —         —         265,306        —         265,306  
Preferred Equity
     —         —         3,801        —         3,801  
Common Equity/Equity Interests/Warrants
     315        —         571,991        29,277        601,583  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 315      $ —       $ 2,141,464      $ 29,277      $ 2,171,056  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value Measurements
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
                                            
Senior Secured Loans
   $ —       $ —       $ 1,245,414      $ —       $ 1,245,414  
Equipment Financing
     —         —         265,952        —         265,952  
Preferred Equity
     —         —         3,801        —         3,801  
Common Equity/Equity Interests/Warrants
     483        —         561,600        9,426        571,509  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 483      $ —       $ 2,076,767      $ 9,426      $ 2,086,676  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
In accordance with ASC
820-10,
certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
 
The following tables provide a summary of the changes in fair value of Level 3 assets for the three and nine months ended September 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at September 30, 2023:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
    
Equipment

Financing
    
Preferred Equity
    
Common Equity/
Equity
Interests/
Warrants
    
Total
 
Fair value, June
 30, 2023
   $ 1,318,512      $ 271,333      $ 3,801      $ 566,427      $ 2,160,073  
Total gains or losses included in earnings:
                                            
Net realized loss
     (29,555      —         —         —         (29,555
Net change in unrealized gain (loss)
     41,505        190        (64      (7,280      34,351  
Purchase of investment securities
*
     168,421        4,190        64        12,895        185,570  
Proceeds from dispositions of investment securities
     (198,517      (10,407      —         (51      (208,975
Transfers in/out of Level 3
     —         —         —         —         —   
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair value, September
 30, 2023
   $ 1,300,366      $ 265,306      $ 3,801      $ 571,991      $ 2,141,464  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                            
Net change in unrealized gain (loss)
   $ 9,782      $ 190      $ (64)      $ (7,251    $ 2,657  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
Senior Secured
Loans
    
Equipment

Financing
    
Preferred Equity
    
Common Equity/
Equity
Interests/
Warrants
    
Total
 
Fair value, December
 31, 2022
   $ 1,245,414      $ 265,952      $ 3,801      $ 561,600      $ 2,076,767  
Total gains or losses included in earnings:
                                            
Net realized loss
     (28,398      —         —         —         (28,398
Net change in unrealized gain (loss)
     35,682        111        (187      (21,639      13,967  
Purchase of investment securities
*
     488,757        34,274        187        32,081        555,299  
Proceeds from dispositions of investment securities
     (441,089      (35,031      —         (51      (476,171
Transfers in/out of Level 3
     —         —         —         —         —   
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair value, September
 30, 2023
   $ 1,300,366      $ 265,306      $ 3,801      $ 571,991      $ 2,141,464  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                            
Net change in unrealized gain (loss)
   $ 29,925      $ 111      $ (187    $ (21,639    $ 8,210  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
Includes PIK capitalization and accretion of discount
While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at September 30, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $521,500, $206,250, $120,313, $80,750, $68,438, $43,375 and $119,138, respectively.
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
    
Equipment

Financing
    
Preferred Equity
    
Common Equity/
Equity
Interests/
Warrants
    
Total
 
Fair value, December
 31, 2021
   $ 939,690      $ 273,795      $ 5,630      $ 450,381      $ 1,669,496  
Total gains or losses included in earnings:
                                            
Net realized gain (loss)
     (36,244      —         —         6        (36,238
Net change in unrealized loss
     (8,065      (6,924      (706      (5,048      (20,743
Purchase of investment securities(1)
     796,389        84,168        266        116,272        997,095  
Proceeds from dispositions of investment securities
     (446,356      (85,087      (1,389      (11      (532,843
Transfers in/out of Level 3
     —         —         —         —         —   
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair value, December
 31, 2022
   $ 1,245,414      $ 265,952      $ 3,801      $ 561,600      $ 2,076,767  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                            
Net change in unrealized loss
   $ (8,920    $ (6,924    $ (706    $ (5,048    $ (21,598
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Mergers.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —   
Net change in unrealized (gain) loss
     —   
Borrowings
     —   
Repayments
     (150,000
Transfers in/out of Level 3
     —   
    
 
 
 
Ending fair value
   $ —   
    
 
 
 
The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively.
 
Quantitative Information about Level 3 Fair Value Measurements
The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.
Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of September 30, 2023 is summarized in the table below:
 
    
Asset or
Liability
    
Fair Value at
September 30, 2023
    
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
     Asset      $
$
1,292,834
7,532
 
 
   Income Approach
Recovery Analysis
  Market Yield
Recoverable Amount
  
10.1% -20.5% (12.8%)
N/A
Equipment Financing
     Asset      $
$
144,486
120,820
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
8.5% -9.5% (9.5%)
1.1x-1.4x (1.2x)
Preferred Equity
     Asset      $ 3,801      Income Approach   Market Yield   
5.0% -5.0% (5.0%)
Common Equity/Equity Interests/Warrants
     Asset      $
$
165,771
406,220
 
 
   Market Multiple
(2)
Market Approach
  Comparable Multiple
Return on Equity
  
6.3x -11.5x (8.8x)
5.5% -30.7% (10.7%)
 
(1)
Includes $120,820 of investments valued using an implied multiple.
(2)
Includes $855 of investments valued using a Black-Scholes model and $164,916 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below:
 
    
Asset or
Liability
    
Fair Value at
December 31, 2022
    
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
     Asset      $
$
1,212,842
32,572
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
9.4% -18.2% (12.0%)
0.1x-21.4x (12.4x)
Equipment Financing
     Asset      $
$
145,132
120,820
 
 
   I
ncome Approach
Market Multiple
(2)
  Market Yield
Comparable Multiple
  
8.5% -9.7% (9.7%)
1.1x-1.4x (1.2x)
Preferred Equity
     Asset      $ 3,801      I
ncome Approach
  Market Yield   
5.0% -5.0% (5.0%)
Common Equity/Equity Interests/Warrants
     Asset      $
$
149,120
412,480
 
 
   Market Multiple
(3)
Market Approach
  Comparable Multiple
Return on Equity
   7.8x –9.8x (8.8x)
6.6% -35.2% (9.2%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using an implied multiple.
(3)
Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple.
Significan
t increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving
bid-ask
spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Debt
9 Months Ended
Sep. 30, 2023
Debt Instruments [Abstract]  
Debt
Note 7. Debt
Our debt obligations consisted of the following as of September 30, 2023 and December 31, 2022:
 
    
September 30, 2023
   
December 31, 2022
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 521,500      $ 517,582
(1)
 
  $ 393,000      $ 388,254
(1)
 
SPV Credit Facility
     206,250        205,263
(2)
 
    155,200        154,302
(2)
 
2023 Unsecured Notes
     —         —        75,000        74,979
(3)
 
2024 Unsecured Notes
     125,000        124,637
(4)
 
    125,000        124,421
(4)
 
2025 Unsecured Notes
     85,000        84,738
(5)
 
    85,000        84,613
(5)
 
2026 Unsecured Notes
     75,000        74,586
(6)
 
    75,000        74,498
(6)
 
2027 Unsecured Notes
     50,000        49,963
(7)
 
    50,000        49,953
(7)
 
2027 Series F Unsecured Notes
     135,000        134,985
(8)
 
    135,000        134,978
(8)
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 1,197,750      $ 1,191,754     $ 1,093,200      $ 1,085,998  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $3,918 and $4,746 as of September 30, 2023 and December 31, 2022, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $987 and $898 as of September 30, 2023 and December 31, 2022, respectively.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $363 and $579 as of September 30, 2023 and December 31, 2022, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized market discount of $262 and $387 as of September 30, 2023 and December 31, 2022, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $414 and $502 as of September 30, 2023 and December 31, 2022, respectively.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $37 and $47 as of September 30, 2023 and December 31, 2022, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $15 and $22 as of September 30, 2023 and December 31, 2022, respectively.
Unsecured Notes
On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
 
On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full on the maturity date, January 20, 2023
.     
Revolving and Term Loan Facilities
On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, subsequent to an August 29, 2023 amendment, the commitment under the SPV Credit Facility is $275,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is SOFR plus
2.00%-2.50%
with no SOFR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2023, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $206,250.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment, a
$25,000 
November 2022 upsizing and 
a $40,000
August 2023 commitment expiration, the Credit Facility is composed of $585,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At September 30, 2023, outstanding USD equivalent borrowings under the Credit Facility totaled $521,500, composed of $421,500 of revolving credit and $100,000 of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.
The average annualized interest cost for all borrowings for the nine months ended September 30, 2023 and the year ended December 31, 2022 was 5.79% and 4.09%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the nine months ended September 30, 2023 and the year ended December 31, 2022 were $1,273,200 and $1,164,200, respectively.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Highlights
9 Months Ended
Sep. 30, 2023
Investment Company, Financial Highlights [Abstract]  
Financial Highlights
Note 8. Financial Highlights
The following is a schedule of financial highlights for the nine months ended September 30, 2023 and 2022:
 
    
Nine months ended
September 30, 2023
   
Nine months ended
September 30, 2022
 
Per Share Data: (a)
                
Net asset value, beginning of year
   $ 18.33     $ 19.93  
    
 
 
   
 
 
 
Net investment income
     1.25       1.06  
Net realized and unrealized loss
     (0.29     (1.08 )* 
    
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     0.96       (0.02
Issuance of common stock in connection with the Mergers
     —        (0.31
Distributions to stockholders:
                
From distributable earnings
     (1.23     (1.06
From return of capital
     —        (0.17
    
 
 
   
 
 
 
Net asset value, end of period
   $ 18.06     $ 18.37  
    
 
 
   
 
 
 
Per share market value, end of period
   $ 15.39     $ 12.32  
Total Return (b)(c)
     20.07     (27.75 %) 
Net assets, end of period
   $ 985,385     $ 1,006,225  
Shares outstanding, end of period
     54,554,634       54,772,651  
Ratios to average net assets (c):
                
Net investment income
     6.90     5.51
    
 
 
   
 
 
 
Operating expenses
     4.89 %**      3.90 %** 
Interest and other credit facility expenses
     5.37     3.22
    
 
 
   
 
 
 
Total expenses
     10.26 %**      7.12 %** 
    
 
 
   
 
 
 
Average debt outstanding
   $ 1,161,095     $ 951,995  
Portfolio turnover ratio
     22.1     13.8
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period.
(b)
Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2022 and December 31, 2021 was $13.91 and $18.43, respectively. Total return does not include a sales load.
(c)
Not annualized for periods less than one year.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the nine months ended September 30, 2023, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.93% and 10.30%, respectively, without the performance-based incentive fee waiver. For the nine months ended September 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.06% and 7.28%, respectively, without the performance-based incentive fee waiver.
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Credit Solutions
9 Months Ended
Sep. 30, 2023
Line of Credit Facility [Abstract]  
SLR Credit Solutions
Note 9. SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of September 30, 2023, total commitments to the revolving credit facility are $300,000.
As of September 30, 2023 SLR Credit had 32 funded commitments to 28 different issuers with total funded loans of approximately $469,495 on total assets of $506,081. As of December 31, 2022 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439,484 on total assets of $460,683. As of September 30, 2023 and December 31, 2022, the largest loan outstanding totaled $40,725 and $33,420, respectively. For the same periods, the average exposure per issuer was $16,768 and $17,579, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $284,472 and $224,325 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Credit had net income of $4,315 and $3,897, respectively, on gross income of $13,897 and $8,596, respectively. For the nine months ended September 30, 2023 and 2022, SLR Credit had net income of $1,411 and $8,557, respectively, on gross income of $42,350 and $22,171, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Equipment Finance
9 Months Ended
Sep. 30, 2023
Schedule of Equity Method Investments [Line Items]  
SLR Equipment Finance
Note 11. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of September 30, 2023 and December 31, 2022, KBHT had total assets of $783,089 and $777,151, respectively. For the same periods, debt recourse to KBHT totaled $239,505 and $222,094, respectively, and
non-recourse
debt totaled $353,415 and $353,128, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2023 and 2022, KBHT had net income of $2,129 and $3,327, respectively, on gross income of $85,544 and $71,332, respectively. For the nine months ended September 30, 2023 and 2022, KBHT had net income of $7,151 and $10,393, respectively, on gross income of $229,051 and $215,074, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
SLR Equipment Finance [Member]  
Schedule of Equity Method Investments [Line Items]  
SLR Equipment Finance
 
Note 10. SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000
non-recourse
facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023. In June 2023, the facility was amended to extend the maturity date to January 31, 2024, with updated commitments totaling $152,147, effective August 1, 2023.
As of September 30, 2023, SLR Equipment had 141 funded equipment-backed leases and loans to 56 different customers with a total net investment in leases and loans of approximately $199,831 on total assets of $251,031. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190,830 on total assets of $241,813. As of September 30, 2023 and December 31, 2022, the largest position outstanding totaled $18,319 and $19,259, respectively. For the same periods, the average exposure per customer was $3,568 and $3,234, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $130,557 and $114,977 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and September 30, 2022, SLR Equipment had net income (loss) of ($1,176) and $1,034, respectively, on gross income of $4,783 and $6,486, respectively. For the nine months ended September 30, 2023 and September 30, 2022, SLR Equipment had net loss of $2,193 and $125, respectively, on gross income of $15,174 and $15,704, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Kingsbridge Holdings, LLC
9 Months Ended
Sep. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Kingsbridge Holdings, LLC
Note 11. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of September 30, 2023 and December 31, 2022, KBHT had total assets of $783,089 and $777,151, respectively. For the same periods, debt recourse to KBHT totaled $239,505 and $222,094, respectively, and
non-recourse
debt totaled $353,415 and $353,128, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2023 and 2022, KBHT had net income of $2,129 and $3,327, respectively, on gross income of $85,544 and $71,332, respectively. For the nine months ended September 30, 2023 and 2022, KBHT had net income of $7,151 and $10,393, respectively, on gross income of $229,051 and $215,074, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Healthcare ABL
9 Months Ended
Sep. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
SLR Healthcare ABL
Note 12. SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of September 30, 2023, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022. Effective with an amendment dated August 24, 2023, SLR Healthcare has a $150,000
non-recourse
credit facility, which is expandable to $200,000 under its accordion facility. The maturity date of this facility is March 31, 2026.
 
 
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2023, the portfolio totaled approximately $237,000 of commitments with a total net investment in loans of $106,484 on total assets of $113,832. As of December 31, 2022, the portfolio totaled approximately $242,106 of commitments with a total net investment in loans of $92,383 on total assets of $108,705. At September 30, 2023, the portfolio consisted of 38 issuers with an average balance of approximately $2,802 versus 41 issuers with an average balance of approximately $2,253 at December 31, 2022. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $81,000 and $77,000 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Healthcare had net income of $1,532 and $822, respectively, on gross income of $4,833 and $3,020, respectively. For the nine months ended September 30, 2023 and 2022, SLR Healthcare had net income of $3,925 and $2,543, respectively, on gross income of $13,109 and $7,898, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Business Credit
9 Months Ended
Sep. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
SLR Business Credit
Note 13. SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2023, the portfolio totaled approximately $612,399 of commitments, of which $257,818 were funded, on total assets of $302,912. As of December 31, 2022, the portfolio totaled approximately $603,432 of commitments, of which $286,006 were funded, on total assets of $332,247. At September 30, 2023, the portfolio consisted of 98 issuers with an average balance of approximately $2,631 versus 108 issuers with an average balance of approximately $2,648 at December 31, 2022. NMC has a senior credit facility with a bank lending group for $285,307 which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had approximately $199,449 and $214,425 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Business Credit had net income of $1,779 and $1,977 respectively, on gross income of $9,709 and $7,607, respectively. For the nine months ended September 30, 2023 and 2022, SLR Business Credit had net income of $5,211 and $5,703 respectively, on gross income of $27,868 and $20,378, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 14. Commitments and Contingencies
Off-Balance
Sheet Arrangements
The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of September 30, 2023 and December 31, 2022 is $367,295 and $364,163, respectively, comprised of the following:
 
    
September 30,
2023
    
December 31,
2022
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Outset Medical, Inc.
     35,084        35,084  
Apeel Technology, Inc.
     32,786        32,786  
Southern Orthodontic Partners Management, LLC
     21,931        1,918  
SLR Senior Lending Program LLC*
     21,250        40,500  
Orthopedic Care Partners Management, LLC
     20,770        1,620  
Human Interest, Inc.
     20,104        20,104  
CVAUSA Management, LLC
     18,239        —   
BDG Media, Inc.
     12,646        3,546  
Neuronetics, Inc.
     11,579        —   
ONS MSO, LLC
     10,961        —   
iCIMS, Inc.
     10,506        11,435  
Cerapedics, Inc.
     9,217        6,735  
Alkeme Intermediate Holdings, LLC
     8,531        —   
Arcutis Biotherapeutics, Inc.
     8,356        8,356  
Ardelyx, Inc.
     7,752        7,752  
West-NR
Parent, Inc.
     6,830        —   
United Digestive MSO Parent, LLC
     5,259        —   
Peter C. Foy & Associates Insurance Services, LLC
     5,062        1,094  
Luxury Asset Capital, LLC
     4,500        7,500  
UVP Management, LLC
     4,386        —   
Kaseya, Inc.
     3,769        3,936  
Urology Management Holdings, Inc.
     3,596        —   
The Townsend Company, LLC
     3,556        —   
SLR Equipment Finance
     3,500        1,000  
Vertos Medical, Inc.
     3,325        —   
Foundation Consumer Brands, LLC
     3,009        3,009  
Kid Distro Holdings, LLC
     2,650        2,650  
Maurices, Incorporated
     2,589        4,314  
Erie Construction
Mid-west,
LLC
     2,403        1,248  
Ultimate Baked Goods Midco LLC
     2,371        1,636  
Basic Fun, Inc.
     2,150        2,675  
Bayside Opco, LLC
     1,721         
SunMed Group Holdings, LLC
     1,621        843  
SCP Eye Care, LLC
     1,459        2,771  
SLR Healthcare ABL*
     1,400        1,400  
RxSense Holdings LLC
     1,250        1,250  
Enverus Holdings, Inc.
     1,239        1,004  
Tilley Distribution, Inc.
     1,158        525  
GSM Acquisition Corp.
     862        784  
Composite Technology Acquisition Corp
     796        1,537  
High Street Buyer, Inc.
     631        327  
CC SAG Holdings Corp. (Spectrum Automotive)
     548        20,670  
ENS Holdings III Corp, LLC
     461        144  
Pinnacle Treatment Centers, Inc.
     386        1,745  
Vessco Midco Holdings, LLC
     327        3,892  
TAUC Management, LLC
     294        294  
All States Ag Parts, LLC
     212        135  
Glooko, Inc.
     —         17,868  
World Insurance Associates, LLC
     —         17,117  
Spectrum Pharmaceuticals, Inc.
     —         8,771  
Atria Wealth Solutions, Inc.
     —         8,215  
Accession Risk Management Group, Inc.
     —         7,498  
Copper River Seafoods, Inc.
     —         3,595  
Meditrina, Inc.
     —         3,367  
One Touch Direct, LLC
     —         3,069  
DeepIntent, Inc.
     —         3,049  
Plastics Management, LLC
     —         2,424  
Pediatric Home Respiratory Services, LLC
     —         1,805  
Ivy Fertility Services, LLC
     —         1,571  
NAC Holdings Corporation
     —         1,479  
SPAR Marketing Force, Inc.
     —         1,338  
Montefiore Nyack Hospital
     —         1,034  
American Teleconferencing Services, Ltd
     —         1,090  
BayMark Health Services, Inc.
     —         391  
    
 
 
    
 
 
 
Total Commitments
   $ 367,295      $ 364,163  
    
 
 
    
 
 
 
 
*
The Company controls the funding of these commitments and may cancel them at its discretion.
 
The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the respective portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of September 30, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Capital Share Transactions
9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Capital Share Transactions
Note 15. Capital Share Transactions
As of September 30, 2023 and September 30, 2022, 200,000,000 shares of $0.01 par value capital stock were authorized.
Transactions in capital stock were as follows:
 
    
Shares
    
Amount
 
    
Three months ended
September 30, 2023
    
Three months ended
September 30, 2022
    
Three months ended
September 30, 2023
    
Three months ended
September 30, 2022
 
Shares issued in connection with the Mergers
     —         —       $ —       $ —   
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     —         —       $ —       $ —   
    
 
 
    
 
 
    
 
 
    
 
 
 
     
    
Shares
    
Amount
 
    
Nine months ended
September 30, 2023
    
Nine months ended
September 30, 2022
    
Nine months ended
September 30, 2023
    
Nine months ended
September 30, 2022
 
Shares issued in connection with the Mergers
     —         12,511,825      $ —       $ 226,839  
Shares repurchased
     (746      —       $ (10    $ —   
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     (746      12,511,825      $ (10    $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Repurchase Program
9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Stock Repurchase Program
Note 16. Stock Repurchase Program
On May 9, 2023, our Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 10, 2024 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. For the nine months ended September 30, 2023, the Company repurchased 746 shares at an average price of approximately $14.02 per share, inclusive of commissions. The total dollar amount of shares repurchased for the nine months ended September 30, 2023 was $10. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2022 was $3,038.
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Senior Lending Program LLC
9 Months Ended
Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
SLR Senior Lending Program LLC
Note 17. SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2023, there were $79,200 of borrowings outstanding on the SSLP Facility.
As of September 30, 2023, the Company and the Investor had contributed combined equity capital in the amount of $57,500. As of September 30, 2023, the Company and the Investors’ remaining commitments to SSLP totaled $21,250 and $21,250, respectively. The Company, along with the Investor, controls the funding of SSLP and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor.
As of September 30, 2023 and December 31, 2022, SSLP had total assets of $137,447 and $19,105, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 27 and 7 different borrowers, respectively. For the three months ended September 30, 2023, SSLP invested $57,456 in 16 portfolio companies. Investments prepaid totaled $1,658 for the three months ended September 30, 2023. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in 7 portfolio companies. Investments prepaid totaled $68 for the period December 1, 2022 (commencement of operations) through December 31, 2022.
 
SSLP Portfolio as of September 30, 2023
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Accession Risk Management Group, Inc.
(4)
   Insurance      S+550        0.75     11.02     11/1/26      $ 9,078      $ 9,078      $ 9,078  
Aegis Toxicology Sciences Corporation
(4)
   Health Care Providers & Services      S+550        1.00     11.13     5/9/25        2,960        2,960        2,960  
Alkeme Intermediary Holdings, LLC
(4)
   Insurance      S+650        1.00     11.92     10/28/26        3,021        2,931        2,930  
All States Ag Parts, LLC
(4)
   Trading Companies & Distributors      S+600        1.00     11.60     9/1/26        2,138        2,138        2,138  
Atria Wealth Solutions, Inc.
(4)
   Diversified Financial Services      S+650        1.00     12.15     2/29/24        2,475        2,475        2,475  
BayMark Health Services, Inc.
(4)
   Health Care Providers & Services      S+500        1.00     10.65     6/11/27        4,043        4,043        4,043  
CC SAG Holdings Corp.
(4)
   Diversified Consumer Services      S+575        0.75     11.18     6/29/28        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
   Trading Companies & Distributors      S+475        1.00     10.24     12/31/25        1,089        1,089        1,089  
Fertility (ITC) Investment Holdco, LLC
(4)
   Health Care Providers & Services      S+650        1.00     11.63     1/3/29        5,970        5,799        5,970  
Foundation Consumer Brands, LLC
(4)
   Personal Products      S+625        1.00     11.77     2/12/27        8,911        8,911        8,911  
High Street Buyer, Inc.
(4)
   Insurance      S+600        0.75     11.54     4/16/28        4,433        4,433        4,433  
iCIMS, Inc.
(4)
   Software      S+725        0.75     12.14     8/18/28        3,059        3,028        3,059  
Kaseya, Inc.
(4)
   Software      S+625        0.75     11.58     6/23/29        9,000        9,000        9,000  
Kid Distro Holdings, LLC
(4)
   Software      S+550        1.00     11.04     10/1/27        8,962        8,962        8,962  
ONS MSO, LLC
(4)
   Health Care Providers & Services      S+625        1.00     11.62     7/8/25        5,936        5,779        5,936  
PhyNet Dermatology LLC
(4)
   Health Care Providers & Services      S+625        1.00     11.45     8/16/24        5,964        5,964        5,964  
Pinnacle Treatment Centers, Inc.
(4)
   Health Care Providers & Services      S+675        1.00     12.10     1/2/26        4,725        4,725        4,725  
Plastics Management, LLC
(4)
   Health Care Providers & Services      S+500        1.00     10.44     8/18/27        5,651        5,476        5,651  
RQM+ Corp.
(4)
   Life Sciences Tools & Services      S+575        1.00     11.40     8/12/26        5,970        5,970        5,970  
RxSense Holdings LLC
(4)
   Diversified Consumer Services      S+500        1.00     10.47     3/13/26        2,977        2,977        2,977  
SunMed Group Holdings, LLC
(4)
   Health Care Equipment & Supplies      S+550        0.75     10.99     6/16/28        8,971        8,971        8,971  
The Townsend Company, LLC
(4)
   Commercial Services & Supplies      S+625        1.00     11.57     8/15/29        3,570        3,482        3,481  
Tilley Distribution, Inc.
(4)
   Trading Companies & Distributors      S+600        1.00     11.54     12/31/26        5,963        5,963        5,963  
Ultimate Baked Goods Midco LLC
(4)
   Packaged Foods & Meats      S+625        1.00     11.67     8/13/27        8,977        8,977        8,977  
Urology Management Holdings, Inc.
(4)
   Health Care Providers & Services      S+625        1.00     11.79     6/15/26        2,465        2,403        2,440  
Vessco Midco Holdings, LLC
(4)
   Water Utilities      S+450        1.00     9.92     11/2/26        1,845        1,845        1,845  
West-NR
Parent, Inc.
(4)
   Insurance      S+625        1.00     11.72     12/27/27        2,674        2,622        2,621  
                                                    
 
 
    
 
 
 
                                                     $ 132,993      $ 133,561  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of September 30, 2023.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
 
SSLP Portfolio as of December 31, 2022
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
   Diversified Financial Services      S+600        1.00     10.84     2/29/24      $ 2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
   Health Care Providers & Services      L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
   Trading Companies & Distributors      L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
   Personal Products      L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
   Insurance      L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
   Health Care Providers & Services      L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
   Software      L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                                                    
 
 
    
 
 
 
                                                     $ 18,032      $ 18,062  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Below is certain summarized financial information for SSLP as of September 30, 2023 and December 31, 2022 and for the three and nine months ended September 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
    
September 30,
2023
    
December 31,
2022
 
Selected Balance Sheet Information for SSLP:
                 
Investments at fair value (cost $132,993 and $18,032, respectively)
   $ 133,561      $ 18,062  
Cash and other assets
     3,886        1,043  
    
 
 
    
 
 
 
Total assets
   $ 137,447      $ 19,105  
    
 
 
    
 
 
 
Debt outstanding
   $ 77,826      $ —   
Distributions payable
     500        —   
Interest payable and other credit facility related expenses
     358        165  
Accrued expenses and other payables
     209        89  
    
 
 
    
 
 
 
Total liabilities
   $ 78,893      $ 254  
    
 
 
    
 
 
 
Members’ equity
   $ 58,554      $ 18,851  
    
 
 
    
 
 
 
Total liabilities and members’ equity
   $ 137,447      $ 19,105  
    
 
 
    
 
 
 
 
    
For the three
months ended
September 30,
2023
    
For the nine
months ended
September 30,
2023
    
For the period
December 1, 2022
(commencement
of operations) to
December 31,
2022
 
Selected Income Statement Information for SSLP:
        
Interest income
   $ 2,757      $ 5,371      $ 152  
  
 
 
    
 
 
    
 
 
 
Service fees*
     66        123      $ 4  
Interest and other credit facility expenses
     1,773        4,025        166  
Organizational costs
     —         —         73  
Other general and administrative expenses
     32        89        88  
  
 
 
    
 
 
    
 
 
 
Total expenses
     1,871        4,237        331  
  
 
 
    
 
 
    
 
 
 
Net investment income (loss)
   $ 886      $ 1,134      $ (179
  
 
 
    
 
 
    
 
 
 
Realized gain on investments
     —         30        —   
Net change in unrealized gain on investments
     177        538        30  
  
 
 
    
 
 
    
 
 
 
Net realized and unrealized gain on investments
   $ 177      $ 568        30  
  
 
 
    
 
 
    
 
 
 
Net income (loss)
   $ 1,063      $ 1,702      $ (149
  
 
 
    
 
 
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events
Note 18. Subsequent Events
The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.
On November 7, 2023, the Board declared a quarterly distribution of $0.41 per share payable on December 28, 2023 to holders of record as of December 14, 2023.
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Summary of Computation of Basic And Diluted Net
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the three and nine months ended September 30, 2023 and 2022:
 
    
Three months ended September 30,
    
Nine months ended September 30,
 
    
2023
    
2022
    
2023
    
2022
 
Earnings (loss) per share (basic & diluted)
                                   
Numerator—net increase (decrease) in net assets resulting from operations:
   $ 26,947      $ 13,528      $ 52,766      $ (655
Denominator – weighted average shares:
     54,554,634        54,772,651        54,554,639        50,647,874  
Earnings (loss) per share:
   $ 0.49      $ 0.25      $ 0.97      ($ 0.01
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis
 
The following tables present the balances of assets measured at fair value on a recurring basis, as of September 30, 2023 and December 31, 2022:
Fair Value Measurements
As of September 30, 2023
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
                                            
Senior Secured Loans
   $ —       $ —       $ 1,300,366      $ —       $ 1,300,366  
Equipment Financing
     —         —         265,306        —         265,306  
Preferred Equity
     —         —         3,801        —         3,801  
Common Equity/Equity Interests/Warrants
     315        —         571,991        29,277        601,583  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 315      $ —       $ 2,141,464      $ 29,277      $ 2,171,056  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value Measurements
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
                                            
Senior Secured Loans
   $ —       $ —       $ 1,245,414      $ —       $ 1,245,414  
Equipment Financing
     —         —         265,952        —         265,952  
Preferred Equity
     —         —         3,801        —         3,801  
Common Equity/Equity Interests/Warrants
     483        —         561,600        9,426        571,509  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 483      $ —       $ 2,076,767      $ 9,426      $ 2,086,676  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
In accordance with ASC
820-10,
certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
Summary of Changes in Fair Value of Level 3 Assets and Liabilities
The following tables provide a summary of the changes in fair value of Level 3 assets for the three and nine months ended September 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at September 30, 2023:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
    
Equipment

Financing
    
Preferred Equity
    
Common Equity/
Equity
Interests/
Warrants
    
Total
 
Fair value, June
 30, 2023
   $ 1,318,512      $ 271,333      $ 3,801      $ 566,427      $ 2,160,073  
Total gains or losses included in earnings:
                                            
Net realized loss
     (29,555      —         —         —         (29,555
Net change in unrealized gain (loss)
     41,505        190        (64      (7,280      34,351  
Purchase of investment securities
*
     168,421        4,190        64        12,895        185,570  
Proceeds from dispositions of investment securities
     (198,517      (10,407      —         (51      (208,975
Transfers in/out of Level 3
     —         —         —         —         —   
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair value, September
 30, 2023
   $ 1,300,366      $ 265,306      $ 3,801      $ 571,991      $ 2,141,464  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                            
Net change in unrealized gain (loss)
   $ 9,782      $ 190      $ (64)      $ (7,251    $ 2,657  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
Senior Secured
Loans
    
Equipment

Financing
    
Preferred Equity
    
Common Equity/
Equity
Interests/
Warrants
    
Total
 
Fair value, December
 31, 2022
   $ 1,245,414      $ 265,952      $ 3,801      $ 561,600      $ 2,076,767  
Total gains or losses included in earnings:
                                            
Net realized loss
     (28,398      —         —         —         (28,398
Net change in unrealized gain (loss)
     35,682        111        (187      (21,639      13,967  
Purchase of investment securities
*
     488,757        34,274        187        32,081        555,299  
Proceeds from dispositions of investment securities
     (441,089      (35,031      —         (51      (476,171
Transfers in/out of Level 3
     —         —         —         —         —   
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair value, September
 30, 2023
   $ 1,300,366      $ 265,306      $ 3,801      $ 571,991      $ 2,141,464  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                            
Net change in unrealized gain (loss)
   $ 29,925      $ 111      $ (187    $ (21,639    $ 8,210  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
Includes PIK capitalization and accretion of discount
While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at September 30, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $521,500, $206,250, $120,313, $80,750, $68,438, $43,375 and $119,138, respectively.
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
    
Equipment

Financing
    
Preferred Equity
    
Common Equity/
Equity
Interests/
Warrants
    
Total
 
Fair value, December
 31, 2021
   $ 939,690      $ 273,795      $ 5,630      $ 450,381      $ 1,669,496  
Total gains or losses included in earnings:
                                            
Net realized gain (loss)
     (36,244      —         —         6        (36,238
Net change in unrealized loss
     (8,065      (6,924      (706      (5,048      (20,743
Purchase of investment securities(1)
     796,389        84,168        266        116,272        997,095  
Proceeds from dispositions of investment securities
     (446,356      (85,087      (1,389      (11      (532,843
Transfers in/out of Level 3
     —         —         —         —         —   
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair value, December
 31, 2022
   $ 1,245,414      $ 265,952      $ 3,801      $ 561,600      $ 2,076,767  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                            
Net change in unrealized loss
   $ (8,920    $ (6,924    $ (706    $ (5,048    $ (21,598
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Mergers.
Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3)
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —   
Net change in unrealized (gain) loss
     —   
Borrowings
     —   
Repayments
     (150,000
Transfers in/out of Level 3
     —   
    
 
 
 
Ending fair value
   $ —   
    
 
 
 
Summary of Quantitative Information about the Company's Level 3 Asset and Liability
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of September 30, 2023 is summarized in the table below:
 
    
Asset or
Liability
    
Fair Value at
September 30, 2023
    
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
     Asset      $
$
1,292,834
7,532
 
 
   Income Approach
Recovery Analysis
  Market Yield
Recoverable Amount
  
10.1% -20.5% (12.8%)
N/A
Equipment Financing
     Asset      $
$
144,486
120,820
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
8.5% -9.5% (9.5%)
1.1x-1.4x (1.2x)
Preferred Equity
     Asset      $ 3,801      Income Approach   Market Yield   
5.0% -5.0% (5.0%)
Common Equity/Equity Interests/Warrants
     Asset      $
$
165,771
406,220
 
 
   Market Multiple
(2)
Market Approach
  Comparable Multiple
Return on Equity
  
6.3x -11.5x (8.8x)
5.5% -30.7% (10.7%)
 
(1)
Includes $120,820 of investments valued using an implied multiple.
(2)
Includes $855 of investments valued using a Black-Scholes model and $164,916 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below:
 
    
Asset or
Liability
    
Fair Value at
December 31, 2022
    
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
     Asset      $
$
1,212,842
32,572
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
9.4% -18.2% (12.0%)
0.1x-21.4x (12.4x)
Equipment Financing
     Asset      $
$
145,132
120,820
 
 
   I
ncome Approach
Market Multiple
(2)
  Market Yield
Comparable Multiple
  
8.5% -9.7% (9.7%)
1.1x-1.4x (1.2x)
Preferred Equity
     Asset      $ 3,801      I
ncome Approach
  Market Yield   
5.0% -5.0% (5.0%)
Common Equity/Equity Interests/Warrants
     Asset      $
$
149,120
412,480
 
 
   Market Multiple
(3)
Market Approach
  Comparable Multiple
Return on Equity
   7.8x –9.8x (8.8x)
6.6% -35.2% (9.2%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using an implied multiple.
(3)
Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple.
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Debt (Tables)
9 Months Ended
Sep. 30, 2023
Debt Instruments [Abstract]  
Schedule of Long-term Debt Instruments
Our debt obligations consisted of the following as of September 30, 2023 and December 31, 2022:
 
    
September 30, 2023
   
December 31, 2022
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 521,500      $ 517,582
(1)
 
  $ 393,000      $ 388,254
(1)
 
SPV Credit Facility
     206,250        205,263
(2)
 
    155,200        154,302
(2)
 
2023 Unsecured Notes
     —         —        75,000        74,979
(3)
 
2024 Unsecured Notes
     125,000        124,637
(4)
 
    125,000        124,421
(4)
 
2025 Unsecured Notes
     85,000        84,738
(5)
 
    85,000        84,613
(5)
 
2026 Unsecured Notes
     75,000        74,586
(6)
 
    75,000        74,498
(6)
 
2027 Unsecured Notes
     50,000        49,963
(7)
 
    50,000        49,953
(7)
 
2027 Series F Unsecured Notes
     135,000        134,985
(8)
 
    135,000        134,978
(8)
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 1,197,750      $ 1,191,754     $ 1,093,200      $ 1,085,998  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $3,918 and $4,746 as of September 30, 2023 and December 31, 2022, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $987 and $898 as of September 30, 2023 and December 31, 2022, respectively.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $363 and $579 as of September 30, 2023 and December 31, 2022, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized market discount of $262 and $387 as of September 30, 2023 and December 31, 2022, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $414 and $502 as of September 30, 2023 and December 31, 2022, respectively.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $37 and $47 as of September 30, 2023 and December 31, 2022, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $15 and $22 as of September 30, 2023 and December 31, 2022, respectively.
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Highlights (Tables)
9 Months Ended
Sep. 30, 2023
Investment Company, Financial Highlights [Abstract]  
Schedule of financial highlights
The following is a schedule of financial highlights for the nine months ended September 30, 2023 and 2022:
 
    
Nine months ended
September 30, 2023
   
Nine months ended
September 30, 2022
 
Per Share Data: (a)
                
Net asset value, beginning of year
   $ 18.33     $ 19.93  
    
 
 
   
 
 
 
Net investment income
     1.25       1.06  
Net realized and unrealized loss
     (0.29     (1.08 )* 
    
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     0.96       (0.02
Issuance of common stock in connection with the Mergers
     —        (0.31
Distributions to stockholders:
                
From distributable earnings
     (1.23     (1.06
From return of capital
     —        (0.17
    
 
 
   
 
 
 
Net asset value, end of period
   $ 18.06     $ 18.37  
    
 
 
   
 
 
 
Per share market value, end of period
   $ 15.39     $ 12.32  
Total Return (b)(c)
     20.07     (27.75 %) 
Net assets, end of period
   $ 985,385     $ 1,006,225  
Shares outstanding, end of period
     54,554,634       54,772,651  
Ratios to average net assets (c):
                
Net investment income
     6.90     5.51
    
 
 
   
 
 
 
Operating expenses
     4.89 %**      3.90 %** 
Interest and other credit facility expenses
     5.37     3.22
    
 
 
   
 
 
 
Total expenses
     10.26 %**      7.12 %** 
    
 
 
   
 
 
 
Average debt outstanding
   $ 1,161,095     $ 951,995  
Portfolio turnover ratio
     22.1     13.8
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period.
(b)
Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2022 and December 31, 2021 was $13.91 and $18.43, respectively. Total return does not include a sales load.
(c)
Not annualized for periods less than one year.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the nine months ended September 30, 2023, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.93% and 10.30%, respectively, without the performance-based incentive fee waiver. For the nine months ended September 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.06% and 7.28%, respectively, without the performance-based incentive fee waiver.
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Summary of unfunded debt and equity commitments The total amount of these unfunded commitments as of September 30, 2023 and December 31, 2022 is $367,295 and $364,163, respectively, comprised of the following:
 
    
September 30,
2023
    
December 31,
2022
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Outset Medical, Inc.
     35,084        35,084  
Apeel Technology, Inc.
     32,786        32,786  
Southern Orthodontic Partners Management, LLC
     21,931        1,918  
SLR Senior Lending Program LLC*
     21,250        40,500  
Orthopedic Care Partners Management, LLC
     20,770        1,620  
Human Interest, Inc.
     20,104        20,104  
CVAUSA Management, LLC
     18,239        —   
BDG Media, Inc.
     12,646        3,546  
Neuronetics, Inc.
     11,579        —   
ONS MSO, LLC
     10,961        —   
iCIMS, Inc.
     10,506        11,435  
Cerapedics, Inc.
     9,217        6,735  
Alkeme Intermediate Holdings, LLC
     8,531        —   
Arcutis Biotherapeutics, Inc.
     8,356        8,356  
Ardelyx, Inc.
     7,752        7,752  
West-NR
Parent, Inc.
     6,830        —   
United Digestive MSO Parent, LLC
     5,259        —   
Peter C. Foy & Associates Insurance Services, LLC
     5,062        1,094  
Luxury Asset Capital, LLC
     4,500        7,500  
UVP Management, LLC
     4,386        —   
Kaseya, Inc.
     3,769        3,936  
Urology Management Holdings, Inc.
     3,596        —   
The Townsend Company, LLC
     3,556        —   
SLR Equipment Finance
     3,500        1,000  
Vertos Medical, Inc.
     3,325        —   
Foundation Consumer Brands, LLC
     3,009        3,009  
Kid Distro Holdings, LLC
     2,650        2,650  
Maurices, Incorporated
     2,589        4,314  
Erie Construction
Mid-west,
LLC
     2,403        1,248  
Ultimate Baked Goods Midco LLC
     2,371        1,636  
Basic Fun, Inc.
     2,150        2,675  
Bayside Opco, LLC
     1,721         
SunMed Group Holdings, LLC
     1,621        843  
SCP Eye Care, LLC
     1,459        2,771  
SLR Healthcare ABL*
     1,400        1,400  
RxSense Holdings LLC
     1,250        1,250  
Enverus Holdings, Inc.
     1,239        1,004  
Tilley Distribution, Inc.
     1,158        525  
GSM Acquisition Corp.
     862        784  
Composite Technology Acquisition Corp
     796        1,537  
High Street Buyer, Inc.
     631        327  
CC SAG Holdings Corp. (Spectrum Automotive)
     548        20,670  
ENS Holdings III Corp, LLC
     461        144  
Pinnacle Treatment Centers, Inc.
     386        1,745  
Vessco Midco Holdings, LLC
     327        3,892  
TAUC Management, LLC
     294        294  
All States Ag Parts, LLC
     212        135  
Glooko, Inc.
     —         17,868  
World Insurance Associates, LLC
     —         17,117  
Spectrum Pharmaceuticals, Inc.
     —         8,771  
Atria Wealth Solutions, Inc.
     —         8,215  
Accession Risk Management Group, Inc.
     —         7,498  
Copper River Seafoods, Inc.
     —         3,595  
Meditrina, Inc.
     —         3,367  
One Touch Direct, LLC
     —         3,069  
DeepIntent, Inc.
     —         3,049  
Plastics Management, LLC
     —         2,424  
Pediatric Home Respiratory Services, LLC
     —         1,805  
Ivy Fertility Services, LLC
     —         1,571  
NAC Holdings Corporation
     —         1,479  
SPAR Marketing Force, Inc.
     —         1,338  
Montefiore Nyack Hospital
     —         1,034  
American Teleconferencing Services, Ltd
     —         1,090  
BayMark Health Services, Inc.
     —         391  
    
 
 
    
 
 
 
Total Commitments
   $ 367,295      $ 364,163  
    
 
 
    
 
 
 
 
*
The Company controls the funding of these commitments and may cancel them at its discretion.
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Capital Share Transactions (Tables)
9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Stockholders Equity
Transactions in capital stock were as follows:
 
    
Shares
    
Amount
 
    
Three months ended
September 30, 2023
    
Three months ended
September 30, 2022
    
Three months ended
September 30, 2023
    
Three months ended
September 30, 2022
 
Shares issued in connection with the Mergers
     —         —       $ —       $ —   
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     —         —       $ —       $ —   
    
 
 
    
 
 
    
 
 
    
 
 
 
     
    
Shares
    
Amount
 
    
Nine months ended
September 30, 2023
    
Nine months ended
September 30, 2022
    
Nine months ended
September 30, 2023
    
Nine months ended
September 30, 2022
 
Shares issued in connection with the Mergers
     —         12,511,825      $ —       $ 226,839  
Shares repurchased
     (746      —       $ (10    $ —   
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     (746      12,511,825      $ (10    $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Senior Lending Program LLC (Tables)
9 Months Ended
Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
SSLP Portfolio
SSLP Portfolio as of September 30, 2023
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Accession Risk Management Group, Inc.
(4)
   Insurance      S+550        0.75     11.02     11/1/26      $ 9,078      $ 9,078      $ 9,078  
Aegis Toxicology Sciences Corporation
(4)
   Health Care Providers & Services      S+550        1.00     11.13     5/9/25        2,960        2,960        2,960  
Alkeme Intermediary Holdings, LLC
(4)
   Insurance      S+650        1.00     11.92     10/28/26        3,021        2,931        2,930  
All States Ag Parts, LLC
(4)
   Trading Companies & Distributors      S+600        1.00     11.60     9/1/26        2,138        2,138        2,138  
Atria Wealth Solutions, Inc.
(4)
   Diversified Financial Services      S+650        1.00     12.15     2/29/24        2,475        2,475        2,475  
BayMark Health Services, Inc.
(4)
   Health Care Providers & Services      S+500        1.00     10.65     6/11/27        4,043        4,043        4,043  
CC SAG Holdings Corp.
(4)
   Diversified Consumer Services      S+575        0.75     11.18     6/29/28        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
   Trading Companies & Distributors      S+475        1.00     10.24     12/31/25        1,089        1,089        1,089  
Fertility (ITC) Investment Holdco, LLC
(4)
   Health Care Providers & Services      S+650        1.00     11.63     1/3/29        5,970        5,799        5,970  
Foundation Consumer Brands, LLC
(4)
   Personal Products      S+625        1.00     11.77     2/12/27        8,911        8,911        8,911  
High Street Buyer, Inc.
(4)
   Insurance      S+600        0.75     11.54     4/16/28        4,433        4,433        4,433  
iCIMS, Inc.
(4)
   Software      S+725        0.75     12.14     8/18/28        3,059        3,028        3,059  
Kaseya, Inc.
(4)
   Software      S+625        0.75     11.58     6/23/29        9,000        9,000        9,000  
Kid Distro Holdings, LLC
(4)
   Software      S+550        1.00     11.04     10/1/27        8,962        8,962        8,962  
ONS MSO, LLC
(4)
   Health Care Providers & Services      S+625        1.00     11.62     7/8/25        5,936        5,779        5,936  
PhyNet Dermatology LLC
(4)
   Health Care Providers & Services      S+625        1.00     11.45     8/16/24        5,964        5,964        5,964  
Pinnacle Treatment Centers, Inc.
(4)
   Health Care Providers & Services      S+675        1.00     12.10     1/2/26        4,725        4,725        4,725  
Plastics Management, LLC
(4)
   Health Care Providers & Services      S+500        1.00     10.44     8/18/27        5,651        5,476        5,651  
RQM+ Corp.
(4)
   Life Sciences Tools & Services      S+575        1.00     11.40     8/12/26        5,970        5,970        5,970  
RxSense Holdings LLC
(4)
   Diversified Consumer Services      S+500        1.00     10.47     3/13/26        2,977        2,977        2,977  
SunMed Group Holdings, LLC
(4)
   Health Care Equipment & Supplies      S+550        0.75     10.99     6/16/28        8,971        8,971        8,971  
The Townsend Company, LLC
(4)
   Commercial Services & Supplies      S+625        1.00     11.57     8/15/29        3,570        3,482        3,481  
Tilley Distribution, Inc.
(4)
   Trading Companies & Distributors      S+600        1.00     11.54     12/31/26        5,963        5,963        5,963  
Ultimate Baked Goods Midco LLC
(4)
   Packaged Foods & Meats      S+625        1.00     11.67     8/13/27        8,977        8,977        8,977  
Urology Management Holdings, Inc.
(4)
   Health Care Providers & Services      S+625        1.00     11.79     6/15/26        2,465        2,403        2,440  
Vessco Midco Holdings, LLC
(4)
   Water Utilities      S+450        1.00     9.92     11/2/26        1,845        1,845        1,845  
West-NR
Parent, Inc.
(4)
   Insurance      S+625        1.00     11.72     12/27/27        2,674        2,622        2,621  
                                                    
 
 
    
 
 
 
                                                     $ 132,993      $ 133,561  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of September 30, 2023.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
 
SSLP Portfolio as of December 31, 2022
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
   Diversified Financial Services      S+600        1.00     10.84     2/29/24      $ 2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
   Health Care Providers & Services      L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
   Trading Companies & Distributors      L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
   Personal Products      L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
   Insurance      L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
   Health Care Providers & Services      L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
   Software      L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                                                    
 
 
    
 
 
 
                                                     $ 18,032      $ 18,062  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Summary financial information for SSLP
Below is certain summarized financial information for SSLP as of September 30, 2023 and December 31, 2022 and for the three and nine months ended September 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
    
September 30,
2023
    
December 31,
2022
 
Selected Balance Sheet Information for SSLP:
                 
Investments at fair value (cost $132,993 and $18,032, respectively)
   $ 133,561      $ 18,062  
Cash and other assets
     3,886        1,043  
    
 
 
    
 
 
 
Total assets
   $ 137,447      $ 19,105  
    
 
 
    
 
 
 
Debt outstanding
   $ 77,826      $ —   
Distributions payable
     500        —   
Interest payable and other credit facility related expenses
     358        165  
Accrued expenses and other payables
     209        89  
    
 
 
    
 
 
 
Total liabilities
   $ 78,893      $ 254  
    
 
 
    
 
 
 
Members’ equity
   $ 58,554      $ 18,851  
    
 
 
    
 
 
 
Total liabilities and members’ equity
   $ 137,447      $ 19,105  
    
 
 
    
 
 
 
 
    
For the three
months ended
September 30,
2023
    
For the nine
months ended
September 30,
2023
    
For the period
December 1, 2022
(commencement
of operations) to
December 31,
2022
 
Selected Income Statement Information for SSLP:
        
Interest income
   $ 2,757      $ 5,371      $ 152  
  
 
 
    
 
 
    
 
 
 
Service fees*
     66        123      $ 4  
Interest and other credit facility expenses
     1,773        4,025        166  
Organizational costs
     —         —         73  
Other general and administrative expenses
     32        89        88  
  
 
 
    
 
 
    
 
 
 
Total expenses
     1,871        4,237        331  
  
 
 
    
 
 
    
 
 
 
Net investment income (loss)
   $ 886      $ 1,134      $ (179
  
 
 
    
 
 
    
 
 
 
Realized gain on investments
     —         30        —   
Net change in unrealized gain on investments
     177        538        30  
  
 
 
    
 
 
    
 
 
 
Net realized and unrealized gain on investments
   $ 177      $ 568        30  
  
 
 
    
 
 
    
 
 
 
Net income (loss)
   $ 1,063      $ 1,702      $ (149
  
 
 
    
 
 
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Organization - Additional Information (Details) - $ / shares
3 Months Ended 9 Months Ended
Apr. 01, 2022
Feb. 10, 2010
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period, shares     0 0 0 12,511,825  
Shares issued, price per share     $ 14.02   $ 14.02   $ 13.98
IPO [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period, shares   5,680,000          
Over-Allotment Option [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Share price   $ 18.5          
Private Placement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period, shares   600,000          
Share price   $ 18.5          
Common Stock [Member] | SUNS Company Merger [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Shares issued, price per share $ 0.7796            
Stock issued during period, shares, acquisitions 12,511,825            
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies - Additional Information (Details)
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Line Items]  
Percentage of excise tax 4.00%
Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Debt instrument term 60 days
Restricted investment term 90 days
Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Debt instrument term 60 days
Restricted investment term 30 days
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Agreements - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Agreement [Line Items]        
Management fees $ 8,051 $ 7,890 $ 23,635 $ 22,019
Administrative fees expense 1,575 1,132 4,563 3,684
Performance Based Incentive Fees Waiver 175 194 $ 410 1,552
Advisory Agreement [Member]        
Agreement [Line Items]        
Pre-incentive fee net investment income Quarter hurdle rate     1.75%  
Pre-incentive fee net investment income Annual hurdle rate     (7.00%)  
Percentage of cumulative realized capital gain loss     20.00%  
Percentage of cumulative net realized gain and unrealized capital appreciation     20.00%  
Management fees 8,051 7,890 $ 23,635 22,019
Performance based incentive fees 5,796 4,965 16,943 9,699
Administrative fees expense $ 1,575 $ 1,132 $ 4,563 $ 3,684
Advisory Agreement [Member] | Minimum [Member]        
Agreement [Line Items]        
Percentage of gross assets     1.00%  
Percentage of total net assets     200.00%  
Percentage of pre-incentive fee net investment income     100.00%  
Advisory Agreement [Member] | Maximum [Member]        
Agreement [Line Items]        
Percentage of gross assets     1.50%  
Percentage of total net assets     200.00%  
Percentage of pre-incentive fee net investment income     20.00%  
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Net Asset Value Per Share - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Net Asset Value Per Share [Abstract]            
Net assets $ 985,385 $ 980,805 $ 999,731 $ 1,006,225 $ 1,015,153 $ 842,281
Net asset value per share $ 18.06   $ 18.33 $ 18.37   $ 19.93
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings per share (basic & diluted)        
Numerator - net increase in net assets resulting from operations: $ 26,947 $ 13,528 $ 52,766 $ (655)
Denominator - weighted average shares, Basic 54,554,634 54,772,651 54,554,639 50,647,874
Denominator - weighted average shares, Diluted 54,554,634 54,772,651 54,554,639 50,647,874
Earnings per share, Basic $ 0.49 $ 0.25 $ 0.97 $ (0.01)
Earnings per share, Diluted $ 0.49 $ 0.25 $ 0.97 $ (0.01)
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Recurring Fair Value [Member] - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets $ 2,171,056 $ 2,086,676
Measured at Net Asset Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 29,277 9,426
Senior Secured Loans [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 1,300,366 1,245,414
Senior Secured Loans [Member] | Measured at Net Asset Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 0 0
Equipment Financing [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 265,306 265,952
Equipment Financing [Member] | Measured at Net Asset Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 0 0
Preferred Equity [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 3,801 3,801
Preferred Equity [Member] | Measured at Net Asset Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 0 0
Common Equity/Equity Interests/Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 601,583 571,509
Common Equity/Equity Interests/Warrants [Member] | Measured at Net Asset Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 29,277 9,426
Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 315 483
Level 1 [Member] | Senior Secured Loans [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 1 [Member] | Equipment Financing [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 1 [Member] | Preferred Equity [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 1 [Member] | Common Equity/Equity Interests/Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 315 483
Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 2 [Member] | Senior Secured Loans [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 2 [Member] | Equipment Financing [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 2 [Member] | Preferred Equity [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 2 [Member] | Common Equity/Equity Interests/Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 2,141,464 2,076,767
Level 3 [Member] | Senior Secured Loans [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 1,300,366 1,245,414
Level 3 [Member] | Equipment Financing [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 265,306 265,952
Level 3 [Member] | Preferred Equity [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 3,801 3,801
Level 3 [Member] | Common Equity/Equity Interests/Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets $ 571,991 $ 561,600
[1] In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance $ 2,160,073 $ 2,076,767 $ 1,669,496
Net realized gain (loss) (29,555) (28,398) (36,238)
Net change in unrealized gain (loss) 34,351 13,967 $ (20,743)
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]     Unrealized Gain (Loss) on Investments
Purchase of investment securities 185,570 555,299 $ 997,095
Proceeds from dispositions of investment securities (208,975) (476,171) (532,843)
Transfers in/out of Level 3 0 0 0
Closing balance 2,141,464 2,141,464 2,076,767
Net change in unrealized gain (loss) 2,657 8,210 $ (21,598)
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]     Unrealized Gain (Loss) on Investments
Senior Secured Loans [Member]      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 1,318,512 1,245,414 $ 939,690
Net realized gain (loss) (29,555) (28,398) (36,244)
Net change in unrealized gain (loss) 41,505 35,682 (8,065)
Purchase of investment securities 168,421 488,757 796,389
Proceeds from dispositions of investment securities (198,517) (441,089) (446,356)
Transfers in/out of Level 3 0 0 0
Closing balance 1,300,366 1,300,366 1,245,414
Net change in unrealized gain (loss) 9,782 29,925 (8,920)
Equipment Financing [Member]      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 271,333 265,952 273,795
Net realized gain (loss) 0 0 0
Net change in unrealized gain (loss) 190 111 (6,924)
Purchase of investment securities 4,190 34,274 84,168
Proceeds from dispositions of investment securities (10,407) (35,031) (85,087)
Transfers in/out of Level 3 0 0 0
Closing balance 265,306 265,306 265,952
Net change in unrealized gain (loss) 190 111 (6,924)
Preferred Equity [Member]      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 3,801 3,801 5,630
Net realized gain (loss) 0 0 0
Net change in unrealized gain (loss) (64) (187) (706)
Purchase of investment securities 64 187 266
Proceeds from dispositions of investment securities 0 0 (1,389)
Transfers in/out of Level 3 0 0 0
Closing balance 3,801 3,801 3,801
Net change in unrealized gain (loss) (64) (187) (706)
Common Equity/Equity Interests/Warrants [Member]      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 566,427 561,600 450,381
Net realized gain (loss) 0 0 6
Net change in unrealized gain (loss) (7,280) (21,639) (5,048)
Purchase of investment securities 12,895 32,081 116,272
Proceeds from dispositions of investment securities (51) (51) (11)
Transfers in/out of Level 3 0 0 0
Closing balance 571,991 571,991 561,600
Net change in unrealized gain (loss) $ (7,251) $ (21,639) $ (5,048)
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) - 2022 Unsecured Notes [Member]
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning fair value $ 150,000
Net realized (gain) loss 0
Net change in unrealized (gain) loss 0
Borrowings 0
Repayments (150,000)
Transfers in/out of Level 3 0
Ending fair value $ 0
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
SLRCTerm Loan And Credit Facility [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure $ 521,500 $ 393,000
SPV Credit Facility [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 206,250 155,200
2023 Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure   75,000
2024 Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 120,313 118,750
2025 Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 80,750 79,688
2026 Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 68,438 68,250
2027 Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 43,375 42,875
2027 Series F Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure $ 119,138 $ 118,125
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) - Level 3 [Member] - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Senior Secured Loans [Member] | Income Approach [Member] | Market Yield [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 1,292,834 $ 1,212,842
Principal Valuation Technique/Methodology Income Approach Income Approach
Unobservable Input Market Yield Market Yield
Senior Secured Loans [Member] | Market Multiple [Member] | Comparable Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets   $ 32,572
Principal Valuation Technique/Methodology   Market Multiple
Unobservable Input   Comparable Multiple
Senior Secured Loans [Member] | Recovery Analysis [Member] | Recoverable Amount [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 7,532  
Principal Valuation Technique/Methodology Recovery Analysis  
Unobservable Input Recoverable Amount  
Equipment Financing [Member] | Income Approach [Member] | Market Yield [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 144,486 $ 145,132
Principal Valuation Technique/Methodology Income Approach Income Approach
Unobservable Input Market Yield Market Yield
Equipment Financing [Member] | Market Multiple [Member] | Comparable Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 120,820 $ 120,820
Principal Valuation Technique/Methodology Market Multiple Market Multiple
Unobservable Input Comparable Multiple Comparable Multiple
Preferred Equity [Member] | Income Approach [Member] | Market Yield [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 3,801 $ 3,801
Principal Valuation Technique/Methodology Income Approach Income Approach
Unobservable Input Market Yield Market Yield
Common Equity/Equity Interests/Warrants [Member] | Market Multiple [Member] | Comparable Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 165,771 $ 149,120
Principal Valuation Technique/Methodology Market Multiple Market Multiple
Unobservable Input Comparable Multiple Comparable Multiple
Common Equity/Equity Interests/Warrants [Member] | Market Approach [Member] | Return on Equity [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 406,220 $ 412,480
Principal Valuation Technique/Methodology Market Approach Market Approach
Unobservable Input Return on Equity Return on Equity
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Measurement Input, EBITDA Multiple [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 164,916 $ 148,444
Black Scholes Pricing Model [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value 855 676
Senior Secured Loans [Member] | Income Approach [Member] | Market Yield [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 1,292,834 $ 1,212,842
Senior Secured Loans [Member] | Income Approach [Member] | Market Yield [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 10.1 9.4
Senior Secured Loans [Member] | Income Approach [Member] | Market Yield [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 20.5 18.2
Senior Secured Loans [Member] | Income Approach [Member] | Market Yield [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 12.8 12
Senior Secured Loans [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value   $ 32,572
Senior Secured Loans [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   0.1
Senior Secured Loans [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   21.4
Senior Secured Loans [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   12.4
Equipment Financing [Member] | Income Approach [Member] | Market Yield [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 144,486 $ 145,132
Equipment Financing [Member] | Income Approach [Member] | Market Yield [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 8.5 8.5
Equipment Financing [Member] | Income Approach [Member] | Market Yield [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.5 9.7
Equipment Financing [Member] | Income Approach [Member] | Market Yield [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.5 9.7
Equipment Financing [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 120,820 $ 120,820
Equipment Financing [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.1 1.1
Equipment Financing [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.4 1.4
Equipment Financing [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.2 1.2
Preferred Equity [Member] | Income Approach [Member] | Market Yield [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 3,801 $ 3,801
Preferred Equity [Member] | Income Approach [Member] | Market Yield [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 5
Preferred Equity [Member] | Income Approach [Member] | Market Yield [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 5
Preferred Equity [Member] | Income Approach [Member] | Market Yield [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 5
Common Equity/Equity Interests/Warrants [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 165,771 $ 149,120
Common Equity/Equity Interests/Warrants [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 6.3 7.8
Common Equity/Equity Interests/Warrants [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 11.5 9.8
Common Equity/Equity Interests/Warrants [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 8.8 8.8
Common Equity/Equity Interests/Warrants [Member] | Market Approach [Member] | Return on Equity [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 406,220 $ 412,480
Common Equity/Equity Interests/Warrants [Member] | Market Approach [Member] | Return on Equity [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5.5 6.6
Common Equity/Equity Interests/Warrants [Member] | Market Approach [Member] | Return on Equity [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 30.7 35.2
Common Equity/Equity Interests/Warrants [Member] | Market Approach [Member] | Return on Equity [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 10.7 9.2
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Debt - Schedule of Long-term Debt Instruments (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Face Amount $ 1,197,750 $ 1,093,200
Total 1,191,754 1,085,998
Credit Facility [Member]    
Debt Instrument [Line Items]    
Face Amount 521,500 393,000
Credit Facility, Carrying Value 517,582 388,254
SPV Credit Facility [Member]    
Debt Instrument [Line Items]    
Face Amount 206,250 155,200
SPV Credit Facility, Carrying Value 205,263 154,302
2023 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 0 75,000
Unsecured Debt 0 74,979
2024 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 125,000 125,000
Unsecured Debt 124,637 124,421
2025 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 85,000 85,000
Unsecured Debt 84,738 84,613
2026 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 75,000 75,000
Unsecured Debt 74,586 74,498
2027 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 50,000 50,000
Unsecured Debt 49,963 49,953
2027 Series F Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 135,000 135,000
Unsecured Debt $ 134,985 $ 134,978
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Credit Facility [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs $ 3,918 $ 4,746
SPV Credit Facility [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Unamortized Discount 987 898
2023 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs   21
2024 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 363 579
2025 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 262 387
2026 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 414 502
2027 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 37 47
2027 Series F Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs $ 15 $ 22
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.23.3
Debt - Additional Information (Details) - USD ($)
4 Months Ended 9 Months Ended 12 Months Ended 49 Months Ended
Dec. 31, 2021
Dec. 18, 2019
Dec. 31, 2011
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Apr. 01, 2022
Jan. 06, 2022
Dec. 28, 2021
Sep. 14, 2021
Nov. 22, 2017
Aug. 26, 2011
Debt Instrument [Line Items]                        
Debt instrument face value       $ 1,197,750,000 $ 1,093,200,000              
Debt instrument maturity date   Dec. 15, 2024                    
Long term debt weighted average interest over a period of time       5.79% 4.09%              
Long term debt maximum amount borrowed during the period       $ 1,273,200,000 $ 1,164,200,000              
SPV LLC [Member] | Citi Bank NA [Member] | Line of Credit [Member] | Amendment Agreement to Increase Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Line of credit facility increase                 $ 25,000,000      
SPV LLC [Member] | Citi Bank NA [Member] | Line of Credit [Member] | Credit Facility Commitment Expired [Member]                        
Debt Instrument [Line Items]                        
Line of credit facility commitment expired                 40,000,000      
Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Debt instrument face value       $ 85,000,000                
Long term debt term       5 years                
Debt instrument maturity date       Mar. 31, 2025                
Debt instrument payment terms       Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30                
Credit Facility One [Member]                        
Debt Instrument [Line Items]                        
Debt instrument face value             $ 85,000,000          
Debt instrument stated interest rate percentage       3.90%                
Line of credit       $ 205,263,000 154,302,000              
Two Thousand And Twenty Seven Series F Unsecured Notes [Member]                        
Debt Instrument [Line Items]                        
Debt instrument face value       $ 135,000,000       $ 135,000,000        
Debt instrument maturity date       Jan. 06, 2027                
Debt instrument payment terms       Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6                
Debt instrument stated interest rate percentage       3.33%                
Two Thousand And Twenty Four Unsecured Notes [Member]                        
Debt Instrument [Line Items]                        
Debt instrument face value   $ 125,000,000   $ 125,000,000 125,000,000              
Debt instrument payment terms       Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15                
Debt instrument stated interest rate percentage       4.20%                
Two Thousand And Twenty Six Unsecured Notes [Member]                        
Debt Instrument [Line Items]                        
Debt instrument face value   $ 75,000,000   $ 75,000,000 $ 75,000,000              
Debt instrument stated interest rate percentage       4.375% 4.375%              
Two Thousand And Twenty Two Tranche C Notes [Member]                        
Debt Instrument [Line Items]                        
Debt instrument maturity date   Dec. 15, 2026                    
Two Thousand And Twenty Three Unsecured Notes [Member]                        
Debt Instrument [Line Items]                        
Debt instrument face value       $ 75,000,000 $ 75,000,000           $ 75,000,000  
Debt instrument maturity date           Jan. 20, 2023            
Debt instrument payment terms           semi-annually on January 20 and July 20            
Debt instrument stated interest rate percentage       4.50% 4.50%              
Proceeds from net debt           $ 73,846,000            
Term Loan And Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Line of credit and term loan outstanding       $ 517,582,000 $ 388,254,000              
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member]                        
Debt Instrument [Line Items]                        
Debt instrument maturity date       Jun. 01, 2026                
Line of credit and term loan outstanding       $ 206,250,000                
Line of credit maximum borrowing capacity and debt instrument face value                 800,000,000      
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member] | Line of Credit [Member]                        
Debt Instrument [Line Items]                        
Line of credit facility, maximum borrowing capacity                 585,000,000      
Other long term debt       421,500,000                
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member] | Term Loan [Member]                        
Debt Instrument [Line Items]                        
Debt instrument face value                 $ 100,000,000      
Line of credit       100,000,000                
Term Loan And Credit Facility [Member] | Credit Facility [Member] | Citi Bank NA [Member]                        
Debt Instrument [Line Items]                        
Line of credit and term loan outstanding       $ 521,500,000                
Term Loan And Credit Facility [Member] | Maximum [Member] | SPV LLC [Member] | Citi Bank NA [Member]                        
Debt Instrument [Line Items]                        
Line of credit facility, maximum borrowing capacity                       $ 600,000,000
Debt instrument variable interest rate spread (1.00%)                      
Term Loan And Credit Facility [Member] | Maximum [Member] | London Interbank Offered Rate [Member] | Citi Bank NA [Member]                        
Debt Instrument [Line Items]                        
Debt instrument variable interest rate spread       (2.00%)                
Term Loan And Credit Facility [Member] | Maximum [Member] | Secured Overnight Financing Rate [Member] | Citi Bank NA [Member]                        
Debt Instrument [Line Items]                        
Debt instrument variable interest rate spread     (2.50%)                  
Term Loan And Credit Facility [Member] | Minimum [Member] | SPV LLC [Member] | Citi Bank NA [Member]                        
Debt Instrument [Line Items]                        
Line of credit facility, maximum borrowing capacity                       $ 275,000,000
Debt instrument variable interest rate spread 0.75%     1.75%                
Term Loan And Credit Facility [Member] | Minimum [Member] | Secured Overnight Financing Rate [Member] | Citi Bank NA [Member]                        
Debt Instrument [Line Items]                        
Debt instrument variable interest rate spread     2.00%                  
Two Thousand And Twenty Seven Unsecured Notes [Member]                        
Debt Instrument [Line Items]                        
Debt instrument face value       $ 50,000,000           $ 50,000,000    
Debt instrument stated interest rate percentage       2.95%           2.95%    
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Highlights - Schedule of Financial Highlights (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Per Share Data:            
Net asset value, beginning of year $ 18.33 $ 19.93        
Net investment income 1.25 1.06        
Net realized and unrealized loss (0.29) (1.08)        
Net increase (decrease) in net assets resulting from operations 0.96 (0.02)        
Issuance of common stock in connection with the Merger   (0.31)        
From distributable earnings (1.23) (1.06)        
From return of capital 0 (0.17)        
Net asset value, end of period 18.06 18.37        
Per share market value, end of period $ 15.39 $ 12.32   $ 13.91   $ 18.43
Total Return 20.07% (27.75%)        
Net assets, end of period $ 985,385 $ 1,006,225 $ 980,805 $ 999,731 $ 1,015,153 $ 842,281
Shares outstanding, end of period 54,554,634 54,772,651   54,555,380    
Ratios to average net assets:            
Net investment income 6.90% 5.51%        
Operating expenses 4.89% 3.90%        
Interest and other credit facility expenses 5.37% 3.22%        
Total expenses 10.26% 7.12%        
Average debt outstanding $ 1,161,095 $ 951,995        
Portfolio turnover ratio 22.10% 13.80%        
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) - $ / shares
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Investment Company, Financial Highlights [Abstract]        
Fair value of common stock per share $ 15.39 $ 12.32 $ 13.91 $ 18.43
Investment company, expense ratio excluding incentive fee 10.30% 7.28%    
Investment Company Operating Expense Ratio Excluding Incentive Fee 4.93% 4.06%    
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Credit Solutions - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jul. 28, 2016
USD ($)
Dec. 28, 2012
USD ($)
Nov. 30, 2012
USD ($)
loans
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
issuers
fund
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
fund
issuers
Number of issuers in business credit | issuers           98   108
Assets       $ 2,539,086   $ 2,539,086   $ 2,537,695
Non-recourse debt       1,191,754   1,191,754   1,085,998
Revolving Credit Facility [Member]                
Line of credit facility, maximum borrowing capacity   $ 275,000            
Crystal Financial [Member]                
Line of credit facility, maximum borrowing capacity     $ 400,000          
SLR Business Credit Facility [Member]                
Line of credit facility, maximum borrowing capacity       40,725   $ 40,725   $ 33,420
Business combination, consideration transferred $ 5,737              
Number of funded commitments | fund           32   29
Number of issuers in business credit | issuers           28   25
Long-term line of credit       469,495   $ 469,495   $ 439,484
Assets       506,081   506,081   460,683
Line of credit facility average outstanding amount           16,768   17,579
Net income (loss)       4,315 $ 3,897 1,411 $ 8,557  
Gross income       13,897 $ 8,596 42,350 $ 22,171  
Non-recourse debt       $ 284,472   284,472   $ 224,325
SLR Business Credit Facility [Member] | Revolving Credit Facility [Member]                
Line of credit facility commitments amount           $ 300,000    
SLR Business Credit Facility [Member] | Crystal Financial [Member]                
Payment to acquire business   $ 275,000            
Equity method investment, ownership percentage 2.00% 98.00%            
Number of loans in business credit | loans     23          
SLR Business Credit Facility [Member] | Crystal Capital Financial Holdings LLC [Member]                
Equity method investment, ownership percentage 100.00%              
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Equipment Finance - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 24, 2023
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2023
USD ($)
Customers
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Customers
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Customers
Jul. 31, 2017
USD ($)
Schedule of Equity Method Investments [Line Items]                
Non-recourse debt     $ 1,191,754   $ 1,191,754   $ 1,085,998  
Line of credit facility, expiration date         Nov. 13, 2025      
SLR Equipment Finance [Member]                
Schedule of Equity Method Investments [Line Items]                
Equity method investment, ownership percentage               100.00%
Equity method investment, aggregate cost               $ 209,866
Equity method investment aggregate equity investment               145,000
Equity method investment aggregate investment in investee leases and loans held               64,866
Line of credit facility, maximum borrowing capacity $ 150,000 $ 213,957 $ 152,147   $ 152,147     150,000
Line of credit facility maximum borrowing capacity with accordion feature $ 200,000 $ 313,957           $ 250,000
Number of funded equipment-backed leases and loans     141   141   131  
Number of Customers | Customers     56   56   59  
Net investment in lease     $ 199,831   $ 199,831   $ 190,830  
Assets under lease     251,031   251,031   241,813  
Equipment backed leases and loans largest position outstanding     18,319   18,319   19,259  
Equipment backed leases and loans average exposure per customer     3,568   3,568   3,234  
Non-recourse debt     130,557   130,557   $ 114,977  
Net income     1,176 $ 1,034 2,193 $ 125    
Gross income     $ 4,783 $ 6,486 $ 15,174 $ 15,704    
Line of credit facility, expiration date Mar. 31, 2026 Jan. 31, 2024     Aug. 01, 2023      
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.23.3
Kingsbridge Holdings, LLC - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Nov. 03, 2020
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Proceeds from unsecured borrowings       $ 0 $ 134,914  
Total assets   $ 2,539,086   2,539,086   $ 2,537,695
Non-recourse debt   1,191,754   1,191,754   1,085,998
KBHT [Member]            
Total assets   783,089   783,089   777,151
Kingsbridge Holdings, LLC [Member]            
Equity method investments $ 216,596          
Payments to acquire investments 136,596          
Proceeds from unsecured borrowings $ 80,000          
Recourse debt   239,505   239,505   222,094
Non-recourse debt   353,415   353,415   $ 353,128
Net income (loss)   2,129 $ 3,327 7,151 10,393  
Gross income   $ 85,544 $ 71,332 $ 229,051 $ 215,074  
Maximum [Member] | Kingsbridge Holdings, LLC [Member]            
Equity method investment, ownership percentage 87.50%          
Minimum [Member] | Kingsbridge Holdings, LLC [Member]            
Equity method investment, ownership percentage 12.50%          
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Healthcare ABL - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Aug. 24, 2023
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
issuers
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
issuers
Jul. 31, 2017
USD ($)
Sep. 30, 2013
USD ($)
Line of credit facility, expiration date         Nov. 13, 2025        
Commitments and contingencies            
Total assets     2,539,086   $ 2,539,086   $ 2,537,695    
Number of issuers in business credit | issuers         98   108    
Long term debt     1,191,754   $ 1,191,754   $ 1,085,998    
SLR Healthcare ABL Credit [Member]                  
Total assets     113,832   $ 113,832   $ 108,705    
Number of issuers in business credit | issuers         38   41    
Long-term line of credit     2,802   $ 2,802   $ 2,253    
Net income (loss)     1,532 $ 822 3,925 $ 2,543      
Gross income     4,833 3,020 13,109 7,898      
Long term debt     81,000   81,000   77,000    
Senior Secured Commitments [Member]                  
Commitments and contingencies     237,000   237,000   242,106    
Commitment funded amount     $ 106,484   $ 106,484        
Senior Secured Commitments [Member] | SLR Healthcare ABL Credit [Member]                  
Commitment funded amount             92,383    
SLR Healthcare ABL [Member]                  
Equity method investments                 $ 32,839
SLR Healthcare ABL [Member] | Maximum [Member]                  
Equity method investment, ownership percentage     93.00%   93.00%        
SLR Healthcare ABL [Member] | Minimum [Member]                  
Equity method investment, ownership percentage     7.00%   7.00%        
SLR Equipment Finance [Member]                  
Equity method investment, ownership percentage               100.00%  
Line of credit facility, maximum borrowing capacity $ 150,000 $ 213,957 $ 152,147   $ 152,147     $ 150,000  
Line of credit facility, expiration date Mar. 31, 2026 Jan. 31, 2024     Aug. 01, 2023        
Net income (loss)     1,176 1,034 $ 2,193 125      
Gross income     4,783 $ 6,486 15,174 $ 15,704      
Long term debt     $ 130,557   $ 130,557   $ 114,977    
Line of credit facility maximum borrowing capacity with accordion feature $ 200,000 $ 313,957           $ 250,000  
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Business Credit - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 03, 2021
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
issuers
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
issuers
Jun. 28, 2019
USD ($)
May 01, 2018
Oct. 20, 2017
USD ($)
SLR Business Credit [Line Items]                  
Commitments and contingencies            
Assets   2,539,086   $ 2,539,086   $ 2,537,695      
Number of issuers in business credit | issuers       98   108      
Line of credit facility, expiration date       Nov. 13, 2025          
SLR Business Credit [Member]                  
SLR Business Credit [Line Items]                  
Long-term line of credit   2,631   $ 2,631   $ 2,648      
Net income   1,779 $ 1,977 5,211 $ 5,703        
Gross income   9,709 $ 7,607 27,868 $ 20,378        
Senior Secured Commitments [Member]                  
SLR Business Credit [Line Items]                  
Commitments and contingencies   237,000   237,000   242,106      
Commitment funded amount   106,484   106,484          
Senior Secured Commitments [Member] | SLR Business Credit [Member]                  
SLR Business Credit [Line Items]                  
Commitments and contingencies   612,399   612,399   603,432      
Commitment funded amount   257,818   257,818   286,006      
Assets   302,912   302,912   332,247      
Fast Pay Partners LLC [Member]                  
SLR Business Credit [Line Items]                  
Percentage of voting interests acquired 100.00%                
Business combination, consideration transferred $ 66,671                
NMCs Credit Facility [Member]                  
SLR Business Credit [Line Items]                  
Line of credit facility, maximum borrowing capacity 47,671           $ 15,500    
SUNS [Member]                  
SLR Business Credit [Line Items]                  
Line of credit facility, maximum borrowing capacity $ 19,000                
NMC Senior Credit Facility [Member]                  
SLR Business Credit [Line Items]                  
Line of credit facility, maximum borrowing capacity   285,307   285,307          
Long-term line of credit   $ 199,449   $ 199,449   $ 214,425      
NM Holdco [Member]                  
SLR Business Credit [Line Items]                  
Percentage of equity interest contributed to another entity             99.00%    
North Mill Capital LLC [Member]                  
SLR Business Credit [Line Items]                  
Equity method investment, ownership percentage               99.00% 100.00%
Equity method investments                 $ 51,000
ESP SSC Corporation [Member]                  
SLR Business Credit [Line Items]                  
Equity method investment, ownership percentage               1.00% 1.00%
Summit Financial Resources [Member]                  
SLR Business Credit [Line Items]                  
Equity method investment, ownership percentage             100.00%    
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies - Additional Information (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Other Commitments [Line Items]    
Other Commitment $ 367,295 $ 364,163
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Oct. 12, 2022
Other Commitments [Line Items]      
Other Commitment $ 367,295 $ 364,163  
Unfunded Debt and Equity Commitments [Member]      
Other Commitments [Line Items]      
Other Commitment 367,295 364,163  
Unfunded Debt and Equity Commitments [Member] | SLR Credit Solutions [Member]      
Other Commitments [Line Items]      
Other Commitment [1] 44,263 44,263  
Unfunded Debt and Equity Commitments [Member] | Outset Medical, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 35,084 35,084  
Unfunded Debt and Equity Commitments [Member] | Apeel Technology, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 32,786 32,786  
Unfunded Debt and Equity Commitments [Member] | Southern Orthodontic Partners Management, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 21,931 1,918  
Unfunded Debt and Equity Commitments [Member] | SLR Senior Lending Program LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 21,250 [1] 40,500 [1] $ 100,000
Unfunded Debt and Equity Commitments [Member] | Orthopedic Care Partners Management, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 20,770 1,620  
Unfunded Debt and Equity Commitments [Member] | Human Interest, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 20,104 20,104  
Unfunded Debt and Equity Commitments [Member] | CVAUSA Management, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 18,239 0  
Unfunded Debt and Equity Commitments [Member] | BDG Media, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 12,646 3,546  
Unfunded Debt and Equity Commitments [Member] | Neuronetics, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 11,579 0  
Unfunded Debt and Equity Commitments [Member] | ONS MSO, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 10,961 0  
Unfunded Debt and Equity Commitments [Member] | iCIMS, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 10,506 11,435  
Unfunded Debt and Equity Commitments [Member] | Cerapedics, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 9,217 6,735  
Unfunded Debt and Equity Commitments [Member] | Alkeme Intermediate Holdings, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 8,531 0  
Unfunded Debt and Equity Commitments [Member] | Arcutis Biotherapeutics, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 8,356 8,356  
Unfunded Debt and Equity Commitments [Member] | Ardelyx, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 7,752 7,752  
Unfunded Debt and Equity Commitments [Member] | West-NR Parent, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 6,830 0  
Unfunded Debt and Equity Commitments [Member] | United Digestive MSO Parent, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 5,259 0  
Unfunded Debt and Equity Commitments [Member] | Peter C. Foy & Associates Insurance Services, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 5,062 1,094  
Unfunded Debt and Equity Commitments [Member] | Luxury Asset Capital, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 4,500 7,500  
Unfunded Debt and Equity Commitments [Member] | UVP Management, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 4,386 0  
Unfunded Debt and Equity Commitments [Member] | Kaseya, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 3,769 3,936  
Unfunded Debt and Equity Commitments [Member] | Urology Management Holdings, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 3,596 0  
Unfunded Debt and Equity Commitments [Member] | The Townsend Company, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 3,556 0  
Unfunded Debt and Equity Commitments [Member] | SLR Equipment Finance [Member]      
Other Commitments [Line Items]      
Other Commitment 3,500 1,000  
Unfunded Debt and Equity Commitments [Member] | Vertos Medical, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 3,325 0  
Unfunded Debt and Equity Commitments [Member] | Foundation Consumer Brands, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 3,009 3,009  
Unfunded Debt and Equity Commitments [Member] | Kid Distro Holdings, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 2,650 2,650  
Unfunded Debt and Equity Commitments [Member] | Maurices, Incorporated [Member]      
Other Commitments [Line Items]      
Other Commitment 2,589 4,314  
Unfunded Debt and Equity Commitments [Member] | Erie Construction Mid-west, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 2,403 1,248  
Unfunded Debt and Equity Commitments [Member] | Ultimate Baked Goods Midco LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 2,371 1,636  
Unfunded Debt and Equity Commitments [Member] | Basic Fun, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 2,150 2,675  
Unfunded Debt and Equity Commitments [Member] | Bayside Opco, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 1,721 0  
Unfunded Debt and Equity Commitments [Member] | SunMed Group Holdings, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 1,621 843  
Unfunded Debt and Equity Commitments [Member] | SCP Eye Care, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 1,459 2,771  
Unfunded Debt and Equity Commitments [Member] | SLR Healthcare ABL [Member]      
Other Commitments [Line Items]      
Other Commitment [1] 1,400 1,400  
Unfunded Debt and Equity Commitments [Member] | RxSense Holdings LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 1,250 1,250  
Unfunded Debt and Equity Commitments [Member] | Enverus Holdings, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 1,239 1,004  
Unfunded Debt and Equity Commitments [Member] | Tilley Distribution, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 1,158 525  
Unfunded Debt and Equity Commitments [Member] | GSM Acquisition Corp. [Member]      
Other Commitments [Line Items]      
Other Commitment 862 784  
Unfunded Debt and Equity Commitments [Member] | Composite Technology Acquisition Corp [Member]      
Other Commitments [Line Items]      
Other Commitment 796 1,537  
Unfunded Debt and Equity Commitments [Member] | High Street Buyer, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 631 327  
Unfunded Debt and Equity Commitments [Member] | CC SAG Holdings Corp. (Spectrum Automotive) [Member]      
Other Commitments [Line Items]      
Other Commitment 548 20,670  
Unfunded Debt and Equity Commitments [Member] | ENS Holdings III Corp, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 461 144  
Unfunded Debt and Equity Commitments [Member] | Pinnacle Treatment Centers, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 386 1,745  
Unfunded Debt and Equity Commitments [Member] | Vessco Midco Holdings, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 327 3,892  
Unfunded Debt and Equity Commitments [Member] | TAUC Management, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 294 294  
Unfunded Debt and Equity Commitments [Member] | All States Ag Parts, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 212 135  
Unfunded Debt and Equity Commitments [Member] | Glooko, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 0 17,868  
Unfunded Debt and Equity Commitments [Member] | World Insurance Associates, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 0 17,117  
Unfunded Debt and Equity Commitments [Member] | Spectrum Pharmaceuticals, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 0 8,771  
Unfunded Debt and Equity Commitments [Member] | Atria Wealth Solutions, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 0 8,215  
Unfunded Debt and Equity Commitments [Member] | Accession Risk Management Group, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 0 7,498  
Unfunded Debt and Equity Commitments [Member] | Copper River Seafoods, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 0 3,595  
Unfunded Debt and Equity Commitments [Member] | Meditrina, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 0 3,367  
Unfunded Debt and Equity Commitments [Member] | One Touch Direct, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 0 3,069  
Unfunded Debt and Equity Commitments [Member] | DeepIntent, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 0 3,049  
Unfunded Debt and Equity Commitments [Member] | Plastics Management, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 0 2,424  
Unfunded Debt and Equity Commitments [Member] | Pediatric Home Respiratory Services, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 0 1,805  
Unfunded Debt and Equity Commitments [Member] | Ivy Fertility Services, LLC [Member]      
Other Commitments [Line Items]      
Other Commitment 0 1,571  
Unfunded Debt and Equity Commitments [Member] | NAC Holdings Corporation [Member]      
Other Commitments [Line Items]      
Other Commitment 0 1,479  
Unfunded Debt and Equity Commitments [Member] | SPAR Marketing Force, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment 0 1,338  
Unfunded Debt and Equity Commitments [Member] | Montefiore Nyack Hospital [Member]      
Other Commitments [Line Items]      
Other Commitment 0 1,034  
Unfunded Debt and Equity Commitments [Member] | American Teleconferencing Services, Ltd [Member]      
Other Commitments [Line Items]      
Other Commitment 0 1,090  
Unfunded Debt and Equity Commitments [Member] | BayMark Health Services, Inc. [Member]      
Other Commitments [Line Items]      
Other Commitment $ 0 $ 391  
[1] The Company controls the funding of these commitments and may cancel them at its discretion.
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.23.3
Capital Share Transactions - Additional Information (Details) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Stockholders' Equity Note [Abstract]      
Shares authorized 200,000,000 200,000,000 200,000,000
Par value $ 0.01 $ 0.01 $ 0.01
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.23.3
Capital Share Transactions - Summary of Transactions In Capital Stock (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Shares repurchased, Shares 0 0 (746) 0 (217,271)
Shares repurchased, Value $ 0 $ 0 $ (10) $ 0 $ (3,038)
Net increase, Shares 0 0 (746) 12,511,825  
Net increase, Value $ 0 $ 0 $ (10) $ 226,839  
Shares issued in connection with the Mergers [Member]          
Shares 0 0 0 12,511,825  
Amount $ 0 $ 0 $ 0 $ 226,839  
XML 75 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Repurchase Program - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
May 09, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Stockholders' Equity Note [Abstract]            
Stock repurchase program, authorized amount $ 50,000          
Stock repurchase program expiration date May 10, 2024          
Stock Repurchased During Period, Shares   0 0 746 0 217,271
Shares Issued, Price Per Share   $ 14.02   $ 14.02   $ 13.98
Stock Repurchased During Period, Value   $ 0 $ 0 $ 10 $ 0 $ 3,038
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Summary of Investment Holdings [Line Items]    
Cost [1] $ 2,204,617  
Fair Value [1] 2,171,056  
SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Cost [2] 132,993 $ 18,032
Fair Value [2],[3] $ 133,561 $ 18,062
Health Care Providers & Services [Member] | Aegis Toxicology Sciences Corporation [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+550  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.13%  
Maturity Date [2] May 09, 2025  
Par Amount [2] $ 2,960  
Cost [2] 2,960  
Fair Value [2],[3] $ 2,960  
Health Care Providers & Services [Member] | BayMark Health Services, Inc. [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2] S+500 [4] L+500 [6]
Floor [2] 1.00% 1.00%
Interest Rate [2] 10.65% [5] 9.73% [7]
Maturity Date [2] Jun. 11, 2027 Jun. 11, 2027
Par Amount [2] $ 4,043 $ 2,992
Cost [2] 4,043 2,992
Fair Value [2],[3] $ 4,043 $ 2,992
Health Care Providers & Services [Member] | Fertility (ITC) Investment Holdco, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+650  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.63%  
Maturity Date [2] Jan. 03, 2029  
Par Amount [2] $ 5,970  
Cost [2] 5,799  
Fair Value [2],[3] $ 5,970  
Health Care Providers & Services [Member] | ONS MSO, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+625  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.62%  
Maturity Date [2] Jul. 08, 2025  
Par Amount [2] $ 5,936  
Cost [2] 5,779  
Fair Value [2],[3] $ 5,936  
Health Care Providers & Services [Member] | PhyNet Dermatology LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+625  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.45%  
Maturity Date [2] Aug. 16, 2024  
Par Amount [2] $ 5,964  
Cost [2] 5,964  
Fair Value [2],[3] $ 5,964  
Health Care Providers & Services [Member] | Pinnacle Treatment Centers, Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+675  
Floor [2] 1.00%  
Interest Rate [2],[5] 12.10%  
Maturity Date [2] Jan. 02, 2026  
Par Amount [2] $ 4,725  
Cost [2] 4,725  
Fair Value [2],[3] $ 4,725  
Health Care Providers & Services [Member] | Plastics Management, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+500  
Floor [2] 1.00%  
Interest Rate [2],[5] 10.44%  
Maturity Date [2] Aug. 18, 2027  
Par Amount [2] $ 5,651  
Cost [2] 5,476  
Fair Value [2],[3] $ 5,651  
Health Care Providers & Services [Member] | Urology Management Holdings, Inc. [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+625  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.79%  
Maturity Date [2] Jun. 15, 2026  
Par Amount [2] $ 2,465  
Cost [2] 2,403  
Fair Value [2],[3] $ 2,440  
Health Care Providers & Services [Member] | Ivy Fertility Services, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[6]   L+625
Floor [2]   1.00%
Interest Rate [2],[7]   10.39%
Maturity Date [2]   Feb. 25, 2026
Par Amount [2]   $ 3,000
Cost [2]   3,000
Fair Value [2],[3]   $ 3,030
Diversified Financial Services [Member] | Atria Wealth Solutions, Inc. [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2] S+650 [4] S+600 [6]
Floor [2] 1.00% 1.00%
Interest Rate [2] 12.15% [5] 10.84% [7]
Maturity Date [2] Feb. 29, 2024 Feb. 29, 2024
Par Amount [2] $ 2,475 $ 2,494
Cost [2] 2,475 2,494
Fair Value [2],[3] $ 2,475 $ 2,494
Trading Companies & Distributors [Member] | All States Ag Parts, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+600  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.60%  
Maturity Date [2] Sep. 01, 2026  
Par Amount [2] $ 2,138  
Cost [2] 2,138  
Fair Value [2],[3] $ 2,138  
Trading Companies & Distributors [Member] | ENS Holdings III Corp. ES Opco USA LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2] S+475 [4] L+475 [6]
Floor [2] 1.00% 1.00%
Interest Rate [2] 10.24% [5] 9.43% [7]
Maturity Date [2] Dec. 31, 2025 Dec. 31, 2025
Par Amount [2] $ 1,089 $ 1,097
Cost [2] 1,089 1,097
Fair Value [2],[3] $ 1,089 $ 1,097
Trading Companies & Distributors [Member] | Tilley Distribution, Inc. [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+600  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.54%  
Maturity Date [2] Dec. 31, 2026  
Par Amount [2] $ 5,963  
Cost [2] 5,963  
Fair Value [2],[3] $ 5,963  
Personal Products [Member] | Foundation Consumer Brands, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2] S+625 [4] L+550 [6]
Floor [2] 1.00% 1.00%
Interest Rate [2] 11.77% [5] 10.15% [7]
Maturity Date [2] Feb. 12, 2027 Feb. 12, 2027
Par Amount [2] $ 8,911 $ 2,963
Cost [2] 8,911 2,963
Fair Value [2],[3] $ 8,911 $ 2,963
Insurance [Member] | Accession Risk Management Group, Inc. [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+550  
Floor [2] 0.75%  
Interest Rate [2],[5] 11.02%  
Maturity Date [2] Nov. 01, 2026  
Par Amount [2] $ 9,078  
Cost [2] 9,078  
Fair Value [2],[3] $ 9,078  
Insurance [Member] | Alkeme Intermediary Holdings, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+650  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.92%  
Maturity Date [2] Oct. 28, 2026  
Par Amount [2] $ 3,021  
Cost [2] 2,931  
Fair Value [2],[3] $ 2,930  
Insurance [Member] | High Street Buyer, Inc. [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2] S+600 [4] L+600 [6]
Floor [2] 0.75% 0.75%
Interest Rate [2] 11.54% [5] 10.73% [7]
Maturity Date [2] Apr. 16, 2028 Apr. 16, 2028
Par Amount [2] $ 4,433 $ 2,494
Cost [2] 4,433 2,494
Fair Value [2],[3] $ 4,433 $ 2,494
Insurance [Member] | West-NR Parent, Inc. [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+625  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.72%  
Maturity Date [2] Dec. 27, 2027  
Par Amount [2] $ 2,674  
Cost [2] 2,622  
Fair Value [2],[3] $ 2,621  
Software [Member] | Kaseya, Inc. [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+625  
Floor [2] 0.75%  
Interest Rate [2],[5] 11.58%  
Maturity Date [2] Jun. 23, 2029  
Par Amount [2] $ 9,000  
Cost [2] 9,000  
Fair Value [2],[3] $ 9,000  
Software [Member] | ICIMS, Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+725  
Floor [2] 0.75%  
Interest Rate [2],[5] 12.14%  
Maturity Date [2] Aug. 18, 2028  
Par Amount [2] $ 3,059  
Cost [2] 3,028  
Fair Value [2],[3] $ 3,059  
Software [Member] | Kid Distro Holdings, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2] S+550 [4] L+575 [6]
Floor [2] 1.00% 1.00%
Interest Rate [2] 11.04% [5] 10.48% [7]
Maturity Date [2] Oct. 01, 2027 Oct. 01, 2027
Par Amount [2] $ 8,962 $ 2,992
Cost [2] 8,962 2,992
Fair Value [2],[3] $ 8,962 $ 2,992
Life Sciences Tools and Services [Member] | RQM+ Corp [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+575  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.40%  
Maturity Date [2] Aug. 12, 2026  
Par Amount [2] $ 5,970  
Cost [2] 5,970  
Fair Value [2],[3] $ 5,970  
Diversified Consumer Services [Member] | CC SAG Holdings Corp [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+575  
Floor [2] 0.75%  
Interest Rate [2],[5] 11.18%  
Maturity Date [2] Jun. 29, 2028  
Par Amount [2] $ 2,992  
Cost [2] 2,992  
Fair Value [2],[3] $ 2,992  
Diversified Consumer Services [Member] | RxSense Holdings LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+500  
Floor [2] 1.00%  
Interest Rate [2],[5] 10.47%  
Maturity Date [2] Mar. 13, 2026  
Par Amount [2] $ 2,977  
Cost [2] 2,977  
Fair Value [2],[3] $ 2,977  
Health Care Equipment and Supplies [Member] | SunMed Group Holdings, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+550  
Floor [2] 0.75%  
Interest Rate [2],[5] 10.99%  
Maturity Date [2] Jun. 16, 2028  
Par Amount [2] $ 8,971  
Cost [2] 8,971  
Fair Value [2],[3] $ 8,971  
Packaged Foods and Meats [Member] | Ultimate Baked Goods Midco LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+625  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.67%  
Maturity Date [2] Aug. 13, 2027  
Par Amount [2] $ 8,977  
Cost [2] 8,977  
Fair Value [2],[3] $ 8,977  
Commercial Services and Supplies [Member] | The Townsend Company LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+625  
Floor [2] 1.00%  
Interest Rate [2],[5] 11.57%  
Maturity Date [2] Aug. 15, 2029  
Par Amount [2] $ 3,570  
Cost [2] 3,482  
Fair Value [2],[3] $ 3,481  
Water Utilities [Member] | Vessco Midco Holdings, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [2],[4] S+450  
Floor [2] 1.00%  
Interest Rate [2],[5] 9.92%  
Maturity Date [2] Nov. 02, 2026  
Par Amount [2] $ 1,845  
Cost [2] 1,845  
Fair Value [2],[3] $ 1,845  
[1] Aggregate net unrealized appreciation for U.S. federal income tax purposes is $31,537; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $152,992 and $121,455, respectively, based on a tax cost of $2,139,519. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
[2] The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
[3] Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
[4] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
[5] Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of September 30, 2023.
[6] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
[7] Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Condensed Financial Statements, Captions [Line Items]          
Investments at fair value (cost $132,993 and $18,032, respectively) [1]   $ 2,171,056   $ 2,171,056  
Total assets $ 2,537,695 2,539,086   2,539,086  
Debt outstanding 1,085,998 1,191,754   1,191,754  
Distributions payable 7,481 0   0  
Total liabilities 1,537,964 1,553,701   1,553,701  
Organizational costs   1,575 $ 1,132 4,563 $ 3,684
Other general and administrative expenses   1,161 935 3,610 4,212
Total expenses   36,457 27,706 101,753 71,078
Net investment income (loss)   23,359 20,055 68,182 53,827
Realized gain on investments   (30,951) (37,326) (29,766) (37,401)
Net change in unrealized gain on investments   34,539 30,799 14,350 (17,081)
Net realized and unrealized gain on investments   3,588 (6,527) (15,416) (54,482)
Net income (loss)   26,947 $ 13,528 52,766 $ (655)
SLR Senior Lending Program LLC [Member]          
Condensed Financial Statements, Captions [Line Items]          
Investments at fair value (cost $132,993 and $18,032, respectively) [2],[3] 18,062 133,561   133,561  
Cash and other assets 1,043 3,886   3,886  
Total assets 19,105 137,447   137,447  
Debt outstanding 0 77,826   77,826  
Distributions payable 0 500   500  
Interest payable and other credit facility related expenses 165 358   358  
Accrued expenses and other payables 89 209   209  
Total liabilities 254 78,893   78,893  
Members' equity 18,851 58,554   58,554  
Total liabilities and members' equity 19,105 137,447   137,447  
Interest income 152 2,757   5,371  
Service fees [4] 4 66   123  
Interest and other credit facility expenses 166 1,773   4,025  
Organizational costs 73 0   0  
Other general and administrative expenses 88 32   89  
Total expenses 331 1,871   4,237  
Net investment income (loss) (179) 886   1,134  
Realized gain on investments 0 0   30  
Net change in unrealized gain on investments 30 177   538  
Net realized and unrealized gain on investments 30 177   568  
Net income (loss) $ (149) $ 1,063   $ 1,702  
[1] Aggregate net unrealized appreciation for U.S. federal income tax purposes is $31,537; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $152,992 and $121,455, respectively, based on a tax cost of $2,139,519. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
[2] Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
[3] The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
[4] Service fees are included within the Company’s Consolidated Statements of Operations as other income.
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]    
Cost [1] $ 2,204,617  
SLR Senior Lending Program LLC [Member]    
Condensed Financial Statements, Captions [Line Items]    
Cost [2] $ 132,993 $ 18,032
[1] Aggregate net unrealized appreciation for U.S. federal income tax purposes is $31,537; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $152,992 and $121,455, respectively, based on a tax cost of $2,139,519. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
[2] The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.23.3
SLR Senior Lending Program LLC - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended
Dec. 12, 2022
Dec. 18, 2019
Dec. 31, 2022
Sep. 30, 2023
Oct. 12, 2022
Summary of Investment Holdings [Line Items]          
Other Commitment     $ 364,163 $ 367,295  
Debt Instrument, Maturity Date   Dec. 15, 2024      
Total assets     2,537,695 2,539,086  
Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment     364,163 367,295  
SLR Senior Lending Program LLC [Member]          
Summary of Investment Holdings [Line Items]          
Other Ownership Interests, Contributed Capital       57,500  
Total assets     19,105 137,447  
Payments to Acquire Investments     18,100 57,456  
Prepaid Expense     68 1,658  
SLR Senior Lending Program LLC [Member] | Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment     $ 40,500 [1] 21,250 [1] $ 100,000
SLR Senior Lending Program LLC [Member] | Senior Secured Revolving Credit Facility [Member] | SLR Senior Lending Program SPV LLC [Member]          
Summary of Investment Holdings [Line Items]          
Long-term Line of Credit $ 100,000     79,200  
Debt Instrument, Maturity Date Dec. 12, 2027        
SLR Senior Lending Program LLC [Member] | Senior Secured Revolving Credit Facility [Member] | SLR Senior Lending Program SPV LLC [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]          
Summary of Investment Holdings [Line Items]          
Line of Credit Facility, Interest Rate During Period 3.25%        
SLR Senior Lending Program LLC [Member] | Investor [Member] | Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment       21,250 50,000
SLR Senior Lending Program LLC [Member] | Management [Member] | Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment       $ 21,250 $ 50,000
[1] The Company controls the funding of these commitments and may cancel them at its discretion.
XML 80 R67.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events - Additional Information (Details)
Nov. 07, 2023
$ / shares
Subsequent Event [Member] | Board [Member]  
Subsequent Event [Line Items]  
Dividends payable, amount per share $ 0.41
XML 81 d458881d10q_htm.xml IDEA: XBRL DOCUMENT 0001418076 2023-01-01 2023-09-30 0001418076 2023-07-01 2023-09-30 0001418076 2022-07-01 2022-09-30 0001418076 2022-01-01 2022-09-30 0001418076 2023-09-30 0001418076 2022-12-31 0001418076 2023-11-03 0001418076 2023-05-09 0001418076 2023-05-09 2023-05-09 0001418076 2022-01-01 2022-12-31 0001418076 2022-09-30 0001418076 2021-12-31 0001418076 2019-12-18 2019-12-18 0001418076 2022-04-01 2022-04-01 0001418076 2015-12-31 0001418076 2014-12-31 0001418076 2013-12-31 0001418076 2020-12-31 0001418076 2019-12-31 0001418076 2018-12-31 0001418076 2017-12-31 0001418076 2016-12-31 0001418076 2023-06-30 0001418076 2022-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputRecoverableAmountMember slrc:ValuationTechniqueRecoveryApproachMember 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-09-30 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-09-30 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-09-30 0001418076 srt:MinimumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 srt:MaximumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 srt:WeightedAverageMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-09-30 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-09-30 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-09-30 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-09-30 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-09-30 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-09-30 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-09-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2023-09-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-09-30 0001418076 slrc:CreditFacilityOneMember 2023-09-30 0001418076 slrc:NmcSeniorCreditFacilityMember 2023-09-30 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2023-09-30 0001418076 slrc:SlrBusinessCreditMember 2023-09-30 0001418076 slrc:KbhtMember 2023-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-09-30 0001418076 slrc:CreditFacilityMember 2023-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblMember 2023-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblMember 2023-09-30 0001418076 slrc:SeniorSecuredCommitmentsMember 2023-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-09-30 0001418076 slrc:KaseyaIncMember 2023-09-30 0001418076 slrc:BridgeBioPharmaIncMember 2023-09-30 0001418076 slrc:VapothermInc.Member 2023-09-30 0001418076 slrc:IcimsInc.Member 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CreditFacilityMember slrc:CitiBankNaMember 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2023-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStatesAgPartsLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NeuroneticsIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AlkemeIntermediateHoldingsLLCMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UVPManagementLLCMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TheTownsendCompanyLLCMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AccessionRiskManagementGroupIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:WestNrParentIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GsmAcquisitionCorpMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CompositeTechnologyAcquisitionCorpMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VesscoMidcoHoldingsLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TaucManagementLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:WorldInsuranceAssociatesLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SpectrumPharmaceuticalsInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ApeelTechnologyIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HumanInterestIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CVAUSAManagementLLCMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BdgMediaInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OnsMsoLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IcimsInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CerapedicsInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArdelyxIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UnitedDigestiveMsoParentLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KaseyaIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UrologyManagementHoldingsIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VertosMedicalInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RxsenseHoldingsLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnverusHoldingsIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaymarkHealthServicesIncMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PlasticsManagementLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MontefioreNyackHospitalMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaysideOpcoLLCMember 2023-09-30 0001418076 slrc:CreditFacilityMember 2023-09-30 0001418076 slrc:CreditFacilityOneMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2023-09-30 0001418076 slrc:TermLoansMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2023-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-09-30 0001418076 slrc:WestNrParentIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:WaterUtilitiesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:PlasticsManagementLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:RqmCorpMember slrc:LifeSciencesToolsAndServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:DiversifiedConsumerServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:HealthCareEquipmentAndSuppliesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:TheTownsendCompanyLLCMember slrc:CommercialServicesAndSuppliesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:TilleyDistributionIncMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:PackagedFoodsAndMeatsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:UrologyManagementHoldingsIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:KidDistroHoldingsLlcMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:OnsMsoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:PhynetDermatologyLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:PinnacleTreatmentCentersIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:CcSagHoldingsCorpMember slrc:DiversifiedConsumerServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:FertilityItcInvestmentHoldcoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:IcimsIncMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:KaseyaIncMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:AccessionRiskManagementGroupIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:AegisToxicologySciencesCorporationMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:AlkemeIntermediaryHoldingsLlcMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:AllStatesAgPartsLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:ASCHoldcoLLCMember 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Foundation Consumer Brands, LLC | Personal Products |S+625 |1.00 % |11.77 %|2/12/2021 |2/12/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Fertility (ITC) Investment Holdco, LLC |Health Care Providers & Services |S+650 |1.00 % |11.63 % |1/4/2023 |1/3/2029 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Erie Construction Mid-west, LLC |Building Products |S+475 |1.00 % |10.34 % |4/1/2022 |7/30/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |GSM Acquisition Corp. |Leisure Equipment & Products |S+500 |1.00 % |10.65 % |4/1/2022 |11/16/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |High Street Buyer, Inc. |Insurance |S+600 |0.75 % |11.54 % |4/1/2022 |4/16/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Higginbotham Insurance Agency, Inc.(16) |Insurance |S+550 |1.00 % |10.92 % |4/1/2022 |11/15/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Human Interest Inc. |Internet Software & Services |S+785 |1.00 % |13.18 % |6/30/2022 |7/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |iCIMS, Inc. |Software |S+725 |0.75 % |12.14 % |8/18/2022 |8/18/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kingsbridge Holdings, LLC |Multi-Sector Holdings |S+700 |1.00 % |1.00 % |12/21/2018 |12/21/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kid Distro Holdings, LLC (Distro Kid) |Software |S+550 |1.00 % |11.04 % |9/24/2021 |10/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kaseya, Inc. |Software |S+625 |0.75 % |11.58 % |6/22/2022 |6/22/2022 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |KORE Wireless Group, Inc. |Logix Holding Company, LLC |S+550 | |10.99 % |12/21/2018 |12/21/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Luxury Asset Capital, LLC |Thrifts & Mortgage Finance |S+675 |1.00 % |12.19 % |7/15/2022 |7/15/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Logix Holding Company, LLC |Communications Equipment |L+575 |1.00 % |11.48 % |9/14/2018 |12/22/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Maurices, Incorporated |Specialty Retail |S+675 |1.00 % |9.94 % |8/27/2021 |6/1/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Maxor Acquisition, Inc. |Health Care Providers & Services |S+675 |1.00 % |12.48 % |3/1/2023 |3/1/2029 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Oldco AI, LLC (f/k/a Amerimark) |Internet & Catalog Retail |S+800 |1.00 % | |7/28/2021 |10/15/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Oldco AI, LLC(f/k/a Amerimark) |Internet & Catalog Retail |P+475 |1.00 % |13.25 % |6/16/2023 |10/31/2023 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |NSPC Intermediate Corp. (National Spine) |Health Care Providers & Services |S+850 |1.00 % |13.20 % |4/1/2022 |2/13/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |ONS MSO, LLC |Health Care Providers & Services |S+625 |1.00 % |11.62 % |2/10/2023 |7/8/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Pediatric Home Respiratory Services, LLC |Health Care Providers & Services |S+625 |1.00 % |11.67 % |8/19/2022 |12/4/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Orthopedic Care Partners Management, LLC |Health Care Providers & Services |S+650 |1.00 % |11.96 % |8/17/2022 |5/16/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Opco, LLC |Healthcare Providers & Services |S+700 |1.00 % |12.54 % |5/31/2023 |5/31/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Opco, LLC |Healthcare Providers & Services |S+725 |1.00 % |12.79 %|5/31/2023 |5/31/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |CC SAG Holdings Corp. (Spectrum Automotive) |Diversified Consumer Services |S+575 |0.75 % |11.18 % |6/29/2021 |6/29/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |BDG Media, Inc | Media |P+525 |5.50 % |13.75 % |7/18/2022 |7/31/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Parent, LLC |Healthcare Providers & Services |S+1000 |1.00 % |15.54 % |5/31/2023 |5/31/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Composite Technology Acquisition Corp. |Building Products |S+450 |1.00 % |10.04 % |4/1/2022 |2/1/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Enhanced Permanent Capital, LLC |Capital Markets |S+700 |S+700 |12.26 % |12/29/2020 |12/29/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |CVAUSA Management, LLC |Health Care Providers & Services |S+650 |1.00 % |11.59 % |5/22/2023 |5/22/2029 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) |Trading Companies & Distributors |S+475 |1.00 % |10.24 % |4/1/2022 |12/31/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Enverus Holdings, Inc. (fka Drilling Info Holdings) |IT Services |S+450 | |9.92 % |4/1/2022 |7/30/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Apex Services Partners, LLC |Diversified Consumer Services |S+525 |1.00 % |10.67 % |8/31/2022 |7/31/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |All States Ag Parts, LLC|Trading Companies & Distributors |S+600 |1.00 % |11.60 % |4/1/2022 |9/1/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Alkeme Intermediary Holdings, LLC |Insurance |S+650 |1.00 % |11.92 % |9/20/2023 |10/28/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Atria Wealth Solutions, Inc. |Diversified Financial Services |S+650 |1.00 % |12.15 % |9/14/2018 |2/29/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |BayMark Health Services, Inc. |Health Care Providers & Services |S+500 |1.00 % |10.65 % |4/1/2022 |6/11/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Basic Fun, Inc.|Specialty Retail |S+650 |1.00 % |12.17 % |10/30/2020 |7/2/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Aegis Toxicology Sciences Corporation |Health Care Providers & Services |S+550 |1.00 % |11.13 % |5/7/2018 |5/9/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.) |Insurance |S+550 |0.75% |11.02% |4/1/2022 |11/1/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Peter C. Foy & Associates Insurance Services, LLC |Insurance |S+600 |0.75 % |11.43 % |4/1/2022 |11/1/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |PhyNet Dermatology LLC |Health Care Providers & Services |S+625 |1.00 % |11.45 % |9/5/2018 |8/16/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |RQM+ Corp. |Life Sciences Tools & Services |S+575 |1.00 % |11.40 % |8/20/2021 |8/12/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Plastics Management, LLC |Health Care Providers & Services|S+500 |1.00 % |10.44 %|4/1/2022 |8/18/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Pinnacle Treatment Centers, Inc. |Health Care Providers & Services |S+675 |1.00 % |12.10 % |1/22/2020 |1/2/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |RxSense Holdings LLC |Diversified Consumer Services |S+500 |1.00 % |10.47 % |4/1/2022 |3/13/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SHO Holding I Corporation (Shoes for Crews) |Footwear |S+523 |1.00 % |10.86 % |4/1/2022 |4/27/2024 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SCP Eye Care, LLC |Health Care Providers & Services |S+575 |1.00 % |11.17 % |10/6/2022 |10/6/2022 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Southern Orthodontic Partners Management, LLC |Health Care Providers & Services |S+625 |1.00 % |11.89 % |6/3/2022 |1/27/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Stryten Resources LLC |Stryten Resources LLC |S+800 |1.00 % |13.43 % |8/11/2021 |10/12/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |The Townsend Company, LLC |Commercial Services & Supplies |S+625 |1.00 % |11.57 % |8/17/2023 |8/15/2029 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |TAUC Management, LLC |Health Care Providers & Services |L+525 |1.00 % |10.59 % |4/1/2022 |2/12/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SunMed Group Holdings, LLC |Health Care Equipment & Supplies |S+550 |0.75 % |10.99 % |6/16/2021|6/16/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Tilley Distribution, Inc. |Trading Companies & Distributors |S+600 |1.00 % |11.54 % |4/1/2022 |12/31/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |United Digestive MSO Parent, LLC |Health Care Providers & Services |S+675 | 1.00 % |12.29 % |3/30/2023 |3/30/2029 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Ultimate Baked Goods Midco LLC (Rise Baking) |Packaged Foods & Meats |S+625 |1.00 % |11.67 % |8/12/2021 |8/13/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Urology Management Holdings, Inc. |Health Care Providers & Services |S+625 |1.00 % |11.79 % |2/7/2023 |6/15/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |UVP Management, LLC |Health Care Providers & Services |S+625 |1.00 % |11.79 % |9/18/2023 |9/15/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |World Insurance Associates, LLC | Insurance |S+575 |1.00 % |11.14 % |4/1/2022 |4/1/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |West-NR Parent, Inc. |Insurance |S+625 |1.00 % |11.72 % |8/1/2023 |12/27/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Vessco Midco Holdings, LLC |Water Utilities |S+450 |1.00 % |9.92 % |4/1/2022 |11/2/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Arcutis Biotherapeutics Inc |Pharamceuticals |S+745 |0.10 % |12.88 % |12/22/2021 |1/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans |ACRES Commercial Mortgage, LLC |Diversified Financial Services |S+705 |1.00 % |12.49 % |12/24/2021 |8/21/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Bank Debt/Senior Secured Loans |RD Holdco Inc |Diversified Consumer Services |S+975 |1.00% |12/23/2013 |10/12/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans |FGI Worldwide LLC |Diversified Financial Services |S+650 |1.00 % |11.82 % |4/17/2023 |4/17/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Alimera Sciences Inc|Pharmaceuticals|S+515|4.60%|10.48 %|12/31/2019|5/1/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Apeel Technology Inc |Biotechnology |S+625 |1.00 % |8.75 % |6/29/2022 |6/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans Vapotherm Inc |Health Care Equipment and Supplies |S+930 |1.00 % |14.73 % |2/18/2022 |2/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Vertos Medical Inc |Health Care Equipment and Supplies |S+515 |4.75 % |10.48 % |6/14/2023 |7/1/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Meditrina Inc |Health Care Equipment & Supplies |S+550 |3.45 % |10.83 % |12/20/2022 |12/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Neuronetics Inc |Health Care Equipment & Supplies |S+565 |3.95 % |10.98 % |3/2/2020 |3/29/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |OmniGuide Holdings Inc |Health Care Equipment and Supplies |S+580 |5.31 % |11.23 % |7/30/2018 |11/1/2025 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans Outset Medical Inc |Health Care Equipment and Supplies |S+515 |2.75 % |10.48 % |11/3/2022 |11/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Ardelyx Inc |Pharmaceuticals |S+795 |1.00 % |13.30 % |2/23/2022 |3/1/2027 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |BridgeBio Pharma Inc |Biotechnology |9.00 % |11/17/2021 |11/17/2026 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Cerapedics Inc |Biotechnology |S+620 |2.75 % |11.53 % |12/27/2022 |1/1/2028 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Glooko Inc |Health Care Technology |S+790 |0.10 % |13.33 % |9/30/2021 |10/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | First National Capital LLC | Diversified Financial Services | 9.00% | 11/5/2021 | 8/1/2026 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 2023-09-30 0001418076 Equipment Financing 26.9% | Georgia Jet Inc | Airlines | 8.00% | 12/4/2017 | 1/4/2024 2023-09-30 0001418076 Equipment Financing 26.9% | GMT Corporation | Machinery | 10.71% | 10/23/2018 | 1/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | Hawkeye Contracting Company LLC | Construction & Engineering | 10.50% | 10/8/2021 | 11/1/2025 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Environmental Protection & Improvement Company LLC | Road & Rail | 8.25% | 9/30/2020 | 10/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% | Equipment Operating Leases LLC | Multi-Sector Holdings | 8.37% | 4/27/2018 | 4/27/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Extreme Steel Crane & Rigging LLC | Commercial Services & Supplies | 9.52% | 3/3/2023 | 3/3/2027 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% | Dongwon Autopart Technology Inc | Auto Components | 7.96% | 2/2/2021 | 1/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | Double S Industrial Contractors Inc | Commercial Services & Supplies | 8.60% | 7/28/2023 | 8/1/2027 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Zamborelli Enterprises Pacific Souther Foundation | Diversified Consumer Services | 8.91% | 12/7/2022 | 1/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% | Womble Company Inc | Energy Equipment & Services | 9.11% | 12/27/2019 | 1/1/2025 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Up Trucking Services LLC | Road & Rail | 11.21% | 3/23/2018 | 8/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Waste Pro of Florida Inc & Waste Pro USA Inc | Commercial Services & Supplies | 9.17% | 4/18/2023 | 4/18/2028 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Star Coaches Inc | Road & Rail | 8.42% | 3/9/2018 | 4/1/2025 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | The Smedley Company & Smedley Services Inc | Commercial Services & Supplies | 4.07% | 7/31/2017 | 1/15/2028 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 2023-09-30 0001418076 Equipment Financing 26.9% | RH Land Construction LLC & Harbor Dredging LA Inc | Construction & Engineering | 8.08% | 5/10/2023 | 5/10/2026 2023-09-30 0001418076 Equipment Financing 26.9% | Royal Express Inc | Road & Rail | 9.53% | 1/17/2019 | 2/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Rotten Rock Hardscaping & Tree Service | Diversified Consumer Services | 8.21% | 12/6/2022 | 12/6/2027 2023-09-30 0001418076 Equipment Financing 26.9% | Rutt Services LLC | Commercial Services & Supplies | 8.95% | 8/11/2023 | 8/11/2030 2023-09-30 0001418076 Equipment Financing 26.9% | Signet Marine Corporation | Transportation Infrastructure | 8.50% | 10/31/2022 | 11/1/2029 2023-09-30 0001418076 Equipment Financing 26.9% | SLR Equipment Finance | Multi-Sector Holdings | 8.50% | 1/24/2022 | 1/27/2024 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Miranda Logistics Enterprise Inc | Construction & Engineering | 7.69% | 4/14/2023 | 4/14/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Mountain Air Helicopters Inc | Commercial Services & Supplies | 10.00% | 7/31/2017 | 2/28/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Nimble Crane LLC | Commercial Services & Supplies | 9.18% | 7/13/2023 | 7/13/2028 2023-09-30 0001418076 Equipment Financing 26.9% | No Limit Construction Services LLC | Commercial Services & Supplies | 7.73% | 5/5/2023 | 6/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Ozzies Inc | Commercial Services & Supplies | 10.72% | 12/23/2022 | 1/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% | PCX Aerostructures LLC | Aerospace & Defense | 9.32% | 11/23/2022 | 12/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Rane Light Metal Castings Inc | Machinery | 10.00% | 6/1/2020 | 6/1/2024 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | International Automotive Components Group North America Inc | Auto Components | 7.95% | 6/23/2021 | 6/23/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Kool Pak LLC | Road & Rail | 8.58% | 2/5/2018 | 3/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Loc Performance Products LLC | Machinery | 10.50% | 12/29/2022 | 6/1/2027 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2023-09-30 0001418076 Equipment Financing 26.9% |A&A Crane and Rigging, LLC |Commercial Services & Supplies |7.78% |3/27/2023 |3/27/2028 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 | 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 | 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2023-09-30 0001418076 Equipment Financing 26.9% |AmeraMex International Inc|Commercial Services and Supplies |10.00% |3/29/2019 |4/15/2025 2023-09-30 0001418076 Equipment Financing 26.9% |Bazzini LLC|Food and Staples Retailing |10.46% |12/23/2022 |1/1/2028 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2023-09-30 0001418076 Equipment Financing 26.9% |Bowman Energy Solutions LLC |Commercial Services and Supplies |7.42% |7/1/2022 |8/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% |C Port or Stone LLC |Oil Gas and Consumable Fuels |8.54% |10/7/2022 |11/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2023-09-30 0001418076 Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 2023-09-30 0001418076 Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2023-09-30 0001418076 srt:MinimumMember Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2023-09-30 0001418076 srt:MaximumMember Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2023-09-30 0001418076 Cash Equivalents 33.7% | U.S. Treasury Bill | Government | 9/29/2023 | 11/21/2023 2023-09-30 0001418076 Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 | 2023-09-30 0001418076 Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2023-09-30 0001418076 Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2023-09-30 0001418076 Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 2023-09-30 0001418076 Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024 2023-09-30 0001418076 Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 2023-09-30 0001418076 Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2023-09-30 0001418076 Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2023-09-30 0001418076 Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 2023-09-30 0001418076 Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 2023-09-30 0001418076 Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 2023-09-30 0001418076 Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 2023-09-30 0001418076 Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 2023-09-30 0001418076 Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 2023-09-30 0001418076 Equipment Financing | SLR Equipment Finance Equity Interests | Multi-Sector Holdings | 7/31/2017 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Assertio Holdings Inc | Pharmaceuticals | 7/31/2023 2023-09-30 0001418076 Common Equity Equity Interests Warrants | aTyr Pharma Inc Warrants | Pharmaceuticals | 11/18/2016 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Bayside Parent LLC | Health Care Providers & Services | 5/31/2023 2023-09-30 0001418076 Common Equity Equity Interests Warrants | CardioFocus Inc Warrants | Health Care Equipment & Supplies | 3/31/2017 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Centrexion Therapeutics Inc Warrants | Pharmaceuticals | 6/28/2019 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2023-09-30 0001418076 Common Equity Equity Interests Warrants | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Meditrina, Inc. Warrants | Health Care Equipment & Supplies | 12/20/2022 2023-09-30 0001418076 Common Equity Equity Interests Warrants | NSPC Holdings, LLC (National Spine) | Health Care Providers & Services | 2/13/2023 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Class B | Diversified Consumer Services | 12/23/2013 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Warrants | Diversified Consumer Services | 12/23/2013 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Senseonics Holdings, Inc | Health Care Equipment & Supplies | 7/25/2019 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR-AMI Topco Blocker, LLC | Internet & Catalog Retail | 6/16/2023 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Business Credit | Diversified Financial Services | 4/1/2022 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Senior Lending Program LLC | Asset Management | 12/1/2022 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Vapotherm, Inc. Warrants | Health Care Equipment & Supplies | 2/18/2022 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) | Health Care Equipment & Supplies | 5/10/2018 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Vertos Medical, Inc. Warrants| Health Care Equipment & Supplies | 6/14/2023 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Total First Lien Life Science Senior Secured Loans 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans 2023-09-30 0001418076 Cash Equivalents 33.7% | Investments & Cash Equivalents 254.1% 2023-09-30 0001418076 Common Equity Equity Interests Warrants 2023-09-30 0001418076 Equipment Financing 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans 2023-09-30 0001418076 Cash Equivalents 33.7% | Liabilities in Excess of Other Assets (154.1%) 2023-09-30 0001418076 Cash Equivalents 33.7% | Net Assets 100.0% 2023-09-30 0001418076 slrc:DiversifiedFinancialServicesIncludesSLRCreditSolutionsSLRBusinessCreditAndSLRHealthcareABLMember 2023-09-30 0001418076 slrc:MultiSectorHoldingsMember 2023-09-30 0001418076 slrc:HealthCareProvidersAndServicesMember 2023-09-30 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2023-09-30 0001418076 slrc:InsuranceMember 2023-09-30 0001418076 slrc:PharmaceuticalsMember 2023-09-30 0001418076 slrc:SoftwareMember 2023-09-30 0001418076 slrc:DiversifiedConsumerServicesMember 2023-09-30 0001418076 slrc:BiotechnologyMember 2023-09-30 0001418076 slrc:CapitalMarketsMember 2023-09-30 0001418076 slrc:CommercialServicesAndSuppliesMember 2023-09-30 0001418076 slrc:ThriftsMortgageFinanceMember 2023-09-30 0001418076 us-gaap:AssetManagement1Member 2023-09-30 0001418076 slrc:RoadAndRailMember 2023-09-30 0001418076 slrc:PersonalProductsMember 2023-09-30 0001418076 slrc:LifeSciencesToolsAndServicesMember 2023-09-30 0001418076 slrc:WirelessTelecommunicationServicesMember 2023-09-30 0001418076 slrc:InternetSoftwareServicesMember 2023-09-30 0001418076 slrc:BuildingProductsMember 2023-09-30 0001418076 slrc:TransportationInfrastructureMember 2023-09-30 0001418076 slrc:InternetAndCatalogRetailMember 2023-09-30 0001418076 slrc:PackagedFoodsAndMeatsMember 2023-09-30 0001418076 slrc:CommunicationsEquipmentMember 2023-09-30 0001418076 slrc:HealthCareTechnologyMember 2023-09-30 0001418076 slrc:ItServicesMember 2023-09-30 0001418076 slrc:LeisureEquipmentProductsMember 2023-09-30 0001418076 slrc:TradingCompaniesDistributorsMember 2023-09-30 0001418076 slrc:AutoPartsAndEquipmentMember 2023-09-30 0001418076 slrc:SpecialtyRetailMember 2023-09-30 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2023-09-30 0001418076 slrc:AerospaceAndDefenseMember 2023-09-30 0001418076 slrc:OilGasAndConsumableFuelsMember 2023-09-30 0001418076 slrc:AutoComponentsMember 2023-09-30 0001418076 slrc:FootwearMember 2023-09-30 0001418076 slrc:MediaMember 2023-09-30 0001418076 slrc:AirlinesMember 2023-09-30 0001418076 slrc:MachineryMember 2023-09-30 0001418076 slrc:MetalsAndMiningMember 2023-09-30 0001418076 slrc:WaterUtilitiesMember 2023-09-30 0001418076 slrc:FoodStaplesRetailingMember 2023-09-30 0001418076 slrc:ConstructionAndEngineeringMember 2023-09-30 0001418076 slrc:ConsumerFinanceMember 2023-09-30 0001418076 slrc:EnergyEquipmentAndServicesMember 2023-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MinimumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:KbhtMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-12-31 0001418076 slrc:AmerimarkMember 2022-12-31 0001418076 slrc:BridgeBioPharmaIncMember 2022-12-31 0001418076 slrc:OmniGuideHoldingsIncMember 2022-12-31 0001418076 slrc:VapothermInc.Member 2022-12-31 0001418076 slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStatesAgPartsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NeuroneticsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AlkemeIntermediateHoldingsLLCMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UVPManagementLLCMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TheTownsendCompanyLLCMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AccessionRiskManagementGroupIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:WestNrParentIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GsmAcquisitionCorpMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CompositeTechnologyAcquisitionCorpMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VesscoMidcoHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TaucManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:WorldInsuranceAssociatesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SpectrumPharmaceuticalsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ApeelTechnologyIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HumanInterestIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CVAUSAManagementLLCMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BdgMediaInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OnsMsoLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CerapedicsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArdelyxIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UnitedDigestiveMsoParentLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KaseyaIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UrologyManagementHoldingsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VertosMedicalInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RxsenseHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnverusHoldingsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PlasticsManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MontefioreNyackHospitalMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaymarkHealthServicesIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaysideOpcoLLCMember 2022-12-31 0001418076 slrc:CreditFacilityMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TermLoansMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Aegis Toxicology Sciences Corporation |Health Care Providers & Services |L+550 |1.00% |10.09% |5/7/2018 |5/9/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |American Teleconferencing Services Ltd |Communications Equipment |L+650 |1.00% |5/5/2016 |9/9/2021 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |All States Ag Parts LLC |Trading Companies & Distributors |S+575 |10.19% |4/1/2022 |9/1/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |American Teleconferencing Services Ltd |Communications Equipment |L+650 |1.00% |9/17/2021 |1/31/2023 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |AmeriMark Intermediate Holdings LLC |Internet & Catalog Retail |L+800 |1.00% |14.77% |7/28/2021 |10/15/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Apex Services Partners LLC |Diversified Consumer Services |S+525 |1.00% |9.80% |8/31/2022 |7/31/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Atria Wealth Solutions Inc. |Diversified Financial Services |S+600 |1.00% |10.84% |9/14/2018 |2/29/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Basic Fun Inc. |Specialty Retail |L+550 |1.00% |10.27% |10/30/2020 |10/30/2023 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |BayMark Health Services Inc. |Health Care Providers & Services |L+500 |1.00% |9.73% |4/1/2022 |6/11/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |BDG Media Inc. |Media |L+900 |0.25% |13.17% |7/18/2022 |4/27/2023 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |CC SAG Holdings Corp. (Spectrum Automotive) |Diversified Consumer Services |L+575 |0.75% |10.48% |6/29/2021 |6/29/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Composite Technology Acquisition Corp. |Building Products |L+475 |1.00% |9.73% |4/1/2022 |2/1/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Copper River Seafoods Inc. |Food Products |P+275 |10.25% |8/31/2022 |4/23/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |DeepIntent Inc. |Media |P+175 |9.25% |10/12/2022 |3/25/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Enhanced Permanent Capital LLC |Capital Markets |L+700 |1.00% |10.13% |12/29/2020 |12/29/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) |Trading Companies & Distributors |S+475 |1.00% |9.43% |4/1/2022 |12/31/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Enverus Holdings Inc. (fka Drilling Info Holdings) |IT Services |L+450 |8.88% |4/1/2022 |7/30/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Erie Construction Mid-west LLC |Building Products |S+475 |1.00% |9.79% |4/1/2022 |7/30/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Foundation Consumer Brands LLC |Personal Products |L+550 |1.00% |10.15% |2/12/2021 |2/12/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |GSM Acquisition Corp. |Leisure Equipment & Products |S+500 |1.00% |9.03% |4/1/2022 |11/16/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Higginbotham Insurance Agency Inc. |Insurance |L+525 |0.75% |9.63% |4/1/2022 |11/25/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |High Street Buyer Inc. |Insurance |L+600|0.75% |10.73% |4/1/2022 |4/16/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Human Interest Inc. |Internet Software & Services |S+785 |1.00% |11.97% |6/30/2022 |7/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |iCIMS Inc. |Software |S+725 |0.75% |11.52% |8/18/2022 |8/18/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Ivy Fertility Services LLC |Health Care Providers & Services |L+625 |1.00% |10.39% |12/22/2021 |2/25/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kaseya Inc. |Software |S+575 |0.75% |10.33% |6/22/2022 |6/23/2029 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kid Distro Holdings LLC (Distro Kid) |Software |L+575 |1.00% |10.48% |9/24/2021 |10/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kingsbridge Holdings LLC |Multi-Sector Holdings |L+700 |1.00% |10.75% |12/21/2018 |12/21/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |KORE Wireless Group Inc. |Wireless Telecommunication Services |S+550 |10.08% |12/21/2018 |12/21/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Logix Holding Company LLC |Communications Equipment |L+575 |1.00% |10.13% |9/14/2018 |12/22/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Luxury Asset Capital LLC |Thrifts & Mortgage Finance |S+675 |1.00% |10.99% |7/15/2022 |7/15/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Maurices Incorporated |Specialty Retail |S+675 |1.00% |8.74% |8/27/2021 |6/1/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Montefiore Nyack Hospital |Health Care Providers & Services |L+495 |9.72% |8/9/2022 |11/15/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |NAC Holdings Corporation (Jaguar) |Insurance |S+525 |1.00% |9.45% |7/30/2021 |9/28/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |National Spine and Pain Centers LLC |Health Care Providers & Services |L+500 |1.00% |7.31% |4/1/2022 |6/2/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |One Touch Direct LLC |Commercial Services & Supplies |P+75 |8.25% |4/3/2020 |3/30/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Orthopedic Care Partners Management LLC |Health Care Providers & Services |S+650 |1.00% |10.91% |8/17/2022 |5/16/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Pediatric Home Respiratory Services LLC |Health Care Providers & Services |S+625 |1.00% |10.67% |8/19/2022 |12/4/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Peter C. Foy & Associates Insurance Services LLC |Insurance |S+600 |0.75% |10.44% |4/1/2022 |11/1/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |PhyNet Dermatology LLC |Health Care Providers & Services |S+625 |1.00% |9.81% |9/5/2018 |8/16/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Pinnacle Treatment Centers Inc.|Health Care Providers & Services |S+650 |1.00% |10.57% |1/22/2020 |1/2/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Plastics Management LLC |Health Care Providers & Services |S+500 |1.00% |9.89% |4/1/2022 |8/18/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |PPT Management Holdings LLC |Health Care Providers & Services |L+850 |1.00% |12.83% |9/14/2018 |1/30/2023 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RQM+ Corp. |Life Sciences Tools & Services |S+575 |1.00% |10.97% |8/20/2021 |8/12/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RSC Acquisition Inc. |Insurance |S+550 |0.75% |9.26% |4/1/2022 |11/1/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RxSense Holdings LLC |Diversified Consumer Services |L+500 |1.00% |9.41% |4/1/2022 |3/13/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SCP Eye Care LLC |Health Care Providers & Services |S+575 |1.00% |9.46% |10/6/2022 |10/5/2029 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SHO Holding I Corporation (Shoes for Crews) |Footwear |L+523 |1.00% |9.66% |4/1/2022 |4/27/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Southern Orthodontic Partners Management LLC |Health Care Providers & Services |S+600 |1.00% |10.77%|1/27/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SPAR Marketing Force Inc. |Media |P+95 |8.45% |7/18/2022 |10/10/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Stryten Resources LLC |Auto Parts & Equipment |S+800 |1.00% |12.44% |8/11/2021 |10/12/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SunMed Group Holdings LLC |Health Care Equipment & Supplies |L+575 |0.75% |10.48% |6/16/2021 |6/16/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |TAUC Management LLC |Health Care Providers & Services |L+525 |1.00% |9.98% |4/1/2022 |2/12/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Tilley Distribution Inc. |Trading Companies & Distributors |S+550 |1.00% |10.14% |4/1/2022 |12/31/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Ultimate Baked Goods Midco LLC (Rise Baking) |Packaged Foods & Meats |L+650 |1.00% |10.88% |8/12/2021 |8/13/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Vessco Midco Holdings LLC |Water Utilities |L+450 |1.00% |7.87% |4/1/2022 |11/2/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |World Insurance Associates LLC |Insurance |S+575 |1.00 |9.31 |4/1/2022 |4/1/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |Second Lien Asset-Based Senior Secured Loans |ACRES Commercial Mortgage LLC |Diversified Financial Services |S+705 |1.00% |11.38% |12/24/2021 |8/21/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |Second Lien Bank Debt/Senior Secured Loans |RD Holdco Inc. |Diversified Consumer Services |S+975 |1.00% |12/23/2013 |10/12/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Alimera Sciences Inc. |Pharmaceuticals |L+765 |1.78% |11.82% |12/31/2019 |7/1/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Apeel Technology Inc |Biotechnology |S+625 |1.00% |8.75% |6/29/2022 |6/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Arcutis Biotherapeutics Inc. |Pharamceuticals |L+745 |0.10% |11.62% |12/22/2021 |1/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Ardelyx Inc. |Pharamceuticals |L+795 |0.10% |12.12% |2/23/2022 |3/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |BridgeBio Pharma Inc. |Biotechnology |9.00% |11/17/2021 |11/17/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Centrexion Therapeutics Inc. |Pharmaceuticals |L+725 |2.45% |11.42% |6/28/2019 |1/1/2024 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Cerapedics Inc. |Biotechnology |S+620 |2.75% |10.52% |12/27/2022 |1/1/2028 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Glooko Inc. |Health Care Technology |L+790 |0.10% |12.07% |9/30/2021 |10/1/2026 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Meditrina Inc. |Health Care Equipment & Supplies |S+550 |3.45% |9.82% |12/20/2022 |12/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Neuronetics Inc. |Health Care Equipment & Supplies |L+765 |1.66% |11.82% |3/2/2020 |2/28/2025 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |OmniGuide Holdings Inc. |Health Care Equipment & Supplies |L+1405 |0.10% |18.22% |7/30/2018 |7/1/2023 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Outset Medical Inc. |Health Care Equipment & Supplies |S+515 |2.75% |9.33% |11/3/2022 |11/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Spectrum Pharmaceuticals Inc. |Biotechnology |S+570 |2.30% |9.88% |9/21/2022 |9/1/2027 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Vapotherm Inc. |Health Care Equipment & Supplies |S+830 |1.00% |12.58% |2/18/2022 |2/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Champion Air LLC |Airlines |10.00% |3/19/2018 |1/1/2023 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028 2022-12-31 0001418076 Equipment Financing 26.6% |Dongwon Autopart Technology Inc. |Auto Components |7.96% |2/2/2021 | 1/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Drillers Choice Inc. |Commercial Services & Supplies |8.00% |10/31/2022 | 11/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |EasyPak LLC |Containers & Packaging |9.01% |1/6/2021 | 1/1/2024 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Environmental Protection & Improvement Company LLC |Road & Rail |8.25% |9/30/2020 | 10/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Equipment Operating Leases LLC |Multi-Sector Holdings |8.37% |4/27/2018 | 4/27/2025 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |First National Capital LLC |Diversified Financial Services | 9.00% |11/5/2021 | 8/1/2026 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023 2022-12-31 0001418076 Equipment Financing 26.6% |Georgia Jet Inc. |Airlines | 8.00% |12/4/2017 | 1/4/2024 2022-12-31 0001418076 Equipment Financing 26.6% |GMT Corporation |Machinery | 10.71% |10/23/2018 | 1/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Hawkeye Contracting Company LLC |Construction & Engineering | 10.50% |10/8/2021 | 11/1/2025 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025 2022-12-31 0001418076 Equipment Financing 26.6% |International Automotive Components Group North America Inc.|Auto Components | 7.95% |6/23/2021 | 6/23/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Kool Pak LLC |Road & Rail | 8.58% |2/5/2018 | 3/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Loc Performance Products LLC |Machinery | 10.50% |12/29/2022 | 6/1/2027 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Mountain Air Helicopters Inc. |Commercial Services & Supplies | 10.00% |7/31/2017 | 2/28/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Ozzies Inc. |Commercial Services & Supplies | 10.72% |12/23/2022 | 1/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |PCX Aerostructures LLC |Aerospace & Defense | 9.32% |11/23/2022 | 12/1/2028 2022-12-31 0001418076 Equipment Financing 26.6% |Rane Light Metal Castings Inc. |Machinery | 10.00% |6/1/2020 | 6/1/2024 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Royal Coach Lines Inc. |Road & Rail | 9.56% |11/21/2019 | 8/1/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Royal Express Inc. |Road & Rail | 9.53% |1/17/2019 | 2/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Rotten Rock Hardscaping & Tree Service |Diversified Consumer Services | 8.21% |12/6/2022 | 12/6/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Signet Marine Corporation |Transportation Infrastructure | 8.50% |10/31/2022 |7/1/2029 2022-12-31 0001418076 Equipment Financing 26.6% |SLR Equipment Finance |Multi-Sector Holdings | 8.50% |1/24/2022 |1/24/2023 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Star Coaches Inc. |Road & Rail | 8.42% |3/9/2018 |4/1/2025 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |The Smedley Company & Smedley Services Inc. |Commercial Services & Supplies | 4.07% |7/31/2017 |1/15/2028 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |U.S. Crane & Rigging LLC |Commercial Services & Supplies | 10.92% |12/23/2022 |3/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Up Trucking Services LLC |Road & Rail | 11.21% |3/23/2018 |8/1/2024 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Womble Company Inc. |DEnergy Equipment & Services |9.11% |12/27/2019 |1/1/2025 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Zamborelli Enterprises Pacific Souther Foundation |Diversified Consumer Services |8.91% |12/7/2022 |1/1/2027 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2022-12-31 0001418076 Equipment Financing 26.6% |AmeraMex International Inc. |Commercial Services & Supplies |10.00% |3/29/2019 |9/15/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Bazzini LLC |Food & Staples Retailing |10.46% |12/23/2022 |1/1/2028 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Bowman Energy Solutions LLC |Commercial Services & Supplies |7.42% |7/1/2022 |8/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |C-Port/Stone LLC |Oil, Gas & Consumable Fuels |8.54% |10/7/2022 |11/1/2027 2022-12-31 0001418076 Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026 2022-12-31 0001418076 srt:MinimumMember Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2022-12-31 0001418076 srt:MaximumMember Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023 2022-12-31 0001418076 Cash Equivalents 41.8% | U.S. Treasury Bill | Government | 12/30/2022 | 2/23/2023 2022-12-31 0001418076 Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029 2022-12-31 0001418076 Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2022-12-31 0001418076 Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028 2022-12-31 0001418076 Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023 2022-12-31 0001418076 Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025 2022-12-31 0001418076 Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024 2022-12-31 0001418076 Equipment Financing 26.6% |SLR Equipment Finance Equity Interests |Multi-Sector Holdings |7/31/2017 2022-12-31 0001418076 Common Equity Equity Interests Warrants | aTyr Pharma Inc Warrants | Pharmaceuticals | 11/18/2016 2022-12-31 0001418076 Common Equity Equity Interests Warrants | CardioFocus Inc Warrants | Health Care Equipment & Supplies | 3/31/2017 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Centrexion Therapeutics Inc Warrants | Pharmaceuticals | 6/28/2019 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2022-12-31 0001418076 Common Equity Equity Interests Warrants | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Meditrina, Inc. Warrants | Health Care Equipment & Supplies | 12/20/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Class B | Diversified Consumer Services | 12/23/2013 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Warrants | Diversified Consumer Services | 12/23/2013 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Senseonics Holdings, Inc | Health Care Equipment & Supplies | 7/25/2019 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Business Credit | Diversified Financial Services | 4/1/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Senior Lending Program LLC | Asset Management | 12/1/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Spectrum Pharmaceuticals, Inc. Warrants | Biotechnology | 9/21/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Vapotherm, Inc. Warrants | Health Care Equipment & Supplies | 2/18/2022 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) | Health Care Equipment & Supplies | 5/10/2018 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Total First Lien Life Science Senior Secured Loans 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans 2022-12-31 0001418076 Equipment Financing 2022-12-31 0001418076 Common Equity Equity Interests Warrants 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Investments 208.7% 2022-12-31 0001418076 Cash Equivalents 41.8% | Investments & Cash Equivalents 250.5% 2022-12-31 0001418076 Cash Equivalents 41.8% | Liabilities in Excess of Other Assets (150.5%) 2022-12-31 0001418076 Cash Equivalents 41.8% | Net Assets 100.0% 2022-12-31 0001418076 slrc:DiversifiedFinancialServicesIncludesSLRCreditSolutionsSLRBusinessCreditAndSLRHealthcareABLMember 2022-12-31 0001418076 slrc:MultiSectorHoldingsMember 2022-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2022-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2022-12-31 0001418076 slrc:PharmaceuticalsMember 2022-12-31 0001418076 slrc:SoftwareMember 2022-12-31 0001418076 slrc:InsuranceMember 2022-12-31 0001418076 slrc:BiotechnologyMember 2022-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2022-12-31 0001418076 slrc:MediaMember 2022-12-31 0001418076 slrc:RoadAndRailMember 2022-12-31 0001418076 slrc:PersonalProductsMember 2022-12-31 0001418076 slrc:CapitalMarketsMember 2022-12-31 0001418076 slrc:ThriftsMortgageFinanceMember 2022-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2022-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2022-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2022-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2022-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2022-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2022-12-31 0001418076 slrc:InternetSoftwareServicesMember 2022-12-31 0001418076 slrc:BuildingProductsMember 2022-12-31 0001418076 slrc:TradingCompaniesDistributorsMember 2022-12-31 0001418076 slrc:HealthCareTechnologyMember 2022-12-31 0001418076 slrc:TransportationInfrastructureMember 2022-12-31 0001418076 slrc:CommunicationsEquipmentMember 2022-12-31 0001418076 slrc:ItServicesMember 2022-12-31 0001418076 slrc:LeisureEquipmentProductsMember 2022-12-31 0001418076 slrc:SpecialtyRetailMember 2022-12-31 0001418076 us-gaap:AssetManagement1Member 2022-12-31 0001418076 slrc:FoodProductsMember 2022-12-31 0001418076 slrc:AutoComponentsMember 2022-12-31 0001418076 slrc:AirlinesMember 2022-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2022-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2022-12-31 0001418076 slrc:AerospaceAndDefenseMember 2022-12-31 0001418076 slrc:MachineryMember 2022-12-31 0001418076 slrc:FootwearMember 2022-12-31 0001418076 slrc:MetalsAndMiningMember 2022-12-31 0001418076 slrc:FoodStaplesRetailingMember 2022-12-31 0001418076 slrc:WaterUtilitiesMember 2022-12-31 0001418076 slrc:ConsumerFinanceMember 2022-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2022-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2022-12-31 0001418076 slrc:ContainersAndPackagingMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-07-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-07-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-07-01 2023-09-30 0001418076 slrc:AdvisoryAgreementMember 2023-07-01 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-07-01 2023-09-30 0001418076 slrc:EquipmentFinancingMember 2023-07-01 2023-09-30 0001418076 slrc:PreferredEquityMember 2023-07-01 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember 2023-07-01 2023-09-30 0001418076 slrc:SlrBusinessCreditMember 2023-07-01 2023-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2023-07-01 2023-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-07-01 2023-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-07-01 2023-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-07-01 2023-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-07-01 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-07-01 2023-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-07-01 2022-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-07-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-07-01 2022-09-30 0001418076 slrc:AdvisoryAgreementMember 2022-07-01 2022-09-30 0001418076 slrc:SlrBusinessCreditMember 2022-07-01 2022-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-07-01 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-07-01 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-07-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-07-01 2022-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-07-01 2022-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:AdvisoryAgreementMember 2022-01-01 2022-09-30 0001418076 slrc:SlrBusinessCreditMember 2022-01-01 2022-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-01-01 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-01-01 2022-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 srt:MinimumMember 2023-01-01 2023-09-30 0001418076 srt:MaximumMember 2023-01-01 2023-09-30 0001418076 srt:MaximumMember slrc:AdvisoryAgreementMember 2023-01-01 2023-09-30 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2023-01-01 2023-09-30 0001418076 slrc:AdvisoryAgreementMember 2023-01-01 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-01-01 2023-09-30 0001418076 slrc:EquipmentFinancingMember 2023-01-01 2023-09-30 0001418076 slrc:PreferredEquityMember 2023-01-01 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember 2023-01-01 2023-09-30 0001418076 slrc:SpreadOneMember 2023-01-01 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-01-01 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputRecoverableAmountMember slrc:ValuationTechniqueRecoveryApproachMember 2023-01-01 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-01-01 2023-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-01-01 2023-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-01-01 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-01-01 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-01-01 2023-09-30 0001418076 slrc:SlrBusinessCreditMember 2023-01-01 2023-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2023-01-01 2023-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CreditFacilityMember 2023-01-01 2023-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2023-01-01 2023-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-01-01 2023-09-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-01-01 2023-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCOneMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmeriMarkIntermediateHoldingsOneLLCMember 2023-01-01 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2023-01-01 2023-09-30 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2023-01-01 2023-09-30 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:LondonInterbankOfferedRateMember slrc:CitiBankNaMember 2023-01-01 2023-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-01-01 2023-09-30 0001418076 us-gaap:RevolvingCreditFacilityMember slrc:SlrBusinessCreditFacilityMember 2023-01-01 2023-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-01-01 2023-09-30 0001418076 slrc:AccessionRiskManagementGroupIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:AegisToxicologySciencesCorporationMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:AlkemeIntermediaryHoldingsLlcMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:AllStatesAgPartsLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:CcSagHoldingsCorpMember slrc:DiversifiedConsumerServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:FertilityItcInvestmentHoldcoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:IcimsIncMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:KaseyaIncMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:KidDistroHoldingsLlcMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:OnsMsoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:PhynetDermatologyLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:PinnacleTreatmentCentersIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:PlasticsManagementLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:RqmCorpMember slrc:LifeSciencesToolsAndServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:DiversifiedConsumerServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:HealthCareEquipmentAndSuppliesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:TheTownsendCompanyLLCMember slrc:CommercialServicesAndSuppliesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:TilleyDistributionIncMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:PackagedFoodsAndMeatsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:UrologyManagementHoldingsIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:WaterUtilitiesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:WestNrParentIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Womble Company Inc | Energy Equipment & Services | 9.11% | 12/27/2019 | 1/1/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Worldwide Flight Services Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Zamborelli Enterprises Pacific Souther Foundation | Diversified Consumer Services | 8.91% | 12/7/2022 | 1/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing | SLR Equipment Finance Equity Interests | Multi-Sector Holdings | 7/31/2017 2023-01-01 2023-09-30 0001418076 Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Assertio Holdings Inc | Pharmaceuticals | 7/31/2023 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | aTyr Pharma Inc Warrants | Pharmaceuticals | 11/18/2016 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Bayside Parent LLC | Health Care Providers & Services | 5/31/2023 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | CardioFocus Inc Warrants | Health Care Equipment & Supplies | 3/31/2017 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Centrexion Therapeutics Inc Warrants | Pharmaceuticals | 6/28/2019 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Meditrina, Inc. Warrants | Health Care Equipment & Supplies | 12/20/2022 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | NSPC Holdings, LLC (National Spine) | Health Care Providers & Services | 2/13/2023 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Class B | Diversified Consumer Services | 12/23/2013 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Warrants | Diversified Consumer Services | 12/23/2013 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Senseonics Holdings, Inc | Health Care Equipment & Supplies | 7/25/2019 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR-AMI Topco Blocker, LLC | Internet & Catalog Retail | 6/16/2023 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Business Credit | Diversified Financial Services | 4/1/2022 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | SLR Senior Lending Program LLC | Asset Management | 12/1/2022 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Vapotherm, Inc. Warrants | Health Care Equipment & Supplies | 2/18/2022 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) | Health Care Equipment & Supplies | 5/10/2018 2023-01-01 2023-09-30 0001418076 Common Equity Equity Interests Warrants | Vertos Medical, Inc. Warrants| Health Care Equipment & Supplies | 6/14/2023 2023-01-01 2023-09-30 0001418076 Cash Equivalents 33.7% | U.S. Treasury Bill | Government | 9/29/2023 | 11/21/2023 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.) |Insurance |S+550 |0.75% |11.02% |4/1/2022 |11/1/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Aegis Toxicology Sciences Corporation |Health Care Providers & Services |S+550 |1.00 % |11.13 % |5/7/2018 |5/9/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Alkeme Intermediary Holdings, LLC |Insurance |S+650 |1.00 % |11.92 % |9/20/2023 |10/28/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |All States Ag Parts, LLC|Trading Companies & Distributors |S+600 |1.00 % |11.60 % |4/1/2022 |9/1/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Apex Services Partners, LLC |Diversified Consumer Services |S+525 |1.00 % |10.67 % |8/31/2022 |7/31/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Atria Wealth Solutions, Inc. |Diversified Financial Services |S+650 |1.00 % |12.15 % |9/14/2018 |2/29/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Basic Fun, Inc.|Specialty Retail |S+650 |1.00 % |12.17 % |10/30/2020 |7/2/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |BayMark Health Services, Inc. |Health Care Providers & Services |S+500 |1.00 % |10.65 % |4/1/2022 |6/11/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Opco, LLC |Healthcare Providers & Services |S+700 |1.00 % |12.54 % |5/31/2023 |5/31/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Opco, LLC |Healthcare Providers & Services |S+725 |1.00 % |12.79 %|5/31/2023 |5/31/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Bayside Parent, LLC |Healthcare Providers & Services |S+1000 |1.00 % |15.54 % |5/31/2023 |5/31/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |BDG Media, Inc | Media |P+525 |5.50 % |13.75 % |7/18/2022 |7/31/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |CC SAG Holdings Corp. (Spectrum Automotive) |Diversified Consumer Services |S+575 |0.75 % |11.18 % |6/29/2021 |6/29/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Composite Technology Acquisition Corp. |Building Products |S+450 |1.00 % |10.04 % |4/1/2022 |2/1/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |CVAUSA Management, LLC |Health Care Providers & Services |S+650 |1.00 % |11.59 % |5/22/2023 |5/22/2029 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Enhanced Permanent Capital, LLC |Capital Markets |S+700 |S+700 |12.26 % |12/29/2020 |12/29/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) |Trading Companies & Distributors |S+475 |1.00 % |10.24 % |4/1/2022 |12/31/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Enverus Holdings, Inc. (fka Drilling Info Holdings) |IT Services |S+450 | |9.92 % |4/1/2022 |7/30/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Erie Construction Mid-west, LLC |Building Products |S+475 |1.00 % |10.34 % |4/1/2022 |7/30/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Fertility (ITC) Investment Holdco, LLC |Health Care Providers & Services |S+650 |1.00 % |11.63 % |1/4/2023 |1/3/2029 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Foundation Consumer Brands, LLC | Personal Products |S+625 |1.00 % |11.77 %|2/12/2021 |2/12/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |GSM Acquisition Corp. |Leisure Equipment & Products |S+500 |1.00 % |10.65 % |4/1/2022 |11/16/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Higginbotham Insurance Agency, Inc.(16) |Insurance |S+550 |1.00 % |10.92 % |4/1/2022 |11/15/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |High Street Buyer, Inc. |Insurance |S+600 |0.75 % |11.54 % |4/1/2022 |4/16/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Human Interest Inc. |Internet Software & Services |S+785 |1.00 % |13.18 % |6/30/2022 |7/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |iCIMS, Inc. |Software |S+725 |0.75 % |12.14 % |8/18/2022 |8/18/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kaseya, Inc. |Software |S+625 |0.75 % |11.58 % |6/22/2022 |6/22/2022 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kid Distro Holdings, LLC (Distro Kid) |Software |S+550 |1.00 % |11.04 % |9/24/2021 |10/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Kingsbridge Holdings, LLC |Multi-Sector Holdings |S+700 |1.00 % |1.00 % |12/21/2018 |12/21/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |KORE Wireless Group, Inc. |Logix Holding Company, LLC |S+550 | |10.99 % |12/21/2018 |12/21/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Logix Holding Company, LLC |Communications Equipment |L+575 |1.00 % |11.48 % |9/14/2018 |12/22/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Luxury Asset Capital, LLC |Thrifts & Mortgage Finance |S+675 |1.00 % |12.19 % |7/15/2022 |7/15/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Maurices, Incorporated |Specialty Retail |S+675 |1.00 % |9.94 % |8/27/2021 |6/1/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Maxor Acquisition, Inc. |Health Care Providers & Services |S+675 |1.00 % |12.48 % |3/1/2023 |3/1/2029 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |NSPC Intermediate Corp. (National Spine) |Health Care Providers & Services |S+850 |1.00 % |13.20 % |4/1/2022 |2/13/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Oldco AI, LLC(f/k/a Amerimark) |Internet & Catalog Retail |P+475 |1.00 % |13.25 % |6/16/2023 |10/31/2023 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Oldco AI, LLC (f/k/a Amerimark) |Internet & Catalog Retail |S+800 |1.00 % | |7/28/2021 |10/15/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |ONS MSO, LLC |Health Care Providers & Services |S+625 |1.00 % |11.62 % |2/10/2023 |7/8/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Orthopedic Care Partners Management, LLC |Health Care Providers & Services |S+650 |1.00 % |11.96 % |8/17/2022 |5/16/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Pediatric Home Respiratory Services, LLC |Health Care Providers & Services |S+625 |1.00 % |11.67 % |8/19/2022 |12/4/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Peter C. Foy & Associates Insurance Services, LLC |Insurance |S+600 |0.75 % |11.43 % |4/1/2022 |11/1/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |PhyNet Dermatology LLC |Health Care Providers & Services |S+625 |1.00 % |11.45 % |9/5/2018 |8/16/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Pinnacle Treatment Centers, Inc. |Health Care Providers & Services |S+675 |1.00 % |12.10 % |1/22/2020 |1/2/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Plastics Management, LLC |Health Care Providers & Services|S+500 |1.00 % |10.44 %|4/1/2022 |8/18/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |RQM+ Corp. |Life Sciences Tools & Services |S+575 |1.00 % |11.40 % |8/20/2021 |8/12/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |RxSense Holdings LLC |Diversified Consumer Services |S+500 |1.00 % |10.47 % |4/1/2022 |3/13/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SCP Eye Care, LLC |Health Care Providers & Services |S+575 |1.00 % |11.17 % |10/6/2022 |10/6/2022 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SHO Holding I Corporation (Shoes for Crews) |Footwear |S+523 |1.00 % |10.86 % |4/1/2022 |4/27/2024 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Southern Orthodontic Partners Management, LLC |Health Care Providers & Services |S+625 |1.00 % |11.89 % |6/3/2022 |1/27/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Stryten Resources LLC |Stryten Resources LLC |S+800 |1.00 % |13.43 % |8/11/2021 |10/12/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |SunMed Group Holdings, LLC |Health Care Equipment & Supplies |S+550 |0.75 % |10.99 % |6/16/2021|6/16/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |TAUC Management, LLC |Health Care Providers & Services |L+525 |1.00 % |10.59 % |4/1/2022 |2/12/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |The Townsend Company, LLC |Commercial Services & Supplies |S+625 |1.00 % |11.57 % |8/17/2023 |8/15/2029 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Tilley Distribution, Inc. |Trading Companies & Distributors |S+600 |1.00 % |11.54 % |4/1/2022 |12/31/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Ultimate Baked Goods Midco LLC (Rise Baking) |Packaged Foods & Meats |S+625 |1.00 % |11.67 % |8/12/2021 |8/13/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |United Digestive MSO Parent, LLC |Health Care Providers & Services |S+675 | 1.00 % |12.29 % |3/30/2023 |3/30/2029 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Urology Management Holdings, Inc. |Health Care Providers & Services |S+625 |1.00 % |11.79 % |2/7/2023 |6/15/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |UVP Management, LLC |Health Care Providers & Services |S+625 |1.00 % |11.79 % |9/18/2023 |9/15/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |Vessco Midco Holdings, LLC |Water Utilities |S+450 |1.00 % |9.92 % |4/1/2022 |11/2/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |West-NR Parent, Inc. |Insurance |S+625 |1.00 % |11.72 % |8/1/2023 |12/27/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Bank Debt/Senior Secured Loans |World Insurance Associates, LLC | Insurance |S+575 |1.00 % |11.14 % |4/1/2022 |4/1/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans |ACRES Commercial Mortgage, LLC |Diversified Financial Services |S+705 |1.00 % |12.49 % |12/24/2021 |8/21/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Asset-Based Senior Secured Loans |FGI Worldwide LLC |Diversified Financial Services |S+650 |1.00 % |11.82 % |4/17/2023 |4/17/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |Second Lien Bank Debt/Senior Secured Loans |RD Holdco Inc |Diversified Consumer Services |S+975 |1.00% |12/23/2013 |10/12/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Alimera Sciences Inc|Pharmaceuticals|S+515|4.60%|10.48 %|12/31/2019|5/1/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Apeel Technology Inc |Biotechnology |S+625 |1.00 % |8.75 % |6/29/2022 |6/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Arcutis Biotherapeutics Inc |Pharamceuticals |S+745 |0.10 % |12.88 % |12/22/2021 |1/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Ardelyx Inc |Pharmaceuticals |S+795 |1.00 % |13.30 % |2/23/2022 |3/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |BridgeBio Pharma Inc |Biotechnology |9.00 % |11/17/2021 |11/17/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Cerapedics Inc |Biotechnology |S+620 |2.75 % |11.53 % |12/27/2022 |1/1/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Glooko Inc |Health Care Technology |S+790 |0.10 % |13.33 % |9/30/2021 |10/1/2026 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Meditrina Inc |Health Care Equipment & Supplies |S+550 |3.45 % |10.83 % |12/20/2022 |12/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Neuronetics Inc |Health Care Equipment & Supplies |S+565 |3.95 % |10.98 % |3/2/2020 |3/29/2028 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |OmniGuide Holdings Inc |Health Care Equipment and Supplies |S+580 |5.31 % |11.23 % |7/30/2018 |11/1/2025 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans Outset Medical Inc |Health Care Equipment and Supplies |S+515 |2.75 % |10.48 % |11/3/2022 |11/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans Vapotherm Inc |Health Care Equipment and Supplies |S+930 |1.00 % |14.73 % |2/18/2022 |2/1/2027 2023-01-01 2023-09-30 0001418076 Senior Secured Loans 132.0% |First Lien Life Science Senior Secured Loans |Vertos Medical Inc |Health Care Equipment and Supplies |S+515 |4.75 % |10.48 % |6/14/2023 |7/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |A&A Crane and Rigging, LLC |Commercial Services & Supplies |7.78% |3/27/2023 |3/27/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Aero Operating LLC | Commercial Services & Supplies |8.47-9.64% |2/12/2021 | 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |AFG Dallas III LLC |Diversified Consumer Services |10.00-11.29% |8/11/2022 |8/11/2026-3/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |AmeraMex International Inc|Commercial Services and Supplies |10.00% |3/29/2019 |4/15/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Bazzini LLC|Food and Staples Retailing |10.46% |12/23/2022 |1/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Boart Longyear Company |Metals and Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Bowman Energy Solutions LLC |Commercial Services and Supplies |7.42% |7/1/2022 |8/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |C Port or Stone LLC |Oil Gas and Consumable Fuels |8.54% |10/7/2022 |11/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% |Capital City Jet Center Inc |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Carolinas Contracting LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | CKD Holdings Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Clubcorp Holdings Inc | Hotels Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Complete Equipment Rentals LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Dongwon Autopart Technology Inc | Auto Components | 7.96% | 2/2/2021 | 1/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Double S Industrial Contractors Inc | Commercial Services & Supplies | 8.60% | 7/28/2023 | 8/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Drillers Choice Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Energy Drilling Services LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Environmental Protection & Improvement Company LLC | Road & Rail | 8.25% | 9/30/2020 | 10/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Equipment Operating Leases LLC | Multi-Sector Holdings | 8.37% | 4/27/2018 | 4/27/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Extreme Steel Crane & Rigging LLC | Commercial Services & Supplies | 9.52% | 3/3/2023 | 3/3/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | First American Commercial Bancorp Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | First National Capital LLC | Diversified Financial Services | 9.00% | 11/5/2021 | 8/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Freightsol LLC | Road & Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Georgia Jet Inc | Airlines | 8.00% | 12/4/2017 | 1/4/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | GMT Corporation | Machinery | 10.71% | 10/23/2018 | 1/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Hawkeye Contracting Company LLC | Construction & Engineering | 10.50% | 10/8/2021 | 11/1/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | International Automotive Components Group North America Inc | Auto Components | 7.95% | 6/23/2021 | 6/23/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Kool Pak LLC | Road & Rail | 8.58% | 2/5/2018 | 3/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Loc Performance Products LLC | Machinery | 10.50% | 12/29/2022 | 6/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Lux Credit Consultants LLC | Road & Rail | 8.28-12.09% | 6/17/2021 | 12/1/2024-12/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Lux Vending LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Miranda Logistics Enterprise Inc | Construction & Engineering | 7.69% | 4/14/2023 | 4/14/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Mountain Air Helicopters Inc | Commercial Services & Supplies | 10.00% | 7/31/2017 | 2/28/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Nimble Crane LLC | Commercial Services & Supplies | 9.18% | 7/13/2023 | 7/13/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | No Limit Construction Services LLC | Commercial Services & Supplies | 7.73% | 5/5/2023 | 6/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Ozzies Inc | Commercial Services & Supplies | 10.72% | 12/23/2022 | 1/1/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | PCX Aerostructures LLC | Aerospace & Defense | 9.32% | 11/23/2022 | 12/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Rane Light Metal Castings Inc | Machinery | 10.00% | 6/1/2020 | 6/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Rango Inc | Commercial Services & Supplies | 9.33-9.77% | 9/24/2019 | 10/1/2023-11/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | RH Land Construction LLC & Harbor Dredging LA Inc | Construction & Engineering | 8.08% | 5/10/2023 | 5/10/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Royal Express Inc | Road & Rail | 9.53% | 1/17/2019 | 2/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Rotten Rock Hardscaping & Tree Service | Diversified Consumer Services | 8.21% | 12/6/2022 | 12/6/2027 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Rutt Services LLC | Commercial Services & Supplies | 8.95% | 8/11/2023 | 8/11/2030 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Signet Marine Corporation | Transportation Infrastructure | 8.50% | 10/31/2022 | 11/1/2029 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | SLR Equipment Finance | Multi-Sector Holdings | 8.50% | 1/24/2022 | 1/27/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Smiley Lifting Solutions LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | ST Coaches LLC | Road & Rail | 8.50-8.58% | 7/31/2017 | 10/1/2023-1/25/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Star Coaches Inc | Road & Rail | 8.42% | 3/9/2018 | 4/1/2025 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Superior Transportation Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | The Smedley Company & Smedley Services Inc | Commercial Services & Supplies | 4.07% | 7/31/2017 | 1/15/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Trinity Equipment Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Trinity Equipment Rentals Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | U S Crane & Rigging LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Up Trucking Services LLC | Road & Rail | 11.21% | 3/23/2018 | 8/1/2024 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Waste Pro of Florida Inc & Waste Pro USA Inc | Commercial Services & Supplies | 9.17% | 4/18/2023 | 4/18/2028 2023-01-01 2023-09-30 0001418076 Equipment Financing 26.9% | Wind River Environmental LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2023-01-01 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:SpreadOneMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 Cash Equivalents 41.8% | U.S. Treasury Bill | Government | 12/30/2022 | 2/23/2023 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | aTyr Pharma Inc Warrants | Pharmaceuticals | 11/18/2016 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | CardioFocus Inc Warrants | Health Care Equipment & Supplies | 3/31/2017 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Centrexion Therapeutics Inc Warrants | Pharmaceuticals | 6/28/2019 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Meditrina, Inc. Warrants | Health Care Equipment & Supplies | 12/20/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Class B | Diversified Consumer Services | 12/23/2013 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | RD Holdco, Inc. (Rug Doctor) Warrants | Diversified Consumer Services | 12/23/2013 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Senseonics Holdings, Inc | Health Care Equipment & Supplies | 7/25/2019 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Business Credit | Diversified Financial Services | 4/1/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | SLR Senior Lending Program LLC | Asset Management | 12/1/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Spectrum Pharmaceuticals, Inc. Warrants | Biotechnology | 9/21/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Vapotherm, Inc. Warrants | Health Care Equipment & Supplies | 2/18/2022 2022-01-01 2022-12-31 0001418076 Common Equity Equity Interests Warrants | Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) | Health Care Equipment & Supplies | 5/10/2018 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Foundation Consumer Brands LLC |Personal Products |L+550 |1.00% |10.15% |2/12/2021 |2/12/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |GSM Acquisition Corp. |Leisure Equipment & Products |S+500 |1.00% |9.03% |4/1/2022 |11/16/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Higginbotham Insurance Agency Inc. |Insurance |L+525 |0.75% |9.63% |4/1/2022 |11/25/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |High Street Buyer Inc. |Insurance |L+600|0.75% |10.73% |4/1/2022 |4/16/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Human Interest Inc. |Internet Software & Services |S+785 |1.00% |11.97% |6/30/2022 |7/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |iCIMS Inc. |Software |S+725 |0.75% |11.52% |8/18/2022 |8/18/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Ivy Fertility Services LLC |Health Care Providers & Services |L+625 |1.00% |10.39% |12/22/2021 |2/25/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kaseya Inc. |Software |S+575 |0.75% |10.33% |6/22/2022 |6/23/2029 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kid Distro Holdings LLC (Distro Kid) |Software |L+575 |1.00% |10.48% |9/24/2021 |10/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Kingsbridge Holdings LLC |Multi-Sector Holdings |L+700 |1.00% |10.75% |12/21/2018 |12/21/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |KORE Wireless Group Inc. |Wireless Telecommunication Services |S+550 |10.08% |12/21/2018 |12/21/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Logix Holding Company LLC |Communications Equipment |L+575 |1.00% |10.13% |9/14/2018 |12/22/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Luxury Asset Capital LLC |Thrifts & Mortgage Finance |S+675 |1.00% |10.99% |7/15/2022 |7/15/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Maurices Incorporated |Specialty Retail |S+675 |1.00% |8.74% |8/27/2021 |6/1/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Montefiore Nyack Hospital |Health Care Providers & Services |L+495 |9.72% |8/9/2022 |11/15/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |NAC Holdings Corporation (Jaguar) |Insurance |S+525 |1.00% |9.45% |7/30/2021 |9/28/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |National Spine and Pain Centers LLC |Health Care Providers & Services |L+500 |1.00% |7.31% |4/1/2022 |6/2/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |One Touch Direct LLC |Commercial Services & Supplies |P+75 |8.25% |4/3/2020 |3/30/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Orthopedic Care Partners Management LLC |Health Care Providers & Services |S+650 |1.00% |10.91% |8/17/2022 |5/16/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Pediatric Home Respiratory Services LLC |Health Care Providers & Services |S+625 |1.00% |10.67% |8/19/2022 |12/4/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Peter C. Foy & Associates Insurance Services LLC |Insurance |S+600 |0.75% |10.44% |4/1/2022 |11/1/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |PhyNet Dermatology LLC |Health Care Providers & Services |S+625 |1.00% |9.81% |9/5/2018 |8/16/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Pinnacle Treatment Centers Inc.|Health Care Providers & Services |S+650 |1.00% |10.57% |1/22/2020 |1/2/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Plastics Management LLC |Health Care Providers & Services |S+500 |1.00% |9.89% |4/1/2022 |8/18/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |PPT Management Holdings LLC |Health Care Providers & Services |L+850 |1.00% |12.83% |9/14/2018 |1/30/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RQM+ Corp. |Life Sciences Tools & Services |S+575 |1.00% |10.97% |8/20/2021 |8/12/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RSC Acquisition Inc. |Insurance |S+550 |0.75% |9.26% |4/1/2022 |11/1/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |RxSense Holdings LLC |Diversified Consumer Services |L+500 |1.00% |9.41% |4/1/2022 |3/13/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SCP Eye Care LLC |Health Care Providers & Services |S+575 |1.00% |9.46% |10/6/2022 |10/5/2029 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SHO Holding I Corporation (Shoes for Crews) |Footwear |L+523 |1.00% |9.66% |4/1/2022 |4/27/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Southern Orthodontic Partners Management LLC |Health Care Providers & Services |S+600 |1.00% |10.77%|1/27/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SPAR Marketing Force Inc. |Media |P+95 |8.45% |7/18/2022 |10/10/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Stryten Resources LLC |Auto Parts & Equipment |S+800 |1.00% |12.44% |8/11/2021 |10/12/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |SunMed Group Holdings LLC |Health Care Equipment & Supplies |L+575 |0.75% |10.48% |6/16/2021 |6/16/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |TAUC Management LLC |Health Care Providers & Services |L+525 |1.00% |9.98% |4/1/2022 |2/12/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Tilley Distribution Inc. |Trading Companies & Distributors |S+550 |1.00% |10.14% |4/1/2022 |12/31/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Ultimate Baked Goods Midco LLC (Rise Baking) |Packaged Foods & Meats |L+650 |1.00% |10.88% |8/12/2021 |8/13/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Vessco Midco Holdings LLC |Water Utilities |L+450 |1.00% |7.87% |4/1/2022 |11/2/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |World Insurance Associates LLC |Insurance |S+575 |1.00 |9.31 |4/1/2022 |4/1/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |Second Lien Asset-Based Senior Secured Loans |ACRES Commercial Mortgage LLC |Diversified Financial Services |S+705 |1.00% |11.38% |12/24/2021 |8/21/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |Second Lien Bank Debt/Senior Secured Loans |RD Holdco Inc. |Diversified Consumer Services |S+975 |1.00% |12/23/2013 |10/12/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Alimera Sciences Inc. |Pharmaceuticals |L+765 |1.78% |11.82% |12/31/2019 |7/1/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Apeel Technology Inc |Biotechnology |S+625 |1.00% |8.75% |6/29/2022 |6/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Arcutis Biotherapeutics Inc. |Pharamceuticals |L+745 |0.10% |11.62% |12/22/2021 |1/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Ardelyx Inc. |Pharamceuticals |L+795 |0.10% |12.12% |2/23/2022 |3/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |BridgeBio Pharma Inc. |Biotechnology |9.00% |11/17/2021 |11/17/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Centrexion Therapeutics Inc. |Pharmaceuticals |L+725 |2.45% |11.42% |6/28/2019 |1/1/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Cerapedics Inc. |Biotechnology |S+620 |2.75% |10.52% |12/27/2022 |1/1/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Glooko Inc. |Health Care Technology |L+790 |0.10% |12.07% |9/30/2021 |10/1/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Meditrina Inc. |Health Care Equipment & Supplies |S+550 |3.45% |9.82% |12/20/2022 |12/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Neuronetics Inc. |Health Care Equipment & Supplies |L+765 |1.66% |11.82% |3/2/2020 |2/28/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |OmniGuide Holdings Inc. |Health Care Equipment & Supplies |L+1405 |0.10% |18.22% |7/30/2018 |7/1/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Outset Medical Inc. |Health Care Equipment & Supplies |S+515 |2.75% |9.33% |11/3/2022 |11/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Spectrum Pharmaceuticals Inc. |Biotechnology |S+570 |2.30% |9.88% |9/21/2022 |9/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Life Science Senior Secured Loans |Vapotherm Inc. |Health Care Equipment & Supplies |S+830 |1.00% |12.58% |2/18/2022 |2/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Aero Operating LLC |Commercial Services & Supplies |8.47-9.64% |2/12/2021 |3/1/2025-12/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |AFG Dallas III LLC |Diversified Consumer Services |10.00% |8/11/2022 |8/11/2026-8/29/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Air Methods Corporation |Airlines |7.08-7.13% |11/3/2021 |11/3/2026-11/23/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |AmeraMex International Inc. |Commercial Services & Supplies |10.00% |3/29/2019 |9/15/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Bazzini LLC |Food & Staples Retailing |10.46% |12/23/2022 |1/1/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Boart Longyear Company |Metals & Mining |8.31-10.44% |5/28/2020 |7/1/2024-10/7/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Bowman Energy Solutions LLC |Commercial Services & Supplies |7.42% |7/1/2022 |8/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |C-Port/Stone LLC |Oil, Gas & Consumable Fuels |8.54% |10/7/2022 |11/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Capital City Jet Center Inc. |Airlines |10.00% |4/4/2018 |10/4/2023-6/22/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Champion Air LLC |Airlines |10.00% |3/19/2018 |1/1/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |CKD Holdings Inc. |Road & Rail |8.10-8.60% |9/22/2022 |3/22/2026-9/22/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Clubcorp Holdings Inc. |Hotels Restaurants & Leisure |9.36-13.01% |5/27/2021 | 4/1/2025-1/1/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Dongwon Autopart Technology Inc. |Auto Components |7.96% |2/2/2021 | 1/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Drillers Choice Inc. |Commercial Services & Supplies |8.00% |10/31/2022 | 11/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |EasyPak LLC |Containers & Packaging |9.01% |1/6/2021 | 1/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Energy Drilling Services LLC |Diversified Consumer Services |6.58-9.16% |8/26/2022 | 12/9/2025-9/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Environmental Protection & Improvement Company LLC |Road & Rail |8.25% |9/30/2020 | 10/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Equipment Operating Leases LLC |Multi-Sector Holdings |8.37% |4/27/2018 | 4/27/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |First American Commercial Bancorp Inc. |Diversified Financial Services| 7.50-9.02% |10/28/2021 | 10/1/2026-3/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |First National Capital LLC |Diversified Financial Services | 9.00% |11/5/2021 | 8/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Freightsol LLC |Road & Rail | 12.51-12.89% |4/9/2019 | 11/1/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Garda CL Technical Services Inc. |Commercial Services & Supplies | 8.30-8.77% |3/22/2018 | 6/5/2023-10/5/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Georgia Jet Inc. |Airlines | 8.00% |12/4/2017 | 1/4/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |GMT Corporation |Machinery | 10.71% |10/23/2018 | 1/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Hawkeye Contracting Company LLC |Construction & Engineering | 10.50% |10/8/2021 | 11/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |HTI Logistics Corporation |Commercial Services & Supplies | 9.69-9.94% |11/15/2018 | 5/1/2024-9/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |International Automotive Components Group North America Inc.|Auto Components | 7.95% |6/23/2021 | 6/23/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Kool Pak LLC |Road & Rail | 8.58% |2/5/2018 | 3/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Loc Performance Products LLC |Machinery | 10.50% |12/29/2022 | 6/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Loyer Capital LLC |Multi-Sector Holdings | 8.73-11.52% |5/16/2019 | 5/16/2024-9/25/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Credit Consultants LLC |Road & Rail | 8.28-12.09% |6/17/2021 | 12/1/2024-12/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Lux Vending LLC |Consumer Finance | 12.46-13.26% |8/20/2021 | 8/20/2024-10/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Mountain Air Helicopters Inc. |Commercial Services & Supplies | 10.00% |7/31/2017 | 2/28/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Ozzies Inc. |Commercial Services & Supplies | 10.72% |12/23/2022 | 1/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |PCX Aerostructures LLC |Aerospace & Defense | 9.32% |11/23/2022 | 12/1/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Rane Light Metal Castings Inc. |Machinery | 10.00% |6/1/2020 | 6/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Rango Inc. |Commercial Services & Supplies | 9.33-9.79% |9/24/2019 | 4/1/2023-11/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Royal Coach Lines Inc. |Road & Rail | 9.56% |11/21/2019 | 8/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Royal Express Inc. |Road & Rail | 9.53% |1/17/2019 | 2/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Rotten Rock Hardscaping & Tree Service |Diversified Consumer Services | 8.21% |12/6/2022 | 12/6/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Signet Marine Corporation |Transportation Infrastructure | 8.50% |10/31/2022 |7/1/2029 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |SLR Equipment Finance |Multi-Sector Holdings | 8.50% |1/24/2022 |1/24/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Smiley Lifting Solutions LLC |Commercial Services & Supplies | 7.82-8.28% |6/30/2022 |9/15/2026-12/29/2029 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |ST Coaches LLC |Road & Rail | 8.47-8.58% |7/31/2017 |7/1/2023-1/25/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Star Coaches Inc. |Road & Rail | 8.42% |3/9/2018 |4/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Superior Transportation Inc. |Road & Rail | 10.22-10.63% |7/31/2017 |1/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |The Smedley Company & Smedley Services Inc. |Commercial Services & Supplies | 4.07% |7/31/2017 |1/15/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Trinity Equipment Rentals Inc. |Commercial Services & Supplies | 7.94-8.75% |10/8/2021 |11/1/2024-12/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |U.S. Crane & Rigging LLC |Commercial Services & Supplies | 10.92% |12/23/2022 |3/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Up Trucking Services LLC |Road & Rail | 11.21% |3/23/2018 |8/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Wind River Environmental LLC |Diversified Consumer Services | 8.43-10.00% |7/31/2019 |8/1/2024-10/5/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Womble Company Inc. |DEnergy Equipment & Services |9.11% |12/27/2019 |1/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Worldwide Flight Services Inc. |Transportation Infrastructure |8.32-9.36% |9/23/2022 |9/23/2027-10/28/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |Zamborelli Enterprises Pacific Souther Foundation |Diversified Consumer Services |8.91% |12/7/2022 |1/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% |SLR Equipment Finance Equity Interests |Multi-Sector Holdings |7/31/2017 2022-01-01 2022-12-31 0001418076 Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Aegis Toxicology Sciences Corporation |Health Care Providers & Services |L+550 |1.00% |10.09% |5/7/2018 |5/9/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |All States Ag Parts LLC |Trading Companies & Distributors |S+575 |10.19% |4/1/2022 |9/1/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |American Teleconferencing Services Ltd |Communications Equipment |L+650 |1.00% |5/5/2016 |9/9/2021 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |American Teleconferencing Services Ltd |Communications Equipment |L+650 |1.00% |9/17/2021 |1/31/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |AmeriMark Intermediate Holdings LLC |Internet & Catalog Retail |L+800 |1.00% |14.77% |7/28/2021 |10/15/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Apex Services Partners LLC |Diversified Consumer Services |S+525 |1.00% |9.80% |8/31/2022 |7/31/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Atria Wealth Solutions Inc. |Diversified Financial Services |S+600 |1.00% |10.84% |9/14/2018 |2/29/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Basic Fun Inc. |Specialty Retail |L+550 |1.00% |10.27% |10/30/2020 |10/30/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |BayMark Health Services Inc. |Health Care Providers & Services |L+500 |1.00% |9.73% |4/1/2022 |6/11/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |BDG Media Inc. |Media |L+900 |0.25% |13.17% |7/18/2022 |4/27/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |CC SAG Holdings Corp. (Spectrum Automotive) |Diversified Consumer Services |L+575 |0.75% |10.48% |6/29/2021 |6/29/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Composite Technology Acquisition Corp. |Building Products |L+475 |1.00% |9.73% |4/1/2022 |2/1/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Copper River Seafoods Inc. |Food Products |P+275 |10.25% |8/31/2022 |4/23/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |DeepIntent Inc. |Media |P+175 |9.25% |10/12/2022 |3/25/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Enhanced Permanent Capital LLC |Capital Markets |L+700 |1.00% |10.13% |12/29/2020 |12/29/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) |Trading Companies & Distributors |S+475 |1.00% |9.43% |4/1/2022 |12/31/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Enverus Holdings Inc. (fka Drilling Info Holdings) |IT Services |L+450 |8.88% |4/1/2022 |7/30/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans 124.6% |First Lien Bank Debt/Senior Secured Loans |Erie Construction Mid-west LLC |Building Products |S+475 |1.00% |9.79% |4/1/2022 |7/30/2027 2022-01-01 2022-12-31 0001418076 us-gaap:IPOMember 2010-02-10 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 0001418076 us-gaap:OverAllotmentOptionMember 2010-02-10 0001418076 slrc:SunsCompanyMergerMember us-gaap:CommonStockMember 2022-04-01 2022-04-01 0001418076 slrc:CreditFacilityOneMember 2022-04-01 0001418076 slrc:SunsCompanyMergerMember us-gaap:CommonStockMember 2022-04-01 0001418076 slrc:CreditFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TermLoansMember 2021-12-31 0001418076 slrc:NefpassFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 2021-12-31 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 0001418076 Preferred Equity | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2022-12-12 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SecuredOvernightFinancingRateMember slrc:CitiBankNaMember 2011-08-26 2011-12-31 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SecuredOvernightFinancingRateMember slrc:CitiBankNaMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 0001418076 slrc:SunsSpvLlcMember slrc:AmendmentAgreementToIncreaseCreditFacilityMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2021-12-28 0001418076 slrc:SunsSpvLlcMember slrc:CreditFacilityCommitmentExpiredMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2021-12-28 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-11-30 2012-11-30 0001418076 slrc:CrystalFinancialMember 2012-11-30 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 2012-12-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 0001418076 us-gaap:RevolvingCreditFacilityMember 2012-12-28 0001418076 slrc:SlrBusinessCreditFacilityMember 2016-07-28 2016-07-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:CrystalCapitalFinancialHoldingsLlcMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:SlrEquipmentFinanceMember 2017-07-31 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 2020-11-03 0001418076 srt:MaximumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 srt:MinimumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:SlrHealthcareAblMember 2013-09-30 0001418076 slrc:NorthMillCapitalLlcMember 2017-10-20 0001418076 slrc:EspSscCorporationMember 2017-10-20 0001418076 slrc:NorthMillCapitalLlcMember 2018-05-01 0001418076 slrc:EspSscCorporationMember 2018-05-01 0001418076 slrc:SummitFinancialResourcesMember 2019-06-28 0001418076 slrc:NmHoldcoMember 2019-06-28 0001418076 slrc:NmcsCreditFacilityMember 2019-06-28 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 2021-06-03 0001418076 slrc:SunsMember 2021-06-03 0001418076 slrc:NmcsCreditFacilityMember 2021-06-03 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-06 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-09-14 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-18 2019-12-18 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 2019-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-08-24 0001418076 slrc:SlrEquipmentFinanceMember 2023-08-24 2023-08-24 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-11-07 0001418076 slrc:CreditFacilityMember 2013-12-31 0001418076 slrc:SeniorSecuredNotesMember 2013-12-31 0001418076 slrc:TermLoansMember 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-12-31 0001418076 slrc:CreditFacilityMember 2014-12-31 0001418076 slrc:SeniorSecuredNotesMember 2014-12-31 0001418076 slrc:TermLoansMember 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-12-31 0001418076 slrc:CreditFacilityMember 2015-12-31 0001418076 slrc:TermLoansMember 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-12-31 0001418076 slrc:SeniorSecuredNotesMember 2015-12-31 0001418076 slrc:CreditFacilityMember 2016-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2016-12-31 0001418076 slrc:TermLoansMember 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-12-31 0001418076 slrc:SeniorSecuredNotesMember 2016-12-31 0001418076 slrc:CreditFacilityMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-12-31 0001418076 slrc:TermLoansMember 2017-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2017-12-31 0001418076 slrc:SeniorSecuredNotesMember 2017-12-31 0001418076 slrc:CreditFacilityMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2018-12-31 0001418076 slrc:NefpassFacilityMember 2018-12-31 0001418076 slrc:SslpFacilityMember 2018-12-31 0001418076 slrc:TermLoansMember 2018-12-31 0001418076 slrc:CreditFacilityMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2019-12-31 0001418076 slrc:SslpFacilityMember 2019-12-31 0001418076 slrc:TermLoansMember 2019-12-31 0001418076 slrc:NefpassFacilityMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-31 0001418076 slrc:CreditFacilityMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2020-12-31 0001418076 slrc:TermLoansMember 2020-12-31 0001418076 slrc:NefpassFacilityMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember 2023-06-30 0001418076 slrc:PreferredEquityMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-09-30 0001418076 slrc:EquipmentFinancingMember 2023-09-30 0001418076 slrc:PreferredEquityMember 2023-09-30 0001418076 us-gaap:EquitySecuritiesMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmeriMarkIntermediateHoldingsOneLLCMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCOneMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2023-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCOneMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmeriMarkIntermediateHoldingsOneLLCMember 2023-09-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-12-31 iso4217:USD shares utr:Day pure utr:Year iso4217:USD shares slrc:issuers slrc:loans slrc:fund slrc:Customers false Q3 0001418076 --12-31 NY http://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestments http://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestments 10-Q true 2023-09-30 2023 false 814-00754 SLR INVESTMENT CORP. MD 26-1381340 500 Park Avenue New York 10022 212 993-1670 Common Stock, par value $0.01 per share SLRC NASDAQ Yes Yes Large Accelerated Filer false false false 54554634 1305572000 1312701000 1320729000 1289082000 59983000 0 43405000 0 839062000 821886000 806922000 797594000 10266000 10743000 332557000 417590000 332557000 417590000 10993000 11192000 11828000 9706000 1598000 1124000 788000 664000 2539086000 2537695000 1197750000 1093200000 5996000 7202000 1191754000 1085998000 332557000 417611000 0 7481000 8051000 7964000 5621000 5422000 7416000 7943000 3678000 1488000 4624000 4057000 1553701000 1537964000 0.01 0.01 200000000 200000000 54554634 54554634 54555380 54555380 546000 546000 1162559000 1162569000 -177720000 -163384000 985385000 999731000 18.06 18.33 43696000 32933000 122301000 82450000 816000 0 1081000 0 2879000 2431000 8404000 6914000 11429000 11969000 33782000 32767000 735000 234000 3814000 1222000 86000 0 143000 0 59641000 47567000 169525000 123353000 8051000 7890000 23635000 22019000 5796000 4965000 16943000 9699000 19874000 12784000 53002000 31464000 1575000 1132000 4563000 3684000 1161000 935000 3610000 4212000 36457000 27706000 101753000 71078000 -175000 -194000 -410000 -1552000 36282000 27512000 101343000 69526000 23359000 20055000 68182000 53827000 -30951000 -37326000 -29766000 -37401000 33439000 28783000 24349000 3521000 1065000 0 -2151000 0 35000 2016000 -7848000 -20602000 34539000 30799000 14350000 -17081000 3588000 -6527000 -15416000 -54482000 26947000 13528000 52766000 -655000 0.49 0.49 0.25 0.25 0.97 0.97 -0.01 -0.01 23359000 20055000 68182000 53827000 -30951000 -37326000 -29766000 -37401000 34539000 30799000 14350000 -17081000 26947000 13528000 52766000 -655000 22367000 20055000 67102000 53827000 0 2401000 0 8413000 22367000 22456000 67102000 62240000 0 0 0 226839000 0 0 10000 0 0 0 -10000 226839000 4580000 -8928000 -14346000 163944000 980805000 1015153000 999731000 842281000 985385000 1006225000 985385000 1006225000 0 0 0 12511825 0 0 746 0 0 0 -746 12511825 -52766000 655000 -29766000 -37401000 14350000 -17081000 1561000 1631000 -556348000 -406302000 474599000 259784000 -9315000 -7760000 -8936000 -1753000 204000 1112000 -474000 102000 2122000 2935000 -199000 2514000 124000 319000 0 -2313000 -85054000 -51089000 87000 455000 199000 2907000 2190000 -1396000 -527000 2591000 567000 600000 -115112000 -148746000 74583000 72081000 0 134914000 75000000 150000000 667695000 743892000 488500000 554000000 10000 0 29602000 102725000 -85510000 -46021000 428333000 322935000 342823000 276914000 53529000 28873000 0 226839000 244691000 226839000 1.32 Insurance 5.50 0.0075 0.1102 2022-04-01 2026-11-01 20221000 20071000 20221000 Health Care Providers & Services 5.50 0.01 0.1113 2018-05-07 2025-05-09 13420000 13218000 13420000 Insurance 6.50 0.01 0.1192 2023-09-20 2026-10-28 8524000 8270000 8268000 Trading Companies & Distributors 6 0.01 0.116 2022-04-01 2026-09-01 2177000 2148000 2177000 Diversified Consumer Services 5.25 0.01 0.1067 2022-08-31 2025-07-31 13916000 13641000 13916000 Diversified Financial Services 6.50 0.01 0.1215 2018-09-14 2024-02-29 16288000 16170000 16288000 Specialty Retail 6.50 0.01 0.1217 2020-10-30 2024-07-02 2150000 2149000 2150000 Health Care Providers & Services 5 0.01 0.1065 2022-04-01 2027-06-11 8286000 8021000 8286000 Healthcare Providers & Services 7 0.01 0.1254 2023-05-31 2026-05-31 402000 402000 402000 Healthcare Providers & Services 7.25 0.01 0.1279 2023-05-31 2026-05-31 18807000 18807000 18807000 Healthcare Providers & Services 10 0.01 0.1554 2023-05-31 2026-05-31 4959000 4959000 4959000 Media 5.25 0.055 0.1375 2022-07-18 2025-07-31 5354000 5354000 5354000 Diversified Consumer Services 5.75 0.0075 0.1118 2021-06-29 2028-06-29 36588000 36020000 36588000 Building Products 4.50 0.01 0.1004 2022-04-01 2025-02-01 11028000 10765000 11028000 Health Care Providers & Services 6.50 0.01 0.1159 2023-05-22 2029-05-22 18855000 18308000 18289000 Capital Markets 7 0.01 0.1226 2020-12-29 2025-12-29 42521000 41790000 42521000 Trading Companies & Distributors 4.75 0.01 0.1024 2022-04-01 2025-12-31 4630000 4507000 4630000 IT Services 4.50 0 0.0992 2022-04-01 2025-07-30 11277000 10950000 11277000 Building Products 4.75 0.01 0.1034 2022-04-01 2027-07-30 8572000 8296000 8572000 Health Care Providers & Services 6.50 0.01 0.1163 2023-01-04 2029-01-03 22653000 22034000 22653000 Personal Products 6.25 0.01 0.1177 2021-02-12 2027-02-12 27560000 26963000 27560000 Leisure Equipment & Products 5 0.01 0.1065 2022-04-01 2026-11-16 10939000 10578000 10939000 Insurance 5.50 0.01 0.1092 2022-04-01 2028-11-15 28856000 28856000 28856000 Insurance 6 0.0075 0.1154 2022-04-01 2028-04-16 3191000 3034000 3191000 Internet Software & Services 7.85 0.01 0.1318 2022-06-30 2027-07-01 20104000 19903000 20104000 Software 7.25 0.0075 0.1214 2022-08-18 2028-08-18 30762000 30327000 30762000 Software 6.25 0.0075 0.1158 2022-06-22 2029-06-23 24365000 24050000 24365000 Software 5.50 0.01 0.1104 2021-09-24 2027-10-01 20259000 19969000 20259000 Multi-Sector Holdings 7 0.01 0.124 2018-12-21 2024-12-21 80000000 79872000 80000000 Wireless Telecommunication Services 5.50 0 0.1099 2018-12-21 2024-12-21 23404000 23108000 23404000 Communications Equipment 5.75 0.01 0.1148 2018-09-14 2024-12-22 14009000 13516000 13729000 Thrifts & Mortgage Finance 6.75 0.01 0.1219 2022-07-15 2027-07-15 30500000 30005000 30500000 Specialty Retail 6.75 0.01 0.0994 2021-08-27 2024-06-01 7395000 7346000 7395000 Health Care Providers & Services 6.75 0.01 0.1248 2023-03-01 2029-03-01 23783000 23118000 23783000 Health Care Providers & Services 8.50 0.01 0.132 2022-04-01 2026-02-13 2216000 2136000 2216000 Internet & Catalog Retail 4.75 0.01 0.1325 2023-06-16 2023-10-31 321000 321000 321000 Internet & Catalog Retail 8 0.01 0 2021-07-28 2026-10-15 4855000 4204000 0 Health Care Providers & Services 6.25 0.01 0.1162 2023-02-10 2025-07-08 17192000 16798000 17192000 Health Care Providers & Services 6.50 0.01 0.1196 2022-08-17 2024-05-16 5502000 5473000 5420000 Health Care Providers & Services 6.25 0.01 0.1167 2022-08-19 2024-12-04 3118000 3082000 3118000 Insurance 6 0.0075 0.1143 2022-04-01 2028-11-01 16920000 16668000 16581000 Health Care Providers & Services 6.25 0.01 0.1145 2018-09-05 2024-08-16 8374000 8361000 8374000 Health Care Providers & Services 6.75 0.01 0.121 2020-01-22 2026-01-02 25243000 24903000 25243000 Health Care Providers & Services 5 0.01 0.1044 2022-04-01 2027-08-18 17184000 16493000 17184000 Life Sciences Tools & Services 5.75 0.01 0.114 2021-08-20 2026-08-12 23696000 23361000 23696000 Diversified Consumer Services 5 0.01 0.1047 2022-04-01 2026-03-13 8677000 8369000 8677000 Health Care Providers & Services 5.75 0.01 0.1117 2022-10-06 2029-10-05 9562000 9281000 9562000 Footwear 5.23 0.01 0.1086 2022-04-01 2024-04-27 5659000 5505000 5376000 Health Care Providers & Services 6.25 0.01 0.1189 2022-06-03 2026-01-27 11505000 11319000 11274000 Auto Parts & Equipment 8 0.01 0.1343 2021-08-11 2026-10-12 10725000 10581000 10586000 Health Care Equipment & Supplies 5.50 0.0075 0.1099 2021-06-16 2028-06-16 15020000 14700000 15020000 Health Care Providers & Services 5.25 0.01 0.1059 2022-04-01 2027-02-12 6893000 6630000 6411000 Commercial Services & Supplies 6.25 0.01 0.1157 2023-08-17 2029-08-15 10073000 9825000 9821000 Trading Companies & Distributors 6 0.01 0.1154 2022-04-01 2026-12-31 3848000 3692000 3848000 Packaged Foods & Meats 6.25 0.01 0.1167 2021-08-12 2027-08-13 14858000 14397000 14858000 Health Care Providers & Services 6.75 0.01 0.1229 2023-03-30 2029-03-30 13257000 12882000 13257000 Health Care Providers & Services 6.25 0.01 0.1179 2023-02-07 2026-06-15 7138000 6959000 7066000 Health Care Providers & Services 6.25 0.01 0.1179 2023-09-18 2025-09-15 15444000 15063000 15058000 Water Utilities 4.50 0.01 0.0992 2022-04-01 2026-11-02 2466000 2408000 2466000 Insurance 6.25 0.01 0.1172 2023-08-01 2027-12-27 13201000 12945000 12937000 Insurance 5.75 0.01 0.1114 2022-04-01 2026-04-01 48250000 48141000 48250000 921022000 928465000 Diversified Financial Services 7.05 0.01 0.1249 2021-12-24 2028-08-21 29925000 29455000 29925000 Diversified Financial Services 6.50 0.01 0.1182 2023-04-17 2028-04-17 8206000 8015000 8206000 37470000 38131000 Diversified Consumer Services 9.75 0.01 0 2013-12-23 2026-10-12 15065000 12297000 7532000 Pharmaceuticals 5.15 0.046 0.1048 2019-12-31 2028-05-01 34738000 34857000 37186000 Biotechnology 6.25 0.01 0.0875 2022-06-29 2027-06-01 3643000 3641000 4062000 Pharamceuticals 7.45 0.001 0.1288 2021-12-22 2027-01-01 66849000 67893000 68019000 Pharmaceuticals 7.95 0.01 0.133 2022-02-23 2027-03-01 9475000 9526000 10503000 Biotechnology 0 0 0.09 2021-11-17 2026-11-17 40753000 40487000 40854000 Biotechnology 6.20 0.0275 0.1153 2022-12-27 2028-01-01 26939000 27000000 27007000 Health Care Technology 7.90 0.001 0.1333 2021-09-30 2026-10-01 11912000 11984000 12150000 Health Care Equipment & Supplies 5.50 0.0345 0.1083 2022-12-20 2027-12-01 3367000 3365000 3384000 Health Care Equipment & Supplies 5.65 0.0395 0.1098 2020-03-02 2028-03-29 19299000 19256000 19396000 Health Care Equipment & Supplies 5.80 0.0531 0.1123 2018-07-30 2025-11-01 24500000 24590000 24561000 Health Care Equipment & Supplies 5.15 0.0275 0.1048 2022-11-03 2027-11-01 35084000 35162000 35171000 Health Care Equipment & Supplies 9.30 0.01 0.1473 2022-02-18 2027-02-01 36826000 37086000 37378000 Health Care Equipment & Supplies 5.15 0.0475 0.1048 2023-06-14 2028-07-01 6651000 6587000 6567000 321434000 326238000 1292223000 1300366000 0.269 Commercial Services & Supplies 0.0778 2023-03-27 2028-03-27 72000 72000 72000 Commercial Services & Supplies 0.0847 0.0964 2021-02-12 2025-03-01 2026-12-01 1493000 1492000 1491000 Diversified Consumer Services 0.10 0.1129 2022-08-11 2026-08-11 2027-03-01 1182000 1182000 1182000 Airlines 0.0708 0.0713 2021-11-03 2026-11-03 2026-11-23 3231000 3275000 3231000 Commercial Services & Supplies 0.10 2019-03-29 2025-04-15 563000 563000 569000 Food & Staples Retailing 0.1046 2022-12-23 2028-01-01 2084000 2146000 2084000 Metals & Mining 0.0831 0.1044 2020-05-28 2024-07-01 2026-10-07 2870000 2870000 2870000 Commercial Services & Supplies 0.0742 2022-07-01 2026-08-01 124000 124000 124000 Oil, Gas & Consumable Fuels 0.0854 2022-10-07 2027-11-01 6366000 6206000 6175000 Airlines 0.10 2018-04-04 2023-10-04 2026-06-22 1536000 1536000 1528000 Diversified Consumer Services 0.084 0.0872 2023-03-07 2028-03-07 2028-05-18 3688000 3723000 3688000 Road & Rail 0.081 0.086 2022-09-22 2026-06-22 2027-09-22 3076000 3076000 3076000 Hotels, Restaurants & Leisure 0.0936 0.1301 2021-05-27 2025-04-01 2028-05-01 6880000 6880000 6880000 Commercial Services & Supplies 0.0675 0.0715 2023-03-23 2028-04-01 2028-06-01 1926000 1895000 1893000 Auto Components 0.0796 2021-02-02 2026-01-01 1411000 1424000 1411000 Commercial Services & Supplies 0.086 2023-07-28 2027-08-01 119000 119000 119000 Commercial Services & Supplies 0.08 0.1008 2022-10-31 2027-11-01 2029-06-01 1962000 1965000 1962000 Diversified Consumer Services 0.0658 0.0916 2022-08-26 2025-11-09 2027-09-01 1139000 1139000 1139000 Road & Rail 0.0825 2020-09-30 2027-10-01 4746000 4769000 4746000 Multi-Sector Holdings 0.0837 2018-04-27 2025-04-27 3498000 3498000 3411000 Commercial Services & Supplies 0.0952 2023-03-03 2027-03-03 902000 910000 902000 Diversified Financial Services 0.075 0.0902 2021-10-28 2026-10-01 2027-03-01 2449000 2451000 2449000 Diversified Financial Services 0.09 2021-11-05 2026-08-01 5739000 5739000 5739000 Road & Rail 0.1251 0.1289 2019-04-09 2023-11-01 289000 289000 289000 Airlines 0.08 2017-12-04 2024-01-04 128000 128000 128000 Machinery 0.1071 2018-10-23 2026-01-01 4070000 4073000 4070000 Construction & Engineering 0.105 2021-10-08 2025-11-01 769000 769000 769000 Commercial Services & Supplies 0.0969 0.0994 2018-11-15 2024-05-01 2025-09-01 189000 189000 184000 Auto Components 0.0795 2021-06-23 2025-06-23 4375000 4394000 4288000 Road & Rail 0.0858 2018-02-05 2024-03-01 71000 71000 71000 Machinery 0.105 2022-12-29 2027-06-01 673000 673000 673000 Multi-Sector Holdings 0.0873 0.1152 2019-05-16 2024-05-16 2024-09-25 7500000 7500000 7361000 Road & Rail 0.0828 0.1209 2021-06-17 2024-12-01 2026-12-01 12142000 12142000 12142000 Consumer Finance 0.1246 0.1326 2021-08-20 2024-07-20 2024-10-01 895000 903000 895000 Construction & Engineering 0.0769 2023-04-14 2028-04-14 824000 824000 824000 Commercial Services & Supplies 0.10 2017-07-31 2025-02-28 279000 278000 279000 Commercial Services & Supplies 0.0918 2023-07-13 2028-07-13 975000 975000 975000 Commercial Services & Supplies 0.0773 2023-05-05 2028-06-01 124000 124000 124000 Commercial Services & Supplies 0.1072 2022-12-23 2027-01-01 1731000 1783000 1731000 Aerospace & Defense 0.0932 2022-11-23 2028-12-01 2401000 2401000 2401000 Machinery 0.10 2020-06-01 2024-06-01 83000 83000 83000 Commercial Services & Supplies 0.0933 0.0977 2019-09-24 2023-10-01 2024-11-01 731000 742000 717000 Diversified Consumer Services 0.0769 0.0827 2023-05-19 2030-05-18 2030-06-30 732000 732000 732000 Construction & Engineering 0.0808 2023-05-10 2026-05-10 124000 124000 124000 Road & Rail 0.0953 2019-01-17 2024-02-01 220000 221000 220000 Diversified Consumer Services 0.0821 2022-12-06 2027-12-06 214000 214000 214000 Commercial Services & Supplies 0.0895 2023-08-11 2030-08-11 1201000 1201000 1201000 Transportation Infrastructure 0.085 2022-10-31 2029-11-01 12712000 12753000 12712000 Multi-Sector Holdings 0.085 2022-01-24 2024-01-27 2500000 2500000 2500000 Commercial Services & Supplies 0.0782 0.0861 2022-06-30 2026-09-15 2030-06-27 6123000 6123000 6123000 Road & Rail 0.085 0.0858 2017-07-31 2023-10-01 2025-01-25 1111000 1111000 1075000 Road & Rail 0.0842 2018-03-09 2025-04-01 2472000 2472000 2218000 Road & Rail 0.1022 0.1063 2017-07-31 2026-01-01 2589000 2589000 2589000 Commercial Services & Supplies 0.0407 2017-07-31 2028-01-15 1476000 1476000 1476000 Commercial Services & Supplies 0.0878 0.0893 2023-05-04 2028-05-04 2028-05-19 1407000 1407000 1407000 Commercial Services & Supplies 0.0794 0.0875 2021-10-08 2024-11-01 2026-12-01 416000 416000 416000 Commercial Services & Supplies 0.0873 0.1092 2022-12-23 2027-03-01 2028-09-01 2717000 2717000 2717000 Road & Rail 0.1121 2018-03-23 2024-08-01 256000 258000 256000 Commercial Services & Supplies 0.0917 2023-04-18 2028-04-18 9330000 9485000 9330000 Diversified Consumer Services 0.0843 0.10 2019-07-31 2024-08-01 2025-10-05 387000 387000 387000 Energy Equipment & Services 0.0911 2019-12-27 2025-01-01 256000 256000 246000 Transportation Infrastructure 0.0832 0.0993 2022-09-23 2027-09-23 2028-08-16 3192000 3240000 3192000 Diversified Consumer Services 0.0891 2022-12-07 2027-01-01 606000 611000 606000 Multi-Sector Holdings 2017-07-31 200 145000000 120820000 290688000 265306000 0.004 Aerospace & Defense 0.05 2012-06-08 2025-06-30 0 5114000 3801000 0.611 Pharmaceuticals 2023-07-31 12510 51000 32000 Pharmaceuticals 2016-11-18 6347 106000 0 Health Care Providers & Services 2023-05-31 6526 11411000 3816000 Health Care Equipment & Supplies 2017-03-31 90 51000 0 Pharmaceuticals 2019-06-28 289102 136000 50000 Health Care Equipment & Supplies 2016-06-15 157500 65000 0 Health Care Equipment & Supplies 2017-08-18 444388 74000 87000 Health Care Technology 2017-03-22 260000 129000 342000 Multi-Sector Holdings 2020-11-03 73500000 136596000 146000000 Health Care Equipment & Supplies 2022-12-20 29366 23000 20000 Health Care Providers & Services 2023-02-13 207043 657000 273000 Diversified Consumer Services 2013-12-23 231177 15683000 0 Diversified Consumer Services 2013-12-23 522 5216000 0 Diversified Consumer Services 2013-12-23 30370 381000 0 Health Care Equipment & Supplies 2019-07-25 469353 235000 283000 Internet & Catalog Retail 2023-06-16 0 19880000 15100000 Diversified Financial Services 2022-04-01 100 81583000 90370000 Diversified Financial Services 2012-12-28 280303 280737000 281000000 Diversified Financial Services 2022-04-01 32839 34335000 34850000 Asset Management 2022-12-01 0 28750000 29277000 Health Care Equipment & Supplies 2022-02-18 48969 290000 28000 Health Care Equipment & Supplies 2018-05-10 2230 152000 0 Health Care Equipment & Supplies 2023-06-14 161761 51000 55000 616592000 601583000 2.204 2204617000 2171056000 0.337 Government 2023-09-29 2023-11-21 335000000 332557000 332557000 2.541 2537174000 2503613000 -1.541 -1518228000 1 985385000 0.25 3741000 0 338000 0 -8000 3411000 -231000 80000000 0 0 0 70000 80000000 -7434000 148444000 0 0 0 2444000 146000000 -10500000 7361000 0 0 0 0 7361000 -565000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6521000 507000 0 0 -504000 7532000 0 89370000 0 0 0 -1000000 90370000 -5250000 288760000 0 0 0 7760000 281000000 -15000000 120820000 0 0 0 0 120820000 0 5000000 2500000 5000000 0 0 2500000 -174000 34350000 0 0 0 -500000 34850000 -2595000 9426000 19250000 0 0 -601000 29277000 -393000 3801000 187000 0 0 187000 3801000 -187000 797594000 22444000 5338000 0 7848000 806922000 -42329000 0.251 31537000 152992000 121455000 2139519000 0.01 0.06 0.03 0.09 0.03875 0 1262000 941000 0 0 321000 -15000 9371000 0 12866000 0 -3495000 0 0 846000 21000 465000 0 0 402000 -32000 18224000 583000 0 0 0 18807000 -784000 4773000 186000 0 0 0 4959000 -250000 4681000 0 0 0 865000 3816000 0 7014000 12867000 0 0 4781000 15100000 0 44909000 14919000 14272000 0 2151000 43405000 -1081000 0.073 0.025 0.216 0.166 0.118 0.065 0.064 0.053 0.035 0.034 0.033 0.02 0.02 0.014 0.014 0.013 0.013 0.011 0.011 0.009 0.009 0.007 0.007 0.007 0.006 0.006 0.005 0.005 0.005 0.005 0.004 0.003 0.003 0.003 0.003 0.003 0.002 0.002 0.002 0.001 0.001 0.001 0.001 0 0 1 1.246 Health Care Providers & Services 5.50 0.01 0.1009 2018-05-07 2025-05-09 17103000 16793000 17103000 Trading Companies & Distributors 5.75 0.01 0.1019 2022-04-01 2026-09-01 4197000 4081000 4197000 Communications Equipment 6.50 0.01 0 2016-05-05 2021-09-09 36135000 25926000 0 Communications Equipment 6.50 0.01 0 2021-09-17 2023-01-31 6405000 6254000 224000 Internet & Catalog Retail 8 0.01 0.1477 2021-07-28 2026-10-15 24087000 23711000 22882000 Diversified Consumer Services 5.25 0.01 0.098 2022-08-31 2025-07-31 14021000 13644000 14021000 Diversified Financial Services 6 0.01 0.1084 2018-09-14 2024-02-29 8149000 8107000 8149000 Specialty Retail 5.50 0.01 0.1027 2020-10-30 2023-10-30 2162000 2152000 2162000 Health Care Providers & Services 5 0.01 0.0973 2022-04-01 2027-06-11 9432000 9078000 9432000 Media 9 0.0025 0.1317 2022-07-18 2023-04-27 14454000 14454000 14454000 Diversified Consumer Services 5.75 0.0075 0.1048 2021-06-29 2028-06-29 20427000 20057000 20427000 Building Products 4.75 0.01 0.0973 2022-04-01 2025-02-01 10386000 9983000 10386000 Food Products 2.75 0 0.1025 2022-08-31 2025-04-23 8405000 8405000 8405000 Media 1.75 0 0.0925 2022-10-12 2025-03-25 16951000 16951000 16951000 Capital Markets 7 0.01 0.1013 2020-12-29 2025-12-29 35205000 34496000 35205000 Trading Companies & Distributors 4.75 0.01 0.0943 2022-04-01 2025-12-31 4978000 4804000 4978000 IT Services 4.50 0 0.0888 2022-04-01 2025-07-30 11598000 11129000 11598000 Building Products 4.75 0.01 0.0979 2022-04-01 2027-07-30 8915000 8580000 8915000 Personal Products 5.50 0.01 0.1015 2021-02-12 2027-02-12 35273000 34421000 35273000 Leisure Equipment & Products 5 0.01 0.0903 2022-04-01 2026-11-16 11022000 10562000 10912000 Insurance 5.25 0.0075 0.0963 2022-04-01 2026-11-25 6223000 5994000 6223000 Insurance 6 0.0075 0.1073 2022-04-01 2028-04-16 5188000 4900000 5188000 Internet Software & Services 7.85 0.01 0.1197 2022-06-30 2027-07-01 20104000 19783000 20104000 Software 7.25 0.0075 0.1152 2022-08-18 2028-08-18 32084000 31548000 31522000 Health Care Providers & Services 6.25 0.01 0.1039 2021-12-22 2026-02-25 30092000 29415000 30393000 Software 5.75 0.0075 0.1033 2022-06-22 2029-06-23 32426000 31966000 32426000 Software 5.75 0.01 0.1048 2021-09-24 2027-10-01 26452000 26015000 26452000 Multi-Sector Holdings 7 0.01 0.1075 2018-12-21 2024-12-21 80000000 79800000 80000000 Wireless Telecommunication Services 5.50 0 0.1008 2018-12-21 2024-12-21 23588000 23123000 23588000 Communications Equipment 5.75 0.01 0.1013 2018-09-14 2024-12-22 14009000 13246000 13449000 Thrifts & Mortgage Finance 6.75 0.01 0.1099 2022-07-15 2027-07-15 27500000 26991000 27500000 Specialty Retail 6.75 0.01 0.0874 2021-08-27 2024-06-01 7808000 7678000 7808000 Health Care Providers & Services 4.95 0 0.0972 2022-08-09 2024-11-15 3966000 3966000 3966000 Insurance 5.25 0.01 0.0945 2021-07-30 2024-09-28 28603000 28214000 28603000 Health Care Providers & Services 5 0.01 0.0731 2022-04-01 2024-06-02 2681000 2564000 2547000 Commercial Services & Supplies 0.75 0 0.0825 2020-04-03 2024-03-30 4431000 4431000 4431000 Health Care Providers & Services 6.50 0.01 0.1091 2022-08-17 2024-05-16 3111000 3092000 3111000 Health Care Providers & Services 6.25 0.01 0.1067 2022-08-19 2024-12-04 1327000 1309000 1313000 Insurance 6 0.0075 0.1044 2022-04-01 2028-11-01 10854000 10699000 10854000 Health Care Providers & Services 6.25 0.01 0.0981 2018-09-05 2024-08-16 14458000 14420000 14458000 Health Care Providers & Services 6.50 0.01 0.1057 2020-01-22 2026-01-02 27997000 27528000 27367000 Health Care Providers & Services 5 0.01 0.0989 2022-04-01 2027-08-18 9491000 9161000 9491000 Health Care Providers & Services 8.50 0.01 0.1283 2018-09-14 2023-01-30 32163000 31987000 25827000 Life Sciences Tools & Services 5.75 0.01 0.1097 2021-08-20 2026-08-12 26823000 26455000 26823000 Insurance 5.50 0.0075 0.0926 2022-04-01 2026-11-01 6985000 6813000 6985000 Diversified Consumer Services 5 0.01 0.0941 2022-04-01 2026-03-13 11775000 11357000 11775000 Health Care Providers & Services 5.75 0.01 0.0946 2022-10-06 2029-10-05 8314000 8050000 8044000 Footwear 5.23 0.01 0.0966 2022-04-01 2024-04-27 5704000 5361000 5419000 Health Care Providers & Services 6 0.01 0.1077 2022-06-03 2026-01-27 1399000 1387000 1399000 Media 0.95 0 0.0845 2022-07-18 2024-10-10 9162000 9162000 9162000 Auto Parts & Equipment 8 0.01 0.1244 2021-08-11 2026-10-12 25922000 25506000 25922000 Health Care Equipment & Supplies 5.75 0.0075 0.1048 2021-06-16 2028-06-16 24953000 24446000 24953000 Health Care Providers & Services 5.25 0.01 0.0998 2022-04-01 2027-02-12 6899000 6585000 6864000 Trading Companies & Distributors 5.50 0.01 0.1014 2022-04-01 2026-12-31 9996000 9527000 9996000 Packaged Foods & Meats 6.50 0.01 0.1088 2021-08-12 2027-08-13 24789000 24038000 24789000 Water Utilities 4.50 0.01 0.0787 2022-04-01 2026-11-02 1728000 1668000 1728000 Insurance 5.75 0.01 0.0931 2022-04-01 2026-04-01 31624000 30785000 30359000 912558000 886513000 Diversified Financial Services 7.05 0.01 0.1138 2021-12-24 2028-08-21 29925000 29398000 29925000 Diversified Consumer Services 9.75 0.01 0 2013-12-23 2026-10-12 13043000 11791000 6521000 Pharmaceuticals 7.65 0.0178 0.1182 2019-12-31 2024-07-01 23159000 23894000 24433000 Biotechnology 6.25 0.01 0.0875 2022-06-29 2027-06-01 3643000 3620000 3643000 Pharamceuticals 7.45 0.001 0.1162 2021-12-22 2027-01-01 66849000 67077000 67685000 Pharmaceuticals 7.95 0.001 0.1212 2022-02-23 2027-03-01 9475000 9437000 9499000 Biotechnology 0 0 0.09 2021-11-17 2026-11-17 39839000 39340000 39839000 Pharmaceuticals 7.25 0.0245 0.1142 2019-06-28 2024-01-01 11844000 12372000 12555000 Biotechnology 6.20 0.0275 0.1052 2022-12-27 2028-01-01 26939000 26874000 26872000 Health Care Technology 7.90 0.001 0.1207 2021-09-30 2026-10-01 15883000 15867000 15922000 Health Care Equipment & Supplies 5.50 0.0345 0.0982 2022-12-20 2027-12-01 3367000 3338000 3359000 Health Care Equipment & Supplies 7.65 0.0166 0.1182 2020-03-02 2025-02-28 18012000 18450000 19003000 Health Care Equipment & Supplies 14.05 0.001 0.1822 2018-07-30 2023-07-01 19201000 19380000 19777000 Health Care Equipment & Supplies 5.15 0.0275 0.0933 2022-11-03 2027-11-01 35084000 34880000 34820000 Biotechnology 5.70 0.023 0.0988 2022-09-21 2027-09-01 10525000 10406000 10420000 Health Care Equipment & Supplies 8.30 0.01 0.1258 2022-02-18 2027-02-01 34455000 34270000 34628000 319205000 322455000 1272952000 1245414000 0.266 Commercial Services & Supplies 0.0847 0.0964 2021-02-12 2025-03-01 2026-12-01 2264000 2262000 2262000 Diversified Consumer Services 0.10 2022-08-11 2026-08-11 2026-08-29 1036000 1036000 1036000 Airlines 0.0708 0.0713 2021-11-03 2026-11-03 2026-11-23 3600000 3660000 3600000 Commercial Services & Supplies 0.10 2019-03-29 2024-09-15 1059000 1059000 1069000 Food & Staples Retailing 0.1046 2022-12-23 2028-01-01 2365000 2440000 2365000 Metals & Mining 0.0831 0.1044 2020-05-28 2024-07-01 2026-10-07 4568000 4568000 4568000 Commercial Services & Supplies 0.0742 2022-07-01 2026-08-01 153000 153000 153000 Oil, Gas & Consumable Fuels 0.0854 2022-10-07 2027-11-01 6708000 6514000 6507000 Airlines 0.10 2018-04-04 2023-10-04 2026-06-22 2241000 2241000 2214000 Airlines 0.10 2018-03-19 2023-01-01 1055000 1055000 1055000 Road & Rail 0.081 0.086 2022-09-22 2026-03-22 2027-09-22 3690000 3690000 3690000 Hotels, Restaurants & Leisure 0.0936 0.1301 2021-05-27 2025-04-01 2028-01-01 6539000 6539000 6539000 Auto Components 0.0796 2021-02-02 2026-01-01 1828000 1849000 1828000 Commercial Services & Supplies 0.08 2022-10-31 2027-11-01 1589000 1589000 1589000 Containers & Packaging 0.0901 2021-01-06 2024-01-01 276000 276000 276000 Diversified Consumer Services 0.0658 0.0916 2022-08-26 2025-12-09 2027-09-01 1321000 1321000 1295000 Road & Rail 0.0825 2020-09-30 2027-10-01 5270000 5300000 5270000 Multi-Sector Holdings 0.0837 2018-04-27 2025-04-27 3837000 3837000 3741000 Diversified Financial Services 0.075 0.0902 2021-10-28 2026-10-01 2027-03-01 2938000 2941000 2938000 Diversified Financial Services 0.09 2021-11-05 2026-08-01 7116000 7116000 7116000 Road & Rail 0.1251 0.1289 2019-04-09 2023-11-01 779000 784000 779000 Commercial Services & Supplies 0.083 0.0877 2018-03-22 2023-06-05 2023-10-05 469000 469000 468000 Airlines 0.08 2017-12-04 2024-01-04 425000 425000 425000 Machinery 0.1071 2018-10-23 2026-01-01 4801000 4806000 4801000 Construction & Engineering 0.105 2021-10-08 2025-11-01 997000 997000 997000 Commercial Services & Supplies 0.0969 0.0994 2018-11-15 2024-05-01 2025-09-01 290000 290000 283000 Auto Components 0.0795 2021-06-23 2025-06-23 6072000 6109000 5951000 Road & Rail 0.0858 2018-02-05 2024-03-01 194000 194000 194000 Machinery 0.105 2022-12-29 2027-06-01 767000 767000 767000 Multi-Sector Holdings 0.0873 0.1152 2019-05-16 2024-05-16 2024-09-25 7500000 7500000 7361000 Road & Rail 0.0828 0.1209 2021-06-17 2024-12-01 2026-12-01 16411000 16411000 16411000 Consumer Finance 0.1246 0.1326 2021-08-20 2024-08-20 2024-10-01 1638000 1663000 1638000 Commercial Services & Supplies 0.10 2017-07-31 2025-02-28 369000 368000 369000 Commercial Services & Supplies 0.1072 2022-12-23 2027-01-01 2005000 2072000 2005000 Aerospace & Defense 0.0932 2022-11-23 2028-12-01 2658000 2658000 2658000 Machinery 0.10 2020-06-01 2024-06-01 159000 159000 159000 Commercial Services & Supplies 0.0933 0.0979 2019-09-24 2023-04-01 2024-11-01 1940000 1960000 1904000 Road & Rail 0.0956 2019-11-21 2025-08-01 849000 849000 775000 Road & Rail 0.0953 2019-01-17 2024-02-01 428000 431000 428000 Diversified Consumer Services 0.0821 2022-12-06 2027-12-06 245000 245000 245000 Transportation Infrastructure 0.085 2022-10-31 2029-07-01 14102000 14152000 14102000 Multi-Sector Holdings 0.085 2022-01-24 2023-01-24 5000000 5000000 5000000 Commercial Services & Supplies 0.0782 0.0828 2022-06-30 2026-09-15 2029-12-29 4139000 4139000 4139000 Road & Rail 0.0847 0.0858 2017-07-31 2023-07-01 2025-01-25 1521000 1521000 1459000 Road & Rail 0.0842 2018-03-09 2025-04-01 2887000 2887000 2591000 Road & Rail 0.1022 0.1063 2017-07-31 2026-01-01 3369000 3369000 3369000 Commercial Services & Supplies 0.0407 2017-07-31 2028-01-15 1706000 1706000 1706000 Commercial Services & Supplies 0.0794 0.0875 2021-10-08 2024-11-01 2026-12-01 577000 577000 577000 Commercial Services & Supplies 0.1092 2022-12-23 2027-03-01 2005000 2005000 2005000 Road & Rail 0.1121 2018-03-23 2024-08-01 469000 473000 469000 Diversified Consumer Services 0.0843 0.10 2019-07-31 2024-08-01 2025-10-05 604000 605000 604000 Energy Equipment & Services 0.0911 2019-12-27 2025-01-01 386000 386000 371000 Transportation Infrastructure 0.0832 0.0936 2022-09-23 2027-09-23 2027-10-28 304000 308000 304000 Diversified Consumer Services 0.0891 2022-12-07 2027-01-01 707000 714000 707000 Multi-Sector Holdings 2017-07-31 200 145000000 120820000 291445000 265952000 0.004 Aerospace & Defense 0.05 2012-06-08 2023-06-30 49273000 4927000 3801000 0.571 Pharmaceuticals 2016-11-18 6347 106000 0 Health Care Equipment & Supplies 2017-03-31 90 51000 0 Pharmaceuticals 2019-06-28 289102 136000 82000 Health Care Equipment & Supplies 2016-06-15 157500 65000 0 Health Care Equipment & Supplies 2017-08-18 444388 74000 103000 Health Care Technology 2017-03-22 260000 129000 366000 Multi-Sector Holdings 2020-11-03 73500000 136596000 148444000 Health Care Equipment & Supplies 2022-12-20 29366 23000 23000 Diversified Consumer Services 2013-12-23 231177 15683000 0 Diversified Consumer Services 2013-12-23 522 5216000 0 Diversified Consumer Services 2013-12-23 30370 381000 0 Health Care Equipment & Supplies 2019-07-25 469353 235000 483000 Diversified Financial Services 2022-04-01 100 81583000 89370000 Diversified Financial Services 2012-12-28 280303 280737000 288760000 Diversified Financial Services 2022-04-01 32839 34335000 34350000 Asset Management 2022-12-01 0 9500000 9426000 Biotechnology 2022-09-21 159470 51000 15000 Health Care Equipment & Supplies 2022-02-18 36996 210000 87000 Health Care Equipment & Supplies 2018-05-10 33430 152000 0 565263000 571509000 2.087 2134587000 2086676000 0.418 Government 2022-12-30 2023-02-23 420000000 417590000 417590000 2.505 2552177000 2504266000 -1.505 -1504535000 1 999731000 0.25 18939000 0 15833000 0 -635000 3741000 -749000 80000000 0 0 0 87000 80000000 -7402000 145996000 0 0 0 -2448000 148444000 -15225000 10725000 0 3500000 0 -136000 7361000 -1003000 0 0 0 0 0 0 0 5216000 0 0 0 5216000 0 0 0 0 0 0 0 0 0 11829000 685000 0 0 5280000 6521000 18000 0 81583000 0 0 -7787000 89370000 -5150000 298766000 0 0 0 10006000 288760000 -20500000 129102000 0 0 0 8282000 120820000 0 0 5000000 0 0 0 5000000 -379000 0 34335000 0 0 -15000 34350000 -2595000 0 9500000 0 0 74000 9426000 0 1121000 0 447000 0 674000 0 -647000 4509000 266000 942000 0 32000 3801000 -266000 706203000 131369000 20722000 0 18630000 797594000 -53898000 0.242 17187000 161053000 143866000 2069489000 0.08 0.0575 0.005 0.03 0.10 0.08 0.03875 0.221 0.175 0.077 0.066 0.055 0.043 0.042 0.039 0.027 0.019 0.017 0.017 0.017 0.013 0.013 0.012 0.012 0.011 0.011 0.011 0.01 0.009 0.009 0.008 0.007 0.007 0.006 0.005 0.005 0.005 0.004 0.004 0.003 0.003 0.003 0.003 0.003 0.003 0.002 0.001 0.001 0.001 0 0 0 1 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 1. Organization </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SLR Investment Corp. (the “Company”, “SLRC”, “we”, “us” or “our”), a Maryland corporation formed in November 2007, is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">closed-end,</div> externally managed, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-diversified</div> management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”) pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders. </div> 5680000 18.5 600000 18.5 0.7796 12511825 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 2. Significant Accounting Policies </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X,</div> as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2023. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The significant accounting policies consistently followed by the Company are: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment transactions are accounted for on the trade date; </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-market</div> pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under GAAP, the Board has approved a multi-step valuation process each quarter, as described below: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:13%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment; </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:13%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser; </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:13%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets; </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:13%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:13%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(5)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> under the 1940 Act; and (6) maintain recordkeeping requirements under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5.</div> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">820-10,</div> certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&amp;A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the nine months ended September 30, 2023, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy: </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 1</div>: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 2</div>: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 3</div>: Unobservable inputs for the asset or liability. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience. </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(c)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Gains or losses on investments are calculated by using the specific identification method. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(d)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(e)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company intends to comply with the applicable provisions of the Code pertaining to RICs to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(f)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(g)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(h)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> and ASC Topic 810—<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consolidation</div></div>, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company. </div> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(i)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(j)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">835-30,</div> the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(k)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">marked-to-market</div></div> by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(l)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">946-20-25.</div></div> </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(m)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments that are expected to pay regularly scheduled interest in cash are generally placed on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(n)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents. </div> </td> </tr> </table> P60D P60D 0.04 P30D P90D <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Note 3. Agreements </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">day-to-day</div></div> operations of, and provides investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income for the immediately preceding calendar quarter. For this purpose, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee). <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-incentive</div> fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-incentive</div> fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income with respect to that portion of such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pro-rated</div> for any period of less than three months. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">investment-by-investment</div></div> basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three and nine months ended September 30, 2023 and 2022. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three and nine months ended September 30, 2023, the Company recognized $8,051 and $23,635, respectively, in base management fees and $5,796 and $16,943, respectively, in performance-based incentive fees. For the three and nine months ended September 30, 2023, $175 and $410, respectively, of such performance-based incentive fees were waived. For the three and nine months ended September 30, 2022, the Company recognized $7,890 and $22,019, respectively, in base management fees and $4,965 and $9,699, respectively, in gross performance-based incentive fees. For the three and nine months ended September 30, 2022, $194 and $1,552 of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment <div style="letter-spacing: 0px; top: 0px;;display:inline;">Adviser.     </div> </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three and nine months ended September 30, 2023, the Company recognized expenses under the Administration Agreement of $1,575 and $4,563 respectively. For the three and nine months ended September 30, 2022, the Company recognized expenses under the Administration Agreement of $1,132 and $3,684 respectively. No managerial assistance fees were accrued or collected for the three and nine months ended September 30, 2023 and 2022. </div> 0.015 2 0.01 2 0.0175 -0.07 1 0.20 0.20 0.20 8051000 23635000 5796000 16943000 175000 410000 7890000 22019000 4965000 9699000 194000 1552000 1575000 4563000 1132000 3684000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 4. Net Asset Value Per Share </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At September 30, 2023, the Company’s total net assets and net asset value per share were $985,385 and $18.06, respectively. This compares to total net assets and net asset value per share at December 31, 2022 of $999,731 and $18.33, respectively. </div> 985385000 18.06 999731000 18.33 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 5. Earnings Per Share </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">260-10,</div> for the three and nine months ended September 30, 2023 and 2022: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Earnings (loss) per share (basic &amp; diluted)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator—net increase (decrease) in net assets resulting from operations:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,528</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52,766</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(655</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator – weighted average shares:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,634</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,772,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,639</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,647,874</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Earnings (loss) per share:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.49</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.97</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">($</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.01</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">260-10,</div> for the three and nine months ended September 30, 2023 and 2022: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Earnings (loss) per share (basic &amp; diluted)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator—net increase (decrease) in net assets resulting from operations:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,528</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52,766</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(655</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator – weighted average shares:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,634</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,772,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,639</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,647,874</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Earnings (loss) per share:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.49</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.97</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">($</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.01</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> 26947000 13528000 52766000 -655000 54554634 54554634 54772651 54772651 54554639 54554639 50647874 50647874 0.49 0.49 0.25 0.25 0.97 0.97 -0.01 -0.01 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 6. Fair Value </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 1.</div></div> Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 2.</div></div> Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Quoted prices for similar assets or liabilities in active markets; </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Quoted prices for identical or similar assets or liabilities in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-active</div> markets; </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">c)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Pricing models whose inputs are observable for substantially the full term of the asset or liability; and </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">d)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 3. </div></div>Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3). </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1. </div><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present the balances of assets measured at fair value on a recurring basis, as of September 30, 2023 and December 31, 2022: </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2023 </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measured at<br/> Net Asset Value*</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,306</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,306</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">315</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">571,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">29,277</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">601,583</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">315</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,141,464</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,277</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,171,056</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measured at<br/> Net Asset Value*</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">571,509</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,086,676</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">820-10,</div> certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members. </div></td></tr></table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables provide a summary of the changes in fair value of Level 3 assets for the three and nine months ended September 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at September 30, 2023: </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:44%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, June</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566,427</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,160,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29,555</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29,555</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">41,505</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">190</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(64</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,280</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,351</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities<div style="letter-spacing: 0px; top: 0px;;display:inline;">*</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">168,421</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,190</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">64</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,895</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">185,570</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(198,517</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,407</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(51</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(208,975</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, September</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,306</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">571,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,141,464</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,782</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">190</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(64)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,251</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,657</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:44%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2022</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(28,398</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(28,398</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,682</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(187</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,639</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,967</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities<div style="letter-spacing: 0px; top: 0px;;display:inline;">*</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">488,757</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,274</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">187</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,081</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">555,299</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(441,089</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(35,031</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(51</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(476,171</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, September</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,306</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">571,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,141,464</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,925</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(187</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,639</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,210</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap;"></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 2%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">*</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes PIK capitalization and accretion of discount </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"></div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at September 30, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $521,500, $206,250, $120,313, $80,750, $68,438, $43,375 and $119,138, respectively. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022: </div> <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:44%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">450,381</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,669,496</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,244</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,238</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden91832968">Net</span> change in unrealized loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,065</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,743</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities(1)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">796,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">116,272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">997,095</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(446,356</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(85,087</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,389</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(532,843</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2022</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden91832969">Net</span> change in unrealized loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,920</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,598</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes positions acquired from SUNS as a result of the Mergers. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Borrowings</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(150,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10.</div> On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively. </div> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative Information about Level 3 Fair Value Measurements </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of September 30, 2023 is summarized in the table below: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:38%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/> Liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation<br/> Technique/Methodology</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted<br/> Average)</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,292,834 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">7,532</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recovery Analysis</div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recoverable Amount</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10.1% -20.5% (12.8%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">N/A</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144,486 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">120,820</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8.5% -9.5% (9.5%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.1x-1.4x (1.2x)</div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.0% -5.0% (5.0%)</div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">165,771 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">406,220</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Comparable Multiple <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">6.3x -11.5x (8.8x)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.5% -30.7% (10.7%)</div></div> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $120,820 of investments valued using an implied multiple. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $855 of investments valued using a Black-Scholes model and $164,916 of investments valued using an EBITDA multiple. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:39%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/> Liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation<br/> Technique/Methodology</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted<br/> Average)</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,212,842 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">32,572</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">9.4% -18.2% (12.0%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.1x-21.4x (12.4x)</div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">145,132 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">120,820</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">I<div style="letter-spacing: 0px; top: 0px;;display:inline;">ncome Approach</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8.5% -9.7% (9.7%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.1x-1.4x (1.2x)</div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">I<div style="letter-spacing: 0px; top: 0px;;display:inline;">ncome Approach</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.0% -5.0% (5.0%)</div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149,120 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">412,480</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Comparable Multiple <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">7.8x –9.8x (8.8x) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">6.6% -35.2% (9.2%)</div></div> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $120,820 of investments valued using an implied multiple. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Significan</div>t increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">bid-ask</div> spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present the balances of assets measured at fair value on a recurring basis, as of September 30, 2023 and December 31, 2022: </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2023 </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measured at<br/> Net Asset Value*</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,306</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,306</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">315</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">571,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">29,277</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">601,583</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">315</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,141,464</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,277</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,171,056</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measured at<br/> Net Asset Value*</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">571,509</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,086,676</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">820-10,</div> certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members. </div></td></tr></table> 0 0 1300366000 0 1300366000 0 0 265306000 0 265306000 0 0 3801000 0 3801000 315000 0 571991000 29277000 601583000 315000 0 2141464000 29277000 2171056000 0 0 1245414000 0 1245414000 0 0 265952000 0 265952000 0 0 3801000 0 3801000 483000 0 561600000 9426000 571509000 483000 0 2076767000 9426000 2086676000 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables provide a summary of the changes in fair value of Level 3 assets for the three and nine months ended September 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at September 30, 2023: </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:44%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, June</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566,427</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,160,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29,555</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29,555</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">41,505</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">190</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(64</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,280</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,351</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities<div style="letter-spacing: 0px; top: 0px;;display:inline;">*</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">168,421</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,190</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">64</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,895</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">185,570</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(198,517</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,407</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(51</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(208,975</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, September</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,306</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">571,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,141,464</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,782</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">190</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(64)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,251</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,657</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:44%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2022</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(28,398</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(28,398</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,682</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(187</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,639</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,967</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities<div style="letter-spacing: 0px; top: 0px;;display:inline;">*</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">488,757</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,274</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">187</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,081</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">555,299</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(441,089</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(35,031</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(51</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(476,171</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, September</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,306</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">571,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,141,464</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,925</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(187</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,639</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,210</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap;"></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 2%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">*</div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes PIK capitalization and accretion of discount </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"></div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at September 30, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $521,500, $206,250, $120,313, $80,750, $68,438, $43,375 and $119,138, respectively. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022: </div> <div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:44%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">450,381</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,669,496</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,244</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,238</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden91832968">Net</span> change in unrealized loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,065</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,743</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities(1)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">796,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">116,272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">997,095</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(446,356</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(85,087</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,389</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(532,843</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2022</div></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden91832969">Net</span> change in unrealized loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,920</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,598</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes positions acquired from SUNS as a result of the Mergers. </div> </td> </tr> </table> 1318512000 271333000 3801000 566427000 2160073000 -29555000 0 0 0 -29555000 41505000 190000 -64000 -7280000 34351000 168421000 4190000 64000 12895000 185570000 -198517000 -10407000 0 -51000 -208975000 0 0 0 0 0 1300366000 265306000 3801000 571991000 2141464000 9782000 190000 -64000 -7251000 2657000 1245414000 265952000 3801000 561600000 2076767000 -28398000 0 0 0 -28398000 35682000 111000 -187000 -21639000 13967000 488757000 34274000 187000 32081000 555299000 -441089000 -35031000 0 -51000 -476171000 0 0 0 0 0 1300366000 265306000 3801000 571991000 2141464000 29925000 111000 -187000 -21639000 8210000 521500000 206250000 120313000 80750000 68438000 43375000 119138000 939690000 273795000 5630000 450381000 1669496000 -36244000 0 0 6000 -36238000 -8065000 -6924000 -706000 -5048000 -20743000 796389000 84168000 266000 116272000 997095000 -446356000 -85087000 -1389000 -11000 -532843000 0 0 0 0 0 1245414000 265952000 3801000 561600000 2076767000 -8920000 -6924000 -706000 -5048000 -21598000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized (gain) loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Borrowings</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(150,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending fair value</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 150000000 0 0 0 -150000000 0 0 393000000 155200000 75000000 118750000 79688000 68250000 42875000 118125000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of September 30, 2023 is summarized in the table below: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:38%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/> Liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation<br/> Technique/Methodology</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted<br/> Average)</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,292,834 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">7,532</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recovery Analysis</div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recoverable Amount</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10.1% -20.5% (12.8%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">N/A</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144,486 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">120,820</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8.5% -9.5% (9.5%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.1x-1.4x (1.2x)</div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.0% -5.0% (5.0%)</div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">165,771 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">406,220</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Comparable Multiple <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">6.3x -11.5x (8.8x)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.5% -30.7% (10.7%)</div></div> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $120,820 of investments valued using an implied multiple. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $855 of investments valued using a Black-Scholes model and $164,916 of investments valued using an EBITDA multiple. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:39%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/> Liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation<br/> Technique/Methodology</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted<br/> Average)</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,212,842 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">32,572</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">9.4% -18.2% (12.0%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.1x-21.4x (12.4x)</div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">145,132 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">120,820</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">I<div style="letter-spacing: 0px; top: 0px;;display:inline;">ncome Approach</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8.5% -9.7% (9.7%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.1x-1.4x (1.2x)</div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">I<div style="letter-spacing: 0px; top: 0px;;display:inline;">ncome Approach</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.0% -5.0% (5.0%)</div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Asset</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149,120 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">412,480</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Comparable Multiple <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">7.8x –9.8x (8.8x) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">6.6% -35.2% (9.2%)</div></div> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $120,820 of investments valued using an implied multiple. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple. </div> </td> </tr> </table> 1292834000 7532000 Income Approach Recovery Analysis Market Yield Recoverable Amount 10.1 20.5 12.8 144486000 120820000 Income Approach Market Multiple Market Yield Comparable Multiple 8.5 9.5 9.5 1.1 1.4 1.2 3801000 Income Approach Market Yield 5 5 5 165771000 406220000 Market Multiple Market Approach Comparable Multiple Return on Equity 6.3 11.5 8.8 5.5 30.7 10.7 120820000 855000 164916000 1212842000 32572000 Income Approach Market Multiple Market Yield Comparable Multiple 9.4 18.2 12 0.1 21.4 12.4 145132000 120820000 Income Approach Market Multiple Market Yield Comparable Multiple 8.5 9.7 9.7 1.1 1.4 1.2 3801000 Income Approach Market Yield 5 5 5 149120000 412480000 Market Multiple Market Approach Comparable Multiple Return on Equity 7.8 9.8 8.8 6.6 35.2 9.2 120820000 676000 148444000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 7. Debt </div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our debt obligations consisted of the following as of September 30, 2023 and December 31, 2022: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Facility</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Credit Facility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">521,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">517,582</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,254</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPV Credit Facility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">206,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">205,263</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">154,302</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,979</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,637</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,421</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,738</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,613</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,586</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,498</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,963</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,953</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Series F Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,985</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,978</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,197,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,191,754</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,085,998</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $3,918 and $4,746 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $987 and $898 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $363 and $579 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(5)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $262 and $387 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(6)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $414 and $502 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(7)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $37 and $47 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(8)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $15 and $22 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Unsecured Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div><div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full on the maturity date, January 20, 2023<div style="letter-spacing: 0px; top: 0px;;display:inline;">.     </div> </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revolving and Term Loan Facilities </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, subsequent to an August 29, 2023 amendment, the commitment under the SPV Credit Facility is $275,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is SOFR plus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2.00%-2.50%</div> with no SOFR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2023, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $206,250. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment, a <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$25,000 </div>November 2022 upsizing and <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">a $40,000</div> August 2023 commitment expiration, the Credit Facility is composed of $585,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">1.75%-2.00%</div> or the alternate base rate plus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">0.75%-1.00%.</div> The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At September 30, 2023, outstanding USD equivalent borrowings under the Credit Facility totaled $521,500, composed of $421,500 of revolving credit and $100,000 of term loans. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The average annualized interest cost for all borrowings for the nine months ended September 30, 2023 and the year ended December 31, 2022 was 5.79% and 4.09%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the nine months ended September 30, 2023 and the year ended December 31, 2022 were $1,273,200 and $1,164,200, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our debt obligations consisted of the following as of September 30, 2023 and December 31, 2022: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Facility</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Credit Facility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">521,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">517,582</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,254</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPV Credit Facility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">206,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">205,263</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">154,302</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,979</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,637</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,421</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,738</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,613</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,586</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,498</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,963</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,953</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Series F Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,985</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,978</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,197,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,191,754</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,085,998</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $3,918 and $4,746 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $987 and $898 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $363 and $579 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(5)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $262 and $387 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(6)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $414 and $502 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(7)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $37 and $47 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(8)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $15 and $22 as of September 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> 521500000 517582000 393000000 388254000 206250000 205263000 155200000 154302000 0 0 75000000 74979000 125000000 124637000 125000000 124421000 85000000 84738000 85000000 84613000 75000000 74586000 75000000 74498000 50000000 49963000 50000000 49953000 135000000 134985000 135000000 134978000 1197750000 1191754000 1093200000 1085998000 3918000 4746000 987000 898000 21000 363000 579000 262000 387000 414000 502000 37000 47000 15000 22000 85000000 85000000 P5Y 0.039 2025-03-31 Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30 135000000 135000000 0.0333 2027-01-06 Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6 50000000 50000000 0.0295 0.0295 125000000 125000000 125000000 0.042 2024-12-15 Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15 75000000 75000000 75000000 0.04375 0.04375 2026-12-15 75000000 75000000 75000000 73846000 semi-annually on January 20 and July 20 0.045 0.045 2023-01-20 275000000 600000000 0.02 -0.025 2026-06-01 206250000 25000000 40000000 585000000 100000000 0.0175 -0.02 0.0075 -0.01 800000000 521500000 421500000 100000000 0.0579 0.0409 1273200000 1164200000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 8. Financial Highlights </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of financial highlights for the nine months ended September 30, 2023 and 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:13%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per Share Data: (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.93</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.06</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.08</td> <td style="white-space:nowrap;vertical-align:bottom">)* </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase (decrease) in net assets resulting from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.96</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.02</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock in connection with the Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.31</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Distributions to stockholders:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From distributable earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.23</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.06</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From return of capital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.17</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.06</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.37</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per share market value, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15.39</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Return (b)(c)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.07</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(27.75</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">985,385</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,006,225</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares outstanding, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,634</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,772,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ratios to average net assets (c):</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.90</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.51</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.89</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.90</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.37</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.22</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.26</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.12</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Average debt outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,161,095</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">951,995</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Portfolio turnover ratio</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> <div style="line-height: 8pt; margin-top: 0px; margin-bottom: 0px; border-bottom: 1px solid rgb(0, 0, 0); width: 11%;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2022 and December 31, 2021 was $13.91 and $18.43, respectively. Total return does not include a sales load. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(c)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not annualized for periods less than one year. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">**</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the nine months ended September 30, 2023, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.93% and 10.30%, respectively, without the performance-based incentive fee waiver. For the nine months ended September 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.06% and 7.28%, respectively, without the performance-based incentive fee waiver. </div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of financial highlights for the nine months ended September 30, 2023 and 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:13%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per Share Data: (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.93</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.06</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.08</td> <td style="white-space:nowrap;vertical-align:bottom">)* </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase (decrease) in net assets resulting from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.96</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.02</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock in connection with the Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.31</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Distributions to stockholders:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From distributable earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.23</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.06</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From return of capital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.17</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.06</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.37</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per share market value, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15.39</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Return (b)(c)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.07</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(27.75</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">985,385</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,006,225</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares outstanding, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,634</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,772,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ratios to average net assets (c):</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.90</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.51</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.89</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.90</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.37</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.22</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.26</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.12</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Average debt outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,161,095</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">951,995</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Portfolio turnover ratio</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> <div style="line-height: 8pt; margin-top: 0px; margin-bottom: 0px; border-bottom: 1px solid rgb(0, 0, 0); width: 11%;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2022 and December 31, 2021 was $13.91 and $18.43, respectively. Total return does not include a sales load. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(c)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not annualized for periods less than one year. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">**</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the nine months ended September 30, 2023, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.93% and 10.30%, respectively, without the performance-based incentive fee waiver. For the nine months ended September 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.06% and 7.28%, respectively, without the performance-based incentive fee waiver. </div></td></tr></table> 18.33 19.93 1.25 1.06 -0.29 -1.08 0.96 -0.02 -0.31 1.23 1.06 0 -0.17 18.06 18.37 15.39 12.32 0.2007 -0.2775 985385000 1006225000 54554634 54772651 0.069 0.0551 0.0489 0.039 0.0537 0.0322 0.1026 0.0712 1161095000 951995000 0.221 0.138 13.91 18.43 0.0493 0.103 0.0406 0.0728 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 9. SLR Credit Solutions </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of September 30, 2023, total commitments to the revolving credit facility are $300,000. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September 30, 2023 SLR Credit had 32 funded commitments to 28 different issuers with total funded loans of approximately $469,495 on total assets of $506,081. As of December 31, 2022 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439,484 on total assets of $460,683. As of September 30, 2023 and December 31, 2022, the largest loan outstanding totaled $40,725 and $33,420, respectively. For the same periods, the average exposure per issuer was $16,768 and $17,579, respectively. SLR Credit’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to the Company, had approximately $284,472 and $224,325 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Credit had net income of $4,315 and $3,897, respectively, on gross income of $13,897 and $8,596, respectively. For the nine months ended September 30, 2023 and 2022, SLR Credit had net income of $1,411 and $8,557, respectively, on gross income of $42,350 and $22,171, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. </div> 275000000 0.98 23 400000000 275000000 0.02 5737000 1 300000000 32 28 469495000 506081000 29 25 439484000 460683000 40725000 33420000 16768000 17579000 284472000 224325000 4315000 3897000 13897000 8596000 1411000 8557000 42350000 22171000 <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 10. SLR Equipment Finance </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023. In June 2023, the facility was amended to extend the maturity date to January 31, 2024, with updated commitments totaling $152,147, effective August 1, 2023. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September 30, 2023, SLR Equipment had 141 funded equipment-backed leases and loans to 56 different customers with a total net investment in leases and loans of approximately $199,831 on total assets of $251,031. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190,830 on total assets of $241,813. As of September 30, 2023 and December 31, 2022, the largest position outstanding totaled $18,319 and $19,259, respectively. For the same periods, the average exposure per customer was $3,568 and $3,234, respectively. SLR Equipment’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to the Company, had approximately $130,557 and $114,977 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and September 30, 2022, SLR Equipment had net income (loss) of ($1,176) and $1,034, respectively, on gross income of $4,783 and $6,486, respectively. For the nine months ended September 30, 2023 and September 30, 2022, SLR Equipment had net loss of $2,193 and $125, respectively, on gross income of $15,174 and $15,704, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. </div> 1 209866000 145000000 64866000 150000000 250000000 213957000 313957000 2024-01-31 152147000 2023-08-01 141 56 199831000 251031000 131 59 190830000 241813000 18319000 19259000 3568000 3234000 130557000 114977000 1176000 1034000 4783000 6486000 2193000 125000 15174000 15704000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 11. Kingsbridge Holdings, LLC </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-ticket</div> lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September 30, 2023 and December 31, 2022, KBHT had total assets of $783,089 and $777,151, respectively. For the same periods, debt recourse to KBHT totaled $239,505 and $222,094, respectively, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> debt totaled $353,415 and $353,128, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2023 and 2022, KBHT had net income of $2,129 and $3,327, respectively, on gross income of $85,544 and $71,332, respectively. For the nine months ended September 30, 2023 and 2022, KBHT had net income of $7,151 and $10,393, respectively, on gross income of $229,051 and $215,074, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us. </div> 0.875 216596000 136596000 0.875 80000000 0.875 0.125 783089000 777151000 239505000 222094000 353415000 353128000 2129000 3327000 85544000 71332000 7151000 10393000 229051000 215074000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 12. SLR Healthcare ABL </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-sized</div> companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-invested</div> in the transaction and continues to lead SLR Healthcare. As of September 30, 2023, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022. Effective with an amendment dated August 24, 2023, SLR Healthcare has a $150,000 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> credit facility, which is expandable to $200,000 under its accordion facility. The maturity date of this facility is March 31, 2026. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"></div> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2023, the portfolio totaled approximately $237,000 of commitments with a total net investment in loans of $106,484 on total assets of $113,832. As of December 31, 2022, the portfolio totaled approximately $242,106 of commitments with a total net investment in loans of $92,383 on total assets of $108,705. At September 30, 2023, the portfolio consisted of 38 issuers with an average balance of approximately $2,802 versus 41 issuers with an average balance of approximately $2,253 at December 31, 2022. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cash-pay</div> loans. SLR Healthcare’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to us, had approximately $81,000 and $77,000 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Healthcare had net income of $1,532 and $822, respectively, on gross income of $4,833 and $3,020, respectively. For the nine months ended September 30, 2023 and 2022, SLR Healthcare had net income of $3,925 and $2,543, respectively, on gross income of $13,109 and $7,898, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. </div> 32839000 0.07 0.93 150000000 200000000 2026-03-31 237000000 106484000 113832000 242106000 92383000 108705000 38 2802000 41 2253000 81000000 77000000 1532000 822000 4833000 3020000 3925000 2543000 13109000 7898000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 13. SLR Business Credit </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">small-to-medium-sized</div></div></div> businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">medium-sized</div> businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671.</div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2023, the portfolio totaled approximately $612,399 of commitments, of which $257,818 were funded, on total assets of $302,912. As of December 31, 2022, the portfolio totaled approximately $603,432 of commitments, of which $286,006 were funded, on total assets of $332,247. At September 30, 2023, the portfolio consisted of 98 issuers with an average balance of approximately $2,631 versus 108 issuers with an average balance of approximately $2,648 at December 31, 2022. NMC has a senior credit facility with a bank lending group for $285,307 which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to us, had approximately $199,449 and $214,425 of borrowings outstanding at September 30, 2023 and December 31, 2022, respectively. For the three months ended September 30, 2023 and 2022, SLR Business Credit had net income of $1,779 and $1,977 respectively, on gross income of $9,709 and $7,607, respectively. For the nine months ended September 30, 2023 and 2022, SLR Business Credit had net income of $5,211 and $5,703 respectively, on gross income of $27,868 and $20,378, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. </div> 1 51000000 0.01 0.99 0.01 1 0.99 15500000 1 66671000 19000000 47671000 612399000 257818000 302912000 603432000 286006000 332247000 98 2631000 108 2648000 285307000 2025-11-13 199449000 214425000 1779000 1977000 9709000 7607000 5211000 5703000 27868000 20378000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 14. Commitments and Contingencies </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Off-Balance</div> Sheet Arrangements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of September 30, 2023 and December 31, 2022 is $367,295 and $364,163, respectively, comprised of the following: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Credit Solutions*</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outset Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apeel Technology, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,786</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,786</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Southern Orthodontic Partners Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,931</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,918</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Senior Lending Program LLC*</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Orthopedic Care Partners Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,770</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,620</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Human Interest, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CVAUSA Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,239</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BDG Media, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,646</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,546</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Neuronetics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ONS MSO, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,961</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">iCIMS, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,506</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,435</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cerapedics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,217</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,735</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Alkeme Intermediate Holdings, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,531</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Arcutis Biotherapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,356</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,356</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ardelyx, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,752</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,752</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">West-NR</div> Parent, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United Digestive MSO Parent, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Peter C. Foy &amp; Associates Insurance Services, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,094</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxury Asset Capital, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">UVP Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,386</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kaseya, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,769</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,936</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Urology Management Holdings, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,596</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">The Townsend Company, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,556</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Equipment Finance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vertos Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,325</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Maurices, Incorporated</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,589</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Erie Construction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Mid-west,</div> LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,403</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ultimate Baked Goods Midco LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,371</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,636</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic Fun, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,150</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bayside Opco, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,721</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SunMed Group Holdings, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,621</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">843</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SCP Eye Care, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,459</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Healthcare ABL*</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RxSense Holdings LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Enverus Holdings, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,239</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,004</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tilley Distribution, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,158</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">GSM Acquisition Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">862</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">784</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Composite Technology Acquisition Corp</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">796</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,537</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">631</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CC SAG Holdings Corp. (Spectrum Automotive)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">548</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">461</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pinnacle Treatment Centers, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">386</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,745</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vessco Midco Holdings, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,892</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TAUC Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">All States Ag Parts, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">212</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Glooko, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,868</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">World Insurance Associates, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,117</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Spectrum Pharmaceuticals, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,215</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accession Risk Management Group, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,498</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Copper River Seafoods, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Meditrina, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">One Touch Direct, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,069</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">DeepIntent, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,049</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plastics Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,424</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pediatric Home Respiratory Services, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,805</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,571</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NAC Holdings Corporation</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,479</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPAR Marketing Force, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,338</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Montefiore Nyack Hospital</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,034</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Teleconferencing Services, Ltd</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,090</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">391</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Commitments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">367,295</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">364,163</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:2%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company controls the funding of these commitments and may cancel them at its discretion. </div> </td> </tr> </table> <div> <div style="line-height:normal;background-color:white;display: inline;"> </div> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the respective portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of September 30, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment. </div> The total amount of these unfunded commitments as of September 30, 2023 and December 31, 2022 is $367,295 and $364,163, respectively, comprised of the following: <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Credit Solutions*</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outset Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apeel Technology, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,786</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,786</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Southern Orthodontic Partners Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,931</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,918</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Senior Lending Program LLC*</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">40,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Orthopedic Care Partners Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,770</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,620</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Human Interest, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CVAUSA Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,239</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BDG Media, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,646</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,546</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Neuronetics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ONS MSO, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,961</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">iCIMS, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,506</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,435</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cerapedics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,217</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,735</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Alkeme Intermediate Holdings, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,531</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Arcutis Biotherapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,356</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,356</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ardelyx, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,752</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,752</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">West-NR</div> Parent, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United Digestive MSO Parent, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Peter C. Foy &amp; Associates Insurance Services, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,094</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxury Asset Capital, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">UVP Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,386</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kaseya, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,769</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,936</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Urology Management Holdings, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,596</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">The Townsend Company, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,556</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Equipment Finance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vertos Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,325</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Maurices, Incorporated</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,589</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Erie Construction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Mid-west,</div> LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,403</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ultimate Baked Goods Midco LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,371</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,636</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic Fun, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,150</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bayside Opco, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,721</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SunMed Group Holdings, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,621</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">843</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SCP Eye Care, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,459</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Healthcare ABL*</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RxSense Holdings LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Enverus Holdings, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,239</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,004</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tilley Distribution, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,158</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">GSM Acquisition Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">862</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">784</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Composite Technology Acquisition Corp</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">796</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,537</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">631</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CC SAG Holdings Corp. (Spectrum Automotive)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">548</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">461</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pinnacle Treatment Centers, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">386</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,745</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vessco Midco Holdings, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,892</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TAUC Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">All States Ag Parts, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">212</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Glooko, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,868</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">World Insurance Associates, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,117</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Spectrum Pharmaceuticals, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,215</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accession Risk Management Group, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,498</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Copper River Seafoods, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Meditrina, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">One Touch Direct, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,069</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">DeepIntent, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,049</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plastics Management, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,424</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pediatric Home Respiratory Services, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,805</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,571</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NAC Holdings Corporation</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,479</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPAR Marketing Force, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,338</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Montefiore Nyack Hospital</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,034</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Teleconferencing Services, Ltd</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,090</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">391</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Commitments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">367,295</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">364,163</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:2%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company controls the funding of these commitments and may cancel them at its discretion. </div> </td> </tr> </table> 367295000 364163000 44263000 44263000 35084000 35084000 32786000 32786000 21931000 1918000 21250000 40500000 20770000 1620000 20104000 20104000 18239000 0 12646000 3546000 11579000 0 10961000 0 10506000 11435000 9217000 6735000 8531000 0 8356000 8356000 7752000 7752000 6830000 0 5259000 0 5062000 1094000 4500000 7500000 4386000 0 3769000 3936000 3596000 0 3556000 0 3500000 1000000 3325000 0 3009000 3009000 2650000 2650000 2589000 4314000 2403000 1248000 2371000 1636000 2150000 2675000 1721000 0 1621000 843000 1459000 2771000 1400000 1400000 1250000 1250000 1239000 1004000 1158000 525000 862000 784000 796000 1537000 631000 327000 548000 20670000 461000 144000 386000 1745000 327000 3892000 294000 294000 212000 135000 0 17868000 0 17117000 0 8771000 0 8215000 0 7498000 0 3595000 0 3367000 0 3069000 0 3049000 0 2424000 0 1805000 0 1571000 0 1479000 0 1338000 0 1034000 0 1090000 0 391000 367295000 364163000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 15. Capital Share Transactions </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September 30, 2023 and September 30, 2022, 200,000,000 shares of $0.01 par value capital stock were authorized. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions in capital stock were as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:36%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in connection with the Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="8" style="height:12pt"> </td> <td colspan="8" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in connection with the Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares repurchased</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(746</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(746</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 200000000 200000000 0.01 0.01 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions in capital stock were as follows: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:36%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in connection with the Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="8" style="height:12pt"> </td> <td colspan="8" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in connection with the Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares repurchased</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(746</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(746</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0 0 0 0 0 0 0 0 0 12511825 0 226839000 746 0 10000 0 -746 12511825 -10000 226839000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 16. Stock Repurchase Program </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May 9, 2023, our Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10b-18</div> of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 10, 2024 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. For the nine months ended September 30, 2023, the Company repurchased 746 shares at an average price of approximately $14.02 per share, inclusive of commissions. The total dollar amount of shares repurchased for the nine months ended September 30, 2023 was $10. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2022 was $3,038. </div> 50000000 2024-05-10 746 14.02 10000 217271 13.98 3038000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 17. SLR Senior Lending Program LLC </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2023, there were $79,200 of borrowings outstanding on the SSLP Facility. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September 30, 2023, the Company and the Investor had contributed combined equity capital in the amount of $57,500. As of September 30, 2023, the Company and the Investors’ remaining commitments to SSLP totaled $21,250 and $21,250, respectively. The Company, along with the Investor, controls the funding of SSLP and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September 30, 2023 and December 31, 2022, SSLP had total assets of $137,447 and $19,105, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 27 and 7 different borrowers, respectively. For the three months ended September 30, 2023, SSLP invested $57,456 in 16 portfolio companies. Investments prepaid totaled $1,658 for the three months ended September 30, 2023. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in 7 portfolio companies. Investments prepaid totaled $68 for the period December 1, 2022 (commencement of operations) through December 31, 2022. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"></div><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">SSLP Portfolio as of September 30, 2023 </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:47%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:10%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Industry</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Spread<br/> Above<br/> Index<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Floor</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest<br/> Rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Maturity<br/> Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Par<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/> Value<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accession Risk Management Group, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Insurance</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.02</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11/1/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Aegis Toxicology Sciences Corporation<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.13</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5/9/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,960</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,960</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,960</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Alkeme Intermediary Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Insurance</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.92</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/28/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,021</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,931</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">All States Ag Parts, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Trading Companies &amp; Distributors</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.60</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9/1/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,138</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,138</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,138</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Diversified Financial Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.15</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/29/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.65</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/11/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CC SAG Holdings Corp.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Diversified Consumer Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.18</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/29/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp. &amp; ES Opco USA LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Trading Companies &amp; Distributors</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.24</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,089</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,089</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,089</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fertility (ITC) Investment Holdco, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.63</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1/3/29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,799</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Personal Products</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.77</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/12/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,911</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,911</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,911</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Insurance</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.54</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,433</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,433</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,433</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">iCIMS, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Software</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+725</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/18/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,059</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,028</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,059</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kaseya, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Software</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.58</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/23/29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Software</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.04</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/1/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,962</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,962</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,962</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ONS MSO, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.62</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7/8/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,936</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,936</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PhyNet Dermatology LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.45</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/16/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,964</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,964</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,964</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pinnacle Treatment Centers, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.10</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1/2/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,725</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,725</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,725</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plastics Management, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.44</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/18/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,476</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RQM+ Corp.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Life Sciences Tools &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.40</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/12/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RxSense Holdings LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Diversified Consumer Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.47</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3/13/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SunMed Group Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Equipment &amp; Supplies</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.99</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,971</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,971</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,971</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">The Townsend Company, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Commercial Services &amp; Supplies</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.57</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/15/29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,570</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,482</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tilley Distribution, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Trading Companies &amp; Distributors</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.54</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ultimate Baked Goods Midco LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Packaged Foods &amp; Meats</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.67</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/13/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Urology Management Holdings, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.79</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/15/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,465</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,403</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,440</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vessco Midco Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Water Utilities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+450</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.92</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11/2/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">West-NR</div> Parent, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Insurance</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.72</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/27/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,674</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,622</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,621</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">132,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">133,561</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of September 30, 2023. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company also holds this security on its Consolidated Statements of Assets and Liabilities. </div></td></tr></table><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">SSLP Portfolio as of December 31, 2022 </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:42%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:17%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Industry</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Spread<br/> Above<br/> Index<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Floor</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest<br/> Rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Maturity<br/> Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Par<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/> Value<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Diversified Financial Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.84</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/29/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/11/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp. &amp; ES Opco USA LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Trading Companies &amp; Distributors</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.43</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Personal Products</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.15</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/12/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Insurance</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.39</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/25/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,030</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Software</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.48</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/1/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,032</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company also holds this security on its Consolidated Statements of Assets and Liabilities. </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below is certain summarized financial information for SSLP as of September 30, 2023 and December 31, 2022 and for the three and nine months ended September 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:72%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Balance Sheet Information for SSLP:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments at fair value (cost $132,993 and $18,032, respectively)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">133,561</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and other assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,886</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">137,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Distributions payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest payable and other credit facility related expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">358</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">165</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other payables</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">209</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78,893</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">254</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Members’ equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58,554</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities and members’ equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">137,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the three<br/> months ended<br/> September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the nine<br/> months ended<br/> September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the period<br/> December 1, 2022<br/> (commencement<br/> of operations) to<br/> December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Income Statement Information for SSLP:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,757</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,371</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service fees*</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">123</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,773</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Organizational costs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other general and administrative expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,871</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">886</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,134</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(179</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Realized gain on investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain on investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">538</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized gain on investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">568</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,063</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(149</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:2%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Service fees are included within the Company’s Consolidated Statements of Operations as other income. </div></td></tr></table> 50000000 50000000 100000000 100000000 2027-12-12 0.0325 79200000 57500000 21250000 21250000 137447000 19105000 57456000 1658000 18100000 68000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">SSLP Portfolio as of September 30, 2023 </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:47%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:10%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Industry</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Spread<br/> Above<br/> Index<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Floor</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest<br/> Rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Maturity<br/> Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Par<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/> Value<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accession Risk Management Group, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Insurance</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.02</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11/1/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Aegis Toxicology Sciences Corporation<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.13</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5/9/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,960</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,960</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,960</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Alkeme Intermediary Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Insurance</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.92</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/28/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,021</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,931</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">All States Ag Parts, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Trading Companies &amp; Distributors</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.60</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9/1/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,138</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,138</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,138</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Diversified Financial Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.15</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/29/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.65</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/11/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CC SAG Holdings Corp.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Diversified Consumer Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.18</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/29/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp. &amp; ES Opco USA LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Trading Companies &amp; Distributors</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.24</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,089</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,089</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,089</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fertility (ITC) Investment Holdco, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.63</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1/3/29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,799</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Personal Products</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.77</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/12/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,911</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,911</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,911</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Insurance</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.54</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,433</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,433</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,433</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">iCIMS, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Software</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+725</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/18/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,059</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,028</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,059</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kaseya, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Software</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.58</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/23/29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Software</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.04</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/1/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,962</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,962</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,962</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ONS MSO, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.62</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7/8/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,936</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,936</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PhyNet Dermatology LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.45</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/16/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,964</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,964</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,964</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pinnacle Treatment Centers, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.10</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1/2/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,725</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,725</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,725</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plastics Management, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.44</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/18/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,476</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RQM+ Corp.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Life Sciences Tools &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.40</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/12/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RxSense Holdings LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Diversified Consumer Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.47</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3/13/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SunMed Group Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Equipment &amp; Supplies</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.99</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,971</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,971</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,971</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">The Townsend Company, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Commercial Services &amp; Supplies</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.57</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/15/29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,570</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,482</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tilley Distribution, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Trading Companies &amp; Distributors</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.54</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ultimate Baked Goods Midco LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Packaged Foods &amp; Meats</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.67</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/13/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,977</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Urology Management Holdings, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.79</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/15/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,465</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,403</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,440</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vessco Midco Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Water Utilities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+450</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.92</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11/2/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">West-NR</div> Parent, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Insurance</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.72</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/27/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,674</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,622</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,621</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">132,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">133,561</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of September 30, 2023. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company also holds this security on its Consolidated Statements of Assets and Liabilities. </div></td></tr></table><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">SSLP Portfolio as of December 31, 2022 </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:42%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:17%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Industry</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Spread<br/> Above<br/> Index<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Floor</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest<br/> Rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Maturity<br/> Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Par<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/> Value<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Diversified Financial Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.84</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/29/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/11/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp. &amp; ES Opco USA LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Trading Companies &amp; Distributors</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.43</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Personal Products</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.15</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/12/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Insurance</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Health Care Providers &amp; Services</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.39</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/25/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,030</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Software</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.48</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/1/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,032</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company also holds this security on its Consolidated Statements of Assets and Liabilities. </div></td></tr></table> S+550 0.0075 0.1102 2026-11-01 9078000 9078000 9078000 S+550 0.01 0.1113 2025-05-09 2960000 2960000 2960000 S+650 0.01 0.1192 2026-10-28 3021000 2931000 2930000 S+600 0.01 0.116 2026-09-01 2138000 2138000 2138000 S+650 0.01 0.1215 2024-02-29 2475000 2475000 2475000 S+500 0.01 0.1065 2027-06-11 4043000 4043000 4043000 S+575 0.0075 0.1118 2028-06-29 2992000 2992000 2992000 S+475 0.01 0.1024 2025-12-31 1089000 1089000 1089000 S+650 0.01 0.1163 2029-01-03 5970000 5799000 5970000 S+625 0.01 0.1177 2027-02-12 8911000 8911000 8911000 S+600 0.0075 0.1154 2028-04-16 4433000 4433000 4433000 S+725 0.0075 0.1214 2028-08-18 3059000 3028000 3059000 S+625 0.0075 0.1158 2029-06-23 9000000 9000000 9000000 S+550 0.01 0.1104 2027-10-01 8962000 8962000 8962000 S+625 0.01 0.1162 2025-07-08 5936000 5779000 5936000 S+625 0.01 0.1145 2024-08-16 5964000 5964000 5964000 S+675 0.01 0.121 2026-01-02 4725000 4725000 4725000 S+500 0.01 0.1044 2027-08-18 5651000 5476000 5651000 S+575 0.01 0.114 2026-08-12 5970000 5970000 5970000 S+500 0.01 0.1047 2026-03-13 2977000 2977000 2977000 S+550 0.0075 0.1099 2028-06-16 8971000 8971000 8971000 S+625 0.01 0.1157 2029-08-15 3570000 3482000 3481000 S+600 0.01 0.1154 2026-12-31 5963000 5963000 5963000 S+625 0.01 0.1167 2027-08-13 8977000 8977000 8977000 S+625 0.01 0.1179 2026-06-15 2465000 2403000 2440000 S+450 0.01 0.0992 2026-11-02 1845000 1845000 1845000 S+625 0.01 0.1172 2027-12-27 2674000 2622000 2621000 132993000 133561000 S+600 0.01 0.1084 2024-02-29 2494000 2494000 2494000 L+500 0.01 0.0973 2027-06-11 2992000 2992000 2992000 L+475 0.01 0.0943 2025-12-31 1097000 1097000 1097000 L+550 0.01 0.1015 2027-02-12 2963000 2963000 2963000 L+600 0.0075 0.1073 2028-04-16 2494000 2494000 2494000 L+625 0.01 0.1039 2026-02-25 3000000 3000000 3030000 L+575 0.01 0.1048 2027-10-01 2992000 2992000 2992000 18032000 18062000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below is certain summarized financial information for SSLP as of September 30, 2023 and December 31, 2022 and for the three and nine months ended September 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:72%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Balance Sheet Information for SSLP:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments at fair value (cost $132,993 and $18,032, respectively)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">133,561</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and other assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,886</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">137,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Distributions payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest payable and other credit facility related expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">358</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">165</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other payables</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">209</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78,893</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">254</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Members’ equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58,554</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities and members’ equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">137,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the three<br/> months ended<br/> September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the nine<br/> months ended<br/> September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the period<br/> December 1, 2022<br/> (commencement<br/> of operations) to<br/> December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Income Statement Information for SSLP:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,757</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,371</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service fees*</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">123</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,773</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Organizational costs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other general and administrative expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,871</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">886</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,134</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(179</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Realized gain on investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain on investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">538</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized gain on investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">568</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,063</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(149</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:2%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Service fees are included within the Company’s Consolidated Statements of Operations as other income. </div></td></tr></table> 132993000 18032000 133561000 18062000 3886000 1043000 137447000 19105000 77826000 0 500000 0 358000 165000 209000 89000 78893000 254000 58554000 18851000 137447000 19105000 2757000 5371000 152000 66000 123000 4000 1773000 4025000 166000 0 0 73000 32000 89000 88000 1871000 4237000 331000 886000 1134000 -179000 0 30000 0 177000 538000 30000 177000 568000 30000 1063000 1702000 -149000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 18. Subsequent Events </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 7, 2023, the Board declared a quarterly distribution of $0.41 per share payable on December 28, 2023 to holders of record as of December 14, 2023. </div> 0.41 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Portfolio and Investment Activity </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the three months ended September 30, 2023, we invested approximately $187.4 million across 35 portfolio companies. This compares to investing approximately $245.4 million in 44 portfolio companies for the three months ended September 30, 2022. Investments sold, prepaid or repaid during the three months ended September 30, 2023 totaled approximately $205.6 million versus approximately $81.1 million for the three months ended September 30, 2022. </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At September 30, 2023, our portfolio consisted of 154 portfolio companies and was invested 37.1% in cash flow senior secured loans, 25.2% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 22.6% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 15.1% in life science senior secured loans, in each case, measured at fair value, versus 135 portfolio companies invested 30.2% in cash flow senior secured loans, 31.9% in asset-based senior secured loans / SLR Credit, 21.6% in equipment senior secured financings / SLR Equipment / KBH, and 16.3% in life science senior secured loans, in each case, measured at fair value, at September 30, 2022. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At September 30, 2023, 78.4% or $1.68 billion of our income producing investment portfolio<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">*</div> is floating rate and 21.6% or $462.1 million is fixed rate, measured at fair value. At September 30, 2022, 79.7% or $1.71 billion of our income producing investment portfolio<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">*</div> is floating rate and 20.3% or $434.9 million is fixed rate, measured at fair value. As of September 30, 2023 and 2022, we had two and two issuers, respectively, on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status. </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:2%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">*</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio. </div></td></tr></table> <div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 2%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Securities </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information about our senior securities is shown in the following table (in thousands) as of the quarter ended September 30, 2023 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities. </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class and Year</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/>Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/>Coverage<br/>Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/>Liquidating<br/>Preference<br/>Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Market Value<br/>Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Credit Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">421,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">642</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">293,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">513</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">222,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">552</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">126,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">421</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">182</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">96,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">593</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">245,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,225</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">990</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">207,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,459</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SPV Credit Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">206,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">372</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">501</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">638</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">923</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">430</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Tranche C Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2023 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">461</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class and Year</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/>Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/>Coverage<br/>Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/>Liquidating<br/>Preference<br/>Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Market Value<br/>Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2024 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">190</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">219</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">309</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">417</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">531</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2025 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2026 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">114</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Series F Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">206</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2042 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">859</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,002</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">982</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">943</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,411</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">934</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Senior Secured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">645</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">527</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,721</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Term Loans</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">175</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">308</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">430</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">351</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,147</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,206</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">NEFPASS Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div><div style="line-height:normal;background-color:white;display: inline;"></div></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SSLP Facility</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">53,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Senior Securities</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,197,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,823</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,915</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">818,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">677,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">593,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">476,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">541,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">390,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">432,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,425</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="line-height: 8pt; margin-top: 0px; margin-bottom: 0px; border-bottom: 1px solid rgb(0, 0, 0); width: 11%;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2023, asset coverage was 182.3%. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively. </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information about our senior securities is shown in the following table (in thousands) as of the quarter ended September 30, 2023 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities. </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class and Year</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/>Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/>Coverage<br/>Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/>Liquidating<br/>Preference<br/>Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Market Value<br/>Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Credit Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">421,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">642</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">293,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">513</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">222,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">552</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">126,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">421</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">182</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">96,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">593</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">245,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,225</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">990</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">207,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,459</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SPV Credit Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">206,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">372</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">501</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">638</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">923</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">430</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Tranche C Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2023 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">461</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class and Year</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/>Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/>Coverage<br/>Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/>Liquidating<br/>Preference<br/>Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Market Value<br/>Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2024 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">190</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">219</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">309</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">417</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">531</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2025 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2026 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">114</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Series F Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">206</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2042 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">859</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,002</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">982</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">943</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,411</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">934</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Senior Secured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">645</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">527</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,721</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Term Loans</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">175</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">308</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">430</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">351</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,147</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,206</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">NEFPASS Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div><div style="line-height:normal;background-color:white;display: inline;"></div></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SSLP Facility</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">53,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Senior Securities</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through September 30, 2023)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,197,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,823</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,915</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">818,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">677,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">593,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">476,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">541,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">390,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">432,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,425</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="line-height: 8pt; margin-top: 0px; margin-bottom: 0px; border-bottom: 1px solid rgb(0, 0, 0); width: 11%;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2023, asset coverage was 182.3%. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively. </div> </td> </tr> </table> 421500000 642 0 293000000 513 0 222500000 552 0 126000000 421 0 42900000 182 0 96400000 593 0 245600000 1225 0 115200000 990 0 207900000 1459 0 0 0 0 0 0 0 206250000 314 0 155200000 272 0 0 0 0 150000000 372 0 150000000 501 0 150000000 638 0 150000000 923 0 150000000 748 0 50000000 430 0 0 0 0 21000000 52 0 21000000 70 0 21000000 89 0 21000000 129 0 21000000 105 0 0 0 0 75000000 131 0 75000000 186 0 75000000 250 0 75000000 319 0 75000000 461 0 75000000 374 0 125000000 190 0 125000000 219 0 125000000 309 0 125000000 417 0 125000000 531 0 85000000 129 0 85000000 149 0 75000000 114 0 75000000 131 0 75000000 186 0 75000000 250 0 75000000 319 0 50000000 76 0 50000000 88 0 50000000 124 0 135000000 206 0 135000000 237 0 0 0 0 100000000 859 0 1002 100000000 702 0 982 100000000 2294 0 943 100000000 2411 0 934 0 0 0 75000000 645 0 75000000 527 0 75000000 1721 0 75000000 1808 0 100000000 152 0 100000000 175 0 100000000 248 0 75000000 250 0 75000000 319 0 50000000 308 0 50000000 250 0 50000000 430 0 50000000 351 0 50000000 1147 0 50000000 1206 0 0 0 0 30000000 100 0 30000000 128 0 30000000 185 0 0 0 0 53785000 331 0 1197750000 1823 0 1093200000 1915 0 818500000 2029 0 677000000 2259 0 593900000 2525 0 476185000 2930 0 541600000 2702 0 390200000 3354 0 432900000 3039 0 225000000 5162 0 225000000 5425 0 <div id="fin458881_14" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Item 1A. Risk Factors </div></div></div></div><div style="font-weight:bold;display:inline;"> </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-K, which</div> could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factors set forth below, there have been no material changes during the period ended September 30, 2023 to the risk factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div> </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-performance</div> by financial institutions or transactional counterparties could have a material adverse effect on us, the Investment Adviser and our portfolio companies. </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash not held in custody accounts and held by us, our Investment Adviser and by our portfolio companies in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest-bearing</div> and interest-bearing operating accounts could, at times, exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. If such banking institutions were to fail, we, our Investment Adviser, or our portfolio companies could lose all or a portion of those amounts held in excess of such insurance limits. In addition, actual events involving limited liquidity, defaults, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-performance</div> or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems, which could adversely affect our, our Investment Adviser’s and our portfolio companies’ business, financial condition, results of operations, or prospects. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we and our Investment Adviser assess our and our portfolio companies’ banking and financing relationships as we believe necessary or appropriate, our and our portfolio companies’ access to funding sources and other credit arrangements in amounts adequate to finance or capitalize current and projected future business operations could be significantly impaired by factors that affect the financial institutions with which we, our Investment Adviser or our portfolio companies have arrangements directly or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we, our Investment Adviser or our portfolio companies have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us, our Investment Adviser, or our portfolio companies to acquire financing on acceptable terms or at all. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our stock repurchase program could affect the price of our common stock and increase volatility and may be suspended or terminated at any time, which may result in a decrease in the trading price of our common stock. </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May 9, 2023, the Board most recently extended our share repurchase program (the “Program”), under which we can repurchase up to $50 million of our outstanding common stock. Under the Program, purchases can be made at management’s discretion from time to time in open-market transactions, in accordance with all applicable securities laws and regulations, at prices below the Company’s NAV as reported in its most recently published consolidated financial statements. We have in the past, and could in the future, enter into a plan to repurchase shares of our common stock pursuant to the Program in a manner intended to comply with the requirements of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10b5-1</div> under the Exchange Act. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Program is discretionary and whether purchases will be made under the Program and how much will be purchased at any time is uncertain and dependent on prevailing market prices and trading volumes, all of which we cannot predict. These activities could have the effect of maintaining the market price of our common stock or retarding a decline in the market price of the common stock, and, as a result, the price of our common stock could be higher than the price that otherwise might exist in the open market. Repurchases pursuant to the Program could affect the price of our common stock and increase its volatility. The existence of the Program could also cause the price of our common stock to be higher than it would be in the absence of such a program and could potentially reduce the market liquidity for our common stock. There can be no assurance that any stock repurchases will enhance stockholder value because the market price of our common stock could decline below the levels at which we repurchased such shares. Any failure to repurchase shares after we have announced our intention to do so could negatively impact our reputation and investor confidence in us and could negatively impact our stock price. Although the Program is intended to enhance long-term stockholder value, short-term stock price fluctuations could reduce the Program’s effectiveness. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions. </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The London Interbank Offered Rate (“LIBOR”) is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom’s Financial Conduct Authority (“FCA”), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBORs, including USD LIBOR, except in very limited circumstances. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States, SOFR is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the filing date of this Quarterly Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q,</div> many of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on SOFR (“CME Term SOFR”) or CME Term SOFR plus a fixed spread adjustment. CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-month</div> and three-month CME Group traded SOFR futures contracts and, in some cases, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">over-the-counter</div></div> SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Since CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used. Further, the composition and characteristics of SOFR and CME Term SOFR are not the same as those of LIBOR. Even with the application of a fixed spread adjustment, LIBOR and CME Term SOFR will not have the same composition and characteristics, and there can be no assurance that the replacement rate, as so adjusted, will be a direct substitute for LIBOR. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There can be no guarantee that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse to the interests of investors in loans referencing SOFR. If the manner in which SOFR or CME Term SOFR is calculated is changed, that change may result in a reduction of the amount of interest payable on such loans and the trading prices of the SOFR Loans. In addition, there can be no guarantee that loans referencing SOFR or CME Term SOFR will continue to reference those rates until maturity or that, in the future, our loans will reference benchmark rates other than CME Term SOFR. Should any of these events occur, our loans, and the yield generated thereby, could be affected. Specifically, the anticipated yield on our loans may not be fully realized and our loans may be subject to increased pricing volatility and market risk. </div> false false false false The Company controls the funding of these commitments and may cancel them at its discretion. AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows: Investment is on non-accrual status. Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2023 in these controlled investments are as follows: Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2023, on a fair value basis, non-qualifying assets in the portfolio represented 25.1% of the total assets of the Company. OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers. Indicates an investment that is wholly held by the Company through NEFPASS LLC. Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of September 30, 2023. The Company’s investment in SOINT, LLC includes a one dollar investment in common shares. Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows: Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 24.2% of the total assets of the Company. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor. Spread is 1.00% Cash / 6.00% PIK. Interest is paid in kind (“PIK”). iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK. Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK. Denotes a subsidiary of SLR Equipment Finance. In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members. AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK. Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022. The Company became an Affiliated Person to Bayside Opco, LLC and Bayside Parent, LLC on May 31, 2023 and to Amerimark Intermediate Holdings, LLC and SLR- AMI Topco Blocker, LLC on June 16, 2023. Non-income producing security. SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary. See note 10 to the consolidated financial statements. Denotes a Level 1 investment. Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation. See note 11 to the consolidated financial statements. Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC. See note 13 to the consolidated financial statements. See note 9 to the consolidated financial statements. See note 12 to the consolidated financial statements. See note 17 to the consolidated financial statements. Spread is 5.75% Cash / 0.50% PIK. BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK. OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK. Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK. The Company also holds this security on its Consolidated Statements of Assets and Liabilities. Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor. Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022. Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2023, asset coverage was 182.3%. The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. Aggregate net unrealized appreciation for U.S. federal income tax purposes is $31,537; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $152,992 and $121,455, respectively, based on a tax cost of $2,139,519. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated. Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK. Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated. On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839. Service fees are included within the Company’s Consolidated Statements of Operations as other income. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor. Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of September 30, 2023. Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively. EXCEL 82 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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

L;%%RYY+DPA:>7I6UYMNNRK3- MP<+"$_.7:^^&UXM[S/QV]JC-8?H#3/L#+%WD6:4%_-W9N\W1ZS?#']]LTD&F M\BOW&*O.=[+>?-L?T+3'0'F@!@YKMA!?K3S?R7KS;1=WVI)@OI>8.5Y6V>TM M)'= M(5M[%&7P[03F+83>,92ZZ_NAS^\):HHRMU''1:VM$=U#M-48-I4X%=9 M,WWQF'GTQX\WUYN;H]]OWIZ].3V/$V@/U[7[:HC?'[3ZW>G%VZ/7'S]\.+]= MI:!&??0WWIU9*XZK;KSQY;/RTSH%\,] +%1@CV/'RLW/6O-M[P73Y@<'6B3] M;N+UBKMR=[36?-O%G79'V'N1])>+@[]%,7-1>VET^@4;W][MHGBWWS/S8:S< M<:TUW_:',>VXL,H2ZTO3W'\L_MZ8NRD>WAN#W5-5\YO:H\J'Z=TX[=VXWV+K M+Q='+NSOS/RNX_'YR[6OC3#;77G[I.YFV+K+&!1 M[3Q-N["Q/4I\F!:2TQ:2SUZV_>7B)$O[\/SHVT?MR]F3B/-S[%'ZPS2'G#:' M?-ZJ[R\79UBJ^_SHV[IC[I&1A3GVJ/MA^D9.^T;.]XT+=\PL#5\J>K5[!K,N MNMU+"O.;V:.RA^D\.>T\N=>2\R\7!R[5='?!^K)&D!.>T#^*LO=+Y\)^+?3#YWUW#V',#\>W]ZF[KJ?"?KS;?]^4_;5!YH:?N[ MB=Y3Q,?UE.^\MRE:7MEZ;QO7NY MN[1]?UP6T__M_E*8W]K3"[W6?-N%GK:U3E,%UB.>T2 MR^>N<[\TP^V=.)W;_=+%[JMV]X+-_';VJ.YA&L%RV@B6*RQVOS2)%KM?N!-G M?HH]:G>89JZ<-G/E?#?VB#MQ%F:X50+FV^#Y.?:HW&&:M7+:K)7/6NS^;OB# MUJ#IN'N1<'X[>]3F,$U7.6VZRCU7N[\;^* 5;8LNJ;J].Y?74=3 M^;<__7AZ]7YXAQ]OXF+S]7@1^6_5<5/\_=T5Y%@ZKXR6$?W?ZK%W-$]FS+_5 MI[O<+PWVY[H6 M!FY]A?)JS\_Q]&JO-=]VM:<=3[7*.O=+TRQ<&ZYVFZ?TVO#\5O8H\&&:IVK: M/%7[+G2_-')F7\[ZI:+:C2'S6]BCGH=IEZIINU0]=Z7[I1D6+@A7V4KWZ07A M^>WL4=W#-%35M*&JYMNAQUT07IADIK;S [6*73GV8L@=ZX4I]BCZ87JQ:MJ+ M5<]=Z'YIAIF*+VWZET_=KWD097Z*/2I^F ZOFG9XU;/6N5\:/E/NY(I:U>XB M<0M;V*.HAVD0JVF#6.VYT/W2P)ER[BYT7U;=KL>]L(4]RGF8GK*:]I35LU:Z M7QH^4]3=I3W*%LE)C/DM[%'4PW1NU;1SJWZ5I>X?TZA_V&S.C_ZR>?/CQ0B> MZ^KOR[/+FT\_VE[QOKN]Z[OYC/WM==YF]CKO_+M]>CNYZGPGZ\VW]8G7TW:R M/M!Z]W<3KU;<5><[66^^[>).N\?Z&>O=+PU^\%TP)5NY'UQKONV23?O!>I4U M[Y>F\;UV_;@U[QL-YWS?N[D8N7;^>WL$=5#M/3U=.>KI[O MJA[1,2_,8->\OQNX=2:B:ZM^^K_=*J_E3M,SU5/>Z[Z60O@WPU_>!FW MVKVO8GXS>Y3F,/U3/>V?ZCW7O[\;6#\L2O*[8.7^9ZWYMHLR[7_J9RU_?S?\ MP9)Z17*K]?QF]BC-81J%9MHH-+_*ZO>/:0VOWGR\.;L^B@#\X^;J](.N.EV/ M'6)<[66^^ M[0]_VL@T!UH#_V[B]8J[?:H]W"9F%K>Q1X,/T4\VTGVH6;AGT M5W071L[LRVD?E?2G\UO8HYZ'Z9R::>?4/'U3W,+U5,^VMFA66PE^:9&;'?8Q+=NMHPQR#5V[+UIION^C3MJQY[DKX2S/, M5'Q^X#^?/J(3GI]CCY(?IMUKINU>\ZR5\)>&S]1[]W)9TW35[DFM^2WL4=3# MM(O-M%UL]EP)?VG@3#EW5\)OVJ[?/24QOX4]RGF8%K.=MICM\U;"7QCNB]KN MKH3?=+J%9JNH\UMX>E'7FF^[J-/6K?U55L)_5-_^=G/^RU\_]>F3&T;5I_=3 MJ:X\+HOQH5W>K=Q5SK;I\^_SZ9WDJO.=K#??]F<][23;0RV)WZZ\7.6J\YVL M-]]V<:>-8[OWDO@O%P?/')OF!S[JQNOY.?:H]F&ZR';:1;;SO>!CV_2%:1;: M]-O1#]OT?K=-G]_*'@4^3%O93MO*=K]U]5\NCIS9E^O'746>W\ >Y3Q,']E. M^\CVV M@>7\"ESS4^Q1],-TC.VT8VR?MXS_R\499BJ^M.FKY29]?HX]2GZ8?K*=]I/M M,P" EXO#9^J]>]VRKY)E$N?9[ M?@-/K^9:\VU7<]I-=L\ !UXN#I^I*7;V4!1UL?OK;7X+>Q3U,&U;-VW;NO\8 M4L'1WUY>G;W]8?/R[/)H["O2NZ[[>TS^,[1W5]#O_IP[\@OO\.G]XZKSG:PW MW_:G/.T?NT-Q!]W*W,&J\YVL-]]V<:?M8C??Y\TWYPN#9XY*\P,?<8OV_ Q[ MU/HPG6,W[1R[^?[OL:WYPC0+K7F7])*[OPQ6;B37FF^[NM-&LEM8TM+WY0LC M9W;CYC&U7+EO7&N^[5I.^\9N:1'+Q:9\88;)$MDE7'7;[*S'[L6%^4WM4>## M](C=M$?L%J"V1S7F"Y/,[+?S [5&,]K9J^?S4^Q1],-TB=VT2^SFV[Q'-.8+ M,\Q4?'[@@XKGC/S"%'M4_# ]9#_M(?N%U4\6^O*%X;[ZO[V_SSUY$KJ8 MN%-I%]=: .O5^SR_MJY?E. MUIMON[C3KK%?NHUU[EGHA<&/:+3G9]BC9(=I!?MI*]C/-W2/;;07IO$]=K_; M%S;'NT\SS<^_1VD/TQGVT\ZP7[BFYQ^%OAWY"%1J?AM[U.4P#5T_;>CZI94Z M%SOFA1G\%>S;@5M7L)&EW96;MK7FVR[LM&GKYSNGQSW_O##)>+MX.WLE>GZ* M/6IWD/:K+";M5_S'5XLS/+SK.U_(:V&.)U=NM?FV*X=IY>9;I87GG^^& M3[,]F[[<.7>UL)T]:G.0AJDL.*W-?,=C'X"^&SAM(]D6Q#/'DWR]W M1:2_/&@)V[Z8//A<'I=J"?O/RN+NJFTQMH3Y1=N%M_ODKF7=^4[6FV_[(Z^G M'WE]F);P;N+UBKMN?[/:?-O%;:;%7;IGV50N33._HO7=Z*T;JW=_2:S;0:TVWW9]NVE]%]:EM-=OET;. M[-%9YY0\_KRPA3WJ>9#&J2SZ:3V7EJ1;#\='93%W 7=ABJ<7?:WYMHL^[$S]=Z].@;T MV#F)NK"%/8IZF%X1TUX1\[VBO8*[-'"FG.5.ZSV4(7MC"'N4\3'N):7N) M^?9RX0KNTO"9HE:[^RA1[Y[/F-_"'D4]3 .':0.'I<[66^^[9U@ MVFBB.5 7CS4;P*]6GN]DO?FVBSMM*+%TD^7,A=VEP<_#C!=FWZ.T? M,=\%/K8_7YC&M^:W Q]B4SL7-Q?FWZ.TAVDE,6TEL;"ZI[WH>S=RJ\,N=U=L M6]C&'G4Y3!/(:1/(I:4]%UOLA1GL1=^[@=M<5+?;7<]OXNF%76N^[<).&SW. M=UN/NNB[-,EXT;>8N^B[,,4>M3M,Q\9IQ\;YENL1%WT79E#A%IXB7IACC\H= MIBWCM"WCPI(A"Q=]N7L)KRR;W2MX\YO9HS2':;$X;;$XWR/Y:[ZW ^N'1=D] M_,]O8(^B'*9%XK1%XL)*( N7?)E8UV72DL]O9H_2'*9QX+1QX-(5JE^K>_S# MYN/5Y<7FTT+7C^X?FSKZQ_ZN?^RU^G7YF=:^+O2GWM\6O%" ISZ#ND6NV)U^M/-_)>O-M%W?:[G#IAL.Y:\ +@_TIKX6!SVP[YV?? MXW,X3&_$:6_$^=[HL6WGPC0+EX5O1S_L/;/?LBLW66O-MU7@9LU54>XN8+:PB:<7=*WYM@LZ;:[*I84M%[O6A1D6+@S?CMYN7?N= M=;$7MK-'=0_3?I73]JN<;YX>=V%X89*9VBXU?UH ZG9A["(_"L_/L4?5#].Z ME=/6K9QOW1YQ97AAAIF2+VWZZI.M9>Z0GI]BCXH?IB,LIQUA.=\1+ET87A@^ M4^[DHEO/7>QM80M[%/4P'64Y[2C+^8[27QA>&#A3SGKWPG#/>F?1K84M[%'. MPW2AY;0++1>6!%FX,+PP?*:HNQPW^K)/BKIR5[?6?-M%G79UY=)EJU^KM?_C M^XNSDX]G;S='7U^>OSV[^&&VPS^]>/NPO^^&)KX^+G'[W"]U?;@=;_)&-R[- M%0U^;3[CE7O05><[66^^[5UAVH.6W8$:_'+-1O"KE><[66^^[>).&\MRZ?[- MN09_8?"WI;NNM#!P_&Z-;R6^8..?LE9__.-\OS^_L3T^EL.TH]6T':T6;KU\ M9+^_,(UO]6\'/FSU=UNG^?F?7MJUYMLN[;0QK1;6R/27F:NLI2SJ9;P=N/UO,W(Z],+,V@QK?OK MTUE\^VIICCTJ=YCNL)IVA]5\D[?4XUGS;Y9QVA]7"^B ++??"\)FBMEE1 MFR0 K-QGK37?=E&G?5:U=*WOUVJY_W)Y;;_E"G M_5W5'ZAYKM;LJKY:>;Z3]>;;*FX][=+JO?""5_<#']RO1%3E[FTY\YMX>EG6 MFF^[+-,.JWZ&0O#J?OB#.Y;8L-QM/^3,<;I]R4A/UT=^JN\4,B^-*-RTUGZ&*,YEEG-^<6O-M[P73GK ^D#9P-_%ZQ5VY]UMKONWB3GN_>KYSFW_D96'P,^\]FI]]CW(> MIB&LIPUAO0HHL#2-/Q=9[UH"]3%V[Y*9W\ >M3U,7UA/^\)Z/T[@U?W(K9.1 M"0NUL(T]ZG*8!J^>-GCU89*_2_NA_^4*FO=\^ZS&_FZ:59:[[MTDR;I6:O=?9?W0]\8,W7 MNZOE+VQ@CZ(;F-R]/KX=_]?@S;O,O[NG=QZKSG:PWW_8'-.T^FNI K5VS M9N_PUMBZ_N!SXXX]96[>[ED/DM[%&5PW01S;2+:)YQ M!^*K^^$/3KAU2&YKF-_.'K4Y3"?13#N)YG W$C[E>'GTMR]>_?FKUT>O+M^_ MWUR].3L]/_K]Y=7-#Z<_;%X<_>YWKX[^]N793YNKZ]C\VZ/?GEV<7N@?O1[> M]=F;\;Q;6]1'?\.=[\GCJK];;*:Z73*V^XQS9][F:[''$63E!FBM^;;WAVD# MU!SJ;L)FY:M-J\YWLMY\V\6==DC-WG<3OEHF=?ZQV'[29W\0>A3U,K]9.>[7VV7?^O5J< M9%Q@III=A75^BCUJ=Y@VJIVV4>VS;^!;F.&+CS\,A9L_US8_Q1Z%.TR+U$Y; MI/89]^^]NA_^X#:\OF=R_%^Y45IKONW:3!NE=J_;\%[=#WQPXU=?U4E55FZ1 MUIIONRK3%JE]QMUTK^Z'/V*/6;E=6&N^[=I,VX7V<#?%/:U]_.W)-T?_\_+J M_.W/\2S:(SO&)I8GO>\8<=PQ_E!]AO;V3HV[/YJ&Z@[Z-J5[Z!;=;Z3]>;;*FXW;7:ZI;4-YQK&A<'[-(SS4SZ]AFO-MUW# M:5/3S3Q3V,#U/-^UYNH6. MY5']XM(D'ZZ.C]#.WIPQ/\4>M3M,V]--VYYNONUY1+^X,,.#PIE^<7Z*/0IW MF)ZHF_9$W7Q/M-0O=KL7CSH6NXM0S&]FC]( M_/O1EYOO;S[+6\4_?ZFU2M[<$I33'/SJ\N+ZX_O-U8,NL6]OKRO>7DTL8VV2 M<@0H.2-0SK_=ISYKY2I_\KMSUKS;==_VO[T\^W/8SO+A6G& M3Z(:5QZ=^TQV6ZK^.+G??7YS>U3Z,"U5/VVI^@77V2\_NC#R6]>UWXY;;%#G MY]^CFH?IH_II']7/MT"/:% 79AAW6<[NK=5N?7>+NW*CM=9\V\6=-EK]0IOT MJ.5,%B99.#C/#QZOB);CDB:FPYV?8H_"'Z91ZZ>-6C_?J#UB]=&%&1:J/C]8 M-B4X2U/.3[%'U0_3 _;3'K"?[P&7ED-9&+Y0\MTK:ZB+9,7M^:WL4=C#])'] MM(_LY_M(OR3*PL"%DG8[G3G(?O?9@/FM[%'2P_2?_;3_[!<$K85E41:&+Q2V MW]E7V[K+(2R?G_W?0\=P^F%X*6_.3O4[\MW0O__K\>OCHW>;MYNKT_.CLXLWE^\W M1S>G?SWZ\/'JP^7UT*2?71_]78D7==G^T]'I_;0_7%U>7]N)XZG]MYNY+>UL M C5?]#TU].] O*CJ^L714+8/FSOC@Z/3^/?SK\.&Z#_G!Z\&+D^O;$R)NKX#V/WIV^.3L??D4>'_WETVLX M^F%S$;.?_W)T&MGE*HIQ\_ EG5TG%]^B8J>GVT^>OF_8=A MWJO+]T.9?C@;NM&QUA^';NA*KT3G9H8X-,SZQ1N5"GTYA)/AG9T.D[\=7MT_ MQ+^+4K#XIX?_7#_$/_VC7O!0R.TR?7KIUQ^__U_#AW1TNP;^OXZ(OS\YU7][O-L,LUWXL/5Y=N/;^)COGUIOQQ_6]U/L/6!_?SCV9L?CW[> MZ*6<7MR]OR_>O1OV@=CXT9^&'O[RXNZ]??_QYNCM9>RK\;%>O8D7>CKL?1&!L]NW@W'#LOWFSTZ;W=O!N^\V]C4U$0]%41I7AQ]/;C9BSIQ? OXIKS M\/%<_GPQS/#B:',613AZ.^QE;V[BYU'-J\N//_PX?$2;^,_WE\/+O=MJ[+K: M2XM7[(CY:?S MX/<[R/WG5A7V<[L[P-Y]8K_*@?;_M>/J_<%P\@KG#H;M=_\2W]3OK\Z&;_7] M4O7CHV7#@>?'S?G;^P+\R\NOC_YR^>'-9?SM4.^C+S?GIS^?JAS#L6K\@AU_ MVWWW>C,>68Z *'2\^.'E7 \?]%L=G=_=WU4U5.9&>\+U\;?]_Y=WN/_3=K9? M-J=7MWO9EYLWMSL9M)/QR3L9BN^^N3VP#'\9MZPJ?MQL_8X_/QL.2]_UQN]C:.Z_H?3?[Q[KWG8>G\?XG/Y)?Q/:&?W5V^>ECC<_\ M?MZKC7[I:6=_>W8=:2!>VX-*WPS_&>'BYAW[I/ M69\J\H7VB-V#R(LQ1+R+MO^G:/LC6IP-;_IBB-0[M;C[MGQZ-_YHWC;X')<:-\PG$#_,^]ZS_LWK5S\%AUYZJ.^JR4[)IPRL)P/;IPQLOOO+[>^ FQ_/XC?]39RS_\L^$#:H_+^TIIASY7E8>/[[U"\=E8M"]>O[J] M!^3%W2_Y_W4Y;/$H=L$AL-_^+M8&[M+LPY(/O4Q/W]OA7?_\XV7\HE3\^/Z7!V_N[C?D'[[Z[9^^>/WZ=LKN MN]^>7YYJQ[^*PKS=?'_S8%^^^>5#K%=Y'H>"T]LJZCL:7]/;(5%8!8!ADU>; M=\,_B!AQ^]G][O+B[5 JO9WOXTZ:/[Z+?_%65P/O \#OOGGYQS_?'3F&K]O= MCS\%@ON,/@S]XY!0+LY^^/'F[D;SX>4_F.[U'W^;S/;Z;K8Q,<0Q8OAB1GC? M_'5\+W?C__3G;W[_U>X$?_KT/J3SKW\=!8Q0OO_QZNK^$N]1AUL MQD_A1B,XWI]']3H>=O8\E$M\>_7(V[!7/VBWWN_^_-DK=*Q_IOC;UE\E_[-3AH>]K]7?_SSG^Z^ M)N,>^YOAFZ&8-OF>#\WXZ??GF^GFH^B3_7=^_*=QPZN;_I(LGG!8(?_S"_+_ M^R_(;M0;=HSRN\DIE^2T3\SR^H_?_.$OMTWAQ9OSCV_U?8H>Y6V< [K:^N>W MOU6N?QP:@=CWJN_N;YT8OD4?3L_48@TYYE/C]*=O_N7^E$K0=8_\!1'MW%#[ ML:V:^VT1O]\>?,7>W>]/D^_EZW_]P^NCUW_Z-[W3!R=_;O_BTVF?UQ^'S_1Q M)\>FYV8>W'?YY\U/E^<_Q6N(;;X:3X7]]O94V,/M[_[]_2[^#]?#$>$/<41X M?,[X1^W6\9(C"T_.L_TT)%@=K2+;:8.75T.Z.!M:Y6B2MW,5FZW#2IP%O/IX M6Y$W;ZX^;K:.)$-ZFQQ'KL=;P:XV0ZV&@!!;U><]?$]?3+YO.KS$@>/%47SA MXV/7%U?;_'0*;K+IJ_B*W&PNIJ??3OT<1^_B3JGA_;3?*;G\/DLN+XX^_=V7 MZMFW?_K--)N]_OC]B[B3]G@8?/R7XR^/M8C/Y=NQ%]?(+Z^.CWZWN;PXO7I[ M_\T;5PI^$^_@U>75AV-]4EMQZFX3#\_7Q! =:MY<_N:E3L)NKJZ/)V.C]]F< MWU;C;1R_CSY^B#]WNHGW]L,=.H0/D=&OCX8OY7%J MC_$M[[^[O;%O^#?U<5O__=&KT^L?CSX[*H[K879-5A;?G;WZYO>OQ\+X%U0> M=VWM7E&)[U[J?-7+H1_XTW"0>7^Z/)]_@R6_V\4:[SZY+R_?1\9]_?'JA]@7 M;[<3'\G]F+N?Z4S-;[Z_+_RW96DG]J\4Q=Q+K;[[M],/Z@/>+TTT]YF6]>2S M&N_@OOVL&OW'^(^:[_YE^ WSRV)QJ<_7;.G_O"_4MV7W^$^A]Y]"=A_!9]<_ M;C8W7Y[>G/Z/_VMXA3]L7FW.S^.7R<>+&]U*$'?4W?]%9+#__E^^P.?OYUF_V\^_SK+OMY__G7??I^B^$-%^G?1"GR&G'X MF_1=8WC;2-\WAC>.])UC>.M(WSN&-X_TW6-X^TC?/X8"(*T AA(@K0&'&C"M M 8<:,*T!AQHPK0&'&C"M 8<:,*T!AQHPK0&'&C"M 8<:,*T!AQHPK0&'&C"M M03G4H$QK4 XU*-,:E$,-RGSOC]T_K4$YU*!,:U .-2C3&I1##CR;!#A(*U!-]2@2VO0#S7HTQKT0PWZM ;]4(,^K4$_ MU*!/:] /->C3&O1##?JT!OU0@SZM03_4H$]KT \UZ/.$%!')9"2%I#PE%1&3 MBCPG%1&4BCPI%1&5BCPK%1&6BCPM%1&7BCPO%1&8BCPQ%1&9BCPS%1&:BCPU M%1&;BKPN"H\N/2H^YG51@#0)4A'29$B%2),B%2--CE20-$E24=)D285)DR85 M)_,\B0B4R!,E(E(BSY2@@G5>EXB5R',E(E@B3Y:(:(D\6R+")?)TB8B7R/,E M(F B3YB(B(D\8R)")O*4B8B9R',F(F@B3YHHU7+D=8FPB3QM(N(F\KR)")S( M$RB+/GHCPB3Q](N(G\OR)2LU87I>( MH,@S*"*$(D^AB!B*/((@(H\H2(B*O*,B@BI MR%,J(J8BSZF(H(H\J2*B*O*LBD8-?%Z7B*O(\RHBL")/K(C(BCRS(D(K\M2* MB*W(9!%1%GF61819Y&D6$6>1YUE$H$6>:!&1%GFF181:Y*D6$6N1YUIT M.NF3UR6B+?)LBPBWR-,M(MXBS[>(@(L\X2(B+O*,BPBYR%,N(N8BS[F(H(L\ MZ2*B+O*LBPB[R-,N>IT.,^?#=$(L/R,6>9=YWF7D7>9YEY%WF>==1MYEGG<9 M>9=YWF7D7>9YEY%WF>==1MYEGG<9>9=YWF7D7>9YE]"IPKPND7>9YUU&WF6> M=QEYEWG>9>1=YGF7D7>9YUU&WF6>=QEYEWG>9>1=FO.G.H%JSJ#J%*H[AZJ3 MJ'E==!K5G$?5B51S)E6G4LVY5)U,-6=3=3K5G$_5"55S1E6G5/.\R\B[S/,N M(^\RS[N,O,L\[[+4Z>6\+I%WF>==1MYEGG<9>9=YWF7D7>9YEY%WF>==1MYE MGG<9>9=YWF7D7>9YEY%WF>==1MYEGG=9Z<1[7I?(N\SS+B/O,L^[C+S+/.\R M\B[SO,O(N\SS+B/O,L^[C+S+/.\R\B[SO,O(N\SS+B/O,L^[K'5)(J]+Y%WF M>9>1=YGG74;>99YW&7F7>=YEY%WF>9>1=YGG74;>99YW&7F7>=YEY%WF>9>1 M=YGG73:Z6)/7)?(N\[S+R+O,\RXC[S+/NXR\RSSO,O(N\[S+R+O,\RXC[S+/ MNXR\RSSO,O(N\[S+R+O,\RY;7<;*ZQ)YEWG>9>1=YGF7D7>9YUU&WF6>=QEY MEWG>9>1=YGF7D7>9YUU&WF6>=QEYEWG>9>1=YGF7G2[PY76)O,L\[S+R+O.\ MR\B[S/,N(^\RS[N,O,L\[S+R+O.\R\B[S/,N(^\RS[N,O,L\[S+R+O.\RUZ7 M/LVU3UW\S*]^1MXM\[Q;1MXM\[Q;1MXM\[Q;1MXM\[Q;1MXM\[Q;1MXM\[Q; M1MXM\[Q;1MXM\[Q;1MXM\[Q;1MXM\[Q;0I>%\[I$WBWSO%M&WBWSO%M&WBWS MO%M&WBWSO%M&WBWSO%M&WBWSO%M&WBWSO%M&WBWSO%M&WBWSO%M&WBWSO%M2 M%\SSND3>+?.\6T;>+?.\6T;>+?.\6T;>+?.\6T;>+?.\6T;>+?.\6T;>+!;BDP]Q3H MI@)S5X%N*\CS;AEYM\SS;AEYM\SS;AEYM\SS;AEYM\SS;EGI)HN\+I%WRSSO MEI%WRSSOEI%WRSSOEI%WRSSOEI%WRSSOEI%WRSSOEI%WRSSOEI%WRSSOEI%W MRSSOEI%WRSSOEK5N/\GK$GFWS/-N&7FWS/-N&7FWS/-N&7FWS/-N&7FWS/-N M&7FWS/-N&7FWS/-N&7FWS/-N&7FWS/-N&7FWS/-NV>C&G+PND7?+/.^6D7?+ M/.^6D7?+/.^6D7?+/.^6D7?+/.^6D7?+/.^6D7?+/.^6D7?+/.^6D7?+/.^6 MD7?+/.^6K6Y9RNL2>;?,\VX9>;?,\VX9>;?,\VX9>;?,\VX9>;?,\VX9>;?, M\VX9>;?,\VX9>;?,\VX9>;?,\VX9>;?,\V[9Z6:NO"Z1=\L\[Y:1=\L\[Y:1 M=\L\[Y:1=\L\[Y:1=\L\[Y:1=\L\[Y:1=\L\[Y:1=\L\[Y:1=\L\[Y:1=\L\ M[Y:];G,S][GI1K?\3K?(NU6>=ZO(NU6>=ZO(NU6>=ZO(NU6>=ZO(NU6>=ZO( MNU6>=ZO(NU6>=ZO(NU6>=ZO(NU6>=ZO(NU6>=ROH%L"\+I%WJSSO5I%WJSSO M5I%WJSSO5I%WJSSO5I%WJSSO5I%WJSSO5I%WJSSO5I%WJSSO5I%WJSSO5I%W MJSSO5M3-D7E=(N]6>=ZM(N]6>=ZM(N]6>=ZM(N]6>=ZM(N]6>=ZM(N]6>=ZM M(N]6>=ZM(N]6>=ZM(N]6>=ZM(N]6>=ZM2MTVFM5UT2ZVYIU8WU9J[:G5;K;FO5C?6FCMK=6MMGG>KR+M5GG>KR+M5GG>KR+M5 MGG>KR+M5GG>KR+M5GG>K6K<:YW6)O%OE>;>*O%OE>;>*O%OE>;>*O%OE>;>* MO%OE>;>*O%OE>;>*O%OE>;>*O%OE>;>*O%OE>;>*O%OE>;=J=!-V7I?(NU6> M=ZO(NU6>=ZO(NU6>=ZO(NU6>=ZO(NU6>=ZO(NU6>=ZO(NU6>=ZO(NU6>=ZO( MNU6>=ZO(NU6>=ZM6MZ?G=8F\6^5YMXJ\6^5YMXJ\6^5YMXJ\6^5YMXJ\6^5Y MMXJ\6^5YMXJ\6^5YMXJ\6^5YMXJ\6^5YMXJ\6^5YM^ITXWY>E\B[59YWJ\B[ M59YWJ\B[59YWJ\B[59YWJ\B[59YWJ\B[59YWJ\B[59YWJ\B[59YWJ\B[59YW MJ\B[59YWJUZ/-)AG&O100_Y40^3=.L^[=>3=.L^[=>3=.L^[=>3=.L^[=>3= M.L^[=>3=.L^[=>3=.L^[=>3=.L^[=>3=.L^[=>3=.L^[-?2X1UZ7R+MUGG?K MR+MUGG?KR+MUGG?KR+MUGG?KR+MUGG?KR+MUGG?KR+MUGG?KR+MUGG?KR+MU MGG?KR+MUGG=KZD&8O"Z1=^L\[]:1=^L\[]:1=^L\[]:1=^L\[]:1=^L\[]:1 M=^L\[]:1=^L\[]:1=^L\[]:1=^L\[]:1=^L\[]:E'A'*ZQ)YM\[S;AUYM\[S M;AUYM\[S;AUYM\[S;AUYM\[S;AUYM\[S;AUYM\[S;AUYM\[S;AUYM\[S;AUY MM\[S;EWIX:F\+I%WZSSOUI%WZSSOUI%WZSSOUI%WZSSOUI%W:_,LF1XF,T^3 MZ7$R\SR9'B@S3Y3ID3+S3)D>*G-/E>FQLKPN>K#,/%FF1\O,LV5ZN,P\7:;' MR_*\6T?>K?.\6T?>K?.\6T?>K?.\6T?>K?.\6T?>K?.\6T?>K?.\6S=ZX"ZO M2^3=.L^[=>3=.L^[=>3=.L^[=>3=.L^[=>3=.L^[=>3=.L^[=>3=.L^[=>3= M.L^[=>3=.L^[=>3=.L^[=:M'$?.Z1-ZM\[Q;1]ZM\[Q;1]ZM\[Q;1]ZM\[Q; M1]ZM\[Q;1]ZM\[Q;1]ZM\[Q;1]ZM\[Q;1]ZM\[Q;1]ZM\[Q;=WI(,Z]+Y-TZ MS[MUY-TZS[MUY-TZS[MUY-TZS[MUY-TZS[MUY-TZS[MUY-TZS[MUY-TZS[MU MY-TZS[MUY-TZS[MUK\=7S?.K>H U?X(U\FZ3Y]TF\FZ3Y]TF\FZ3Y]TF\FZ3 MY]TF\FZ3Y]TF\FZ3Y]TF\FZ3Y]TF\FZ3Y]TF\FZ3Y]TF\FZ3Y]T&>K0WKTOD MW2;/NTWDW2;/NTWDW2;/NTWDW2;/NTWDW2;/NTWDW2;/NTWDW2;/NTWDW2;/ MNTWDW2;/NTWDW2;/NPWUT'->E\B[39YWF\B[39YWF\B[39YWF\B[39YWF\B[ M39YWF\B[39YWF\B[39YWF\B[39YWF\B[39YWF\B[39YWFU*/@^=UB;S;Y'FW MB;S;Y'FWB;S;Y'FWB;S;Y'FWB;S;Y'FWB;S;Y'FWB;S;Y'FWB;S;Y'FWB;S; MY'FWB;S;Y'FWJ?2@?%Z7R+M-GG>;R+M-GG>;R+M-GG>;R+M-GG>;R+M-GG>; MR+M-GG>;R+M-GG>;R+M-GG>;R+M-GG>;R+M-GG>;6DL(Y'6)O-OD>;>)O-OD M>;>)O-OD>;>)O-N8]12TH()944%+*I@U%;2H@EE50%RVO8-97T (+9H4%+;&0Y]TF\FZ3Y]TF\FZ3Y]TF\FZ3Y]TF\FZ3 MY]TF\FZ3Y]TF\FZ3Y]TF\FZ3Y]VFU;(3>5TB[S9YWFTB[S9YWFTB[S9YWFTB M[S9YWFTB[S9YWFTB[S9YWFTB[S9YWFTB[S9YWFTB[S9YWFTB[S9YWFTZ+;?.\ MVT;>;?.\VT;>;?.\VT;>;?.\VT;>;?.\VT;>;?.\VT;>;?.\VT;>;?.\VT;> M;?.\VT;>;?.\VS9:2"NO2^3=-L^[;>3=-L^[;>3=UJPIID7%S*IB6E;,K"NF MA<7,RF):6LRL+:;%QS*POI@7&W IC6F(LKXL6&3.KC&F9L3SOMI%W MVSSOMI%WVSSOMI%WVSSOMI%WVSSOMI%WVSSOMI%WVSSOMI%WVSSOMI%WVSSO MMIT67\OK$GFWS?-N&WFWS?-N&WFWS?-N&WFWS?-N&WFWS?-N&WFWS?-N&WFW MS?-N&WFWS?-N&WFWS?-N&WFWS?-NVVM9.K,NG1:FRU>FB[S;Y7FWB[S;Y7FW MB[S;Y7FWB[S;Y7FWB[S;Y7FWB[S;Y7FWB[S;Y7FWB[S;Y7FWB[S;Y7FWB[S; MY7FW@Y;LR^L2>;?+\VX7>;?+\VX7>;?+\VX7>;?+\VX7>;?+\VX7>;?+\VX7 M>;?+\VX7>;?+\VX7>;?+\VX7>;?+\VY'+6:8UR7R;I?GW2[R;I?GW2[R;I?G MW2[R;I?GW2[R;I?GW2[R;I?GW2[R;I?GW2[R;I?GW2[R;I?GW2[R;I?GW:[4 M,H]Y72+O=GG>[2+O=GG>[2+O=GG>[2+O=GG>[2+O=GG>[2+O=GG>[2+O=GG> M[2+O=GG>[2+O=GG>[2+O=GG>[2HM@)G7)?)NE^?=+O)NE^?=+O)NE^?=+O)N ME^?=+O)NE^?=+O)NE^?=+O)NE^?=+O)NE^?=+O)NE^?=+O)NE^?=KM;2H'E= M(N]V>=[M(N]V>=[M(N]V>=[M(N]V>=[M(N]V>=[M(N]V>=[M(N]V>=[M(N]V M>=[M(N]V>=[M(N]V>=[M&BV:FM5TB[W9Y MWNTB[W9F75TMK&M6UM72NF9M72VN:U;7U?*Z9GU=+;!K5MC5$KMFC5TMLFM6 MV=4RNVZ=72VTF]=%2^WF>;>+O-OE>;>+O-OE>;>+O-OE>;>+O-OE>;>+O-OE M>;>+O-OE>;>+O-OE>;>+O-OE>;>+O-OE>;?KM02Q68-8BQ#GJQ!'WNWSO-M' MWNWSO-M'WNWSO-M'WNWSO-M'WNWSO-M'WNWSO-M'WNWSO-M'WNWSO-M'WNWS MO-M'WNWSO-M#RS/G=8F\V^=YMX^\V^=YMX^\V^=YMX^\V^=YMX^\V^=YMX^\ MV^=YMX^\V^=YMX^\V^=YMX^\V^=YMX^\V^=YMZ<6KL[K$GFWS_-N'WFWS_-N M'WFWS_-N'WFWS_-N'WFWS_-N'WFWS_-N'WFWS_-N'WFWS_-N'WFWS_-N'WFW MS_-N7VI)[[PND7?[/._VD7?[/._VD7?[/._VD7?[/._VD7?[/._VD7?[/._V MD7?[/._VD7?[/._VD7?[/._VD7?[/._VE18[S^L2>;?/\VX?>;?/\VX?>;?/ M\VX?>;?/\VX?>;?/\VX?>;?/\VX?>;?/\VX?>;?/\VX?>;?/\VX?>;?/\VY? M:QGXO"Z1=_L\[_:1=_L\[_:1=_L\[_:1=_L\[_:1=_L\[_:1=_L\[_:1=_L\ M[_:1=_L\[_:1=_L\[_:1=_L\[_:-%LC/ZQ)YM\_S;A]YM\_S;A]YM\_S;A]Y MM\_S;A]YM\_S;A]YM\_S;A]YM\_S;A]YM\_S;A]YM\_S;A]YM\_S;M^*#LCK M$GFWS_-N'WFWS_-N'WFWS_-N'WFWS_-N'WFWS_-N'WFWS_-N'WFWS_-N'WFW MS_-N'WFWS_-N'WFWS_-NWPE5R.L2>;=. MC/"$DR=&>L+9$R,^X?2)D9]P_L0(4#B!8B0HC$%1C(*942@*C#R'J94@BL)( M%(4HBL)8%(4PBL)H%(4XBL)X%(5 BL*(%(5(BL*8%(50BL*H%(58BL*X%(5@ MBL+(%(5HBL+8% 5'S,342CQ%87R*0D!%882*0D1%88R*0DA%892*0DQ%89R* M0E!%8:2*0E1%8:R*0EA%8;2*0EQ%8;R*0F!%8<2*HASI%U,KH16%42L*L16% M<2L*P16%D2L*T16%L2L*X16%T2L*\16%\2L* 1:%$2P*$1:%,2P*(1:%42P* M,1:%<2R*:H1R3*U$613&LBB$611&LRC$613&LR@$6A1&M"A$6A3&M"B$6A1& MM2C$6A3&M2@$6Q1&MBA$6Q3&MBB$6Q1&MRCJD14RM1)P41CAHA!Q41CCHA!R M41CEHA!S41CGHA!T41CIHA!U41CKHA!V41CMHA!W41COHA!X41CQHA!Y41CS MHFA&A,G42NQ%8=R+0O!%8>2+0O1%8>R+0OA%8?2+0OQ%8?R+0@!&802,0@1& M80R,0@A&812,0@Q&81R,0A!&822,HAW)*E,K81B%T3 *<1B%\3 *@1B%$3$* MD1B%,3$*H1B%43$*L1B%<3$*P1B%D3$*T1B%L3$*X1B%T3$*\1B%\3&*;@2^ M3*U$9!3&R"B$9!1&R2C$9!3&R2@$911&RBA$913&RBB$911&RRC$913&RR@$ M9A1&S"A$9A3&S"B$9A1&S2CZD4-S'MH(HAD13;G=67$C%N>TN)&+/H)P3Y492SIER(RKG5+F1 ME7.NW C+.5ENI.6<+3?B< M/3?B-@)T3[$;"SAEV(V+G M%+N1L7..W0C9.EN MI.Z<=3=B=TZ[&[D[X]U!X!V,> >1=S#F'83>P:AW$'L'X]Y!\!V,? ?1=S#V M'83?P>AW$'\'X]]! !Z,@ <1># &'H3@P2AX$(,'X^!!$!Z,A =1># 6'H3A MP6AX$(<'X^%!(!Z,B >1># F'H3BP:AX$(L'X^*!(P3M).B1@K86](A!FUJ- M'+3SH$<0VHG0(PGM3.@1A78J],A".Q=ZA*&=##W2T":W"\N#T?(@+@_&RX/ M/!@Q#R+S8,P\",V#4?,@-@_&S8/@/!@Y#Z+S8.P\",^#T?,@/@_&SX, /1A! M#R+T8 P]"-?0@1@_&T8,@/1A)#Z+T8"P]"-.#T?0@3@_&TX- /1A1#R+U M8$P]"-6#4?4@5@_&U8-@/1A9#Z+U8&P]"->#T?4@7@_&UX. /1AA#R+V8(P] M"-F#4?8@9@_&V8.@/1AI#Z+V8*P]"-N#T?8@;@_&VX/ /1AQ#R+W8,P]"-V# M4?<@=@_&W8/@/1AY#Z+W8.P]"-^#T?<@?@_&WX, /AB!#R+X8 P^".?@@ MA@_&X8,@/AB)#Z+X8"P^"..#T?@@C@_&XX- /AB1#R+Y8$P^".6#4?D@E@_& MY8-@/AB9#Z+Y8&P^".>#T?D@G@_&YX. /ABA#R+Z8(P^".F#4?H@I@_&Z8.@ M/ABI#Z+Z8*P^".N#T?H@K@_&ZX/ /ABQ#R+[8,P^".V#4?L@M@_&[8/@/ABY M#Z+[8.P^".^#T?L@O@_&[X, /QC!#R+\8 P_"/?P@Q@_&\8,@/QC)#Z+\ M8"P_"/.#T?P@S@_&\X- /QC1#R+]8$P_"/6#4?T@U@_&]8-@/QC9#Z+]8&P_ M"/>#T?T@W@_&]X. /QCA#R+^8(P_"/F#4?X@Y@_&^8.@/QCI#Z+^8*P_"/N# MT?X@[@_&^X/ /QCQ#R+_8,P_"/V#4?\@]@_&_8/@/QCY#Z+_8.P_"/^#T?\@ M_@_&_X, 0!@!$"( 80Q " &$40 A!A#& 80@0!@)$*( 82Q " .$T0 A#A#& M X1 0!@1$"(!84Q " 6$40$A%A#&!81@0!@9$*(!86Q " >$T0$A'A#&!X2 M0!@A$"("88Q " F$40(A)A#&"82@0!@I$*("8:Q " N$T0(A+A#&"X3 0!@Q M$"(#8Q " ^$T0,A/A#�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

KF\O;L0-U]$S$).D!T6<4RR8F#ED6S%$"I5A?9.O([B_5IF4>:H M9B?G3%IX*EPK!Y'LR+D)%RY8S$R^.!1.!%XFN3Q ZO#I MX>"YC\7Y;,>?A\'[A9BN;5="<:4XJVZJ3)0GW7W&[)Z*N^B8;(0YZT(N#ZP\ M/*Y\P[-=<9S:*N,\2XJ76X+7A$D!<7V3B6*HWD@#AR/\KO\/4$L#!!0 ( M (N"9U???*%OA0@ TW 9 >&PO=V]R:W-H965THB;>3;^FXJEC5/YVVC(I\2SPNF19J5D[.3]K.K^NRD M6C5Y5O*K&HE54:3U/^]Y7CV<3O#D\8//V=VB41],STZ6Z1V_YLV7Y54MWTVW M4>99P4N1526J^>WIY!U^F_A4-6@5?V3\0>R\1LK*357]I=Y>>G_,\5Y%D/_[>!)ULCZD:[KY^C/ZQ-2_-W*2"GU?YG]F\69Q.H@F: M\]MTE3>?JX=?^,:0K^+-JERT_Z.'C=:;H-E*-%6Q:2Q[4&3E^F_Z;3,0.PUD M'+@!V30@^S:@FP;4:$"CG@9LTX"U([.VTHY#DC;IV4E=/:!:J64T]:(=S+:U MM)^5:MZOFUI^F\EVS=G'-*O1'VF^XN@87:\G'U6WZ'R1EG=?H,DMOLCQK,JE_E? FS7+Q6H;[>)NGO"9;([;YL3AAF[7$&WCT<$U M=/2X+#[Q5*QJ/D=R:W_FLU5=9^4=>I^*3!RA+V5U(WA]G][D'%V4RU6C-%4Y MDXLH;;/!UTMY"'31\$+\%UHOZ_XPN#\J5;X5RW3&3RZ%5> M"?$:LK2.Y.]TX9C$ON\;CB!91./(, 3(:$!H!/L)MGZ"03^S-J.J5+@J]_46 M6+VAC/K8L&:K,(VMJ0JLJ3J6<\HH["S<.@N=SJR]?_2,_7Z$?F['X5*-PQ&Z M;E*Y\WG9J'IS4&IU7A=PT"\4<]_SQ\Z\?OC7J$Q7Z0[DJ>-U&!+.& MT\E3L\:8P1+W&'_1ZV5GG%1JO2CON6C44 E'_HBV_%%OA]ZQAJU97*+DC@V%FED+=(X#KW8AQ=IO#46NXW5U8SS MN4"W=56@>2:6EP@02&A6P:X=H.^0@M6 3MM.CP ]-@[8J(MB:)@(4 ^S' M/64.:Q+$3L#9JQQ<-UF>HU]X/E>E 4IMARL![NX_M0:,&BT9&-J75@&L,1*[ M.?):8J0<[&LU56>\)X_JF-&2L:)UQU*#+/9_L',C M[$3K)T_&F-&2L:)U)T-3.'9C^!XG2!B":4DTF)B)%A 2YLM:8N9:&[QCB>=Q M7UW4Y(W=6/B4DZ1-J,&S)% 'G"9!.GF>Q%B/*8V@V,V@SZZ.-F R['N6/UM& M_2 BICU;=AQY00^&8LVA> !$GT/8V.9$'$2,F*>!@(Y%46@B0@+HPCB@40R[ M(QH[B1L[1\)L8C/D,8[E%C19!Q(RAKW(/*N A8&<^1[+FDV)FTV?0]K$1DN3 MM(< RIY/DM\TYXM.XYBTC=7&M*(&](^_+W*ENUN^IB53&C$1N]2(@I-2]B0[K MCWVSVH/Q:-AWU8EH0B/C$1JQB2 M&*2COD?-B81TD>]%/1?5J.8P.CZ'T6$.&Y8D3DG7C>8P^F(.H^#50.J9&+:G M+H%UN[FRZV7GWO!A((S:W&3O,DAD90] Y,@>5!,8=1/85) M7^Y83[YE/2I^C16M.XX:O^B/AE]T5/P:-5HR5K3N9&C\HB_&+PK.!%A\%K6)(X)5T7&KSH8<"+0KADW@F#1#@RKQ5!JM#K MN6Q"-7C1 X 7M5G)=@5<*[--V2(2]'AB&KG8=T$N-GP?=EB2 ))CW'N)CVG. M8N-S%AOFK&%)XI1TW6C.8B_F+&9S$9#L]E(E0ZJN"TU8[#"$Q2 N,C<4)+)W M%*3J31-LY_=L;L(ZKXI"EO,U7DTWE'51-EQ6OD9,_TQKN1P;][U)]R&>6NM' MC9:,%:T[O!J\V(\&7FQ4\!HU6C)6M.YD:/!B+P8O!L%2P(AY-@[JU,\\S5UK MZY@\:8_Z,I+&+S8>?K%A_!J6)("D+_MH_&*'P2\&,1.)+%> C." FC>O()WO ML9Y+1$PS&#L @S& KT@4F[=9 1DE7F051" :#DC8<]'!URSF?Q<6\P&*LGY] MNX\H@42X9Y_YFL;\\6G,'Z:Q84GBE'3=:!KS7TQCODU0?HCCV)J3_70)I.MF MRJX7S63^89AL$S;HY@Y[S0$R*'= .B!W3'>>'RIX?=<^AR70K%J5S?I1HNVG MVV>]WK5/.$VU?/V@V*>TOLOD-LOYK6SJO0GEV-;K9Z_6;YIJV3Z-=%,U356T M+Q<\G?-:">3WMU75/+Y1!]@^ 7?V?U!+ P04 " "+@F=7M/TXD1H# !- M" &0 'AL+W=O"35*J"&IRJS->E IJXH(+[81", M_8(RX443MW:MHHFL#&<"KA7155%0]3(#+E=3;^"]+MRP+#=VP8\F)OC5_0S9Q[-+*B&$\E_L\3D4^_ (PFDM.+F M1JY^06-H9/%BR;7[)JMF;^"1N-)&%DTP*BB8J'_I5M/R 6C"\:98:!) 517"A MP!(X&6Z1S5,PE'&]A3QA$(:X74/LH*ZD0>2'2R@6H![)!F&"W.:RTE0D>N(; MM&G%^G%C:59;"C^P- C)I10FU^2G2"!Y#^!C?MHDA:])FH6]B*<0[Y+A8+L1 M/C\EFQM;/;C#-OE#ASO\-/G;[Y)\^9IDO+8W-DG*YGI&-=/;'6FV>Z2(,9JZ MF_YP@3SDW$"A'[O25XO:ZQ9ER\"1+FD,4P_?<\L$7O3]VV <_.BQO-=:WNM# MCV:0,2&LG=2:7UKS71IKE+%#L95E&0U& 7XF_K*#?=2RCWK9K[#,8>WB["\F M=S/#HK5%N-2=EZQ&&JTI^(!\W)*//R6/\$E\5,OZJD/U6R'[_&4B% M$7@&G73[7Z4[:.D.>NENH*0O6,A-)]W!?W0[?2=]V)(>]I+>*BIT"DICKGWL M1K:FN5I4W^1AEY3#KSH?!&_5->B5@17H\[O>8(Q[B/VU"E^ REP?TR26E3!U ML6]7VUYY7'>(M^UUH[VD"E]!33BD&!KL[J-A5?>N>F)DZ?K%0AKL/FZ88[\' M93?@\U1BO6XFEJ#]!Q'] U!+ P04 " "+@F=72_:<$7X$ #%&P &0 M 'AL+W=O1OM@@@%KDIBUG3+S[]<.:3X*>"9;C\0+Y./>$]_C[AE_*M8$R+!MS3)Q,A92[FY8JE.^%A<>^#C( M;O"*S(A\VCQP=>96* N:DDQ0E@%.EB/G([R:H$ G%!'/E&Q%XQCH4N:,?=4G MMXN1X^D1D83$4D-@]?=")B1)-)(:Q[\EJ%,]4R@Z( 7A>Y&5I0UQ1*/AYQM =?1"DT?%-P4V:H:FNEIG$FN M[E*5)\7@"U!?7T![BB>TX1*2@1("18Y5Q=S0;,5F-%5 M1I/DT^$I^".X0Q\S!9@HIBC M4I$;:SZ_@R_W))T3_L^A4HW8NKNOQ ;'9.2H]M6T$V?\^V\P]/X\5+@EL!8- M?D6#7Z#[/Y3814M*]Z]24MW\2.*<A5_/:.,IF0N%05"\ER]/^5%HS?!E(HX89K&0Q3L<,," M5[_/7\8!@H'G#=V79G'[8?[ ]QIAK6$'U; #L_H?GCOIW8C6=;XL@;4*#ZO" MPU/4>VB3/TM@+?[Z%7_]7Z3W'6[0$#+R0A2\U?M^& P"=$SO437LR#AL_;,.\72=X, MW)6%$JW9&OW@Z)< -DPF_%%O]#KUAAFOTAHM%COZ1!__W6//!_Z;[X*A^)@U ^.B;^V;]#LWY3X@V[B-^)UGCA+:.WJ M:Q<(@Y,4OU4[:0NMS6%M**'1;[U'_.&>J".OO^>(#H3U!V$4'9%^[>2@V&$$8G*7VKQM(66IO#VEI"H_-ZC_0'>YH.HYX?O97^ MH3!T[*V/:DN'S)9.2;_?2?IFO,X+/I;0VM77A@_!4Y0^LFH;;:&U.6RL'IJ7 M#_^_]$O@IJ9[OM\/WDC_4!B*&F'M@==>#9F]6B']&>%ZPF^Z]8#513M;:&T: M:M^'>B?9 U;=HRVT-H>U>T3F1<1W]$"PMZH)X0#NO?\/QD40O>T"M[''HC>X M[C%?T4R A"Q5HG?95SA\MV>T.Y%L4VR[S)F4+"T.UP0O"-I?&*[&@8 %\K 9 >&PO=V]R:W-H M965T=Y,IJ3!,NW/"5,GYERD6"EWXJ9)U-!\"0/2F(/^G[/2S!E MG=$P/W8K1D.^4#%EY%8 N4@2+)[?DY@_G7>"SO+ '9W-57; &PU3/"/W1'U- M;X5^YU4J$YH0)BEG0)#I>>'<9PBP@'_&-DB>Y\AID5L:<_\C>7$_..WZ6 M$8E)I#()K/\]DDL2QYF2SN.A%.U4GYD%KKY>JG_,S6LS8RS))8^_TXF:GW<& M'3 A4[R(U1U_^D1*0]U,+^*QS/^"IW*LWP'10BJ>E,$Z@X2RXC_^619B)0!N M"H!E -PV )4!*#=:9);;NL(*CX:"/P&1C=9JV8N\-GFT=D-9-HWW2NBS5,>I MT4=,!?B&XP4!?X#[8BX!GX*_%I@IJG!69'#-BNLEK_M87PQ S0FXY$F*V?-O M$GPFCR0&"%Q(J2\\S";@,\5C&E/U#%Y?$85I+-]H_>6X?VY(,B;B7WWHZ_T5 M>/WJ#7@%* -?YGPA=;@<>DI[RS+THM+'^\('W.#C#-QPIN82?& 3,FF(O[3' M!] BX.FB5I6%R\J^AU;%>Y*^!F@:J)1KA=N M3(=1+L ]B1:"Z GBF$DS$?_I.8YX0L!%F@J.H_GJJ1LL?NAY_9N2>%(=;YHB M:P990WHG4QR1\X[N.)*(1](9_?I+T//_;"J/([%:L<*J6&&NCMI7Q0W!4E=, M=RZE:Y0NE,PO\.QDL2"^D&C.Z,."Z')^UCK@6I%$-M8G=%D?1V*U^G2K^G2M M%U.^T!M7:1'7R^.RKY!'O;+.X "%0^]Q-?NF<0$RY*7>[](L%TC0EVP@4<]"L4K/IY53:F&_V535/M?N54_N4D\IJL MG6ZJCS6179>F([%:STH-#<=FU6!; MR<\&.07"!0;C@) P7.(4X M5VKU&AF,"_;EN& =T/I=!%]0G%U^W_0-[ 5'I+T6[>6Z*GFM7%R-*!J=6D7V=6IH,+#CX(>'!4WS1?R1,JQGGLU-S(9[XKIMPW;0!=NUB*PN^$9?^X;731F*@W:*:VE=#F]D[8GL MNCI=J=7+9A@.GH3AH%.&#9= %EK6(F,6_A=%MI;:Y/X4&RJ =RFX%F1*1W9IF/4X] MNR8R^\?OO%:/0630$!D\"9%!IT3F2JW^F,H0&=J7R%###VH#/WC1S=I&U=,R M-(:.2&,MVEL\6CA$H>[8@!AR 6(M(FT@MG=XW=3*4U [B.DVF.B9*WJ55[:L M:Z:(OI25]+YC(3!3QWK*8$]NYR>DQX S9. ,G03.D%,X% M^W);N$YDH=^#:_>A3>,"& XVM+K0L%MX1'9KT5[M43: VTIF&X +#<"%+@"N M1>3EHF_T=HA$8*I_F&R#%7BB?YRSG!$R*R ?K\E'.U?)-]0+6G M=O0_4$L#!!0 ( (N"9U=ZZ9L#M0D +YB 9 >&PO=V]R:W-H965T M#&:8.# MXGR@Y;5%A!>%I.P$Z(_ODE(T7&DUTE:S9CXDEK1\/7RY$ST[LY1.GHORSNIZ_&8VJZ4QD<34LYB*7KSP491;7\F'Y.*KFI8COVX.R=,3' MXV"4Q4D^.#MIG[LISTZ*19TFN;@I6;7(LKC\]E:DQ?/IP!E\?^)#\CBKFR=& M9R?S^%'7-V?#L9-1"(5T[J1B.4_3^)"I&FC)./XLA(=K']G(@7:?VA>/Y-K$[(;_2F15JU?[/GU=CQ@$T7 M55UDJX-E!%F2+_^-OZZ,Z!S ^8X#^.H ?N@![NH MSW1963M:5W&=7QV4A;/ MK&Q&2[7FA]:;]FAY-DG>7,;;NI2O)O*X^NQ=G)3LSSA="/8+NUU>2U8\L-\7 M<5XG==R8S*[RY7QI?;^3DX'5,\$NBFP>Y]]^JMA[\212YK+SJI(3+\[OV?LD MODO2I/[&7MW$I\(_5;,A\P=_\SXF+OLC]M+]NK'UQJ9"USF4DREC-/*<+W,2)JZ M=I:OG>6MKK=#]UK$U:(4E )G0ERBVCL>FKLTIWU4BIHI9K_M)_.G,";.,')Z*E[/IIA7N1Y MWGJ8$JF_CM1'(WV;QM//['8Z*U)Y@6[*9)KDC^RZN)>3V7!VH[_(].H1B2F> M!&M/@CYF=T#I#Y&8XD^X]B>DF]U+*;\S;2/?WYC:VV.",-#/ZV@=8X3&>"OR MI"C9K9C*RR??SHHXK[H3^BJ?%IE@Y_-Y6<336?>EZ[C\+-\%_Y>(]-XT!]"@ M3*\QD9CBWV3MWZ2/')A0^D,DIOCCC(&[QG19L-)2_O?F$QZYWD8J: 9(L,S0@\*M-+3J6F>@A$Z/ ^LL(A!4,J-=4C0$,'):NS M]X4$B(^BS%@W0[;LTOJP5';<[NP?#YW-'-$,FPQW@) #S.;@T&8C0>*O^Q,$ MC+C)4[IA3C3<]18" MW.?@X&5^N"N# "(Y M#I'V,NB0-0L>G+%'-BJ1'+"6>[UD$"FV4JFI'@&VL3[#*YL[(.__:[5 M70"IYP?(R7'DM)A.!ZQP\.",+;)1^N3 P#SL)9U(T99*3?4(T);CQ==CTHD4 M7U=JZGK)V54JX,"E'.=2>_EDM!["HS0VRT8]U05H=L>]]!1):9A*3?4(:-C% M:[A')!:N;.R#HUU=[4@L%U#6Q5'VUR^+9-Z>R+LDC_.V&6F_:X,'9>R-EMCEO@XE=8&*7L#_OZCKOGA=M-NBUXWS'W;$86OHN*=E2J:D> =FZ>'7WF#>7:-AN9D> M^E'!1/FC3Q8/"-+#"9(^68Q6+'ATIC."2DWU$F#5ZV4W@$=*HU1JJD= HYZU MW0">MLV_E37:48=E36<[)\Z+>[+&;C\'C\UX/MBHM'K LEXO&P0\4EBE4E,] M ECU\&JMV>[A0+-A;!SQ\6:>[!VG1@O8Z.'8:"TW#EFDX+$97W<;95,/0-;K M94> 1TJJ5&JJ1T"JGK4= 9YN1\#6YK)]H]1=]D"//DZ/]K+D@+4*'IOQUGP; M-5 ?"-;O94> 3TJF5&JJ1T"F/EY&/2)+5LH;\W]SF_*^46K<0(L^3HO6LL1H MD8(':3P5;)0Z?4!7OY?VOT\*I51JJD>=>Z"LM?]]3Z>RT7)W?GE%JW "* M/@Z*-Z5X$&73@6P2I_[V JT2/"+CZVZCXND#NOJ]]/)]4BBE4E,] BCU\>JJ MT6)DI:5L!XO&FXBU;Y0:*:"ACZ,A<38W/"FR(&C$07X 3'W%6&"TO\-",+[V5.^4[M\KW MN1I_BLHR;K_%\L%'## !4@UZZ[0$IC%*IJ9\P 3 :$MY='VIN MF@_\,-Q<>.C&>1-G5P\D!"P,<2Q\T7PY9&&"QVLZ%ZC45'^NPA*:92 MJ:D> ::&UOKLH::#'@S=S=S1C H[MU.J<0,ZAC@ZOFSF'+!XP>,UGA4V"ILA M8&[82[<])"58*C75(R#8T-KM^*'N/GMG:XN*;MAD&(V[?W94O\+.9S+AD/FB MB62TWL$#-YXM-LJA(9!QV$N//B3E6RHUU2/@V]!:CS[4=-^CG:FR.ENC8]1/ M$P,>C7 >_??II:LC?!#UHLS96M#X8\9(:ZI4:JJU ,]1+PW]B!2!J=14CP"! M(\);_*/MF_*]<<"WMH3IQCGFGG1Z342Z6F>@34&UEKYT>:1KV_!72Z4<%PUR=6 HE&.(F^8-H M$C9*L!'0<=1+IS\B15LJ-=6CSB>F6KMK/]+<9^^.A^%FWNB&^;OVP40 G!$. MG"^7.$8+'SQJX]EAHR [ 0">]+([8$)*LE1JJD= LA-KNP,FNAOJMS-(-VPR M=-"[74:=+Q=HOME!3OW')*]8*AZDAOP=\MVL7'Y9PO)!7&ULM5E=;]LX$/PKA*XX MM$ ;B:0^<[:!UD'1 .TAJ)O<0W$/BDW;0B711]%Q\^^/DE51M"0Z@MF71+)V MQS,TQ[M>3@Z4_2BVA'#P,TOS8FIM.=]=VW:QW)(L+J[HCN3BR9JR+.;BEFWL M8L=(O*J2LM1&CN/;69SDUFQ2O7;'9A.ZYVF2DSL&BGV6Q>SY TGI86I!Z]<+ M7Y/-EI'WNSLF[NP&995D)"\2F@-&UE/K/;R>8[],J"(>$G(H M6M>@E/)(Z8_RYG8UM9R2$4G)DI<0L?CW1.8D34LDP>._&M1JWK-,;%__0O]8 MB1=B'N."S&GZ3[+BVZD56F!%UO$^Y5_IX1.I!7DEWI*F1?47'.I8QP++?<%I M5B<+!EF2'__'/^N%:"5 =R !U0GHI0FX3L"5T".S2M9-S./9A-$#8&6T0"LO MJK6ILH6:)"\_Q@5GXFDB\OCLACQR\ XLQ/98[5,"Z!I\IOGF'2$QTE:O!$I]XL;\/K5&_ *)#GXMJ7[(LY7Q<3F@E6);2]K!A^. M#- @P7970'LO 7(0;@G?:Y/OR%+D0ZK=*2FVV(MF@5!S8*@"@_K%D1J!M\_ MBP!PRTE6_-LG[HCF]J.5)KPN=O&23"WALH*P)V+-_OP#^LY??5(-@2G"<2,< MZ]!G'P4P>)_1?<[[=!Z3_2JY_&YXFD$8!8'G3.RGMH2>."?"XENEB5/8N0T[ M5\ON&^5QVL?KF.:IO&#@N2>\>N*@IYS:I%N M&(ZP,^20L.$6CMF);\$\9NPYR3?@(4[WI(]OV.4KG!.B$[[=,!R&J.4PA6_4 M\(VT?!=W#V",>[1H8S>1(3!%.'1DS76,^J>&,Z3=%)HJOM5PP$L\5&>W=QMR M?-2I,SUQT/,&ZPR4]1]JJVS?OGR)EVI4E;>'?'S*NQL'/1<[:("W+-]07[_+ M]@GE<90E/5R_8 NF8MI6TW1HLWA*:*EST(U#XXQVCQ1F\:0VBJ>MDNP-"L8[3MQVCQAM!4\;+W@/KFXYQCHNZ7-%+\4*LX M&Z?^!I4= M(6X1?XI@90W]KU<7!"L3_.17" HJSC2%_'A7N\4>[1XXW^J6P( M357?FA(8'A.8G1/\CD$!DJT&NFA44&>WMUS88YZS82H[V0H@_:C@!=[I#@-" M-\#A*<&^,!_B 8*R7"-]N1;.\<[ZBSUD7).L^IR M2^(5866 >+ZFPD_U37D\VQS'S_X'4$L#!!0 ( (N"9U>*A/NU+@0 %,9 M 9 >&PO=V]R:W-H965TU^_2A9U86\E%C.>JX1EL!)(YFE*Q;>WD/#CW,'.]QL?V&ZO MBAON8G:@.UB#>CZLA%ZY-4K,4L@DXQD2L)T[O^+[!S(J$LJ(3PR.LG6-"BH; MSK\4BZ=X[GA%19! I H(JC]>X &2I$#2=?Q5@3KU.XO$]O5W],>2O":SH1(> M>/('B]5^[DP<%,.6YHGZP(^_046H+##BB2S_HF,5ZSDHRJ7B:96L*TA9=OJD M7ZM&M!)P<"6!5 GDWR;X58)?$CU55M):4D47,\&/2!31&JVX*'M39FLV+"NV M<:V$?LITGEHL8:/0&[36\HCS!!#?HG<\V[U1(%)4/GS*I!*YWCDETUTMT\^H6O4(L0Q_W/)(^(1OR?]P9R^A$BGXS*==--=W9NZ0:1N$"GQ@BMX#P)BIM C MC5C"U#?T^3VD&Q!_]A$S(A5?R'MYH!','?V-DR!>P%G\_!,.O5_Z:%H"ZY#V M:])^B>Z;5-%L//K\3@>@)P6I["7NVR1N":Q#/*B)!\;=+K2/2NW'10ORC*9< M*/8WQ*<;3,J<9A&@B$O5*^X3?ECB%V?HR\*?XLG,?6E3O P*QD%8!W5*']6E MCXREKU>?3FT8HE@CY-"-LP3681_6[$.KB@UM$K<$UB$^KHF/C=M^1OPU>FYI M=LEDQ/-,]77@!#MJ:7 Z&9_I]#)F,IWTRW12USLQUENC4)G%+8!WBV&M,AO<_'ZOF%PSM1H76%C;!_;K& M+2>%?Z3L8)"RS7B#.5E"Z[)O;!(F5M6-K9HE6VA=\HU=PD938D/?_H4B_= _ M.XY[@D;CZ17=-I8'FSV/UNUHF&Z->(.WSA):EWWCFO#(KFZM6B9;:%WRC6G" M1FMB0[?AY4D:DG/=7@;Y+:_1+;XQ/MCL?+1NPV&Z->(-WCI+:%WVC8W"$[NZ MM>JC;*%UR3=."AO]B@W=3B\D&>#@7+>702./].N6-&:(F,V0UNUXD&[->(/G M"I;0NNP;ET2P5=T2JR;)%EJ7?&N69!XF_7?=5B_H'*7G_[7UQ 173EO26!QB MMCBE:M<@F!;KXS#Y6IT.V4+KMJ$Q2R2P*U^K7LD66I=\XY6(><1D0;ZCB\D7 M'IW+]S*&G!^Z;FOB7?S<\)Z*'):&X2,A4 )UF M 0 9 >&PO=V]R:W-H965T%^7B]7ZW=GM9G/W\_GY>GJ;+I/UF^PN M717?N<[R9;(I/LUOSM=W>9K,=H.6B_->IS,Z7R;SU=GEV]W7/N67;[/M9C%? MI9]R;[U=+I/\VX=TD3V\.^N>/7WAU_G-[:;\POGEV[OD)OV<;GZ_^Y07GYT_ M*[/Y,EVMY]G*R]/K=V?ONS^;R44Y8/>(/^;IP_K%QU[YHWS)LC_+3^3LW5FG MW*)TD4XW)9$4_[M/K]+%HI2*[?AGA9X]SUD.?/GQDQ[L?OCBA_F2K-.K;/&_ M\]GF]MW9Y,R;I=?)=K'Y-7N(TNH'&I;>-%NL=__U'JK'=LZ\Z7:]R9;5X&(+ MEO/5X_^3K]43\6) =W!@0*\:T-L?,#PPH%\-Z)\Z8% -&.P-./@S#*L!P_T9 M1@<&C*H!H[T!@T,SC*L!XU.?I4DU8'+J@(MJP,6I [J=IU>N<_*0YQ?[Y%>[ M^_1R=U^]W@>'/+W@W=TK?O[XN[C[1?:337+Y-L\>O+Q\?.&5'^RJ83>^^/V= MK\K"_;S)B^_.BW&;2S_]LO'^YKV?S>9E(24+3ZX>VT%95C_XZ2:9+]8_%@_Y M_;/O_?"?/[X]WQ33EH//I]44_N,4O0-3##R3K3:W:T^L9NFL8;QPC[\X-CYP MC^_VC@'AD1_ M07GQ1/^_*SWGI[U#SVGZ*?3-UZ_^Y/7Z_2Z#1MT=<+P[J0< MWKUH>D%.GKW;-+MP#_^]'*?_[+VF%^/?>^HB]_#W=_D;KW-X M=ND>KI)5,7QT<+@Z8>-[DX,;'Y_PS'<'!X=K]_"/V7TQ>V_WNH\;AILC3]WV MIA@^:OJUL8J@_]QZ^CNO[VH]Y-MB3V#C_5T7#_#D)EVN_]&P=1\>M4&S M5N[@_+R^2Z;IN[-B#V:=YO?IV>5__T=WU/F?I@(C,9_$!(D%)!:26$1BDL04 MB<4DIDG,0)A5^H/GTA^X],?2G]>E?UU,Y-TGBVW:5/A.JVWADYA/8N(1&^VP MV;H]M6[E'//S)*W>-!DVE2FZ,(+& MQ$(2BTA,DI@BL9C$-(D9"+/*??1<[B-G2>EL=>-MTGSISN-EQ1>\Q+M+\WDV\[)K;S-?-O8#YWQM^P&)^20F'K&+%W^< M.V\ZP_'%WM_PQH<-.GL/"\E-BTA,DI@BL9C$-(D9"+,*>OQOG V[0JZ:92=L[4MI1)S"2[IB;.D/W_ZP]/ZRON[29=? MTOP?WK^\J_EF[GU(5G]Z']^__/KNX%KQQ_DJ3V?SS[/?KW-WF: M[C[:9)Y<3?,T6:=/(X)D.E^4N_M/0YOZ@G-SV_8%$O-)3)!80&(AB44D)DE, MD5A,8IK$#(19O>7BN;=PO3Q;__UT]_^>;53T-0 W&3;#H!J/JH)5 M0+42U"-4D MJJE*>[GDZNU.ENPON&)T7HUJAM+L0G\1_^G^]2N(_17"5;9[O0;Q]6Y> M?->Y:'!O8NO&06H^J@E4"U M1+4(U22J*52+44VCFJ$TN[GTZN;20Y<0%4!.C'8';(+ #0RB&H^ MJ@E4"U M1+4(U22J*52+44VCFJ$TNQ'46<*N.TS8+O#OQEJW 30JB&JBTEX> MPYXT'L,.T'E#5(M03:*:0K48U32J&4JS2[Q.%W9;Q0O+CQIK&XT.HIJ/:N+( M\S7TOJ5)OF[\>.9/DCV]?+]^H-&PL?C0/B&H1JDE44Z@6HYI&-4-I=O'7N<"N,WOT MJOCODF^/F>'B+W[3G[,/;J]U\:/90%031YXY^?R6J=7N_15E"_!^7ZW3Z;;, M2'S,-NG:FZ^]V3;UUNER_K=DM=HFB\6W)W!S;1L) MJOFH)E M0+40U2)4DZBF4"U&-8UJAM+L1E"G$'M=]#Q!#TT,HIJ/:@+5 E0+ M42U"-8EJ"M5B5-.H9BC-;@2]NA$X@T@MSQ.XL=9M ,T+HII M0#50E2+*NWX M&1&)SJM0+48UC6J&TNP2K[. /7<6<+_$UYNDO*S(\^5$\N+3\LH#T^*;R4US MW:.!0%3S44U4VMY50OK[UQ)!)PU1+4(UB6H*U6)4TZAF*,TN^CH-V',&C?8" MP(TU3>:>KE#-1S51:=;[UCK#WJC_^J1_]="72=3N<-#O]%Y?5 3=Q@C5)*HI M5(M13:.:H32[:.OT7L]]4;W?'C+OM]MLNRX/-K\O_OWMH?B;_,W[G-ZGJ^*_ M^3Q=>\&K ]C.(WAHP _5?%03J!:@6HAJ$:I)5%.H%J.:1C5#:7:OJ -^O1%[ M! ^-^*&:CVH"U0)4"U$M0C6):@K58E33J&8HS6X$=0RPYXZUM3R"AZ8!4HIE'-4)I=P'6VKP=G^]Q>ZQI&LWVH M)HX\<[N;P^SN#E,F>YKNL!*@VQ.B6H1J$M44JL6HIE'-4)I=_76XKP>'^]Q> MZ^I'PWVH)HX\V?Z^OW]Y8'Z*PA MJD6H)E%-H5J,:AK5#*7955^G^?KN:PH>.F\09-N\U=D"]SRM:Q^-^:&:0+4 MU4)4BU!-HII"M1C5-*H92K,[1!WSZ[,7!NRC03]4\U%-H%J :B&J1:@F44VA M6HQJ&M4,I=F-X,4M@-N% =UG"]Q8ZS;0?WWPN?D"TCXZL3A]XJ#_^E)T!QX: MHML8H9I$-85J,:II5#.49E=GG=KK.P-&[0\&NKW6!4IJ/JJ)(\]G' M +>K]''F[G!W!-!/IX_O\^TV7C$ _2QN?. 8(!HE/'G>X.1'AN@61J@F44VA6HQJ&M4,I=FE6<[M?TJ8\,T2V,4$VBFD*U&-4TJAE*LVIZ4(?R!NY0 MWJ&%^>[K>;*:WJ;>U0D+<_P/V:GP#-*:':CZJ"50+4"U$M0C5)*HI5(M13:.:H32[$=0QO4&[J_$= M?2N@VVO="8YMW?2-UQT^OMNNZ?TQ/KHY M4"5 M1+4(UB6H*U6)4TZAF*,TN M_CJ:-W!'\PXN$V[S-&UU!L\]4>NN@%ZN#]4$J@6H%J):A&H2U12JQ:BF4&ZL=1M LWRH)BKMA+-\)S\R1+AIK7+LTZAC=H M=^?=XVMX-&^':CZJ"50+4"T\\JKN+C74ZSP>^^@W%C8:L4,UA6HQJFE4,Y1F M%W\=L1NTNQC?T3?PN+W6Q8]F[%!-H%J :N&15]5]T:!>Y_FJ04]?:.P/:/(. MU12JQ:BF4X96G<,].I_J"8J;?^-.?O9GM,>%J+; M%J&:1#6%:C&J:50SE&97I_R;)JFL[5WG6=+;Y5NO%E1WXU%BV;R M4,U'-8%J :J%E6:M(?N3P>C5&C)"YY6HIE M1C6-:H;2K/(>UKF]X9'<7K'3 M[NDL6>W.QNW?.]=U LX-MRUW5/-13:!:@&HAJD6H)E%-H5J,:AK5#*79+:%. MZ@W9I-X03>JAFH]J M4"5 M1+4(UB6H*U6)4TZAF*,UN!'52;^C.PNWJ_OG^ M>KL#0.4Q/F]1[BYDVTVQL%_-YJN;QJ: AO90S4I/[^-[]ZH C>6AFH]J M4"5 M1+4(UB6H*U6)4TZAF*,WN M'G4L;SA@5P5D%.D*U7Q4$Z@6H%J(:A&J2513J!:CFD8U0VEV(ZAC><-VL;RC MV1^WU[H3H,D\5!-'GCFUW=W*JWOXS44!NCTAJD6H)E%-H5J,:AK5#*79U5\G M_X;NC-B_=4P #0&BFH]JHM)>+O1[G='C-;;WCPF@"3]4BU!-HII"M1C5-*H9 M2K,KOH[[#=W!L+V*7R9?Y\OMTON2Y0555+HW38K9RQV LAG,6H7VW5.W[@AH M,A#5!*H%J!:B6H1J$M54I;V\\\&DTVE*V,?HQ!K5#*79':$.^ W= 3_\0&+Q M]:0.)>XM.:ZK78N?'(N/ MIO[@GJ5M?T U']4$J@6H%J):A&H2U52EO5Q=#">-[]^-T8DUJAE*LXN_CA^. MW#?Z_65SF^;>(BN*>W=D\=#;#=Q,Z^I&8X>H)BKMY>_5H-<=-KWC'YTX1+4( MU22J*52+44VCFJ$TN[KK3.'(G2G\*XX=U*;KL(%[PUKW"S21B&H"U0)4"U$M M0C6):@K58E33J&8HS6XI=:YQU$H%J&:1#6%:C&J M:50SE&;7=9TK'!VYL>^IQP5_EHWC>PXYN#>V]9X$&F!$-8%J :J%J!:AFD0UA6HQJFE4,Y1F MMYDZP#@>L(<9VE[(WWKV%K%W^O+OZ_.$M9 M^1:?H;O_,P3HK"&J1:@F44VA6HQJ&M4, MI=G57&D!&P:Y0S4UD@T#D#5 M1+4(UB6H*U6)4TZAF*,VN^#H".3D2 M@7S(O-]NL^VZO()3N<[X[:$H_&_% N(^77F_K];50N)CMDG7[M4!FEU$-1_5 M!*H%J!:B6H1J$M44JL6HIE'-4)K=(NKLXH3-+D[0["*J^:@F4"U M1#5(E23 MJ*90+48UC6J&TNQ&4&<7)^VRB^[;/[BQUFT #2JBFI@T7.6Q^2KQZ+PAJD6H M)E%-H5I\\NNET7D-I=GE6X<.)^[0X7[YKC?%6GZVM[2_2_-I\]/+TNZKW[\_O>V7DQLG[XY=N[HG1-DM\4 MA>XMTNMB:.=-^3;+O#P+^/3))KLK2>]+MMEDR]V'MVDR2_/R <7WK[-BN5]] M4D[PD.5_[C;O\O\ 4$L#!!0 ( (N"9U?V!P\WK@8 -LK 9 >&PO M=V]R:W-H965T=N3:3W+6?%2S $]NBEDAR_?65; >P4!0\L_E ;+/[M.:MY-UG73[S\E&L M&9/H)<\*<=5;2[FY& S$8LUR*OI\PPKUS9*7.97JM%P-Q*9D-*F<\FQ /&\T MR&E:]*:7U;7;I_Q14R(=J@L_D[9LS@X1OI6'CA_U"=? MDZN>IR-B&5M(#4'5ORWI,>2MB2;C-YQY^_L.:& HVWX)FH/M%S8^OUT&(K),\;9Q5!GA;U?_K2 M_! '#@K'[D :!V(Z#-]P\!L'_U2'8>,P/-4A:!R"4QU&CEGR9U1J:X6F#RI^*V_%2%KH5+R7I?HV57YR&J4%+18IS= 715JF MB1/H$[I7*9]L,X;X$EE-SN9,TC03Y\KXQ_T"%HFX'$@5M!YZL&@"O*X#)&\$&*)OO)!K@6Z*A"5M_X&ZV=T= MD]<[OB9.P'NVZ2/?^XB(1WQ+/+/3W8G%?>YV_V-;.$>_<;O/V4*YXS='CTX? MW>8>GSXZ=E#A[Y+/K_#\-_!N68GN=<(@G;L7MN2H 89V +U.7X@-7;"KGEJ( M!2N?6&_ZVR]XY/UN8Q82; X)=@,)%D&"Q4!@K?P8[O)CZ$*?_JD>Q50(]?E$ MLRW[B![8*BV*M%CI=>DGHZ4M96K,<86IG\1/4SSI^VJR/1WF@L4J[(>&U=P9 M7U>2(<$B2+ 8"*Q%N3T.#89J9(GA@D.^/K2C(D6 0)%@.!M4@>[T@>GS!Y%XI8P=!9PNJC,%'!&WS4% M(,$B2+ 8"*R5 I-="DR<*?!5B*WJ#ZI602W=N>HO5=>R>-0YL.!%T?20,)%D&"Q4!@K00)=PD2.A,DTG,^ M284LTX>MI ^JJU25FZ[BK/,_M"[NQ*S?[&9'#WIG:%WYA02+(,%B(+ 6O]C; M:PC>^PR73&[+HEH%Z":5-+/V^C50<+BX&\0V)N;,Q6.#67=,7:D%18M T6(H MM#:[!PH1[M:%,57,*9K54SSEB95E;"G")T>3<_:&G7]$M3/ SE1#HD6@:#$4 M6IMJLJ>:.*G6@DREX*&V&@;3H[*5ZN=6>7.W3%U9A=450)% MBZ'0VNSNA27L5I:^%I(I7%F]7N!RK;J71\14(*QVWAB;U+H# MZDHM*%H$BA9#H;6IW8M-Q"TV?6YJN80]R,-*W4HR/NXH\ A[H=GS6 S# (>F MW=P=6V>6074F4+08"JW-\EYG(N_H3+R42YZE'&D=@RO.4?5&T,HRL2D:Q"R] MK&;8-]\)NP/K3#$D6@2*%D.AU10/#K88YOH-GMX]*M"";PM9[[W;7=WM4/U< M[=IRH# "* M"@ &0 'AL+W=O ';.>?XWN.O M.UQ+]:P7 (:\E%SH4; PIKH,0YTOH*2Z(RL0^&4F54D-=M4\U)4"6CA2R<,D MBOIA29D(LJ$;NU?94"X-9P+N%='+LJ3J[S5PN1X%<; 9>&#SA;$#83:LZ!P> MP7RO[A7VPE:E8"4(S:0@"F:CX"J^G/8MW@%^,%CKK3:QF3Q)^6P[=\4HB&Q MP"$W5H'BWPK&P+D5PC#^-)I!.Z4E;K MC<*O#'DFNV&"BIQ13F[14FYMU>0S><3]6"PY$#DC7LC9/54@S (,RRG7'PDY MFX"AS#8_D_OPJ?7H\/3Y@1MJN=^KT MTE?T[L0*M,&#;LA8EA45?S_Y%_C7U9,V"L_Q;]\2UI-T_9/8N^U25S2'48"7 MEP:U@B#[\"[N1U]\_I]2;')*L>F)Q'96JMNN5/>0>G9#F2(KRI?N$.:R+/%> MQ?L@?R85J/IX^9:F5CUWJO:56&5QKY,.AN%JVW,/*NFDR2YJXD&EG4&\BYIZ M4!>=;MJB=M+OM>GW#J:_M5'SS4:%%WP>-1!%\9'!7LZ7!1-SPD2..'QPR R\ MGM13#;8BC#IQE.YYXD-%Y\G%GBD'XW[K#CN1V([%_=;B_K$6-W-UP_.ZVGK]5WK]8W?Z[[/Q>Y@WVP_+.KOF7TP@[>:?2*QVNQPZ]$M0&ULO9Q; M;Z-('L6_2LD[6O5(W3$4%T,VB=0QUU5ZU.KL[#ZL]H'891L-%P^%G6FI/_P6 MF!AC<+7I/3LO"6#_?Z> 0U%P,'>O>?$;WS!6DC_2)./WDTU9;F^G4[[8L#3B M-_F69>*355ZD42EFB_64;PL6+>NB-)E213&G:11GDX>[>MGGXN$NWY5)G+'/ M!>&[-(V*KX\LR5_O)^KD;<&7>+TIJP73A[MMM&;/K/QU^[D0<],C91FG+.-Q MGI&"K>XG']7;D%I50?V-?\;LE9],DVI57O+\MVHF7-Y/E*I%+&&+LD)$XM^> MS5F25"31CM\;Z.2H616>3K_1O7KEQ/V7O#;?529DL>-EGC;%H@5IG!W^1W\T&^*D@-(+!;0IH-<6 M:$V!=EY@72C0FP+]6@6C*3"N+3"; O.L0#,N%,R:@MFU"E938%VK8#<%=FV' MP_ZK=[X3E='#79&_DJ+ZMJ!5$[6#ZFJQS^.L,OMS68A/8U%7/CP_?2'S@BWC MDCSGR:XR("E6"*FHX2$V>&0JJSYSF%E%"?\9_(3B3/RCTV^XU&VY'?3 M4K2E(DX7C:Y[T*47=#7R*<_*#2=NMF3+@7I?7F]_KSZ4UZM4 IB*C7C\FVT8/<34M2_4C1 BH:#HC/3-H8=9!P=9,C[L3S[4+!%OBLX$^/3EW+(3%+$ M6#,A80X2YAK] U2UU9FAGYD)*>I?*1H@1<,!4<4R;/M"=V0>S61*S?2%[?-D M'V?KM]&L%RWB)"Z_DG]_8M7Y\C]#[I(RQ[H+"7.0,!<)\Y P'PD+D+ 0!.N8 M>78T\TQJYBL M?Q*8&8JB=/L*!ZGI(F$>$N8C80$2%H)@'=]:1]]:4M_.BZ^\C!+BQ5F4+6(Q M)>M\I:RQ]D3"'"3,1<(\),Q'P@(D+ 3!.B:VCR:V_XS.5RHRUMU(F&/W>G)= M47H]N8O4]) P'PD+D+ 0!.OX5E7:6[F*U+G5O=S'M_M 8X;!E.9#:0&4%J)H76>?A!3JG]$GRU5&^QQ)/9*O]Z+V8R'B]9<8C#RB+* M^(H5Q6 "]=@HG#;-F&FS[N:8R]LQVD9(F@NE>5":#Z4%4%J(HG6]VP9$ZK4) M414]L67EX30N4Y:5G'R[%)$]RJFCNT=H, 2EN5":!Z7Y:C^LT>AY%PI-AP84 MJ7VA_VSC(56>#_WO*:5<8+0=H4D2E.9":1Z4YC>TCCG.LTJH8CBD>"%J4MNL M296'34]YMOY0LB(E26Y49KOLN'>"QK[0&D. ME.9":1Z4YC>T3LYMSLS>F1.:_0R)SHS9I;%<&^NH\ESG%U:*T9NXB&#D79)S M/O1DW*.<,=IWT$ '2G,;6J<#T-3>.=/JWYBP[+.K?W^ I>IJKP/KLRS#.&.% MJ+7LNJ3-351Y<.(7PAJ-3P8- HU$H#0'2G,;6F>G]O>]I_:3&,NPS7.']&$Z MU0SEW")]&*7J3#WWR/\CHJ!M1$'E$<55SWS)&6.- J4Y4)K;T#H[S=+UV=GU MO@=5]1N:\1W5 *H:#JTKU;5+EW:T#0>H/!RX*O8BW\B//2(F%Q]M1FAF *6Y M4)H'I?E06@"EA2A:U_YM4$'E0<6EJX;3>[Z7KQ;D\-'VAF894)H+I7E0FD_[ M29$V\$Q& %4-4;2N<=N4@LI3BFO[[7%/EO!2_Y&P#JQFW*CG%UGS >_=?Z#.$?>V-&61-(\*,V'T@(H+431NI9LLQ8J MSUK:5+G^*?-PIGSI5\Z/E.9#:0&4%J)H7=.V MN0Z5YSIC![KS:!MW![Q!GE2I#R=/3W/YZ!<:_D!I#I3F0FD>E.9#:0&4%J)H MW6.AC9*H/$H"C"FLWFA!/1]00,,C*,V%TCPHS8?2 B@M1-$.OIV>O#$G9<6Z M?MU2]:SO+BL/;^(X+CV^TNEC_2*CL^6N>NNI \M]]38XO+"IQ1_>'_4I*M:Q M&+HD;"6DE)N9..47AU0< &T\ 9 >&PO=V]R:W-H M965T[%="];RA6\+/V(YF\LB*Y5LBY&:^'O)=3LFR"-JF0]NR)L,M M2;+!_*+8]R&?7["]2).,?L@1WV^W)/]^35/V<#G @\<='Y/U1J@=P_G%CJSI M+16?=A]RN36L*L SE='4YN,+GD>VH@*+$GPE]X >_D3J5.\:^J(UH M>3FP5(UH2F.A$$3^NZS!WA](:E?R5+ ML;DJK#5 \9X+MJV"90VV25;^)]^J M"W$08-M' NPJP.X;X%0!3B? .18PJ@)&?17&5<"XK\*D"ICT59A6 =.^"K,J M8-97P:T"W,(.Y?TK;KY'!)E?Y.P!Y:JTI*D?A8.*:'G/DTR9_5;D\F@BX\3\ M]NU'M/BZ3W;2P +Y24:RF*+7Z&JY3)0;28JBK'RFE#=?>E20).6_H1Z6P?4380>]8)C8<+;(E76KB?7.\:X@?RHM07PG[ M\4IX,.9;"8-> \7ICFMJ@ MF\(0--==[T5_H&VHEP]=KP"F7J$9X]%88G ;8ZQ79 :^V:>/0#S5UZME,Z=^ MX)R"ZQP[7_FZ6NY3BMBJ>/#$=_2.B@U;RN?LGG*AGD../K^582@2=,O_UM3] MNM08Z374"_*<[TA,+P?R#)&P!"?,A80$D+(2$ M14"PEKE'M;E')OK\/YS1F^YQ3V>6X$SKO&A&G>A<2YI6P20%3O<3[.<8N MGHY'%\/[0UM"BOH]10-(T5 C:LW&KCMKBT9 HBTSC6LSC8UF*II V4K&.95] M$;0B<9+*YO(5HM]V25[V1Y9$4)W'C.13/08)\R!A"TB8;[X;[]G]&<+.*Z3> ML&-=DPA9F1 2%@'!6BZ>U"Z>&*^;OH/]^1W=WM%<^VXW\D[U+B3,@X0M(&$^ M)"R A(60L @(UC+RM#;R]'_HN$XAS0T)\R!A"TB8#PD+(&$A)"P"@K7,/:O- M/3.VTI6AMZ6AD]K0KQ![R.3WXR;9H1W-8[F+K+4]#B/_5&-#PCQ(V (2YD/" M DA8" F+2MCLL+-==[-;;G5KM[H_Z%:R7N=T+3O%*&9<^_5E))_J4TB8!PE; M0,)\2%@ "0LA89'[Y*/0MMS99*(W*[::(6;KA^QZX%9:%FF.Z:QKECG5NZ T M#Y2V *7YH+0 E!:"TJ**-CYL:D=CR[*.6/@@2X+_JX4/=B99M44I2BGAE".2 M+5'*2,;1AJ:Z=,>UN08GNQN2YH'2%J T'Y06@-)"4%I4T0[=/1D=;Y_MQMSV MCPVT;#BNK9L]ICBC>:X*&[,'QYQB, IZ2,0&D3AF M^5(-V*XH$?M<^P55:;?['SK_/"WG:/T#FHH"I?F@M "4%H+2(MU=-7FQ237A M9W)->S6"JMRXVJLI $4?LAAE?7U'XB]R1_?5JS4=:#8*E.95M'9O!G=;/]!D M5!_) %0RU$DZ'JV<4H'^,LPNNS<23C06:@ZIHAY=\ M/.GZ"C2WU$,Q %4,=8INUU4_(S&$F\P0-J>&WE/1^6HH6BRMFT"30J TKZ*U M>DRN.^L^PPM05;^G:@"J&FI5K9EC=9WU,S(UN$G58.-@^?R*8:=KJI^1(<%-B@0_GR,IL]A' M^E12QO>!"'I=?!%H#@B9-0&E>16MU2V3KXG;]!YH0Z2<: M@(J&.E'7?OJR!!)MNZ])>>#GM^PXZ MU@Y%:[NC&9*WS4/R0$.R M!C#2F@1TVEAN"[8J%CW=,R&^ XN>&DB7-50%Y?,68>-Q0 O4*X_F_4$L#!!0 M ( (N"9U?G@N (D04 8G 9 >&PO=V]R:W-H965T5Z2[]&%)[S84O:%KP@1Z%N>%?QRM!)B?3X> M\WA%\HB?T34IY#>/E.61D(=L.>9K1J*D"LJSL6D8TW$>I<5H?E&=NV/S"[H1 M65J0.X;X)L\C]OV*9'1[.<*CYQ/WZ7(ERA/C^<4Z6I('(CZO[Y@\&K>4),U) MP5-:($8>+T=O\7F(W3*@:O%G2K9\[S,JA[*@]$MY\#ZY'!EECTA&8E$B(OGG MB5R3+"M)LA]?&^BHU2P#]S\_TX-J\'(PBXB3:YK]E29B=3F:C5!"'J--)N[I M]AUI!F27O)AFO/J-MDU;8X3B#1 M(],P#=5X].$/9'V&+*,*MQ3AWO'AIFHV?DT]^#7U4!_ND5B&8U5XQPJK35&K MXDT.\.X8C0E).'ID-$>;@I-XPTB"%I1)4IFPBCY>:9GE#?ZTS$.1%*+[71IWHY&?4)_WY!\0=@_*KNTX:?:!0GS(&$^ M)"R A(5 L$YV.&UV.+]T^]5&GYHI0RIZ1^G&4!JA@I-Q\$V M5E_(L]:JF?Y"/OBZKKNZM9 P'Q(60,)"(%@G9=PV95QMROA?-ZGX MCG(B5C21R[0GPD5."O6E[@Y?&?#4=GNO*==:Q5-S !+F0\("2%@(!.OD #9V MRWQ#OXB*OE>F(T%1%,N48.1'N= 0.R\CEB(9],JG9@,HS0>E!:"T$(K6S8B] MP@_^'Y;5#73_#C$SY$\_)[3:)^<$),T'I06@M!"*ULT)=-X,6R%#L5'J&%VK=@5 MM+"^HA4R.?^-&4H70*M9#:WS"+7M2;^8I6CF8&E$WX=A,]-TC:$3BG;8-IQ^ M'1AJK%TK=H4JK*]4W43?TGR3M\M9]"_ZN36O7N=DST!K6J T'Y06@-)"*%HW MFW:%+:RO;!U:^[Y&=%L0QE?I&JT)B^6I:*F^]&L!=_\?+&: T'Y06@-)"*%HWFW:%-OQS ME;83[C:NXFZ#S<'=!K3^!DKS06D!*"V$HM7Y,=[;=9,3MJPV5'$D5V*%J'#4J#=^C;_#U!+ P04 " "+ M@F=7'I"%WFT) 48 &0 'AL+W=O!*C,: !W#2+LIT[3Y-(V2;')SM?OL:W%SE6^K M=9+QKP4IMVD:%3]N^3I_N9[0R>L'WY*G5=5\,+VYVD1/_)Y7OVV^%O6[Z8&R M3%*>E4F>D8(_7D\^T9W_'UNB'5]?BCA4X.FDW!X]>O='>W\_7./$0EO\O7_TZ6U>IZ8DW( MDC]&VW7U+7_Q>;M#1L.+\W6Y^YN\[+9M@?FY"F9;P#Q7P6H+ M6.47I\K[ZO*4*0#3^B<\_([L]7>\94KBI^W3!6&SCX1I3">_W=ODPT\_2RIV MI\;<\\T%T;4&0Q<*C'TV1ED;YWP,4V#<=]2&)&6YY87,/!ZF5KX:8_.XQE 1 MHZA5H,:%V_4KCIJ*6H7G&^"-(R?X4S^TMVWR&,7) M.JE^?"3\^R8I]NU[&55<4N-;);D9P"_+313SZTD]0I>\>.:3F[__CIAC,3UB)!D3SR+$R[K &Z5N+'M FSWP$CLB: K)0+JI2'K)0/ MJE2 K%0(@@FMP#BT D/9"G[-JWJ:%Y4EKZ2F5Y8>:WHDS-[#C!VL.0U\OF&& MOM"L^=7T^=C42%%W#YN?$O60HKY4U)PO#%$T0(J&()A@ROG!E'/U^+A-'WC1 MS%?:^5ASOO&P+>O-RO)U#O.G8K)VJ^2/M2T29B-A#A+FS@<-:F'U;(W4\X=Z M5.L)!DC!$ 03+&T>+&VJ)^!Y]D0J7J1DR1\JF665Y<=:%@FSS>&!H@MJ&K-> M3XL4== M\']E5E4RQUH5";.1, <)V 23, M7DBZ:]W26:^W1FJZ"TEO/=3TD)J^1%.S3*T_*T9JAB"8X$BJ=1?KM?_SO%@M M,-:V4)H-I3E0FMO2CAN5WI\<0Q5]B>*,]JP-50Q1--'<1TD4/3E#_F4W0UX+ M%ZNE-E:B1ML82;-;FG!APM+ZO2]4TVUI1*T'I M"V;T+3=$,6/6,XD/WB 50T1-%$;W91%55G5?<\ M2_*"W/-X6\\,R7& J[I:I::.-BPTQ(+2'"C-A=(\*,V'T@(H+431Q%;296=4 M'9Z-OJ]!S1O=/J!I&1V&1$P?]G,.5-4]4]6#JOHRU1FCVKS?IT-#,11-=&L7 MBU%U+M:YE3QNFYLQ293FVTP^\X!&9%":3671T7QF]3,RJ*I[IJH'5?6AM !* M"U$TT_474 -VID@*9Q4)H-I3E0F@NE>5":3XK?$F2[)F7^[F5M&U (T(HS8;2'"C-A=(\*,V'T@(H+63#.%1GEMX%%*+I MN\R1J3-'Q9!0GTE\B;XGZ395CQ+00!)*LZ$T!TISH30/2O.AM !*"U$TL<%T MB2E3)Z9OC1(?2?Z2\:)<)1NRX45+?J8* MU73/TO2@FCZ4%D!I(8HF&KR+:)DZHCTQ(B39Z1$!&N%":3:4YD!I+I3F06D^ ME!9 :2&*)C:8+C=FZMP8,") (V0HS6YI8N^L-6G5T1_:'R"@2?%[JN!!J^!# M:0&4%J)HHOV[0)BI ^%FO&B:P&9W+=5-LBB+N7I\@";"4)H-I3E0F@NE>5": M#Z4%4%J(HHD-I,N@F3J#!HP/T&0:2K.A- =*M3?29N"-;PEP= &]\[<2;9C M5%\8IKB=+>4Q.C/[,QIH9GRFJ@=5]:&TX,PC$:)41=]U.2]3Y[QO^NZ,I:E. MH+]$Q7Y1KF:=I;FTJU4#PBCK #-I[PI-=Z$T]\3.[=:L(UJ[=[JT1X4FNE!: M *6%*)JX.EL7_.HGGNP\Y\DB-6/L+ -*L_7AXXJ4FOVU>&1;:7KO;C6WW4H< M&@;7&V6L_O-'/G0G R@M1-%$RW5IJJY.4T\]6:0N/MIMT !5'SYC.3/[MX8X M^C"2F\_Z2S6Y$A8UJ-F_A5("HX:IS?J&@T:44%J(HHF&ZY),79UDGGZT2 T8 M;3EH4JD/GV2DNF;TYZL.5-4]4]6#JOHR53I;F#W5 *H:HFBB/8]62'W7$JF* MTQ_RDE0K$L5Q7BR;6>HCCZIM(>],]>&0IDG.BB3;Z;*S(O6^C)UV0FDNE.9! M:3Z4%LB.JNP,"Z6Z=_;T:+GOE!=/N^7E2Q(W-\?N5P0^?'I8PO[3;N'VWNH[_'Z]_/J$ZBG)2K+FC[64=F'6HV:Q7X)^_Z;*-[O%QA_R MJLK3W=**4? MA L -R0 9 >&PO=V]R:W-H965TK&:DG^ L,V02I@UWE*G5ZHV9[]V*U%PY4@C78IFV3=$OSX]V[EZ3K,_\K64!?D>;Y+\>K NBNWE<)@OUS(.\XMT M*Y/R)P]I%H=%>3-['.;;3(:K_:!X,[0,8SR,PR@9S*[V]]UELZMT5VRB1-YE M)-_%<9C]N)&;]/EZ8 Y>[_@2/:Z+ZH[A[&H;/LJ%++YN[[+RUO"@K*)8)GF4 M)B23#]>#C^:E<";5@/TC_AW)Y_SH>U(]E?LT_:.ZP5?7 Z/:(KF1RZ(BPO++ MDYS+S::2RNWX5J.#0\UJX/'WKSK=/_GRR=R'N9RGF_]$JV)]/9@,R$H^A+M- M\25]#F3]A$:5MTPW^?[_Y/GEL:XQ(,M=7J1Q/;C<@CA*7KZ&W^L7XFB 9;TQ MP*H'6.<.L.L!]KD#G'J TQI@O_4<1O6 T;D5QO6 \;D5W'J >VZ%23U@TAI@ MVF\,F-8#IN=6,(W7WYRQ[Z"77_F^7[RP"&=76?I,LNKQI5=]LV^Z_?BR3:*D MFA^+(BM_&I7CBMGBTQ=RL\O+>_.)F'5S+]Z ML@BC3?X;^85$"?G7.MWE8;+*KX9%N2D5.%S69>-]_?CI>^.9?KQI:8!A^1H>7DCK]86\L;2BV"47Q+ _$,NP3/)UX9%??_FM MZX71,PNYO2"VL6=L#>.=SU@:QO^)K2%1GN]DUO5;IYBM8GK&D\N2,55&LU7! M&;\Y:U)QYE2S55S/W(8_B+'?*'/2,5KH1_]S690;L7]I3+=[(Y2VM _SV]Z[ M=H_Y_=]/Y4W""QGG_^O8TIL7T>D6JS?LRWP;+N7UH'Q'SF7V) >SO__-'!O_ MZ&IW).8A,1^)423&D%B Q#@2$R!,F1?.85XX.GTV3^,X*LJ%7I&3\BV,+,MW M@RAYE,DRDEW_AMQHN;Z3XB*@38J0&X41V("A"FS8'28 M!2/M+/B8Y[+H;'?MN+[M_H*-]EBUP_8TLT;VU)B,KX9/Q^V,+.J_8./WBE)D M4=99U!U/1VK1 %F4(S$!PI1V'!_:<:QMQ\^[^%YF)'UX7QGWKZN7YQ6K\)"=C6S5N[;S$C,0V*^_@7\G#Y= M$+/EA3DSA']-,D?,"B7E(S$=B%(DQ)!8@ M,8[$! A3YH5I-/F$H5] I0^MR:&:0&EJBQY%:*9^B2J+9)LYU:(]>PU4Z]I-.[QWNUFGGS2XQDF[62 53C4$V@-+7AF@#1U.8PLX5,HC0C"[GVUZ=7>?0B-$:&: M#]4H5&-0+8!J'*H)E*;.DB9.-!WX#IP)S12AF@?5?*A&H1J#:@%4XU!-H#1U MBC19HZD/&WM'[GJO]_SH2"%MUS",]F(&FD*>695"J[*NJHYE&N/V3ATTAX1J M J6IW=I$D:8^BVRZE3SLJF,$21BGNZ3[Y$.C1:@F4)IZRDX3+EKZ M<+'/(E]/]6U4JR-<'+D3L_4QMP>MZI]9E4*KLJZJD[%QLC<*K<_UQ7NW M/S05A6H4JC&H%D U#M4$2E/;OTE%+7TJ>GAW6*;Q?93LSPCZ4'ULDD\Z":#]4H5&-0+8!J'*H)E*9.A29RM=XY M_?-V?E@DT?I$.?W.!#1WA6H>5/.A&H5J#*H%4(U#-8'2U/G19+B6B]^9@":T M4,V#:CY4HU"-0;4 JG&H)E":.D6:A-;2GUNZGPU=IUO'X?5DE]&H?80=AQ85*$WM M\R9FM?0QZ^+KYX5^:02-5:&:!]5\J$:A&H-J 53C4$V@-/4B=TV0:QOPI9$- M#72AF@?5?*A&H1J#:@%4XU!-H#1UBC01LJV/D$%+([OKU-*3X]GG^HWI/1V@ M<3-4HU"-0;4 JG&H)E":.AV:Z-K61]>?;^>D/BBZST=.>K7WFP8TOX9J/E2C M4(U!M0"J<:@F4)HZ2XZN'OP77#X8>_U@[ 6$L5<0QEY"&'L-8>Q%A+%7$<9> M1OBOR*_M)K^V]?DU:EV%##7GM:8>JP>BBJ_[:I/@UX/ M1=V?RIA%][M"KDB1DC!)B[7,2#G@K24]]-1?J.9!-1^J4:C&H%I0:\>''!L7 M[1,].;2F0&GJK&BR9EN?-7].LV)-;J/-ALS#;52$FW?/\M&+O3L?FCY#-1^J M4:C&H%H U3A4$RA-_5-23?KLX--G!YH^0S4/JOE0C4(U!M4"J,:AFD!IZA1I MTF='GS[[+XNI6!;K=%6NJ9[*%55UWOT'DCY7)XZNHRW9'I9?G1,&>J(S5/.@ MF@_5*%1C4"V :KS6]&LST?&HYKA.M;N;,-G1A\EO=7?W7Q*$1LA0S8-J/E2C M4(U!M0"J<:@FG-,+:H_,XR-VU*9OLF%'?V%H?W%'%HLYF:?9-JW/5-/M%.BY MWGT/S86AF@_5*%1C4"V :ARJ"92F3H^C/S#KX'<*H"$P5/.@F@_5*%1C4"V M:ARJ"92F3I$F4';T@3)@IP :,T,U#ZKY4(U"-0;5 JC&:TW=*3#,]D[!.X]2 M&[P)HAU]$+W85=>7(S1*PF09A1OR1>;IKFQH_=_.T*N]NQJ:3$,U'ZI1J,:@ M6@#5.%03*$V=)4TR[>"3:0>:3$,U#ZKY4(U"-0;5 JC&H9I :>H4:9)I1Y], M U9*T# :JGE0S8=J%*HQJ!8XIV%T:V'#H04%2GN9!<-\+67AA44XNXIE]BCG M+H7I+)A^KBTY>F9'??[YB7=WS]L^-G5MIPA MMV'V&"4YVF .R'U:%&F\_W8MPY7,J@>4/W]( MT^+U1E7@.&PO=V]R:W-H965T>> MR)7QJ^7$W9$>>#H_LG\,VIV6-34P4_P[*VV5X7<8E;"A.V[OU>$.6CUCSU:K5 6F?[=C\)'@3T$X-D_XOKJQVN\SA;#Y30C#K?HLUB,H2S92T3&Y!%@P, M>HMNRI)YORE'"]E<&N_^Y1PL9=QFI@5DV/6; ;T'G+]^-9Q$'_K$ M_B>R9]*33GKR$OM?TOO$-@R3P."?BGV>3*[C]^.4[$]E]*6-AI.D2VL*)"GZG>,FD0AXT#1H/K,4:ZZ<@FL*H.EWJMK&N1,*W<(P;:)[C]C5+V&/@^ MZ9[%_ ]02P,$% @ BX)G5W.R04&;%@ $@$! !D !X;"]W;W)K&ULM5UM;]LXUOTK0I[%8@:8:42]N]L&2)R$+;8O0=W. M?!CL!]5A$J&VY)7DM@'VQS^28X<4R:$H^6@^=)+XZNCR2M?2$8]X7OTHRF_5 M V.U\W.]RJO7)P]UO7EY>EHM']@ZK5X4&Y8WG]P5Y3JMFU_+^]-J4[+T=K?1 M>G7JN6YTNDZS_.3LU>YO-^79JV);K[*Z_L\6K/ZRN2F;WTZ?46ZS-=YI MNZ'X\P']>C?Z9C1?TXK-B]6?V6W]\/HD.7%NV5VZ7=6?BA]OV'Y$88NW+%;5 M[E_GQS[6/7&6VZHNUON-FPS66?[T__3GOA+"!L3_FPV\_0:>O$'P-QOX^PU\ MVST$^PT"VSV$^PU"VSU$^PTBVSW$^PWBW<%ZJN[NT%RF=7KVJBQ^.&4;W:"U M/^R.[V[KYHAD>7LN+NJR^31KMJO/YL5ZG=7-R5573IK?.O,BK[/\GN7+C%7. M[\[BZ1QUBCOG2WZWS6_9K7/)OM:[X*O_;K/ZT1$Q?KED=9JMJE^;;;\L+IU? M_O&K\P\GRYW/#\6V:C:J7IW63=[MWD^7^QSG3SEZ?Y/C@FU>.+[[F^.YGJ_9 M_,J\^25;-IN3W>:>9G-JWOSCLG[A$$^W^6E3[.>*>\\5]W9X_M_AU0^L[-3L MKW=-B/.V9NOJ/[KJ/.$%>KSVR^IEM4F7[/5)\VU4L?([.SG[Y_^1R/V7KE9( M, H"Z]31?ZZC;T)7ZJBKW!-"M$-HOY6_G_E1[,W"5Z??Q9KHP@(2^=TP:LQG MY&B#Y]$&QM%:-=]?[]GZ*RNU)Y$1?NA)A 2C(+!.6TLBM6V MO0T]3A MYOT//36A:!2%UJV]P$@(N,WW@*AB(M$H"JU;3$XVB/$>W.K"O(?H7')#-PFD MOK4+H^:$Q@Z8LP)BI@5#._=\P]C*^!,V/>E9]I4&/'!#5P*_ M'@5.]UN)S\*)V_[WC-XMFS#K828B@QEU>TG?M'S:F:SSP[8_6=$*C?"6X<2VU[I0DCD2=%47,^ M8\?+F8EG9B9#F_G-=IWF#;&N69--;4&QS?L??*Y!YUE0:-W:C&A9(; M*!I%H76+RIS.N3-T+T+9350-(I"Z\H_.*OQS7,T5@(05[V:)IX_DP4@ M:IA\Q34G,W:PG'7XYMOUH7U[<4EWLU&IQ<76O.NAYQ@4C:+0NF7GK,5'B[5\ M*.6 HE$46K>8@F +H-CRU8;UHD!^GJT)\T,YBIKS&3M>S@I\H&:KZ=D/;%L6 M.:NS9673M=")$R@:1:%U"\_IB8]6=?E0O@%%HRBT;C$YW_"/EW;YJFB+D#!6 M+K-JF'*9G8(/^)P/^%AEU\'D'+L@(H MNX"B411:MYB<703'R[("56\U\T@L-ZT:%<5JSTYQ_Q_P^_\ *\HZ7WUC:_8T MV;-NGT#5S'E3K%HM1]5_GVQ.9O!Y!YVK0*%U#P3G)@%:B!5 20<4C:+0NL7D MI",X7H@5J JK)%1T6)HH^3;9G,O8L7).$&!%6.?EK\$*59E4XH?R?;-5 M%#6G,W:XG">$6.W4>7G+5H\_+1K6O./!YQATM@*%UBTZYRHA6B 50@D(%(VB MT+K%Y 0D/%X@%:K*IS@./;EA;:*H.9VQPQ7>*L?JH_YD5?W[AT^MR'$GL>CO M6^QKZ-CWT*?@*R'G*R%:'Q5".0<4C:+0NL7DG",\7A\5JL*G*/%E7:,F2KY- M-NJ$\>:N)DAO8G,O8L7)6$&$U4C>L M;FOSPKDN'IU_INO-OYSSJBJ6[2.KJKD&5]LRS9?,63299DMF\?3*G.#0$Q&* M1E%HW8/#.4R$5E)%4&X"1:,HM&XQ.3>)CE=21:I$*G0C^79:$T7;K)ZG9-CM[FA4YY0-$H"JU[ #B?B=""J@A* M4*!H%(76+::P5!9@K2Q5*14HK_A=::)B)8J:TQD[7$XA(JRDZLL?-X->-S#O M?O"9!IWD0*%U2\\938165D506@)%HRBT;C$Y+8F.5U9%FK6M?&4Q#DV4TK-3 ML(:8LX88*ZSZ=UJQ1YM7#8K2R*H:R#2@:1:%UB\G9 M1GR\LBK6K&<51S+MU47-?'F"R)S.V.%R/A!C=55?RMU:5\)U5I!H]#X:B,VN\ON=9;O MGC$;NQ8ZO0%%HRBT[H+0G*@D:%55 F4@4#2*0NL6DS.0Y'A55:+JI7SUP90F MBKC*@RES.F.'RSE"@E55_<'*NJ@&K/%LWO_@4PTZ@8%"Z]:>$Y8$+:Y*H*0# MBD91:-UB")DIIVBDX0<(Y08)55ET737BZ<[V:%WFU M73>5NBA;'Z+^NV5S*H-/.>@Q@X74G0(JL$2CV@:!2%UBTFIQ[)\2*K M1)5/^:XK/ZRRBJ+F=,8.5W#QP.JL_IVU(JNJ+HL![Q&96451 M8DFF"9,?8/6D,WK @LF@"W89W.;OV]OGLMAN!CR![DEC^'F'-15$P4F'0; 5 M=.&^@B[66! *1V%P4D4%;T$78"[H:FP#(TTG:]:^"F2/[IZ$1@]9L!=TP>*K M^8US] G6 :/3 MPH'ROKXNS(MEWDQ[,AH]9H%$]%B4CQ%0OF'IJGY8ML: YQ?OS$V,,B0_E!4Z M"0*#D\HO\!F"EF(1L $ZV %]&@MTT0/=[ MNT\07?1AZ>\[Y8;-N[ROZ2[LP MVI/$Z%()Y*/'XGQH[W_ZN6!YQ1>4[;^$HRS-#X6%SI_ X*0#() A@A9R$;!7 M.M@L?1JW=-$NW6PA;GD)5X5:JC_PE5T8[2E MPYX4AI]VT&D4&)QT" 0F1-"J+@)V3 =;ID_BF4X$TW1B-A*W:V1/8S"H^@MJ MPUS%&[0GH]%C%OA'CROXX-<0L]6*/3[),[.OVU8G8M/+YBP&GWE0. J#DXZ" MP(@\M,Z+8)W.L7 4!B=55" Y9@-PRU[6K(5%PD3I9(O90-RND7U5YQ4IIDJZ*-]3^G@20W,B M.)J3'DOSP9?GN;,XI_SQ]=--]B^+#5O6Y7;MG&_K8EVTJ\G_VM/;V"D8*!R% MP4G'12 _/EPFAO53Q\)1&)Q448',F&W&+7M;U7^%\EL45[HHSXUBY;'V),;G M1' ^)SW6YX,?:W]8\-9^^_;MKKTM9"8HT_-#?;$S*I-8LA/!DYWX<*48UFX= M"T=A<%)%!0YC=B&W;&95 A8H)N&Z*!(H/'H25W0BV**3'E_TP=X069ZGRU5# MHTN6[CYVYJRU-+6:JT+YHA]JC)U9F<2UG0BV[22 Z\:PENQ8. J#DRHJ:M;N4Q:EU420.E.?;DUBG$\$[G?28IP]?OJNJEL7^_<LD N>BS5!T\[GW^9#S*)Z$E@^#F'G5B9Q.*="![O)(#+P+!.[5@X"H.3 M*BJ0%K.!N647J_HN3S9?NK**HCWYC!ZQ0"IZ+-4'NQ2O5LZBWGFMG=^WQHFU MU>48.Y<"A:,P..D@"#PG@,O L*;M6#@*@^M65/!M)V8O<[M&#C6+=Q%ESED3 M17SESGH2;W4BF*N3'G?UP(:@GG]$C%MA#C]/Z8.OQHES= M"F:GW '5XF*,LED_%!D[9S*)"3P17.!)"!> 88W=L7 4!B=55. I9K]SRWY6 MI5UJ/VL6_(H)46:8)_%?)X(!.^EQ8!_\=N1A*OGF(2W736;;NEVNWNJQ-=9[$ MC)T(;NRDQXY],$>NRRQU_MR][>PLBM7N#0NK7D9YL>\+#(6C,#CI0 @<)X*+ MO[#F[E@X"H.3*BJ0EP@@_HI469?2RYJ8Q",*33:G,WK K?H,6$?W,O+):NJ M5H/]*:N^B=Z+NZ6%K)H:.W,"A:,P..F("-PG@JN^L*;O6#@*@Y,J*C 8LQ>Z M95/WKOIUI8N)@YE"GR>Q9B>"-SOI,6#73GH,VP=[5;#;K+G=SFU\S'OV/?QDPTZ:3&(?3P3_>!+#%5Y8:W@L'(7! M2145"(O9,=VN?6-5NZ6TKR;&]R/EP=IL60T39Z(1+#-5U8RW@L'(7!=2LJN,83LY.Z M71\GJEI+Z6--C!=XBC9S$F-W(CB[DQYK]\%]W'#AM"'#2^=-L6;.)U9MLC*M MB_+1633I/5DZ]O8URN#]4&SLC,DD]O-$\)\G"5SNA;64Q\)1&)Q448&QF)W6 M+?O:0NZEB6F:6'G&-8GQ.Q&!PE$8 MG'06'=Y+!R%P4D5%ES@ MA[;RA_-Y=QV1UENYG5TV]S%VD@0*1V%PTD$0^$X"EWAAG>:Q&EB2! KE'D2/W@B&,*3'D?XP8+-F_-/#5TNO[&Z:67GNBB7S.;A M%\H)?E]>*!R%P4F'06 \,[C "^L\CX6C,#BIH@)=,1NRVW7RS$+@I8DAOJ]H M02;QAR>"03SI<8@?/(%T^6WYO+>?DWB$D\$FWC2XQ,_ M6*FY9F6V3'/G,UNQ99'?L9+ER_;J+##F^K:GK;%3*5 X"H.3CHE =V9P@1?6 ME!X+1V%P4D4%[F+V:K=L:PN!ER:&N#-E>;Y)K..)X!U/>LSC1S@QM_?9>_,X MH9M5CX2@,3JHH$2IZO-SK@!$9FED7 MX\_DIU\]V8P>;TLNI#_Y0@G,M]]_D?]\?F"[%>W3_-%IKL-U6:PJIZF,TS9^ M>STN[MI?*]9\RL^]]IM@G39;M"\TK]J M9/63M9\=)M5RY*UC\E>Z!(_K1X8 MJR_3.CU[U=P#W+,Y6S5[7!;;O&Z_$(6_.B6[:[^C7EZ0DU/E[W/R\E+W]ROR M\EKW]Z88WLOKMF#:S_SV,[_][)2G=?9JD]ZSYAOM/LLK9\7NFA3=%ZWJI,SN M'YY_J8M-\[5ZXGPMZKI8[WY\8.DM*]N YO.[HJ@/O[0[^%&4WW9E./M_4$L# M!!0 ( (N"9U>8.QT\:@( ,(& 9 >&PO=V]R:W-H965TR@/XXYYS?8[M2[27:JMS $/N"E'JJ9<;4TTHU6D.!=,# M64&),VNI"F:PJS945PI8YD"%H('O7]""\=*+(S>V4'$D:R-X"0M%=%T43-U? M@9#[J3?T'@9N^"8W=H#&4<4VL 3SHUHH[-&.)>,%E)K+DBA83[W9<)*,;+P+ M^,EAKP_:Q"I92;FUG>MLZOEV02 @-9:!X6<'L>5+I=#N3?9-[.78(VFMC2Q: M,*Z@X&7S97>M#P> X>@((&@!P;F L 6$YP)&+$&19'2NZ)LM'( M9AO.3(=&^;RTV[XT"F0]F649MVV>0%K MA/D#6P]54S&;CI&5JR$K:; BN6:./QE0-@#GUQ(/>MNQ9:G[;<7_ %!+ P04 M " "+@F=7J*CSQX<# #G#@ &0 'AL+W=OS@;(D$$BWOB38/N=<^_AB?*<[QN]%#"#1KS2A8F;$4F83TQ1A#"D6ERP# MJD8VC*=8JB;?FB+C@*."E":F8UF^F6)"C?FTZ+OE\RG+94(HW'(D\C3%_/,3V<92=YCS:8:WL ;Y);OEJF76*A%)@0K"*.*PF1E7]F0UUO@" M\)7 3NP]([V2.\;N=>-#-#,L/2%(()1: :N_!UA DF@A-8V?E:91A]3$_>=' M]56Q=K66.RQ@P9)O))+QS!@9*((-SA/YB>W>0[4>3^N%+!'%+]I56,M 82XD M2RNRFD%*:/F/?U4^[!&43CO!J0C.,6%P@N!6!/?<"(.*,#@W@E<1O&."?X+@ M5P2_\+XTJW ZP!+/IYSM$-=HI:8?BNTJV,I@0G5BK257HT3QY'R!,R)Q@M8Q MYH ^*:IYDX3UZ'8#$)!%O%.G+.D"O7[Y!+Q&A MZ'/,M[ M$4$3<3$<^(>@9:_,JD7&L8?.T*YQ!WX,:C\&3_;C*TYR:+.CE/([[.A%!$W$ MA7V$6?:JK%I47,L=M7OAU5YXG5Y\5-]C0D/UG170E15>;U;T(H(FHB4KFB#; M\6Q[Y'A'=G2N2]\Q)B+#(,CQSK7](^.#6O'AN>\X^07D30BU@V$:T' M2.&ULK5C;T,>8DGT.2UU'UH2HS5E3SP$$.@E MCA(^UD(ATJ&N*>KO^$ M?3B.?_T;JT-33D9US0N 3+&<0D*7[Q2QF'#8#9/0"P2H"U"^@= -@E MP#[50[<$=$_UT"L!O5,]]$M ?Q?0/P!P2H"3)ZN(;IX:%PL\&3&Z1DQ92S;5 MR/.;HV5&2**4N!!,/B42)R8+0?TG= ]IQOQ0IA3-&5TQ'*,_T%40$"47'*'; MI-"\$L\7%P0F$?\J31X6+OKRZ2OZA'3$0\R (Y*@AX0(?B$'9?OOD&8<)P$? MZ4).5SG5_7)J-\74K -3L]$=343(D9<$$-3@O6;\Y3'\K!EO6@T$NHQS%6SK M+=C75B/C'7Y%QN4%L@S+KHM',WH!:0?9QD&X>SK??S+[QK2[=;9*Y;9)Y;9)-VR2;M42V)9IN)9IN M$WM9*]E[K4R+6GF!<"9"RLB_$" OJ1R/\7*FT2>:U239MDVS6$MF65/J55/HG2.7]K!4@-V,D6:$Y,$*#"[3( MCU!U2FDD/G??*U;6*9C.69EMA5GIXJS MTQSGXB1ZRWD&,JIS1GQ0,2[B6Q?>1KYSPUN0.1N+,KL=P]H)<9LNO9-<3MMT M.:MQ:7CU;>#J_S*O#-^8PY=LV;<,X?3XM/ M.WWQH>(.LQ5).(I@*5T9'4>^RJRX_!<=0=/\[OE(A;S)YLT0L#QU*P/Y?$GE MF;OL* ?5%YC)?U!+ P04 " "+@F=7'B)1;DP? 'P$ &0 'AL+W=O M.L^_(&2:((DT'\9!J[JMK8RB;/X.'W;'A03!=%V6VV!G+&2S2Y?:_R?==)A0#%AD,^,Z M=PV&!H-H9Q#M.\)@9S#8=X1X9Q#O.\)P9S#?JO^LEFNC;5,<+JL3JVK,I>_3:5=^>[J\G-P)99IE@>78CE+E[?!ISR[S9-% M<'EY&OPMN-J>+J;T.EV0MPPH4GP,5N6=T5POIR)F<;^ MG+9GG'!P++/SE")>I^B4DQZOQ.HHB,+#@(<\TDV(-C\34VG.-N:!K]D\VKQBN"/2WE\\*$4B^)?NNQOG0_TSJL;V>MB ME4S%VP-YIRI$?B\.WOWU+VP8_JR+W)&S5AX&3WD84-[?G69%J9G3>]KJ#Z;- MRM9HN#&J[L;W[S@/!T,V>G-\KP9,.K<,.'X*.":G?I&D>?#/9+X6NK!I6T/8 M6Z-8#9N-6!@/.V&3SBW#'CZ%/22G#NY0?WP4BVN1:\,C'3_W7'?DK)6#T5,. M1CZO^9'+/#ARULK#^"D/8ZMKGK;Z@VNS,NZ=_"SBDTG4.??'O5L#&X<1?SJJ M%I_.1%X$?TT6JY_E%9S?IU-1/%VOP?\$)^(V+8(OV?=44DQV^QA< M35.QK XZS7))&F/A\TWJN#D.KN7,4OD^ZZ[HH"3S24UT"<+#/\JCD-M6D@[V[0TD,A(]GIW M,<^R7)L)VLYPK]Q9C95;1G@4=N\KM&_;F!L@9#3;?5B60OHM@\])J;VO OO- M61#KX]]:3EKQ,\:Z'Q;T"+89: B1T9CW,2G7>5H^!F>F# !,-*P^&O4Q",+) M85!]Q8FU%X,/@&0-03(:(3\E>7"RR-9++3P 8U-.AOVO#)-AV#T??% C:["1 MD31FY"5@9@IYU/^ZH G9!R"RAA 9#7LT60%C JU8GP-UP9/^;8-OJ)+1:/A< M GN?/'Y,\F_!SJX^Y%!^D$Z/7)$7.>5GTX8C;^U*4(.X//1)7MPIA;KRULY% M0Z&<)+L]R0LX,=QJT-"OXE!'76=H-"WCG0.K2\-H%VBTX;^H1#>(RVG&-+(< ML#/EEN_#BX5U.DR<-=L#8E(:X M]T$_" ==T-</:679K7,/NK94>P38#RN-O MFJ(@_0![T^K35O]()+P$8;2EEXGV:O!1_8P:*HQHO*)9"!B;DM)_+AY/1MVB M!^W;-O & B.:XTS,!,Q,(?>?B<>CR:0;LH^"9M1@8D3S'LU6P)A@JZA?U-2M MMX^B9M2 942SX7,9[+=?KX*/5[^Y)"UZAL_>1>.C8AHU3!N-?9)6Y)0Z77EK MYZ*ASH@NH.Y)6GL\H#>0%AC^U5#_ (6VL]UIU0#H@"9 (VD!.\,]=F<%2(OV M;1MS0Y<#FA(A:0%[@K1VECW2XMT,^&#-0<.: YH5(6D!>]/JTU;_6,\KTAH3 MCQ-I#[9Y:0AT0+,@35K V)242//)&W7WX=&^;0-7=ES2E&C<S.6#,^.&,V.:%R%S 7N"N7:67>8:Q-VM M[CZH,VZH,Z:I$3(7L#>L/K Z6=\>!6RX1:Z![F*@'=BFI4'1F(9"&KF L2DG M7/,1/!QTSP4&=.X"-YS@:QI0JY8 M5\SL!^^#-V/E'1\:&9^-7.ERF4SG(O@B/T2W%'$JJKOH=A.7(_:B)_UM&_;F!O>C&ENQ.RU1]73P%X3'7OQ7@)\P.>P@<\A#8\0 MO8"]8?&!U>[!(M^RUU!W,= >;//2(.F0AD.:O8"Q*2FLOXEGQ+LL3ONV#;R! MSB'-C2;V F:FD'F/O70A^\#-88.;0_#:$,E>P)A@KV&_O*D+W@=X#AOP'-+L M^&SVFB=%F4Z+X&.R3&Y%A1$N'S+2LWWVZ\L^N';8<.TP]@E=0Z< ZLI;.Q?* M"^W@C?:]H LX(: +#6_8SGY.V]FFI6'1(=@P:H(N8&>ZWX[V@2[:MVW,#6@. M:6"$T 7L">C:67:WQ ^Z7WCI$6PST&#GD,9&3%U6Y4Y@M2UXC8G-[+0#VWX/ M#8R.:"RDH0L8&W*RLVH50(9Q]XJ@?=L&WM#FB 9&$W0!,U/(K%_P&HRZC]EH MW[8A-YPY N_WD- %C GH&FD*G)KU]D&ZON;;!XL-B+]FT;L])5B29'2%_ GJ"OG67W<6-O>PL]@FT& M&OXJ\'.,4V.Q@9;5L"YLVJ]63@(>PVV? #GN '.,7B+B*0O8$S0U[A?XN2# M07W?-O@&/<@)/Y!V['77IUC MIPSJREL[%PV#CNGJZG[PWYP%W68*N_B=/IW?>>O6T**)(0,->8YI MQ-J^]T7RB8PX6X/@JXGN+::5':>])@2',7,#;EQ.G[2>-^&Z@H#$/# M^= YYAF1B-W6:$F;?7LD"<]BC.'/&E0*:);H.ZQT=/0 ]5ICZ5)OV8: MA9$I^ 8Z)S0WGJ7W$K32FU3,@HMTF2RG:3+7-TDM\S0)?M\UZ,KFZZHIJMM2 M%SW79V?,!]%.&J*=<)_(-7&*GZZ\M7/1X.>$KJWNAUS B>$>@X8V](PX0Z/I M.W3AT?0=NM!H9(>N2<.V$QH'C1 '[$RY'>Q3/$-'M6-I@'1"@R6$,V!OBBG6 MH11GW0Y=R+N^0Y?>>SCN/.R\0-[)#EV3!G G-*!"O /VIAR"$NX&R";$+OX7 M.&AGH@'="0V)--$!8U,:-+V=!J-N)4U[U&1@N#P:1)W8M: '9J90^DWH=:'H MCC*&HO2@?U$3>OLN]+I*9S\HW5&FH%BH=J&GV?!+GFSPYS1;K))E*NIZUEE: M2):Z7I=9WB:LN22O4EZH17 BH2G)2Z<%+3#=Y[>>]])[/E2:SX=^N\^';MO/ MNW+7R0=7\N&D SWP0K6@1Q,PT,\Y,+3.C=*%/K1M0P\,32VHP_T:T=/>K0-7 M6M&'--GA7O3 =6,?F?:ZQ_1RX*/)^TL5-K1AR_M1P\<&$\#\)"]DNP*0D8\ M800NK).C-*4/7]25'E@;,Z/I2\^B<>_4\-*8/E0ZTX>6K>F!G3%N37-Z7=Q> MNM.'2GOZ\$7]Z8$UU: ^U'2HUV7 2XOZ4.E1']+D^%P^.__UJJ&+#Q\^;-2! MCH+SJ^"WU30+OEZ=.*4UM^WJ7;GK* 4I-,R\=JQGCH63/"DGJ=))+KK6(R^F MNQ :_-5 ^[[C&1Q/7Q9#9I>&\2[@>&1AC*GR3$ @R4R 6)-)G^*]VM?#PSH! M*4@+%)(PV5E*+#%]#WO>J6&=0?_Z$IG>?S@9\(GZOT[!# Y&5LR8*MX$U)

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 84 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 85 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1578 317 1 true 261 0 false 10 false false R1.htm 1001 - Document - Cover Page Sheet http://www.slrinvestments.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Consolidated Statements of Assets And Liabilities Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities Consolidated Statements of Assets And Liabilities Statements 2 false false R3.htm 1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical Consolidated Statements of Assets And Liabilities (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Consolidated Statements of Operations Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Consolidated Statements of Changes In Net Assets Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets Consolidated Statements of Changes In Net Assets Statements 5 false false R6.htm 1006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 7 false false R8.htm 1008 - Statement - Consolidated Schedule of Investments Sheet http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments Consolidated Schedule of Investments Statements 8 false false R9.htm 1010 - Statement - Consolidated Schedule of Investments (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical Consolidated Schedule of Investments (Parenthetical) Statements 9 false false R10.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 10 false false R11.htm 995470 - Disclosure - N-2 Sheet http://xbrl.sec.gov/cef/role/N2 N-2 Notes 11 false false R12.htm 999001 - Disclosure - Organization Sheet http://www.slrinvestments.com/role/Organization Organization Notes 12 false false R13.htm 999002 - Disclosure - Significant Accounting Policies Sheet http://www.slrinvestments.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 13 false false R14.htm 999003 - Disclosure - Agreements Sheet http://www.slrinvestments.com/role/Agreements Agreements Notes 14 false false R15.htm 999004 - Disclosure - Net Asset Value Per Share Sheet http://www.slrinvestments.com/role/NetAssetValuePerShare Net Asset Value Per Share Notes 15 false false R16.htm 999005 - Disclosure - Earnings Per Share Sheet http://www.slrinvestments.com/role/EarningsPerShare Earnings Per Share Notes 16 false false R17.htm 999006 - Disclosure - Fair Value Sheet http://www.slrinvestments.com/role/FairValue Fair Value Notes 17 false false R18.htm 999007 - Disclosure - Debt Sheet http://www.slrinvestments.com/role/Debt Debt Notes 18 false false R19.htm 999008 - Disclosure - Financial Highlights Sheet http://www.slrinvestments.com/role/FinancialHighlights Financial Highlights Notes 19 false false R20.htm 999009 - Disclosure - SLR Credit Solutions Sheet http://www.slrinvestments.com/role/SlrCreditSolutions SLR Credit Solutions Notes 20 false false R21.htm 999010 - Disclosure - SLR Equipment Finance Sheet http://www.slrinvestments.com/role/SlrEquipmentFinance SLR Equipment Finance Notes 21 false false R22.htm 999011 - Disclosure - Kingsbridge Holdings, LLC Sheet http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc Kingsbridge Holdings, LLC Notes 22 false false R23.htm 999012 - Disclosure - SLR Healthcare ABL Sheet http://www.slrinvestments.com/role/SlrHealthcareAbl SLR Healthcare ABL Notes 23 false false R24.htm 999013 - Disclosure - SLR Business Credit Sheet http://www.slrinvestments.com/role/SlrBusinessCredit SLR Business Credit Notes 24 false false R25.htm 999014 - Disclosure - Commitments and Contingencies Sheet http://www.slrinvestments.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 999015 - Disclosure - Capital Share Transactions Sheet http://www.slrinvestments.com/role/CapitalShareTransactions Capital Share Transactions Notes 26 false false R27.htm 999016 - Disclosure - Stock Repurchase Program Sheet http://www.slrinvestments.com/role/StockRepurchaseProgram Stock Repurchase Program Notes 27 false false R28.htm 999017 - Disclosure - SLR Senior Lending Program LLC Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc SLR Senior Lending Program LLC Notes 28 false false R29.htm 999018 - Disclosure - Subsequent Events Sheet http://www.slrinvestments.com/role/SubsequentEvents Subsequent Events Notes 29 false false R30.htm 999019 - Disclosure - Earnings Per Share (Tables) Sheet http://www.slrinvestments.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.slrinvestments.com/role/EarningsPerShare 30 false false R31.htm 999020 - Disclosure - Fair Value (Tables) Sheet http://www.slrinvestments.com/role/FairValueTables Fair Value (Tables) Tables http://www.slrinvestments.com/role/FairValue 31 false false R32.htm 999021 - Disclosure - Debt (Tables) Sheet http://www.slrinvestments.com/role/DebtTables Debt (Tables) Tables http://www.slrinvestments.com/role/Debt 32 false false R33.htm 999022 - Disclosure - Financial Highlights (Tables) Sheet http://www.slrinvestments.com/role/FinancialHighlightsTables Financial Highlights (Tables) Tables http://www.slrinvestments.com/role/FinancialHighlights 33 false false R34.htm 999023 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.slrinvestments.com/role/CommitmentsAndContingencies 34 false false R35.htm 999024 - Disclosure - Capital Share Transactions (Tables) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsTables Capital Share Transactions (Tables) Tables http://www.slrinvestments.com/role/CapitalShareTransactions 35 false false R36.htm 999025 - Disclosure - SLR Senior Lending Program LLC (Tables) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables SLR Senior Lending Program LLC (Tables) Tables http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc 36 false false R37.htm 999026 - Disclosure - Organization - Additional Information (Details) Sheet http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails Organization - Additional Information (Details) Details 37 false false R38.htm 999027 - Disclosure - Significant Accounting Policies - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails Significant Accounting Policies - Additional Information (Details) Details 38 false false R39.htm 999028 - Disclosure - Agreements - Additional Information (Details) Sheet http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails Agreements - Additional Information (Details) Details 39 false false R40.htm 999029 - Disclosure - Net Asset Value Per Share - Additional Information (Details) Sheet http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails Net Asset Value Per Share - Additional Information (Details) Details 40 false false R41.htm 999030 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details) Sheet http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details) Details 41 false false R42.htm 999031 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 42 false false R43.htm 999032 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) Details 43 false false R44.htm 999033 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) Details 44 false false R45.htm 999034 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) Details 45 false false R46.htm 999035 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) Details 46 false false R47.htm 999036 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) Details 47 false false R48.htm 999037 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details) Sheet http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails Debt - Schedule of Long-term Debt Instruments (Details) Details 48 false false R49.htm 999038 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) Details 49 false false R50.htm 999039 - Disclosure - Debt - Additional Information (Details) Sheet http://www.slrinvestments.com/role/DebtAdditionalInformationDetails Debt - Additional Information (Details) Details 50 false false R51.htm 999040 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details) Sheet http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails Financial Highlights - Schedule of Financial Highlights (Details) Details 51 false false R52.htm 999041 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) Sheet http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) Details 52 false false R53.htm 999042 - Disclosure - SLR Credit Solutions - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails SLR Credit Solutions - Additional Information (Details) Details 53 false false R54.htm 999043 - Disclosure - SLR Equipment Finance - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails SLR Equipment Finance - Additional Information (Details) Details 54 false false R55.htm 999044 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details) Sheet http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails Kingsbridge Holdings, LLC - Additional Information (Details) Details 55 false false R56.htm 999045 - Disclosure - SLR Healthcare ABL - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails SLR Healthcare ABL - Additional Information (Details) Details 56 false false R57.htm 999046 - Disclosure - SLR Business Credit - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails SLR Business Credit - Additional Information (Details) Details 57 false false R58.htm 999047 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 58 false false R59.htm 999048 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) Details 59 false false R60.htm 999049 - Disclosure - Capital Share Transactions - Additional Information (Details) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails Capital Share Transactions - Additional Information (Details) Details 60 false false R61.htm 999050 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails Capital Share Transactions - Summary of Transactions In Capital Stock (Details) Details 61 false false R62.htm 999051 - Disclosure - Stock Repurchase Program - Additional Information (Details) Sheet http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails Stock Repurchase Program - Additional Information (Details) Details 62 false false R63.htm 999052 - Disclosure - SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) Details 63 false false R64.htm 999053 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) Details 64 false false R65.htm 999054 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details) Details 65 false false R66.htm 999055 - Disclosure - SLR Senior Lending Program LLC - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails SLR Senior Lending Program LLC - Additional Information (Details) Details 66 false false R67.htm 999056 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 67 false false All Reports Book All Reports d458881d10q.htm slrc-20230930.xsd slrc-20230930_cal.xml slrc-20230930_def.xml slrc-20230930_lab.xml slrc-20230930_pre.xml http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/cef/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 88 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d458881d10q.htm": { "nsprefix": "slrc", "nsuri": "http://www.slrinvestments.com/20230930", "dts": { "inline": { "local": [ "d458881d10q.htm" ] }, "schema": { "local": [ "slrc-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/2006/xbrldi-2006.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/cef/2023/cef-2023.xsd", "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "slrc-20230930_cal.xml" ] }, "definitionLink": { "local": [ "slrc-20230930_def.xml" ] }, "labelLink": { "local": [ "slrc-20230930_lab.xml" ] }, "presentationLink": { "local": [ "slrc-20230930_pre.xml" ] } }, "keyStandard": 221, "keyCustom": 96, "axisStandard": 24, "axisCustom": 6, "memberStandard": 26, "memberCustom": 203, "hidden": { "total": 7, "http://fasb.org/us-gaap/2023": 2, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 1578, "entityCount": 1, "segmentCount": 261, "elementCount": 945, "unitCount": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 3352, "http://fasb.org/srt/2023": 1, "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/cef/2023": 184, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.slrinvestments.com/role/CoverPage", "longName": "1001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:DocumentPeriodEndDate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R2": { "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "longName": "1002 - Statement - Consolidated Statements of Assets And Liabilities", "shortName": "Consolidated Statements of Assets And Liabilities", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:Cash", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R3": { "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "longName": "1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical)", "shortName": "Consolidated Statements of Assets And Liabilities (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:InvestmentOwnedAtCost", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "slrc:CashEquivalentsAtCost", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R4": { "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "longName": "1004 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:GrossInvestmentIncomeOperating", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:GrossInvestmentIncomeOperating", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "longName": "1005 - Statement - Consolidated Statements of Changes In Net Assets", "shortName": "Consolidated Statements of Changes In Net Assets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:InvestmentIncomeNet", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:InvestmentIncomeNet", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "longName": "1006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:NetIncreaseInNetAssetsResultingFromoperations", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:NetIncreaseInNetAssetsResultingFromoperations", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical", "longName": "1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical)", "shortName": "Consolidated Statements of Cash Flows (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "P04_01_2022To04_01_2022", "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P04_01_2022To04_01_2022", "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "longName": "1008 - Statement - Consolidated Schedule of Investments", "shortName": "Consolidated Schedule of Investments", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:InvestmentOwnedAtCost", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:InvestmentOwnedPercentOfNetAssets", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R9": { "role": "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "longName": "1010 - Statement - Consolidated Schedule of Investments (Parenthetical)", "shortName": "Consolidated Schedule of Investments (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://xbrl.sec.gov/cef/role/N2", "longName": "995470 - Disclosure - N-2", "shortName": "N-2", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:EntityFileNumber", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "cef:SeniorSecuritiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "cef:SeniorSecuritiesNoteTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R12": { "role": "http://www.slrinvestments.com/role/Organization", "longName": "999001 - Disclosure - Organization", "shortName": "Organization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.slrinvestments.com/role/SignificantAccountingPolicies", "longName": "999002 - Disclosure - Significant Accounting Policies", "shortName": "Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.slrinvestments.com/role/Agreements", "longName": "999003 - Disclosure - Agreements", "shortName": "Agreements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:AgreementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:AgreementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.slrinvestments.com/role/NetAssetValuePerShare", "longName": "999004 - Disclosure - Net Asset Value Per Share", "shortName": "Net Asset Value Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:NetAssetValuePerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:NetAssetValuePerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.slrinvestments.com/role/EarningsPerShare", "longName": "999005 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.slrinvestments.com/role/FairValue", "longName": "999006 - Disclosure - Fair Value", "shortName": "Fair Value", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.slrinvestments.com/role/Debt", "longName": "999007 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.slrinvestments.com/role/FinancialHighlights", "longName": "999008 - Disclosure - Financial Highlights", "shortName": "Financial Highlights", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.slrinvestments.com/role/SlrCreditSolutions", "longName": "999009 - Disclosure - SLR Credit Solutions", "shortName": "SLR Credit Solutions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:SlrCreditSolutionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:SlrCreditSolutionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.slrinvestments.com/role/SlrEquipmentFinance", "longName": "999010 - Disclosure - SLR Equipment Finance", "shortName": "SLR Equipment Finance", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023_SlrEquipmentFinanceMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R22": { "role": "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc", "longName": "999011 - Disclosure - Kingsbridge Holdings, LLC", "shortName": "Kingsbridge Holdings, LLC", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": null }, "R23": { "role": "http://www.slrinvestments.com/role/SlrHealthcareAbl", "longName": "999012 - Disclosure - SLR Healthcare ABL", "shortName": "SLR Healthcare ABL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:SlrHealthcareAblTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:SlrHealthcareAblTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.slrinvestments.com/role/SlrBusinessCredit", "longName": "999013 - Disclosure - SLR Business Credit", "shortName": "SLR Business Credit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:SlrBusinessCreditDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:SlrBusinessCreditDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.slrinvestments.com/role/CommitmentsAndContingencies", "longName": "999014 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.slrinvestments.com/role/CapitalShareTransactions", "longName": "999015 - Disclosure - Capital Share Transactions", "shortName": "Capital Share Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:CapitalShareTransactionsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:CapitalShareTransactionsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.slrinvestments.com/role/StockRepurchaseProgram", "longName": "999016 - Disclosure - Stock Repurchase Program", "shortName": "Stock Repurchase Program", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc", "longName": "999017 - Disclosure - SLR Senior Lending Program LLC", "shortName": "SLR Senior Lending Program LLC", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.slrinvestments.com/role/SubsequentEvents", "longName": "999018 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.slrinvestments.com/role/EarningsPerShareTables", "longName": "999019 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.slrinvestments.com/role/FairValueTables", "longName": "999020 - Disclosure - Fair Value (Tables)", "shortName": "Fair Value (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.slrinvestments.com/role/DebtTables", "longName": "999021 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.slrinvestments.com/role/FinancialHighlightsTables", "longName": "999022 - Disclosure - Financial Highlights (Tables)", "shortName": "Financial Highlights (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables", "longName": "999023 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:OtherCommitmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:OtherCommitmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsTables", "longName": "999024 - Disclosure - Capital Share Transactions (Tables)", "shortName": "Capital Share Transactions (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables", "longName": "999025 - Disclosure - SLR Senior Lending Program LLC (Tables)", "shortName": "SLR Senior Lending Program LLC (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "longName": "999026 - Disclosure - Organization - Additional Information (Details)", "shortName": "Organization - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P02_10_2010To02_10_2010_IPOMemberusgaapSubsidiarySaleOfStockAxis", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R38": { "role": "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "longName": "999027 - Disclosure - Significant Accounting Policies - Additional Information (Details)", "shortName": "Significant Accounting Policies - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:PercentageOfExciseTax", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:PercentageOfExciseTax", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "longName": "999028 - Disclosure - Agreements - Additional Information (Details)", "shortName": "Agreements - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:ManagementFeeExpense", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "slrc:PerformanceBasedIncentiveFeesWaiver", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "slrc:AgreementsTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R40": { "role": "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails", "longName": "999029 - Disclosure - Net Asset Value Per Share - Additional Information (Details)", "shortName": "Net Asset Value Per Share - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:AssetsNet", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": null }, "R41": { "role": "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails", "longName": "999030 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details)", "shortName": "Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "slrc:IncreaseDecreaseInNetAssetsFromOperation", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "slrc:IncreaseDecreaseInNetAssetsFromOperation", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "longName": "999031 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "shortName": "Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "longName": "999032 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details)", "shortName": "Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "PAsOn06_30_2023", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn06_30_2023", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "longName": "999033 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details)", "shortName": "Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "PAsOn12_31_2021_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2021_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "longName": "999034 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details)", "shortName": "Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "PAsOn09_30_2023_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "name": "us-gaap:DebtInstrumentFairValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "name": "us-gaap:DebtInstrumentFairValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "longName": "999035 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details)", "shortName": "Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "PAsOn09_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_IncomeApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_InvestmentInSeniorSecuredLoansMemberusgaapFairValueByAssetClassAxis_MeasurementInputMarketYieldMemberusgaapMeasurementInputTypeAxis", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_IncomeApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_InvestmentInSeniorSecuredLoansMemberusgaapFairValueByAssetClassAxis_MeasurementInputMarketYieldMemberusgaapMeasurementInputTypeAxis", "name": "slrc:DescriptionOfFairValueMeasurementValuationProcess", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R47": { "role": "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "longName": "999036 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)", "shortName": "Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "PAsOn09_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputEbitdaMultipleMemberSLRCMeasurementInputTypeOneAxis", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputEbitdaMultipleMemberSLRCMeasurementInputTypeOneAxis", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "longName": "999037 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details)", "shortName": "Debt - Schedule of Long-term Debt Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "longName": "999038 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details)", "shortName": "Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "PAsOn09_30_2023_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "name": "us-gaap:DeferredFinanceCostsNet", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "name": "us-gaap:DeferredFinanceCostsNet", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "longName": "999039 - Disclosure - Debt - Additional Information (Details)", "shortName": "Debt - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:LongTermDebtWeightedAverageInterestRateOverTime", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R51": { "role": "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "longName": "999040 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details)", "shortName": "Financial Highlights - Schedule of Financial Highlights (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:NetAssetValuePerShare", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "slrc:NetAssetValuePerShareTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R52": { "role": "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails", "longName": "999041 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details)", "shortName": "Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "slrc:FairValueOfCommonStockPerShare", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:InvestmentCompanyExpenseRatioExcludingIncentiveFee", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "div", "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R53": { "role": "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "longName": "999042 - Disclosure - SLR Credit Solutions - Additional Information (Details)", "shortName": "SLR Credit Solutions - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "slrc:NumberOfIssuerInBusinessCredit", "unitRef": "Unit_issuers", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "slrc:SlrBusinessCreditDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn12_28_2012_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "slrc:SlrCreditSolutionTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R54": { "role": "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "longName": "999043 - Disclosure - SLR Equipment Finance - Additional Information (Details)", "shortName": "SLR Equipment Finance - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:LongTermDebt", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn07_31_2017_SlrEquipmentFinanceMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "name": "us-gaap:EquityMethodInvestmentAggregateCost", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R55": { "role": "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "longName": "999044 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details)", "shortName": "Kingsbridge Holdings, LLC - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ProceedsFromIssuanceOfUnsecuredDebt", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2022_KbhtMemberdeiLegalEntityAxis", "name": "us-gaap:Assets", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R56": { "role": "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "longName": "999045 - Disclosure - SLR Healthcare ABL - Additional Information (Details)", "shortName": "SLR Healthcare ABL - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:LineOfCreditFacilityExpirationDate1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "slrc:SlrBusinessCreditDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2022_SlrHealthcareAblCreditMemberusgaapLineOfCreditFacilityAxis", "name": "us-gaap:Assets", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R57": { "role": "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "longName": "999046 - Disclosure - SLR Business Credit - Additional Information (Details)", "shortName": "SLR Business Credit - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:CommitmentsAndContingencies", "unitRef": "Unit_USD", "xsiNil": "true", "lang": null, "decimals": null, "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2022_SlrBusinessCreditMemberusgaapLineOfCreditFacilityAxis", "name": "us-gaap:LineOfCredit", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "slrc:SlrBusinessCreditDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R58": { "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "longName": "999047 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "shortName": "Commitments and Contingencies - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:OtherCommitment", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": null }, "R59": { "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "longName": "999048 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details)", "shortName": "Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:OtherCommitment", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_SlrCreditSolutionsMemberdeiLegalEntityAxis_UnfundedDebtAndEquityCommitmentsMemberusgaapOtherCommitmentsAxis", "name": "us-gaap:OtherCommitment", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R60": { "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "longName": "999049 - Disclosure - Capital Share Transactions - Additional Information (Details)", "shortName": "Capital Share Transactions - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2022", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "div", "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R61": { "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "longName": "999050 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details)", "shortName": "Capital Share Transactions - Summary of Transactions In Capital Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:StockRepurchasedDuringPeriodShares", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:InvestmentCompanyIncreaseDecreaseFromShareTransaction", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R62": { "role": "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails", "longName": "999051 - Disclosure - Stock Repurchase Program - Additional Information (Details)", "shortName": "Stock Repurchase Program - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "PAsOn05_09_2023", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn05_09_2023", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails", "longName": "999052 - Disclosure - SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details)", "shortName": "SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:InvestmentOwnedAtCost", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023_AegisToxicologySciencesCorporationMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_HealthcareSectorMemberusgaapEquitySecuritiesByIndustryAxis_SlrSeniorLendingProgramLlcMemberdeiLegalEntityAxis", "name": "slrc:InvestmentsOwnedSpreadAboveIndexRate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R64": { "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "longName": "999053 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Details)", "shortName": "SLR Senior Lending Program LLC - Summary financial information for SSLP (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2022_SlrSeniorLendingProgramLlcMemberdeiLegalEntityAxis", "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R65": { "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails", "longName": "999054 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details)", "shortName": "SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:InvestmentOwnedAtCost", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": null }, "R66": { "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "longName": "999055 - Disclosure - SLR Senior Lending Program LLC - Additional Information (Details)", "shortName": "SLR Senior Lending Program LLC - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:OtherCommitment", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_SlrSeniorLendingProgramLlcMemberdeiLegalEntityAxis", "name": "us-gaap:OtherOwnershipInterestsValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "unique": true } }, "R67": { "role": "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails", "longName": "999056 - Disclosure - Subsequent Events - Additional Information (Details)", "shortName": "Subsequent Events - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "PAsOn11_07_2023_BoardMembersrtTitleOfIndividualAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "name": "us-gaap:DividendsPayableAmountPerShare", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn11_07_2023_BoardMembersrtTitleOfIndividualAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "name": "us-gaap:DividendsPayableAmountPerShare", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d458881d10q.htm", "first": true, "unique": true } } }, "tag": { "slrc_OrthopedicCarePartnersManagementLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "OrthopedicCarePartnersManagementLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Orthopedic Care Partners Management, LLC [Member]", "documentation": "Orthopedic care partners management, LLC." } } }, "auth_ref": [] }, "slrc_MediaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MediaMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Media [Member]", "documentation": "Media member." } } }, "auth_ref": [] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r803" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "slrc_WorldInsuranceAssociatesLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "WorldInsuranceAssociatesLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "World Insurance Associates LLC [Member]", "terseLabel": "World Insurance Associates, LLC [Member]", "documentation": "World Insurance associates LLC." } } }, "auth_ref": [] }, "slrc_DeepintentInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "DeepintentInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "DeepIntent, Inc. [Member]", "documentation": "DeepIntent, inc." } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "terseLabel": "Long term debt unamortized debt issuance costs", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r49", "r895" ] }, "slrc_AmericanTeleconferencingServicesLtd.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AmericanTeleconferencingServicesLtd.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "American Teleconferencing Services, Ltd. [Member]", "terseLabel": "American Teleconferencing Services, Ltd [Member]", "documentation": "American teleconferencing services, ltd." } } }, "auth_ref": [] }, "slrc_FastPayPartnersLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "FastPayPartnersLlcMember", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fast Pay Partners LLC [Member]", "terseLabel": "Fast Pay Partners LLC [Member]", "documentation": "Fast Pay Partners LLC [Member]." } } }, "auth_ref": [] }, "slrc_MauricesIncorporatedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MauricesIncorporatedMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Maurices, Incorporated [Member]", "terseLabel": "Maurices, Incorporated [Member]", "documentation": "Maurices, incorporated." } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Nonconsolidated Investee [Axis]", "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity." } } }, "auth_ref": [ "r113", "r133", "r212", "r358" ] }, "slrc_NmHoldcoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NmHoldcoMember", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "NM Holdco [Member]", "terseLabel": "NM Holdco [Member]", "documentation": "NM Holdco [Member]." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument variable interest rate spread", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Nonconsolidated Investee [Domain]", "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity." } } }, "auth_ref": [ "r113", "r133", "r212", "r358" ] }, "slrc_GlookoInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "GlookoInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Glooko, Inc. [Member]", "terseLabel": "Glooko, Inc. [Member]", "documentation": "Glooko, inc." } } }, "auth_ref": [] }, "slrc_HumanInterestIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "HumanInterestIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Human Interest Inc [Member]", "terseLabel": "Human Interest, Inc. [Member]", "documentation": "Human interest Inc." } } }, "auth_ref": [] }, "slrc_SouthernOrthodonticPartnersManagementLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SouthernOrthodonticPartnersManagementLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Southern Orthodontic Partners Management LLC [Member]", "terseLabel": "Southern Orthodontic Partners Management, LLC [Member]", "documentation": "Southern Orthodontic Partners Management LLC." } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "documentation": "Information by title of individual or nature of relationship to individual or group of individuals." } } }, "auth_ref": [ "r877", "r906" ] }, "slrc_NacHoldingsCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NacHoldingsCorporationMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "NAC Holdings Corporation [Member]", "terseLabel": "NAC Holdings Corporation [Member]", "documentation": "NAC Holdings Corporation" } } }, "auth_ref": [] }, "slrc_UrologyManagementHoldingsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "UrologyManagementHoldingsIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Urology Management Holdings, Inc [Member]", "terseLabel": "Urology Management Holdings, Inc. [Member]", "documentation": "Urology Management Holdings, Inc Member." } } }, "auth_ref": [] }, "slrc_VesscoMidcoHoldingsLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "VesscoMidcoHoldingsLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Vessco Midco Holdings LLC [Member]", "terseLabel": "Vessco Midco Holdings, LLC [Member]", "documentation": "Vessco midco holdings LLC." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings", "terseLabel": "Net change in unrealized gain (loss)", "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r351" ] }, "slrc_ApeelTechnologyIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ApeelTechnologyIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Apeel Technology Inc [Member]", "terseLabel": "Apeel Technology, Inc. [Member]", "documentation": "Apeel technology Inc." } } }, "auth_ref": [] }, "us-gaap_OtherOwnershipInterestsValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOwnershipInterestsValue", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Ownership Interests, Contributed Capital", "terseLabel": "Other Ownership Interests, Contributed Capital", "documentation": "The amount of capital contributed by other unit holders." } } }, "auth_ref": [ "r38" ] }, "cef_LatestSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LatestSharePrice", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Latest Share Price (Deprecated 2023-01-31)" } } }, "auth_ref": [ "r783" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgram" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stock Repurchase Program", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r81", "r132", "r268", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r283", "r341", "r549", "r550", "r646" ] }, "slrc_OneTouchDirectLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "OneTouchDirectLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "One Touch Direct, LLC [Member]", "terseLabel": "One Touch Direct, LLC [Member]", "documentation": "One touch direct, llc." } } }, "auth_ref": [] }, "slrc_BaymarkHealthServicesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BaymarkHealthServicesIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "BayMark Health Services Inc [Member]", "terseLabel": "BayMark Health Services, Inc. [Member]", "documentation": "BayMark health services, Inc." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r806" ] }, "slrc_AtriaWealthSolutionsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AtriaWealthSolutionsIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Atria Wealth Solutions, Inc [Member]", "terseLabel": "Atria Wealth Solutions, Inc. [Member]", "documentation": "Atria wealth solutions, inc." } } }, "auth_ref": [] }, "srt_ScheduleOfCondensedFinancialStatementsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfCondensedFinancialStatementsTable", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Condensed Financial Statements [Table]", "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows." } } }, "auth_ref": [ "r108", "r109", "r110", "r111", "r134", "r853" ] }, "slrc_GrossIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "GrossIncome", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Gross Income", "terseLabel": "Gross income", "documentation": "Gross income." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r814" ] }, "slrc_HotelsRestaurantsAndLeisureMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "HotelsRestaurantsAndLeisureMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Hotels, Restaurants and Leisure [Member]", "documentation": "Hotels, restaurants and leisure member." } } }, "auth_ref": [] }, "dei_InvestmentCompanyActFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyActFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Company Act File Number" } } }, "auth_ref": [ "r718", "r785", "r786", "r787" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,554,634 and 54,555,380 shares issued and outstanding, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r63", "r424", "r671" ] }, "slrc_LineOfCreditFacilityCommitmentsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LineOfCreditFacilityCommitmentsAmount", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line Of Credit Facility Commitments Amount", "terseLabel": "Line of credit facility commitments amount", "documentation": "Line Of Credit Facility Commitments Amount" } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsTable", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Table]", "documentation": "Disclosure of information about obligations resulting from other commitments." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r365", "r373" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares, outstanding", "verboseLabel": "Shares outstanding, end of period", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r10", "r63", "r502", "r522", "r935", "r937" ] }, "slrc_SlrEquipmentFinanceDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrEquipmentFinanceDebtMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "SLR Equipment Finance Debt [Member]", "documentation": "SLR Equipment Finance Debt." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r813" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Computation of Basic And Diluted Net", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r876" ] }, "slrc_NumberOfFundedCommitment": { "xbrltype": "integerItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NumberOfFundedCommitment", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number Of Funded Commitment", "terseLabel": "Number of funded commitments", "documentation": "Number of funded commitment." } } }, "auth_ref": [] }, "slrc_SlrCreditSolutionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrCreditSolutionsMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "SLR Credit Solutions [Member]", "documentation": "Slr credit solutions." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r365", "r373" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r365", "r373" ] }, "srt_CondensedFinancialStatementsCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedFinancialStatementsCaptionsLineItems", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Condensed Financial Statements, Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r108", "r109", "r110", "r111", "r134", "r853" ] }, "slrc_NumberOfIssuerInBusinessCredit": { "xbrltype": "integerItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NumberOfIssuerInBusinessCredit", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number Of Issuer In Business Credit", "terseLabel": "Number of issuers in business credit", "documentation": "Number of issuer in business credit." } } }, "auth_ref": [] }, "slrc_BridgeBioPharmaIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BridgeBioPharmaIncMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Bridge Bio Pharma, Inc [Member]", "documentation": "Bridge Bio Pharma, Inc member." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r21", "r34" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "terseLabel": "Total liabilities and members' equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r66", "r93", "r426", "r671", "r871", "r887", "r902" ] }, "slrc_SunsSpvLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SunsSpvLlcMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SPV LLC [Member]", "documentation": "Suns SPV LLC." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r365", "r373" ] }, "slrc_BaysideParentLlcEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BaysideParentLlcEquityMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Bayside Parent, LLC (equity) [Member]", "verboseLabel": "Bayside Parent, LLC (equity) [Member]" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r696", "r708", "r789", "r816" ] }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDebtNetOfIssuanceCosts", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Debt, Net of Issuance Costs", "verboseLabel": "Proceeds from net debt", "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination." } } }, "auth_ref": [ "r126" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 25.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Other liabilities and accrued expenses", "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other." } } }, "auth_ref": [ "r868" ] }, "slrc_TermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TermLoanMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Term Loan [Member]", "documentation": "Term loan." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsTableTextBlock", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Table Text Block]", "terseLabel": "Summary of unfunded debt and equity commitments", "documentation": "Tabular disclosure of information about obligations resulting from other commitments." } } }, "auth_ref": [] }, "slrc_ASCHoldcoLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ASCHoldcoLLCMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "ASC Holdco LLC [Member]", "verboseLabel": "ASC Holdco LLC [Member]", "documentation": "ASC Holdco, LLC" } } }, "auth_ref": [] }, "slrc_WaterUtilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "WaterUtilitiesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Water Utilities [Member]", "terseLabel": "Water Utilities [Member]", "documentation": "Water utilities." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsDomain", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Domain]", "documentation": "Other future obligation." } } }, "auth_ref": [] }, "slrc_LineOfCreditMaximumBorrowingCapacityAndDebtInstrumentFaceValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LineOfCreditMaximumBorrowingCapacityAndDebtInstrumentFaceValue", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line Of Credit Maximum Borrowing Capacity And Debt Instrument Face Value", "terseLabel": "Line of credit maximum borrowing capacity and debt instrument face value", "documentation": "Line of credit maximum borrowing capacity and debt instrument face value." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsAxis", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Axis]", "documentation": "Information by type of other commitment." } } }, "auth_ref": [] }, "slrc_LongTermDebtMaximumAmountBorrowedDuringThePeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LongTermDebtMaximumAmountBorrowedDuringThePeriod", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long Term Debt Maximum Amount Borrowed During The Period", "terseLabel": "Long term debt maximum amount borrowed during the period", "documentation": "Long term debt maximum amount borrowed during the period." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases", "terseLabel": "Purchase of investment securities", "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r45" ] }, "slrc_SlramiTopcoBlockerLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlramiTopcoBlockerLlcMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "SLRAMI Topco Blocker, LLC [Member]", "documentation": "SLR-AMI topco blocker, LLC." } } }, "auth_ref": [] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r814" ] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Investments [Domain]", "documentation": "Asset obtained to generate income or appreciate in value." } } }, "auth_ref": [ "r477", "r479", "r480", "r483", "r487", "r552", "r561", "r576", "r584", "r597", "r606", "r607", "r633", "r637", "r638", "r639", "r640", "r675" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales", "terseLabel": "Proceeds from dispositions of investment securities", "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r45" ] }, "slrc_LineOfCreditFacilityIncrease": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LineOfCreditFacilityIncrease", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line Of Credit Facility Increase", "terseLabel": "Line of credit facility increase", "documentation": "Line of credit facility increase." } } }, "auth_ref": [] }, "slrc_BaysideOpcoLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BaysideOpcoLLCMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Bayside Opco LLC [Member]", "verboseLabel": "Bayside Opco LLC [Member]", "terseLabel": "Bayside Opco, LLC [Member]", "documentation": "Bayside Opco, LLC." } } }, "auth_ref": [] }, "slrc_AmerimarkIntermediateHoldingsLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AmerimarkIntermediateHoldingsLlcMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "AmeriMark Intermediate Holdings, LLC [Member]", "verboseLabel": "AmeriMark Intermediate Holdings LLC [Member]", "documentation": "Ameri mark intermediate holdings, llc" } } }, "auth_ref": [] }, "cef_LowestPriceOrBidNav": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LowestPriceOrBidNav", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, NAV" } } }, "auth_ref": [ "r781" ] }, "slrc_AmendmentAgreementToIncreaseCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AmendmentAgreementToIncreaseCreditFacilityMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Amendment Agreement To Increase Credit Facility [Member]", "terseLabel": "Amendment Agreement to Increase Credit Facility [Member]", "documentation": "Amendment agreement to increase credit facility." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsLineItems", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r801" ] }, "slrc_LineOfCreditFacilityCommitmentExpired": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LineOfCreditFacilityCommitmentExpired", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line Of Credit Facility Commitment Expired", "terseLabel": "Line of credit facility commitment expired", "documentation": "Line of credit facility commitment expired." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r814" ] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Cash", "terseLabel": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r100", "r423", "r474", "r510", "r671", "r687", "r862" ] }, "slrc_CreditFacilityCommitmentExpiredMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CreditFacilityCommitmentExpiredMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility Commitment Expired [Member]", "documentation": "Credit facility commitment expired." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r690" ] }, "slrc_PortfolioTurnoverRatio": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PortfolioTurnoverRatio", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Portfolio Turnover Ratio", "terseLabel": "Portfolio turnover ratio", "documentation": "Portfolio turnover ratio." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r690" ] }, "slrc_RdHoldcoIncCommonEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "RdHoldcoIncCommonEquityMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "RD Holdco Inc Common Equity [Member]", "documentation": "RD Holdco Inc Common Equity." } } }, "auth_ref": [] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r814" ] }, "slrc_KingsbridgeHoldingsLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "KingsbridgeHoldingsLlcMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Kingsbridge Holdings, LLC [Member]", "terseLabel": "Kingsbridge Holdings, LLC [Member]", "documentation": "Kingsbridge Holdings, LLC." } } }, "auth_ref": [] }, "slrc_ContainersAndPackagingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ContainersAndPackagingMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Containers and Packaging [Member]", "documentation": "Containers and packaging member." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r705", "r714", "r795", "r814", "r822", "r826", "r834" ] }, "slrc_PerShareDataAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PerShareDataAbstract", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Per Share Data [Abstract]", "terseLabel": "Per Share Data:", "documentation": "Per share data." } } }, "auth_ref": [] }, "slrc_LoyerCapitalLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LoyerCapitalLlcMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Loyer Capital LLC [Member]", "documentation": "Loyer capital llc." } } }, "auth_ref": [] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r705", "r714", "r795", "r814", "r822", "r826", "r834" ] }, "slrc_FairValueOfCommonStockPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "FairValueOfCommonStockPerShare", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Of Common Stock Per Share", "definitionGuidance": "Per share market value, end of period", "verboseLabel": "Fair value of common stock per share", "documentation": "Fair value of common stock per share." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "presentationGuidance": "Net income (loss)", "verboseLabel": "Net income", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r67", "r77", "r94", "r113", "r119", "r120", "r123", "r133", "r138", "r140", "r141", "r142", "r143", "r146", "r147", "r153", "r166", "r170", "r172", "r174", "r212", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r344", "r358", "r428", "r525", "r543", "r544", "r653", "r685", "r892" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r695", "r707", "r788", "r815" ] }, "slrc_InvestmentCompanyInterestAndOtherCreditFacilityExpensesRatioAfterIncentiveAllocation": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentCompanyInterestAndOtherCreditFacilityExpensesRatioAfterIncentiveAllocation", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company Interest And Other Credit Facility Expenses Ratio After Incentive Allocation", "terseLabel": "Interest and other credit facility expenses", "documentation": "Investment company interest and other credit facility expenses ratio after incentive allocation." } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrentAndNoncurrent", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense", "terseLabel": "Prepaid Expense", "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs." } } }, "auth_ref": [ "r52", "r118", "r515", "r916" ] }, "slrc_SlrHealthcareAblMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrHealthcareAblMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SLR Healthcare ABL [Member]", "terseLabel": "SLR Healthcare ABL [Member]", "documentation": "SLR healthcare ABL." } } }, "auth_ref": [] }, "slrc_IssuanceOfCommonStockInConnectionWithTheMerger": { "xbrltype": "perShareItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IssuanceOfCommonStockInConnectionWithTheMerger", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Issuance of Common Stock in Connection With the Merger", "terseLabel": "Issuance of common stock in connection with the Merger", "documentation": "Issuance of common stock in connection with the merger." } } }, "auth_ref": [] }, "us-gaap_NetInvestmentIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentIncome", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Net Investment Income", "totalLabel": "Net investment income", "terseLabel": "Net investment income (loss)", "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments." } } }, "auth_ref": [ "r101", "r431", "r432", "r530", "r685" ] }, "slrc_InvestmentCompanyOperatingExpensesRatioAfterIncentiveAllocation": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentCompanyOperatingExpensesRatioAfterIncentiveAllocation", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company Operating Expenses Ratio After Incentive Allocation", "terseLabel": "Operating expenses", "documentation": "Investment company operating expenses ratio after incentive allocation." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "lang": { "en-us": { "role": { "label": "Earnings (loss) Per Share, Diluted", "terseLabel": "Earnings per share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r125", "r140", "r141", "r142", "r143", "r144", "r151", "r154", "r155", "r156", "r160", "r343", "r344", "r419", "r433", "r651" ] }, "cef_HighestPriceOrBid": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "HighestPriceOrBid", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid" } } }, "auth_ref": [ "r777" ] }, "slrc_InvestmentCompanyOperatingExpenseRatioExcludingIncentiveFee": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentCompanyOperatingExpenseRatioExcludingIncentiveFee", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company Operating Expense Ratio Excluding Incentive Fee", "documentation": "Investment company operating expense ratio excluding incentive fee." } } }, "auth_ref": [] }, "slrc_SlrEquipmentFinanceEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrEquipmentFinanceEquityMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "SLR Equipment Finance Equity [Member]", "documentation": "SLR Equipment Finance Equity." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Property Subject to or Available for Operating Lease, Number of Units", "terseLabel": "Number of funded equipment-backed leases and loans", "documentation": "The number of units (items of property) under operating lease arrangements." } } }, "auth_ref": [ "r889", "r903" ] }, "slrc_CrystalCapitalFinancialHoldingsLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CrystalCapitalFinancialHoldingsLlcMember", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Crystal Capital Financial Holdings LLC [Member]", "documentation": "Crystal capital financial holdings LLC." } } }, "auth_ref": [] }, "slrc_CrystalFinancialMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CrystalFinancialMember", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Crystal Financial [Member]", "terseLabel": "Crystal Financial [Member]", "documentation": "Crystal Financial(Member)" } } }, "auth_ref": [] }, "us-gaap_DerivativeMaturityDates": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeMaturityDates", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Maturity Date", "verboseLabel": "Maturity Date", "documentation": "Date derivative contract ends, in YYYY-MM-DD format." } } }, "auth_ref": [ "r488", "r489", "r601", "r602", "r603", "r604", "r605", "r675" ] }, "slrc_OmniGuideHoldingsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "OmniGuideHoldingsIncMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Omni Guide Holdings, Inc [Member]", "documentation": "Omni Guide Holdings, Inc member." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Paid-in capital in excess of par", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r64" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r695", "r707", "r788", "r815" ] }, "cef_BdcFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "BdcFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "BDC File Number" } } }, "auth_ref": [] }, "us-gaap_StockRepurchaseProgramExpirationDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramExpirationDate", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Repurchase Program Expiration Date", "terseLabel": "Stock repurchase program expiration date", "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format." } } }, "auth_ref": [] }, "slrc_NumberOfLoanInBusinessCredit": { "xbrltype": "integerItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NumberOfLoanInBusinessCredit", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number Of Loan In Business Credit", "terseLabel": "Number of loans in business credit", "documentation": "Number of Loan in business credit." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "slrc_VapothermInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "VapothermInc.Member", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Vapotherm, Inc. [Member]", "documentation": "Vapotherm, inc." } } }, "auth_ref": [] }, "slrc_PreferredEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PreferredEquityMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Equity [Member]", "terseLabel": "Preferred Equity [Member]", "documentation": "Preferred equity." } } }, "auth_ref": [] }, "slrc_InvestmentInSeniorSecuredLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentInSeniorSecuredLoansMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Investment in Senior Secured Loans [Member]", "terseLabel": "Senior Secured Loans [Member]", "documentation": "Investment in senior secured loans." } } }, "auth_ref": [] }, "slrc_BaysideParentLlcLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BaysideParentLlcLoanMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Bayside Parent, LLC (loan) [Member]", "verboseLabel": "Bayside Parent, LLC (loan) [Member]" } } }, "auth_ref": [] }, "slrc_IcimsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IcimsIncMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "ICIMS, Inc [Member]", "terseLabel": "ICIMS, Inc [Member]", "documentation": "ICIMS, inc." } } }, "auth_ref": [] }, "us-gaap_InvestmentInterestRateFloor": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentInterestRateFloor", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Investment, Interest Rate, Floor", "terseLabel": "Floor", "documentation": "Minimum rate of interest on investment." } } }, "auth_ref": [ "r942", "r944", "r946", "r948" ] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued, price per share", "verboseLabel": "Shares Issued, Price Per Share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "terseLabel": "Transfers in/out of Level\u00a03", "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy." } } }, "auth_ref": [] }, "slrc_EquipmentFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EquipmentFinancingMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Equipment Financing [Member]", "terseLabel": "Equipment Financing [Member]", "documentation": "Equipment financing." } } }, "auth_ref": [] }, "slrc_SeniorSecuredRevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SeniorSecuredRevolvingCreditFacilityMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Senior Secured Revolving Credit Facility [Member]", "verboseLabel": "Senior Secured Revolving Credit Facility [Member]", "documentation": "senior secured revolving credit facility member." } } }, "auth_ref": [] }, "slrc_AmeriMarkIntermediateHoldingsOneLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AmeriMarkIntermediateHoldingsOneLLCMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "AmeriMark Intermediate Holdings One LLC [Member]", "verboseLabel": "AmeriMark Intermediate Holdings LLC [Member]" } } }, "auth_ref": [] }, "slrc_BoardMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BoardMember", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Board [Member]", "terseLabel": "Board [Member]", "documentation": "Board [Member]." } } }, "auth_ref": [] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "dei_DividendOrInterestReinvestmentPlanOnly": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DividendOrInterestReinvestmentPlanOnly", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dividend or Interest Reinvestment Plan Only" } } }, "auth_ref": [ "r717", "r718", "r798" ] }, "dei_DelayedOrContinuousOffering": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DelayedOrContinuousOffering", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Delayed or Continuous Offering" } } }, "auth_ref": [ "r717", "r718", "r798" ] }, "slrc_SpreadDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SpreadDomain", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Spread [Domain]" } } }, "auth_ref": [] }, "dei_EffectiveUponFiling462e": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveUponFiling462e", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective Upon Filing, 462(e)" } } }, "auth_ref": [ "r846" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par or stated value per share", "verboseLabel": "Par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r63" ] }, "slrc_SpreadAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SpreadAxis", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Spread [Axis]" } } }, "auth_ref": [] }, "slrc_IncreaseDecreaseInNetAssetsFromOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IncreaseDecreaseInNetAssetsFromOperation", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Net Assets From Operation", "terseLabel": "Numerator - net increase in net assets resulting from operations:", "documentation": "Increase decrease in net assets from operation." } } }, "auth_ref": [] }, "slrc_SlrSeniorLendingProgramSpvLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrSeniorLendingProgramSpvLlcMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SLR Senior Lending Program SPV LLC [Member]", "terseLabel": "SLR Senior Lending Program SPV LLC [Member]", "documentation": "SLR Senior Lending Program SPV LLC member." } } }, "auth_ref": [] }, "slrc_SpreadOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SpreadOneMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Spread One [Member]" } } }, "auth_ref": [] }, "slrc_InterestPayableAndOtherCreditFacilityRelatedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InterestPayableAndOtherCreditFacilityRelatedExpenses", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Interest payable and other credit facility related expenses", "terseLabel": "Interest payable and other credit facility related expenses", "documentation": "Interest payable and other credit facility related expenses." } } }, "auth_ref": [] }, "slrc_PercentageOfPreIncentiveFeeNetInvestmentIncome": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageOfPreIncentiveFeeNetInvestmentIncome", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage of Pre Incentive Fee Net Investment Income", "terseLabel": "Percentage of pre-incentive fee net investment income", "documentation": "Percentage of pre-incentive fee net investment income." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInterestPayableNet", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Interest payable", "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity." } } }, "auth_ref": [ "r5" ] }, "dei_AdditionalSecuritiesEffective413b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdditionalSecuritiesEffective413b", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Additional Securities Effective, 413(b)" } } }, "auth_ref": [ "r842" ] }, "slrc_CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Companies More Than Five Percentage Less Than Twenty Five Percentage Owned [Member]", "terseLabel": "Companies more than 5% less than 25% owned [Member]", "documentation": "Companies more than five percentage less than twenty five percentage owned." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r284", "r292", "r315", "r316", "r317", "r381", "r405", "r435", "r488", "r489", "r555", "r574", "r580", "r581", "r617", "r649", "r650", "r654", "r662", "r668", "r672", "r675", "r890", "r894", "r911", "r912", "r913", "r914", "r915" ] }, "us-gaap_InvestmentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentMaturityDate", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Investment Maturity Date", "terseLabel": "Maturity Date", "documentation": "Maturity date of investment, in YYYY-MM-DD format." } } }, "auth_ref": [ "r555", "r556", "r574", "r575", "r579", "r580", "r617", "r618", "r675", "r879", "r881" ] }, "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedInterestReceivableNet", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accrued Interest Receivable, Net", "negatedLabel": "Interest receivable", "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments." } } }, "auth_ref": [ "r5" ] }, "slrc_OutsetMedicalInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "OutsetMedicalInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Outset Medical, Inc. [Member]", "documentation": "Outset medical, inc." } } }, "auth_ref": [] }, "slrc_ItServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ItServicesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "IT Services [Member]", "documentation": "IT services member." } } }, "auth_ref": [] }, "dei_EffectiveWhenDeclaredSection8c": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveWhenDeclaredSection8c", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective when Declared, Section 8(c)" } } }, "auth_ref": [ "r850" ] }, "slrc_PercentageOfExciseTax": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageOfExciseTax", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Of Excise Tax", "terseLabel": "Percentage of excise tax", "documentation": "Percentage of excise tax." } } }, "auth_ref": [] }, "dei_EffectiveUponFiling486b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveUponFiling486b", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective upon Filing, 486(b)" } } }, "auth_ref": [ "r848" ] }, "slrc_ConsumerFinanceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ConsumerFinanceMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Consumer Finance [Member]", "documentation": "Consumer finance member." } } }, "auth_ref": [] }, "slrc_SparMarketingForceInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SparMarketingForceInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "SPAR Marketing Force, Inc. [Member]", "documentation": "SPAR marketing force, Inc." } } }, "auth_ref": [] }, "slrc_RestrictedInvestmentTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "RestrictedInvestmentTerm", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Investment Term", "terseLabel": "Restricted investment term", "documentation": "Restricted investment term." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r292", "r405", "r435", "r488", "r489", "r555", "r574", "r580", "r581", "r617", "r649", "r650", "r654", "r662", "r668", "r672", "r894", "r910", "r911", "r912", "r913", "r914", "r915" ] }, "dei_EffectiveOnSetDate486b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnSetDate486b", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(b)" } } }, "auth_ref": [ "r848" ] }, "slrc_InvestmentsOwnedIndustryName": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentsOwnedIndustryName", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Investments Owned Industry Name", "terseLabel": "Industry", "documentation": "Investments owned industry name." } } }, "auth_ref": [] }, "slrc_BdgMediaInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BdgMediaInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "BDG Media, Inc. [Member]", "documentation": "BDG media, Inc." } } }, "auth_ref": [] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r284", "r292", "r315", "r316", "r317", "r381", "r405", "r435", "r488", "r489", "r555", "r574", "r580", "r581", "r617", "r649", "r650", "r654", "r662", "r668", "r672", "r675", "r890", "r894", "r911", "r912", "r913", "r914", "r915" ] }, "slrc_SpectrumPharmaceuticalsInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SpectrumPharmaceuticalsInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Spectrum Pharmaceuticals, Inc. [Member]", "documentation": "Spectrum pharmaceuticals, Inc." } } }, "auth_ref": [] }, "slrc_AgreementAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AgreementAxis", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Agreement [Axis]", "documentation": "Agreement Axis" } } }, "auth_ref": [] }, "slrc_EnergyEquipmentAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EnergyEquipmentAndServicesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Energy Equipment and Services [Member]", "documentation": "Energy equipment and services member." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r292", "r405", "r435", "r488", "r489", "r555", "r574", "r580", "r581", "r617", "r649", "r650", "r654", "r662", "r668", "r672", "r894", "r910", "r911", "r912", "r913", "r914", "r915" ] }, "slrc_AgreementsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AgreementsTable", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Agreements [Table]", "documentation": "Agreements [Table]" } } }, "auth_ref": [] }, "dei_EffectiveOnDate486b": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnDate486b", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(b)" } } }, "auth_ref": [ "r848" ] }, "slrc_ArdelyxIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ArdelyxIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Ardelyx Inc [Member]", "terseLabel": "Ardelyx, Inc. [Member]", "documentation": "Ardelyx Inc." } } }, "auth_ref": [] }, "slrc_InvestmentsOwnedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentsOwnedInterestRate", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Investments Owned Interest Rate", "terseLabel": "Interest Rate", "documentation": "Investments owned interest rate." } } }, "auth_ref": [] }, "slrc_AgreementDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AgreementDomain", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Agreement [Domain]", "documentation": "Agreement Domain" } } }, "auth_ref": [] }, "slrc_OnsMsoLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "OnsMsoLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "ONS MSO, LLC [Member]", "terseLabel": "ONS MSO, LLC [Member]", "documentation": "ONS MSO, LLC Member." } } }, "auth_ref": [] }, "slrc_AdvisoryAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AdvisoryAgreementMember", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Advisory Agreement [Member]", "terseLabel": "Advisory Agreement [Member]", "documentation": "Advisory Agreement (Member)" } } }, "auth_ref": [] }, "dei_EffectiveAfter60Days486a": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveAfter60Days486a", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective after 60 Days, 486(a)" } } }, "auth_ref": [ "r847" ] }, "slrc_InvestmentOwnedAcquisitionDate": { "xbrltype": "dateItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentOwnedAcquisitionDate", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Investment Owned Acquisition Date", "terseLabel": "Acquisition Date", "documentation": "Investment owned acquisition date." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Assets [Abstract]", "terseLabel": "(Increase) decrease in operating assets:" } } }, "auth_ref": [] }, "slrc_InvestmentCompanyPercentageOfHolding": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentCompanyPercentageOfHolding", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Investment Company Percentage of Holding", "verboseLabel": "Investment company percentage of holding", "documentation": "Investment company percentage of holding." } } }, "auth_ref": [] }, "slrc_PercentageRepresentingLiabilitiesInExcessOfOtherAssetsInInvestmentsOwned": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageRepresentingLiabilitiesInExcessOfOtherAssetsInInvestmentsOwned", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Representing Liabilities in Excess of Other Assets in Investments Owned", "terseLabel": "Percentage representing liabilities in excess of other assets in investments owned", "documentation": "Percentage representing liabilities in excess of other assets in investments owned." } } }, "auth_ref": [] }, "slrc_SharesIssuedInConnectionWithTheMergersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SharesIssuedInConnectionWithTheMergersMember", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails" ], "lang": { "en-us": { "role": { "label": "Shares Issued In Connection With The Mergers [Member]", "terseLabel": "Shares issued in connection with the Mergers [Member]", "documentation": "Shares issued in connection with the mergers." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Liabilities [Abstract]", "terseLabel": "Increase (decrease) in operating liabilities:" } } }, "auth_ref": [] }, "dei_EffectiveOnSetDate486a": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnSetDate486a", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(a)" } } }, "auth_ref": [ "r847" ] }, "slrc_UnfundedDebtAndEquityCommitmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "UnfundedDebtAndEquityCommitmentsMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Unfunded Debt and Equity Commitments [Member]", "terseLabel": "Unfunded Debt and Equity Commitments [Member]", "verboseLabel": "Unfunded Debt and Equity Commitments [Member]", "documentation": "Unfunded Debt and Equity Commitments [Member]" } } }, "auth_ref": [] }, "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables" ], "lang": { "en-us": { "role": { "label": "Condensed Financial Statements [Table Text Block]", "terseLabel": "Summary financial information for SSLP", "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows." } } }, "auth_ref": [ "r861", "r872" ] }, "slrc_PercentageRepresentingCashEquivalentsInInvestmentsOwned": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageRepresentingCashEquivalentsInInvestmentsOwned", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Representing Cash Equivalents in Investments Owned", "terseLabel": "Percentage representing cash equivalents in investments owned", "documentation": "Percentage representing cash equivalents in investments owned." } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r253", "r285", "r290", "r347", "r378", "r663", "r664", "r665" ] }, "slrc_AgreementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AgreementLineItems", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Agreement [Line Items]", "documentation": "Agreement [Line item]" } } }, "auth_ref": [] }, "slrc_InvestmentsOwnedSpreadAboveIndexRate": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentsOwnedSpreadAboveIndexRate", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Investments Owned Spread Above Index Rate", "verboseLabel": "Spread Above Index", "documentation": "Investments owned Spread above index rate." } } }, "auth_ref": [] }, "slrc_PercentageSpreadAsCash": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageSpreadAsCash", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Spread as Cash", "terseLabel": "Percentage spread as cash", "documentation": "Percentage spread as cash." } } }, "auth_ref": [] }, "slrc_KidDistroHoldingsLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "KidDistroHoldingsLlcMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Kid Distro Holdings, LLC [Member]", "terseLabel": "Kid Distro Holdings, LLC [Member]", "documentation": "Kid distro holdings, LLC." } } }, "auth_ref": [] }, "dei_EffectiveOnDate486a": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnDate486a", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(a)" } } }, "auth_ref": [ "r847" ] }, "slrc_PercentageOfNonQualifyingAssetsInThePortfolioOfTotalAssets": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageOfNonQualifyingAssetsInThePortfolioOfTotalAssets", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage of Non Qualifying Assets in the Portfolio of Total Assets", "terseLabel": "Percentage of non-qualifying\u00a0assets in the portfolio of total assets", "documentation": "Percentage of non qualifying\u00a0assets in the portfolio of total assets." } } }, "auth_ref": [] }, "slrc_InvestmentOwnedUnrecognizedUnrealizedReductions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentOwnedUnrecognizedUnrealizedReductions", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Unrecognized Unrealized Reductions", "negatedLabel": "Gross Reductions", "documentation": "Investment owned, unrecognized unrealized reductions." } } }, "auth_ref": [] }, "slrc_PercentageOfGrossAssets": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageOfGrossAssets", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Of Gross Assets", "terseLabel": "Percentage of gross assets", "documentation": "Percentage of gross assets." } } }, "auth_ref": [] }, "slrc_InvestmentOwnedUnrecognizedUnrealizedAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentOwnedUnrecognizedUnrealizedAdditions", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Unrecognized Unrealized Additions", "terseLabel": "Gross Additions", "documentation": "Investment owned, unrecognized unrealized additions." } } }, "auth_ref": [] }, "slrc_PercentageSpreadAsPaidInKind": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageSpreadAsPaidInKind", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Spread as Paid in Kind", "terseLabel": "Percentage spread as paid in kind", "documentation": "Percentage spread as paid in kind ." } } }, "auth_ref": [] }, "slrc_PhynetDermatologyLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PhynetDermatologyLlcMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "PhyNet Dermatology LLC [Member]", "terseLabel": "PhyNet Dermatology LLC [Member]", "documentation": "Phynet dermatology llc." } } }, "auth_ref": [] }, "dei_NewEffectiveDateForPreviousFiling": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NewEffectiveDateForPreviousFiling", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "New Effective Date for Previous Filing" } } }, "auth_ref": [ "r718", "r785", "r786", "r787" ] }, "slrc_InvestmentOwnedUnrecognizedUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentOwnedUnrecognizedUnrealizedGainLoss", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Unrecognized Unrealized Gain Loss", "negatedLabel": "Net change in unrealized gain (loss)", "documentation": "Investment owned, unrecognized unrealized gain loss." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireInvestments", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Investments", "terseLabel": "Payments to acquire investments", "verboseLabel": "Payments to Acquire Investments", "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period." } } }, "auth_ref": [ "r74" ] }, "dei_AdditionalSecurities462bFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdditionalSecurities462bFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Additional Securities, 462(b), File Number" } } }, "auth_ref": [ "r843" ] }, "slrc_InvestmentOwnedUnrecognizedRealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentOwnedUnrecognizedRealizedGainLoss", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Unrecognized Realized Gain Loss", "negatedLabel": "Net realized gain (loss)", "documentation": "Investment owned, unrecognized realized gain loss." } } }, "auth_ref": [] }, "slrc_PerformanceBasedIncentiveFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PerformanceBasedIncentiveFees", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Performance Based Incentive Fees", "terseLabel": "Performance based incentive fees", "documentation": "Performance Based Incentive Fees" } } }, "auth_ref": [] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "auth_ref": [] }, "slrc_InvestmentOwnedInterestAndDividendIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentOwnedInterestAndDividendIncome", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Interest And Dividend Income", "negatedLabel": "Interest/Dividend Income", "documentation": "Investment owned, interest and dividend income." } } }, "auth_ref": [] }, "slrc_AlkemeIntermediaryHoldingsLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AlkemeIntermediaryHoldingsLlcMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Alkeme Intermediary Holdings, LLC [Member]", "terseLabel": "Alkeme Intermediary Holdings, LLC [Member]", "documentation": "Alkeme intermediary holdings, llc." } } }, "auth_ref": [] }, "slrc_BasicAndDilutedEarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BasicAndDilutedEarningsPerShareAbstract", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "lang": { "en-us": { "role": { "label": "Basic And Diluted Earnings Per Share [Abstract]", "terseLabel": "Earnings per share (basic\u00a0& diluted)", "documentation": "Basic And Diluted Earnings Per Share." } } }, "auth_ref": [] }, "dei_AdditionalSecurities462b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdditionalSecurities462b", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Additional Securities. 462(b)" } } }, "auth_ref": [ "r843" ] }, "slrc_PercentageRepresentingNetAssetsInInvestmentsOwned": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageRepresentingNetAssetsInInvestmentsOwned", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Representing Net Assets in Investments Owned", "terseLabel": "Percentage representing net assets in investments owned", "documentation": "Percentage representing net assets in investments owned." } } }, "auth_ref": [] }, "slrc_PercentageOfTotalNetAssets": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageOfTotalNetAssets", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Of Total Net Assets", "terseLabel": "Percentage of total net assets", "documentation": "Percentage of total net assets." } } }, "auth_ref": [] }, "slrc_FertilityItcInvestmentHoldcoLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "FertilityItcInvestmentHoldcoLlcMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Fertility ITC investment holdco LLC [Member]", "terseLabel": "Fertility (ITC) Investment Holdco, LLC [Member]", "documentation": "Fertility (ITC) investment holdco, LLC." } } }, "auth_ref": [] }, "slrc_PercentageRepresentingTotalInvestmentsInInvestmentsOwned": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageRepresentingTotalInvestmentsInInvestmentsOwned", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Representing Total Investments in Investments Owned", "terseLabel": "Percentage representing total investments in investments owned", "documentation": "Percentage representing total investments in investments owned." } } }, "auth_ref": [] }, "slrc_PreIncentiveFeeNetInvestmentIncomeAnnualHurdleRate": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PreIncentiveFeeNetInvestmentIncomeAnnualHurdleRate", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Pre Incentive Fee Net Investment Income Annual Hurdle Rate", "terseLabel": "Pre-incentive fee net investment income Annual hurdle rate", "documentation": "Pre-incentive fee net investment income annual hurdle rate." } } }, "auth_ref": [] }, "slrc_EnsHoldingsIiiCorp.EsOpcoUsaLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EnsHoldingsIiiCorp.EsOpcoUsaLlcMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "ENS Holdings III Corp. ES Opco USA LLC [Member]", "terseLabel": "ENS Holdings III Corp. ES Opco USA LLC [Member]", "documentation": "ENS holdings III corp. & ES Opco USA LLC member." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "slrc_PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Representing Senior Secured Loans In Investments Owned", "terseLabel": "Percentage representing senior secured loans in investments owned", "documentation": "Percentage representing senior secured loans in investments owned." } } }, "auth_ref": [] }, "slrc_CcSagHoldingsCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CcSagHoldingsCorpMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "CC SAG Holdings Corp [Member]", "documentation": "CC sag holdings corp." } } }, "auth_ref": [] }, "dei_NoSubstantiveChanges462cFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoSubstantiveChanges462cFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c), File Number" } } }, "auth_ref": [ "r844" ] }, "slrc_PercentageRepresentingCommonEquityOrEquityInterestsOrWarrantsOwned": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageRepresentingCommonEquityOrEquityInterestsOrWarrantsOwned", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Representing Common Equity Or Equity Interests Or Warrants Owned", "terseLabel": "Percentage representing common equity or equity interests or warrants owned", "documentation": "Percentage representing common equity or equity interests or warrants owned." } } }, "auth_ref": [] }, "slrc_PercentageRepresentingEquipmentFinancingInInvestmentsOwned": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageRepresentingEquipmentFinancingInInvestmentsOwned", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Representing Equipment Financing in Investments Owned", "terseLabel": "Percentage representing equipment financing in investments owned", "documentation": "Percentage representing equipment financing in investments owned." } } }, "auth_ref": [] }, "slrc_PreIncentiveFeeNetInvestmentIncomeQuarterHurdleRate": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PreIncentiveFeeNetInvestmentIncomeQuarterHurdleRate", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Pre Incentive Fee Net Investment Income Quarter Hurdle Rate", "terseLabel": "Pre-incentive fee net investment income Quarter hurdle rate", "documentation": "Pre-incentive fee net investment income Quarter hurdle rate." } } }, "auth_ref": [] }, "dei_NoSubstantiveChanges462c": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoSubstantiveChanges462c", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c)" } } }, "auth_ref": [ "r844" ] }, "slrc_PercentageOfOutstandingVotingSecuritiesOfTheInvestment": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageOfOutstandingVotingSecuritiesOfTheInvestment", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage of Outstanding Voting Securities of the Investment", "terseLabel": "Percentage of outstanding voting securities of the investment", "documentation": "Percentage of outstanding voting securities of the investment." } } }, "auth_ref": [] }, "slrc_PerformanceBasedIncentiveFeesWaiver": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PerformanceBasedIncentiveFeesWaiver", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Performance Based Incentive Fees Waiver", "documentation": "Performance based incentive fees waiver." } } }, "auth_ref": [] }, "slrc_AegisToxicologySciencesCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AegisToxicologySciencesCorporationMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Aegis Toxicology Sciences Corporation [Member]", "terseLabel": "Aegis Toxicology Sciences Corporation [Member]", "documentation": "Aegis toxicology sciences corporation." } } }, "auth_ref": [] }, "slrc_PercentageRepresentingTotalInvestmentsAndCashEquivalentsInInvestmentsOwned": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageRepresentingTotalInvestmentsAndCashEquivalentsInInvestmentsOwned", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Representing Total Investments and Cash Equivalents in Investments Owned", "terseLabel": "Percentage representing total investments and cash equivalents in investments owned", "documentation": "Percentage representing total investments and cash equivalents in investments owned." } } }, "auth_ref": [] }, "slrc_PercentageOfCumulativeNetRealizedGainAndUnrealizedCapitalAppreciation": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageOfCumulativeNetRealizedGainAndUnrealizedCapitalAppreciation", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Of Cumulative Net Realized Gain And Unrealized Capital Appreciation", "terseLabel": "Percentage of cumulative net realized gain and unrealized capital appreciation", "documentation": "Percentage Of Cumulative Net Realized Gain And Unrealized Capital Appreciation" } } }, "auth_ref": [] }, "slrc_PinnacleTreatmentCentersIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PinnacleTreatmentCentersIncMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Pinnacle Treatment Centers, Inc [Member]", "terseLabel": "Pinnacle Treatment Centers, Inc [Member]", "documentation": "Pinnacle treatment centers, inc." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r5" ] }, "slrc_PercentageRepresentingPreferredEquityInInvestmentsOwned": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageRepresentingPreferredEquityInInvestmentsOwned", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Percentage Representing Preferred Equity in Investments Owned", "terseLabel": "Percentage representing preferred equity in investments owned", "documentation": "Percentage representing preferred equity in investments owned." } } }, "auth_ref": [] }, "slrc_PercentageOfCumulativeRealizedCapitalGainLoss": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageOfCumulativeRealizedCapitalGainLoss", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage of Cumulative Realized Capital Gain Loss", "terseLabel": "Percentage of cumulative realized capital gain loss", "documentation": "Percentage Of Cumulative Realized Capital Gain Loss" } } }, "auth_ref": [] }, "slrc_RqmCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "RqmCorpMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "RQM Corp [Member]", "terseLabel": "RQM+ Corp [Member]", "documentation": "RQM+ Corp." } } }, "auth_ref": [] }, "dei_ExhibitsOnly462d": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ExhibitsOnly462d", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d)" } } }, "auth_ref": [ "r845" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r10", "r23", "r112", "r121", "r122", "r123", "r135", "r136", "r137", "r139", "r145", "r147", "r161", "r214", "r215", "r283", "r319", "r320", "r321", "r322", "r323", "r334", "r335", "r336", "r337", "r338", "r339", "r342", "r359", "r360", "r361", "r362", "r363", "r364", "r369", "r436", "r437", "r438", "r459", "r547" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r689" ] }, "slrc_NefpassFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NefpassFacilityMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "NEFPASS Facility [Member]", "verboseLabel": "NEFPASS Facility [Member]" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r806" ] }, "slrc_TwoThousandAndTwentyTwoTrancheCNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TwoThousandAndTwentyTwoTrancheCNotesMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Two Tranche C Notes [Member]", "verboseLabel": "2022 Tranche C Notes [Member]", "documentation": "Two thousand and twenty two tranche C notes." } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r806" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "slrc_BaysideOpcoLLCOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BaysideOpcoLLCOneMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Bayside Opco LLC One [Member]", "verboseLabel": "Bayside Opco LLC [Member]", "documentation": "Bayside Opco, LLC one." } } }, "auth_ref": [] }, "slrc_SlrSeniorLendingProgramLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrSeniorLendingProgramLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "SLR Senior Lending Program LLC [Member]", "terseLabel": "SLR Senior Lending Program LLC [Member]", "verboseLabel": "SLR Senior Lending Program LLC [Member]", "documentation": "SLR Senior Lending Program LLC" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r691" ] }, "slrc_IcimsInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IcimsInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "iCIMS, Inc. [Member]", "documentation": "iCIMS, Inc." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r10", "r112", "r121", "r122", "r123", "r135", "r136", "r137", "r139", "r145", "r147", "r161", "r214", "r215", "r283", "r319", "r320", "r321", "r322", "r323", "r334", "r335", "r336", "r337", "r338", "r339", "r342", "r359", "r360", "r361", "r362", "r363", "r364", "r369", "r436", "r437", "r438", "r459", "r547" ] }, "slrc_TermLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TermLoansMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Term Loans [Member]", "verboseLabel": "Term Loans [Member]" } } }, "auth_ref": [] }, "slrc_AmerimarkMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AmerimarkMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Amerimark [Member]", "terseLabel": "Amerimark [Member]", "documentation": "Amerimark member." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r806" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r806" ] }, "slrc_SoaggLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SoaggLlcMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "SOAGG LLC [Member]", "documentation": "Soagg llc." } } }, "auth_ref": [] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r807" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.slrinvestments.com/role/Organization" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r58", "r85", "r441", "r442" ] }, "slrc_KaseyaIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "KaseyaIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Kaseya Inc [Member]", "verboseLabel": "Kaseya, Inc. [Member]", "terseLabel": "Kaseya, Inc. [Member]", "documentation": "Kaseya Inc." } } }, "auth_ref": [] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r805" ] }, "srt_WeightedAverageMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "WeightedAverageMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]", "documentation": "Average of a range of values, calculated with consideration of proportional relevance." } } }, "auth_ref": [ "r649", "r650", "r910", "r912", "r915" ] }, "slrc_SointLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SointLlcMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "SOINT LLC [Member]", "documentation": "Soint llc." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Used in Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r75", "r76", "r77" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r807" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r10", "r62", "r63", "r84", "r459", "r547", "r642", "r686" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Denominator - weighted average shares, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r150", "r156" ] }, "slrc_RdHoldcoIncClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "RdHoldcoIncClassBMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "RD Holdco Inc Class B [Member]", "documentation": "RD Holdco Inc Class B." } } }, "auth_ref": [] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r46", "r86" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r807" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r807" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Denominator - weighted average shares, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r149", "r156" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r807" ] }, "slrc_RdHoldcoIncWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "RdHoldcoIncWarrantsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "RD Holdco Inc Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r291", "r370", "r371", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r495", "r496", "r497", "r498", "r499", "r521", "r523", "r551", "r907" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r807" ] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Acquisitions", "verboseLabel": "Amount", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r10", "r23", "r84" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r807" ] }, "slrc_SlrBusinessCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrBusinessCreditMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SLR Business Credit [Member]", "terseLabel": "SLR Business Credit [Member]", "documentation": "SLR Business Credit [Member]." } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r808" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r128" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r44", "r46" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock", "verboseLabel": "Stock issued during period, shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r10", "r62", "r63", "r84", "r448", "r547", "r642" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r253", "r285", "r286", "r287", "r288", "r289", "r290", "r347", "r378", "r379", "r380", "r658", "r659", "r663", "r664", "r665" ] }, "slrc_KbhTopcoLlcKingsbridgeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "KbhTopcoLlcKingsbridgeMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "KBH Topco LLC (Kingsbridge) [Member]", "documentation": "Kbh topco llc (kingsbridge)." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "auth_ref": [] }, "slrc_SeniorSecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SeniorSecuredNotesMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Secured Notes [Member]", "verboseLabel": "Senior Secured Notes [Member]" } } }, "auth_ref": [] }, "slrc_RdHoldcoIncDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "RdHoldcoIncDebtMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "RD Holdco Inc Debt [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r346", "r347", "r349", "r350", "r354" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r810" ] }, "slrc_EquipmentOperatingLeasesLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EquipmentOperatingLeasesLlcMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Equipment Operating Leases LLC [Member]", "documentation": "Equipment operating leases llc," } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r809" ] }, "cef_NoPublicTradingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "NoPublicTradingTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "No Public Trading [Text Block]" } } }, "auth_ref": [ "r780" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r812" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r811" ] }, "slrc_TwoThousandAndTwentyTwoUnsecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TwoThousandAndTwentyTwoUnsecuredNotesMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Two Thousand and Twenty Two Unsecured Notes [Member]", "verboseLabel": "2022 Unsecured Notes [Member]", "terseLabel": "2022 Unsecured Notes [Member]", "documentation": "Two thousand and twenty two unsecured notes." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r812" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r832" ] }, "cef_ReturnAtMinusTenPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ReturnAtMinusTenPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Return at Minus Ten [Percent]" } } }, "auth_ref": [ "r776" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred", "terseLabel": "Business combination, consideration transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r0", "r1", "r9" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r835" ] }, "cef_LatestNav": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LatestNav", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Latest NAV (Deprecated 2023-01-31)" } } }, "auth_ref": [ "r783" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r833" ] }, "cef_ReturnAtMinusFivePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ReturnAtMinusFivePercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Return at Minus Five [Percent]" } } }, "auth_ref": [ "r776" ] }, "cef_EffectsOfLeverageTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "EffectsOfLeverageTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Table Text Block]" } } }, "auth_ref": [ "r776" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r830" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r831" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r105", "r115", "r116", "r117", "r133", "r151", "r152", "r154", "r156", "r164", "r165", "r212", "r230", "r232", "r233", "r234", "r237", "r238", "r269", "r270", "r272", "r275", "r282", "r358", "r448", "r449", "r450", "r451", "r459", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r475", "r502", "r526", "r547", "r641", "r642", "r643", "r644", "r645", "r851", "r869", "r875" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r832" ] }, "cef_ReturnAtZeroPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ReturnAtZeroPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Return at Zero [Percent]" } } }, "auth_ref": [ "r776" ] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrivatePlacementMember", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "cef_ReturnAtPlusFivePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ReturnAtPlusFivePercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Return at Plus Five [Percent]" } } }, "auth_ref": [ "r776" ] }, "us-gaap_IncreaseDecreaseInManagementFeePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInManagementFeePayable", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Management Fee Payable", "terseLabel": "Management fee payable", "documentation": "Amount of increase (decrease) in fee payable for management of fund or trust." } } }, "auth_ref": [ "r938" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r832" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r346", "r347", "r353" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "cef_ReturnAtPlusTenPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ReturnAtPlusTenPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Return at Plus Ten [Percent]" } } }, "auth_ref": [ "r776" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3." } } }, "auth_ref": [ "r12", "r46" ] }, "cef_EffectsOfLeveragePurposeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "EffectsOfLeveragePurposeTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage, Purpose [Text Block]" } } }, "auth_ref": [ "r776" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r833" ] }, "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]" } } }, "auth_ref": [ "r719" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r804" ] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r833" ] }, "cef_SharePriceTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SharePriceTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Share Price [Table Text Block]" } } }, "auth_ref": [ "r778" ] }, "us-gaap_StockholdersEquityPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityPeriodIncreaseDecrease", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Period Increase (Decrease)", "terseLabel": "Net capital transactions", "documentation": "The increase (decrease) in stockholders' equity during the period." } } }, "auth_ref": [ "r10", "r84", "r548", "r645", "r686", "r921" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r346", "r347", "r353" ] }, "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" ], "lang": { "en-us": { "role": { "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired", "terseLabel": "Noncash or part noncash acquisition, value of assets acquired", "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r30", "r31", "r32" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "cef_SecurityTitleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityTitleTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Title [Text Block]" } } }, "auth_ref": [ "r720" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r833" ] }, "cef_NoTradingHistoryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "NoTradingHistoryTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "No Trading History [Text Block]" } } }, "auth_ref": [ "r784" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "cef_LatestPremiumDiscountToNavPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LatestPremiumDiscountToNavPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Latest Premium (Discount) to NAV [Percent]" } } }, "auth_ref": [ "r783" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r11" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r833" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Changes in Fair Value of Level 3 Assets and Liabilities", "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset." } } }, "auth_ref": [ "r12", "r46" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of Quantitative Information about the Company's Level 3 Asset and Liability", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r11" ] }, "cef_SecurityDividendsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityDividendsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Dividends [Text Block]" } } }, "auth_ref": [ "r721" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset." } } }, "auth_ref": [ "r12", "r46" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "cef_CapitalStockTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "CapitalStockTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Capital Stock [Table Text Block]" } } }, "auth_ref": [ "r720" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r135", "r136", "r137", "r161", "r406", "r443", "r475", "r492", "r495", "r496", "r497", "r498", "r499", "r502", "r505", "r506", "r507", "r508", "r509", "r511", "r512", "r513", "r514", "r517", "r518", "r519", "r520", "r521", "r523", "r527", "r528", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r547", "r676" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "periodStartLabel": "Opening balance", "periodEndLabel": "Closing balance", "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r12" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r834" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net", "terseLabel": "Transfers in/out of Level\u00a03", "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r690" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r692" ] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r264", "r280", "r340", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r429", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r882", "r883", "r884", "r885" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r834" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3)", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r12", "r46" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments", "terseLabel": "Equity method investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r169", "r207", "r863", "r886" ] }, "slrc_FootwearMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "FootwearMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Footwear [Member]", "documentation": "Footwear member." } } }, "auth_ref": [] }, "cef_SecurityVotingRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityVotingRightsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Voting Rights [Text Block]" } } }, "auth_ref": [ "r722" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Net change in unrealized (gain) loss", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r351" ] }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "auth_ref": [] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r834" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r799" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "slrc_SecuredOvernightFinancingRateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SecuredOvernightFinancingRateMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Secured Overnight Financing Rate [Member]" } } }, "auth_ref": [] }, "cef_ExpenseExampleYears1to3": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ExpenseExampleYears1to3", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 3" } } }, "auth_ref": [ "r750" ] }, "cef_SeniorSecuritiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities [Table Text Block]" } } }, "auth_ref": [ "r762" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.slrinvestments.com/role/Debt" ], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r80", "r131", "r239", "r245", "r246", "r247", "r248", "r249", "r250", "r255", "r262", "r263", "r265" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r348" ] }, "slrc_TrancheDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TrancheDomain", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Tranche [Domain]", "documentation": "Tranche." } } }, "auth_ref": [] }, "cef_ExpenseExampleYears1to5": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ExpenseExampleYears1to5", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 5" } } }, "auth_ref": [ "r750" ] }, "slrc_LongTermDebtOneDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LongTermDebtOneDomain", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long Term Debt One [Domain]", "documentation": "Long term debt one." } } }, "auth_ref": [] }, "cef_ExpenseExampleYears1to10": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ExpenseExampleYears1to10", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 10" } } }, "auth_ref": [ "r750" ] }, "slrc_LongTermDebtOneAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LongTermDebtOneAxis", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long Term Debt One [Axis]", "documentation": "Long term debt one." } } }, "auth_ref": [] }, "slrc_TrancheAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TrancheAxis", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Tranche [Axis]", "documentation": "Tranche." } } }, "auth_ref": [] }, "cef_PurposeOfFeeTableNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "PurposeOfFeeTableNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Purpose of Fee Table , Note [Text Block]" } } }, "auth_ref": [ "r744" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r208", "r209", "r211" ] }, "slrc_MeasuredAtNetAssetValueMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MeasuredAtNetAssetValueMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Measured at Net Asset Value [Member]", "documentation": "Measured at net asset value." } } }, "auth_ref": [] }, "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Management Fee not based on Net Assets, Note [Text Block]" } } }, "auth_ref": [ "r755" ] }, "slrc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings", "terseLabel": "Net realized (gain) loss", "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability realized gain loss included in earnings." } } }, "auth_ref": [] }, "cef_BasisOfTransactionFeesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "BasisOfTransactionFeesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Basis of Transaction Fees, Note [Text Block]" } } }, "auth_ref": [ "r751" ] }, "slrc_FairValueMeasurementWithUnobservableInputsReconciliationBasisRealizedGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationBasisRealizedGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Basis Realized Gain Loss Included In Earnings", "terseLabel": "Net realized gain (loss)", "documentation": "Fair value measurement with unobservable inputs reconciliation basis realized gain loss included in earnings." } } }, "auth_ref": [] }, "slrc_TermLoanAndCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TermLoanAndCreditFacilityMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Term Loan And Credit Facility [Member]", "verboseLabel": "SLRCTerm Loan And Credit Facility [Member]", "terseLabel": "Credit Facility [Member]", "documentation": "Term loan and credit facility." } } }, "auth_ref": [] }, "cef_IncentiveAllocationMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "IncentiveAllocationMinimumPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation Minimum [Percent]" } } }, "auth_ref": [ "r748" ] }, "cef_OtherTransactionFeesBasisNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionFeesBasisNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Note [Text Block]" } } }, "auth_ref": [ "r752" ] }, "slrc_MeasurementInputComparableMultipleMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MeasurementInputComparableMultipleMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Comparable Multiple [Member]", "terseLabel": "Comparable Multiple [Member]", "documentation": "Measurement input comparable multiple." } } }, "auth_ref": [] }, "cef_OtherTransactionFeesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionFeesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees, Note [Text Block]" } } }, "auth_ref": [ "r752" ] }, "slrc_MeasurementInputReturnOnEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MeasurementInputReturnOnEquityMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Return on Equity [Member]", "terseLabel": "Return on Equity [Member]", "documentation": "Measurement input return on equity." } } }, "auth_ref": [] }, "cef_OtherTransactionFeesBasisMaximum": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionFeesBasisMaximum", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum" } } }, "auth_ref": [ "r752" ] }, "slrc_MeasurementInputRecoverableAmountMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MeasurementInputRecoverableAmountMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Recoverable Amount [Member]", "terseLabel": "Recoverable Amount [Member]", "documentation": "Measurement input recoverable amount." } } }, "auth_ref": [] }, "cef_OtherTransactionFeesBasisMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionFeesBasisMaximumPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum [Percent]" } } }, "auth_ref": [ "r752" ] }, "slrc_MeasurementInputMarketYieldMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MeasurementInputMarketYieldMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Market Yield [Member]", "terseLabel": "Market Yield [Member]", "documentation": "Measurement input market yield." } } }, "auth_ref": [] }, "cef_OtherExpensesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherExpensesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Expenses, Note [Text Block]" } } }, "auth_ref": [ "r753" ] }, "slrc_DescriptionOfFairValueMeasurementValuationProcess": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "DescriptionOfFairValueMeasurementValuationProcess", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Description Of Fair Value Measurement Valuation Process", "terseLabel": "Principal Valuation Technique/Methodology", "documentation": "Description of fair value measurement valuation process." } } }, "auth_ref": [] }, "slrc_DescriptionOfSignificantUnobservableInputUsed": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "DescriptionOfSignificantUnobservableInputUsed", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Description of Significant Unobservable Input Used", "terseLabel": "Unobservable Input", "documentation": "Description of significant unobservable input used." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Accumulated distributable net loss", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r65", "r84", "r425", "r439", "r440", "r452", "r503", "r671" ] }, "slrc_ValuationApproachMarketMultipleMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ValuationApproachMarketMultipleMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Approach Market Multiple [Member]", "terseLabel": "Market Multiple [Member]", "documentation": "Valuation approach market multiple." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityExpirationDate1", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Line of credit facility, expiration date", "documentation": "Date the credit facility terminates, in YYYY-MM-DD format." } } }, "auth_ref": [ "r17" ] }, "slrc_ValuationTechniqueRecoveryApproachMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ValuationTechniqueRecoveryApproachMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Technique Recovery Approach [Member]", "terseLabel": "Recovery Analysis [Member]", "documentation": "Valuation technique recovery approach." } } }, "auth_ref": [] }, "slrc_MetalsAndMiningMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MetalsAndMiningMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Metals and Mining [Member]", "documentation": "Metals and mining member." } } }, "auth_ref": [] }, "cef_AcquiredFundFeesEstimatedNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AcquiredFundFeesEstimatedNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees Estimated, Note [Text Block]" } } }, "auth_ref": [ "r747" ] }, "slrc_LongTermInvestmentsMeasurementInput": { "xbrltype": "pureItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LongTermInvestmentsMeasurementInput", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Long Term Investments Measurement Input", "documentation": "Long term investments measurement input." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r7" ] }, "cef_AcquiredFundFeesAndExpensesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AcquiredFundFeesAndExpensesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses, Note [Text Block]" } } }, "auth_ref": [ "r745" ] }, "slrc_MeasurementInputTypeOneAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MeasurementInputTypeOneAxis", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type One [Axis]", "documentation": "Measurement input type one." } } }, "auth_ref": [] }, "cef_SeniorSecuritiesAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesAmount", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Amount (Deprecated 2023-01-31)" } } }, "auth_ref": [ "r763" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "lang": { "en-us": { "role": { "label": "Earnings (loss) Per Share, Basic", "terseLabel": "Earnings per share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r125", "r140", "r141", "r142", "r143", "r144", "r149", "r151", "r154", "r155", "r156", "r160", "r343", "r344", "r419", "r433", "r651" ] }, "cef_AcquiredFundIncentiveAllocationNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AcquiredFundIncentiveAllocationNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Incentive Allocation, Note [Text Block]" } } }, "auth_ref": [ "r748" ] }, "cef_HighestPriceOrBidPremiumDiscountToNavPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "HighestPriceOrBidPremiumDiscountToNavPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "auth_ref": [ "r782" ] }, "cef_IncentiveAllocationPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "IncentiveAllocationPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation [Percent]" } } }, "auth_ref": [ "r748" ] }, "slrc_MeasurementInputTypeOneDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MeasurementInputTypeOneDomain", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type One [Domain]", "documentation": "Measurement input type one." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET DECREASE IN CASH AND CASH EQUIVALENTS", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r4", "r75" ] }, "slrc_BlackScholesPricingModelMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BlackScholesPricingModelMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Black Scholes Pricing Model [Member]", "documentation": "Black scholes pricing model." } } }, "auth_ref": [] }, "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Total Annual Expenses, Note [Text Block]" } } }, "auth_ref": [ "r749" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Gross", "terseLabel": "Face Amount", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r15", "r92", "r266" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r802" ] }, "cef_IncentiveAllocationMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "IncentiveAllocationMaximumPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation Maximum [Percent]" } } }, "auth_ref": [ "r748" ] }, "slrc_CollateralAgentAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CollateralAgentAxis", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Collateral Agent [Axis]", "documentation": "Collateral agent." } } }, "auth_ref": [] }, "slrc_LineOfCreditAndTermLoanOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LineOfCreditAndTermLoanOutstanding", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Line Of Credit And Term Loan Outstanding", "terseLabel": "Credit Facility, Carrying Value", "verboseLabel": "Line of credit and term loan outstanding", "documentation": "Line of credit and term loan outstanding." } } }, "auth_ref": [] }, "cef_FinancialHighlightsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "FinancialHighlightsAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Financial Highlights [Abstract]" } } }, "auth_ref": [ "r758" ] }, "cef_SeniorSecuritiesAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Amount" } } }, "auth_ref": [ "r763" ] }, "slrc_CollateralAgentDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CollateralAgentDomain", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Collateral Agent [Domain]", "documentation": "Collateral agent." } } }, "auth_ref": [] }, "us-gaap_InvestmentInterestRatePaidInKind": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentInterestRatePaidInKind", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Investment, Interest Rate, Paid in Kind", "terseLabel": "Investment interest rate, Paid in kind", "documentation": "Rate of interest paid in kind on investment." } } }, "auth_ref": [ "r556", "r575", "r579", "r618" ] }, "slrc_CitiBankNaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CitiBankNaMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Citi Bank NA [Member]", "documentation": "Citi Bank NA." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodStartLabel": "CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD", "periodEndLabel": "CASH AND CASH EQUIVALENTS AT END OF PERIOD", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r28", "r75", "r129" ] }, "us-gaap_InvestmentBasisSpreadVariableRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentBasisSpreadVariableRate", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Investment, Basis Spread, Variable Rate", "terseLabel": "Spread Above Index", "documentation": "Percentage added to reference rate used to compute variable rate on investment." } } }, "auth_ref": [ "r556", "r575", "r579", "r618" ] }, "slrc_LondonInterbankOfferedRateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LondonInterbankOfferedRateMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "London Interbank Offered Rate [Member]", "documentation": "London interbank offered rate." } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r135", "r136", "r137", "r161", "r406", "r443", "r475", "r492", "r495", "r496", "r497", "r498", "r499", "r502", "r505", "r506", "r507", "r508", "r509", "r511", "r512", "r513", "r514", "r517", "r518", "r519", "r520", "r521", "r523", "r527", "r528", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r547", "r676" ] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Dividends Payable", "terseLabel": "Distributions payable", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding." } } }, "auth_ref": [ "r60", "r61", "r91", "r684", "r917" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "slrc_LeisureEquipmentProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LeisureEquipmentProductsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Leisure Equipment Products [Member]" } } }, "auth_ref": [] }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertySubjectToOrAvailableForOperatingLeaseNet", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, after Accumulated Depreciation", "terseLabel": "Assets under lease", "documentation": "Amount, after accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease." } } }, "auth_ref": [ "r99", "r889", "r903" ] }, "cef_SharePricesNotActualTransactionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SharePricesNotActualTransactionsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Share Prices Not Actual Transactions [Text Block]" } } }, "auth_ref": [ "r779" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Employee-related Liabilities", "terseLabel": "Performance-based incentive fee payable (see note 3)", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r54", "r917" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Interest Payable", "terseLabel": "Interest payable (see note 7)", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r54", "r917" ] }, "slrc_AerospaceAndDefenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AerospaceAndDefenseMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Aerospace and Defense [Member]", "documentation": "Aerospace and defense member." } } }, "auth_ref": [] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Investments, Fair Value Disclosure", "terseLabel": "Assets", "verboseLabel": "Investments at fair value", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r346" ] }, "srt_ManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ManagementMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Management [Member]", "terseLabel": "Management [Member]", "documentation": "Person or persons designated as part of management." } } }, "auth_ref": [ "r877", "r906" ] }, "slrc_AutoPartsAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AutoPartsAndEquipmentMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Auto Parts and Equipment [Member]", "documentation": "Auto parts and equipment member." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring Fair Value [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r345", "r354" ] }, "us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which net income is reported that includes unrealized gain (loss) from asset measured at fair value using unobservable input (level 3) and still held." } } }, "auth_ref": [ "r352" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Term", "terseLabel": "Debt instrument term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from asset measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r351" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date", "verboseLabel": "Debt instrument maturity date", "terseLabel": "Debt Instrument, Maturity Date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r103", "r657", "r901" ] }, "slrc_PeterC.FoyAssociatesInsuranceServicesLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PeterC.FoyAssociatesInsuranceServicesLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Peter C. Foy Associates Insurance Services LLC [Member]", "terseLabel": "Peter C. Foy & Associates Insurance Services, LLC [Member]", "documentation": "Peter C. Foy Associates Insurance Services LLC." } } }, "auth_ref": [] }, "slrc_SunsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SunsMember", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SUNS [Member]", "terseLabel": "SUNS [Member]", "documentation": "SUNS [Member]." } } }, "auth_ref": [] }, "cef_ProspectusLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ProspectusLineItems", "lang": { "en-us": { "role": { "label": "Prospectus [Line Items]" } } }, "auth_ref": [ "r718" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r703", "r715", "r796", "r823" ] }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Other General and Administrative Expense", "terseLabel": "Other general and administrative expenses", "verboseLabel": "Other general and administrative expenses", "documentation": "Amount of general and administrative expense classified as other." } } }, "auth_ref": [ "r68", "r933" ] }, "slrc_NmcsCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NmcsCreditFacilityMember", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "NMCs Credit Facility [Member]", "terseLabel": "NMCs Credit Facility [Member]", "documentation": "NMC's credit facility [Member]." } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodValue", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchases of common stock", "negatedTerseLabel": "Shares repurchased, Value", "verboseLabel": "Stock Repurchased During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r10", "r62", "r63", "r84", "r459", "r547", "r644", "r686" ] }, "us-gaap_ScheduleOfInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentsAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Investments [Abstract]", "terseLabel": "Schedule of Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r291", "r370", "r371", "r495", "r496", "r497", "r498", "r499", "r521", "r523", "r551" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r697", "r709", "r790", "r817" ] }, "us-gaap_TechnologySectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TechnologySectorMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Technology Sector [Member]", "terseLabel": "Software [Member]", "documentation": "Sector of the economy consisting of companies engaged in technology-related business activities." } } }, "auth_ref": [ "r675", "r940", "r943", "r945", "r947" ] }, "cef_LowestPriceOrBid": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LowestPriceOrBid", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid" } } }, "auth_ref": [ "r777" ] }, "us-gaap_DebtInstrumentPaymentTerms": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentPaymentTerms", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Payment Terms", "verboseLabel": "Debt instrument payment terms", "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment." } } }, "auth_ref": [ "r20", "r57" ] }, "us-gaap_PrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets." } } }, "auth_ref": [] }, "slrc_NmcSeniorCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NmcSeniorCreditFacilityMember", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "NMC Senior Credit Facility [Member]", "terseLabel": "NMC Senior Credit Facility [Member]", "documentation": "NMC senior credit facility." } } }, "auth_ref": [] }, "cef_ProspectusTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ProspectusTable", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Prospectus:" } } }, "auth_ref": [ "r718" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r701", "r713", "r794", "r821" ] }, "us-gaap_AssetManagement1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetManagement1Member", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Asset Management [Member]", "documentation": "Management of investment fund portfolio. Excludes investment advisory, distribution and servicing, and performance fee." } } }, "auth_ref": [ "r897" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r698", "r710", "r791", "r818" ] }, "us-gaap_AssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNet", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Net Assets", "totalLabel": "Total net assets", "periodEndLabel": "Net assets at end of period", "periodStartLabel": "Net assets at beginning of period", "terseLabel": "Net assets", "verboseLabel": "Net assets, end of period", "documentation": "Amount of net assets (liabilities)." } } }, "auth_ref": [ "r8" ] }, "us-gaap_FinancialServicesSectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialServicesSectorMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Financial Services Sector [Member]", "terseLabel": "Diversified Financial Services [Member]", "documentation": "Sector of the economy consisting of companies engaged in financial services." } } }, "auth_ref": [ "r675", "r940", "r943", "r945", "r947" ] }, "slrc_UVPManagementLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "UVPManagementLLCMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "UVP Management LLC [Member]", "terseLabel": "UVP Management, LLC [Member]", "documentation": "UVP Management, llc." } } }, "auth_ref": [] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r698", "r710", "r791", "r818" ] }, "slrc_AlkemeIntermediateHoldingsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AlkemeIntermediateHoldingsLLCMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Alkeme Intermediate Holdings LLC [Member]", "terseLabel": "Alkeme Intermediate Holdings, LLC [Member]", "documentation": "Alkeme intermediate holdings, llc." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r21", "r134", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r367", "r657", "r658", "r659", "r660", "r661", "r870" ] }, "slrc_NeuroneticsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NeuroneticsIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Neuronetics, Inc [Member]", "terseLabel": "Neuronetics, Inc. [Member]", "documentation": "Neuronetics, inc." } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r699", "r711", "r792", "r819" ] }, "slrc_SlrBusinessCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrBusinessCreditFacilityMember", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SLR Business Credit Facility [Member]", "terseLabel": "SLR Business Credit Facility [Member]", "documentation": "SLR Business Credit Facility" } } }, "auth_ref": [] }, "slrc_EnsHoldingsIiiCorpLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EnsHoldingsIiiCorpLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "ENS Holdings III Corp, LLC [Member]", "documentation": "ENS holdings III corp, LLC." } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense", "terseLabel": "Interest and other credit facility expenses", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r49", "r96", "r124", "r168", "r366", "r529", "r685", "r931" ] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r326" ] }, "slrc_NumberOfCustomers": { "xbrltype": "integerItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NumberOfCustomers", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number Of Customers", "terseLabel": "Number of Customers", "documentation": "Number of Customers." } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r700", "r712", "r793", "r820" ] }, "us-gaap_EquitySecuritiesByIndustryAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesByIndustryAxis", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Industry Sector [Axis]", "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate." } } }, "auth_ref": [ "r478", "r482", "r485", "r561", "r576", "r597", "r633", "r655", "r675" ] }, "slrc_VertosMedicalInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "VertosMedicalInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Vertos Medical, Inc. [Member]", "terseLabel": "Vertos Medical, Inc. [Member]", "documentation": "Vertos Medical, Inc." } } }, "auth_ref": [] }, "us-gaap_HealthcareSectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HealthcareSectorMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Healthcare Sector [Member]", "terseLabel": "Health Care Providers & Services [Member]", "documentation": "Sector of the economy consisting of companies engaged in healthcare-related business activities." } } }, "auth_ref": [ "r675", "r940", "r943", "r945", "r947" ] }, "slrc_SlrBusinessCreditLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrBusinessCreditLineItems", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SLR Business Credit [Line Items]", "documentation": "SLR Business Credit [Line Item]" } } }, "auth_ref": [] }, "slrc_EquityMethodInvestmentAggregateEquityInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EquityMethodInvestmentAggregateEquityInvestment", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment Aggregate Equity Investment", "terseLabel": "Equity method investment aggregate equity investment", "documentation": "Equity method investment aggregate equity investment." } } }, "auth_ref": [] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r326" ] }, "us-gaap_DerivativeFloorInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFloorInterestRate", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Floor Interest Rate", "terseLabel": "Floor", "documentation": "Floor rate on an interest rate derivative such as an interest rate floor or collar. If market rates falls below the floor rate, a payment or receipt is triggered on the contract." } } }, "auth_ref": [] }, "slrc_EquipmentBackedLeasesAndLoansaverageExposurePerCustomer": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EquipmentBackedLeasesAndLoansaverageExposurePerCustomer", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equipment Backed Leases and LoansAverage Exposure Per Customer", "terseLabel": "Equipment backed leases and loans average exposure per customer", "documentation": "Equipment backed leases and loans average exposure per customer." } } }, "auth_ref": [] }, "slrc_KbhtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "KbhtMember", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "KBHT [Member]", "documentation": "KBHT" } } }, "auth_ref": [] }, "slrc_CVAUSAManagementLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CVAUSAManagementLLCMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "CVAUSA Management LLC [Member]", "terseLabel": "CVAUSA Management, LLC [Member]", "documentation": "CVAUSA Management, LLC,," } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r702", "r714", "r795", "r822" ] }, "us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxBasisOfInvestmentsCostForIncomeTaxPurposes", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Tax Basis of Investments, Cost for Income Tax Purposes", "terseLabel": "Investment Owned tax costs", "documentation": "Amount of cost of investment for federal income tax purpose." } } }, "auth_ref": [ "r447" ] }, "slrc_EquityMethodInvestmentAggregateInvestmentInInvesteeLeasesAndLoansHeld": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EquityMethodInvestmentAggregateInvestmentInInvesteeLeasesAndLoansHeld", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment Aggregate Investment In Investee Leases and Loans held", "terseLabel": "Equity method investment aggregate investment in investee leases and loans held", "documentation": "Equity method investment aggregate investment in investee leases and loans held." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Debt Instrument, Unamortized Discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r47", "r50", "r895" ] }, "slrc_CcSagHoldingsCorp.SpectrumAutomotiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CcSagHoldingsCorp.SpectrumAutomotiveMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "CC SAG Holdings Corp. (Spectrum Automotive) [Member]", "terseLabel": "CC SAG Holdings Corp. (Spectrum Automotive) [Member]", "documentation": "Cc sag holdings corp. (spectrum automotive)." } } }, "auth_ref": [] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r702", "r714", "r795", "r814", "r822" ] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Repurchased During Period, Shares", "negatedTerseLabel": "Repurchases of common stock", "negatedLabel": "Shares repurchased, Shares", "verboseLabel": "Stock Repurchased During Period, Shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r10", "r62", "r63", "r84", "r451", "r547", "r644" ] }, "slrc_LineOfCreditFacilityMaximumBorrowingCapacityWithAccordionFeature": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LineOfCreditFacilityMaximumBorrowingCapacityWithAccordionFeature", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line Of Credit Facility Maximum Borrowing Capacity with Accordion Feature", "terseLabel": "Line of credit facility maximum borrowing capacity with accordion feature", "documentation": "Line of credit facility maximum borrowing capacity with accordion feature." } } }, "auth_ref": [] }, "slrc_EquipmentBackedLeasesAndLoansLargestPositionOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EquipmentBackedLeasesAndLoansLargestPositionOutstanding", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equipment Backed Leases And Loans Largest Position Outstanding", "terseLabel": "Equipment backed leases and loans largest position outstanding", "documentation": "Equipment backed leases and loans largest position outstanding." } } }, "auth_ref": [] }, "slrc_CompositeTechnologyAcquisitionCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CompositeTechnologyAcquisitionCorpMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Composite Technology Acquisition Corp [Member]", "documentation": "Composite technology acquisition corp." } } }, "auth_ref": [] }, "slrc_RecourseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "RecourseDebt", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Recourse Debt", "terseLabel": "Recourse debt", "documentation": "Recourse debt." } } }, "auth_ref": [] }, "slrc_ArcutisBiotherapeuticsInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ArcutisBiotherapeuticsInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Arcutis Biotherapeutics, Inc. [Member]", "documentation": "Arcutis Biotherapeutics, Inc." } } }, "auth_ref": [] }, "slrc_UnitedDigestiveMsoParentLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "UnitedDigestiveMsoParentLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "United Digestive MSO Parent, LLC [Member]", "documentation": "United Digestive MSO Parent, LLC Member." } } }, "auth_ref": [] }, "slrc_CommitmentFundedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CommitmentFundedAmount", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Commitment Funded Amount", "terseLabel": "Commitment funded amount", "documentation": "Commitment funded amount." } } }, "auth_ref": [] }, "slrc_CerapedicsInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CerapedicsInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Cerapedics, Inc. [Member]", "documentation": "Cerapedics, inc." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentsAbstract", "lang": { "en-us": { "role": { "label": "Debt Instruments [Abstract]" } } }, "auth_ref": [] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r704", "r716", "r797", "r824" ] }, "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxBasisOfInvestmentsGrossUnrealizedDepreciation", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Tax Basis of Investments, Gross, Unrealized Depreciation", "terseLabel": "Tax Basis of Investments, Gross, Unrealized Depreciation", "documentation": "Amount of cumulative decrease in investment from unrealized loss when cost for federal income tax purpose exceeds value." } } }, "auth_ref": [ "r445" ] }, "us-gaap_NoninterestIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoninterestIncome", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Noninterest Income", "terseLabel": "Other income", "verboseLabel": "Service fees", "documentation": "The total amount of noninterest income which may be derived from: (1) fees and commissions; (2) premiums earned; (3) insurance policy charges; (4) the sale or disposal of assets; and (5) other sources not otherwise specified." } } }, "auth_ref": [ "r95" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r134", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r367", "r657", "r658", "r659", "r660", "r661", "r870" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r702", "r714", "r795", "r822" ] }, "us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedUnderlyingFaceAmountAtMarketValue", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Face Amount", "verboseLabel": "Par Amount", "documentation": "Nominal or face amount on the investment owned." } } }, "auth_ref": [ "r42", "r43" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r15", "r59", "r60", "r90", "r92", "r134", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r367", "r657", "r658", "r659", "r660", "r661", "r870" ] }, "slrc_SlrHealthcareAblCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrHealthcareAblCreditMember", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SLR Healthcare ABL Credit [Member]", "terseLabel": "SLR Healthcare ABL Credit [Member]", "documentation": "SLR Healthcare ABL Credit." } } }, "auth_ref": [] }, "slrc_TilleyDistributionIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TilleyDistributionIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Tilley Distribution Inc [Member]", "terseLabel": "Tilley Distribution, Inc. [Member]", "documentation": "Tilley Distribution, Inc." } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r702", "r714", "r795", "r822" ] }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtLongtermAndShorttermCombinedAmount", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Debt, Long-term and Short-term, Combined Amount", "verboseLabel": "Debt ($1,197,750 and $1,093,200 face amounts, respectively, reported net of unamortized debt issuance costs of $5,996 and $7,202, respectively. See notes 6 and 7)", "terseLabel": "Debt outstanding", "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r21", "r35", "r37", "r47", "r48", "r50", "r56", "r82", "r83", "r134", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r367", "r657", "r658", "r659", "r660", "r661", "r870" ] }, "slrc_SeniorSecuredCommitmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SeniorSecuredCommitmentsMember", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Senior Secured Commitments [Member]", "terseLabel": "Senior Secured Commitments [Member]", "documentation": "Senior-secured commitments [Member]." } } }, "auth_ref": [] }, "slrc_GsmAcquisitionCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "GsmAcquisitionCorpMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "GSM Acquisition Corp [Member]", "terseLabel": "GSM Acquisition Corp. [Member]", "documentation": "GSM acquisition corp." } } }, "auth_ref": [] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r703", "r715", "r796", "r823" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r702", "r714", "r795", "r822" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r253", "r285", "r286", "r287", "r288", "r289", "r290", "r378", "r379", "r380", "r658", "r659", "r663", "r664", "r665" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r702", "r714", "r795", "r822" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r806" ] }, "slrc_HighStreetBuyerIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "HighStreetBuyerIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "High Street Buyer Inc [Member]", "terseLabel": "High Street Buyer, Inc. [Member]", "documentation": "High street buyer, Inc." } } }, "auth_ref": [] }, "slrc_SlrBusinessCreditTable": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrBusinessCreditTable", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SLR Business Credit [Table]", "documentation": "SLR Business Credit Table" } } }, "auth_ref": [] }, "slrc_PercentageOfEquityInterestContributedToAnotherEntity": { "xbrltype": "percentItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PercentageOfEquityInterestContributedToAnotherEntity", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Of Equity Interest Contributed To Another Entity", "terseLabel": "Percentage of equity interest contributed to another entity", "documentation": "Percentage of equity interest contributed to another entity." } } }, "auth_ref": [] }, "slrc_PediatricHomeRespiratoryServicesLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PediatricHomeRespiratoryServicesLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Pediatric Home Respiratory Services, LLC [Member]", "documentation": "Pediatric home respiratory services, LLC." } } }, "auth_ref": [] }, "cef_PrimaryShelfFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "PrimaryShelfFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Primary Shelf [Flag]" } } }, "auth_ref": [ "r718" ] }, "slrc_SummitFinancialResourcesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SummitFinancialResourcesMember", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Summit Financial Resources [Member]", "terseLabel": "Summit Financial Resources [Member]", "documentation": "Summit Financial Resources [Member]." } } }, "auth_ref": [] }, "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxBasisOfInvestmentsGrossUnrealizedAppreciation", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Tax Basis of Investments, Gross, Unrealized Appreciation", "terseLabel": "Tax Basis of Investments, Gross, Unrealized Appreciation", "documentation": "Amount of cumulative increase in investment from unrealized gain when value exceeds cost for federal income tax purpose." } } }, "auth_ref": [ "r444" ] }, "slrc_EnverusHoldingsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EnverusHoldingsIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Enverus Holdings Inc [Member]", "terseLabel": "Enverus Holdings, Inc. [Member]", "documentation": "Enverus holdings Inc." } } }, "auth_ref": [] }, "cef_RegisteredClosedEndFundFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RegisteredClosedEndFundFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Registered Closed-End Fund [Flag]" } } }, "auth_ref": [ "r718" ] }, "slrc_EspSscCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "EspSscCorporationMember", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "ESP SSC Corporation [Member]", "terseLabel": "ESP SSC Corporation [Member]", "documentation": "ESP SSC Corporation Member" } } }, "auth_ref": [] }, "slrc_LuxuryAssetCapitalLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LuxuryAssetCapitalLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Luxury Asset Capital, LLC [Member]", "documentation": "Luxury asset capital, LLC." } } }, "auth_ref": [] }, "cef_BusinessDevelopmentCompanyFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "BusinessDevelopmentCompanyFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Business Development Company [Flag]" } } }, "auth_ref": [ "r718" ] }, "slrc_AllStatesAgPartsLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AllStatesAgPartsLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "All States Ag Parts LLC [Member]", "terseLabel": "All States Ag Parts, LLC [Member]", "documentation": "All States Ag Parts, LLC." } } }, "auth_ref": [] }, "slrc_ErieConstructionMidwestLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ErieConstructionMidwestLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Erie Construction Midwest LLC [Member]", "terseLabel": "Erie Construction Mid-west, LLC [Member]", "documentation": "Erie Construction mid-west LLC." } } }, "auth_ref": [] }, "slrc_NorthMillCapitalLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NorthMillCapitalLlcMember", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "North Mill Capital LLC [Member]", "terseLabel": "North Mill Capital LLC [Member]", "documentation": "North Mill Capital LLC Member" } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency [Abstract]", "terseLabel": "REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:" } } }, "auth_ref": [] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r835" ] }, "dei_ExhibitsOnly462dFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ExhibitsOnly462dFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d), File Number" } } }, "auth_ref": [ "r845" ] }, "us-gaap_ScheduleOfInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentsTable", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Table]", "documentation": "Disclosure of information about investments owned by investment company." } } }, "auth_ref": [ "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r608", "r609", "r610", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r631", "r632", "r633", "r634", "r635", "r636" ] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IPOMember", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "IPO [Member]", "terseLabel": "IPO [Member]", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentsLineItems", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r631", "r632", "r633", "r634", "r635", "r636" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r805" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r836" ] }, "us-gaap_InterestReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestReceivable", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Interest Receivable", "terseLabel": "Interest receivable", "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable." } } }, "auth_ref": [ "r864", "r939" ] }, "us-gaap_InvestmentInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentInterestRate", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Investment Interest Rate", "terseLabel": "Interest Rate", "documentation": "Rate of interest on investment." } } }, "auth_ref": [ "r555", "r556", "r574", "r575", "r579", "r580", "r617", "r618", "r675", "r878", "r880" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318" ] }, "us-gaap_InterestRateRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Interest Rate Risk [Member]", "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability." } } }, "auth_ref": [] }, "us-gaap_MeasurementInputEbitdaMultipleMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputEbitdaMultipleMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, EBITDA Multiple [Member]", "documentation": "Measurement input using earnings before interest, tax, depreciation and amortization (EBITDA) multiple." } } }, "auth_ref": [ "r900" ] }, "slrc_OilGasAndConsumableFuelsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "OilGasAndConsumableFuelsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Oil, Gas and Consumable Fuels [Member]", "documentation": "Oil, gas and consumable fuels member." } } }, "auth_ref": [] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r837" ] }, "us-gaap_InvestmentOwnedPercentOfNetAssets": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedPercentOfNetAssets", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Percent of Net Assets", "terseLabel": "Percentage of Total Investments (at fair value)", "documentation": "Percentage of investment owned to net assets." } } }, "auth_ref": [ "r479", "r483", "r484", "r561", "r583", "r597", "r600", "r633", "r675", "r927" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r694", "r838" ] }, "us-gaap_OtherCommitment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitment", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitment", "terseLabel": "Other Commitment", "verboseLabel": "Other Commitment", "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfSecuredDebt", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Secured Debt", "negatedLabel": "Repayment of secured borrowings", "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt." } } }, "auth_ref": [ "r27" ] }, "slrc_AirlinesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AirlinesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Airlines [Member]", "documentation": "Airlines member." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r690" ] }, "slrc_FoodStaplesRetailingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "FoodStaplesRetailingMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Food Staples Retailing [Member]" } } }, "auth_ref": [] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r694", "r838" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r694", "r838" ] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt", "terseLabel": "Total", "presentationGuidance": "Non-recourse debt", "verboseLabel": "Long term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r15", "r92", "r252", "r267", "r658", "r659", "r918" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r365", "r373" ] }, "us-gaap_PreferredStockLiquidationPreference": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockLiquidationPreference", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Liquidating Preference", "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share." } } }, "auth_ref": [ "r35", "r36", "r62", "r869", "r896" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfUnsecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfUnsecuredDebt", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Unsecured Debt", "negatedLabel": "Repayment of unsecured borrowings", "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt." } } }, "auth_ref": [ "r27" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_AssetsNet", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities", "verboseLabel": "Total liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r18", "r133", "r212", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r329", "r332", "r333", "r358", "r500", "r652", "r687", "r892", "r908", "r909" ] }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount", "documentation": "Amount of stock repurchase plan authorized." } } }, "auth_ref": [] }, "cef_PrimaryShelfQualifiedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "PrimaryShelfQualifiedFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Primary Shelf Qualified [Flag]" } } }, "auth_ref": [ "r718" ] }, "cef_DividendReinvestmentAndCashPurchaseFees": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "DividendReinvestmentAndCashPurchaseFees", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dividend Reinvestment and Cash Purchase Fees" } } }, "auth_ref": [ "r743" ] }, "cef_IntervalFundFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "IntervalFundFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Interval Fund [Flag]" } } }, "auth_ref": [ "r718" ] }, "us-gaap_InvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestorMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Investor [Member]", "terseLabel": "Investor [Member]", "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value." } } }, "auth_ref": [ "r904", "r905" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": 1.0, "order": 1.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net increase (decrease) in net assets resulting from operations", "terseLabel": "Net income (loss)", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r113", "r119", "r120", "r127", "r133", "r138", "r146", "r147", "r166", "r170", "r172", "r174", "r212", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r327", "r330", "r331", "r344", "r358", "r420", "r427", "r457", "r525", "r543", "r544", "r653", "r669", "r670", "r686", "r866", "r892" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r148", "r157", "r158", "r159" ] }, "cef_NewCefOrBdcRegistrantFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "NewCefOrBdcRegistrantFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "New CEF or BDC Registrant [Flag]" } } }, "auth_ref": [ "r718" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r673", "r674", "r675", "r677", "r678", "r679", "r680", "r873", "r874", "r899", "r922", "r935" ] }, "cef_FeeTableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "FeeTableAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Fee Table [Abstract]" } } }, "auth_ref": [ "r743" ] }, "cef_ShareholderTransactionExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ShareholderTransactionExpensesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Shareholder Transaction Expenses [Table Text Block]" } } }, "auth_ref": [ "r743" ] }, "us-gaap_UnsecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredDebt", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Unsecured Debt", "terseLabel": "Unsecured Debt", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r15", "r92", "r918" ] }, "cef_InterestExpensesOnBorrowingsPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "InterestExpensesOnBorrowingsPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Interest Expenses on Borrowings [Percent]" } } }, "auth_ref": [ "r756" ] }, "cef_SalesLoadPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SalesLoadPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Sales Load [Percent]" } } }, "auth_ref": [ "r743" ] }, "cef_OtherTransactionExpense3Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionExpense3Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expense 3 [Percent]" } } }, "auth_ref": [ "r752" ] }, "cef_UnderwritersCompensationPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "UnderwritersCompensationPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Underwriters Compensation [Percent]" } } }, "auth_ref": [ "r752" ] }, "cef_OtherTransactionExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionExpensesAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Abstract]" } } }, "auth_ref": [ "r752" ] }, "cef_OtherTransactionExpense1Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionExpense1Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expense 1 [Percent]" } } }, "auth_ref": [ "r752" ] }, "cef_OtherTransactionExpense2Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionExpense2Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expense 2 [Percent]" } } }, "auth_ref": [ "r752" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities", "terseLabel": "Accrued expenses and other payables", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r53" ] }, "cef_OtherTransactionExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionExpensesPercent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Percent]" } } }, "auth_ref": [ "r752" ] }, "us-gaap_LineOfCreditFacilityAverageOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAverageOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Average Outstanding Amount", "terseLabel": "Line of credit facility average outstanding amount", "documentation": "Average amount borrowed under the credit facility during the period." } } }, "auth_ref": [] }, "cef_AnnualExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualExpensesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Expenses [Table Text Block]" } } }, "auth_ref": [ "r753" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r21" ] }, "cef_ManagementFeesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ManagementFeesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Management Fees [Percent]" } } }, "auth_ref": [ "r754" ] }, "cef_IncentiveFeesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "IncentiveFeesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Incentive Fees [Percent]" } } }, "auth_ref": [ "r757" ] }, "cef_DistributionServicingFeesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "DistributionServicingFeesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Distribution/Servicing Fees [Percent]" } } }, "auth_ref": [ "r757" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r803" ] }, "slrc_CommunicationsEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CommunicationsEquipmentMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Communications Equipment [Member]", "documentation": "Communications equipment member." } } }, "auth_ref": [] }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg." } } }, "auth_ref": [ "r898" ] }, "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": { "xbrltype": "dateOrAsapItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Approximate Date of Commencement of Proposed Sale to Public", "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "slrc_HealthCareTechnologyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "HealthCareTechnologyMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Health Care Technology [Member]", "documentation": "Health care technology member." } } }, "auth_ref": [] }, "slrc_SpecialtyRetailMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SpecialtyRetailMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Specialty Retail [Member]", "documentation": "Specialty retail member." } } }, "auth_ref": [] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "slrc_PharmaceuticalsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PharmaceuticalsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Pharmaceuticals [Member]", "documentation": "Pharmaceuticals member." } } }, "auth_ref": [] }, "slrc_DiversifiedConsumerServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "DiversifiedConsumerServicesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Diversified Consumer Services [Member]", "terseLabel": "Diversified Consumer Services [Member]", "documentation": "Diversified consumer services member." } } }, "auth_ref": [] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "BusinessContactMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r693", "r706" ] }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Interest Rate During Period", "terseLabel": "Line of Credit Facility, Interest Rate During Period", "documentation": "The effective interest rate during the reporting period." } } }, "auth_ref": [ "r17" ] }, "slrc_SoftwareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SoftwareMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Software [Member]", "documentation": "Software member." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityLenderDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLenderDomain", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Lender [Domain]", "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "auth_ref": [ "r17", "r870" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, maximum borrowing capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r17" ] }, "slrc_BiotechnologyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BiotechnologyMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Biotechnology [Member]", "documentation": "Biotechnology member." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r805" ] }, "slrc_CapitalMarketsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CapitalMarketsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Capital Markets [Member]", "documentation": "Capital markets member." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAxis", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Lender Name [Axis]", "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit." } } }, "auth_ref": [ "r17", "r870" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r802" ] }, "slrc_ThriftsMortgageFinanceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ThriftsMortgageFinanceMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Thrifts Mortgage Finance [Member]" } } }, "auth_ref": [] }, "slrc_TradingCompaniesDistributorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TradingCompaniesDistributorsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Trading Companies Distributors [Member]", "terseLabel": "Trading Companies & Distributors [Member]", "documentation": "Trading companies &\ndistributors member." } } }, "auth_ref": [] }, "slrc_CommercialServicesAndSuppliesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CommercialServicesAndSuppliesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Commercial Services and Supplies [Member]", "documentation": "Commercial services and supplies member." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAbstract", "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending fair value", "periodStartLabel": "Beginning fair value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r12" ] }, "slrc_RoadAndRailMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "RoadAndRailMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Road and Rail [Member]", "documentation": "Road and rail member." } } }, "auth_ref": [] }, "slrc_PayableForInvestmentsAndCashEquivalentsPurchased": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PayableForInvestmentsAndCashEquivalentsPurchased", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Payable For Investments And Cash Equivalents Purchased", "terseLabel": "Payable for investments and cash equivalents purchased", "documentation": "Payable for investments and cash equivalents purchased." } } }, "auth_ref": [] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelName", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "slrc_PersonalProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PersonalProductsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Personal Products [Member]", "terseLabel": "Personal Products [Member]", "documentation": "Personal products member." } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Line of Credit", "terseLabel": "SPV Credit Facility, Carrying Value", "presentationGuidance": "Line of credit", "verboseLabel": "Long-term line of credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r15", "r92", "r918" ] }, "slrc_WirelessTelecommunicationServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "WirelessTelecommunicationServicesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Wireless Telecommunication Services [Member]", "documentation": "Wireless telecommunication services member." } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeDividend", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Investment Income, Dividend", "terseLabel": "Dividends", "documentation": "Amount of dividend income on nonoperating securities." } } }, "auth_ref": [ "r69" ] }, "slrc_LifeSciencesToolsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "LifeSciencesToolsAndServicesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Life Sciences Tools and Services [Member]", "documentation": "Life sciences tools and services member." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "slrc_InternetSoftwareServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InternetSoftwareServicesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Internet Software Services [Member]" } } }, "auth_ref": [] }, "slrc_InvestmentHoldingsAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentHoldingsAxis", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Investment Holdings [Axis]", "documentation": "Investment Holdings." } } }, "auth_ref": [] }, "slrc_ReceivableForInvestmentsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ReceivableForInvestmentsSold", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Receivable for Investments Sold", "terseLabel": "Receivable for investments sold", "documentation": "Receivable for investments sold." } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Investment Income, Interest", "verboseLabel": "Interest", "definitionGuidance": "Interest income", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r71", "r167" ] }, "slrc_BuildingProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BuildingProductsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Building Products [Member]" } } }, "auth_ref": [] }, "slrc_InvestmentOwnedAtFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentOwnedAtFairValueAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Investment Owned At Fair Value [Abstract]", "terseLabel": "Investments at fair value:", "documentation": "Investment owned at fair value." } } }, "auth_ref": [] }, "slrc_InternetAndCatalogRetailMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InternetAndCatalogRetailMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Internet and Catalog Retail [Member]", "documentation": "Internet and catalog retail member." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "slrc_AdministrativeServicesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AdministrativeServicesPayable", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Administrative Services Payable", "terseLabel": "Administrative services payable (see note 3)", "documentation": "Administrative services payable." } } }, "auth_ref": [] }, "slrc_PackagedFoodsAndMeatsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PackagedFoodsAndMeatsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Packaged Foods and Meats [Member]", "documentation": "Packaged foods and meats member." } } }, "auth_ref": [] }, "slrc_TransportationInfrastructureMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TransportationInfrastructureMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Transportation Infrastructure [Member]" } } }, "auth_ref": [] }, "slrc_NetAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NetAssetsAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Net Assets [Abstract]", "terseLabel": "Net Assets", "documentation": "Net assets [Abstract]." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available." } } }, "auth_ref": [ "r113", "r133", "r208", "r209", "r211", "r212", "r358" ] }, "us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyFinancialHighlightsTableTextBlock", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsTables" ], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Highlights [Table Text Block]", "terseLabel": "Schedule of financial highlights", "documentation": "Tabular disclosure of financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver." } } }, "auth_ref": [ "r460" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r841" ] }, "us-gaap_InvestmentCompanyFinancialHighlightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyFinancialHighlightsTextBlock", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlights" ], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Highlights [Text Block]", "terseLabel": "Financial Highlights", "documentation": "The entire disclosure of financial highlights reported by investment company." } } }, "auth_ref": [ "r454", "r460", "r464", "r468" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r208", "r209", "r211" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r133", "r208", "r209", "r211", "r212", "r358" ] }, "us-gaap_InvestmentCompanyFinancialHighlightsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyFinancialHighlightsAbstract", "lang": { "en-us": { "role": { "label": "Investment Company, Financial Highlights [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyInvestmentIncomeLossPerShare", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Investment Income (Loss), Per Share", "terseLabel": "Net investment income", "documentation": "Per share or unit amount, after investment expense, of dividend and interest investment income (loss)." } } }, "auth_ref": [ "r467" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r105", "r115", "r116", "r117", "r133", "r151", "r152", "r154", "r156", "r164", "r165", "r212", "r230", "r232", "r233", "r234", "r237", "r238", "r269", "r270", "r272", "r275", "r282", "r358", "r448", "r449", "r450", "r451", "r459", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r475", "r502", "r526", "r547", "r641", "r642", "r643", "r644", "r645", "r851", "r869", "r875" ] }, "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyGainLossOnInvestmentPerShare", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Gain (Loss) on Investment, Per Share", "terseLabel": "Net realized and unrealized loss", "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r468" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flow information:" } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Investment Income (Loss) from Operations, Per Share", "totalLabel": "Net increase (decrease) in net assets resulting from operations", "documentation": "Per share or unit amount of investment income (loss) and realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r469" ] }, "us-gaap_DeferredFinanceCostsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsGross", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Gross", "terseLabel": "Debt issuance costs", "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r49" ] }, "us-gaap_InvestmentCompanyDistributionToShareholdersPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyDistributionToShareholdersPerShare", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Distribution to Shareholders, Per Share", "negatedLabel": "From distributable earnings", "documentation": "Per share or unit amount of distribution to shareholders. Includes, but is not limited to, dividend and capital gain. Excludes distribution for tax return of capital." } } }, "auth_ref": [ "r455", "r470" ] }, "us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyTaxReturnOfCapitalDistributionPerShare", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Tax Return of Capital Distribution, Per Share", "terseLabel": "From return of capital", "documentation": "Per share or unit amount of capital distribution in excess of tax basis earnings." } } }, "auth_ref": [ "r455", "r470" ] }, "us-gaap_InvestmentCompanyFinancialRatiosAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyFinancialRatiosAbstract", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Ratios [Abstract]", "verboseLabel": "Ratios to average net assets:" } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatio": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyInvestmentIncomeLossRatio", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Investment Income (Loss) Ratio", "terseLabel": "Net investment income", "documentation": "Percentage of investment income (loss) to average net assets." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_AssetsNet", "weight": -1.0, "order": 18.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "verboseLabel": "Commitments and contingencies (see note 14)", "terseLabel": "Commitments and contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r22", "r55", "r422", "r501" ] }, "us-gaap_UnrealizedGainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnInvestments", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 4.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Unrealized Gain (Loss) on Investments", "presentationGuidance": "Net change in unrealized gain (loss) on investments and cash equivalents", "terseLabel": "Net change in unrealized gain (loss)", "verboseLabel": "Net change in unrealized gain on investments", "documentation": "Amount of unrealized gain (loss) on investment." } } }, "auth_ref": [ "r6" ] }, "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Period Increase (Decrease)", "terseLabel": "Net capital stock activity", "verboseLabel": "Net increase, Shares", "documentation": "The increase (decrease) during the period in the number of shares issued." } } }, "auth_ref": [ "r10", "r935", "r936" ] }, "us-gaap_InvestmentCompanyTotalReturn": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyTotalReturn", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Total Return", "terseLabel": "Total Return", "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions." } } }, "auth_ref": [ "r453", "r462", "r465" ] }, "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyExpenseRatioAfterIncentiveAllocation", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Expense Ratio after Incentive Allocation", "terseLabel": "Total expenses", "documentation": "Percentage of expense, after incentive allocation, to average net assets." } } }, "auth_ref": [ "r923" ] }, "us-gaap_InvestmentCompanyDistributionToShareholdersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyDistributionToShareholdersAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Investment Company, Distribution to Shareholders [Abstract]", "verboseLabel": "Distributions to stockholders:" } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyDividendDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyDividendDistribution", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Investment Company, Dividend Distribution", "negatedTotalLabel": "Net distributions to stockholders", "documentation": "Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital." } } }, "auth_ref": [ "r455", "r458", "r459", "r545" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyCapitalShareTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyCapitalShareTransactionsAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transactions [Abstract]", "terseLabel": "Capital transactions (see note 12):" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.slrinvestments.com/role/FairValue" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r345" ] }, "us-gaap_NetInvestmentInLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentInLease", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Net Investment in Lease, before Allowance for Credit Loss", "terseLabel": "Net investment in lease", "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases." } } }, "auth_ref": [ "r102", "r218", "r368", "r888" ] }, "us-gaap_AdministrativeFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdministrativeFeesExpense", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Administrative Fees Expense", "terseLabel": "Administrative services expense (see note 3)", "verboseLabel": "Administrative fees expense", "definitionGuidance": "Organizational costs", "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost." } } }, "auth_ref": [ "r51", "r523", "r933" ] }, "us-gaap_ManagementFeeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ManagementFeeExpense", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Management Fee Expense", "terseLabel": "Management fees (see note 3)", "verboseLabel": "Management fees", "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment." } } }, "auth_ref": [ "r51", "r528", "r685", "r930" ] }, "us-gaap_DividendsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsReceivable", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Dividends Receivable", "terseLabel": "Dividends receivable", "documentation": "Carrying amount as of the balance sheet date of dividends declared but not received." } } }, "auth_ref": [ "r864", "r939" ] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" ], "lang": { "en-us": { "role": { "label": "Stock Issued", "verboseLabel": "Issuance of shares in connection with the Mergers", "terseLabel": "Stock issued", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r30", "r31", "r32" ] }, "slrc_SlrBusinessCreditDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrBusinessCreditDisclosureTextBlock", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCredit" ], "lang": { "en-us": { "role": { "label": "SLR Business Credit Disclosure [Text Block]", "terseLabel": "SLR Business Credit", "documentation": "SLR Business Credit Disclosure TextBlock" } } }, "auth_ref": [] }, "slrc_ScpEyeCareLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ScpEyeCareLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "SCP Eye Care, LLC [Member]", "documentation": "SCP eye care, LLC." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r805" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of voting interests acquired", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r40" ] }, "slrc_CapitalShareTransactionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CapitalShareTransactionsTextBlock", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactions" ], "lang": { "en-us": { "role": { "label": "Capital Share Transactions [Text Block]", "verboseLabel": "Capital Share Transactions", "documentation": "Capital share transactions." } } }, "auth_ref": [] }, "slrc_IvyFertilityServicesLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IvyFertilityServicesLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Ivy Fertility Services, LLC [Member]", "terseLabel": "Ivy Fertility Services, LLC [Member]", "documentation": "Ivy fertility services, llc." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r79", "r224", "r225", "r648", "r891" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)", "terseLabel": "Net change in unrealized gain (loss)", "documentation": "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held." } } }, "auth_ref": [ "r352" ] }, "slrc_SunsCompanyMergerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SunsCompanyMergerMember", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SUNS Company Merger [Member]" } } }, "auth_ref": [] }, "us-gaap_RealizedInvestmentGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealizedInvestmentGainsLosses", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 3.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Realized Investment Gains (Losses)", "presentationGuidance": "Net realized loss on investments and cash equivalents (companies less than 5% owned)", "terseLabel": "Net realized loss", "disclosureGuidance": "Realized gain on investments", "documentation": "Amount of realized gain (loss) on investment." } } }, "auth_ref": [ "r434" ] }, "slrc_PinnacleTreatmentCentersInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PinnacleTreatmentCentersInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Pinnacle Treatment Centers, Inc. [Member]", "terseLabel": "Pinnacle Treatment Centers, Inc. [Member]", "documentation": "Pinnacle treatment centers, inc." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r39", "r41", "r324", "r666", "r667" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r324", "r666", "r667" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r372", "r374" ] }, "slrc_SslpFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SslpFacilityMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "SSLP Facility [Member]", "verboseLabel": "SSLP Facility [Member]" } } }, "auth_ref": [] }, "slrc_TheTownsendCompanyLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TheTownsendCompanyLLCMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "The Townsend Company LLC [Member]", "terseLabel": "The Townsend Company, LLC [Member]", "documentation": "The townsend company, llc." } } }, "auth_ref": [] }, "slrc_CreditFacilityOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CreditFacilityOneMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Credit Facility One [Member]", "verboseLabel": "SPV Credit Facility [Member]", "terseLabel": "SPV\u00a0Credit Facility [Member]", "documentation": "Credit facility one." } } }, "auth_ref": [] }, "slrc_SlrHealthcareAblTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrHealthcareAblTextBlock", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAbl" ], "lang": { "en-us": { "role": { "label": "SLR Healthcare ABL [Text Block]", "verboseLabel": "SLR Healthcare ABL", "documentation": "SLR healthcare ABL." } } }, "auth_ref": [] }, "slrc_WestNrParentIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "WestNrParentIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "West NR Parent Inc [Member]", "terseLabel": "West-NR Parent, Inc. [Member]", "documentation": "West-NR parent, inc." } } }, "auth_ref": [] }, "us-gaap_ManagementFeePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ManagementFeePayable", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Management Fee Payable", "terseLabel": "Management fee payable (see note 3)", "documentation": "Amount of fee payable for management of fund or trust." } } }, "auth_ref": [ "r494" ] }, "slrc_AccessionRiskManagementGroupIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AccessionRiskManagementGroupIncMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Accession Risk Management Group Inc [Member]", "terseLabel": "Accession Risk Management Group, Inc. [Member]", "documentation": "Accession risk management group, inc." } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "slrc_TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Seven Series F Unsecured Notes [Member]", "verboseLabel": "2027 Series F Unsecured Notes [Member]", "terseLabel": "2027 Series F Unsecured Notes [Member]", "documentation": "Two thousand and twenty seven series F unsecured notes." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Accrued Liabilities and Other Liabilities", "terseLabel": "Other liabilities and accrued expenses", "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other." } } }, "auth_ref": [] }, "slrc_TwoThousandAndTwentyThreeUnsecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TwoThousandAndTwentyThreeUnsecuredNotesMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Three Unsecured Notes [Member]", "verboseLabel": "2023 Unsecured Notes [Member]", "terseLabel": "2023 Unsecured Notes [Member]", "documentation": "Two thousand and twenty three unsecured notes." } } }, "auth_ref": [] }, "slrc_TwoThousandAndFortyTwoUnsecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TwoThousandAndFortyTwoUnsecuredNotesMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Forty Two Unsecured Notes [Member]", "verboseLabel": "2042 Unsecured Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "slrc_TwoThousandAndTwentyFourUnsecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TwoThousandAndTwentyFourUnsecuredNotesMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Four Unsecured Notes [Member]", "verboseLabel": "2024 Unsecured Notes [Member]", "terseLabel": "2024 Unsecured Notes [Member]", "documentation": "Two thousand and twenty four unsecured notes." } } }, "auth_ref": [] }, "slrc_MeditrinaInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MeditrinaInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Meditrina, Inc. [Member]", "documentation": "Meditrina, inc." } } }, "auth_ref": [] }, "slrc_TwoThousandAndTwentyFiveUnsecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TwoThousandAndTwentyFiveUnsecuredNotesMember", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Five Unsecured Notes [Member]", "verboseLabel": "2025 Unsecured Notes [Member]", "terseLabel": "2025 Unsecured Notes [Member]", "documentation": "Two thousand and twenty five unsecured notes." } } }, "auth_ref": [] }, "slrc_TwoThousandAndTwentySixUnsecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TwoThousandAndTwentySixUnsecuredNotesMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Six Unsecured Notes [Member]", "verboseLabel": "2026 Unsecured Notes [Member]", "terseLabel": "2026 Unsecured Notes [Member]", "documentation": "Two thousand and twenty six unsecured notes." } } }, "auth_ref": [] }, "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables" ], "lang": { "en-us": { "role": { "label": "Investment Holdings, Schedule of Investments [Table Text Block]", "verboseLabel": "SSLP Portfolio", "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments." } } }, "auth_ref": [ "r924", "r925", "r926", "r927", "r928", "r929" ] }, "slrc_TwoThousandAndTwentySevenUnsecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TwoThousandAndTwentySevenUnsecuredNotesMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Seven Unsecured Notes [Member]", "verboseLabel": "2027 Unsecured Notes [Member]", "terseLabel": "2027 Unsecured Notes [Member]", "documentation": "Two thousand and twenty seven unsecured notes." } } }, "auth_ref": [] }, "slrc_CreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CreditFacilityMember", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Member]", "terseLabel": "Credit Facility [Member]", "documentation": "Credit Facility." } } }, "auth_ref": [] }, "slrc_BasicFunInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "BasicFunInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Basic Fun, Inc. [Member]", "terseLabel": "Basic Fun, Inc. [Member]", "documentation": "Basic fun, Inc." } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "slrc_SunmedGroupHoldingsLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SunmedGroupHoldingsLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "SunMed Group Holdings, LLC [Member]", "terseLabel": "SunMed Group Holdings, LLC [Member]", "documentation": "Sunmed group holdings, llc." } } }, "auth_ref": [] }, "slrc_AgreementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AgreementsAbstract", "lang": { "en-us": { "role": { "label": "Agreements [Abstract]", "documentation": "Agreements Abstract" } } }, "auth_ref": [] }, "slrc_PlasticsManagementLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "PlasticsManagementLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Plastics Management LLC [Member]", "terseLabel": "Plastics Management, LLC [Member]", "documentation": "Plastics Management LLC." } } }, "auth_ref": [] }, "slrc_AgreementsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AgreementsTextBlock", "presentation": [ "http://www.slrinvestments.com/role/Agreements" ], "lang": { "en-us": { "role": { "label": "Agreements [Text Block]", "terseLabel": "Agreements", "documentation": "Disclosure of Agreements." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "slrc_RxsenseHoldingsLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "RxsenseHoldingsLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "RxSense Holdings LLC [Member]", "terseLabel": "RxSense Holdings LLC [Member]", "documentation": "RxSense holdings LLC." } } }, "auth_ref": [] }, "slrc_UltimateBakedGoodsMidcoLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "UltimateBakedGoodsMidcoLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Ultimate Baked Goods Midco LLC [Member]", "verboseLabel": "Ultimate Baked Goods Midco LLC [Member]", "terseLabel": "Ultimate Baked Goods Midco LLC [Member]", "documentation": "Ultimate baked goods midco llc." } } }, "auth_ref": [] }, "slrc_FoundationConsumerBrandsLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "FoundationConsumerBrandsLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Foundation Consumer Brands, LLC [Member]", "terseLabel": "Foundation Consumer Brands, LLC [Member]", "documentation": "Foundation consumer brands, llc" } } }, "auth_ref": [] }, "slrc_NetAssetValuePerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NetAssetValuePerShareAbstract", "lang": { "en-us": { "role": { "label": "Net Asset Value Per Share [Abstract]", "terseLabel": "Net Asset Value Per Share [Abstract]", "documentation": "Net asset value per share." } } }, "auth_ref": [] }, "slrc_TaucManagementLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "TaucManagementLlcMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "TAUC Management LLC [Member]", "terseLabel": "TAUC Management, LLC [Member]", "documentation": "TAUC management, LLC." } } }, "auth_ref": [] }, "slrc_KidDistroHoldingsLlcDistroKidMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "KidDistroHoldingsLlcDistroKidMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Kid Distro Holdings, LLC (Distro Kid) [Member]", "verboseLabel": "Kid Distro Holdings, LLC [Member]", "documentation": "Kid distro holdings, llc (distro kid)." } } }, "auth_ref": [] }, "slrc_NetAssetValuePerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NetAssetValuePerShareTextBlock", "presentation": [ "http://www.slrinvestments.com/role/NetAssetValuePerShare" ], "lang": { "en-us": { "role": { "label": "Net Asset Value Per Share [Text Block]", "terseLabel": "Net Asset Value Per Share", "documentation": "Net asset value per share." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis", "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances." } } }, "auth_ref": [ "r13", "r44", "r46", "r87" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares, issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r63" ] }, "slrc_SlrCreditSolutionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrCreditSolutionTextBlock", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutions" ], "lang": { "en-us": { "role": { "label": "SLR Credit Solution [Text Block]", "terseLabel": "SLR Credit Solutions", "documentation": "SLR Credit Solution Text Block" } } }, "auth_ref": [] }, "slrc_CopperRiverSeafoodsInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CopperRiverSeafoodsInc.Member", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Copper River Seafoods, Inc. [Member]", "documentation": "Copper river seafoods, Inc." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, shares authorized", "verboseLabel": "Shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r63", "r502" ] }, "slrc_SlrEquipmentFinanceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "SlrEquipmentFinanceMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "SLR Equipment Finance [Member]", "terseLabel": "SLR Equipment Finance [Member]", "verboseLabel": "SLR Equipment Finance [Member]", "documentation": "SLR equipment finance." } } }, "auth_ref": [] }, "slrc_MontefioreNyackHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MontefioreNyackHospitalMember", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Montefiore Nyack Hospital [Member]", "documentation": "Montefiore nyack Hospital." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "cef_SeniorSecuritiesCvgPerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesCvgPerUnit", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Coverage per Unit" } } }, "auth_ref": [ "r764" ] }, "us-gaap_GrossInvestmentIncomeOperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossInvestmentIncomeOperating", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetInvestmentIncome", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gross Investment Income, Operating", "totalLabel": "Total investment income", "documentation": "Amount, before investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments." } } }, "auth_ref": [ "r430", "r685", "r932" ] }, "cef_AnnualDividendPaymentInitial": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualDividendPaymentInitial", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Initial" } } }, "auth_ref": [ "r774" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "cef_SeniorSecuritiesCoveragePerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesCoveragePerUnit", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)" } } }, "auth_ref": [ "r764" ] }, "us-gaap_InvestmentOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtFairValue", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Investment Owned, at Fair Value", "presentationGuidance": "Investments at fair value:", "terseLabel": "Fair Value", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "verboseLabel": "Fair Value", "definitionGuidance": "Investments at fair value (cost $132,993 and $18,032, respectively)", "documentation": "Fair value of investment in security owned." } } }, "auth_ref": [ "r443", "r476", "r477", "r478", "r480", "r482", "r483", "r484", "r487", "r492", "r493", "r505", "r506", "r552", "r561", "r562", "r571", "r583", "r584", "r597", "r598", "r599", "r612", "r615", "r631", "r633", "r636", "r675", "r687", "r927" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for interest", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r29" ] }, "us-gaap_LongTermDebtWeightedAverageInterestRateOverTime": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtWeightedAverageInterestRateOverTime", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Weighted Average Interest Rate, over Time", "terseLabel": "Long term debt weighted average interest over a period of time", "documentation": "Weighted average interest rate of long-term debt outstanding calculated over time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "cef_RiskTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RiskTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Risk [Text Block]" } } }, "auth_ref": [] }, "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)" } } }, "auth_ref": [ "r765" ] }, "slrc_FoodProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "FoodProductsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Food Products [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_InvestmentOwnedBalanceShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedBalanceShares", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Balance, Shares", "terseLabel": "Shares/Units", "documentation": "Number of shares of investment owned." } } }, "auth_ref": [ "r476", "r487", "r559", "r587", "r620", "r675" ] }, "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Annualized, Note [Text Block]" } } }, "auth_ref": [ "r760", "r767" ] }, "cef_SeniorSecuritiesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities, Note [Text Block]" } } }, "auth_ref": [ "r759", "r767" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r840" ] }, "cef_SeniorSecuritiesAverageMarketValuePerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesAverageMarketValuePerUnit", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Average Market Value per Unit" } } }, "auth_ref": [ "r766" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_DividendsPayableAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableAmountPerShare", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Dividends Payable, Amount Per Share", "terseLabel": "Dividends payable, amount per share", "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date." } } }, "auth_ref": [ "r30" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r690" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r688" ] }, "cef_SeniorSecuritiesHeadingsNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesHeadingsNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Headings, Note [Text Block]" } } }, "auth_ref": [ "r769" ] }, "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Averaging Method, Note [Text Block]" } } }, "auth_ref": [ "r768" ] }, "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Audited, Note [Text Block]" } } }, "auth_ref": [ "r761", "r767" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "cef_GeneralDescriptionOfRegistrantAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "GeneralDescriptionOfRegistrantAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "General Description of Registrant [Abstract]" } } }, "auth_ref": [ "r770" ] }, "cef_InvestmentObjectivesAndPracticesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "InvestmentObjectivesAndPracticesTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Objectives and Practices [Text Block]" } } }, "auth_ref": [ "r771" ] }, "cef_RiskFactorsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RiskFactorsTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Risk Factors [Table Text Block]" } } }, "auth_ref": [ "r772" ] }, "dei_PreEffectiveAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreEffectiveAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment Number", "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective." } } }, "auth_ref": [ "r688" ] }, "us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net", "terseLabel": "Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net", "documentation": "Amount of cumulative increase (decrease) in investment from unrealized gain (loss) when value exceeds (is less than) cost for federal income tax purpose." } } }, "auth_ref": [ "r446" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r78", "r130" ] }, "slrc_ConstructionAndEngineeringMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ConstructionAndEngineeringMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Construction and Engineering [Member]", "documentation": "Construction and engineering member." } } }, "auth_ref": [] }, "dei_PreEffectiveAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreEffectiveAmendment", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment" } } }, "auth_ref": [ "r688" ] }, "cef_AllRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AllRisksMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "All Risks:" } } }, "auth_ref": [] }, "us-gaap_MembersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MembersEquity", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Members' Equity", "terseLabel": "Members' equity", "documentation": "Amount of ownership interest in limited liability company (LLC), attributable to the parent entity." } } }, "auth_ref": [ "r84", "r162", "r163", "r164", "r165" ] }, "cef_RiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RiskAxis", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Risk [Axis]" } } }, "auth_ref": [] }, "cef_AnnualDividendPayment": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualDividendPayment", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment" } } }, "auth_ref": [ "r774" ] }, "dei_PostEffectiveAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PostEffectiveAmendment", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment" } } }, "auth_ref": [ "r688" ] }, "cef_EffectsOfLeverageTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "EffectsOfLeverageTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Text Block]" } } }, "auth_ref": [ "r773" ] }, "dei_EntityInvCompanyType": { "xbrltype": "invCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInvCompanyType", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Inv Company Type", "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)." } } }, "auth_ref": [ "r839" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_PostEffectiveAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PostEffectiveAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment Number", "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective." } } }, "auth_ref": [ "r688" ] }, "us-gaap_PaymentsOfDistributionsToAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDistributionsToAffiliates", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of Distributions to Affiliates", "negatedLabel": "Cash distributions paid", "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership." } } }, "auth_ref": [ "r26" ] }, "dei_InvestmentCompanyActRegistration": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyActRegistration", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Company Act Registration" } } }, "auth_ref": [ "r800" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "cef_AnnualInterestRateInitialPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualInterestRateInitialPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Initial [Percent]" } } }, "auth_ref": [ "r774" ] }, "us-gaap_SummaryOfInvestmentHoldingsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfInvestmentHoldingsTable", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Investment Holdings [Table]", "documentation": "The summary of investment holding table is used for any listing of investment in a summary form. Table lists the 50 largest investments and any other investment the value of which exceeded 1 percent of net asset value of the registrant as of the close of the period." } } }, "auth_ref": [ "r456", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r490", "r491", "r526", "r675" ] }, "cef_AnnualDividendPaymentCurrent": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualDividendPaymentCurrent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Current" } } }, "auth_ref": [ "r774" ] }, "us-gaap_SummaryOfInvestmentHoldingsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfInvestmentHoldingsLineItems", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Investment Holdings [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r456", "r476", "r477", "r478", "r479", "r480", "r481", "r483", "r484", "r485", "r486", "r487", "r490", "r491", "r526", "r675" ] }, "dei_InvestmentCompanyRegistrationAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyRegistrationAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment Number" } } }, "auth_ref": [ "r800" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r804" ] }, "us-gaap_InvestmentOwnedAtCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtCost", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Investment Owned, at Cost", "verboseLabel": "Investment owned, at cost", "terseLabel": "Cost", "definitionGuidance": "Cost", "documentation": "Cost of the investment." } } }, "auth_ref": [ "r443", "r483", "r484", "r565", "r573", "r590", "r632", "r675", "r687", "r927" ] }, "us-gaap_IncreaseDecreaseInDividendsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDividendsReceivable", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 18.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Dividends Receivable", "negatedLabel": "Dividends receivable", "documentation": "The increase (decrease) during the reporting period in cash disbursements due from investments, representing the shareholders' portion of profits." } } }, "auth_ref": [ "r5" ] }, "dei_InvestmentCompanyRegistrationAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyRegistrationAmendment", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment" } } }, "auth_ref": [ "r800" ] }, "cef_AnnualInterestRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualInterestRatePercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate [Percent]" } } }, "auth_ref": [ "r774" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r849" ] }, "us-gaap_NetIncomeLossAttributableToReportingEntityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToReportingEntityAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Increase (decrease) in net assets resulting from operations:" } } }, "auth_ref": [] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeAxis", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Investment Type [Axis]", "documentation": "Information by type of investments." } } }, "auth_ref": [ "r477", "r479", "r480", "r483", "r487", "r552", "r561", "r576", "r584", "r597", "r606", "r607", "r633", "r637", "r638", "r639", "r640", "r675" ] }, "us-gaap_InvestmentOwnedBalancePrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedBalancePrincipalAmount", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Balance, Principal Amount", "terseLabel": "Par Amount", "documentation": "Amount of principal of investment owned." } } }, "auth_ref": [ "r476", "r487", "r559", "r587", "r620", "r675" ] }, "cef_AnnualCoverageReturnRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualCoverageReturnRatePercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Coverage Return Rate [Percent]" } } }, "auth_ref": [ "r775" ] }, "cef_AnnualInterestRateCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualInterestRateCurrentPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Current [Percent]" } } }, "auth_ref": [ "r774" ] }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsDisclosureTextBlock", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc", "http://www.slrinvestments.com/role/SlrEquipmentFinance" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "SLR Equipment Finance", "definitionGuidance": "Kingsbridge Holdings, LLC", "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group." } } }, "auth_ref": [ "r104", "r210", "r213", "r852" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "terseLabel": "Borrowings", "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r45" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r253", "r285", "r290", "r347", "r379", "r658", "r659", "r663", "r664", "r665" ] }, "cef_SecurityLiquidationRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityLiquidationRightsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Liquidation Rights [Text Block]" } } }, "auth_ref": [ "r723" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r802" ] }, "cef_SecurityLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityLiabilitiesTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Liabilities [Text Block]" } } }, "auth_ref": [ "r724" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r253", "r285", "r286", "r287", "r288", "r289", "r290", "r347", "r380", "r658", "r659", "r663", "r664", "r665" ] }, "cef_LongTermDebtPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtPrincipal", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Principal" } } }, "auth_ref": [ "r732" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "terseLabel": "Repayments", "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r45" ] }, "cef_OtherSecurityDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherSecurityDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Security, Description [Text Block]" } } }, "auth_ref": [ "r737" ] }, "cef_LongTermDebtTitleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtTitleTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Title [Text Block]" } } }, "auth_ref": [ "r732" ] }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSecuredDebt", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Secured Debt", "terseLabel": "Proceeds from secured borrowings", "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt." } } }, "auth_ref": [ "r25" ] }, "cef_SecurityPreemptiveAndOtherRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityPreemptiveAndOtherRightsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Preemptive and Other Rights [Text Block]" } } }, "auth_ref": [ "r725" ] }, "us-gaap_ValuationTechniqueDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationTechniqueDomain", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Approach and Technique [Domain]", "documentation": "Valuation approach and technique." } } }, "auth_ref": [ "r11" ] }, "us-gaap_MarketApproachValuationTechniqueMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketApproachValuationTechniqueMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Valuation, Market Approach [Member]", "terseLabel": "Market Approach [Member]", "documentation": "Valuation approach using price and other relevant information generated by market transaction involving identical or comparable asset, liability, or group of assets and liabilities." } } }, "auth_ref": [ "r11" ] }, "slrc_AutoComponentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "AutoComponentsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Auto Components [Member]", "documentation": "Auto components member." } } }, "auth_ref": [] }, "cef_DistributionsMayReducePrincipalTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "DistributionsMayReducePrincipalTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Distributions May Reduce Principal [Text Block]" } } }, "auth_ref": [ "r727" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount", "verboseLabel": "Debt instrument face value", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r48", "r50", "r240", "r367", "r658", "r659" ] }, "us-gaap_InvestmentIncomeInvestmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInvestmentExpense", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Investment Income, Investment Expense", "totalLabel": "Total expenses", "verboseLabel": "Total expenses", "documentation": "Amount of expenses related to the generation of investment income." } } }, "auth_ref": [ "r73", "r685", "r920" ] }, "cef_SecurityObligationsOfOwnershipTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityObligationsOfOwnershipTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Obligations of Ownership [Text Block]" } } }, "auth_ref": [ "r726" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Fair Value Disclosure", "verboseLabel": "Debt Instrument, Fair Value Disclosure", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r253", "r357", "r658", "r659" ] }, "us-gaap_ValuationTechniqueAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationTechniqueAxis", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Approach and Technique [Axis]", "documentation": "Information by valuation approach and technique." } } }, "auth_ref": [ "r11" ] }, "cef_PreferredStockRestrictionsArrearageTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "PreferredStockRestrictionsArrearageTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Arrearage [Text Block]" } } }, "auth_ref": [ "r728" ] }, "cef_PreferredStockRestrictionsOtherTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "PreferredStockRestrictionsOtherTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Other [Text Block]" } } }, "auth_ref": [ "r729" ] }, "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Rights Subject to Other than Majority Vote [Text Block]" } } }, "auth_ref": [ "r730" ] }, "cef_RightsLimitedByOtherSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RightsLimitedByOtherSecuritiesTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Rights Limited by Other Securities [Text Block]" } } }, "auth_ref": [ "r731" ] }, "cef_LongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt [Table Text Block]" } } }, "auth_ref": [ "r732" ] }, "us-gaap_IncomeApproachValuationTechniqueMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeApproachValuationTechniqueMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Valuation, Income Approach [Member]", "terseLabel": "Income Approach [Member]", "documentation": "Valuation approach converting future amounts to single current discounted amount." } } }, "auth_ref": [ "r11" ] }, "us-gaap_InvestmentIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeNet", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Investment Income, Net", "terseLabel": "Net investment income", "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r70", "r72" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.slrinvestments.com/role/DebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r21", "r35", "r37", "r47", "r48", "r50", "r56", "r82", "r83", "r658", "r660", "r872" ] }, "us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfUnsecuredDebt", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Unsecured Debt", "terseLabel": "Proceeds from unsecured borrowings", "documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt." } } }, "auth_ref": [ "r25" ] }, "cef_LongTermDebtStructuringTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtStructuringTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Structuring [Text Block]" } } }, "auth_ref": [ "r733" ] }, "cef_OutstandingSecurityNotHeldShares": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OutstandingSecurityNotHeldShares", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Not Held [Shares]" } } }, "auth_ref": [ "r742" ] }, "cef_OtherSecurityTitleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherSecurityTitleTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Security, Title [Text Block]" } } }, "auth_ref": [ "r737" ] }, "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Issuance and Substitution [Text Block]" } } }, "auth_ref": [ "r735" ] }, "cef_LongTermDebtDividendsAndCovenantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtDividendsAndCovenantsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Dividends and Covenants [Text Block]" } } }, "auth_ref": [ "r734" ] }, "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]" } } }, "auth_ref": [ "r736" ] }, "us-gaap_InvestmentCompanyExpenseRatioExcludingIncentiveFee": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyExpenseRatioExcludingIncentiveFee", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Expense Ratio Excluding Incentive Fee", "terseLabel": "Investment company, expense ratio excluding incentive fee", "documentation": "Percentage, after deduction of fee waiver and before deduction of incentive fee, of expense to average net assets." } } }, "auth_ref": [ "r461" ] }, "cef_OtherSecuritiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherSecuritiesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Securities [Table Text Block]" } } }, "auth_ref": [ "r737" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "verboseLabel": "Share price", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "slrc_MachineryMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MachineryMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Machinery [Member]", "documentation": "Machinery member." } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r264", "r280", "r340", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r429", "r656", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r882", "r883", "r884", "r885" ] }, "cef_WarrantsOrRightsCalledPeriodDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "WarrantsOrRightsCalledPeriodDate", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Period [Date]" } } }, "auth_ref": [ "r737" ] }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency", "totalLabel": "Net realized and unrealized gain (loss) on investments and cash equivalents", "terseLabel": "Net realized and unrealized gain on investments", "documentation": "Amount, before tax, of realized and unrealized gain (loss) on investment and derivative, classified as operating, and foreign currency transaction. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity." } } }, "auth_ref": [ "r524", "r647", "r685", "r934" ] }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc" ], "lang": { "en-us": { "role": { "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "SLR Senior Lending Program LLC", "documentation": "The entire disclosure for investments in certain debt and equity securities." } } }, "auth_ref": [ "r88", "r97", "r98", "r107", "r175", "r176", "r355", "r356" ] }, "cef_WarrantsOrRightsCalledAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "WarrantsOrRightsCalledAmount", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Amount" } } }, "auth_ref": [ "r737" ] }, "cef_WarrantsOrRightsCalledTitleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "WarrantsOrRightsCalledTitleTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Title" } } }, "auth_ref": [ "r737" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "verboseLabel": "Debt instrument stated interest rate percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r19", "r241" ] }, "cef_WarrantsOrRightsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "WarrantsOrRightsExercisePrice", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Exercise Price" } } }, "auth_ref": [ "r737" ] }, "cef_OutstandingSecuritiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OutstandingSecuritiesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Outstanding Securities [Table Text Block]" } } }, "auth_ref": [ "r738" ] }, "us-gaap_EquitySecuritiesIndustryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesIndustryMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Industry Sector [Domain]", "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate." } } }, "auth_ref": [ "r478", "r482", "r485", "r561", "r576", "r597", "r633", "r675" ] }, "cef_OutstandingSecurityAuthorizedShares": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OutstandingSecurityAuthorizedShares", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Authorized [Shares]" } } }, "auth_ref": [ "r740" ] }, "cef_OutstandingSecurityTitleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OutstandingSecurityTitleTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Title [Text Block]" } } }, "auth_ref": [ "r739" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318" ] }, "cef_OutstandingSecurityHeldShares": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OutstandingSecurityHeldShares", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Held [Shares]" } } }, "auth_ref": [ "r741" ] }, "cef_OtherAnnualExpense1Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherAnnualExpense1Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense 1 [Percent]" } } }, "auth_ref": [ "r757" ] }, "slrc_InsuranceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InsuranceMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Insurance [Member]", "terseLabel": "Insurance [Member]", "documentation": "Insurance member." } } }, "auth_ref": [] }, "cef_OtherMasterFundExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherMasterFundExpensesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Master Fund Expenses [Percent]" } } }, "auth_ref": [ "r757" ] }, "cef_DividendAndInterestExpensesOnShortSalesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "DividendAndInterestExpensesOnShortSalesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dividend and Interest Expenses on Short Sales [Percent]" } } }, "auth_ref": [ "r757" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r26" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r825" ] }, "us-gaap_LongTermDebtTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTerm", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Term", "verboseLabel": "Long term debt term", "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r901" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r12" ] }, "slrc_DiversifiedFinancialServicesIncludesSLRCreditSolutionsSLRBusinessCreditAndSLRHealthcareABLMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "DiversifiedFinancialServicesIncludesSLRCreditSolutionsSLRBusinessCreditAndSLRHealthcareABLMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Diversified Financial Services Includes SLR Credit Solutions SLR Business Credit And SLR Healthcare ABL [Member]" } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r827" ] }, "slrc_DeferredFinancingCostsNetOfMarketDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "DeferredFinancingCostsNetOfMarketDiscount", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 28.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Deferred Financing Costs Net Of Market Discount", "terseLabel": "Deferred financing costs/market discount", "documentation": "Deferred financing costs net of market discount." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payment to acquire business", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r24", "r325" ] }, "us-gaap_InvestmentIdentifierAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIdentifierAxis", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Investment, Identifier [Axis]", "documentation": "Identification of investment in security, including, but not limited to, name, title, and other identifying information." } } }, "auth_ref": [ "r476", "r477", "r478", "r483", "r484", "r485", "r490", "r491", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r563", "r564", "r565", "r566", "r567", "r569", "r570", "r571", "r572", "r573", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r594", "r595", "r596", "r599", "r600", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r632", "r634", "r635", "r636", "r675" ] }, "us-gaap_LongTermDebtAverageAmountOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAverageAmountOutstanding", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Average Amount Outstanding", "terseLabel": "Average debt outstanding", "documentation": "Average amount outstanding of long-term debt." } } }, "auth_ref": [ "r105", "r106", "r529" ] }, "cef_LoanServicingFeesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LoanServicingFeesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Loan Servicing Fees [Percent]" } } }, "auth_ref": [ "r757" ] }, "us-gaap_NetAssetValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetAssetValuePerShare", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "presentationGuidance": "Net Asset Value Per Share", "definitionGuidance": "Net asset value per share", "periodStartLabel": "Net asset value, beginning of year", "periodEndLabel": "Net asset value, end of period", "label": "NAV Per Share", "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure." } } }, "auth_ref": [ "r2", "r3", "r14", "r466", "r473", "r475", "r504", "r522", "r641", "r687" ] }, "us-gaap_EquityMethodInvestmentAggregateCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentAggregateCost", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Aggregate Cost", "terseLabel": "Equity method investment, aggregate cost", "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting." } } }, "auth_ref": [ "r16" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value by Liability Class [Domain]", "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r12" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r208" ] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Stock issued during period, shares, acquisitions", "verboseLabel": "Shares", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r62", "r63", "r84" ] }, "us-gaap_OtherLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLongTermDebt", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Long-term Debt", "terseLabel": "Other long term debt", "documentation": "Amount of long-term debt classified as other." } } }, "auth_ref": [ "r15", "r92", "r918" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r690" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r825" ] }, "cef_OtherFeederFundExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherFeederFundExpensesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Feeder Fund Expenses [Percent]" } } }, "auth_ref": [ "r757" ] }, "slrc_InvestmentHoldingsDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentHoldingsDomain", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Investment Holdings [Domain]", "documentation": "Investment Holdings." } } }, "auth_ref": [] }, "cef_DividendExpenseOnPreferredSharesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "DividendExpenseOnPreferredSharesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dividend Expenses on Preferred Shares [Percent]" } } }, "auth_ref": [ "r757" ] }, "slrc_HealthCareEquipmentAndSuppliesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "HealthCareEquipmentAndSuppliesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Health Care Equipment and Supplies [Member]", "terseLabel": "Health Care Equipment and Supplies [Member]", "documentation": "Health care equipment and supplies member." } } }, "auth_ref": [] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r825" ] }, "slrc_HealthCareProvidersAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "HealthCareProvidersAndServicesMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Health Care Providers and Services [Member]", "documentation": "Health care providers and services." } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesMember", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Equity Securities [Member]", "terseLabel": "Common Equity/Equity Interests/Warrants [Member]", "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants." } } }, "auth_ref": [ "r33", "r681", "r682", "r683", "r941" ] }, "us-gaap_LaborAndRelatedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LaborAndRelatedExpense", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Labor and Related Expense", "terseLabel": "Performance-based incentive fees (see note 3)", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit." } } }, "auth_ref": [ "r867" ] }, "slrc_CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Companies More than Five Percentage and Less Than Twenty Five Percentage Owned [Member]", "verboseLabel": "Companies 5% to 25% owned [Member]", "documentation": "Companies More than Five Percentage and Less Than Twenty Five Percentage Owned." } } }, "auth_ref": [] }, "cef_OtherAnnualExpense2Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherAnnualExpense2Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense 2 [Percent]" } } }, "auth_ref": [ "r757" ] }, "slrc_CompaniesLessThanFivePercentageOwnedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CompaniesLessThanFivePercentageOwnedMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Companies Less Than Five Percentage Owned [Member]", "verboseLabel": "Companies less than 5% owned [Member]", "documentation": "Companies less than five percentage owned." } } }, "auth_ref": [] }, "cef_OtherAnnualExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherAnnualExpensesAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Abstract]" } } }, "auth_ref": [ "r757" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r825" ] }, "slrc_CompaniesMoreThanTwentyFivePercentageOwnedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CompaniesMoreThanTwentyFivePercentageOwnedMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Companies More Than Twenty Five Percentage Owned [Member]", "verboseLabel": "Companies more than 25% owned [Member]", "terseLabel": "Companies more than 25% owned [Member]", "documentation": "Companies more than twenty five percentage owned." } } }, "auth_ref": [] }, "slrc_CashEquivalentsAtCost": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CashEquivalentsAtCost", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "lang": { "en-us": { "role": { "label": "Cash Equivalents At Cost", "terseLabel": "Cash equivalents at cost", "documentation": "Cash equivalents at cost." } } }, "auth_ref": [] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Cash Equivalents, at Carrying Value", "verboseLabel": "Cash equivalents (cost: $332,557 and $417,590, respectively)", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r862", "r919" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:" } } }, "auth_ref": [] }, "slrc_MultiSectorHoldingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "MultiSectorHoldingsMember", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "lang": { "en-us": { "role": { "label": "Multi Sector Holdings [Member]", "documentation": "Multi-sector holdings member." } } }, "auth_ref": [] }, "cef_HighestPriceOrBidNav": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "HighestPriceOrBidNav", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, NAV" } } }, "auth_ref": [ "r781" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r825" ] }, "slrc_ExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ExpensesAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Expenses [Abstract]", "terseLabel": "EXPENSES:", "documentation": "Expenses." } } }, "auth_ref": [] }, "cef_OtherAnnualExpense3Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherAnnualExpense3Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense 3 [Percent]" } } }, "auth_ref": [ "r757" ] }, "slrc_ChangeInUnrealizedGainLossOnInvestmentsAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "ChangeInUnrealizedGainLossOnInvestmentsAndCashEquivalentsAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Change In Unrealized Gain Loss On Investments And Cash Equivalents [Abstract]", "terseLabel": "Net change in unrealized gain (loss) on investments and cash equivalents:", "documentation": "Change in unrealized gain loss on investments and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r825" ] }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityTableTextBlock", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stockholders Equity [Table Text Block]", "terseLabel": "Schedule of Stockholders Equity", "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented." } } }, "auth_ref": [ "r10" ] }, "slrc_NetIncreaseInNetAssetsResultingFromoperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NetIncreaseInNetAssetsResultingFromoperations", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Increase In Net Assets Resulting From Operations", "negatedLabel": "Net increase (decrease) in net assets resulting from operations", "documentation": "Net increase in net assets resulting from\u00a0operations." } } }, "auth_ref": [] }, "slrc_InvestmentCompanyPerformanceBasedIncentiveFeesWaived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentCompanyPerformanceBasedIncentiveFeesWaived", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Investment Company Performance Based Incentive Fees Waived", "terseLabel": "Performance-based incentive fees waived (see note 3)", "documentation": "Investment company performance based incentive fees waived." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsAndShortTermInvestments", "crdr": "debit", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, and Short-term Investments", "verboseLabel": "Cash and other assets", "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable." } } }, "auth_ref": [ "r865" ] }, "cef_OtherAnnualExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherAnnualExpensesPercent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Percent]" } } }, "auth_ref": [ "r757" ] }, "slrc_InterestAndOtherCreditFacilityExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InterestAndOtherCreditFacilityExpenses", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest And Other Credit Facility Expenses", "terseLabel": "Interest and other credit facility expenses (see note 7)", "documentation": "Interest and other credit facility expenses." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "cef_LowestPriceOrBidPremiumDiscountToNavPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LowestPriceOrBidPremiumDiscountToNavPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "auth_ref": [ "r782" ] }, "slrc_InvestmentIncomeInvestmentExpensesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentIncomeInvestmentExpensesNet", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetInvestmentIncome", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Investment Income Investment Expenses Net", "terseLabel": "Net expenses", "documentation": "Investment income investment expenses net." } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r826" ] }, "slrc_InvestmentIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentIncomeAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Investment Income [Abstract]", "terseLabel": "INVESTMENT INCOME:", "documentation": "Investment income." } } }, "auth_ref": [] }, "cef_NetExpenseOverAssetsPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "NetExpenseOverAssetsPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Net Expense over Assets [Percent]" } } }, "auth_ref": [ "r757" ] }, "us-gaap_InvestmentCompanyCapitalShareTransactionsStockIssuedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyCapitalShareTransactionsStockIssuedAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transactions, Stock Issued [Abstract]", "terseLabel": "Capital stock activity (see note 12):" } } }, "auth_ref": [] }, "us-gaap_InvestmentCompanyIncreaseDecreaseFromShareTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyIncreaseDecreaseFromShareTransaction", "crdr": "credit", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails" ], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transaction, Increase (Decrease)", "verboseLabel": "Net increase, Value", "documentation": "Amount of increase (decrease) in equity from change in number of shares or units by investment company." } } }, "auth_ref": [ "r546", "r686" ] }, "slrc_NetChangeInUnrealizedGainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NetChangeInUnrealizedGainLossOnInvestments", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Change In Unrealized Gain Loss On Investments", "negatedLabel": "Net change in unrealized (gain) loss on investments", "documentation": "Net change in unrealized gain loss on investments." } } }, "auth_ref": [] }, "slrc_InvestmentCompanyReturnOfCapitalDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentCompanyReturnOfCapitalDistribution", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "parentTag": "us-gaap_InvestmentCompanyDividendDistribution", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Investment Company Return Of Capital Distribution", "negatedLabel": "From return of capital", "documentation": "Represents the amount of distributions to stockholders return of capital." } } }, "auth_ref": [] }, "slrc_InvestmentCompanyNetAssetsFromOperationIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentCompanyNetAssetsFromOperationIncreaseDecreaseAbstract", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "lang": { "en-us": { "role": { "label": "Investment Company Net Assets From Operation Increase Decrease [Abstract]", "verboseLabel": "Investment Company Change in Net Assets", "documentation": "Investment Company Net Assets From Operation Increase Decrease" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r825" ] }, "cef_WaiversAndReimbursementsOfFeesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "WaiversAndReimbursementsOfFeesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Waivers and Reimbursements of Fees [Percent]" } } }, "auth_ref": [ "r757" ] }, "slrc_NetRealizedGainLossOnInvestmentsAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "NetRealizedGainLossOnInvestmentsAndCashEquivalents", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Realized Gain Loss On Investments And Cash Equivalents", "negatedLabel": "Net realized loss on investments and cash equivalents", "documentation": "Net realized (gain) loss on investments and cash equivalents." } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "slrc_InvestmentCompanyEarningsDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentCompanyEarningsDistribution", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "parentTag": "us-gaap_InvestmentCompanyDividendDistribution", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Investment Company Earnings Distribution", "negatedLabel": "From net investment income", "documentation": "Investment company earnings distribution." } } }, "auth_ref": [] }, "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "InvestmentCompanyIncreaseDecreaseInNetAssets", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "lang": { "en-us": { "role": { "label": "Investment Company Increase Decrease In Net Assets", "totalLabel": "Total increase (decrease) in net assets", "documentation": "Increase (decrease) in net assets." } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r826" ] }, "slrc_IncreaseDecreaseInPayableForInvestmentsAndCashEquivalentsPurchased": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IncreaseDecreaseInPayableForInvestmentsAndCashEquivalentsPurchased", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Payable For Investments And Cash Equivalents Purchased", "terseLabel": "Payable for investments and cash equivalents purchased", "documentation": "Increase decrease in payable for investments and cash equivalents purchased." } } }, "auth_ref": [] }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "auth_ref": [] }, "cef_ExpenseExampleTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ExpenseExampleTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Expense Example [Table Text Block]" } } }, "auth_ref": [ "r743" ] }, "slrc_IncreaseDecreaseInPerformanceBasedIncentiveFeePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IncreaseDecreaseInPerformanceBasedIncentiveFeePayable", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Performance Based Incentive Fee Payable", "terseLabel": "Performance-based incentive fee payable", "documentation": "Increase decrease In performance-based incentive fee payable." } } }, "auth_ref": [] }, "slrc_IncreaseDecreaseInAdministrativeServicesExpensePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IncreaseDecreaseInAdministrativeServicesExpensePayable", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Administrative Services Expense Payable", "terseLabel": "Administrative services expense payable", "documentation": "Increase decrease in administrative services expense payable." } } }, "auth_ref": [] }, "cef_TotalAnnualExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "TotalAnnualExpensesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Total Annual Expenses [Percent]" } } }, "auth_ref": [ "r756" ] }, "slrc_IncreaseDecreaseInPaymentsToAcquireInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IncreaseDecreaseInPaymentsToAcquireInvestments", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Payments To Acquire Investments", "terseLabel": "Purchase of investments", "documentation": "Increase decrease in payments to acquire investments." } } }, "auth_ref": [] }, "cef_AcquiredFundFeesAndExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AcquiredFundFeesAndExpensesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses [Percent]" } } }, "auth_ref": [ "r746" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r690" ] }, "slrc_CollectionsOfPaymentInKindIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CollectionsOfPaymentInKindIncome", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Collections Of Payment In Kind Income", "terseLabel": "Collections of payment-in-kind income", "documentation": "Collections of\u00a0payment-in-kind\u00a0income." } } }, "auth_ref": [] }, "slrc_IncreaseDecreaseReceivableForInvestmentsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IncreaseDecreaseReceivableForInvestmentsSold", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 26.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease Receivable For Investments Sold", "terseLabel": "Receivable for investments sold", "documentation": "Increase decrease receivable for investments sold." } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r829" ] }, "slrc_IncreaseDecreaseOfCashAcquiredInMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IncreaseDecreaseOfCashAcquiredInMerger", "crdr": "credit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 27.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease Of Cash Acquired In Merger", "negatedLabel": "Cash acquired in the Mergers", "documentation": "Increase decrease of cash acquired in merger." } } }, "auth_ref": [] }, "us-gaap_OverAllotmentOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OverAllotmentOptionMember", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option [Member]", "documentation": "Right given to the underwriter to sell additional shares over the initial allotment." } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r828" ] }, "slrc_IncreaseDecreaseInProceedsFromSaleMaturityAndCollectionsOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IncreaseDecreaseInProceedsFromSaleMaturityAndCollectionsOfInvestments", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease IN Proceeds From Sale Maturity And Collections Of Investments", "terseLabel": "Proceeds from disposition of investments", "documentation": "Increase decrease in proceeds from sale maturity and collections of investments." } } }, "auth_ref": [] }, "cef_ExpenseExampleYear01": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ExpenseExampleYear01", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Expense Example, Year 01" } } }, "auth_ref": [ "r750" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "parentTag": "us-gaap_AssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets", "terseLabel": "Assets", "verboseLabel": "Total assets", "disclosureGuidance": "Total assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r89", "r114", "r133", "r166", "r171", "r173", "r212", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r328", "r332", "r358", "r421", "r516", "r671", "r687", "r892", "r893", "r908" ] }, "slrc_CapitalizationOfPaymentInKindIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "CapitalizationOfPaymentInKindIncome", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Capitalization Of Payment In Kind Income", "terseLabel": "Capitalization of payment-in-kind income", "documentation": "Capitalization of\u00a0payment-in-kind\u00a0income." } } }, "auth_ref": [] }, "slrc_IncreaseDecreaseInInvestmentIncomeAmortizationOfDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.slrinvestments.com/20230930", "localname": "IncreaseDecreaseInInvestmentIncomeAmortizationOfDiscount", "crdr": "debit", "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Investment Income Amortization Of Discount", "terseLabel": "Net accretion of discount on investments", "documentation": "Increase decrease in investment income amortization of discount." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "59", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-59" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479910/205-30-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2C", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.12)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "320", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB TOPIC 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "10", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480679/815-10-10-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "20", "Section": "10", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480769/815-20-10-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "940", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//940-320/tableOfContent" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.13)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//942-320/tableOfContent" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//946-320/tableOfContent" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "220", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-5" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "323", "Publisher": "FASB", "URI": "https://asc.fasb.org//323/tableOfContent" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1403", "Paragraph": "(b)", "Publisher": "SEC" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "5", "Subsection": "04", "Paragraph": "c", "Subparagraph": "Schedule I", "Publisher": "SEC" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "7", "Subsection": "05", "Paragraph": "c", "Subparagraph": "Schedule II", "Publisher": "SEC" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "9", "Subsection": "06", "Publisher": "SEC" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-4" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(2)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(2)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-7" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-8" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-9" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-13" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-18" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-24" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column C)(Footnote 6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column D)(Footnote 6)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "36", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-36" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r652": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r653": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r654": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r655": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12" }, "r656": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r657": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r658": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r659": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r660": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r661": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r662": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r663": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r666": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r667": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r688": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r689": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r690": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r691": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r693": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r694": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r695": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r696": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r697": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r698": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r699": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r700": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r701": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r702": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r703": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r704": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r705": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r706": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r707": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r708": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r709": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r710": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r711": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r712": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r713": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r714": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r715": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r716": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r717": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form F-3" }, "r718": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2" }, "r719": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10" }, "r720": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a" }, "r721": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "1" }, "r722": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "2" }, "r723": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "3" }, "r724": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "4" }, "r725": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "5" }, "r726": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "6" }, "r727": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "Instruction 2" }, "r728": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "b", "Subparagraph": "1" }, "r729": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "b", "Subparagraph": "2" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "c" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "d" }, "r732": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "2" }, "r733": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "2", "Paragraph": "a" }, "r734": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "2", "Paragraph": "b" }, "r735": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "2", "Paragraph": "c" }, "r736": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "2", "Paragraph": "e" }, "r737": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "3" }, "r738": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "5" }, "r739": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "5", "Paragraph": "1" }, "r740": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "5", "Paragraph": "2" }, "r741": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "5", "Paragraph": "3" }, "r742": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "5", "Paragraph": "4" }, "r743": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1" }, "r744": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 1" }, "r745": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 10", "Subparagraph": "a" }, "r746": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 10", "Subparagraph": "a, g, h" }, "r747": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 10", "Subparagraph": "f" }, "r748": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 10", "Subparagraph": "g" }, "r749": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 10", "Subparagraph": "i" }, "r750": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 11" }, "r751": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 4" }, "r752": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 5" }, "r753": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 6" }, "r754": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 7", "Subparagraph": "a" }, "r755": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 7", "Subparagraph": "b" }, "r756": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 8" }, "r757": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 9" }, "r758": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "1", "Paragraph": "Instruction 2" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "1", "Paragraph": "Instruction 3" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "1", "Paragraph": "Instruction 8" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "2" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "3", "Subparagraph": "Instruction 2" }, "r765": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "4", "Subparagraph": "Instruction 3" }, "r766": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "5" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "Instruction 1" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "Instruction 4" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "Instruction 5" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "2", "Paragraph": "b, d" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "3", "Paragraph": "a" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "3", "Paragraph": "b" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "3", "Paragraph": "b", "Subparagraph": "1" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "3", "Paragraph": "b", "Subparagraph": "2" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "3", "Paragraph": "b", "Subparagraph": "3" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b", "Subparagraph": "4" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b", "Subparagraph": "Instruction 2" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b", "Subparagraph": "Instruction 3" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b", "Subparagraph": "Instruction 4" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b", "Subparagraph": "Instructions 4, 5" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "c" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "e" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-3" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-4" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form S-3" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Investment Company Act", "Number": "270" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r803": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r804": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r806": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r807": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r808": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r809": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r810": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r821": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r822": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r823": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r826": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r827": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r828": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r829": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "313" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "413", "Subsection": "b" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "b" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "c" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "d" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "e" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "486", "Subsection": "a" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "486", "Subsection": "b" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Section": "8", "Subsection": "c" }, "r851": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r852": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "323", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2" }, "r853": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "(a)", "Publisher": "SEC" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-13" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-13" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480369/946-230-45-1" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 89 0001193125-23-272454-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-272454-xbrl.zip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¬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

MYC1C,G0X(?"5"I^PC#!R^=TDJIZ &+MX[; M"))ZB],7 /D*CTU Y'<4>JF>FH4>&1GOZ#&@:2%FZ&LDLDQQKB$*:7>.3J'0 M >$C@A&53^*@9DZ%3((8R2=.0$^1T%-V4^P6S0:?>W#](/-$U'>-&,6@R#?5 MQ14+[@+%:5-H)]!IQ&#JEQ&$I%] 4@#(VR&QP.>:=?9RMG7<*G@:4 WS'*X: M <-9%% K,AC6<&ON51!M),A]9C[R,&2YS@011@NRR L')S4%],*]9$!-W(G" M";R>./58SBC)06.2['AZ/)+6)KT7I;(H@BYW#A04'YV]^>#"EH0J.2O??&1@ MF]JD:-!$H2 '?PYGXG)7(D5I*C$0>$8<8+ (I0@_G%\7N-85-VWRUDV<_/IK MJ9)9=7N.[D%^!X&NB%)" ^YXC$'@XE0Y_+KEL/M28)1KS[WWS(<8GN7\_?;Z MG_$S'*?5C<] LSR^/<::EQA[[_-G__'QC[IQZ2Z CBY$#DHTQD<92",'(VP8 M6QSG'R\C?!B]IZ&F>JK_WE%T?\X&"'.&NW20:]"=KL3R-(SO;OH: I$?QQ=, ML,GQ#B^N,C@UU@RX4](0R+T2" "^,O]&_<1 >K@R5T$:J)0T9"KE0< M.!S2HJN,_M0:=IO&^3B(;E2^F=["QE_^SG-+0=%XH!0#\^PBYX;N-6/#$F&/\^<,ST;F%E'83 M@O%E\O@[PC4&FUL3]H"*ERQN^(?_9F$H'NA=4(H^B"G*MD5[QL7ED5=.WK"D M=E@)06!D6 D#!:Q>Y+OV1.$0"##4R(Y$PIB(KQFYGD?AY,(MGED5@ER=TD(4E2DP?PV. M'2,HY"Y3_IK)4]7X?>23-&.C_5CZ.Y] *OL:$30F(SMHI3J8I PT%*?_F8GS MX-2+9R$V(TF0W,3&1$N.O:*-C!))^1FAD9^[ _Q*P<#4XL3H8+H_6I[KI,-9 M<"F(V,367W[]>'7#S9*K+S=XFO_+/)&)F[.1 176BEXF#H*9GL-O1**_X$?T M2EX)0&YTZOLBF"8.X5&'&,$8. 08X",98H5FT(B'T" +H]^%ED2<&&U3GGG$!X$BH M1$S1[1_/6PUE/!J*%$-6V[9/+W](\BF,9W! M'&^=1$T#JEA!<8.<$0!Z&2#'[$=)$F7;R8C9B]_):.B5.TGW=<\6*B(@/\+J M/[>O?[A/<"A>G%G.)O<8/H0%6U(,!JO Q$XSIX(%3BLD<><'& _B36@P+F/B M4 I73[^83?EVG]?MKAD+@!$9Y;Z6EH&/^:63:+7HY> MN<=8(\%/,&L P'KB Y,W!LO<=1FZ;'"X&CO.IR4OW%O M\:1\93R>E#P.QMH(T_YIR0),E3:&[]YFA&_*0IQ)KZVR<_+ M$:U%#)U7KW-SFSXW%-=8*O1 =0_;3:REW\%J\[W>NZ6=S0YWS?="*/5_MQB, MNER$^"?"4_?F*Q?*\^TG 4C>+:OHGRHSK!#<^G#D%P8EBZ&-K,"'8L.?5[TI MJU[NRG>_;36:S5TL\LV[GUOF[O:NQ*>TLT-:7N06!:X6I7L2I=]9H-Y!BS#+ M:ZQ32L8&_O0_S/2J)&1_V9-\;3::_5VL[]#%ZY[.!XYGL!_M4?5,E?U=?$46 M/D^N>I[3)2+=@;D>[*4C;+HQ=P1Z%+DGHRH3YOG=DM=1!!(B9.XNW2^%=F"=B#\M9L07J2@R?GRSR_6"#B'O M7GW79T _[ZQ:^%OSG?'YT;3#*"L]#GMGS1@^$=BB_U8G4OR5&^DAVUE.X$\IT?)U-O_.';#HM+#T\8WECS^&A9 MT4'>R4_B\Q^KYQ^G=1AO32P+/:7.$""N;T*;%;\+K8YYTNJ]9>]DZ0F1KH*) M=MP#?\Z#-EK#3I?W87C@-YUJ%L)GJ7W@X3@9X:.\8J/K-Q;1?UT$,6!@>/H. M'0ZXZ-;UX@NY%^QT DU:O!=GIB1BG*P'(H.)5(15R:R MU81X9USWFS.1-:;DHBG%RU ^*%8O!A@QJ?/I\'M\/WS ^]__%:$F4;<3)863 M@ $?U)?ETOG;1 93E-G@A3:+[GT>HL@7F+](JXH7@5$D2@,2'N;R\! Z%D\C M$)X2+_>PZ%_B"RFL&D*:&(2Q.QA5R>X+EBO(R@ M*YZUEDE;&'5%=?2CR<-HN%8Q@SCE21RF,G%96P=C!Y[HHCTF2\R#6U"RR;_# MR;VX\4QOU-CU@Q-QKY8HA1DE.$:5VW,V9$5"1]7 X8Z!R>@=)D7+V\VO#B4[ MV3$FN<*;Z)C!;DAL4/+\0:&3/6'P;S$788@*QJ-1^C<7K"0!HCBV[)Q$<1X1 MF^)QQ)&'7G0<7#.-19S7) Y1 ND.)ME_0M,+>%%:PF/T.$Y)"3"4P7Z4FD5J M1 @2;!+Q@XE* .GGZZ^;> 5S!P8Z=V!U[D#>[B2X]#6E^==D)Q2;G)#ENVB7 M)6O@U>JCC)Z-Z_.;.^/KUX9Q=??'YQOCZ_5#+4C)C:POI-T58.N0% K"--9DD?CCR MK8D%B%=DCEO5*8%MJ,&CR')JQ\9!*U\DPGBO+BV<'V"]VABJ5R>;:-4W M*;86_DAH7P2\A=2%<>5<&\:7M)^7','K%RGBODV9&^Q&H6]+BY)0)>H_N)PB MF^C)I'R30W]\SU\@#''AF,^H)9GT_>8#/6%EXH@%7L']/_1=L<_ M:K1;\-L-*N'K9NLO^!]"O3NW.?RKTZ2?:P;SQ^8X EPXM WDIOKUV7L7M@J.=&2_V71 MB-A9A#D#\!NUDU$]PG5CX8:R.A&FI$]#M$"HQH&$<+OM_M@7!83T7Z&1=+Y]263EB_Z-$LW$6)'8;%D3=/_E'G M/U(^A0#(/'UER?SBP;^1X,T2-B#^?W4S\V\PCX(GZ$U ,'C6*/8M)E%Z]_N$AL"56(3J8?O6J#KHA"J6I,(/8JHK.85D?,=I]D_AJI@Q$F=#FQ MM1Q%D"N&N;@"69DV% 7/JR_>"8%3Q^OB;QN MAL)PR_/U,]5",O2=6/!?&"^ MN7.1XJ"T!O65G+ID#FI4"3TNOBC3-D231:HX1RR&]QE49<)RY,6^;?TG!#2( MX"=*LME6TV]1R1O]TH(41@ME)8AVK4#T,$.!$-=IX059J,Z:Z%#%I>+Z',\P MOS:>1,>9T+(@,^5%FO("^TE2ZBJS>6]0.%!WLJ#N:*$L($9_I/P=?IV6LS)X M(F=QVZGA!N'1[ MAS$MIF7SZ^CL3:Y+JRQKASEUXIT=WC[Q7'8E-YN7AY0M8N5I*XW"^5W:TKP3 MW=03S*TR-&\1G,'86RA^FLW645DD,TN2\4LPSJ'9W%]?S?O1\ F27B,697/8 M58]$2:+UA+1$HRU\H+HZ5)\"37@I5*6]B?UOE9G)Z"=1?$$48>;JWQ0)\LL= MGFWLQ$"^=DR9/7G"J[WH'-$ !<,/+UUYNBTGLBS8DT>S<3G)?-$G>YNO1$[U M;"N6M@VF25EQL1#-\7_GM1)_D72KE0)F9\(TQ4ZOLB2 \T_,0 M4T9!A5*.F!/V'PQ,B:N 4(&R,2_ZA3V-94JVN&/]-R_Q(-N+RUI@2A.2J':@ M4H%!5*2P1/B.!*T>,BRT'D*K 5HI6K?'4+HF+7&W XQBU2T0!B M/<'O42*]6,I8)O=B[$==5,:C(T"E])A(C8W9$VW2 N/< 0E*IT(^*&FGG)Q MF=$]1<:F!HLY(\Z*5E*79P\#QV^,&@?0"]4]H1ZJ7CB/L!2>@9S#9K(RH\I) M2B8Z[)Y7\.&^,K$4+B))T$E!0.5&7R*K\PX$=5PN927FO+RD9.WRUY.@TC7& MR^GW68?/ RFFT6J5[>+ENF*MO;3;+U)7.Y&T"?3!8Z55@HC#::(Z/41WHH@J MZ7%E,0L?S%YYLER9&.1U]M&[\ B(CD>%/#PPC[X1RV&J_JJZFF=@RC$OG:%- MD_-EC12T]A(7T4IP'G46 K8V'4'E?';6F(,I60##482T%,6. K2DQ*Y'944> M3(XO UZ$-FH"+ZJ'_Q2TQ,N',<7A*%LBYC;G^="B/*Z'4!K(8PUU:(N[=H:E M%*EH+KH=X1!G)G?X4]5-P<"Q:@/5SB.K1/&(!W1@TK>YJ2.2L93B3Q+NH28- M_3EW_2"'4QEV'A_'<:6XNR'IA-^(6<-,U 2A" _L.,%[7V3/9S]F[)5C?#.% MUVDHJQS@?#_R?II8!1I+D1.4H-+#M!MX!)26EG$$:LBI*(8J[;NZ4)Y1B2F, MBU.&".?(,K_TFGQ",&5;B<95"RHD=^[/J*&9>"%UX*$Q?5FKBBK&4Y\5&>T3 M(6STU6%)>*PSDY6# :+'.1&E<=2"M+P>$G5#)P#'6T9C6?&X\+P?Q^C:YI,L M14XEQT5'M(#3A,\]E)F!.M_/_\E+E8MP4"QQ <(R>3KS$$"*/^/A@O$5HB+' M03HRD44CVQPI=HZL=<_5MV+JU-7T$;"-;=/AN2_1N1$M^)E]DY:PB./V>&K$M'KK1_V4)BQ72O]<"-2. M(Z"&4L:H"_HU<:>9%$/P)W$7*8*&)[GWD2LN+<_G*%*C1_]JU3;:THP(+",G M!,O@,5A1&M[R"M5E;+"NY2F_8'WMU/KB@+!$9SR9NXP!8892ZJ+5 X$L_WGW MH?9K\85!%UY_\*SS2& _M":P4XX$*F;%GBVJ/B58<3);E;."58G2T>1K[ M9Z$U(I487O/[;)H)<^+-2+T$#7!>+W7UB_B%L[H%8+\]R:T1*S5'OGP5]P1% M4#4&/&K%29'4JYQ;;#9.H_ N%7_>K2F*BIV,4A9+U%]DQI.2XRX@!N9EH+6Q0*)Z&(@::,OWT]4=8VG,.';P<$;[[>DE/Q=AG>B?*2LE ^LA8P[ M$=5K:?]XV,C$-?#\:$[2\92LC8N#('R5['SB;1NZ0V):$6Q=0BT)[(-M5V_ MUJY'N1#U\7E$0I5%8;VX!R:1'E"/;2+E\?I3LD!KAL<]]LZ^$I^N8#4U/BH[*U\A(%9+2HQ"K+/]K6-!8NJGVX'Y,>]_'2=2:NR!3" M"Q+,N:,R7<>AU8Z7\[2M!)- M3HY[$G>@C)T82X4@ER,*MNFBQ6/Z>O'9^ C3GJ& 3S=CEZ?T]>-Y=$8B0YM: M>/%,5)\*6V*('6)?M( MWWKFP$JM96K\>?M);#SL'+K"7;63G8R"2EUYDV/9H=OM?\ ;)VXL&.-$M0O1 M/.4\!,'MX:*BJ("+\]AIQ'672W>GC%>5ADW!P.TG7-/,&B'&H&U!4.>'W9X'55:3,(K'2V1!S+,"27!^Q;1%?W8\L;A _J?QCLBD*^.NHFW M 2\90K5P18^V.9$]LG5";DH.HP4UHF^8Q@-O_!D#4)^P;E1H'DC'GZFT014P M [RWH(Q8V$VZ*Q =1!>*#F_8\+G,1,H!=ZV=]I->2P5[+EHU9*G\Q% MG?8JU6>*TG3I7=;# Z@57@YXCKXV3B^;C4V09+5"XWYCTF>2 F.RI!W Z2%] M)CV/!6FN1^:O5EU;C0>(BC"(.,<)27W1C^&_>38D[/L. A[_6W9&?T"P+B V M5QAT3-'92= 11Y#*4@N$F>4)TZ)XI9T3VW5_R+LPSIT)BK[X]AF['X?S?%5P M*810Q%Q$&%)6X@!W.#9^&JD*H(3$'XRY30WFI]8S(G^@91,#4OX=\ONL1NII M3J+HXD\O0R%>_#.P(O4I'?%K6U=$1,0A"Y$\403YI\HYHE^" MB;+EHARWDB9#ECY6=L(M0\62B#D0Q!:\B^3/QZ M>2JB2N1+Y8[CY+/87EQ_VNY3[%ER>?H8X8$3/L_TGHIC5]Z$FT_:B)J'I ]^ MXHH\ P2F3#AS%/NBGGUSNME*5JQ!'4!.FIH<3GF5= M.O!DXV'NIYB9R.% @'Z 38JPTI(DW10Q*YD:I+:I5XJ8G8!MG[&E0W0-)FX4 M95!JKABO*S69D^],]MJ)WKQF$5&[I%7^+6Z!$8;A152(@V!-OBNFAF<9-286 MT)"2&RDD* %7=V-Z)99S#TC#!*$FEI/<+E'31UZ04.@2Z#C4^@'/9T&(Q^W- MZ$93VF9JVHL(KQ5>56GI^G'_ 1YE)%"'2MA1RJQQ7W6< MTB4WX=-6XJJ3R-Z*Y=728:D=N50@AFS%Q1HLQ<*@K2#T1%U$?$L]?=L=0S\: M-QYK%.$S 6+BQ*/$?$#J\20X@25YU+&,0L;R'\I+XH9D',KS0#%1L@PCD^I* M5VA1_ ->P L_C7D -!V5(YMD3,1((K65+T51$3PM#P2''16:2CXW2C2IDX[\ M"1VJN&])!LM$CJ&[9#NRH_;6[LP7O5/?7KKX8/Y39VE]>M+VT]LK;1 M"#^5_78:211_7U'-G==.3B6&]VI+=);1"01+O2]M>7%YW=O-"8^3L]N-+"=\ M,#E;6^=^S>*5OQKTYZV7O5]?Y+Z2B?9_.AZ[Q_MB1%FWILUQ!?8X!P5TJ[@@ M_^0 6E0P$9KU*YHJGG$=W;MF?7=%H33>YL8[DU7!7UL4?+\UUUY-(#NK&#ZQ M)KRXAW-O\MIKH4H'OJ0#)DX[L:!UYX#KRDZP'\"=6-+IECH6-8K5^*ZE^^^XZ3&L?K7WRM$__ MF+1/5VN? ]<^WS#J]-:<,C"JXIX96NN43NL$2FJ:UC]:_^3IG\$QZ9^>UC\' MKG]X!<"O2HW*_6@>'=&?>'P'N;IWXK[YVL;+RS+4J_X4.R&G (5,>S-?I"@F MFEE3F(TG[W$O<>6M<\\[G[@PQN2+;=YO6%&8,\;O->LY>$^1(S!]VV>U[!K& M^#ZP4'?]2O5]=]Z#$^QTA<6]$=[&EA.I7_9[W($,0V4HZ!XCYT0CK-TT'3LU M3UIOI[+G6'96_#O#Y)3!R=<55!W7RN"_1VV4S#'%6V#\U5@6V7[R+)B9PPL+ M3$4MG2@F'".:33M*>U/<_8$+?PDL?\JCPDW8'1+_CQ@%.&6.S^(B:%NO'?!V MO'JCJ,0+[$+AKQ=!P%C<#]>7T<>D>*DKHWR47"M9SS9)F0BRC&YS +M#!Q 5 MOBA^@K>KBM:NL66R0U"2!D-D)(@A/U[=?/I\&I%J_+V-[@O;I3N[R!6\^I) L MDE')LV"(8_#Z]/&PKT6MG, M.7,F25I6#P[VSWAUN,_22E(3J)U]?A8)1MIWL4>(?T<)%=@=$ 4/DV=""0J6 MC6%L/O7%B-)'/)$TXAFBP)?EC$7Y69ZM$,?UJ4M:>G'@"JD2O1-K$F#M/WLA M7AU%Z=Y^OGC_ J]*NVQ>E?8^O2I\W=RK0L%R& M/'Q'R$\Y.(6JVKC]R%;VOZ4PEO*9027)*' 53%[\W[L/1M05CB3%"4J&8ST[ ML/Q&R;2JE_DC)4=NPGP_)^*3@G[3^20HX40)7XZI(/F(E.U+9"2]5T1(.Q,G MK>,5)Y^HWPP5)E[O3\W3@RVBO@2IR(T\?3T831,CT!=\V?F]%C=WW,K;7J%W M.?+X6<6+-E*FUBV.P]5_VXW6"QE^]Y(&M^25!RL3&V9!\/^W=[7-:>- ^*]H MTND,Z03;LAT(32(WV=KGT4JK?7;\69:?GY^EB=V3'IU?]M] M!*U[JE=N--I!:6$HDR&=T;_RG5P1!XFA3R$ADM_(F'7/R&D]B3X%+JTR+7G4 M(K.B$95#;S2J*.K9M=T+K%MC MNFR-<_HI"JKL"38X9C;0!!LD8@-" (JJZKI,:*!4,CD/0#OYIO4R:$;,.:%M MSZ5YWC:Z:GQT-4#FQF* XLFL'$X6JKR"Y+88HK($*5T,44F' M*/*CI+(ARN)HHOI*-&67RO895/RR"LV'7/.IG5,%EK*$)3$\)<*2JA>U<_5" MMG2-0.J<0:K (%6GT0(J+!&<336=7\'95 &F4U@]0UU[^FPS22 (EU,-,.XF M4M$YJG77](KTE"<3IS?@0KH3-'5!:\7.:0*EQXU2-6,S,8OM0X!5%<_Q*S^; M+I561@UZ5P 58,T3CV_[N<(MD-OKH3+3D8/X\""(!=H M6>4"+88+*&P#POP"KP*O!X/7C.U!".!5/50_WF!UZGC=6*4 ;8(=VH8)Y6;L M2?[A96B_>I!5%445,#U^F&;5Q58/U<46,!4P789I5KU?]3W>KX"2@!+,5A0L MU9M&!A!4I_]!?U;:#50?L<)GZ-KIT;H9B!9SPY>\E $_:GE'YX4]S/'8-EU/ M8)^6(Z35=\F=S*E)(#?T"YU":AU]VM1\9(E]$""U+)Y@-[^'WRSO>=(G ;)C M YE1OR4^W=0FO0#[;WI]^\F;7<$&9>]2J6TE)W MHW^AFI,$?_:5JT@G+@% MHE;0;U\K:#,B0+[VCZ\'Q-4PE$##TJM,A$B-DRE[G/;Q).(*=JRD> >7AY\8 MN2&4^)4)N+)';Q7X&!Q ME _?;?%;84E1YE_K@T+_A76QV*GI# OOW[!BD_;7^,]X"9:\(04XL/19X_W? M\/E;H!!@S=4< NY;D#X8>S#WLU&N)*3*=4:U_-"U;E_#[-K#2(]/] _OGU:[ MMK_^:;GV!"J[QCKFHIMH-^E;[*(JK0[?@K)?T4O&WNISAU9AAI/'K$:8?S*D MZE!YMITO1J^>M2U0?&(IRN6A_B5RJ/?F OAC:$*T'\C+I MRJLE(S.2+*$?! MO/E7\YZ@:5H>ZQ=%3?=4?UG?D(]Z9XYFIOO*6T+3^A0I5CLT4[A4!2X/ I<, M'4UG\\]8@8L;N^OZP"@)8 2 H0E@' 0P6LYDZ@\P44-+83=#2U$M%2Z6(!2= M,RXP1#&D"PPM8(BI7V\+,Q?Y;V'KC-2'$\8))O;IB$SSAO8W* 2"%<;W;WS; M8Z:XH6734$!OMT$\=8V*>Z )$4&\F!@>"^%%1/!8G.Y#B?Z[Y%\<(G@!(XT- MV$D7&GFY\ M;]<,E,24U!AS?E=!JE9@%S,L6KGVS]G I3X55:)9V-F,-:B8@,]SUFGB7+R0 M5$T?2L#,R,A%5]*LA6H,I E=&TW()V5C!BRS=>V^.?P!%1G@1K1Z#COAC F1 MSD;D*GI#8A1]QR6O'>$-%5D9+6E-\9>(D@NIBK_L(2ZL!\+"B0+!B_@K1L9Y M5T6&\:K(L+K%R'!P/7J^,*Z=K&PSP1CX0 MR.@^B-P0GUX&O@B6E.+XY>2J7KTMU_@>2F1(Z&O*Z]L/AK$R0KJ#SEOW13=S M^BZ=R4T$LN\'9+"QA[1376>M6B4-XEXW/O[P\0&8#\RQ ]BO/7TJ^$2W) M5H9]?+9H.Q.5Q.=#S=S.X&P??[Y?M*6K[^7JUQMK^3D)'RZM;#;:/6 M%GQ_B!Q9<6<]FW;JV.D/0_3UF[V+X'O!]X+OH_@^+6/?UMOEOSGA_R6A;RDO M+]_5:H+N#Y$BC?[ -?^C?6K^8]N_,]O'Z <<"1/[[P4BU $1W=7$?!1Q U] MZ;KR5<3(&OA)T"EW'>N5_-J?/@VO_@=02P,$% @ C()G5RC0ROI' P M(@D !$ !D-#4X.#@Q9&5X,C,Q+FAT;;56;6^;2!#^'BG_8834ZDXRQB^7 MW)5@)-M0VRJU+8R:YN,:C^V]F%VT+'%[O_YFP;1.DU:JE'R!W6%G]IGGF676 MFR8?(]^;AL/ O[SPDED2A7[XV>[UVUW/J:=D=TX+P!LM@CL83<:+:!$/K-OI M+ DM6"5W43BP#ER@O4>^VVMW+E7&#I8/EQ?D/T:A4?E>,/O4+#[RC=Z[_[2O MN+" '?A.4 #<:JO:9MDLRYC:<6%KF;N=7-_ :;Z66LNL-FVET';!_T.W^WV^ M91D_?'43GF$!R ^_[/F::S 9@^>,?,]9FI2? M0]#MO0 $?RX?,%NC>BO617[S=PMZG5X?S+;/Y_TRNZZB&&;B 0N=D1@PEBIO MPR]R?0FV?3.\D^J^!0L15?(HV*YT:9=R]+O]^W>U=7U=<]SC)O_ZL!ON=Z#PB+'5(.6H/<(1;G^ MUTS5>4)%DU +C@@LO2?P!]SL$&2I@!V90H%% 7);Q2@+-&^%7%Q>D,TL4IA+ MI6%#@3;P?#TJ/%1?"4GM\< )*_ES2+@F3A&OQ_^$$_4M/PZ=!7%=)3A* IA'$;1:CDUTWE@P6L1!&%?V$X;:8E/3B8;+5>@V@U^6RH]U]>W?GU;- MR/09ZC0&8NR?!L$C(-0)DL \XK.E#:2<[=!>*V3W-J_*QF4/DF_@]R#YIVT_ MG: 1K=8Y^?"8;GCV^)Q,IGFZW7:G@]D-:/RB;5X5BVLWQM\Z9T[AP(?EQPF0 M4D;,[V0\)N(LZ%E"TW VF29$Y+7U4\]7I/!IWSG7DEZF*BM/AZXD9#]=4&J5 M'7/)(6-U-_H?4$L#!!0 ( (R"9U#,Q,2YH=&W-66UOVL@6_H[$?QBQZJJ1(.2E[>X2@L2+$RR1D MNM_TX MV&,8Q?9X/3:4_?7W.6,;""%-TMT;W7Y(X_&9,\]Y>\X9ISUT;D:=]M#J#CK5 M2MNQG9'5L;XVSD^/3]O-_!'KS4* M7OCP3?6N^Z/1^/)9>W/H>U8-39UOHVL MRUH@(]%8"#E?I*U;E80\J'58M8+]?1&E(NFT!_:74G@EO731^OWXHXQJC =R M'D&!\-.:.>:N% MY,I=1(U5QZR1.+UCQ/%-IJL)\R5=1VM#R;]$ZW3[[/)3! MNN7(4&AV*U9LHD*.D[HC^_KVLI80R%JGW8.Q0[MG.XPL9NUFK]-NWI')AQ"< MGOT+$.C0OC5Q["N[WW7L\2T;7['VU?C6V;AF(5/1T#%W12M2JX3'M4Y_W.@/ M;>NJW23)#K.^6OW/COW%PFXHLB;/8?_T+T&_^SR9?NX"K#-F4ZMO##@_.2,C MG*'%IMU)KWMK31OCKR/K&^OV'7IS=@*)MP!HU]F-=!=*)]-1Q-F1TNATQ (65\E\?'% M#\Q\,HO_D9UGQZS'-8R#&>&:W0-L(+RYJ%?3H$X$Z_),OWP+,=U,L,U).7>J+($"U-Q2:E/)D!*1T4/]=\L! MNT22B(";D.;DN>/%>D$R]%*"#X!%JT!Z/#5 9UIZDB>2#"#^(7HVW!:1JDP3 M[9J:TH:D3>$K+8 H!='0KAA=6+I9P(FO8)=!L6$-RJN\&^PV,?PV$R0(2L%^ MX;T]G<^.V(,05RLOKIM'H7YYQ;TXXLB2I?0HD%RKB!-7<8TDH"Y+T>6)5SH: ML9=\)@.9KHG0#QU+>6=B8MR=IXSRJY5#72OGQ.^%17&6Q(BW-AW(=57B&02F M8<]%A,82(.QX(V)**!+!,)*'%HDG8[#(VP?7/6)BR8/,)#D9+GP?[5(N@5AK M8WIZL'V\H&CSQ\.=T(02&U%P.N^W,Y6E!Q&8Q9?0"M]("YHF_-WB.CP;L5DY MIYCL+#P!/!>DG&ZC;QL-[Z@T]+'#:'HMNHYY/Z"+M]X0+V)BJA!F[:2*/L@VLHQS4@NL- M_+UUSAHM[HW'KK(V_,;)\#'GYS6J/EO M4Z>^S6LJL]WX;5/EHYHY97C;( R^OW'Q&P"A I7J@ M%KB'G5IL2N&IJ!5]$#O@>W2K>LZE]!5#9R&\!G\88PK^.7@OVU;)FUYJ,)(0 M'?H)4JT.CPA3'?"IN2T7SJ_G?"*CI0J6@D@EXO/BTI\4!27".%!K@;>KA5=CO?%D8$W,C[MW4:I6__!#GOE'T#;9:,9 FG>*70:?== :;)_:E^)*:NV8#Z_1= M+1Z94]TY$F#V'M^Z0XO0A3HS=VG/$-#/S.S!V& M_7)B_M4ZOT8S'5\<4D5G[,7V:35-W2#P3++>GIMZ=;HGOC?1SWNC=.?]2K5KJ>ZXV= MGO.E<=X^/>LV\T<<;Q8"K#N8C+ZRP8?A9#R97M7^O'$]I\9FWM>QP M9E,9<]RI/W8_W%[5%(&L];H#5/;&';@>(XU9MSGH=9MWI/(Q!.VSGP"!-ATZ M4\^]=H=]SYW*I[7><-(8WKC.=;=)DCWF M?'&&GSSWLX.S<2%G^ASVWW\2]+M/T]FG/H+U)FSF#*T"YZTS4L*[<=BL/QWT M;YU98_)E['QE_:%';\Y:K6>-^U, NG4V4)D/[#^G;);*902JSGQ01H0;9I;< M=!A!.!Y@3R$P\,TT1!)@$'?>__I*1.U3YK(E7T&UHF E8 T! A&:_95QA4D1 M;9B"5"K#9,*N,6N>CX5VJ_'?,@YDR&;C*7.3%6@3(T(VE"H]O?R.FD]&\3_2 M\^R4#;A&Y5"->,/N$6P$P0+JU8I5MU RD#@MD8;YN!@7">/)AF6)41DP;;@! MJP-JQ1$AFD?PB(7R20@ ]:<[4AD9C? YIY;TV-8P'4&6X9 M4?+3'B3@"^5G,8HE.!V1!* 8&MU?,IW1QV[^&A04BY "L= 1\$ D"[869HD* MZA1\"Q#7K592Q"8#U'.%\P(VW[ ].[R]?\Z?\H^U0B@2- #9E"!0NAC>*X$:?!'#C"S'7+':%+ M,#NX#WSQ6LK_1\YX?\J\!\!_^Z7]_O=+75B[("P*+1F& A^M1B[C"JSMT!9B M'@'IR##O^3P2>DGB)!9C6E%JT7,@M!])G>$\2C@EH]R(J9(^!#B,/GN'1@L MO9!;QOGF+WFR -;'8)YF$2)_GI'.>:-]\0Y.2EJB/9Z?=1'DLQY,$]0J)'DT M$&!&";07)+G32+EG@:-/7X@\_"'DX0XY>>(P%G$E(OXW+SG\I%H)0&-+A8:Q M+/9\&-2)8'V>Z9=/(::; ]ONE'.GS!0N@#FW$MIF,DI!8M>A^KOC@'TB41!Q MZ]*L6"](AEX*Y /$HF4D FXLT+D6@>!*D +$/T3/EML26BK31+LVI[0E M:9OX4@,B,D@T-"O%*BS\+.+$5ZB71;%E#8JKO!KL%S'\-@<21$K!^1"\/9W/ M3]@#%U<:]V.,8)2L1D".YE@DGKN(:@X"J+'F7JZ T-/I>\+F( MA-D0H1_;EN+.^L2:.P\9&58KQZI6SHG?"HW23*7H;VTKD.]+%5@$MF O(,'" M$J';\0VD%% D@LU([EH,/)$BB[R]<_T3!BL>93;(27$(0RR78H6(M;:JFZ/E MXP5)FS\>KX36E3@1$T[G]78N,W,4@1U\":WPK310-Q'N)]?QWHC-RS[%1F=A M"<1S28O3:?1MO1&45Z44$*7T_4V25'1E17W6X:BRU MP:D^M5W<<1XC>Q; _$"Y@8U<%MNVFCCS)MK!.HZ,$/Y.NO,=!^=F\M=)F7YS<.@(L?[-:H^.]"I[Z+ M:TJS??_M0MSF]BN8_%&]+*%Q+)E&*KWE3CN *\9XB#( CWOG%BR1V8IFSYCE88,L\/+,S7L$; 4H58_D @]P MIH9M*CSEM:(.X@RT/5:K>LZE&HE49S%:#>UAE2GXY^BY;)95-1D4)1X[\ [DWX+;'N45 \9RNILY:9^>//+6W X$X MN )]!*G6^RV9Z_32ZD*7N/W!V&%#9SR>W?6'[NV'JUJK9I_O^J-1^?RG._)N MKFKM5NO7&AM,IB-G:L<+#/E(8S@9C_MW,Z=3?OFNOH?&V5ZW^O;^EZYVJQ4+ M<=HKOHQ*(!>(H]=M>J/=F\_%[%S5'>12\.$"[_]=CN/'=&^K4J44 ZTQQ_2\ MQQ#'Q^1WP MSU&%.D$;ZU:T.7(_XWCQ2T/N^R;]6H&#]D>.OP%02P,$% @ C()G5T7) MCVIK!P O1@ !$ !D-#4X.#@Q9&5X,S$S+FAT;<59;7/BMA;^S@S_04.G MGEM"F.'%V?A>%G+!W7;[3=ART(UMN98-2W_]?8YL PGD;;M-\X%@ MZ4AZSMMSCDSGVODXZG:NK=ZP6ZUT'-L965WKM\;9R?%9IYD_8KQ9"+!.?S+\ MS/H?!I/19'I9^_7:=JP:FSF?1]9E+9"1:"R$O%VD[;%*0A[4NJQ:P?J!B%*1 M=#M#^U,IO))>NFC_='PNHQKC@;R-L('PTYHYYJ84"WER*Z-&JN)V*TXO6/$\ M5VFJPGS(5U':T/)/T3[9/OL\E,&Z[D,J'$)R#<_#*=_=(;.\R95"LS:V!0G;5."9ES;;%9 M;]KOC:U98_+;R/K,>@.'9DY;D'@#@':=S18RX7^RS\?L/_Q_0M29*Y)4^FN6 M+GC:9D^X[#$$J?B2-F3D(3#;[[]_):*38V:S!5\*EHBE%"OA 8C4[(^,)XCS M8(WQ6"4I4Q&[0B*PSM4$UBTC?R%3T= Q=T4[4JN$Q]BQU?AOITE27:9\-AM- MF1TMA4Y# &0#E<3'%T^I^6AD_B4]3X]9GVMH!SW"-;L#VD!XM["_4;=0TE-8 M%:F4N=B+RXCQ:,VR*$TRP73*4V%T@%8< &$>R0/FP,^J6@GYG<#!.YMJR'M @S,#2F@ZA 1O1"**34B#4.I <$]&MVPETP4TU+%P#4+:-P8VY4'/)99Y;+[>M<,_X)^S M)_PCF"\C&(",N56X#N= '-/)SKR,?*+K5&(?&;E!YF%/&'5'NSH\(BFR8]B$ M_$E^#H*-PZJ5PE;ZP=D("D_2SG6R9A9 %Y2,*4Y3QM +M<+Y@=JI4L7)N)6 MZC3A.(G38 X<,.L[GM EFCVX_X SWA\SYQ[P'[X[>?_CA2ZL73 6A9;R?8E' MHY'->"),G,$6@CF:18 ^?.4=,8;)^?OQ%')2W3&\ZO. MO7S5O662RG^41P,!9I1!.T&2.XV4>Q8X?/I"Y/Y7(?>WR,D3#V,1.Q'QYS7G M=47O+T47/ZI6/*'1)L$PAL6>#X,Z,:S+,_WR)<1T<\$V)^72%) M:N)]3QANBVBK3!/OFIS2AJ1-XBLM@"@%T="J&&58NEG B;"@ET&QY6^LR*O! M;A7#M[D@05 *U@OOX@D7_ST,,C]B]UQ[''$25+Z9$CN581 M)Z[B&D% 59:\RQ.O-#1\+_E57*X>J5LZ)7PJ- MXBR)X6]M2I#KJL0S"$S!OA41"DL MV-&Q!10)()N)'91M81SFH!=<;YJ:$,=$@/$,EQAI%FJ_17-^)@)KP??GZ:PRTF]T;"UWD MY?F- ^#\*[LU<^O;A$Y]&]>49KO^VX:XR>U7,/E>O2RA<93,5"5ZPYUF #N& MN$6E0NSWSN7*N0(YT[0G <_L\0Y>1LIJH@3\I[I=LK?X(Y- ;Z(PBUS3IA^] M_2V;'YD;!M4E"1=0^T6=H2L%3%:PWJ;S6 E^1S26EP5#9*:BF4MF>=D@"[P\ M<_,> :T I>J!7. >5FJQ287'O%;40:R [5&MZCF7:A"ISD)8#?8PRA3\<_!> MMLV2-[W4H"4A.O03A%H=%A$F.V!3[UN.EQQ@ 4S@7N MIZ>MT[,]3^V<0" >O-;<@U3K_A#-=7QA=*$7L[W^R&(#:S2:W?0&]OC#9:U5 M,\\WO>&P?/[5'CK7E[635NO[&NM/ID-K:L8+#/E(8S 9C7HW,ZM=?GE2WX?& MV;Q"=IF[JY99_:Q-QIUK^UI[_=.,W\PKRV+B=Z_+:L!>;OP#^-II0'V@BW8@VA_8GC!>_'>2>;]+O#Q@T/UO\'U!+ P04 M " ",@F=7Y-(+=C\$ !""P $0 &0T-3@X.#%D97@S,C$N:'1MQ59M M3^,X$/Z.Q'\89<6J2$W;M,"R)41*TT CI4TW"2S[T6V=UMJ\76+>[M??V$E* M0;!H[[@[5*%X/)Z9YYGQC/5).'4-?6*;8V-_3P^=T+4-^T8=]#N:WJV6*._6 M"J"/O/$/&%U:GNOYY\KWB1/:"@3A#]<^5V*64G5#V7K#A[.L2$BL&+"_A^#/P+D"_\&;AEIH- MXU0M<[*DPS2[+TBN&):G6A/'OM"[0M, ^\:VKD+GVL;3:,CVWXO]Y(-"GU_Y MP96)P88>!+8E 7SMG0@0X<2&P/1'YLP.5._&M7^ :85BI]_K]:&EG<)5)^A8 M'= &Q[W#O\TVIP]<9>D*BVIX=/";$)P4EEF:TB5G60KWC&^ ;RA\NR4%EFC\ M"#[-LX(#;EY@#;^?&:VG?FNR$F6%M);3@F4KH!CC"@*:YT_:T9>SRJGX/CT[A"R"P/7!2>]HR1.$"596Y!UY IH#:U;R M@J3-H3:0$B(6H\,MJ( N;PO&&3) TA78#\L-2=<4K24)*TM! /Z$YHIP"AM: MT"QJ@].&J6--3-N%H .7OA<$;:GU?I5FJK5A--I6Z0-&P-D=!2^*V)(6 IJ$ M_11_6_I=/ )NEL@>*&?/,)/=(#(UE3$0?@01-F\WB7>JO-_5#0M M[;!*7HAQU042W<98+4%+P41;[),XQLCPFC$2(T]ECLR456E%+"7I4LC1 MXHI)VP(H:MW&DDC(\%9)IV5#VU,1=2I&Q @S1ZX-ENVZP=RTG-GEN=)3Y'IN MCL?-^KLS#B?GRE'O0(&1YX]M7XIK.BN)BD/.->>!/6P^?DG22T;%(,-1)D+R MC?ICW#C6C@ZPFW;#\=/.=3V:JIQM0]0:Q><&3H\;.?[S=UPU&':"$;'4IR>V MK)>_%.,JEA?,R5\O,CSVV:Z9;>R--6# MJ>FZ1M46]6ZUDNVQWA%=LI'_MZS5Y(CA/,,F,:S&ZILD_H*;'4M3AFV(QA)A MD97EUNC_ 6N,/>-C8,VRNYU1_*6:Q,^QB>>N;"+23!>?K"BO'[#5)>N*1S * MY=OY+U!+ P04 " ",@F=7VB]QO4 $ !""P $0 &0T-3@X.#%D97@S M,C(N:'1MQ59M3^,X$/Z.Q'\89<6J2$U?@65+B)2D@>84FFX26/AH6J>U-F^; MN+S<7>H0O%X/#//,^,9:Y/PPM6UB6V,]=T=+71"U];M:W4X MZ RT;K5$>;=6 ,WTQC=@GEN>Z_FGRO>)$]H*!.&-:Y\J,4NINJ)LN>*C:58D M)%9TV-W!\Q9-.2UT;>Q<-KT! MM/K'<-D).E8'^L/#WO[?9IO3!ZZR=(%%-3K8^TT(3@KS+$WIG+,LA7O&5\!7 M%+ZM28$E&C^"3_.LX(";9UC#[V>FWU._-5F)LD):RVG!L@50C'$! @ CI?%XPS9("D"[ ?YBN2+BE:2Q)6EH( M_ G-!>$45K2@6=0&IPVF?VG9\$<'@IDW<6V_+;7>K]),M5:,1ILJ?< (.+NC MX$41F]-"0).PG^)O2[^WCX#;G$6/Z"J3WFX1O-!/'N$'.D!D2RKB('P$HFQ> M[Q)OU?D_*II6?[]*7HAQU042K6.LEGF6Y+$@>$-Z07^N64%%VDH,?W4%+P41;[),XQLCPFC$2(T]ECLR4 M56E%+"7I7,C1XH))VP(H:JUC221D>*NDT[*A[:F(.A4C8H09IFN#9;MN,#,L M9WI^JO04N9X9XW&S_NZ,P\FI;$/N-XG,#QX>-'/_Y6ZX: M#%O!B%CJTQ/;.9^$:/7HN=4M.2!:I XC&6Q[>&X])TNJWA:4_,"2*MF"CLA= MQA;PFPR]@([U^SRLEYS4WNN4J:87AMX% GR ,HO1_:>>_%/TJEA?,R5\O,CS MVV:Z9;>R9&K!A>&ZNFB+6K?ZENVQEE==LMGY;UFKR1'#>8I-8E2-U3=)_ 4W M6Y;,8CVG$F&>K6):;(S^'[#&V#,^!M8TN]L:Q5^J2?P 2C4+Z=_P)02P,$% @ C()G5Q9VNETM! Z0H !$ !D M-#4X.#@Q9&5X,S(S+FAT;<56;6_:2!#^CL1_&+E*123>#$F:$L>2,2;XZF!J M.VUSWS:PAFW]=O;FA?[ZFUT; KFDI^BB7H0B[^SLS/,\,_NB38)+1]DZKG>N?)W8@:6 'UP[UKD2 ML82V5I0M5WPP3?.81(H.]1JN-VG"::YK(_O+QOF>+?AJ<-H^9HD")&++! /0 MD"LRS6SC%I-\R9(63[-!-^-G4(UO4L[3N#2%:<);!?M)!^KC."0QB]:#@,6T M@"F]!R^-"68R'/MB>J[D J2B:T,D.[&'=@"",6B=H:YU9H+RU.P1V#.;&M,8SMJ3$U;<-!$\Y:WA;0\XJM]N#AGH*5VV_;;9![1]W M#_\%\8L*2<%.8)XF"9USEB9PS_@*^(K"YUN28]M%:_!H MEN8<<'*,?0G:V$6R2+5JQ17CM%5D9$X'27J?DTS1U6[KL]81?CKFSF6\C.8L M70!%E OP:<9I?$/S]\E-D9WUNTT4I->'AO!\_TX]^G!69A7?IV>'D(;@.Q[8 MR1TM>(P\P4SSK+V_8,D*GI-DLZ@)I("019AOR\JG\]N<<882D&0!UL-\19(E MQ6AQS(I"*( _X;D@G,**YC0-FV WP9_8GO$G7+?KM4_&'Y;5E%[FBM$0QBPA MR9R1"-PP9'.:"[QB^A%34\:Z60/.P MW!:X0SC!$WH!+*DJ6\I#F-@B64X+(4133),H0F2X=T1#X$2&RA1ENX3;1L& M"R9#"Z+H=1N5.J:X463.XI]-U"X5$7>-,70L,"W'\6>&:4\OSI6N(LR+ M28!13_:C[M@!V:)TB*2WFV$_>D:6M'634_(#6ZI@"SH@=RE;P"L5>D(=^WE"]J^ MI=B+Y*Y:3GY(@ M^4[I-N;_P6J$)\;;L)JF=SMWZX?R:MWG)EZE\@B183KXLD1[]IL\Y\ MZ]S7UY^^_;MI;<@5# _#(" M>.FR]26\_R4BZ$S?OGP%/^&O5S]>?&9/>#W'_.+-JS=OG?]Z]?K]Z[?OWWS_ MW\[_C.[_]^)"HA#N"J^1$R"^Q,%GM,9B@US\X46&GO YH4]8!!)*1%#6]^K= M6\F:C^7C6\;7-WB!0C_X\.*W$/ED0;#WP@%94/$>:G";5ZG*Y#[_]O8EXTOX MY-7KR[_?CV<*W>IWJ:? M0D6DHFH2ZRG[O1>D!;(?_W 9O=RAJ*CW[^,,B%!<+!':I)\OD)BK3^,72G#) MQRX+:<"W>0@"NR^7[.DR?IDO$'(.UJDK$;_-%?$P*?\:7N0^Q,_NJOQ+^2;W M*47$%>7?JE>YCP5QRS^%%[D/04+!=H-%J>S4FWR]P89K*H8W>S+8<.S*EJM5 MX[M+Q%W.? Q4W> "/V]\1%' ^/86?J5!$!P_SP'B@8R1]E8<7\+T".73P M^E*^EF5>7;QZ??'F=6H/>*$Q!;S(&PY>7( ,M!_+EU$!VE?FTV MA"Z8_%,VM_=22H^ QY%_?)G>U7452JK7T+?Q![2$UD= "[N?:;4>AHZ2***O MH>> 7C'3GZKO'5G@SY?[7R<5A )[$_H7]3>P(Z"DXD$VS[A4_$E9B5V%S;YW MD>^&OI[ 94Y6784G1Q#B20N> 5.J#Q>3Q4@('(@1]<8$S8D/Z+%(Y-NBA$8% M;T#N:5FE@UV=NQ?"80LGJM:!>IU,Q6=550O^ 4%W':QP0 !A>[WEBVN4^+:K M$IWO@2BSOZ&0>1 M(5>KI.1[C6I^:*Z:N%*8$3A0;=R@SEK*2!V)U:W/OM4I)_U,HY,_MM )U.6H MRLZ**)%PBS%(4T:CHC^9J.@\V.RI#*;.7NCCR>)N]VF)EDH_TRCFQTK%Q#5) MM63J.NNA1, C/\ [?+"5\B2OZIB$7ZR#TID_:[=^_B> 1KL]$R#'\R!8[14'.R)*2!=@1#4:N MBA42NGP $W33($#U)UI1O]D7=:8>9U>1D]1TBM(?+3G&F=$X\ULKU[?[! %8ZJXQ3E_!%Q"LU5 MY$5<>*J5[@_[TDV*GK98;Q'ARKHB>>Y^:@7YQWU!RC*1A9ZB &_P/(ADI_[2 MBNU/^V*3GY^BP&X)1=0ER/]$EBL?_DL&G[(76G'^6+#"I+2S*WZ*XIWY_)IC MCP2S9+$^]J**S[7"?5=PG<93)RKMI,5/5+@??PO)1FT^4 :'4^D67NC$JR9= M!?&FQ6-+/LG.]&#$U=QDH+V^0Q3PO@84^D*Q*)(W8V* M]UJ!%^9XLN^.:G'B:A*1GZS?$4DY;25H9F/Y#11_8U6#<6YHG;FUEG[0NLMM+ M1IZG4"+_CBX87ZN'-SA Q!?%/2R57VMU4YAR9JN4>P726IU,M\S"]1KQ[60!'O(FC+B<+*Z0("XXW3?$#P/L@9!S"NU: MB4Z];PMS_9)(B@Q@*7(J@V!'4/Y4))6#'Q-5]G'2"D_C+*F2RE(*[S&2$O=& M0?K]A(ZF6&:6@_RE7$7.!/JO5FL4A:!%)@"4,X8XCQ'MY3$F(!P49(N"Q2 G MA:),1YQ-):_3-%ENI[[%&#]A_VV9MFL,Q*PRK5D4XRP:LTB2\PC-J7_A*.+. M6YW=G&TAI[[T25D#_R*@#65\WB^4S07F3W(>>4>ABQ:1IFM,I%<:6LLI1(=T MEK-[GK>,==*CR$T&RYROGP7E1*B<[V)#^_W9I Z@[EQJC0W[*B6H-;9"#,R> ML>63CL[&E[>%OX4@0B+Y>\*9Z<%HSL+@<86E9XGH5F1&J,P M:TQM'XJUQI5 M(:"G,ZHLCMPD"$DD#AB'$V/YG7F#IF=/F(Y7%M\T">-,?5D4AY)[M5":W:2Q,MI,(SV:RR[HL *H]> M9JH_ZZQ6 _KV;EY4BDEV#=9OVY71ZK0T(V<_:>_<&S?-ZVNDN%:%M)HK3?DIY .>5= M>P;EM HL1,6TJ89G)3;*1FS4^)J7T"JN="M9/HOQK+%FB8Z-5-:BB%9GQ:RF M8H+D66EMMRK7J\^TL%:1A4!-];;FLTI;JC0-NGZABY!ZV%,S>^I)SR+89@HV M57/K"K6J+T1UZE2?B=8FQ*/H@OPXHI^KX[1M0K/!O4$;-RFIU7(A'E2Q8?[< MNMMH,FV)V8=W-/EG1:_J$0.ZK4/[?=EFDP::N;"7\S>V \6#"?L'UGV:RT5I^E\:&*M)E< M6YW-Q@^_$\XFH796;:5RTEAIIC7<,BXUUD[+#2K2*KPTK-1(X8LTU$LRK1G^ M4G9PUKVIRO0KI[W7JK6*0JRJ-ZLX+[4VL9)&<1*3LEJ-M\V7/ _G30XN::#' M-B6TVBN&N_8///G_KS#YC[Q-<8H7CKHK\7T KS^\$&2]\>5%B.K9BLMKY.2M MCQ?)M8[_ )9>/J_]Y!-9<\45B$K1^U*("2=5Q/?K5=_E")6P#>9RQ^ME OZ% M<]D#0R#QM@SEE71<[/AHWI8=*(+]X^,$3+LM)WNMH6=^+C,7'E[FKT($9L"1 M=VCIQ:NZVT:C.UO'S%755!21ORZ2FD@*3Y0Q-JFFM5R\B)!%QIF4OL!R)YHHRR,;/E%[560B@KDOPP M))Z_\[49]6R9])<9_RLMLFK5AG_-<*=F0W\G.X_4?.T%HV(5D MR >=25=?!-P43K:6C[M*6J+378'I=SL]X]_EQ=ZVPVIF3O@S8D&DT@V@XFKGRM77)^2K MK?WQR@!4$KG-ZB[[]VL&_1GBV[L K^6\[H6#YB+@T*-\>+% OO3MH@_!DR7, M>U1%(P<2>BI*?%\2__ BX,DU)=+U_D=[4"!8$9! ;87\B;-PDR D@"P!,4>^ M=%P_O'#C [Q+Y#'RUC"EDCS(G*$9YD_$E3<9*T!6F*]!T!NGZ;VRHQAUGCMX M1NBRC+<(;Y$U+XRN_:W@K81F#3\EP'K.-E".7HFPJK6\H0UC'G!>X_ UP(>W]6;8U+G#5LC M0A-V8)R-?(KWGGI^<)82\NW-+\J%)%B,L1"/*T1OH0=ZP-R54;,E5I9^C]=S MS"TQUP90!W;O&=SM&P343@97N M6$.YKWXX.G'FCGZA'".?_!-[/X&&QDR(":WTO"P.M#U@;*]QF ]#KX]M\EDD M:>(9!9B#1$ 8DV"%X^RC6^2J)/:$0@^6VVA<:H:E?Y\BSNB'YJ_6RZ#O/S=^2!#EOCW>]$"9]Q'[U9*TE40NG? M)")R@TP/]DEWF>_$]I/.HFXY6T\ F4(#A*"'%/@&1_\?A%M#A#T(98J#D-/) M(MYK>B-GT&0>1L@':>:5B [6[24G41Z! ,JA'(SS??.ZHZD9#B2 2D0]=O#[ M5 8(ZC423W><_1E/ 4O%H-Q?^,],3$V@'4XRY0')>,0>6#3-L!W0:M!6&>TC M&[E@L#SCTECK=-IAZFWNR'P?1RD>DT5,\H[^3*@7>3QVN*]'<2C='SA4:Z!Y M6[';/%7IWXA5;&D@]7O,E[OHCUT)Z+ <P1.'TQP589E MQC:/H5\P@=I;=Q$YP?%](4/V&$V '&[ *$P,UXP'*1BY'5ANMAK*1)JBZTL^ MX Y/VT7U[$C&!%>?"[,-@Y[6A-$83V]"N,$+S.%UG!U#ES+R+<-#D\4]XE]Q M8+>IM(#38]M(&FAFWCC%(O1E KWLQ5D26;%G"6T@]6<,X-MS018D50#R$U\? M /FAA\5L/-T[; N>[)U*0CUXECE)MH>=Z5NOH=,, MUY@/TNX;X&C/W!5A 797E/ELN;7*3BEEDQT4:M(5N4IV%5).VFC_"^@R.V0/ MU>\V0M*>P<<5)XM [J,)EFB)X[,IK7)6#<%@.R5#'LAFBHAOE8\2N@:C"?0C M,N\7_ *1,7\PCZP)D/;L_4HX/!#B$?YUH6&& ME$0[\P?AL3$:P[U%,*U,ANI!^*L#83"TAL2/CV*PW\ITQ TZ;WGBEDPDB3=: M+#B25R6X06C9DVL"Q* O1.Y7&!"\6\8\V6[O,;+=(58A,&]-*I ([@E;3M6! M#H.T)AT(,RL$P77>!K($O@8D\*B75 MZ2"==AT(H\[;4R'E>"M[NE^*<;NL-0'2GKT1E'] 7*V:#-,E5"(P")%LL)Q] M!=L!^FP-;8->#2;VOHS=!TC&O:)K;2/3MMNYU>,P,#G,FKHRPB8^ 05+I5$ /'*CH(^Q[!)406C/TH3X/Z'X$&T1KM66 MFQ!;COC6@3#KJ&7?SZA0Q=)&[65X!M&W'8[R1$U6(7#'D%VU]VR% U, MAT\-;8-8&8+YYI<@O<[: M9F"LE+396#P+T,;'(G+ ;"NC"H#1V!Q%9Z"$](TIC(L8\P'&YQH89JS)U;B% W7Y&^SM!]2EK_23KE-'O M@Y\H_W4*/4]139LH-_WP3&5!=#]J1>ZL%NK T9L,6U$E'CPY'#_E](U6U>)# M :8X/@\6C"NYZ)O(C5@?G\&PQ62ATI:C+6[9G;&19*VIM#_ /2199HY46,3; MM?H11/U1",VP]&40>[M[CT[_#?!U$<4,*"%O)"29 3C-D^_<;;>#.3E9VWIR:#-,_:?)5M"=8B_ROHY)&%E0!S@-H8)RLKG]B(2Q@V1#%/O) M#X,+H@CH4&+(G%MR0^3&7;OI2'1_Y.F*B;\5\35 M4M8Q"*8=U+X$M'=]NIR_'YO%-(/812 P(PL#.:^1YQXF;??(I-, 7[=&])G1OX7@_BVV M0"T9^<$ZTPL2P5:EAO)'_5AM2&TA]C$W?T#$B[+6!YRA9T&8;*11M=@Y^S=+ MK,MYOU$]5L_XS9,TE?.$6D[JVJ?:^PF]_U+'\Q[P;-[1&I#*#"?EV*WETGZ MDW1:4,!X?&UWH;XY'H,=^V@K8"(.6F#A$4OLM\[ZF;G[7:3%ZLQM&?J9ZG9.2?>='0-NKG,H>(S"WO8]<0-V)C+Y2#!V@UM2@,=AFO*?DIA&XE,5EHD79W M&%< :,_.+VC#Y :%-=3RTBH?I90-QA?5?UP1%IVU85L;>O*]M)D;/+>;E%.# MP8BIO:.3;/.C(6^P@<$E:V&]G12H&NE <\.];5W4P.C@10_C+O?E%]N. FFI M&SB22."M]7ZW0-7D3"6T7%IO WM$36 3%0^P##M/M-LDRD="7 TV?URQ4" J#Y:*EA#@V1D M%2*#[B*[G\<^=WKR!KJ#F:?:D617/_M4>S,Z><2/N\+71V-SI8#:L_L9+S8P M8"=7U%GE3$/;H-T(?S,(!V6$#19\<[<$VIZK:*GWU'96'.-CZ[+UF/IA>H:? ML#Q^CF!Q>V2\UT/K*H);QH]KG*X&U(_&;UG(CX;A.D@]L4R>CJUAZR'UU*[) M\Y%QK$748T=V;"SK,74=>P<<>#O$:)&L QONL@:J#R-&04)3$/P6,# M+ 9Z#*F(SV"(+EBTV\9TU+LEF7Q\=HG C^AYD/R1#'6# #>68ZD;R&SA)/-& M1O_VCF>)$?7-AIYZ)Q](TK+JN\44]9DAJZTTA'".M9DA:666,EKVZ'5):DFK MLIK74J!J8#+>$Q&,;].J[.[.T%'O8/MC&)(D3*L6E"':K1^%$D(,F(F7HV_$ MBO:J=4NG8-1 Z.M MWW8$#3T!ST!6H$5EH.W:ON1O(>(!YD?9SY5@Z]8OU),< M1/5-8)EL?!7$52/YXMO,P:5)NCH[W<_!F>C-'3-%.I6-48Y0"G)R#/#V7UT!'=CJ M327)CDEYO--P2^&U*(S[JZA/!]E/<1!R.ADBN;P9E.XLJA4"+B'#A[W M$7F[W<"K5E9;?QU"(PS=^UP)9T*QI07-2NI=EC\I'[=>:N MF(_% R=J3LL\;/<WM'RBEVJ69[55HM7EI:!OLWR(!N4+TZV>[%S(6R1H-3!ZH1QZL M-H>J)HL%!IN3ZP:63ZBJ@V&2#ZJ"D!,8P2E9KG9A/.O<-4)BD'(0)3%::OHY M:EV:?%R1U::^1]/<@9,YV?:\FU*J762_5Z%5'6AHFV='#Q)DZ] ?A53,-D_6 M3T!!9)9'I9-'7NB2* [*ISP. ME:BY]L?G#>'[T2F+#)<@Z8WS$?SMJ5W%R>;01Y8(>,!UD?:PNF9 %H0\8$JD M%HO!=J#D3HK'D%,9$9M**/:V_6C(&^UK4KMG;E" +.[E*2?;8<$=&K9[;94'H]8JC":#-E;Z.'\>*=P'(M!_E 'S3>' M8\QJ6ND0C!6(&Z34A[+D9"'GWWPZ% $8"Q?=VU:]NU]"M,->[BOD?L5>=$@KN(EJBSB2V[^6&$9[ M=98"S"026E;")<;8^K+79"MCL&*9E/C1W/2ZA6@(]V;*O9/AAKF3/\*"!V/',\XM,,=/%X"HH=CMVR= MK:,CW.6(G5DH)9)&(:980#_CVCXSM1]']:T8!_ERFI3^R$547Y7VD4/NV MGY!Q_5AEALW -M=NU+L.&$:HP6"V#\GZ#J0._ M4,RMKS3HR9MH);JFQK(N\D0-DE50R F,NS+8&HU=EO=H5 $PB%3[C'UEUF]] M+))M#_U3N$8TZ;5M7]"G(]Z>C2^<^6RYO4<4!B/Y?*B;=YL ,6CFR$WJ&?'M6)A0_LM!=W1". M7>LW26JI&^@$W%#TJPHVI+?[6E=,-08#UY&%TJ&F$RYCWN!J$S?Q)G8=C_WK M/]N!,C!*6?,&?$#W&G$\/,$8S*TIO/)N MB%SL)D_X7C!P=09PMQK@,-"C,@AO"+,L)VV0APL$\/:&B"CB3F0"OUW-5"(P M"*>)]9!M24_>Q+_P8/@&!_,36^,I%AL"Y!G?#N=:-,9C$$LDR]4LX!@'5^%6 MI4[8C29JR9LX2$^8AV*H***>O $KG.!KIE*+5:[4/?&^00]JW>&KA6'@7_C^ M+)#>\6@I9]_66U,%?8/D_O YY%MU(/! 2_"5" R&5G>&EMF8\$1>.YW=A\*6F3]O05?JH%F;4:*' :%[<\#6F$ MQ,"5_>5AN*F5CKB!Q[?"C^P;%9AZ<:J>;5XJ$1@8GBO/)(7/IT1\W0E)%;8> MK6^&Q2"0!L/=9Q[-66PSI:%M MP!N[&_J;(#$82E'H#F=X6NHF MA^0-;CK M5^@KC!'2 M3^&NNQXEH8!N,4H12Y/G[D&$7'9& Y/['?S)H ,? LW,W'+98[ M&:P[%&64#=K>8AZHS<%#Q5=K,!CL>0D#@8.A%C:UU W,:X-X=&,!#-ZW MC+O8.C?5$$Q8BJ)'#RO$U\A5RXK(M]\?-,!A,$_REE+O]N=Y981--C"*>V%] MV"E0-5DS]["_?;8>]2B0-5DH7JB459D[/*+QU8I#I6,V!6/0[.41=T(=V.-I M#Z&SG-K3"E*7X\O$Y!O%WFP#KH?W7;P5%=;BH,;#*-!H/:"6 ^H5 PF# E'M5=X.XL(,I!LCYI:H:E^]H+ MWPYEBXV0]+ <..S:WT'F@<Q@AGA)Q"-[)JYJMS.78 ISF*&RCIK#,0C3 M_K:V;H9[-/O8N?ORHYAL7/9%H.'W\)9B,7 W7+*VWISVB9IX25$FXP/:2@KE MI^].L;SLR$M.FK5RIHP9L/Y.G,F>C#+%3\Q_DL=+#7@D8 M 1H=/1 3&6)T& M]<#9DJ/U$'>.-$%B$!I@B-M=_,E1; +X4K@KO$9_^3]02P,$% @ C()G M5YQB-D'5"0 OX, !4 !S;')C+3(P,C,P.3,P7V-A;"YX;6SM76UOXS82 M_G[ _0>?[[-C)^E=-T&WA3>)%T:3.+!OBP*'PT*6*)M8B?214A+WT/]>4K;\ MRE=%D2A?O^PZ,F /$2$+2FR];M8/C8^O73^+XU1#3QD ]:M]A/8X"2 M5J=9C?[)/O0^=1_P, MXBD@G8O>Q67KW[WSZ_/+ZXOO_M/Z7__A]TZ'2Q%!]&WJ4=!B4B/ZL;WSGMKW+;MZPO6IY_4KA7NN7R[SM>??7A_N)/P>QUX%K5394G(V([OSJ MZJJ;?M7"UI"_Y7)V_6X8\ZYQ>=R_.S5QJTN0T(CL 8 MA*WL]=?)<@$^MBF,%Q$7.WLV)R!DSR+B9Z;L75WV./7?;S!' @8^A-8003"&B[Q=_S93S<4X;QA.@9T"2CS-#DS;IVG+OOH\9H MP;LG[V;E"+_+[YU$OIE[: ;H$#V"9&6KB;G MV:!.:6?F>8LN-V871 G-GV3FS4R[?O!U]7H&6N3??$\XN=RU>,%9 M>E&[A4D "%O\VJT7 &?S)/M8H76'FSXZ>D$@Z"<##Y)?O"@%"HNKB!Q 00:! M2FPQ+!=UP<*G(@4 JZ\=-O5*0+%1+^LTZMU_4_CL17S.[2- J$070_1=71#=PF<8L(65CH$/F-#32(6+L+7#8 CE%2/PC_H6A 00-DT: M 2!J[+#]1>**S?_/@N8_WKOR)U^W+QQ@LEV&Z 1'@<"\D_OQC8;&02L;2"TV M]O=U]?4G A8>#.Y>%P!1P/;>HV0.B';#J29S$!DSP<7@?*@+G#VW78K%L7/O MK >P)ZK8V%=;8W_5V\B/ 2@#&(>#QU1R_+\63+R'7X;/61 %M;'"#WU(K- MCD;4KD-HI(0$MZ+1 \DNI!_$$$&:\)34,Y@ \@Q]0.537[9&:XA<-;^)[!*K M%PT:O#U%XOLDW1OEN6]GYD09TKL*F:4:$O1JBT(PSR*&VRTL1@E$,X!\-69* M*K<=8:7H$G0^"#SC[D&"MO*WEU M\!L.(?.NJ3JZMFU42S\N8$-9N&VKB;-I7Z87CH$Z\2]L7>L<<]R3 MY,G>'9D=R_*.@1?!WT"PE?6S!Q'E:BGG?@V=X\AHI'.C*3L/+]WRG3R<9L= C68Y)7VSUR1#);5):;OTA.EF M9PR2E"!^$F\!$R_2 "2X9,$^]_&8)'G3&Y3Y@S-G@"!.- =D#*@;?:T::"@-GU><48W$WE( M:2J0]A&\9-^HMB^&]"> JUY);;;>F9#$SL6!^KS)[=_KHR86OJ6 MJ[V^*21\%Z[R6'B$903,QDFE3;EQ#NN-;):3RH/H- M 0%,!I[/(^O+M2R*H*09=;. L5+-L'BW7&7+C3G]F5DQ"4B5, A*R, MX+H;Z1>BX[8-Q$:@1FQT45_C\.AT[.;YUPBPW>)AEO'OUHY37K&,?LO/ 8Z;B71@" M7[7(5BU(M3MU+B_;\/()//BT_$*Y0SF R$,^$Z_O)VQJUUQ)L&%2ZP"NIT<) M? =C@4N8&*VOQ? MQ6=/Z1)_HOW ]#&$'6G95!9A/J$T%5J:,V85@UK 3[ 1TP S"C\;P M>J6C\ O;??@I 0$OG:#.'>BIFPZKB8Z.)1;%,D_>@.GDY!&=Z/&LK8(76R4V MDXL9BE**AF,GU4N;K:IX8MT5U'0Z5="<$&Q&4^?WM0$G47834'F+KR-D\J>O M8V6NM[B8)4E$Q>'N*+7[\6R+%4MN52: M',2Q*B%Z7%U*@:0UIX;#::VO/DU6%JBK._I#9']6(%?.F$/#03364Y\Y*^EV MX.%UCMQI9EZRSWH3 08 VG)I,HBVNI:<6#/'<<>GFK IX<%+4@*3958-)(K8 MVL]G_E%8#-XBS$\,]2(FJ":AM[ZP"G_+##,*UQUTB'Z&*)!F4S,]C4B;#*21 M@B57:C,>LX<)R'Z,2;(1]1927U(@5M)'3?DU&=#B6E=3UVUO,K 9B5JZ)J.F MU\ZU^F_'_6Q="NVXX+VNT(\=HX;"7%1=?>6XBL-/QPK8_8"&(?W)P6SQ0QS" MRG-UH;LNX'\+0D (L/[A@J(,3PY_,[4E':+LR)/0:RNEZGL9G!N*?6GZ2XY6 MU'B@^U GRWKDI@P:"KRMFA)\BQZ',A_C@(28Q#R=_,G+E/.99*L[R)K*R@69 M-130MZ@L ??= USB^M'K9<8:73-NIP6OFJN-NZ7R+RA@)M MIZ0$V1J+2TI<14&U\8TQS*JOOYWUR?4(6P-(>DO)X;)#.8O\JI\=CX8"6T!3 M"8*E%ZWSNFL3(#AGSLN[@Z__)?_]F.:__1*:)65Q=]_WO]U M[^>?2)&6DZQX_OO/\_KIE[.?_]M__3__C__R?_WRR^^D(#2IR>2GQ[>?/EY> M??[IOW^XO_[IJJCJI$C)3Q_+=#XE1?W3+S^]U/7L;[_]]OW[]U\G3UE1E?F\ M9C]0_9J6T]_8O_\I?O"G^\-?]]A_LC_MG?WRN7PETT="?SG8.SC\Z?_=V__; M_N'?#H[^OY_^_]'-__KE%TY%GA7?'I.*_,2H+JJ__[SV.S\>:?YK29]_.]C; M._QM,?!G,?)O/ZIL8_3WP\78_=_^^\WU.'TAT^273$)9SN*?4_B7_\F;.+ECFY)T\_-93^K7Z;D;__7&736)<]D]]D_ZAH!UX%A\ MNR.4<4X__7.>S?BG+[-": \N]"H_T)&H6_J<%-F_FE-I-)ED_'^3_*IX*NFT M^(DPT-C^\V.I%\F&?TSR>=D/)].$_JFOLEO2%+-*9F,ZN7XVV)TS_5 1OWS MAZ3*JE8H/?P\.D.6M^KJQY^NR2O)#U6T(K&AY8^B@U_^C4H>7RK&_;5M]Z4H M'RM"7Y/'G%P5LWE="9*1>()+2YRLVKC-8N*;FC!T)O['G-&0,R5KQ]WH ML9S7#R_DHIS.DN*M6ML*:SOA#8EA2$1$QAP?2\L'11W9]I$\UBM%\;HLGA\( MG?*_Y9XMVKBTVIW2;E_N T9WD7;X&02 >.H2_+7NAL$%.RZS>KQP?B)JKH[? MQK=Q4+&X?;PCF'^PZZMZI-GDF?Q1YMS/75WG*1Z>-M_O+I\_2)+7+RG;=Z/' M'%4X#E_N#N/#G&D7I*K$ZD;%X?+ISNZ-Z323/I-B[,B&9,24F'[^P;?% DZ)*TN887A*R M_I=7Q6)X7:;?VF%'^+WNNW-,BJRDUZ3@I]H=+9]I,F5GVY*(<97/QG]L0/U)FKU&UVAS9F1 M_L\YH^73*Z[?T>W+3C VGJ6?DNJQ>>2>5[\\)\E,O$V3O*[XW_!/5JM7:D(F MTUT8.Y]H /"QOWWZ49.BRAYS\JE@-HQXT+O.JN5[34+3!=GRCSOOWOS+65'_ M-LFFO\DQOR5Y_K,53D4LP.(IGPPFJ]U(8?]F<,LBU\FY"F9YS4B<8IO M(Y%:3I.L\$.I_'0G0IMO_#)M8E1)3Q0_<">Q/;7-<$'IWOF.]$9TDV:V>A:?E@O)Z7A^HN74E7?RYTL7 M%&)M_BUE]@M;;I_RYLV.K6_RS/^P^O>\K,CD[S_7=,XX-J\8F'(F[M6??RKI MA-"__[S?6GKFRY3_S4J6\B^^+L,O+O*DJI@>SJV+T8],M?S .9*'>UZD:CCN M0"EO2VM#P@ZPU!)KO]_:2&R=NH\;EZA"5+N#)9A]+S+27>\K 3DP6RTE$R*U M> Z'*)ZOF^J6-S%M*HR]R&D%32VOHQZNKP?V1>#*XD,DR<=^I*!2,7$OK$T, M:G8?>V3WB!$Q:=X \N19P^^-,9+8DZ$Q7 -"S?&3'A;X':%9.?E43#XVH7W& ME;XQ5A)_.C0) DCCM01*7694F^?\@";UD?P.I]5NC)8"SH4I#"T MY"&6B;U$UL9+$'YLE]YDH@2DELJY1ZE<9/7;B)+DHISHCJGU(8+4(T_:JS_> MJS%H#, ]C_SFV4SYW4M9D,_S=9A;/-\>)FD^&!K?]3@TO&]O?<.\_\2#I-[& MTR3/%^_6&O8K1DK*#X".*$M0&A'Y-)8?:,(? M,\=OT\8/M*V-V6R,5BE(9ZBL0R4+4+PJ21CW\S_=.4T&>V:W^GY??Z M1>:1&<6CG"$=#@.5#@!)(QS_MCO?S!;F^FK8U_V37]0CVS]X?,AJ;43B]C!!\_'@'+IZ'!K>^[3+%\1\^I$V%2L,3G754$G[ MX/R&9BP:.?@TQS?.QB9TZY;>T?(U$^4/P?MA:XK$,E!C \*DD8]_TUP2QM^$ M;^E#^5T5(6@8+1$,5(TRP-&$;_JWQ25-=V55)_G_D\T,P0CZ"1+'X$+7;!!I M)-.'@9Z6=%:*S*UF)U_PDE[T#121<:9$-E#=UQ*:1FC^K7:>FLT)*]-O36YS M=3NO>0E>_L9F=D :)DI< ]62[9!I)+;0BW[;3'+RE_;D4+ V0*;*DNV*M:0? MS+E\;Z=P(40S;4VLH>/?) F53E M##:,;N <^LJN\24?(Y 8DUR_C=WMK<-0^HF;$NN EW!]J$02 M1"V$>*MW"ZH1H.>CM9'%/2]OR#293PDM>,%G9N?/I_/F_/S(F)MFIEL%GBS1 M!GDO;"SPQ"4XZ7F((X@]O)"8"!G@W7:G,UB!BEICVT&"-I#V(6M=PJ MNZ2C)[RU9[O%ZY0"[L%1D-NF_<.4#@-ZIEM[28 2$.J_IU*7EIS7\='$]17= MZ#ELG7PW]R0EV2OP8J$8+5"?!W6;NLG!" (C<4UC$:Z\[K??BXU^>Y")",^4 M.S[HLY&=%)P!H6>QM7M]T!%L?'3031+HSL*I3BX"T+T[P.#0$]Q:V?Y)]6*R M]]D_R^T?U/OH=H9M4HV1JZ8YM%9GY.:[X;C,M8^IICGR^@NJ,#D<5'90T//5 MVJSS.TIFS/K\]&-&BHHL8B5 ;W4?U14+I M6U8\@QY*XT1Y*@3U'KN?939XT)/?NH0A6*G+NX,EF@$GA)BLOLE3OY4T96\DP:*_5FXVK<%H_]%Z2)&\3=8KGL%6)J M@P\CVPT2V$U)R2XY/"-*TOGPG?W56WMY=OT!7IGD;.]XJ.+&@P]DTJ&N!BRA M@^":I1XN7@!'MM8H-2)<^"HB3(;<:%\ZL,S(H]-^S5/''&&;:2*5,$QI/!ON M:IP*5HAB2([L8K\>G?KQ\[2Q7PW"T%&.:;_&9+X>>7I*Z&J^"J8[F:]'^O<% MC%L?U8(Z\O4*W=EZ;;CH:C@=Z=^CG5X6>F)][,9K6QE QBM&&N/@3*$@3Z66 M6Z8'4TA[)CII>[$X,H[W@I3I0Q"G SZ$U,<8+=?C,!%PB%O1&F44J8[DB5!* M)I=9D10IN2BKNOJ=ELJ.4^ < >U@8):5!9P8$AEY(NU543&;H:E*D*3$*K%8 M-44"BS$ARR@G"(W'+,3=-WVV3+0'GVJP)#-H3)8]TVUPH+?&Z^@@NDOH+6T@ M3FSS0"QF2[Q!LG=0W$4PL-A2&H6#:S2O7TJ:_4M9Y,1BEL078RJ#BY]/!2B* MO,>=@%G-D6@<+S#M#TQE *!$D=2XLY"NJFKNMI?$#+GL@B:F(.RC;3! WF+@ M=Z/;&1%U6P=6.O/T]+S?!Z)%DO'B5ON05%EJ(%LY_NO^\>G><=AX>1,_U4L< M@(+P%J13AILJ]E?%EX*2).=7T^\,X34SF6X+8RDN*"^H\X<;EIV=1EA74R5( M;,PQE. $8!AV)C!3P R88H0H*/5^MF9 #)4^5X3)IB[WDG:&WPR$#;@L* M"U%3*%6UP/'Q,PT#S\-8X/VL(#_<\O=D)]-:P'MA>QRC[?#P.$ROR9;'O!X" MPBL<;J%72:IA5ZJ&B[5Y%.[E1<]A]68Q@XBA1.AFT2]&906+1CM'0 M8A<95 M/A9(8BC_V23D_4X*9J_E[!3=I!J6E\UT"3A<2*>KZ-Q (;R#:4-"1*[7(F_R M@I))QI\.>"3FVP*5/D#$9K;$$>0QQ4DXK3 AO'R!X3I25V%F;-,RI4BY)4LF M5P5_/)5;_Z^$_4&;H-WF6\Q0/CD_WXO_/$1 B/$PUKTY0_)84K;N9&U1^&A4 M3Y!7=+CZA:Z'(00CBF>TU?KB7:.F9/7?L)S N?(X"5)PM97('!!AO)V!)Z2& M"DU5-?O)\H2(7[%H PGCD37#?I=&HHO=00[9ZT MQ8CU9,ETS9<3;+3B_#8G889RD0L044 M(FN/TF-IT;[SW!B@&-2R-F)SP(=1B_2]9*G&X)'HLDN[PX^BTND=+9^R^MJ< M);<:)"-I@O8;<]?:5?1'4K$4+\C)HC^&CY\3N\93K4YO*\(O)Z*HO;I M"*= MPZDX'F/?_5,SSJ[H[D><7@RM#P/(Q"@&FS@-"81\5Q=%%M9&67Z[9[,YC1] MX8%<'^=LBSVS@S@K)U#G!'#NU_W#PZ!:9@?AZ!X3["#'D O5T"KR3G?(_$R^ M-_]B/I,LYDN&!4W/]2-E>^0Q)$0U)+^4.?OIBJ?NU&^"9G9A,_6Z(A^)^%]( MWA:?D.Z0H$GS?D3N!!XA+ZG_[J:GIW%FI^KO5P7Y,:0L[2S CSS#('N< MRF8=RN741E>"OR87=)3&A(.VY +47XU A7^BGM."61#B6%FG$GZ?A+_!3Y'3 M@Z.@PNLD"N,[I@M^?W4$=^A9>!E:"5,UN4%Q&K;@G'$QWA>*S4C6)L$81BN?"B#B*Y"Z-P29*+[4S MA-R^QLW^8=C 1F$ZF<,6_(@BNS%^!>23%J!96 E^0#R6[*$K*<\<^ M%756VX0WN7],LG4@PL; &67ZG=GGK!@M\01--NXB! MG/[$I,(71?Z=OXB_TZ.@1@F^#"TA8V3H15Z&]/0X2.*%/]%:@P92 4.'FR75 MRV5>?A]:E-G97K^OUEU,M;,]/U=3&U.MX9NUJ=90CFFJ]5O/GZWMK;*P]X0_ M$:1L$_!_:$I,K?_%VDBUC_#3CS2?\V0>]H\>S3TQ,Q6@S]$L(E=[9W M%O0J=5]]H7@40]0;NYTX(*;Q\8>LR8>W+TUYNF59DU%:9Z]-(VP[\]3Q8U(T M,>;6&!9,%YPQ1+_9TX\B[.;]^_PLM"W;6F1=%\$*?PQ!<+NNLR7):VWOK9Z M73XD\A+#E*;QMPC:\L!?,]]=BNZ2-ZY579;46+;^;O%HI?:3R&Q%#!?!?/*$V92CU99XPL1:QBFM-9X?9IH30=!4W4PUDY^!R)H:[Z M+IJ-@OUR7S@M$-4')%,#AX[X709FW#[+K^^<9H:JU7J)MO^8+%WP#C8Y!@]\ M%G/?.7HV:OZ/"7W-TF4'!V=1VWQ-'%^A(X$\RMJ-"5&$!>Z"6%3,E/1"KYCP M='EK!;4"?!_@)M111/@9&"!"*+H9?YO?D#6'@A[JO=I].OA1A/SMTKV(8*_N M24J8@>*JIBGF"\RGL9IY.@'92MJ(.(K@/H7F0#T.R18H0#6NZ[U7VP MZ0 KM+ M[:!CQ"!:[F41GB3/?T;7#:'/^M*Q=K-%MZ.EQC],&;;"Z[4/P*Y>5J:$3*I+ M!GZ>4A]<5DXUKHYU.Y/YQP ^N64Q\8/ MC,1[4_C\;KB&[I!Q_Y($?.'Y!GM1! M5< 0_2;L$=C 85^LV]4(#64L/O237/.39NKI0"*#-/#/O;_B/RO@P:FH1WRW?! M'T5OB$XY'08%L=-W11S ^<"R'9 @1]$Y8CR?S40669(O\@^OBB8HJY$#;"%8 M?J'!O;\78]T%4QZ>*[@H.DVL%>#9-TEN;9AT3885CRNS-3)3P@(Z3?3V5L)T MC8?D!ZGNDFP"OH=L#9;(P]8)Q!&2"9Q&5/W&A&E4AZ4VAY$':/A8\\AW$F4C M'O<\0"N<&JGWZUV[)S,9ZW#[]*6H2#IG&OQ'\F@2KG:./'QBC/2SDHA:QA9P M-:+L-^9K_26&WP8\R/SV:6PE4G"NT.+"]IK!%ZT#;(V(^\W<7%^*=H+5S)"X M0E>\\;A3E6 U0NRY'>F2QO6:T3S6[.DIRS-V!1DK3\&S)=YW=@P[ =<(NM]L M2O7I8GO+6LR6>(/:,'T=RAK@&D'W7#).+LW+DJY*_]X^7933:5DTUIG%AM9/ M_KI_ VQ-]F!D%KY-NOS\@>/XI)).O#Q%@MHX/(V^#72'_A#PA1OBQ](9-Y M3C:#QWKT=*E^_]JFE)EQ8O,DLW\>JD1JTSM>MI*_?3+5.K:>VR Z"OO@:LMS MG;GZ):",\=:L!M[Q7M!4,"P)&L A%/<"B\17S7EP54SF[.9] M^YSH(UE-K5Q63:) M"%7#OX]6 E'-DG0/4(5P A='X:E-6FL>.V2O_HGQ$E+8)UU,E6\;5AQUGK9( MO$PR"C4^UT^2X(+:NL@R4V"+J^OC(D5'T'O:%:DV2S)1U--F*K3? DY:%H"ZMZ#8$928TEE1C@;51+5N[CLU+@BJ92D M6F%@%T33M ;A8=@D?A_;;AM=%.6.E$#!-@K:28(SGF1G;JG026(VB#!;+?0; M^<*CC>NWYL6_>4#X\+;P!HQ^9*9M:IXHEO*IGW?T%S:3IO-'\@O[6U)4V:KE MMJ7PM\6G%+PM0HSB1.AR7)!ZLW&:6FJ7$CO%W'TZH5H*PH[0>H@ M1M'RT+,@OS(1)O.\]BW0Q:^$E.@*J\_E= MR<2@W@7;C:OPX/7''HS"2IJU=<-SQ1A\-OZ/,N<=<2KSHM!.D.0&39[J($T+ M7![+&PGQ7S#QRP@,RM.N%ZO)+!&;N1)$4*NF@W#<('JL9K0BA*.9<4V/$\*3 M4#)[.>GG2A!!(W]1Y&0#T6-]H:NBFE-N]II%LC5,DA8TCJ$#][5H/!8&NGM) MZ#1)";O"Q'LZ;E\4C#^910NVL9G"C)#^K@QU%_(7P>J\1\R,J:I"]%F9?/>@-6 M-U22HX,(C(@\EFJ15>E$W1!@&ZC&2B*#OHYT8+L9DL>J*3P G]!U.]-: M^;28*B$,U1QW0HA1 T4CI(<7FCVQ95'2^CEY)L(U %S2ICF2Z*':U7;0HB@^ MTL1MK]I[[8/^4/4$B6J MK8M+HRJ(IK=7JT9+0H5K-$"B,\A\:[E]G3V2<9H0=B-5#6>;V M/C]XI@!P/E2SV@4@1JD.C83^RBC)254]L/^?,@5C7C KG_^0G9@LITLH0[7* MG5%B%.30.OYJ0@M2+SP%=G(RSY*$#]50MP6'44-#9Z7/L^9)Q>Z:48^6A [6 M5@= 812_T%DD-"FJ&5/ FTUY53S1A!'-B)A#SD-XI@0P5%/>!2!&U0J=&I:D MWYBR/;DLRPF_Z6Y( NIB^BF2Y*%:C%;(,"I+ %=(4_>Z3O+R^9[4H#UBGB4) M'ZIOQ18<1CT(@^]KJ5A4R^=%V.NEG23)'JK!:(D-*-* \QC^8.F"U\^0! _5 MB+0!ILEV17GNKBWUW%JA_!V%36OMW88HD>:C6H!4RC3 P#/+QC/"7LOK-1K55#I9D#M7P S!I6(]AC?]1 MUB1O*O0G/%JK60+R 64)VBB)'^H1H8#/HUX,$SQ$:%E-4M2WBB<]TPI*D L MV@F2W*&:X1:X-&+ ,,*Y\6^G6>V.% 3N#]66, '2+&->FRX$F>L/JZ/582.52GDQF2AN\85C<[%.OO)*'@7; V2A(V MX'M "4;#90PK^H9,LL3,XK4A\EH:Z@FO1*)A+HH!G-&*'ZK.QAZ>1#8;A MNL@&L\I\4 Z69 [53 4P:2JZ8EBGGY@.\/RVD7MM]2X,S9/$#]5JM8>GD0U" M5;N*UFLY*.R_5ODG[#^^WO-&[)IZ6!O_WM!Z<.+G[O9<]DH#1,-T)X.V/=/U M.V-SA*37TX4-UJG2\$[#X&V2-2Q&* 3G@\6A*TAUX354$>K$R5'J>FI@"2,32.UQ1J,I4G774+9_[R0IHI*GQV[ M=II*&U:2L@/UX>&Y6TA.9YH?DA]-EZ(-!O)>!)R3V945+Q35L\7V?)HW1G716??C## MA%%\R[8#%;W$KHKM#BXZ2P[K^X(7R]#,R,7M"7H,K;Z63 #+8F\,E)SR\W!D M+H7MO$EUE".6O,9XOQ--X70V^N8(#N+45^R7FVZA8^[N!E*1[Z]%E_BUCQOF MKIJA8HRDR9/R#-O?.@YI&;E-MK_V6FU9&=S.[LA3T-9&X^UM 979VQPF*0SB M,#4L02U?%80CM+/2)E@N+MQ%I5W3H:H>S>ED9/JYWWP=L! 4A$94UBPWGQ:Z M\9)63VJAW2$,<=&*\=MP$-I*]<3Z* YM#S( 2^EC/) MDZ!N2DH>7I+B,GLE M*\/AFE[N,5E..WI#)&Y=# MJPL([ 8U PP;>C0E-.,E?9M:)U,>&UZ3Q3')S*/KZPL@<-OV \T=MQ>F,I]^ M12M._A:(/'9!^I"\5=F$B(>BZSR]+I/"+!']#$EP$.^VDPAL('CL#K3]\R(& MRXWKZW,DT4$TH$Y\5X/PV!!H-+[@.RTMX7-G9Z0D,(CSR>V ,9#NL8G/.*?) M-'LH9VGY@TT^1) <)IG?BMA4&CSUYFNMDJKE.0 G8S19 PA2! M=K];'>!X;.$CS[K;F<5AHQHKB0P2&=#F4-<0[[%3S_U$''-71G>_D'\YA!$OL?>.^RG MEPDD,K''YA0'IC5+9#],X3]7SMOA\-A9YW9:9+_/V0V^.,[8I6+FOGX&O_=/ MSX_B=\+80,#HGJ/A^9_)K.3!C@( "/W6X4A]A'\@@4H31.DN?>(&Y.&Q0>F]TP"K9:H8-\ M5XX76M5I_">?$O9RW='EO+,'F.29&5])H4LI/' M,TVF-KY#XSQ!?)CL.]<%;0G$8RN9I>/,TEVX<;W$[R_1TNVQ/\RF7PP,==4, MES[D^'4]D'Z/C5[^D53D#5;SMH;)J*CXKSPMW1[;M8S+Y/D9/H0W1LDK./Y[ M3D>VQT8KXS)KGCPA?JZ/DH3%[Q/5D>VQ2\JZ!SQ/JNJ#O=M_;;ATE<=OX('T M>VR#LO;;?R6TJ2%NS>S-"=(BBO_$M4#@L1<*TP@_S"M>X;$2I@ZH":N&2_]M M_)H#2+_'!B?_>'QIGN[9X;7VL .H$88Y\G$B?JO##H3'QB5+O\GMC-"DR2DF M3,^!7Q'!B9+\^$-'')!X;%JR=M;!;COE8*Z0GIR':5K2]EA74>^Q/N$;]#7)>0V#KK4B MP,^)^@A+E]H0)-@9J<=.)RO:9"9TQ>F"9;8^6A :YC+O+!(U$(Q.)YC5IGB8 M'OOS/0-YEV23JX(I(ZJ=93M5NJP'LHO<47GLC+)S'G\FM2CFS(1!)=3GCLJ6.@Z+Z[>+<_(2'%4/^B5^'J^>"QB\\6/0NM MGO?\S%ZS"2DFHDRFI5RU\R68?XM#V8()&,V!_-21_9VRI;>F,,R8=9YF#6\, M:K3KIV2IU: =B)"JR5JA]-B42.W;6J[NKNY PX=DH=2!N#"Z8O38S4A-U4-9 M)_D:/5TE"7]/@ W;G!1%H"Y0/79"4A,G8BB;1C9DP@LZ=):LS1P M&,V6>KEH/Q*TBW;]4_(*&LAS6W>4& VLW=/CV\D!6!L&1=OB95S"$]''4%BM$:JY,NS4QSY+") M-K\@&3+\4[L;>(P&7DZKX8Y-(92ICXO[I9OHP<_)HVP@2A@.4HQN81:']N>R M^(\Y4PB?WAAY"R.>G3IW):V?RCPKV1G$%Z?X)YN#V^V+4O,,$BB.<'BW!0MT M%0MH5JD]<>O&PF>BNL"[?U1R)\CK,K*IY8A7LQIP76.+,#%C]!4X1P:8!6TM MW3E23@5'(X.%&PNQS]]&O>*4/(D.?U+K>[LM\K<>^_&V!K; Y M3%(6U%)R7>XZ!/XZU&EVV --BO2%7+0_@11?D%LTJ$V#

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̇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ⅅ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